<SEC-DOCUMENT>0001213900-23-027997.txt : 20230406
<SEC-HEADER>0001213900-23-027997.hdr.sgml : 20230406
<ACCEPTANCE-DATETIME>20230406163038
ACCESSION NUMBER:		0001213900-23-027997
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		64
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230406
DATE AS OF CHANGE:		20230406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Freedom Acquisition I Corp.
		CENTRAL INDEX KEY:			0001838987
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40117
		FILM NUMBER:		23806561

	BUSINESS ADDRESS:	
		STREET 1:		C/O MAPLES CORPORATE SERVICES LIMITED
		STREET 2:		UGLAND HOUSE, PO BOX 309
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1104
		BUSINESS PHONE:		(212) 618-1798

	MAIL ADDRESS:	
		STREET 1:		C/O MAPLES CORPORATE SERVICES LIMITED
		STREET 2:		UGLAND HOUSE, PO BOX 309
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1104
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>f10k2022_freedomacq1.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Apr 06 13:36:40 UTC 2023 -->
<html xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:fact="http://www.FreedomAcquisitionICorp.com/20221231" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
D.C. 20549</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>FORM
<ix:nonNumeric contextRef="c0" name="dei:DocumentType">10-K</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric>&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNUAL
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric></ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric>&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
file number </b>&#8206;<ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber"><b>001-40117</b></ix:nonNumeric>&#8206;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><b>FREEDOM
ACQUISITION I CORP.</b></ix:nonNumeric>&#8206;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in Its Charter)</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; padding-right: 5.75pt; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cayman Islands</b></span></ix:nonNumeric></td> <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 2%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; text-indent: -9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; text-indent: -9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: hidden-fact-0">N/A</span></b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or Other Jurisdiction of<br/> Incorporation or Organization)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer<br/> Identification Number)</span></td></tr> </table><div>
</div><p style="text-align: center; padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;<b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1">14
Wall Street</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine2">20th Floor</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New
York</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10005</b></span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of Principal Executive Offices)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1
<ix:nonNumeric contextRef="c0" name="dei:CityAreaCode">212</ix:nonNumeric>-<ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber">618-1798</ix:nonNumeric></b>&#8206;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p><div>

</div><p style="text-align: center; padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="vertical-align: bottom; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-top: 0pt; width: 34%; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Each Class</span></td> <td style="text-align: center; padding-bottom: 1.5pt; width: 1%; vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-top: 0pt; width: 32%; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading <span style="font-weight: normal">&#8206;</span>Symbol(s)<span style="font-weight: normal">&#8206;</span></span></td> <td style="text-align: center; padding-bottom: 1.5pt; width: 1%; vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-top: 0pt; width: 32%; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Each Exchange on Which Registered</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: center; padding-left: 0pt"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class A ordinary shares, par value $0.0001 per share</span></ix:nonNumeric></td> <td>&#160;</td> <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: center; padding-left: 0pt"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FACT</span></ix:nonNumeric></td> <td>&#160;</td> <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: center; padding-left: 0pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The New York Stock Exchange</span></ix:nonNumeric></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; "> <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable warrants, each whole warrant exercisable for one &#8206;Class A ordinary share at an exercise price of $11.50</span></td> <td>&#160;</td> <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FACT WS</span></td> <td>&#160;</td> <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The New York Stock Exchange</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units, each consisting of one Class A ordinary share and one-&#8206;fourth of one redeemable warrant</span></td> <td>&#160;</td> <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FACT.U&#8206;</span></td> <td>&#160;</td> <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The New York Stock Exchange</span></td></tr> </table><div>
</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities registered pursuant to Section 12(g) of the Act:</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>None</b></span></p><div>


</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;Yes&#160;&#9744;&#160;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric>&#160;&#9746;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&#160;Yes&#160;&#9744;&#160;&#160; <ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric>&#160;&#9746;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities &#8206;Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), &#8206;and
(2) has been subject to such filing requirements for the past 90 days&#8206;.&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric>&#160;&#9746;&#160;&#160;No&#160;&#9744;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted &#8206;pursuant
to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the &#8206;Registrant
was required to submit such files).&#8206; <ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160; No&#160;&#9744;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller &#8206;reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller &#8206;reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> <td style="width: 30%">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer&#160;&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td>&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric>&#160;&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td> <td>&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntitySmallBusiness"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td>&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in">&#160;</td> <td>&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for &#8206;complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#8206; <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. &#9744;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of &#8206;the Act).&#8206;&#8206; Yes&#160;<ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric>&#160;&#160;No&#160;&#9744;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate market value of the Registrant&#8217;s voting and non-voting common equity held by non-affiliates, computed by reference to
the closing sales price for the Class A ordinary shares on June 30, 2022, as reported on the New York Stock Exchange, was $<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="dei:EntityPublicFloat" scale="0" unitRef="usd">339,256,450</ix:nonFraction>.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, <ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares">34,500,000</ix:nonFraction> Class A ordinary shares, par value $0.0001 per share, &#8206;and <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares">8,625,000</ix:nonFraction> Class B ordinary shares, par
value $0.0001 per share, were issued and outstanding, &#8206;respectively.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DOCUMENTS
INCORPORATED BY REFERENCE</b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>None</b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FREEDOM
ACQUISITION I CORP.<br/>
ANNUAL REPORT ON FORM 10-K</b></span></p><div>




</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
OF CONTENTS</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="padding-bottom: 1.5pt; width: 5%">&#160;</td>
    <td style="padding: 0pt 0pt 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&#160;</span></td>
    <td style="padding: 0pt 0pt 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 77%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; width: 9%; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="3"><a href="#k_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cautionary Note Regarding Forward-Looking Statements and Risk Factor Summary</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="3"><a href="#k_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART I</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1A.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_004">Risk Factors</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1B.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unresolved Staff Comments</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    2.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    3.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Proceedings</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    4.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mine Safety Disclosures</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td colspan="3"><a href="#k_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART II</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    5.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    6.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Reserved]</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    7.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    7A.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quantitative and Qualitative Disclosures about Market Risk</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    8.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Statements and Supplementary Data</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9A.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Controls and Procedures</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9B.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Information.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt">59</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9C.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt">59</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td colspan="3"><a href="#k_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART III</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    11.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Compensation.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    12.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    13.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Relationships and Related Transactions, and Director Independence</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    14.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Accountant Fees and Services.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="3"><a href="#k_024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART IV</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    15.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits, Financial Statement Schedules</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td>&#160;</td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    16.</span></td>
    <td style="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt"><a href="#k_026"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form 10-K Summary</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-top: 0pt; padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td></tr>
  </table><div>
</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTAIN
TERMS</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise stated in this Annual Report on Form 10-K (this &#8220;Annual Report&#8221;), references to:</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;we,&#8221;
&#8220;us,&#8221; &#8220;our,&#8221; &#8220;company,&#8221; &#8220;our company,&#8221; or &#8220;Freedom&#8221; are to Freedom Acquisition
I Corp., a Cayman Islands exempted company;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;amended
and restated memorandum and articles of association&#8221; are to our Amended and Restated Memorandum and Articles of Association;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Class
A ordinary shares&#8221; are to our Class A ordinary shares, par value $0.0001 per share;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Class
B ordinary shares&#8221; are to our Class B ordinary shares, par value $0.0001 per share;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Companies
Act&#8221; are to the Companies Act (As Revised) of the Cayman Islands as the same may be amended from time to time;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;directors&#8221;
are to our current directors;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;founder
shares&#8221; are to our Class B ordinary shares initially purchased by our sponsor in a private placement prior to our initial public
offering and our Class A ordinary shares that will be issued upon the automatic conversion of the Class B ordinary shares at the time
of our initial business combination;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Freedom
Acquisition LLC&#8221; are to a member of our sponsor, Freedom Acquisition LLC, a Cayman Islands limited liability company that is owned
by Tidjane Thiam, our Executive Chairman, Abhishek Bhatia, a board observer, and Adam Gishen, our Chief Executive Officer;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;initial
shareholders&#8221; are to holders of our founder shares prior to our initial public offering;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;management&#8221;
or our &#8220;management team&#8221; are to our officers and directors;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;NextG&#8221;
are to NextG Tech Limited, a Cayman Islands exempted company, which is a member of our sponsor and is affiliated with Edward Zeng, one
of our directors;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;ordinary
shares&#8221; are to our Class A ordinary shares and our Class B ordinary shares;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;private
placement warrants&#8221; are to the warrants issued to our sponsor in a private placement simultaneously with the closing of our initial
public offering;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;public
shares&#8221; are to our Class A ordinary shares sold as part of the units in our initial public offering (whether they were purchased
in our initial public offering or thereafter in the open market);</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;public
shareholders&#8221; are to the holders of our public shares, including our initial shareholders and management team to the extent our
initial shareholders and/or members of our management team purchase public shares, provided that each initial shareholder&#8217;s and
member of our management team&#8217;s status as a &#8220;public shareholder&#8221; shall only exist with respect to such public shares;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;public
warrants&#8221; are to the warrants sold as part of the units in our initial public offering (whether they were purchased in our initial
public offering or thereafter in the open market);</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;sponsor&#8221;
are to Freedom Acquisition I LLC, a Cayman Islands limited liability company;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;warrants&#8221;
are to our public warrants and private placement warrants; and</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;$,&#8221;
&#8220;US$&#8221; and &#8220;U.S. dollar&#8221; each refer to the United States dollar.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 3; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="k_001"></a></div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cautionary
Note Regarding Forward-Looking Statements and Risk Factor Summary</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of the statements contained in this Annual Report may constitute &#8220;forward-looking statements,&#8221; for purposes of the federal
securities laws. Our forward-looking statements include, but are not limited to, statements regarding our or our management team&#8217;s
expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts
or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The
words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221;
&#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221;
&#8220;project,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and similar expressions may identify forward-looking statements, but
the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Annual Report may
include, for example, statements about:</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
associated with our proposed business combination with Complete Solaria;</span></td>
</tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to select an appropriate target business or businesses;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to complete our initial business combination;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            expectations around the performance of the prospective target business or businesses;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            success in retaining or recruiting, or changes required in, our officers, key employees or
                                            directors following our initial business combination;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            officers and directors allocating their time to other businesses and potentially having conflicts
                                            of interest with our business or in approving our initial business combination;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            potential ability to obtain additional financing to complete our initial business combination;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            pool of prospective target businesses;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            ability of our officers and directors to generate a number of potential business combination
                                            opportunities;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            material weakness in our internal control over financial reporting;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            public securities&#8217; liquidity and trading;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            use of proceeds not held in the trust account or available to us from interest income on
                                            the trust account balance;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            trust account not being subject to claims of third parties; or</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            financial performance.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forward-looking statements contained in this Annual Report are based on our current expectations and beliefs concerning future developments
and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated.
These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions
that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.
These risks and uncertainties include, but are not limited to, those factors described in &#8220;Item 1A.-Risk Factors.&#8221; Should
one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in
material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities
laws.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt">&#160;</p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary
of Risk Factors</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
investment in our securities involves a high degree of risk. The occurrence of one or more of the events or circumstances described in
the section titled &#8220;Risk Factors,&#8221; alone or in combination with other events or circumstances, may materially adversely affect
our business, financial condition and operating results. In that event, the trading price of our securities could decline, and you could
lose all or part of your investment. Such risks include, but are not limited to:</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may not be able to complete the proposed Business Combination with Complete Solaria. If we
                                            are unable to do so, we will incur substantial costs associated with withdrawing from the
                                            transaction and may not be able to find additional sources of financing to cover those costs.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the proposed Business Combination with Complete Solaria fails, it may be difficult to complete
                                            a business combination with a new prospective target business, negotiate and agree to a new
                                            business combination, and/or arrange for new sources of financing by the end of the Extension
                                            Period, in which case we would cease all operations except for the purpose of winding up
                                            and we would redeem our public shares and liquidate.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are a blank check company with no operating history and no revenues, and you have no basis
                                            on which to evaluate our ability to achieve our business objective.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Past
                                            performance by our management team, directors, advisors and their respective affiliates may
                                            not be indicative of future performance of an investment in the Company.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may issue notes or other debt securities, or otherwise incur substantial debt, to complete
                                            a business combination, which may adversely affect our leverage and financial condition and
                                            thus negatively impact the value of our shareholders&#8217; investment in us.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            search for a business combination, and any prospective partner business with which we ultimately
                                            consummate a business combination, may be materially adversely affected by the coronavirus
                                            (COVID-19) pandemic and the status of debt and equity markets.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlike
                                            some other similarly structured special purpose acquisition companies, our initial shareholders
                                            will receive additional Class A ordinary shares if we issue certain shares to consummate
                                            an initial business combination.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resources
                                            could be wasted in researching business combinations that are not completed, which could
                                            materially adversely affect subsequent attempts to locate and acquire or merge with another
                                            business. If we are unable to complete our initial business combination, our public shareholders
                                            may only receive their pro rata portion of the funds in the trust account that are available
                                            for distribution to public shareholders, and our warrants will expire worthless.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            public shareholders may not be afforded an opportunity to vote on our proposed initial business
                                            combination, which means we may complete our initial business combination even though a majority
                                            of our public shareholders do not support such a combination.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                            only opportunity to effect your investment decision regarding a potential business combination
                                            may be limited to the exercise of your right to redeem your shares from us for cash.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we seek shareholder approval of our initial business combination, our initial shareholders
                                            and management team have agreed to vote in favor of such initial business combination, regardless
                                            of how our public shareholders vote.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            ability of our public shareholders to redeem their shares for cash may make our financial
                                            condition unattractive to potential business combination targets, which may make it difficult
                                            for us to enter into a business combination with a target or prevent us from completing the
                                            most desirable business combination or optimizing our capital structure.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the funds available to us outside the trust account to fund our working capital requirements
                                            are insufficient to allow us to operate for at least the Extension Period, it could limit
                                            the amount available to fund our search for a target business or businesses and complete
                                            our initial business combination, and we will depend on loans from our sponsor or management
                                            team to fund our search and to complete our initial business combination.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            are not entitled to protections normally afforded to investors of many other blank check
                                            companies.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            requirement that we complete our initial business combination during the Extension Period
                                            may give potential target businesses leverage over us in negotiating a business combination
                                            and may limit the time we have in which to conduct due diligence on potential business combination
                                            targets, in particular as we approach our dissolution deadline, which could undermine our
                                            ability to complete our initial business combination on terms that would produce value for
                                            our shareholders.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
                                            of our limited resources and the significant competition for business combination opportunities,
                                            it may be more difficult for us to complete our initial business combination. If we are unable
                                            to complete our initial business combination, our public shareholders may receive only their
                                            pro rata portion of the funds in the trust account that are available for distribution to
                                            public shareholders, and our warrants will expire worthless.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are deemed to be an investment company under the Investment Company Act, we may be required
                                            to institute burdensome compliance requirements and our activities may be restricted, which
                                            may make it difficult for us to complete our initial business combination. To mitigate the
                                            risk of being deemed to be an investment company for purposes of the Investment Company Act,
                                            we may instruct the trustee of the trust account to liquidate the securities held in the
                                            trust account and instead hold all funds in the trust account in a bank deposit account.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have identified a material weakness in our internal control over financial reporting. This
                                            material weakness could continue to adversely affect our ability to report our results of
                                            operations and financial condition accurately and in a timely manner.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            NYSE may delist our securities from trading on its exchange, which could limit investors&#8217;
                                            ability to make transactions in our securities and subject us to additional trading restrictions.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            will not have any rights or interests in funds from the trust account, except under certain
                                            limited circumstances. Therefore, to liquidate your investment, you may be forced to sell
                                            your public shares or warrants, potentially at a loss.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            a shareholder fails to receive notice of our offer to redeem our public shares in connection
                                            with our initial business combination, or fails to comply with the procedures for submitting
                                            or tendering its shares, such shares may not be redeemed.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we seek shareholder approval of our initial business combination and we do not conduct redemptions
                                            pursuant to the tender offer rules, and if you or a &#8220;group&#8221; of shareholders are
                                            deemed to hold in excess of 15% of our Class A ordinary shares, you will lose the ability
                                            to redeem all such shares in excess of 15% of our Class A ordinary shares.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous
                                            to you, thereby making your warrants worthless.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
                                            members of our management team may be involved in and have a greater financial interest in
                                            the performance of other entities with which they are affiliated, and such activities may
                                            create conflicts of interest in making decisions on our behalf.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            initial shareholders stand to make a substantial profit on the founder shares even if an
                                            initial business combination subsequently declines in value or is unprofitable for our public
                                            shareholders, and may have an incentive to recommend such an initial business combination
                                            to our shareholders.</span></td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="k_002"></a></div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
I</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 40.5pt; text-indent: -40.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="k_003"></a></div><p style="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1. Business</span></p><div>



</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a blank check company, incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset
acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout
Annual Report as our initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Freedom
Acquisition I Corp. was established by Tidjane Thiam, Adam Gishen and Abhishek Bhatia to leverage their extensive experience in acquiring,
building, operating and scaling global financial services businesses in constantly evolving environments. Mr. Thiam, with his more than
30 years of experience in financial services businesses, led global institutions like Credit Suisse and Prudential as CEO for 5 years
and 6 years, respectively. Mr. Gishen has over 20 years of experience in financial services and has held senior leadership responsibilities
in recent years at Credit Suisse running its Global Investor Relations and Corporate Communications functions. Mr. Bhatia has more than
20 years of global experience in life and general insurance and asset management and has created businesses from scratch, including a
technology-enabled life insurer in Europe and a full-stack digital insurer in Asia for which he served as CEO.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
History</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2020, the sponsor paid $25,000, or approximately $0.003 per share, to cover certain offering costs in consideration for
7,187,500 Class B ordinary shares, par value $0.0001 per share (the &#8220;founder shares&#8221;). On February 25, 2021, the Company
effected a share dividend whereby the Company issued 1,437,500 Class B ordinary shares, resulting in an aggregate of 8,625,000 Class
B ordinary shares outstanding and held by our sponsor. Our Class B ordinary shares will automatically convert into Class A ordinary shares,
on a one-for-one basis, upon the completion of a business combination. The number of founder shares issued was determined based on the
expectation that the founder shares would represent 20% of the issued and outstanding ordinary shares upon completion of the initial
public offering.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 2, 2021, we completed our initial public offering of 34,500,000 units at a price of $10.00 per unit (the &#8220;units&#8221;),
generating gross proceeds of $345,000,000. Each unit consists of one of the Company&#8217;s Class A ordinary shares, par value $0.0001
per share, and one-fourth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary
share at a price of $11.50 per share, subject to certain adjustments.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially
concurrently with the completion of the initial public offering, our sponsor purchased an aggregate of 6,266,667 warrants (the &#8220;private
placement warrants&#8221;) at a price of $1.50 per warrant, or $9,400,000 in the aggregate. A total of $345,000,000, comprised of $338,595,000
of the proceeds from the initial public offering, including $12,075,000 of the underwriters&#8217; deferred discount, and $6,405,000
of the proceeds of the sale of the private placement warrants, was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A.,
maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 16, 2021, we announced that, commencing April 19, 2021, holders of the 34,500,000 units sold in the initial public offering may
elect to separately trade the Class A ordinary shares and the warrants included in the units. Those units not separated continued to
trade on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;FACT.U&#8221; and the Class A ordinary shares and warrants
that were separated trade under the symbols &#8220;FACT&#8221; and &#8220;FACT WS,&#8221; respectively.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amendment
to Amended and Restated Memorandum and Articles of Association</b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 28, 2023, Freedom held an extraordinary general meeting of shareholders (the &#8220;Extraordinary General Meeting&#8221;), at
which holders of 35,373,848 ordinary shares, comprised of 26,773,848 Class&#160;A ordinary shares and 8,600,000 Class&#160;B ordinary
shares, were present in person or by proxy, representing approximately 82.02% of the voting power of the 43,125,000 issued and outstanding
ordinary shares of Freedom entitled to vote at the Extraordinary General Meeting at the close of business on January 23, 2023, which
was the record date (the &#8220;Record Date&#8221;) for the Extraordinary General Meeting (such shares, the &#8220;Outstanding Shares&#8221;).
The Outstanding Shares on the Record Date were comprised of 34,500,000 Class A ordinary shares and 8,625,000 Class B ordinary shares.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Extraordinary General Meeting, the shareholders approved, by special resolution, the proposal (the &#8220;Extension Amendment Proposal&#8221;)
to amend the amended and restated memorandum and articles of association to extend the date by which Freedom must (i) consummate a merger,
amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination, which Freedom refers
to as its initial business combination, (ii) cease its operations except for the purpose of winding up if it fails to complete such initial
business combination, and (iii) redeem all of the Class A ordinary shares, included as part of the units sold in the initial public offering,
for an additional three months, from March 2, 2023 to June 2, 2023, and thereafter to up to three (3) times by an additional one month
each time (or up to September 2, 2023) (the &#8220;Extension Amendment,&#8221; and such period, as may be extended, the &#8220;Extension
Period&#8221;). The voting results for such proposal were as follows:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Against</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Abstain</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 31%; text-align: center">35,047,305</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 31%; text-align: center">326,543</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 30%; text-align: center">0</td><td style="width: 1%; text-align: center">&#160;</td></tr>
  </table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Extension Amendment, public shareholders elected to redeem an aggregate of 23,256,504 Class&#160;A ordinary shares
at a redemption price of $10.21 per share, representing approximately 67.41% of the issued and outstanding Class A ordinary shares, for
an aggregate redemption amount of approximately $237,372,952. Following such redemptions, approximately $114,759,374 remained in the
trust account and 11,243,496 Class A ordinary shares remain outstanding.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Extraordinary General Meeting, the public shareholders also approved the proposal to amend the Investment Management Trust Agreement,
dated as of February 25, 2021 (the &#8220;Trust Agreement&#8221;), by and between Freedom and Continental Stock Transfer &amp; Trust
Company, as trustee (&#8220;Continental&#8221;), to reflect the Extension Amendment. The amendment to the Trust Agreement provides that
Continental shall commence liquidation of the trust account only and promptly (x) after its receipt of the applicable instruction letter
delivered by Freedom in connection with either the consummation of an initial business combination or Freedom&#8217;s inability to effect
an initial business combination within the time frame specified in Freedom&#8217;s amended and restated memorandum and articles of association
or (y) upon the date that is the later of the end of the Extension Period and such later date as may be approved by Freedom&#8217;s shareholders
in accordance with the amended and restated memorandum and articles of association, if the aforementioned termination letter has not
been received by Continental prior to such date. The voting results for such proposal were as follows:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Against</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Abstain</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 31%; text-align: center">35,047,305</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 31%; text-align: center">326,543</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 30%; text-align: center">0</td><td style="width: 1%; text-align: center">&#160;</td></tr>
  </table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Proposed Business Combination</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Combination Agreement</b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 3, 2022, Freedom entered into a Business Combination Agreement (as amended by the First Amendment to the Business Combination
Agreement dated December 26, 2022 and the Second Amendment to the Business Combination Agreement dated January 17, 2023, and as may be
further amended and supplemented from time to time, the &#8220;Business Combination Agreement&#8221;), with Jupiter Merger Sub I Corp.,
a Delaware corporation and a wholly owned subsidiary of Freedom (&#8220;First Merger Sub&#8221;), Jupiter Merger Sub II LLC, a Delaware
limited liability company and a wholly owned subsidiary of Freedom (&#8220;Second Merger Sub&#8221;), Complete Solaria, Inc. (formerly
known as Complete Solar Holding Corporation), a Delaware corporation (&#8220;Complete Solaria&#8221;) and The Solaria Corporation, a
Delaware corporation (&#8220;Solaria&#8221;).</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Mergers</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement provides that, among other things and upon the terms and subject to the conditions thereof, the following
transactions will occur (together with the other agreements and transactions contemplated by the Business Combination Agreement, the
&#8220;Business Combination&#8221;):</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">at
                                            the closing of the transactions contemplated by the Business Combination Agreement (the &#8220;Closing&#8221;),
                                            upon the terms and subject to the conditions thereof, and in accordance with the Delaware
                                            General Corporation Law, as amended (the &#8220;DGCL&#8221;), (i) First Merger Sub will merge
                                            with and into Complete Solaria, with Complete Solaria surviving as a wholly owned subsidiary
                                            of Freedom, (ii) immediately thereafter and as part of the same overall transaction, Complete
                                            Solaria will merge with and into Second Merger Sub, with Second Merger Sub surviving as a
                                            wholly owned subsidiary of Freedom, and (iii) immediately after the consummation of the Second
                                            Merger and as part of the same overall transaction, Solaria will merge with and into a newly
                                            formed Delaware limited liability company and wholly-owned subsidiary of Freedom (&#8220;Third
                                            Merger Sub&#8221;), with Third Merger Sub surviving as a wholly-owned subsidiary of Freedom
                                            (the &#8220;Additional Merger,&#8221; and together with the First Merger and the Second Merger,
                                            the &#8220;Mergers&#8221;);</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">at
                                            the Closing, all outstanding shares of capital stock of Complete Solaria (subject to certain
                                            restrictions) and all options and warrants to acquire shares of capital stock of Complete
                                            Solaria will convert into the right to receive shares of common stock, par value $0.0001
                                            per share, of Freedom (after the Domestication (as defined below)) (&#8220;Freedom Common
                                            Stock&#8221;) or comparable equity awards that are settled or are exercisable for shares
                                            of Freedom Common Stock; and</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">at
                                            the Closing, Freedom will be renamed &#8220;Complete Solaria, Inc.&#8221;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">A
special committee (the &#8220;Freedom Special Committee&#8221;) of the Board of Directors of Freedom (the &#8220;Freedom Board&#8221;)
and the Freedom Board have (i) approved the Business Combination Agreement and the Business Combination and (ii) resolved to recommend
that the shareholders of Freedom approve the Business Combination Agreement and the Business Combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Domestication</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Closing, subject to the approval of Freedom&#8217;s shareholders, and in accordance with the DGCL, the Cayman Islands Companies
Act (As Revised) (the &#8220;CICA&#8221;) and Freedom&#8217;s Amended and Restated Memorandum and Articles of Association, Freedom will
effect a deregistration under the CICA and a domestication under Section 388 of the DGCL (by means of filing a certificate of domestication
with the Secretary of State of the State of Delaware), pursuant to which Freedom&#8217;s jurisdiction of incorporation will be changed
from the Cayman Islands to the State of Delaware (the &#8220;Domestication&#8221;).</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Domestication, (i) each of the then issued and outstanding Class A ordinary shares, par value $0.0001 per share,
of Freedom, will convert automatically, on a one-for-one basis, into a share of Freedom Common Stock, which is entitled to one vote per
share, (ii) each of the then issued and outstanding Class B ordinary shares, par value $0.0001 per share, of Freedom, will convert automatically,
on a one-for-one basis, into a share of Freedom Common Stock.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conditions
to the Closing</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligation of the parties to consummate the Business Combination is subject to the satisfaction or waiver of certain closing conditions,
including (i) approval of the Business Combination and related matters by the respective shareholders of Freedom and Complete Solaria,
(ii) expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, as amended, (iii) the absence
of any law or injunctions prohibiting the consummation of the Mergers, (iv) Freedom having at least $5,000,001 of net tangible assets
upon the Closing, (v) the size and composition of the Board conforming to the requirements set forth in the Business Combination Agreement,
(vi) receipt of approval for listing by The New York Stock Exchange of the shares of Freedom common stock to be issued in the Business
Combination, (vii) effectiveness of the registration statement on Form S-4 filed by Freedom in connection with the Business Combination
and (viii) the receipt by the Freedom Board or Freedom Special Committee of a fairness opinion from a reputable financial advisory or
valuation firm with respect to the Business Combination (which was received on October 31, 2022).</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
conditions to Freedom&#8217;s obligation to consummate the Business Combination include (i) the consummation of the Required Transaction
(as defined below) (which was consummated on November 4, 2022) and (ii) the receipt by Complete Solaria of certain consents.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
party&#8217;s obligation to consummate the Business Combination is also conditioned upon the accuracy of the other party&#8217;s representations
and warranties, subject to customary materiality and material adverse effect qualifiers, and the performance in all material respects
by the other party of its covenants in the Business Combination Agreement to be performed as of or prior to the Closing.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Covenants</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement contains additional covenants, including, among others, providing for (i) the parties to conduct their
respective businesses in the ordinary course through the Closing, (ii) the parties to not initiate any negotiations or enter into any
agreements for certain alternative transactions, (iii) Complete Solaria to prepare and deliver to Freedom certain audited and unaudited
consolidated financial statements of Complete Solaria and its subsidiaries (including Solaria), (iv) Freedom to prepare and file a registration
statement on Form S-4, including a proxy statement/prospectus, and to take certain other actions to obtain the requisite approval of
Freedom shareholders of certain proposals regarding the Business Combination (including the Domestication), (v) the parties to use reasonable
best efforts to obtain necessary approvals from governmental authorities, (vi) if determined in good faith by Freedom and Complete Solaria
that it is probable that the Business Combination will be consummated after March 1, 2023, and subject to the conditions set forth in
the Business Combination Agreement, Freedom to seek the approval of its shareholders to amend its organizational documents to extend
the time period for Freedom to consummate its initial business combination for six months from March 1, 2023 to September 1, 2023 (which
was obtained on February 28, 2023).</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Governance</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Business Combination Agreement, the board of directors of Complete Solaria following the Closing will consist of no more than
seven directors, to initially consist of (i) the individuals designated by Complete Solaria prior to Closing, consisting of a majority
of &#8220;independent&#8221; directors for the purposes of NYSE rules and (ii) Tidjane Thiam and Adam Gishen (or any other substitute
director designated by the Sponsor, subject to the prior approval of Complete Solaria). Complete Solaria has agreed to cause Mr. Thiam&#160;to
be nominated for election to its board of directors at each of its first three annual meetings of stockholders following the Closing.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Representations
and Warranties</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement contains customary representations and warranties by Freedom, First Merger Sub, Second Merger Sub and
Complete Solaria. The representations and warranties of the parties to the Business Combination Agreement will not survive the Closing.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Termination</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement contains the following termination rights:</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
right of the parties to terminate the Business Combination Agreement by mutual consent;</span></td>
</tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
right of either Freedom or Complete Solaria to terminate the Business Combination Agreement if:</span></td>
</tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shareholders
                                            of the other party fail to approve the Business Combination;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            governmental authority issues or otherwise enters a final, nonappealable order making consummation
                                            of the Mergers illegal or otherwise prevents or prohibits consummation of the Mergers;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            other party breaches its representations, warranties, covenants or other agreements contained
                                            in the Business Combination Agreement in a way that would entitle the party seeking to terminate
                                            the Business Combination Agreement to not consummate the Business Combination, subject to
                                            the right of the breaching party to cure the breach;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Required Transaction has not been consummated within 30 days following the date of the Business
                                            Combination Agreement (this termination right is no longer applicable as the Required Transaction
                                            was consummated on November 4, 2022);</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 1.25in; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="text-indent: -0.25in; margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; padding-left: 0pt; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Freedom Board or Freedom Special Committee has not received a fairness opinion from a reputable
                                            financial advisory or valuation firm with respect to the Business Combination within 30 days
                                            of the date of the Business Combination Agreement and such party exercises the right to termination
                                            within such 30 day period (this termination right is no longer applicable as such fairness
                                            opinion was received on October 31, 2022); or</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Closing has not occurred on or before the end of the Extension Period;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            right of Complete Solaria to terminate the Business Combination Agreement if the Freedom
                                            Board or Freedom Special Committee changes its recommendation with respect to the Business
                                            Combination.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt -0.5in; padding-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Related Agreements and Transactions</b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt -0.25in; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Required Transaction</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 3, 2022, Complete Solar Holding Corporation (the predecessor of Complete Solaria) entered into that certain Agreement and Plan
of Merger with Complete Solaria Midco, LLC, a Delaware limited liability company and a wholly owned subsidiary of Solaria (&#8220;Midco&#8221;),
Complete Solaria Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Midco, Solaria and Fortis Advisors, LLC, a
Delaware limited liability company, solely in its capacity as the representative of Complete Solaria&#8217;s stockholders (the &#8220;Required
Transaction&#8221;). On November 4, 2022, the Required Transaction was consummated.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt -0.25in; padding-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Complete
Solaria Convertible Note Financing</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 3, 2022, Complete Solaria entered into note subscription agreements (the &#8220;Pre-Signing Complete Solaria Subscription Agreements&#8221;)
with certain investors, consisting of (i) Rodgers Massey Revocable Living Trust (&#8220;RMRLT&#8221;), which is affiliated with T.J.
Rodgers, a former investor in Solaria, (ii) Tidjane Thiam, Executive Chairman of Freedom, (iii) Adam Gishen, Chief Executive Officer
of Freedom, and (iv) NextG, an affiliate of Edward Zeng, a director of Freedom, pursuant to which such investors agreed to purchase convertible
notes from Complete Solaria for an aggregate purchase price of $7 million. In addition, RMRLT purchased convertible notes from Complete
Solaria following the consummation of the Required Transaction in an amount equal to approximately $6.7 million in consideration for
RMRLT&#8217;s former investment in Solaria, which was assumed and cancelled by Complete Solaria.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement also contemplates that, following the date of the Business Combination Agreement, Complete Solaria will
enter into additional subscription agreements on terms substantially similar to, or no less favorable in all material respects to Complete
Solaria than, the Pre-Signing Complete Solaria Subscription Agreements (the &#8220;Post-Signing Complete Solaria Subscription Agreements&#8221;
and, together with the Pre-Signing Complete Solaria Subscription Agreements, the &#8220;Complete Solaria Subscription Agreements&#8221;)
with additional investors pursuant to which such investors agree, subject to the terms and conditions set forth therein, to purchase
convertible notes from Complete Solaria for an aggregate purchase price of up to $23 million. In November 2022, December 2022, and February
2023, Complete Solaria entered into note subscription agreements with additional investors, pursuant to which such investors purchased
convertible notes from Complete Solaria for an aggregate purchase price of $16 million.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt -0.25in; padding-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sponsor
Support Agreement</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 3, 2022, Freedom entered into a Sponsor Support Agreement (the &#8220;Sponsor Support Agreement&#8221;) with Freedom Acquisition
I LLC, a Cayman Islands limited liability company (the &#8220;Sponsor&#8221;), certain directors and officers of Freedom, and Complete
Solaria, pursuant to which the Sponsor and each such director and officer of Freedom has agreed to, among other things, (i) vote in favor
of the Business Combination Agreement and the transactions contemplated thereby, (ii) not redeem their Freedom ordinary shares, (iii)
from the Closing, at each of the first three annual meetings of the stockholders of Complete Solaria vote all of their shares of common
stock of Complete Solaria in favor of Mr. Thiam for election to the board of directors of Complete Solaria, and (iv) be bound by certain
other agreements and covenants related to the Business Combination, including vesting and forfeiture restrictions with respect to certain
shares held by the Sponsor.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt -0.25in; padding-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Complete
Solaria Stockholder Support Agreement</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 3, 2022, Freedom entered into a Company Stockholders Support Agreement (the &#8220;Complete Solaria Stockholder Support Agreement&#8221;)
with Complete Solaria and certain stockholders of Complete Solaria (the &#8220;Complete Solaria Stockholders&#8221;). Under the Complete
Solaria Stockholder Support Agreement, each Complete Solaria Stockholder has agreed to, among other things (i) vote its shares, (ii)
execute and deliver a written consent adopting the Business Combination Agreement and related transactions and approving the Business
Combination, (iii) from the Closing, at each of the first three annual meetings of the stockholders of Complete Solaria vote all of its
shares of Complete Solaria common stock in favor of Mr. Thiam for election to the board of directors of Complete Solaria, and (iv) be
bound by certain other agreements and covenants related to the Business Combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt -0.25in; padding-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Amended
and Restated Registration Rights Agreement</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement contemplates that, at the Closing, Complete Solaria, the Sponsor, certain equityholders of Complete Solaria
and certain of their respective affiliates, as applicable, and the other parties thereto, will enter into an Amended and Restated Registration
Rights Agreement (the &#8220;A&amp;R Registration Rights Agreement&#8221;), pursuant to which Complete Solaria will grant customary registration
rights to the other parties thereto, including to register for resale, pursuant to Rule 415 under the Securities Act of 1933, as amended
(the &#8220;Securities Act&#8221;), certain securities of Complete Solaria held by the other parties thereto.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt -0.25in; padding-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lock-Up
Agreement</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement contemplates that, at the Closing, Complete Solaria, the Sponsor, the Sponsor Key Holders (as defined
in the Lock-Up Agreement) and Complete Solaria Key Holders (as defined in the Lock-Up Agreement), will enter into a Lock-Up Agreement
(the &#8220;Lock-Up Agreement&#8221;).</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Lock-Up Agreement contains certain restrictions on transfer with respect to securities of Complete Solaria to be held by the Sponsor,
Sponsor Key Holders and Complete Solaria Key Holders immediately following the Closing (including shares of Complete Solaria common stock
and any such shares issuable upon the exercise, conversion or settlement of derivative securities and promissory notes). Such restrictions
begin at the Closing and end on the earlier of (x) the 12 month anniversary of the Closing and (y) the date on which the volume weighted
average price of Complete Solaria common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30 consecutive trading day period beginning after the date that is
180 calendar days after the Closing and ending 365 calendar days following the Closing.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as specifically discussed, this Annual Report does not assume the closing of the Business Combination and related transactions.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
Business Combination</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rules of the NYSE require and our amended and restated memorandum and articles of association provide that we must consummate an initial
business combination with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets
held in the trust account (excluding the amount of any deferred underwriting commission held in trust) as determined at the time of our
signing a definitive agreement in connection with our initial business combination. This is the case with respect to the proposed Business
Combination with Complete Solaria. If we do not complete the proposed Business Combination with Complete Solaria, and instead pursue
an alternative business combination and our board of directors is not able to independently determine the fair market value of our initial
business combination (including with the assistance of financial advisors), we will obtain an opinion from an independent investment
banking firm or a valuation or appraisal firm with respect to the satisfaction of such criteria. While we consider it likely that our
board of directors will be able to make an independent determination of the fair market value of our initial business combination, it
may be unable to do so if it is less familiar or experienced with the business of a particular target or if there is a significant amount
of uncertainty as to the value of the target&#8217;s assets or prospects. In addition, we have agreed not to enter into a definitive
agreement regarding an initial business combination without the prior written consent of NextG. NextG has consented to our proposed Business
Combination with Complete Solaria.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
proposed Business Combination with Complete Solaria is structured so that the post-transaction company will own all of the equity interests
of Complete Solaria. If we do not complete the proposed Business Combination and pursue an alternative initial business combination,
we may structure it similarly or we may structure it such that the post-transaction company owns or acquires less than 100% of the equity
interests or assets of the target business in order to meet certain objectives of the target management team or shareholders or for other
reasons, but we will only complete such business combination if the post-transaction company owns or acquires 50% or more of the outstanding
voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required
to register as an investment company under the Investment Company Act of 1940, as amended, or the Investment Company Act. Even if the
post-transaction company owns or acquires 50% or more of the voting securities of the target, our shareholders prior to the business
combination may collectively own a minority interest in the post-business combination company, depending on valuations ascribed to the
target and us in the business combination. For example, we could pursue a transaction in which we issue a substantial number of new shares
in exchange for all of the outstanding capital stock, shares or other equity interests of a target, or issue a substantial number of
new shares to third parties in connection with financing our initial business combination. In this case, we would acquire a 100% controlling
interest in the target. However, as a result of the issuance of a substantial number of new shares, our shareholders immediately prior
to our initial business combination could own less than a majority of our issued and outstanding shares subsequent to our initial business
combination. If less than 100% of the outstanding equity interests or assets of a target business or businesses are owned or acquired
by the post-transaction company, the portion of such business or businesses that is owned or acquired is what will be taken into account
for purposes of the 80% of net assets test described above. If the business combination involves more than one target business, the 80%
of net assets test will be based on the aggregate value of all of the target businesses.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
Information</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive offices are located at 14 Wall Street, 20th Floor, New York, 10005, and our telephone number is (212) 618-1798. Our corporate
website address is freedomac1.com. Our website and the information contained on, or that can be accessed through, the website is not
deemed to be incorporated by reference in, and is not considered part of, this Annual Report.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a Cayman Islands exempted company. Exempted companies are Cayman Islands companies conducting business mainly outside the Cayman
Islands and, as such, are exempted from complying with certain provisions of the Companies Act. As an exempted company, we have received
a tax exemption undertaking from the Cayman Islands government that, in accordance with Section 6 of the Tax Concessions Act (As Revised)
of the Cayman Islands, for a period of 20 years from the date of the undertaking, no law which is enacted in the Cayman Islands imposing
any tax to be levied on profits, income, gains or appreciations will apply to us or our operations and, in addition, that no tax to be
levied on profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax will be payable (i) on
or in respect of our shares, debentures or other obligations or (ii) by way of the withholding in whole or in part of a payment of dividend
or other distribution of income or capital by us to our shareholders or a payment of principal or interest or other sums due under a
debenture or other obligation of us.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;). As such, we are eligible to
take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not &#8220;emerging
growth companies&#8221; including, but not limited to, not being required to comply with the auditor attestation requirements of Section
404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in
our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation
and shareholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive
as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Section 107 of the JOBS Act also provides that an &#8220;emerging growth company&#8221; can take advantage of the extended
transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other
words, an &#8220;emerging growth company&#8221; can delay the adoption of certain accounting standards until those standards would otherwise
apply to private companies. We intend to take advantage of the benefits of this extended transition period.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of
the completion of our initial public offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which
we are deemed to be a large accelerated filer, which means the market value of our Class A ordinary shares that are held by non-affiliates
exceeds $700 million as of the prior June 30, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt
securities during the prior three-year period. References herein to &#8220;emerging growth company&#8221; will have the meaning associated
with it in the JOBS Act.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we are a &#8220;smaller reporting company&#8221; as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take
advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements.
We will remain a smaller reporting company until the last day of any fiscal year for so long as either (1) the market value of our ordinary
shares held by non-affiliates did not exceed $250 million as of the prior June 30, or (2) our annual revenues did not exceed $100 million
during such completed fiscal year and the market value of our ordinary shares held by non-affiliates did not exceed $700 million as of
the prior June 30.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effecting
Our Initial Business Combination</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 3, 2022, we entered into a Business Combination Agreement to consummate a proposed Business Combination with Complete Solaria,
as described under &#8220;&#8212; The Proposed Business Combination.&#8221; If the proposed Business Combination with Complete Solaria
is not consummated, we may seek to effectuate a business combination with another target business, as described below.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not presently engaged in, and we will not engage in, any operations for an indefinite period of time following our initial public
offering. We intend to effectuate our initial business combination using cash from the proceeds of our initial public offering and the
sale of the private placement warrants, the proceeds of the sale of our shares in connection with our initial business combination (pursuant
to forward purchase agreements or backstop agreements we may enter into), shares issued to the owners of the target, debt issued to bank
or other lenders or the owners of the target, or a combination of the foregoing. We may seek to complete our initial business combination
with a company or business that may be financially unstable or in its early stages of development or growth, which would subject us to
the numerous risks inherent in such companies and businesses.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our initial business combination is paid for using equity or debt, or not all of the funds released from the trust account are used for
payment of the consideration in connection with our initial business combination or used for redemptions of our Class A ordinary shares,
we may use the balance of the cash released to us from the trust account following the closing for general corporate purposes, including
for maintenance or expansion of operations of the post-transaction company, the payment of principal or interest due on indebtedness
incurred in completing our initial business combination, to fund the purchase of other companies or for working capital.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sources
of Target Businesses</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that target business candidates will be brought to our attention from various unaffiliated sources, including investment bankers
and private investment funds. Target businesses may be brought to our attention by such unaffiliated sources as a result of being solicited
through calls or mailings. These sources may also introduce us to target businesses in which they think we may be interested on an unsolicited
basis, since many of these sources will know what types of businesses we are targeting. Our officers and directors, as well as their
affiliates, may also bring to our attention target business candidates of which they become aware through their business contacts as
a result of formal or informal inquiries or discussions they may have, as well as attending trade shows or conventions. In addition,
we expect to receive a number of proprietary deal flow opportunities that would not otherwise necessarily be available to us as a result
of the track record and business relationships of our officers and directors. While we do not presently anticipate engaging the services
of professional firms or other individuals that specialize in business acquisitions on any formal basis, we may engage these firms or
other individuals in the future, in which event we may pay a finder&#8217;s fee, consulting fee or other compensation to be determined
in an arm&#8217;s length negotiation based on the terms of the transaction. We will engage a finder only to the extent our management
determines that the use of a finder may bring opportunities to us that may not otherwise be available to us or if finders approach us
on an unsolicited basis with a potential transaction that our management determines is in our best interest to pursue. Payment of a finder&#8217;s
fee is customarily tied to completion of a transaction, in which case any such fee will be paid out of the funds held in the trust account.
In no event, however, will our sponsor or any of our existing officers or directors, or any entity with which they are affiliated, be
paid any finder&#8217;s fee, consulting fee or other compensation by the company prior to, or for any services they render in order to
effectuate, the completion of our initial business combination (regardless of the type of transaction that it is).</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, officers or directors,
or completing the business combination through a joint venture or other form of shared ownership with our sponsor, officers or directors.
In the event we seek to complete an initial business combination with a target that is affiliated with our sponsor, officers or directors,
a committee of independent and disinterested directors would consider, review and approve the transaction. Additionally, we, or a committee
of independent and disinterested directors, would obtain an opinion from an independent investment banking firm or a valuation or appraisal
firm that such an initial business combination is fair to our company from a financial point of view. We are not required to obtain such
an opinion in any other context.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluation
of a Target Business and Structuring of Our Initial Business Combination</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
evaluating a prospective target business, we expect to conduct a due diligence review which may encompass, among other things, meetings
with incumbent management and employees, document reviews, interviews of customers and suppliers, inspection of facilities, as applicable,
as well as a review of financial, operational, legal and other information which will be made available to us. If we determine to move
forward with a particular target, we will proceed to structure and negotiate the terms of the business combination transaction.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
time required to select and evaluate a target business and to structure and complete our initial business combination, and the costs
associated with this process, are not currently ascertainable with any degree of certainty. Any costs incurred with respect to the identification
and evaluation of, and negotiation with, a prospective target business with which our initial business combination is not ultimately
completed will result in our incurring losses and will reduce the funds we can use to complete another business combination. The company
will not pay any consulting fees to members of our management team, or any of their respective affiliates, for services rendered to or
in connection with our initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we have agreed not to enter into a definitive agreement regarding an initial business combination without the prior written
consent of NextG. NextG has consented to our proposed Business Combination with Complete Solaria.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lack
of Business Diversification</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
an indefinite period of time after the completion of our initial business combination, the prospects for our success may depend entirely
on the future performance of a single business. Unlike other entities that have the resources to complete business combinations with
multiple entities in one or several industries, it is probable that we will not have the resources to diversify our operations and mitigate
the risks of being in a single line of business. By completing our initial business combination with only a single entity, our lack of
diversification may:</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                            us to negative economic, competitive and regulatory developments, any or all of which may
                                            have a substantial adverse impact on the particular industry in which we operate after our
                                            initial business combination, and</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cause
                                            us to depend on the marketing and sale of a single product or limited number of products
                                            or services.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption
Rights for Public Shareholders upon Completion of Our Initial Business Combination</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will provide our public shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion
of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust
account calculated as of two business days prior to the consummation of our initial business combination, including interest earned on
the funds held in the trust account and not previously released to us to pay our taxes, divided by the number of then outstanding public
shares, subject to the limitations and on the conditions described herein. At the completion of our initial business combination, we
will be required to purchase any ordinary shares properly delivered for redemption and not withdrawn. The amount in the trust account
is initially anticipated to be $10.00 per public share. The per-share amount we will distribute to investors who properly redeem their
shares will not be reduced by the deferred underwriting commissions we will pay to the underwriters. There will be no redemption rights
upon the completion of our initial business combination with respect to our warrants. Our initial shareholders, sponsor, officers and
directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect
to any founder shares and public shares held by them in connection with the completion of our initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limitations
on Redemptions</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated memorandum and articles of association provide that in no event will we redeem our public shares in an amount that
would cause our net tangible assets to be less than $5,000,001. In addition, our proposed initial business combination may impose a minimum
cash requirement for (i) cash consideration to be paid to the target or its owners, (ii) cash for working capital or other general corporate
purposes or (iii) the retention of cash to satisfy other conditions. In the event the aggregate cash consideration we would be required
to pay for all Class A ordinary shares that are validly submitted for redemption plus any amount required to satisfy cash conditions
pursuant to the terms of the proposed initial business combination exceed the aggregate amount of cash available to us, we will not complete
the initial business combination or redeem any shares, and all Class A ordinary shares submitted for redemption will be returned to the
holders thereof. We may, however, raise funds through the issuance of equity or equity-linked securities or through loans, advances or
other indebtedness in connection with our initial business combination, including pursuant to forward purchase agreements or backstop
arrangements we may enter into, in order to, among other reasons, satisfy such net tangible assets or minimum cash requirements.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manner
of Conducting Redemptions</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will provide our public shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion
of our initial business combination either (i) in connection with a general meeting called to approve the initial business combination
or (ii) without a shareholder vote by means of a tender offer. The decision as to whether we will seek shareholder approval of a proposed
initial business combination or conduct a tender offer will be made by us, solely in our discretion, and will be based on a variety of
factors such as the timing of the transaction and whether the terms of the transaction would require us to seek shareholder approval
under applicable law or stock exchange listing requirement or whether we were deemed to be a foreign private issuer. Asset acquisitions
and share purchases would not typically require shareholder approval while direct mergers with our company and any transactions where
we issue more than 20% of our issued and outstanding ordinary shares or seek to amend our amended and restated memorandum and articles
of association would typically require shareholder approval. So long as we obtain and maintain a listing for our securities on the NYSE,
we will be required to comply with the NYSE&#8217;s shareholder approval rules.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
requirement that we provide our public shareholders with the opportunity to redeem their public shares by one of the two methods listed
above is contained in provisions of our amended and restated memorandum and articles of association and will apply whether or not we
maintain our registration under the Exchange Act or our listing on the NYSE. Such provisions may be amended if approved by holders of
two-thirds of our ordinary shares entitled to vote thereon, so long as we offer redemption in connection with such amendment.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we provide our public shareholders with the opportunity to redeem their public shares in connection with a general meeting, we will,
pursuant to our amended and restated memorandum and articles of association:</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">conduct
                                            the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the
                                            Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender
                                            offer rules, and</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">file
                                            proxy materials with the SEC.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that we seek shareholder approval of our initial business combination, we will distribute proxy materials and, in connection
therewith, provide our public shareholders with the redemption rights described above.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we seek shareholder approval, we will complete our initial business combination only if we receive an ordinary resolution under Cayman
Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company.
A quorum for such meeting will be present if the holders of a majority of issued and outstanding shares entitled to vote at the meeting
are represented in person or by proxy. Our initial shareholders, sponsor, officers and directors will count toward this quorum and, pursuant
to the letter agreement, our initial shareholders, sponsor, officers and directors have agreed to vote any founder shares and public
shares held by them in favor of our initial business combination. For purposes of seeking approval of an ordinary resolution, non-votes
will have no effect on the approval of our initial business combination once a quorum is obtained. These quorum and voting thresholds,
and the voting agreement of our initial shareholders, officers and directors, may make it more likely that we will consummate our initial
business combination. Each public shareholder may elect to redeem their public shares without voting and, if they do vote, irrespective
of whether they vote for or against the proposed transaction.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a shareholder vote is not required and we do not decide to hold a shareholder vote for business or other reasons, we will:</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">conduct
                                            the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate
                                            issuer tender offers, and</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">file
                                            tender offer documents with the SEC prior to completing our initial business combination
                                            which contain substantially the same financial and other information about the initial business
                                            combination and the redemption rights as is required under Regulation 14A of the Exchange
                                            Act, which regulates the solicitation of proxies.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event we conduct redemptions pursuant to the tender offer rules, our offer to redeem will remain open for at least 20 business days,
in accordance with Rule 14e-1(a) under the Exchange Act, and we will not be permitted to complete our initial business combination until
the expiration of the tender offer period. In addition, the tender offer will be conditioned on public shareholders not tendering more
than the number of public shares we are permitted to redeem. If public shareholders tender more shares than we have offered to purchase,
we will withdraw the tender offer and not complete the initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the public announcement of our initial business combination, if we elect to conduct redemptions pursuant to the tender offer rules, we
and our sponsor will terminate any plan established in accordance with Rule 10b5-1 to purchase our Class A ordinary shares in the open
market, in order to comply with Rule 14e-5 under the Exchange Act.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to require our public shareholders seeking to exercise their redemption rights, whether they are record holders or hold their
shares in &#8220;street name,&#8221; to, at the holder&#8217;s option, either deliver their share certificates to our transfer agent
or deliver their shares to our transfer agent electronically using The Depository Trust Company&#8217;s DWAC (Deposit/Withdrawal At Custodian)
system, prior to the date set forth in the proxy materials or tender offer documents, as applicable. In the case of proxy materials,
this date may be up to two business days prior to the scheduled vote on the proposal to approve the initial business combination. In
addition, if we conduct redemptions in connection with a shareholder vote, we intend to require a public shareholder seeking redemption
of its public shares to also submit a written request for redemption to our transfer agent two business days prior to the scheduled vote
in which the name of the beneficial owner of such shares is included. The proxy materials or tender offer documents, as applicable, that
we will furnish to holders of our public shares in connection with our initial business combination will indicate whether we are requiring
public shareholders to satisfy such delivery requirements. We believe that this will allow our transfer agent to efficiently process
any redemptions without the need for further communication or action from the redeeming public shareholders, which could delay redemptions
and result in additional administrative cost. If the proposed initial business combination is not approved and we continue to search
for a target company, we will promptly return any certificates or shares delivered by public shareholders who elected to redeem their
shares.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated memorandum and articles of association provide that in no event will we redeem our public shares in an amount that
would cause our net tangible assets to be less than $5,000,001. In addition, our proposed initial business combination may impose a minimum
cash requirement for (i) cash consideration to be paid to the target or its owners, (ii) cash for working capital or other general corporate
purposes or (iii) the retention of cash to satisfy other conditions. In the event the aggregate cash consideration we would be required
to pay for all Class A ordinary shares that are validly submitted for redemption plus any amount required to satisfy cash conditions
pursuant to the terms of the proposed initial business combination exceed the aggregate amount of cash available to us, we will not complete
the initial business combination or redeem any shares, and all Class A ordinary shares submitted for redemption will be returned to the
holders thereof.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limitation
on Redemption upon Completion of Our Initial Business Combination If We Seek Shareholder Approval</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business
combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association provide that a public
shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as
a &#8220;group&#8221; (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to
more than an aggregate of 15% of the shares sold in our initial public offering (the &#8220;Excess Shares&#8221;) without our prior consent.
We believe this restriction will discourage shareholders from accumulating large blocks of shares, and subsequent attempts by such holders
to use their ability to redeem their shares as a means to force us, our sponsor or our management to purchase their shares at a significant
premium to the then-current market price or on other undesirable terms. Absent this provision, a public shareholder holding more than
an aggregate of 15% of the shares sold in our initial public offering could threaten to exercise its redemption rights if such holder&#8217;s
shares are not purchased by us, our sponsor or our management at a premium to the then-current market price or on other undesirable terms.
By limiting our shareholders&#8217; ability to redeem to no more than 15% of the shares sold in our initial public offering, we believe
we will limit the ability of a small group of shareholders to unreasonably attempt to block our ability to complete our initial business
combination, particularly in connection with a business combination with a target that requires as a closing condition that we have a
minimum net worth or a certain amount of cash.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
we would not be restricting our shareholders&#8217; ability to vote all of their shares (including Excess Shares) for or against our
initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delivering
Share Certificates in Connection with the Exercise of Redemption Rights</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described above, we intend to require our public shareholders seeking to exercise their redemption rights, whether they are record holders
or hold their shares in &#8220;street name,&#8221; to, at the holder&#8217;s option, either deliver their share certificates to our transfer
agent or deliver their shares to our transfer agent electronically using The Depository Trust Company&#8217;s DWAC (Deposit/Withdrawal
At Custodian) system, prior to the date set forth in the proxy materials or tender offer documents, as applicable. In the case of proxy
materials, this date may be up to two business days prior to the scheduled vote on the proposal to approve the initial business combination.
In addition, if we conduct redemptions in connection with a shareholder vote, we intend to require a public shareholder seeking redemption
of its public shares to also submit a written request for redemption to our transfer agent two business days prior to the scheduled vote
in which the name of the beneficial owner of such shares is included. The proxy materials or tender offer documents, as applicable, that
we will furnish to holders of our public shares in connection with our initial business combination will indicate whether we are requiring
public shareholders to satisfy such delivery requirements. Accordingly, a public shareholder would have up to two business days prior
to the scheduled vote on the initial business combination if we distribute proxy materials, or from the time we send out our tender offer
materials until the close of the tender offer period, as applicable, to submit or tender its shares if it wishes to seek to exercise
its redemption rights. In the event that a shareholder fails to comply with these or any other procedures disclosed in the proxy or tender
offer materials, as applicable, its shares may not be redeemed. Given the relatively short exercise period, it is advisable for shareholders
to use electronic delivery of their public shares.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is a nominal cost associated with the above-referenced process and the act of certificating the shares or delivering them through the
DWAC system. The transfer agent will typically charge the broker submitting or tendering shares a fee of approximately $80.00 and it
would be up to the broker whether or not to pass this cost on to the redeeming holder. However, this fee would be incurred regardless
of whether or not we require holders seeking to exercise redemption rights to submit or tender their shares. The need to deliver shares
is a requirement of exercising redemption rights regardless of the timing of when such delivery must be effectuated.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
request to redeem such shares, once made, may be withdrawn at any time up to the date set forth in the proxy materials or tender offer
documents, as applicable (unless we elect to allow additional withdrawal rights). Furthermore, if a holder of a public share delivered
its certificate in connection with an election of redemption rights and subsequently decides prior to the applicable date not to elect
to exercise such rights, such holder may simply request that the transfer agent return the certificate (physically or electronically).
It is anticipated that the funds to be distributed to holders of our public shares electing to redeem their shares will be distributed
promptly after the completion of our initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our initial business combination is not approved or completed for any reason, then our public shareholders who elected to exercise their
redemption rights would not be entitled to redeem their shares for the applicable pro rata share of the trust account. In such case,
we will promptly return any certificates delivered by public holders who elected to redeem their shares.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption
of Public Shares and Liquidation if No Initial Business Combination</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we have not completed our initial business combination during the Extension Period, we will: (i) cease all operations except for the
purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares,
at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned
on the funds held in the trust account (less taxes payable and up to $100,000 of interest income to pay dissolution expenses), divided
by the number of then outstanding public shares, which redemption will completely extinguish public shareholders&#8217; rights as shareholders
(including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such
redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject, in each
case, to our obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements
of applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless
if we fail to complete our initial business combination during the Extension Period.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
initial shareholders, sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have waived
their rights to liquidating distributions from the trust account with respect to any founder shares held by them if we fail to complete
our initial business combination during the Extension Period. However, if our sponsor or management team acquire public shares, they
will be entitled to liquidating distributions from the trust account with respect to such public shares if we fail to complete our initial
business combination during the Extension Period.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
initial shareholders, sponsor, officers and directors have agreed, pursuant to a written agreement with us, that they will not propose
any amendment to our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation
to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we have not consummated
an initial business combination during the Extension Period or (B) with respect to any other material provisions relating to shareholders&#8217;
rights or pre-initial business combination activity, unless we provide our public shareholders with the opportunity to redeem their public
shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the
trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our taxes, divided
by the number of then outstanding public shares. However, we may not redeem our public shares in an amount that would cause our net tangible
assets to be less than $5,000,001. If this optional redemption right is exercised with respect to an excessive number of public shares
such that we cannot satisfy the net tangible asset requirement, we would not proceed with the amendment or the related redemption of
our public shares at such time.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that all costs and expenses associated with implementing our plan of dissolution, as well as payments to any creditors, will be
funded from amounts held outside the trust account, although we cannot assure you that there will be sufficient funds for such purpose.
However, if those funds are not sufficient to cover the costs and expenses associated with implementing our plan of dissolution, to the
extent that there is any interest accrued in the trust account not required to pay income taxes on interest income earned on the trust
account balance, we may request the trustee to release to us an additional amount of up to $100,000 of such accrued interest income to
pay those costs and expenses.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we were to expend all of the net proceeds of our initial public offering and the sale of the private placement warrants, other than the
proceeds deposited in the trust account, and without taking into account interest, if any, earned on the trust account, the per-share
redemption amount received by shareholders upon our dissolution would be approximately $10.00. The funds deposited in the trust account
could, however, become subject to the claims of our creditors, which would have higher priority than the claims of our public shareholders.
We cannot assure you that the actual per-share redemption amount received by shareholders will not be substantially less than $10.00.
While we intend to pay such amounts, if any, we cannot assure you that we will have funds sufficient to pay or provide for all creditors&#8217;
claims.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we will seek to have all vendors, service providers, prospective target businesses and other entities with which we do business execute
agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit
of our public shareholders, there is no guarantee that they will execute such agreements or even if they execute such agreements that
they would be prevented from bringing claims against the trust account including but not limited to fraudulent inducement, breach of
fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order
to gain an advantage with respect to a claim against our assets, including the funds held in the trust account. If any third party refuses
to execute an agreement waiving such claims to the monies held in the trust account, our management will consider whether competitive
alternatives are reasonably available to us and will only enter into an agreement with such third party if management believes that such
third party&#8217;s engagement would be in the best interests of the company under the circumstances. Examples of possible instances
where we may engage a third party that refuses to execute a waiver include the engagement of a third-party consultant whose particular
expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute
a waiver or in cases where management is unable to find a service provider willing to execute a waiver. Marcum LLP, our independent registered
public accounting firm, and the underwriters of our initial public offering will not execute agreements with us waiving such claims to
the monies held in the trust account. In addition, there is no guarantee that such entities will agree to waive any claims they may have
in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against
the trust account for any reason. In order to protect the amounts held in the trust account, our sponsor has agreed that it will be liable
to us if and to the extent any claims by a third party (other than Marcum LLP, our independent registered public accounting firm) for
services rendered or products sold to us, or a prospective target business with which we have entered into a written letter of intent,
confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below
the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the
liquidation of the trust account, if less than $10.00 per public share due to reductions in the value of the trust assets, in each case
less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed
a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply
to any claims under our indemnity of the underwriters of our initial public offering against certain liabilities, including liabilities
under the Securities Act. However, we have not asked our sponsor to reserve for such indemnification obligations, nor have we independently
verified whether our sponsor has sufficient funds to satisfy its indemnity obligations and we believe that our sponsor&#8217;s only assets
are securities of our company. Therefore, we cannot assure you that our sponsor would be able to satisfy those obligations. As a result,
if any such claims were successfully made against the trust account, the funds available for our initial business combination and redemptions
could be reduced to less than $10.00 per public share. In such event, we may not be able to complete our initial business combination,
and you would receive such lesser amount per share in connection with any redemption of your public shares. None of our officers or directors
will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the funds in the trust account are reduced below the lesser of (i) $10.00 per public share and (ii) the actual amount
per public share held in the trust account as of the date of the liquidation of the trust account if less than $10.00 per public share
due to reductions in the value of the trust assets, in each case less taxes payable, and our sponsor asserts that it is unable to satisfy
its indemnification obligations or that it has no indemnification obligations related to a particular claim, our independent directors
would determine whether to take legal action against our sponsor to enforce its indemnification obligations. While we currently expect
that our independent directors would take legal action on our behalf against our sponsor to enforce its indemnification obligations to
us, it is possible that our independent directors, in exercising their business judgment, may choose not to do so in any particular instance
if, for example, the cost of such legal action is deemed by the independent directors to be too high relative to the amount recoverable
or if the independent directors determine that a favorable outcome is not likely. Accordingly, we cannot assure you that due to claims
of creditors the actual value of the per-share redemption price will not be substantially less than $10.00 per share.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will seek to reduce the possibility that our sponsor will have to indemnify the trust account due to claims of creditors by endeavoring
to have all vendors, service providers, prospective target businesses and other entities with which we do business execute agreements
with us waiving any right, title, interest or claim of any kind in or to monies held in the trust account. Our sponsor will also not
be liable as to any claims under our indemnity of the underwriters of our initial public offering against certain liabilities, including
liabilities under the Securities Act. In the event that we liquidate and it is subsequently determined that the reserve for claims and
liabilities is insufficient, shareholders who received funds from our trust account could be liable for claims made by creditors.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed,
the funds held in the trust account could be subject to applicable bankruptcy or insolvency law, and may be included in our bankruptcy
estate and subject to the claims of third parties with priority over the claims of our shareholders. To the extent any bankruptcy claims
deplete the trust account, we cannot assure you we will be able to return $10.00 per share to our public shareholders. Additionally,
if we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed,
any distributions received by shareholders could be viewed under applicable debtor/creditor and/or bankruptcy or insolvency laws as either
a &#8220;preferential transfer&#8221; or a &#8220;fraudulent conveyance.&#8221; As a result, a bankruptcy or insolvency court could seek
to recover some or all amounts received by our shareholders. Furthermore, our board of directors may be viewed as having breached its
fiduciary duty to our creditors and/or may have acted in bad faith, and thereby exposing itself and our company to claims of punitive
damages, by paying public shareholders from the trust account prior to addressing the claims of creditors. We cannot assure you that
claims will not be brought against us for these reasons.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
public shareholders will be entitled to receive funds from the trust account only (i) in the event of the redemption of our public shares
if we do not complete our initial business combination during the Extension Period, (ii) in connection with a shareholder vote to amend
our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to allow redemption
in connection with our initial business combination or to redeem 100% of our public shares if we have not consummated an initial business
combination during the Extension Period or (B) with respect to any other material provisions relating to shareholders&#8217; rights or
pre-initial business combination activity or (iii) if they redeem their respective shares for cash upon the completion of our initial
business combination. In no other circumstances will a shareholder have any right or interest of any kind to or in the trust account.
In the event we seek shareholder approval in connection with our initial business combination, a shareholder&#8217;s voting in connection
with the business combination alone will not result in a shareholder&#8217;s redeeming its shares to us for an applicable pro rata share
of the trust account. Such shareholder must have also exercised its redemption rights described above. These provisions of our amended
and restated memorandum and articles of association, like all provisions of our amended and restated memorandum and articles of association,
may be amended with a shareholder vote.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conflicts
of Interest</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our officers and directors presently has, and any of them in the future may have additional, fiduciary or contractual obligations
to another entity pursuant to which such officer or director is or will be required to present a business combination opportunity to
such entity. Accordingly, if any of our officers or directors becomes aware of a business combination opportunity which is suitable for
an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual
obligations to present such business combination opportunity to such entity, subject to their fiduciary duties under Cayman Islands law.
Our amended and restated memorandum and articles of association provide that, to the fullest extent permitted by applicable law: (i)
no individual serving as a director or an officer shall have any duty, except and to the extent expressly assumed by contract, to refrain
from engaging directly or indirectly in the same or similar business activities or lines of business as us; and (ii) we renounce any
interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate
opportunity for any director or officer on the one hand, and us, on the other. We do not believe, however, that the fiduciary duties
or contractual obligations of our officers or directors will materially affect our ability to complete our initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facilities</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently utilize office space at 14 Wall Street, 20th Floor, New York, 10005. We consider our current office space adequate for our
current operations.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have one officer, Adam Gishen. Mr. Gishen and any additional officers that may be appointed are not obligated to devote any
specific number of hours to our matters but they intend to devote as much of their time as they deem necessary to our affairs until we
have completed our initial business combination. The amount of time they will devote in any time period will vary based on whether a
target business has been selected for our initial business combination and the stage of the business combination process we are in. We
have engaged certain employees and advisors to assist us with the completion of our initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 40.5pt; text-indent: -40.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 40.5pt; text-indent: -40.5pt"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 40.5pt; padding-left: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_004"></a></div><p style="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1A. Risk Factors</span></p><div>



</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>An
investment in our securities involves a high degree of risk. You should consider carefully all of the risks described below, together
with the other information contained in this Annual Report, before making a decision to invest in our securities. If any of the following
events occur, our business, financial condition and operating results may be materially adversely affected. In that event, the trading
price of our securities could decline, and you could lose all or part of your investment.</i></span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Associated with the Business Combination Agreement</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We
may not be able to complete the proposed Business Combination with Complete Solaria. If we are unable to do so, we will incur substantial
costs associated with withdrawing from the transaction and may not be able to find additional sources of financing to cover those costs.</i></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination Agreement, we have incurred substantial costs researching, planning and negotiating the transaction.
These costs include, but are not limited to, costs associated with securing sources of debt financing, costs associated with employing
and retaining third-party advisors who performed the financial, auditing and legal services required to complete the transaction, and
the expenses generated by our officers, executives, managers and employees in connection with the transaction. If, for whatever reason,
the transactions contemplated by the Business Combination Agreement fail to close, we will be responsible for these costs, but will have
no source of revenue with which to pay them. We may need to obtain additional sources of financing in order to meet our obligations,
which we may not be able to secure on the same terms as our existing financing or at all. If we are unable to secure new sources of financing
and do not have sufficient funds to meet our obligations, we will be forced to cease operations and liquidate the trust account.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the proposed Business Combination with Complete Solaria fails, it may be difficult to complete a business combination with a new prospective
target business, negotiate and agree to a new business combination, and/or arrange for new sources of financing by the end of the Extension
Period, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate.</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finding,
researching, analyzing and negotiating with Complete Solaria took a substantial amount of time and effort, and if the proposed Business
Combination with Complete Solaria fails for any reason, we may not be able to find, research, negotiate and agree to terms with, and/or
arrange for new sources of financing for a business combination with, a new prospective target business during the Extension Period,
in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate.</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Associated with Our Business Strategy and Business Combination</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a blank check company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve
our business objective.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a blank check company incorporated under the laws of the Cayman Islands and all of our activities to date have been related to our
formation, our initial public offering and our search for a business combination target. Because we lack an operating history, you have
no basis upon which to evaluate our ability to achieve our business objective of completing our initial business combination. If we fail
to complete our initial business combination, we will never generate any operating revenues.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 9.35pt"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Past
performance by our management team, directors, advisors and their respective affiliates, including investments and transactions in which
they have participated and businesses with which they have been associated, may not be indicative of future performance of an investment
in the Company.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
regarding our management team, directors, advisors and their respective affiliates, including investments and transactions in which they
have participated and businesses with which they have been associated, is presented for informational purposes only. Not all of the businesses
in which our management team directors, advisors or their respective affiliates have invested have achieved the same level of value creation.
Any past experience and performance by our management team, directors, advisors and their respective affiliates and the businesses with
which they have been associated, is not a guarantee that we will be able to successfully complete our initial business combination, that
we will be able to provide positive returns to our shareholders, or of any results with respect to any initial business combination we
may consummate. You should not rely on the historical experiences of our management team directors, advisors and their respective affiliates,
including investments and transactions in which they have participated and businesses with which they have been associated, as indicative
of the future performance of an investment in us or as indicative of every prior investment by each of the members of our management
team directors, advisors or their respective affiliates. The market price of our securities may be influenced by numerous factors, many
of which are beyond our control, and our shareholders may experience losses on their investment in our securities.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may seek business combination opportunities in industries or sectors that may be outside of our management&#8217;s areas of expertise.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will consider a business combination outside of our management&#8217;s areas of expertise if a business combination candidate is presented
to us and we determine that such candidate offers an attractive business combination opportunity for our company. Although our management
will endeavor to evaluate the risks inherent in any particular business combination candidate, we cannot assure you that we will adequately
ascertain or assess all of the significant risk factors. We also cannot assure you that an investment in our securities will not ultimately
prove to be less favorable to investors than a direct investment, if an opportunity were available, in a business combination candidate.
In the event we elect to pursue a business combination outside of the areas of our management&#8217;s expertise, our management&#8217;s
expertise may not be directly applicable to its evaluation or operation, and the information contained in this Annual Report regarding
the areas of our management&#8217;s expertise would not be relevant to an understanding of the business that we elect to acquire. As
a result, our management may not be able to ascertain or assess adequately all of the relevant risk factors. Accordingly, any shareholders
or warrant holders who choose to remain shareholders or warrant holders following the business combination could suffer a reduction in
the value of their securities. Such shareholders or warrant holders are unlikely to have a remedy for such reduction in value.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, we may
enter into our initial business combination with a target that does not meet such criteria and guidelines, and as a result, the target
business with which we enter into our initial business combination may not have attributes entirely consistent with our general criteria
and guidelines.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we have identified general criteria and guidelines for evaluating prospective target businesses, it is possible that a target business
with which we enter into our initial business combination will not have all of these positive attributes. If we complete our initial
business combination with a target that does not meet some or all of these criteria and guidelines, such combination may not be as successful
as a combination with a business that does meet all of our general criteria and guidelines. In addition, if we announce a prospective
business combination with a target that does not meet our general criteria and guidelines, a greater number of shareholders may exercise
their redemption rights, which may make it difficult for us to meet any closing condition with a target business that requires us to
have a minimum net worth or a certain amount of cash. In addition, if shareholder approval of the transaction is required by applicable
law, or we decide to obtain shareholder approval for business or other reasons, it may be more difficult for us to attain shareholder
approval of our initial business combination if the target business does not meet our general criteria and guidelines. If we are unable
to complete our initial business combination, our public shareholders may only receive their pro rata portion of the funds in the trust
account that are available for distribution to public shareholders, and our warrants will expire worthless.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
we complete our initial business combination with an affiliated entity, we are not required to obtain an opinion regarding fairness,
and consequently, you may have no assurance from an independent source that the price we are paying for the business is fair to our shareholders
from a financial point of view.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
we complete our initial business combination with an affiliated entity, we are not required to obtain an opinion that such an initial
business combination is fair to our company from a financial point of view. While we have obtained a fairness opinion with respect to
the proposed Business Combination with Complete Solaria, if the transaction is not consummated and we seek to effectuate a business combination
with another target and no opinion is obtained, our shareholders will be relying on the judgment of our board of directors, who will
determine fair market value based on standards generally accepted by the financial community. Such standards used will be disclosed in
our proxy materials or tender offer documents, as applicable, related to our initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 9.35pt"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have engaged or intend to engage one or more of the underwriters of our initial public offering or their affiliates to provide additional
services to us, including to act as financial advisor in connection with an initial business combination or as placement agent in connection
with a related financing transaction. The underwriters of our initial public offering are entitled to receive deferred commissions that
will be released from the trust only on a completion of an initial business combination. These financial incentives may cause the underwriters
to have potential conflicts of interest in rendering any such additional services to us, including, for example, in connection with the
consummation of an initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have engaged or intend to engage one or more of the underwriters of our initial public offering or their affiliates to provide additional
services to us, including, for example, identifying potential targets, providing financial advisory services, acting as a placement agent
in a private offering or arranging debt financing. We will pay the underwriters or their affiliates fair and reasonable fees or other
compensation that would be determined at that time in an arm&#8217;s length negotiation. The underwriters are also entitled to receive
deferred commissions that are conditioned on the completion of an initial business combination. The fact that the underwriters or their
affiliates&#8217; financial interests are tied to the consummation of a business combination transaction may give rise to potential conflicts
of interest in providing any such additional services to us, including potential conflicts of interest in connection with the consummation
of an initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may seek acquisition opportunities with an early stage company, a financially unstable business or an entity lacking an established record
of revenue or earnings.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent we complete our initial business combination with an early stage company, a financially unstable business or an entity lacking
an established record of sales or earnings, we may be affected by numerous risks inherent in the operations of the business with which
we combine. These risks include investing in a business without a proven business model and with limited historical financial data, volatile
revenues or earnings, intense competition and difficulties in obtaining and retaining key personnel. Although our officers and directors
will endeavor to evaluate the risks inherent in a particular target business, we may not be able to properly ascertain or assess all
of the significant risk factors and we may not have adequate time to complete due diligence. Furthermore, some of these risks may be
outside of our control and leave us with no ability to control or reduce the chances that those risks will adversely impact a target
business.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may attempt to complete our initial business combination with a private company about which little information is available, which may
result in a business combination with a company that is not as profitable as we suspected, if at all.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
pursuing our business combination strategy, we may seek to effectuate our initial business combination with a privately held company.
Very little public information generally exists about private companies, and we could be required to make our decision on whether to
pursue a potential initial business combination on the basis of limited information, which may result in a business combination with
a company that is not as profitable as we suspected, if at all.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may issue notes or other debt securities, or otherwise incur substantial debt, to complete a business combination, which may adversely
affect our leverage and financial condition and thus negatively impact the value of our shareholders&#8217; investment in us.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may choose to incur substantial debt to complete our initial business combination. We have agreed that we will not incur any indebtedness
unless we have obtained from the lender a waiver of any right, title, interest or claim of any kind in or to the monies held in the trust
account. As such, no issuance of debt will affect the per-share amount available for redemption from the trust account.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevertheless,
the incurrence of debt could have a variety of negative effects, including:</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">default
                                            and foreclosure on our assets if our operating revenues after an initial business combination
                                            are insufficient to repay our debt obligations;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">acceleration
                                            of our obligations to repay the indebtedness even if we make all principal and interest payments
                                            when due if we breach certain covenants that require the maintenance of certain financial
                                            ratios or reserves without a waiver or renegotiation of that covenant;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            immediate payment of all principal and accrued interest, if any, if the debt is payable on
                                            demand;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to obtain such financing while the debt is outstanding;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            inability to pay dividends on our Class A ordinary shares;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">using
                                            a substantial portion of our cash flow to pay principal and interest on our debt, which will
                                            reduce the funds available for dividends on our Class A ordinary shares if declared, expenses,
                                            capital expenditures, acquisitions and other general corporate purposes;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
                                            on our flexibility in planning for and reacting to changes in our business and in the industry
                                            in which we operate;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased
                                            vulnerability to adverse changes in general economic, industry and competitive conditions
                                            and adverse changes in government regulation; and</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
                                            on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions,
                                            debt service requirements, execution of our strategy and other purposes and other disadvantages
                                            compared to our competitors who have less debt.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
search for a business combination, and any prospective partner business with which we ultimately consummate a business combination, may
be materially adversely affected by the coronavirus (COVID-19) pandemic and other events and the status of debt and equity markets.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be unable to complete a business combination if concerns relating to COVID-19 continue to restrict travel, limit the ability to have
meetings with potential investors or the prospective partner business&#8217;s personnel, vendors and services providers are unavailable
to negotiate and consummate a transaction in a timely manner. The extent to which COVID-19 impacts our search for a business combination
will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning
the severity of COVID-19, the emergence of new COVID-19 variants and the actions to contain COVID-19 or treat its impact, among others.
If the disruptions posed by COVID-19 or other matters of global concern continue for an extensive period of time or other events (such
as the ongoing military conflict between Russia and Ukraine, terrorist attacks, natural disasters or a significant outbreak of other
infectious diseases) occur, our ability to consummate a business combination, or the operations of a prospective partner business with
which we ultimately consummate a business combination, may be materially adversely affected. In addition, our ability to consummate a
transaction may be dependent on the ability to raise equity and debt financing which may be impacted by COVID-19 and other events (such
as terrorist attacks, natural disasters or a significant outbreak of other infectious diseases), including as a result of increased market
volatility, decreased market liquidity and third-party financing being unavailable on terms acceptable to us or at all. Finally, the
outbreak of COVID-19 may also have the effect of heightening many of the other risks described in this &#8220;Item 1A.-Risk Factors&#8221;
section, such as those related to the market for our securities and cross-border transactions.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may only be able to complete one business combination with the proceeds of our initial public offering and the sale of the private placement
warrants, which will cause us to be solely dependent on a single business which may have a limited number of products or services. This
lack of diversification may negatively impact our operations and profitability.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving effect to the redemption of 23,256,504 Class A ordinary shares in connection with the Extension Amendment, we have approximately
$111,740,624 in our trust account that we may use to complete our initial business combination (after taking into account the $3,018,750
of deferred underwriting commissions being held in the trust account).</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may effectuate our initial business combination with a single target business or multiple target businesses simultaneously or within
a short period of time. However, we may not be able to effectuate our initial business combination with more than one target business
because of various factors, including the existence of complex accounting issues and the requirement that we prepare and file pro forma
financial statements with the SEC that present operating results and the financial condition of several target businesses as if they
had been operated on a combined basis. By completing our initial business combination with only a single entity, our lack of diversification
may subject us to numerous economic, competitive and regulatory developments. Further, we would not be able to diversify our operations
or benefit from the possible spreading of risks or offsetting of losses, unlike other entities which may have the resources to complete
several business combinations in different industries or different areas of a single industry. Accordingly, the prospects for our success
may be:</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">solely
                                            dependent upon the performance of a single business, property or asset, or</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dependent
                                            upon the development or market acceptance of a single or limited number of products, processes
                                            or services.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
lack of diversification may subject us to numerous economic, competitive and regulatory risks, any or all of which may have a substantial
adverse impact upon the particular industry in which we may operate subsequent to our initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may attempt to simultaneously complete business combinations with multiple prospective targets, which may hinder our ability to complete
our initial business combination and give rise to increased costs and risks that could negatively impact our operations and profitability.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we determine to simultaneously acquire several businesses that are owned by different sellers, we will need for each of such sellers
to agree that our purchase of its business is contingent on the simultaneous closings of the other business combinations, which may make
it more difficult for us, and delay our ability, to complete our initial business combination. With multiple business combinations, we
could also face additional risks, including additional burdens and costs with respect to possible multiple negotiations and due diligence
investigations (if there are multiple sellers) and the additional risks associated with the subsequent assimilation of the operations
and services or products of the acquired companies in a single operating business. If we are unable to adequately address these risks,
they could negatively impact our profitability and results of operations.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management may not be able to maintain control of a target business after our initial business combination. We cannot provide assurance
that, upon loss of control of a target business, new management will possess the skills, qualifications or abilities necessary to profitably
operate such business.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may structure our initial business combination so that the post-business combination company in which our public shareholders own shares
will own or acquire less than 100% of the outstanding equity interests or assets of a target business, but we will only complete such
business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target
or otherwise acquires a controlling interest in the target business sufficient for us not to be required to register as an investment
company under the Investment Company Act. We will not consider any transaction that does not meet such criteria. Even if the post-transaction
company owns or acquires 50% or more of the voting securities of the target, our shareholders prior to the business combination may collectively
own a minority interest in the post-business combination company, depending on valuations ascribed to the target and us in the business
combination. For example, we could pursue a transaction in which we issue a substantial number of new shares in exchange for all of the
outstanding capital stock, shares or other equity interests of a target, or issue a substantial number of new shares to third-parties
in connection with financing our initial business combination. In this case, we would acquire a 100% controlling interest in the target.
However, as a result of the issuance of a substantial number of new shares, our shareholders immediately prior to such transaction could
own less than a majority of our issued and outstanding shares subsequent to such transaction. In addition, other minority shareholders
may subsequently combine their holdings resulting in a single person or group obtaining a larger share of the company&#8217;s shares
than we initially acquired. Accordingly, this may make it more likely that our management will not be able to maintain control of the
target business.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 9.35pt"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">&#160;</p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are dependent upon our officers and directors and their loss could adversely affect our ability to operate. In addition, reputational
harm to our officers and directors could have adverse consequences on our ability to operate or consummate a business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations are dependent upon a relatively small group of individuals and, in particular, our officers and directors. We believe that
our success depends on the continued service of our officers and directors, at least until we have completed our initial business combination.
In addition, our officers and directors are not required to commit any specified amount of time to our affairs and, accordingly, will
have conflicts of interest in allocating their time among various business activities, including identifying potential business combinations
and monitoring the related due diligence. We do not have an employment agreement with, or key-man insurance on the life of, any of our
directors or officers. The unexpected loss of the services of one or more of our directors or officers could have a detrimental effect
on us.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, certain of our officers and directors are currently, and may in the future be, a party to litigation, regulatory and other
government investigations and enforcement actions. This includes enforcement proceedings initiated by the Swiss Financial Market Supervisory
Authority (FINMA) against Credit Suisse in September 2020, which covers the period during which certain of our officers and directors
were executives of Credit Suisse. Whether or not such proceedings are determined adversely to our officers and directors, the negative
publicity and reputational harm associated with such proceedings may divert resources and the attention of management from our business
and adversely impact our ability to consummate a business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
ability to successfully effect our initial business combination and to be successful thereafter will be dependent upon the efforts of
our key personnel, some of whom may join us following our initial business combination. The loss of key personnel could negatively impact
the operations and profitability of our post-combination business.</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to successfully effect our initial business combination is dependent upon the efforts of our key personnel. The role of our key
personnel in the target business, however, cannot presently be ascertained. Although some of our key personnel may remain with the target
business in senior management or advisory positions following our initial business combination, it is likely that some or all of the
management of the target business will remain in place. While we intend to closely scrutinize any individuals we engage after our initial
business combination, we cannot assure you that our assessment of these individuals will prove to be correct. These individuals may be
unfamiliar with the requirements of operating a company regulated by the SEC, which could cause us to have to expend time and resources
helping them become familiar with such requirements.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the directors and officers of an acquisition candidate may resign upon completion of our initial business combination. The
departure of a business combination target&#8217;s key personnel could negatively impact the operations and profitability of our post-combination
business. The role of an acquisition candidate&#8217;s key personnel upon the completion of our initial business combination cannot be
ascertained at this time. Although we contemplate that certain members of an acquisition candidate&#8217;s management team will remain
associated with the post-combination company following our initial business combination, it is possible that members of the management
of an acquisition candidate will not wish to remain in place. The loss of key personnel could negatively impact the operations and profitability
of our post-combination business.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
key personnel may negotiate employment or consulting agreements with a target business in connection with a particular business combination,
and a particular business combination may be conditioned on the retention or resignation of such key personnel. These agreements may
provide for them to receive compensation following our initial business combination and as a result, may cause them to have conflicts
of interest in determining whether a particular business combination is the most advantageous.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
key personnel may be able to remain with our company after the completion of our initial business combination only if they are able to
negotiate employment or consulting agreements in connection with the business combination. Such negotiations would take place simultaneously
with the negotiation of the business combination and could provide for such individuals to receive compensation in the form of cash payments
and/or our securities for services they would render to us after the completion of the business combination. Such negotiations also could
make such key personnel&#8217;s retention or resignation a condition to any such agreement. The personal and financial interests of such
individuals may influence their motivation in identifying and selecting a target business, subject to their fiduciary duties under Cayman
Islands law.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 9.35pt"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may have a limited ability to assess the management of a prospective target business and, as a result, may effect our initial business
combination with a target business whose management may not have the skills, qualifications or abilities to manage a public company.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
evaluating the desirability of effecting our initial business combination with a prospective target business, our ability to assess the
target business&#8217;s management may be limited due to a lack of time, resources or information. Our assessment of the capabilities
of the target business&#8217;s management, therefore, may prove to be incorrect and such management may lack the skills, qualifications
or abilities we suspected. Should the target business&#8217;s management not possess the skills, qualifications or abilities necessary
to manage a public company, the operations and profitability of the post-combination business may be negatively impacted. Accordingly,
any shareholders or warrant holders who choose to remain shareholders or warrant holders following the business combination could suffer
a reduction in the value of their securities. Such shareholders or warrant holders are unlikely to have a remedy for such reduction in
value.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
officers and directors of an acquisition candidate may resign upon completion of our initial business combination. The loss of a business
combination target&#8217;s key personnel could negatively impact the operations and profitability of our post-combination business.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
role of an acquisition candidate&#8217;s key personnel upon the completion of our initial business combination cannot be ascertained
at this time. Although we contemplate that certain members of an acquisition candidate&#8217;s management team will remain associated
with the post-combination business following our initial business combination, it is possible that members of the management of an acquisition
candidate will not wish to remain in place.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may issue additional Class A ordinary shares or preferred shares to complete our initial business combination or under an employee incentive
plan after completion of our initial business combination. We may also issue Class A ordinary shares upon the conversion of the founder
shares at a ratio greater than one-to-one at the time of our initial business combination as a result of the anti-dilution provisions
contained in our amended and restated memorandum and articles of association. Any such issuances would dilute the interest of our shareholders
and likely present other risks.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated memorandum and articles of association authorizes the issuance of up to 200,000,000 Class A ordinary shares, par
value $0.0001 per share, 20,000,000 Class B ordinary shares, par value $0.0001 per share, and 1,000,000 preferred shares, par value $0.0001
per share. As of December 31, 2022, there were 165,500,000 and 11,375,000 authorized but unissued Class A ordinary shares and Class B
ordinary shares, respectively, available for issuance which amounts do not take into account shares reserved for issuance upon exercise
of outstanding warrants or shares issuable upon conversion of the Class B ordinary shares. The Class B ordinary shares are automatically
convertible into Class A ordinary shares concurrently with or immediately following the consummation of our initial business combination,
initially at a one-for-one ratio but subject to adjustment as set forth in our amended and restated memorandum and articles of association,
including in certain circumstances in which we issue Class A ordinary shares or equity-linked securities related to our initial business
combination. As of December 31, 2022, there were no preferred shares issued and outstanding.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may issue a substantial number of additional Class A ordinary shares or preferred shares to complete our initial business combination
or under an employee incentive plan after completion of our initial business combination. We may also issue Class A ordinary shares upon
conversion of the Class B ordinary shares at a ratio greater than one-to-one at the time of our initial business combination as a result
of the anti-dilution provisions as set forth in our amended and restated memorandum and articles of association or in connection with
the redemption of our public warrants. However, our amended and restated memorandum and articles of association provide, among other
things, that prior to our initial business combination, we may not issue additional securities that would entitle the holders thereof
to (i) receive funds from the trust account or (ii) vote on any initial business combination. These provisions of our amended and restated
memorandum and articles of association, like all provisions of our amended and restated memorandum and articles of association, may be
amended with a shareholder vote. The issuance of additional ordinary or preferred shares may:</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">significantly
                                            dilute the equity interest of holders of our Class A ordinary shares, which dilution would
                                            increase in the anti-dilution provisions in the Class B ordinary shares result in the issuance
                                            of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class
                                            B ordinary shares;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding-left: 0pt; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">subordinate
                                            the rights of holders of Class A ordinary shares if preferred shares are issued with rights
                                            senior to those afforded our Class A ordinary shares;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cause
                                            a change in control if a substantial number of our Class A ordinary shares are issued, which
                                            may affect, among other things, our ability to use our net operating loss carry forwards,
                                            if any, and could result in the resignation or removal of our present officers and directors;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
                                            the effect of delaying or preventing a change of control of us by diluting the share ownership
                                            or voting rights of a person seeking to obtain control of us;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adversely
                                            affect prevailing market prices for our units, Class A ordinary shares and/or warrants; and</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                            result in adjustment to the exercise price of our warrants.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlike
some other similarly structured special purpose acquisition companies, our initial shareholders will receive additional Class A ordinary
shares if we issue certain shares to consummate an initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
founder shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of
our initial business combination on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations,
recapitalizations and the like, and subject to further adjustment as provided in our amended and restated memorandum and articles of
association. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection
with our initial business combination, the number of Class A ordinary shares issuable upon conversion of all founder shares will equal,
in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions
of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued, or deemed issued or
issuable upon conversion or exercise of any equity-linked securities issued or deemed issued, by the Company in connection with the consummation
of the initial business combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible
into Class A ordinary shares issued, deemed issued or to be issued, to any seller in the initial business combination and any private
placement warrants issued to our sponsor, officers or directors upon conversion of working capital loans; provided that such conversion
of founder shares will never occur on a less than one-for-one basis.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resources
could be wasted in researching business combinations that are not completed, which could materially adversely affect subsequent attempts
to locate and acquire or merge with another business. If we are unable to complete our initial business combination, our public shareholders
may only receive their pro rata portion of the funds in the trust account that are available for distribution to public shareholders,
and our warrants will expire worthless.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
investigation of each specific target business and the negotiation, drafting and execution of relevant agreements, disclosure documents
and other instruments will require substantial management time and attention and substantial costs for accountants, attorneys, consultants
and others. If we decide not to complete a specific initial business combination, the costs incurred up to that point for the proposed
transaction likely would not be recoverable. Furthermore, we may fail to complete our initial business combination for any number of
reasons including those beyond our control. Any such event will result in a loss to us of the related costs incurred, which could materially
adversely affect subsequent attempts to locate and acquire or merge with another business. If we are unable to complete our initial business
combination, our public shareholders may only receive their pro rata portion of the funds in the trust account that are available for
distribution to public shareholders, and our warrants will expire worthless.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 9.35pt"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
public shareholders may not be afforded an opportunity to vote on our proposed initial business combination, and even if we hold a vote,
holders of our founder shares will participate in such vote, which means we may complete our initial business combination even though
a majority of our public shareholders do not support such a combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may choose not to hold a shareholder vote to approve our initial business combination unless the business combination would require shareholder
approval under applicable law or stock exchange listing requirements. In such case, the decision as to whether we will seek shareholder
approval of a proposed business combination or will allow shareholders to sell their shares to us in a tender offer will be made by us,
solely in our discretion, and will be based on a variety of factors, such as the timing of the transaction and whether the terms of the
transaction would otherwise require us to seek shareholder approval. Even if we seek shareholder approval, the holders of our founder
shares will participate in the vote on such approval and have agreed to vote in favor of our initial business combination. Accordingly,
we may complete our initial business combination even if holders of a majority of our ordinary shares do not approve of the business
combination we complete.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
only opportunity to effect your investment decision regarding a potential business combination may be limited to the exercise of your
right to redeem your shares from us for cash.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time of your investment in us, you will not be provided with an opportunity to evaluate the specific merits or risks of our initial
business combination. While we will hold a shareholder vote to approve our proposed Business Combination with Complete Solaria, if the
Business Combination is not consummated and we seek to effectuate a business combination with another target business, our board of directors
may complete such business combination without seeking shareholder approval, and then public shareholders may not have the right or opportunity
to vote on the business combination, unless we seek such shareholder vote. Accordingly, your only opportunity to effect your investment
decision regarding our initial business combination may be limited to exercising your redemption rights within the period of time (which
will be at least 20 business days) set forth in our tender offer documents mailed to our public shareholders in which we describe our
initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we seek shareholder approval of our initial business combination, our initial shareholders and management team have agreed to vote in
favor of such initial business combination, regardless of how our public shareholders vote.</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
initial shareholders own approximately 43.4% of our issued and outstanding ordinary shares (after giving effect to the redemption of
23,256,504 Class A ordinary shares in connection with the Extension Amendment). Our initial shareholders and management team also may
from time to time purchase Class A ordinary shares prior to our initial business combination. Our amended and restated memorandum and
articles of association provide that, if we seek shareholder approval of an initial business combination, such initial business combination
will be approved if we receive an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of
the shareholders who attend and vote at a general meeting of the company, including the founder shares. As a result, in addition to our
initial shareholders&#8217; founder shares, we would need 1,309,249, or 11.6%, of the 11,243,496 Class A ordinary shares to be voted
in favor of an initial business combination in order to have our initial business combination approved. Accordingly, if we seek shareholder
approval of our initial business combination, the agreement by our initial shareholders and management team to vote in favor of our initial
business combination will increase the likelihood that we will receive an ordinary resolution, being the requisite shareholder approval
for such initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
do not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete
our initial business combination with which a substantial majority of our shareholders do not agree.</i></b></span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated memorandum and articles of association provide that in no event will we redeem our public shares in an amount that
would cause our net tangible assets to be less than $5,000,001. In addition, our proposed initial business combination may impose a minimum
cash requirement for (i) cash consideration to be paid to the target or its owners, (ii) cash for working capital or other general corporate
purposes or (iii) the retention of cash to satisfy other conditions. As a result, we may be able to complete our initial business combination
even though a substantial majority of our public shareholders do not agree with the transaction and have redeemed their shares or, if
we seek shareholder approval of our initial business combination and do not conduct redemptions in connection with our initial business
combination pursuant to the tender offer rules, have entered into privately negotiated agreements to sell their shares to our sponsor,
officers, directors, advisors or any of their affiliates. In the event the aggregate cash consideration we would be required to pay for
all Class A ordinary shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to
the terms of the proposed business combination exceed the aggregate amount of cash available to us, we will not complete the business
combination or redeem any shares, all Class A ordinary shares submitted for redemption will be returned to the holders thereof, and we
instead may search for an alternate business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 9.35pt"></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have amended our amended and restated memorandum and articles of association to extend the time to consummate an initial business combination,
and we cannot assure you that we will not seek to further amend our amended and restated memorandum and articles of association or governing
instruments in a manner that will make it easier for us to complete our initial business combination that our shareholders may not support.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to effectuate a business combination, special purpose acquisition companies have, in the recent past, amended various provisions
of their charters and governing instruments, including their warrant agreements. For example, we have amended our amended and restated
memorandum and articles of association to extend the time to consummate an initial business combination, and other special purpose acquisition
companies have amended the definition of business combination, increased redemption thresholds and, with respect to their warrants, amended
their warrant agreements to require the warrants to be exchanged for cash and/or other securities. Amending our amended and restated
memorandum and articles of association requires a special resolution under Cayman Islands law, which requires the affirmative vote of
a majority of at least two-thirds of the shareholders who attend and vote at a general meeting of the company (other than amendments
relating to the rights of holders of Class B ordinary shares to appoint or remove directors, which may be amended by a special resolution
passed by a majority of at least 90% of our ordinary shares voting in a general meeting), and amending our warrant agreement will require
a vote of holders of at least 65% of the public warrants and, solely with respect to any amendment to the terms of the private placement
warrants or any provision of the warrant agreement with respect to the private placement warrants, at least 65% of the then outstanding
private placement warrants. In addition, our amended and restated memorandum and articles of association require us to provide our public
shareholders with the opportunity to redeem their public shares for cash if we propose an amendment to our amended and restated memorandum
and articles of association (A) to modify the substance or timing of our obligation to allow redemption in connection with our initial
business combination or to redeem 100% of our public shares if we have not consummated an initial business combination during the Extension
Period or (B) with respect to any other material provisions relating to shareholders&#8217; rights or pre-initial business combination
activity. To the extent any of such amendments would be deemed to fundamentally change the nature of the securities offered through our
initial public offering, we would register, or seek an exemption from registration for, the affected securities. We cannot assure you
that we will not seek to further amend our amended and restated memorandum and articles of association or governing instruments or extend
the time to consummate an initial business combination in order to effectuate our initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions of our amended and restated memorandum and articles of association that relate to our pre-business combination activity (and
corresponding provisions of the agreement governing the release of funds from our trust account) may be amended with the approval of
holders of not less than two-thirds of our ordinary shares who attend and vote at a general meeting of the company (or 65% of our ordinary
shares who attend and vote at a general meeting of the company with respect to amendments to the trust agreement governing the release
of funds from our trust account), which is a lower amendment threshold than that of some other special purpose acquisition companies.
It may be easier for us, therefore, to amend our amended and restated memorandum and articles of association and trust agreement to facilitate
the completion of an initial business combination that some of our shareholders may not support.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated memorandum and articles of association provide that any of its provisions related to pre-business combination activity
(including the requirement to deposit proceeds of our initial public offering and the sale of the private placement warrants into the
trust account and not release such amounts except in specified circumstances, and to provide redemption rights to public shareholders
as described herein) may be amended if approved by special resolution under Cayman Islands law, which requires the affirmative vote of
a majority of at least two-thirds of the shareholders who attend and vote at a general meeting of the company (other than amendments
relating to the rights of holders of Class B ordinary shares to appoint or remove directors, which may be amended by a special resolution
passed by a majority of at least 90% of our ordinary shares voting in a general meeting), and corresponding provisions of the trust agreement
governing the release of funds from our trust account may be amended if approved by holders of 65% of our ordinary shares who attend
and vote at a general meeting of the company. Our initial shareholders, who collectively beneficially own 43.4% of our ordinary shares
(after giving effect to the redemption of 23,256,504 Class A ordinary shares in connection with the Extension Amendment), may participate
in any vote to amend our amended and restated memorandum and articles of association and/or trust agreement and have the discretion to
vote in any manner they choose. As a result, we may be able to amend the provisions of our amended and restated memorandum and articles
of association that govern our pre-business combination behavior more easily than some other special purpose acquisition companies, and
this may increase our ability to complete a business combination with which you do not agree. Our shareholders may pursue remedies against
us for any breach of our amended and restated memorandum and articles of association.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
initial shareholders, sponsor, officers and directors have agreed, pursuant to a written agreement with us, that they will not propose
any amendment to our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation
to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we have not consummated
an initial business combination during the Extension Period or (B) with respect to any other material provisions relating to shareholders&#8217;
rights or pre-initial business combination activity, unless we provide our public shareholders with the opportunity to redeem their Class
A ordinary shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit
in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our taxes,
divided by the number of then outstanding public shares. Our shareholders are not parties to, or third-party beneficiaries of, these
agreements and, as a result, will not have the right to approve any waiver to these agreements and will not have the ability to pursue
remedies against our sponsor, officers or directors for any breach of these agreements. As a result, in the event of a breach, our shareholders
would need to pursue a shareholder derivative action, subject to applicable law.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business
combination targets, which may make it difficult for us to enter into a business combination with a target or prevent us from completing
the most desirable business combination or optimizing our capital structure.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Extension Amendment, our public shareholders elected to redeem 23,256,504 Class A ordinary shares. After giving effect
to those redemptions, we have approximately $111,740,624 in our trust account (after taking into account the $3,018,750 of deferred underwriting
commissions being held in the trust account). The amount of the deferred underwriting commissions payable to the underwriters will not
be adjusted for any shares that are redeemed in connection with a business combination and such amount of deferred underwriting discount
is not available for us to use as consideration in an initial business combination. Furthermore, in no event will we redeem our public
shares in an amount that would cause our net tangible assets, after payment of the deferred underwriting commissions, to be less than
$5,000,001 upon completion of our initial business combination, or any greater net tangible asset or cash requirement that may be contained
in the agreement relating to our initial business combination. Consequently, if accepting all properly submitted redemption requests
would cause our net tangible assets, after payment of the deferred underwriting commissions, to be less than $5,000,001 upon completion
of our initial business combination, we would not proceed with such redemption of our public shares and the related business combination,
and we may instead search for an alternate business combination. If we do not consummate the proposed Business Combination with Complete
Solaria and we seek to effectuate a business combination with another target, then we may seek to enter into a business combination transaction
agreement with a minimum cash requirement. If our initial business combination agreement requires us to use a portion of the cash in
the trust account to pay the purchase price, or requires us to have a minimum amount of cash at closing, then the probability that our
initial business combination would be unsuccessful is increased. If too many public shareholders exercise their redemption rights, then
we would not be able to meet such closing condition and, as a result, would not be able to proceed with the business combination. Alternatively,
we may seek to restructure the transaction to reserve a greater portion of the cash in the trust account or arrange for third-party financing.
Raising additional third-party financing may involve dilutive equity issuances or the incurrence of indebtedness at higher than desirable
levels. Furthermore, this dilution would increase to the extent that the anti-dilution provision of the Class B ordinary shares results
in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares at the time
of our initial business combination. Prospective targets will be aware of these risks and, thus, may be reluctant to enter into a business
combination transaction with us. If we are able to consummate an initial business combination, the per-share value of shares held by
non-redeeming shareholders will reflect our obligation to pay the deferred underwriting commissions. The above considerations may limit
our ability to complete the most desirable business combination available to us or optimize our capital structure.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our initial business combination is unsuccessful, you would not receive your pro rata portion of the trust account until we liquidate
the trust account. If you are in need of immediate liquidity, you could attempt to sell your shares in the open market; however, at such
time our shares may trade at a discount to the pro rata amount per share in the trust account. You may suffer a material loss on your
investment or lose the benefit of funds expected in connection with your exercise of redemption rights until we liquidate or you are
able to sell your shares in the open market.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 9.35pt"></p><div>

</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">&#160;</p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we must furnish our shareholders with the target business&#8217;s financial statements, we may lose the ability to complete an otherwise
advantageous initial business combination with some prospective target businesses.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
federal proxy rules require that the proxy statement with respect to the vote on an initial business combination include historical and
pro forma financial statement disclosure. We will include the same financial statement disclosure in connection with our tender offer
documents, whether or not they are required under the tender offer rules. These financial statements may be required to be prepared in
accordance with, or be reconciled to, accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) or
international financial reporting standards as issued by the International Accounting Standards Board (&#8220;IFRS&#8221;) depending
on the circumstances and the historical financial statements may be required to be audited in accordance with the standards of the Public
Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;). These financial statement requirements may limit the pool of
potential target businesses we may acquire because some targets may be unable to provide such financial statements in time for us to
disclose such statements in accordance with federal proxy rules and complete our initial business combination within the prescribed time
frame.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
requirement that we complete our initial business combination during the Extension Period may give potential target businesses leverage
over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business
combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial
business combination on terms that would produce value for our shareholders.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
potential target business with which we enter into negotiations concerning a business combination will be aware that we must complete
our initial business combination during the Extension Period. Consequently, such target business may obtain leverage over us in negotiating
a business combination, knowing that if we do not complete our initial business combination with that particular target business, we
may be unable to complete our initial business combination with any target business. This risk will increase as we get closer to the
timeframe described above. In addition, we may have limited time to conduct due diligence and may enter into our initial business combination
on terms that we would have rejected upon a more comprehensive investigation.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the funds available to us outside the trust account to fund our working capital requirements are insufficient to allow us to operate
for at least the Extension Period, it could limit the amount available to fund our search for a target business or businesses and complete
our initial business combination, and we will depend on loans from our sponsor or management team to fund our search and to complete
our initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, we had $72,923 available to us outside the trust account to fund our working capital requirements. On each of April
1, 2022 and June 6, 2022, we issued an unsecured promissory note in the amount of up to $500,000 to our sponsor; on December 14, 2022,
we issued an unsecured promissory note in the amount of up to $325,000 to Tidjane Thiam, the Company&#8217;s Executive Chairman, Adam
Gishen, the Company&#8217;s Chief Executive Officer, Edward Zeng, a director of the Company, and Abhishek Bhatia, a board observer of
the Company (collectively, the &#8220;Convertible Notes&#8221;). The Convertible Notes may be drawn down from time to time until we complete
our initial business combination for general working capital purposes, as further described in &#8220;Item 7. Management&#8217;s Discussion
and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources.&#8221; In addition, on February
28, 2023, we issued to our sponsor an unsecured promissory note in the amount of up to $2,100,000, $1,600,000 of which was drawn
down immediately, $400,000 of which may be drawn down, with the mutual consent of us and our sponsor, if we wish to
extend the date by which we will consummate a business combination beyond June 2, 2023, and $100,000 of which may be drawn down on an
as-needed basis at the discretion of our sponsor, to be used for general working capital purposes, as further described in &#8220;Item
7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Recent Developments&#8212;Promissory
Note.&#8221; We believe that the funds available to us outside of the trust account will be sufficient to allow us to operate for at
least the Extension Period; however, we cannot assure you that our estimate is accurate. Of the funds available to us, we could use a
portion of the funds available to us to pay fees to consultants to assist us with our search for a target business. We could also use
a portion of the funds as a down payment or to fund a &#8220;no-shop&#8221; provision (a provision in letters of intent or merger agreements
designed to keep target businesses from &#8220;shopping&#8221; around for transactions with other companies or investors on terms more
favorable to such target businesses) with respect to a particular proposed business combination, although we do not have any current
intention to do so. If we entered into a letter of intent or merger agreement where we paid for the right to receive exclusivity from
a target business and were subsequently required to forfeit such funds (whether as a result of our breach or otherwise), we might not
have sufficient funds to continue searching for, or conduct due diligence with respect to, a target business.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have in the past and may in the future need to borrow funds from our sponsor, management team or other third parties to operate or may
be forced to liquidate. Neither our sponsor, members of our management team nor any of their affiliates is under any obligation to advance
funds to, or invest in, us in such circumstances. Any such loans may be repaid only from funds held outside the trust account or from
funds released to us upon completion of our initial business combination. After giving effect to the $1,325,000 principal amount of Convertible
Notes, up to $675,000 of additional loans may be convertible into private placement warrants of the post-business combination entity
at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. Prior
to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor or an affiliate
of our sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights
to seek access to funds in our trust account. If we are unable to complete our initial business combination because we do not have sufficient
funds available to us, we will be forced to cease operations and liquidate the trust account. Consequently, our public shareholders may
only receive an estimated $10.00 per share, or possibly less, on our redemption of our public shares, and our warrants will expire worthless.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and
complete an initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for directors and officers liability insurance for special purpose acquisition companies has changed in ways adverse to us and
our management team. Fewer insurance companies are offering quotes for directors and officers liability coverage, the premiums charged
for such policies have generally increased and the terms of such policies have generally become less favorable. These trends may continue
into the future.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increased cost and decreased availability of directors and officers liability insurance could make it more difficult and more expensive
for us to negotiate and complete an initial business combination. In order to obtain directors and officers liability insurance or modify
its coverage as a result of becoming a public company, the post-business combination entity might need to incur greater expense and/or
accept less favorable terms. Furthermore, any failure to obtain adequate directors and officers liability insurance could have an adverse
impact on the post-business combination&#8217;s ability to attract and retain qualified officers and directors.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, after completion of any initial business combination, our directors and officers could be subject to potential liability from
claims arising from conduct alleged to have occurred prior to such initial business combination. As a result, in order to protect our
directors and officers, the post-business combination entity may need to purchase additional insurance with respect to any such claims
(&#8220;run-off insurance&#8221;). The need for run-off insurance would be an added expense for the post-business combination entity
and could interfere with or frustrate our ability to consummate an initial business combination on terms favorable to our investors.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be unable to obtain additional financing to complete our initial business combination or to fund the operations and growth of a target
business, which could compel us to restructure or abandon a particular business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
target businesses with enterprise values that are greater than we could acquire solely with the net proceeds of our initial public offering
and the sale of the private placement warrants. As a result, if the cash portion of the purchase price exceeds the amount available from
the trust account, net of amounts needed to satisfy any redemption by public shareholders and pay deferred underwriting commissions,
we may be required to seek additional financing to complete such proposed initial business combination. We cannot assure you that such
financing will be available on acceptable terms, if at all. To the extent that additional financing proves to be unavailable when needed
to complete our initial business combination, we would be compelled to either restructure the transaction or abandon that particular
business combination and seek an alternative target business candidate. Further, we may be required to obtain additional financing in
connection with the closing of our initial business combination for general corporate purposes, including for maintenance or expansion
of operations of the post-transaction businesses, the payment of principal or interest due on indebtedness incurred in completing our
initial business combination, or to fund the purchase of other companies. If we are unable to complete our initial business combination,
our public shareholders may only receive their pro rata portion of the funds in the trust account that are available for distribution
to public shareholders, and our warrants will expire worthless. In addition, even if we do not need additional financing to complete
our initial business combination, we may require such financing to fund the operations or growth of the target business. The failure
to secure additional financing could have a material adverse effect on the continued development or growth of the target business. None
of our officers, directors or shareholders is required to provide any financing to us in connection with or after our initial business
combination.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 9.35pt"></p><div>

</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">&#160;</p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to complete our initial business combination during the Extension Period, in which case we would cease all operations
except for the purpose of winding up and we would redeem our public shares and liquidate.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be able to find a suitable target business and complete our initial business combination during the Extension Period. Our ability
to complete our initial business combination may be negatively impacted by general market conditions, volatility in the capital and debt
markets and the other risks described herein. For example, the COVID-19 pandemic continues to grow both in the U.S. and globally and,
while the extent of the impact of the pandemic on us will depend on future developments, it could limit our ability to complete our initial
business combination, including as a result of increased market volatility, decreased market liquidity and third-party financing being
unavailable on terms acceptable to us or at all. Additionally, the COVID-19 pandemic may negatively impact businesses we may seek to
acquire. If we have not completed our initial business combination within such time period, we will: (i) cease all operations except
for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public
shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest
earned on the funds held in the trust account (less taxes payable and up to $100,000 of interest income to pay dissolution expenses),
divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders&#8217; rights
as shareholders (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible
following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve,
subject, in each case, to our obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the
other requirements of applicable law.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are not entitled to protections normally afforded to investors of many other blank check companies.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the net proceeds of our initial public offering and the sale of the private placement warrants are intended to be used to complete an
initial business combination with a target business that has not been selected, we may be deemed to be a &#8220;blank check&#8221; company
under the United States securities laws. However, because we have net tangible assets in excess of $5,000,000 as of the completion of
our initial public offering and the sale of the private placement warrants and we filed a Current Report on Form 8-K, including an audited
balance sheet demonstrating this fact, we are exempt from rules promulgated by the SEC to protect investors in blank check companies,
such as Rule 419. Accordingly, investors are not be afforded the benefits or protections of those rules. Among other things, this means
our units were immediately tradable and we have a longer period of time to complete our initial business combination than do companies
subject to Rule 419. Moreover, if our initial public offering were subject to Rule 419, that rule would have prohibited the release of
any interest earned on funds held in the trust account to us unless and until the funds in the trust account were released to us in connection
with our completion of an initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 9.35pt"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete
our initial business combination. If we are unable to complete our initial business combination, our public shareholders may receive
only their pro rata portion of the funds in the trust account that are available for distribution to public shareholders, and our warrants
will expire worthless.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to encounter competition from other entities having a business objective similar to ours, including private investors (which may
be individuals or investment partnerships), other blank check companies and other entities, domestic and international, competing for
the types of businesses we intend to acquire. Many of these individuals and entities are well-established and have extensive experience
in identifying and effecting, directly or indirectly, acquisitions of companies operating in or providing services to various industries.
Many of these competitors possess similar or greater technical, human and other resources to ours or more local industry knowledge than
we do and our financial resources will be relatively limited when contrasted with those of many of these competitors. Additionally, the
number of blank check companies looking for business combination targets has increased compared to recent years and many of these blank
check companies are sponsored by entities or persons that have significant experience with completing business combinations. While we
believe there are numerous target businesses we could potentially acquire with the net proceeds of our initial public offering and the
sale of the private placement warrants, our ability to compete with respect to the acquisition of certain target businesses that are
sizable will be limited by our available financial resources. This inherent competitive limitation gives others an advantage in pursuing
the acquisition of certain target businesses. Furthermore, we are obligated to offer holders of our public shares the right to redeem
their shares for cash at the time of our initial business combination in conjunction with a shareholder vote or via a tender offer. Target
companies will be aware that this may reduce the resources available to us for our initial business combination. Any of these obligations
may place us at a competitive disadvantage in successfully negotiating a business combination. If we are unable to complete our initial
business combination, our public shareholders may receive only their pro rata portion of the funds in the trust account that are available
for distribution to public shareholders, which may only be $10.00 per share or possibly less in certain circumstances, and our warrants
will expire worthless.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the number of special purpose acquisition companies increases, there may be more competition to find an attractive target for an initial
business combination. This could increase the costs associated with completing our initial business combination and may result in our
inability to find a suitable target for our initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
recent years, the number of special purpose acquisition companies that have been formed has increased substantially. Many companies have
entered into business combinations with special purpose acquisition companies, and there are still many special purpose acquisition companies
seeking targets for their initial business combination, as well as many additional special purpose acquisition companies currently in
registration. As a result, at times, fewer attractive targets may be available, and it may require more time, effort and resources to
identify a suitable target for an initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, because there are more special purpose acquisition companies seeking to enter into an initial business combination with available
targets, the competition for available targets with attractive fundamentals or business models may increase, which could cause target
companies to demand improved financial terms. Attractive deals could also become scarcer for other reasons, such as economic or industry
sector downturns, geopolitical tensions or increases in the cost of additional capital needed to close business combinations or operate
targets post-business combination. This could increase the cost of, delay or otherwise complicate or frustrate our ability to find a
suitable target for and/or complete our initial business combination.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
to our completion of our initial business combination, we may be required to take write-downs or write-offs, restructuring and impairment
or other charges that could have a significant negative effect on our financial condition, results of operations and the price of our
securities, which could cause you to lose some or all of your investment.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if we conduct extensive due diligence on a target business with which we combine, we cannot assure you that this diligence will identify
all material issues that may be present with a particular target business that it would be possible to uncover all material issues through
a customary amount of due diligence, or that factors outside of the target business and outside of our control will not later arise.
As a result of these factors, we may be forced to later write-down or write-off assets, restructure our operations, or incur impairment
or other charges that could result in our reporting losses. Even if our due diligence successfully identifies certain risks, unexpected
risks may arise and previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though
these charges may be non-cash items and not have an immediate impact on our liquidity, the fact that we report charges of this nature
could contribute to negative market perceptions about us or our securities. In addition, charges of this nature may cause us to violate
net worth or other covenants to which we may be subject as a result of assuming pre-existing debt held by a target business or by virtue
of our obtaining debt financing to partially finance the initial business combination or thereafter. Accordingly, any shareholders or
warrant holders who choose to remain shareholders or warrant holders following the business combination could suffer a reduction in the
value of their securities. Such shareholders or warrant holders are unlikely to have a remedy for such reduction in value.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 9.35pt"></p><div>

</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">&#160;</p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
third parties bring claims against us, the funds held in the trust account could be reduced and the per-share redemption amount received
by shareholders may be substantially less than $10.00 per share.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
placing of funds in the trust account may not protect those funds from third-party claims against us.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we will seek to have all vendors, service providers, prospective target businesses and other entities with which we do business execute
agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit
of our public shareholders, such parties may not execute such agreements, or even if they execute such agreements they may not be prevented
from bringing claims against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility
or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with
respect to a claim against our assets, including the funds held in the trust account. If any third party refuses to execute an agreement
waiving such claims to the monies held in the trust account, our management will consider whether competitive alternatives are reasonably
available to us and will only enter into an agreement with such third party if management believes that such third party&#8217;s engagement
would be in the best interests of the company under the circumstances. Marcum LLP, our independent registered public accounting firm,
and certain underwriters of our initial public offering will not execute agreements with us waiving such claims to the monies held in
the trust account.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Examples
of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third-party consultant
whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would
agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. In addition,
there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of,
any negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason. Upon redemption
of our public shares, if we have not completed our initial business combination within the prescribed timeframe, or upon the exercise
of a redemption right in connection with our initial business combination, we will be required to provide for payment of claims of creditors
that were not waived that may be brought against us within the 10 years following redemption. Accordingly, the per-share redemption amount
received by public shareholders could be less than the $10.00 per public share initially held in the trust account, due to claims of
such creditors. Our sponsor has agreed that it will be liable to us if and to the extent any claims by a third party (other than Marcum
LLP, our independent registered public accounting firm) for services rendered or products sold to us, or a prospective target business
with which we have entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement,
reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public
share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per public share due to reductions
in the value of the trust assets, in each case less taxes payable, provided that such liability will not apply to any claims by a third
party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or
not such waiver is enforceable) nor will it apply to any claims under our indemnity of the underwriters of our initial public offering
against certain liabilities, including liabilities under the Securities Act. However, we have not asked our sponsor to reserve for such
indemnification obligations, nor have we independently verified whether our sponsor has sufficient funds to satisfy its indemnity obligations
and we believe that our sponsor&#8217;s only assets are securities of our company. Therefore, we cannot assure you that our sponsor would
be able to satisfy those obligations. As a result, if any such claims were successfully made against the trust account, the funds available
for our initial business combination and redemptions could be reduced to substantially less than $10.00 per public share. In such event,
we may not be able to complete our initial business combination, and you would receive such lesser amount per share in connection with
any redemption of your public shares. None of our officers or directors will indemnify us for claims by third parties including, without
limitation, claims by vendors and prospective target businesses.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not have sufficient funds to satisfy indemnification claims of our directors and officers.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to indemnify our officers and directors to the fullest extent permitted by law. However, our officers and directors have
agreed to waive any right, title, interest or claim of any kind in or to any monies in the trust account and to not seek recourse against
the trust account for any reason whatsoever. Accordingly, any indemnification provided will be able to be satisfied by us only if (i)
we have sufficient funds outside of the trust account or (ii) we consummate an initial business combination. Our obligation to indemnify
our officers and directors may discourage shareholders from bringing a lawsuit against our officers or directors for breach of their
fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against our officers and
directors, even though such an action, if successful, might otherwise benefit us and our shareholders. Furthermore, a shareholder&#8217;s
investment may be adversely affected to the extent we pay the costs of settlement and damage awards against our officers and directors
pursuant to these indemnification provisions.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 9.35pt"></p><div>

</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities in which we invest the funds held in the trust account could bear a negative rate of interest, which could reduce the value
of the assets held in trust such that the per-share redemption amount received by public shareholders may be less than $10.00 per share.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proceeds held in the trust account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less
or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S.
government treasury obligations. While short-term U.S. government treasury obligations currently yield a positive rate of interest, they
have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates below zero in
recent years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the future adopt
similar policies in the United States. In the event that we do not to complete our initial business combination or make certain amendments
to our amended and restated memorandum and articles of association, our public shareholders are entitled to receive their pro-rata share
of the proceeds held in the trust account, plus any interest income earned thereon (less taxes payable and up to $100,000 of interest
income to pay dissolution expenses). Negative interest rates could reduce the value of the assets held in trust such that the per-share
redemption amount received by public shareholders may be less than $10.00 per share.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
after we distribute the funds in the trust account to our public shareholders, we file a bankruptcy or winding-up petition or an involuntary
bankruptcy or winding-up petition is filed against us that is not dismissed, a bankruptcy or insolvency court may seek to recover such
proceeds, and the members of our board of directors may be viewed as having breached their fiduciary duties to our creditors, thereby
exposing the members of our board of directors and us to claims of punitive damages.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
after we distribute the funds in the trust account to our public shareholders, we file a bankruptcy or winding-up petition or an involuntary
bankruptcy or winding-up petition is filed against us that is not dismissed, any distributions received by shareholders could be viewed
under applicable debtor/creditor and/or bankruptcy or insolvency laws as either a &#8220;preferential transfer&#8221; or a &#8220;fraudulent
conveyance.&#8221; As a result, a bankruptcy or insolvency court could seek to recover some or all amounts received by our shareholders.
In addition, our board of directors may be viewed as having breached its fiduciary duty to our creditors and/or having acted in bad faith,
thereby exposing itself and us to claims of punitive damages, by paying public shareholders from the trust account prior to addressing
the claims of creditors.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
before distributing the funds in the trust account to our public shareholders, we file a bankruptcy or winding-up petition or an involuntary
bankruptcy or winding-up petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority
over the claims of our shareholders and the per-share amount that would otherwise be received by our shareholders in connection with
our liquidation may be reduced.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
before distributing the funds in the trust account to our public shareholders, we file a bankruptcy or winding-up petition or an involuntary
bankruptcy or winding-up petition is filed against us that is not dismissed, the funds held in the trust account could be subject to
applicable bankruptcy or insolvency law, and may be included in our bankruptcy estate and subject to the claims of third parties with
priority over the claims of our shareholders. To the extent any bankruptcy claims deplete the trust account, the per-share amount that
would otherwise be received by our shareholders in connection with our liquidation may be reduced.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors may decide not to enforce the indemnification obligations of our sponsor, resulting in a reduction in the amount of funds in
the trust account available for distribution to our public shareholders.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the funds in the trust account are reduced below the lesser of (i) $10.00 per public share and (ii) the actual amount
per public share held in the trust account as of the date of the liquidation of the trust account if less than $10.00 per public share
due to reductions in the value of the trust assets, in each case less taxes payable, and our sponsor asserts that it is unable to satisfy
its obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine
whether to take legal action against our sponsor to enforce its indemnification obligations. While we currently expect that our independent
directors would take legal action on our behalf against our sponsor to enforce its indemnification obligations to us, it is possible
that our independent directors in exercising their business judgment and subject to their fiduciary duties may choose not to do so in
any particular instance if, for example, the cost of such legal action is deemed by the independent directors to be too high relative
to the amount recoverable or if the independent directors determine that a favorable outcome is not likely. If our independent directors
choose not to enforce these indemnification obligations, the amount of funds in the trust account available for distribution to our public
shareholders may be reduced below $10.00 per share.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 9.35pt"></p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has recently issued proposed rules relating to certain activities of special purpose acquisition companies. Certain of the procedures
that we, a potential business combination target or others may determine to undertake in connection with such proposals may increase
our costs and the time needed to complete our initial business combination and may constrain the circumstances under which we could complete
an initial business combination. The need for compliance with the SPAC Rule&#160;Proposals may cause us to liquidate the funds in the
Trust Account or liquidate the Company at an earlier time than we might otherwise choose.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March&#160;30, 2022, the SEC issued proposed rules (the &#8220;SPAC Rule&#160;Proposals&#8221;) relating, among other things, to disclosures
in SEC filings in connection with business combination transactions between special purpose acquisition companies such as us and private
operating companies; the financial statement requirements applicable to transactions involving shell companies; the use of projections
by special purpose acquisition companies in SEC filings in connection with proposed business combination transactions; the potential
liability of certain participants in proposed business combination transactions; and the extent to which special purpose acquisition
companies could become subject to regulation under the Investment Company Act, including a proposed rule that would provide special purpose
acquisition companies a safe harbor from treatment as an investment company if they satisfy certain conditions that limit a special purpose
acquisition company&#8217;s duration, asset composition, business purpose and activities. The SPAC Rule&#160;Proposals have not yet been
adopted, and may be adopted in the proposed form or in a different form that could impose additional regulatory requirements on special
purpose acquisition companies. Certain of the procedures that we, a potential business combination target or others may determine to
undertake in connection with the SPAC Rule&#160;Proposals, or pursuant to the SEC&#8217;s views expressed in the SPAC Rule&#160;Proposals,
may increase the costs and time of negotiating and completing an initial business combination, and may constrain the circumstances under
which we could complete an initial business combination. The need for compliance with the SPAC Rule&#160;Proposals may cause us to liquidate
the funds in the trust account or liquidate the Company at an earlier time than we might otherwise choose. Were we to liquidate, our
warrants would expire worthless, and our securityholders would lose the investment opportunity associated with an investment in the combined
company, including potential price appreciation of our securities.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements
and our activities may be restricted, which may make it difficult for us to complete our initial business combination. To mitigate the
risk of being deemed to be an investment company for purposes of the Investment Company Act, we may instruct trustee of the trust account
to liquidate the securities held in the trust account and instead hold all funds in the trust account in a bank deposit account.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including:</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
                                            on the nature of our investments; and</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
                                            on the issuance of securities, each of which may make it difficult for us to complete our
                                            initial business combination. In addition, we may have imposed upon us burdensome requirements,
                                            including:</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">registration
                                            as an investment company with the SEC;</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adoption
                                            of a specific form of corporate structure; and</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reporting,
                                            record keeping, voting, proxy and disclosure requirements and other rules and regulations
                                            that we are currently not subject to.</span></td></tr></table><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must
ensure that we are engaged primarily in a business other than investing, reinvesting or trading of securities and that our activities
do not include investing, reinvesting, owning, holding or trading &#8220;investment securities&#8221; constituting more than 40% of our
assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. Our business is to identify and complete
a business combination and thereafter to operate the post-transaction business or assets for the long term. We do not plan to buy businesses
or assets with a view to resell or profit from their resale. We do not plan to buy unrelated businesses or assets or to be a passive
investor.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described further above, the SPAC Rule Proposals relate, among other matters, to the circumstances in which special purpose acquisition
companies such as us could potentially be subject to the Investment Company Act and the regulations thereunder. The SPAC Rule Proposals
would provide a safe harbor for such companies from the definition of &#8220;investment company&#8221; under Section&#160;3(a)(1)(A)
of the Investment Company Act, provided that a special purpose acquisition company satisfies certain criteria, including a limited time
period to announce and complete a&#160;de-SPAC&#160;transaction. Specifically, to comply with the safe harbor, the SPAC Rule Proposals
would require a company to file a report on Form&#160;8-K&#160;announcing that it has entered into an agreement with a target company
for a business combination no later than 18 months after the effective date of its registration statement for its initial public offering.
The company would then be required to complete its initial business combination no later than 24 months after the effective date of the
registration statement for its initial public offering.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently some uncertainty concerning the applicability of the Investment Company Act to a special purpose acquisition company. We
completed our initial public offering in March 2021 and have operated as a blank check company searching for a target business with which
to consummate a business combination since such time. As a result, it is possible that a claim could be made that we have been operating
as an unregistered investment company.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts held in the trust account have, since our initial public offering and until the 24-month anniversary of our initial public offering,
been invested only in United States &#8220;government securities&#8221; within the meaning of Section 2(a)(16) of the Investment Company
Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment
Company Act which invest only in direct U.S. government treasury obligations. The longer that the funds in the trust account are held
in U.S. government securities or in money market funds invested exclusively in such securities, the greater risk that we may be considered
an unregistered investment company, in which case we may be required to liquidate. To mitigate the risk of us being deemed to have been
operating as an unregistered investment company, prior to the&#160;24-month&#160;anniversary of the consummation of our initial public
offering, we instructed Continental, the trustee with respect to the trust account, to liquidate the U.S. government treasury obligations
or money market funds held in the trust account and to hold all funds in the trust account in cash in a bank deposit account. Interest
on the bank deposit account is variable and yields materially less than the trust account&#8217;s prior investments in U.S. government
treasury obligations and money market funds.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we were deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional
expenses for which we have not allotted funds and may hinder our ability to complete a business combination. If we are unable to complete
our initial business combination, our public shareholders may only receive their pro rata portion of the funds in the trust account that
are available for distribution to public shareholders, and our warrants will expire worthless. The trust account is intended as a holding
place for funds pending the earliest to occur of either: (i) the completion of our initial business combination; (ii) the redemption
of any public shares properly submitted in connection with a shareholder vote to amend our amended and restated memorandum and articles
of association (A) to modify the substance or timing of our obligation to allow redemption in connection with our initial business combination
or to redeem 100% of our public shares if we have not consummated an initial business combination during the Extension Period or (B)
with respect to any other material provisions relating to shareholders&#8217; rights or pre-initial business combination activity; or
(iii) absent an initial business combination during the Extension Period, our return of the funds held in the trust account to our public
shareholders as part of our redemption of the public shares.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
warrants are accounted for as liabilities and the changes in value of our warrants could have a material effect on our financial results.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the SEC together issued a statement
regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled &#8220;Staff
Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (the &#8220;SEC Statement&#8221;).
Specifically, the SEC Statement focused on certain settlement terms and provisions related to certain tender offers following a business
combination, which terms are similar to those contained in the warrant agreement governing our warrants.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, included on our consolidated balance sheet as of December 31, 2022 contained elsewhere in this Annual Report are
derivative liabilities related to embedded features contained within our warrants. Accounting Standards Codification 815,
&#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;), provides for the remeasurement of the fair value of such derivatives at each balance
sheet date, with a resulting non-cash gain or loss related to the change in the fair value being recognized in earnings in the
statements of operations. As a result of the recurring fair value measurement, our financial statements and results of operations
may fluctuate quarterly based on factors which are outside of our control. Due to the recurring fair value measurement, we expect
that we will recognize non-cash gains or losses on our warrants each reporting period and that the amount of such gains or losses
could be material.</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have identified a material weakness in our internal control over financial reporting. This material weakness could continue to adversely
affect our ability to report our results of operations and financial condition accurately and in a timely manner.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is responsible for establishing and maintaining adequate internal control over financial reporting designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with GAAP. Our management is likewise required, on a quarterly basis, to evaluate the effectiveness of our internal controls and to disclose
any changes and material weaknesses identified through such evaluation in those internal controls. A material weakness is a deficiency,
or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material
misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in">As described elsewhere in this Annual Report, we determined that a
material weakness exists in our internal control over financial reporting related to the accounting for complex financial instruments,
accrued expenses and accounts payable, and foreign exchange transactions. As a result of this material weakness, our management concluded
that our internal control over financial reporting was not effective as of December 31, 2022. This material weakness resulted in a material
misstatement of our warrant liabilities, change in fair value of warrant liabilities, additional paid-in capital, accumulated deficit
and related financial disclosures.</p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
respond to this material weakness, we have devoted, and plan to continue to devote, significant effort and resources to the remediation
and improvement of our internal control over financial reporting. While we have processes to identify and appropriately apply applicable
accounting requirements, we are enhancing these processes to better evaluate our research and understanding of the nuances of the complex
accounting standards that apply to our financial statements, including providing enhanced access to accounting literature, research materials
and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting
applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives
will ultimately have the intended effects.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
failure to maintain such internal control could adversely impact our ability to report our financial position and results from operations
on a timely and accurate basis. If our financial statements are not accurate, investors may not have a complete understanding of our
operations. Likewise, if our financial statements are not filed on a timely basis, we could be subject to sanctions or investigations
by the stock exchange on which our ordinary shares are listed, the SEC or other regulatory authorities. In either case, there could result
a material adverse effect on our business. Failure to timely file will cause us to be ineligible to utilize short form registration statements
on Form S-3 or Form S-4, which may impair our ability to obtain capital in a timely fashion to execute our business strategies or issue
shares to effect an acquisition. Ineffective internal controls could also cause investors to lose confidence in our reported financial
information, which could have a negative effect on the trading price of our securities.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
can give no assurance that the measures we have taken and plan to take in the future will remediate the material weakness identified
or that any additional material weaknesses or restatements of financial results will not arise in the future due to a failure to implement
and maintain adequate internal control over financial reporting or circumvention of these controls. In addition, even if we are successful
in strengthening our controls and procedures, in the future those controls and procedures may not be adequate to prevent or identify
irregularities or errors or to facilitate the fair presentation of our financial statements.</span></p><div>

</div><p style="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; padding-left: 0pt; margin: 0pt 0pt 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt"><b><i>Our independent registered public accounting
firm&#8217;s report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a &#8220;going
concern.&#8221;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In connection with our assessment of going concern
considerations in accordance with Financial Accounting Standards Board&#8217;s Accounting Standards Update 2014-15, &#8220;Disclosures
of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; we have determined that if we are unable to complete
a business combination during the Extension Period, then we will cease all operations except for the purpose of liquidating. The date
for mandatory liquidation and subsequent dissolution, as well as our liquidity condition, raise substantial doubt about our ability to continue as a going concern. The financial
statements contained elsewhere in this report do not include any adjustments that might result from our inability to continue as a going
concern.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">We may face litigation and other risks as a
result of the material weakness in our internal control over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">As a result of the material weakness described
in &#8220;Item 9A. Controls and Procedures,&#8221; we face potential for litigation or other disputes which may include, among others,
claims invoking the federal and state securities laws, contractual claims or other claims arising from the restatement and material weaknesses
in our internal control over financial reporting and the preparation of our financial statements. As of the date of this Annual Report,
we have no knowledge of any such litigation or dispute. However, we can provide no assurance that such litigation or dispute will not
arise in the future. Any such litigation or dispute, whether successful or not, could have a material adverse effect on our business,
results of operations and financial condition or our ability to complete our initial business combination.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Compliance obligations under the Sarbanes-Oxley
Act may make it more difficult for us to effectuate our initial business combination, require substantial financial and management resources,
and increase the time and costs of completing an initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Section 404 of the Sarbanes-Oxley Act requires
that we evaluate and report on our system of internal controls. Only in the event we are deemed to be a large accelerated filer or an
accelerated filer, and no longer qualify as an emerging growth company, will we be required to comply with the independent registered
public accounting firm attestation requirement on our internal control over financial reporting. The fact that we are a blank check company
makes compliance with the requirements of the Sarbanes-Oxley Act particularly burdensome on us as compared to other public companies because
a target business with which we seek to complete our initial business combination may not be in compliance with the provisions of the
Sarbanes-Oxley Act regarding adequacy of its internal controls. The development of the internal controls of any such entity to achieve
compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such business combination.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Changes in laws or regulations, or a failure
to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial
business combination, and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We are subject to laws and regulations enacted
by national, regional and local governments. In particular, we will be required to comply with certain SEC and other legal requirements,
our business combination may be contingent on our ability to comply with certain laws and regulations and any post-business combination
company may be subject to additional laws and regulations. Compliance with, and monitoring of, applicable laws and regulations may be
difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to
time, including as a result of changes in economic, political, social and government policies, and those changes could have a material
adverse effect on our business, including our ability to negotiate and complete our initial business combination, and results of operations.
In addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect
on our business, including our ability to negotiate and complete our initial business combination, and results of operations.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Cyber incidents or attacks directed at us could
result in information theft, data corruption, operational disruption and/or financial loss.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We depend on digital technologies, including information
systems, infrastructure and cloud applications and services, including those of third parties with which we may deal. Sophisticated and
deliberate attacks on, or security breaches in, our systems or infrastructure, or the systems or infrastructure of third parties or the
cloud, could lead to corruption or misappropriation of our assets, proprietary information and sensitive or confidential data. As an early
stage company without significant investments in data security protection, we may not be sufficiently protected against such occurrences.
We may not have sufficient resources to adequately protect against, or to investigate and remediate any vulnerability to, cyber incidents.
It is possible that any of these occurrences, or a combination of them, could have adverse consequences on our business and lead to financial
loss.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Risks Associated with Our Securities and Redemption</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">The NYSE may delist our securities from trading
on its exchange, which could limit investors&#8217; ability to make transactions in our securities and subject us to additional trading
restrictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our units, Class A ordinary shares and warrants
are listed on the NYSE. We cannot assure you that our securities will continue to be listed on the NYSE in the future or prior to our
initial business combination. In order to continue listing our securities on the NYSE prior to our initial business combination, we must
maintain certain financial, distribution and share price levels. Generally, following our initial public offering, we must maintain a
minimum amount in Shareholders&#8217; equity (generally $2,500,000) and a minimum number of holders of our securities (generally 300 public
holders). Additionally, in connection with our initial business combination, we will be required to demonstrate compliance with the NYSE&#8217;s
initial listing requirements, which are more rigorous than the NYSE&#8217;s continued listing requirements, in order to continue to maintain
the listing of our securities on the NYSE. For instance, in order for our Class A ordinary shares to be listed upon the consummation of
our initial business combination, at such time, our share price would generally be required to be at least $4.00 per share, our global
market capitalization would be required to be at least $200 million, the aggregate market value of publicly-held shares would be required
to be at least $100 million and we would be required to have at least 400 round lot holders. We cannot assure you that we will be able
to meet those initial listing requirements at that time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">If the NYSE delists any of our securities from
trading on its exchange and we are not able to list such securities on another national securities exchange, we expect our securities
could be quoted on an over-the-counter market. If this were to occur, we cou<span style="font-family: Times New Roman, Times, Serif">ld
face significant material adverse consequences, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif">a
                                            limited availability of market quotations for our securities;</span></td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                          </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif">reduced
                                            liquidity for our securities;</span></td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                          </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif">a
                                            determination that our Class A ordinary shares are a &#8220;penny stock&#8221; which will
                                            require brokers trading in our Class A ord</span>inary shares to adhere to more stringent
                                            rules and possibly result in a reduced level of trading activity in the secondary trading
                                            market for our securities;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>a limited amount of news and analyst coverage; and</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                     </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>a decreased ability to issue additional securities or obtain additional financing in the future.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The National Securities Markets Improvement Act
of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred
to as &#8220;covered securities.&#8221; Because our units and our Class A ordinary shares and warrants are listed on the NYSE, our units,
Class A ordinary shares and warrants qualify as covered securities under the statute. Although the states are preempted from regulating
the sale of covered securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and,
if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case.
While we are not aware of a state having used these powers to prohibit or restrict the sale of securities issued by blank check companies,
other than the State of Idaho, certain state securities regulators view blank check companies unfavorably and might use these powers,
or threaten to use these powers, to hinder the sale of securities of blank check companies in their states. Further, if we were no longer
listed on the NYSE, our securities would not qualify as covered securities under the statute and we would be subject to regulation in
each state in which we offer our securities.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Our initial shareholders control a substantial
interest in us and thus may exert a substantial influence on actions requiring a shareholder vote, potentially in a manner that you do
not support.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our initial shareholders own approximately 20%
of our issued and outstanding ordinary shares and only holders of Class B ordinary shares will have the right to appoint or remove directors
in any general meeting held prior to or in connection with the completion of our initial business combination. Accordingly, our initial
shareholders may exert a substantial influence on actions requiring a shareholder vote, potentially in a manner that you do not support,
including amendments to our amended and restated memorandum and articles of association. If our initial shareholders purchase any additional
Class A ordinary shares in the aftermarket or in privately negotiated transactions, this would increase their control. Neither our initial
shareholders nor, to our knowledge, any of our officers or directors, have any current intention to purchase additional securities. Factors
that would be considered in making such additional purchases would include consideration of the current trading price of our Class A ordinary
shares. In addition, our board of directors, whose members were appointed by our sponsor, is and will be divided into three classes, each
of which will generally serve for a term of three years with only one class of directors being appointed in each year. We may not hold
an annual general meeting to appoint or remove new directors prior to the completion of our initial business combination, in which case
all of the current directors will continue in office until at least the completion of the business combination. If there is an annual
general meeting prior to our initial business combination, as a consequence of our &#8220;staggered&#8221; board of directors, only a
minority of the board of directors will be considered for appointment and our initial shareholders, because of their ownership position,
will control the outcome. In addition, we have agreed not to enter into a definitive agreement regarding an initial business combination
without the prior written consent of NextG. Accordingly, our initial shareholders will continue to exert control at least until the completion
of our initial business combination.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">We may not hold an annual general meeting until
after the consummation of our initial business combination, which could delay the opportunity for our shareholders to appoint directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In accordance with NYSE corporate governance requirements,
we are not required to hold an annual general meeting until one year after our first fiscal year end following our listing on the NYSE.
There is no requirement under the Companies Act for us to hold annual or extraordinary general meetings to appoint directors. Until we
hold an annual general meeting, public shareholders may not be afforded the opportunity to appoint directors and to discuss company affairs
with management. Our board of directors is divided into three classes with only one class of directors being appointed in each year and
each class (except for those directors appointed prior to our first general meeting) serving a three-year term. In addition, as holders
of our Class A ordinary shares, our public shareholders will not have the right to vote on the appointment of directors until after the
consummation of our initial business combination.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Provisions in our amended and restated memorandum
and articles of association may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future
for our Class A ordinary shares and could entrench management.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our amended and restated memorandum and articles
of association contain provisions that may discourage unsolicited takeover proposals that shareholders may consider to be in their best
interests. These provisions include a staggered board of directors and the ability of the board of directors to designate the terms of
and issue new series of preferred shares, which may make the removal of management more difficult and may discourage transactions that
otherwise could involve payment of a premium over prevailing market prices for our securities.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Our letter agreement with our initial shareholders,
sponsor, officers and directors, subscription agreements, and registration rights agreement may be amended without shareholder approval.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our letter agreement with our initial shareholders,
sponsor, officers and directors contains provisions relating to transfer restrictions of our founder shares and private placement warrants,
indemnification of the trust account, waiver of redemption rights and participation in liquidating distributions from the trust account.
The letter agreement, subscription agreements, and the registration rights agreement may be amended, and provisions therein may be waived,
without shareholder approval. On June 6, 2022, we amended our letter agreement to permit us to pay China Bridge Capital, which is an affiliate
of NextG, for certain advisory services and investment banking services to us in connection with a potential business combination.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">You will not have any rights or interests in
funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to
sell your public shares or warrants, potentially at a loss.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our public shareholders will be entitled to receive
funds from the trust account only upon the earliest to occur of: (i) our completion of an initial business combination, and then only
in connection with those Class A ordinary shares that such shareholder properly elected to redeem, subject to the limitations and on the
conditions described herein, (ii) the redemption of any public shares properly submitted in connection with a shareholder vote to amend
our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to allow redemption
in connection with our initial business combination or to redeem 100% of our public shares if we have not consummated an initial business
combination during the Extension Period or (B) with respect to any other material provisions relating to shareholders&#8217; rights or
pre-initial business combination activity, and (iii) the redemption of our public shares if we have not completed an initial business
combination during the Extension Period, subject to applicable law and as further described herein. In no other circumstances will a public
shareholder have any right or interest of any kind in the trust account. Holders of warrants will not have any right to the funds held
in the trust account with respect to the warrants. Accordingly, to liquidate your investment, you may be forced to sell your public shares
or warrants, potentially at a loss.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">If a shareholder fails to receive notice of
our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for
submitting or tendering its shares, such shares may not be redeemed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We will comply with the proxy rules or tender
offer rules, as applicable, when conducting redemptions in connection with our initial business combination. Despite our compliance with
these rules, if a shareholder fails to receive our proxy materials or tender offer documents, as applicable, such shareholder may not
become aware of the opportunity to redeem its shares. In addition, proxy materials or tender offer documents, as applicable, that we will
furnish to holders of our public shares in connection with our initial business combination will describe the various procedures that
must be complied with in order to validly tender or submit public shares for redemption. For example, we intend to require our public
shareholders seeking to exercise their redemption rights, whether they are record holders or hold their shares in &#8220;street name,&#8221;
to, at the holder&#8217;s option, either deliver their share certificates to our transfer agent, or to deliver their shares to our transfer
agent electronically prior to the date set forth in the proxy materials or tender offer documents, as applicable. In the case of proxy
materials, this date may be up to two business days prior to the scheduled vote on the proposal to approve the initial business combination.
In addition, if we conduct redemptions in connection with a shareholder vote, we intend to require a public shareholder seeking redemption
of its public shares to also submit a written request for redemption to our transfer agent two business days prior to the scheduled vote
in which the name of the beneficial owner of such shares is included. In the event that a shareholder fails to comply with these or any
other procedures disclosed in the proxy or tender offer materials, as applicable, its shares may not be redeemed. See the section of this
Annual Report entitled &#8220;Item 1. Business&#8212; Delivering Share Certificates in Connection with the Exercise of Redemption Rights.&#8221;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">If we seek shareholder approval of our initial
business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a &#8220;group&#8221; of shareholders
are deemed to hold in excess of 15% of our Class A ordinary shares, you will lose the ability to redeem all such shares in excess of 15%
of our Class A ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">If we seek shareholder approval of our initial
business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer
rules, our amended and restated memorandum and articles of association provide that a public shareholder, together with any affiliate
of such shareholder or any other person with whom such shareholder is acting in concert or as a &#8220;group&#8221; (as defined under
Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an aggregate of 15% of the
shares sold in our initial public offering, which we refer to as the &#8220;Excess Shares,&#8221; without our prior consent. However,
we would not be restricting our shareholders&#8217; ability to vote all of their shares (including Excess Shares) for or against our initial
business combination. Your inability to redeem the Excess Shares will reduce your influence over our ability to complete our initial business
combination and you could suffer a material loss on your investment in us if you sell Excess Shares in open market transactions. Additionally,
you will not receive redemption distributions with respect to the Excess Shares if we complete our initial business combination. And as
a result, you will continue to hold that number of shares exceeding 15% and, in order to dispose of such shares, would be required to
sell your shares in open market transactions, potentially at a loss.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">If we are unable to consummate our initial business
combination within the allotted time period, our public shareholders may be forced to wait beyond the Extension Period before redemption
from our trust account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">If we are unable to consummate our initial business
combination within the allotted time period, the funds then on deposit in the trust account, including interest earned on the funds held
in the trust account (less taxes payable and up to $100,000 of interest income to pay dissolution expenses), will be used to fund the
redemption of our public shares, as further described herein. Any redemption of public shareholders from the trust account will be effected
automatically by function of our amended and restated memorandum and articles of association prior to any voluntary winding up. If we
are required to wind-up, liquidate the trust account and distribute such amount therein, pro rata, to our public shareholders, as part
of any liquidation process, such winding up, liquidation and distribution must comply with the applicable provisions of the Companies
Act. In that case, investors may be forced to wait beyond the allotted time period before the redemption proceeds of our trust account
become available to them, and they receive the return of their pro rata portion of the funds from our trust account. We have no obligation
to return funds to investors prior to the date of our redemption or liquidation unless, prior thereto, we consummate our initial business
combination or amend certain provisions of our amended and restated memorandum and articles of association and only then in cases where
investors have properly sought to redeem their Class A ordinary shares. Only upon our redemption or any liquidation will public shareholders
be entitled to distributions if we are unable to complete our initial business combination within the required time period and do not
amend certain provisions of our amended and restated memorandum and articles of association prior thereto.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Our shareholders may be held liable for claims
by third parties against us to the extent of distributions received by them upon redemption of their shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">If we are forced to enter into an insolvent liquidation,
any distributions received by shareholders could be viewed as an unlawful payment if it was proved that immediately following the date
on which the distribution was made, we were unable to pay our debts as they fall due in the ordinary course of business. As a result,
a liquidator could seek to recover some or all amounts received by our shareholders. Furthermore, our directors may be viewed as having
breached their fiduciary duties to us or our creditors and/or may have acted in bad faith, thereby exposing themselves and our company
to claims, by paying public shareholders from the trust account prior to addressing the claims of creditors. We cannot assure you that
claims will not be brought against us for these reasons. We and our directors and officers who knowingly and willfully authorized or permitted
any distribution to be paid out of our share premium account while we were unable to pay our debts as they fall due in the ordinary course
of business would be guilty of an offence and may be liable to a fine of $18,293 and to imprisonment for five years in the Cayman Islands.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">You will not be permitted to exercise your warrants
unless we register and qualify the underlying Class A ordinary shares or certain exemptions are available.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">If the issuance of the Class A ordinary shares
upon exercise of the warrants is not registered, qualified or exempt from registration or qualification under the Securities Act and applicable
state securities laws, holders of warrants will not be entitled to exercise such warrants and such warrants may have no value and expire
worthless. In such event, holders who acquired their warrants as part of a purchase of units will have paid the full unit purchase price
solely for the Class A ordinary shares included in the units.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have not registered, and will not register
the Class A ordinary shares issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time.
However, under the terms of the warrant agreement, we have agreed that, as soon as practicable, but in no event later than 15 business
days, after the closing of our initial business combination, we will use our commercially reasonable efforts to file with the SEC a registration
statement covering the registration under the Securities Act of the issuance of the Class A ordinary shares issuable upon exercise of
the warrants and thereafter will use our commercially reasonable efforts to cause the same to become effective within 60 business days
following our initial business combination and to maintain a current prospectus relating to the Class A ordinary shares issuable upon
exercise of the warrants until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement.
We cannot assure you that we will be able to do so if, for example, any facts or events arise which represent a fundamental change in
the information set forth in the registration statement or prospectus, the financial statements contained or incorporated by reference
therein are not current, complete or correct or the SEC issues a stop order.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">If the Class A ordinary shares issuable upon exercise
of the warrants are not registered under the Securities Act, under the terms of the warrant agreement, holders of warrants who seek to
exercise their warrants will not be permitted to do so for cash and, instead, will be required to do so on a cashless basis, in which
case the number of Class A ordinary shares that the holders of warrants will receive upon cashless exercise will be based on a formula
subject to a maximum number of shares equal to 0.361 Class A ordinary shares per warrant (subject to adjustment).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In no event will warrants be exercisable for cash
or on a cashless basis, and we will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance
of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption
from registration or qualification is available.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">If our Class A ordinary shares are at the time
of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221;
under Section 18(b)(1) of the Securities Act, we may, at our option, not permit holders of warrants who seek to exercise their warrants
to do so for cash and, instead, require them to do so on a cashless basis in accordance with Section 3(a)(9) of the Securities Act; in
the event we so elect, we will not be required to file or maintain in effect a registration statement or register or qualify the shares
underlying the warrants under applicable state securities laws, and in the event we do not so elect, we will use our commercially reasonable
efforts to register or qualify the shares underlying the warrants under applicable state securities laws to the extent an exemption is
not available.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In no event will we be required to net cash settle
any warrant, or issue securities (other than upon a cashless exercise as described above) or other compensation in exchange for the warrants
in the event that we are unable to register or qualify the shares underlying the warrants under the Securities Act or applicable state
securities laws.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">The grant of registration rights to our initial
shareholders and holders of our private placement warrants may make it more difficult to complete our initial business combination, and
the future exercise of such rights may adversely affect the market price of our Class A ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Pursuant to an agreement that was entered into
concurrently with the consummation of our initial public offering, our initial shareholders and their permitted transferees can demand
that we register the resale of the Class A ordinary shares into which founder shares are convertible, holders of our private placement
warrants and their permitted transferees can demand that we register the resale of the private placement warrants and the Class A ordinary
shares issuable upon exercise of the private placement warrants, and holders of warrants that may be issued upon conversion of working
capital loans may demand that we register the resale of such warrants or the Class A ordinary shares issuable upon exercise of such warrants.
We will bear the cost of registering these securities. The registration and availability of such a significant number of securities for
trading in the public market may have an adverse effect on the market price of our Class A ordinary shares. In addition, the existence
of the registration rights may make our initial business combination more costly or difficult to conclude. This is because the shareholders
of the target business may increase the equity stake they seek in the combined entity or ask for more cash consideration to offset the
negative impact on the market price of our Class A ordinary shares that is expected when the ordinary shares owned by our initial shareholders,
holders of our private placement warrants or holders of our working capital loans or their respective permitted transferees are registered
for resale.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt"><b><i>We may amend the terms of the warrants in
a manner that may be adverse to holders of public warrants with the approval by the holders of at least 65% of the then outstanding public
warrants. As a result, the exercise price of your warrants could be increased, the exercise period could be shortened and the number of
Class A ordinary shares purchasable upon exercise of a warrant could be decreased, all without your approval.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our warrants are issued in registered form under
a warrant agreement between Continental Stock Transfer &amp; Trust Company, as warrant agent, and us. The warrant agreement provides that
the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but
requires the approval by the holders of at least 65% of the then outstanding public warrants to make any change that adversely affects
the interests of the registered holders of public warrants. Accordingly, we may amend the terms of the public warrants in a manner adverse
to a holder of public warrants if holders of at least 65% of the then outstanding public warrants approve of such amendment. Although
our ability to amend the terms of the public warrants with the consent of at least 65% of the then outstanding public warrants is unlimited,
examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, convert the warrants
into cash or shares, shorten the exercise period or decrease the number of Class A ordinary shares purchasable upon exercise of a warrant.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">A provision of our warrant agreement may make
it more difficult for us to consummate an initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">If (i) we issue additional ordinary shares or
equity-linked securities for capital-raising purposes in connection with the closing of our initial business combination at a Newly Issued
Price of less than $9.20 per Class A ordinary share, (ii) the aggregate gross proceeds from such issuances represent more than 60% of
the total equity proceeds, and interest thereon, available for the funding of our initial business combination (net of redemptions), and
(iii) the volume weighted average trading price of our Class A ordinary shares during the 20 trading day period starting on the trading
day prior to the day on which we consummate our initial business combination (such price, the &#8220;Market Value&#8221;) of our Class
A ordinary shares is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal
to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices will
be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
This may make it more difficult for us to consummate an initial business combination with a target business.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">We may redeem your unexpired warrants prior
to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have the ability to redeem the outstanding
warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, if, among other things,
the last reported sales price of our Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending
on the third trading day prior to the date on which we send the notice of redemption to the warrant holders (the &#8220;Reference Value&#8221;).
If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the
underlying securities for sale under all applicable state securities laws. Redemption of the outstanding warrants as described above could
force you to (i) exercise your warrants and pay the exercise price therefor at a time when it may be disadvantageous for you to do so,
(ii) sell your warrants at the then-current market price when you might otherwise wish to hold your warrants or (iii) accept the nominal
redemption price which, at the time the outstanding warrants are called for redemption, we expect would be substantially less than the
Market Value of your warrants. None of the private placement warrants will be redeemable by us so long as they are held by our sponsors
or their permitted transferees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In addition, we have the ability to redeem the
outstanding warrants at any time after they become exercisable and prior to their expiration, at a price of $0.10 per warrant if, among
other things, the Reference Value equals or exceeds $10.00 per share (as adjusted). In such a case, the holders will be able to exercise
their warrants prior to redemption for a number of our Class A ordinary shares determined based on the redemption date and the fair market
value of our Class A ordinary shares. The value received upon exercise of the warrants (1) may be less than the value the holders would
have received if they had exercised their warrants at a later time where the underlying share price is higher and (2) may not compensate
the holders for the value of the warrants, including because the number of ordinary shares received is capped at 0.361 of our Class A
ordinary shares per warrant (subject to adjustment) irrespective of the remaining life of the warrants.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Our warrants may have an adverse effect on the
market price of our Class A ordinary shares and make it more difficult to effectuate our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have issued warrants to purchase 8,625,000
Class A ordinary shares and, simultaneously with the closing of our initial public offering, we issued in a private placement an aggregate
of 6,266,667 private placement warrants, at $1.50 per warrant. In addition, as described in &#8220;Item 7. Management&#8217;s Discussion
and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources,&#8221; our sponsor and its affiliates
made working capital loans to us in the aggregate amount of $1,325,000, which are convertible into 883,333 private placement warrants,
at a price of $1.50 per warrant. If our sponsor makes any additional working capital loans, it may convert those loans into up to an additional
450,000 private placement warrants, at the price of $1.50 per warrant. To the extent we issue ordinary shares to effectuate a business
transaction, the potential for the issuance of a substantial number of additional Class A ordinary shares upon exercise of these warrants
could make us a less attractive acquisition vehicle to a target business. Such warrants, when exercised, will increase the number of issued
and outstanding Class A ordinary shares and reduce the value of the Class A ordinary shares issued to complete the business transaction.
Therefore, our warrants may make it more difficult to effectuate a business transaction or increase the cost of acquiring the target business.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Because each unit contains one-fourth of one
redeemable warrant and only a whole warrant may be exercised, the units may be worth less than units of other special purpose acquisition
companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Each unit contains one-fourth of one redeemable
warrant. Pursuant to the warrant agreement, no fractional warrants will be issued upon separation of the units, and only whole warrants
will trade. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise,
round down to the nearest whole number the number of Class A ordinary shares to be issued to the warrant holder. This is different from
other offerings similar to ours whose units include one ordinary share and one whole warrant to purchase one whole share. We have established
the components of the units in this way in order to reduce the dilutive effect of the warrants upon completion of a business combination
since the warrants will be exercisable in the aggregate for one-fourth of the number of shares compared to units that each contain a whole
warrant to purchase one share, thus making us, we believe, a more attractive business combination partner for target businesses. Nevertheless,
this unit structure may cause our units to be worth less than if it included a warrant to purchase one whole share.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">We are an emerging growth company and a smaller
reporting company within the meaning of the Securities Act, and if we take advantage of certain exemptions from disclosure requirements
available to emerging growth companies or smaller reporting companies, this could make our securities less attractive to investors and
may make it more difficult to compare our performance with other public companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We are an &#8220;emerging growth company&#8221;
within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to, not
being required to comply with the auditor internal controls attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously
approved. As a result, our shareholders may not have access to certain information they may deem important. We could be an emerging growth
company for up to five years, although circumstances could cause us to lose that status earlier, including if the market value of our
Class A ordinary shares held by non-affiliates equals or exceeds $700 million as of any June 30 before that time, in which case we would
no longer be an emerging growth company as of the following December 31. We cannot predict whether investors will find our securities
less attractive as a result of our reliance on these exemptions. If some investors find our securities less attractive as a result of
our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less
active trading market for our securities and the trading prices of our securities may be more volatile.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but
any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period, which means that when
a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company,
can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our
financial statements with another public company which is neither an emerging growth company nor an emerging growth company that has opted
out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Additionally, we are a &#8220;smaller reporting
company&#8221; as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure
obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting
company until the last day of any fiscal year for so long as either (1) the market value of our ordinary shares held by non-affiliates
did not exceed $250 million as of the prior June 30, or (2) our annual revenues did not exceed $100 million during such completed fiscal
year and the market value of our ordinary shares held by non-affiliates did not equal or exceed $700 million as of the prior June 30.
To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial statements with other
public companies difficult or impossible.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Our warrant agreement designates the courts
of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for
certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of warrant holders
to obtain a favorable judicial forum for disputes with our company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our warrant agreement provides that, subject to
applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement, including
under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District Court for
the Southern District of New York, and (ii) that we irrevocably submit to such jurisdiction, which jurisdiction shall be the exclusive
forum for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that such courts represent
an inconvenient forum.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Notwithstanding the foregoing, these provisions
of the warrant agreement will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim
for which the federal district courts of the United States of America are the sole and exclusive forum. Any person or entity purchasing
or otherwise acquiring any interest in any of our warrants shall be deemed to have notice of and to have consented to the forum provisions
in our warrant agreement. If any action, the subject matter of which is within the scope of the forum provisions of our warrant agreement,
is filed in a court other than a court of the State of New York or the United States District Court for the Southern District of New York
(a &#8220;foreign action&#8221;) in the name of any holder of our warrants, such holder shall be deemed to have consented to: (x) the
personal jurisdiction of the state and federal courts located in the State of New York in connection with any action brought in any such
court to enforce the forum provisions (an &#8220;enforcement action&#8221;), and (y) having service of process made upon such warrant
holder in any such enforcement action by service upon such warrant holder&#8217;s counsel in the foreign action as agent for such warrant
holder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">This choice-of-forum provision may limit a warrant
holder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with our company, which may discourage
such lawsuits. Alternatively, if a court were to find this provision of our warrant agreement inapplicable or unenforceable with respect
to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters
in other jurisdictions, which could materially and adversely affect our business, financial condition and results of operations and result
in a diversion of the time and resources of our management and board of directors.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Because we are incorporated under the laws of
the Cayman Islands, you may face difficulties in protecting your interests, and your ability to protect your rights through the U.S. Federal
courts may be limited.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We are an exempted company incorporated under
the laws of the Cayman Islands. As a result, it may be difficult for investors to effect service of process within the United States upon
our directors or officers, or enforce judgments obtained in the United States courts against our directors or officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our corporate affairs are governed by our amended
and restated memorandum and articles of association, the Companies Act (as the same may be supplemented or amended from time to time)
and the common law of the Cayman Islands. We are also subject to the federal securities laws of the United States. The rights of shareholders
to take action against the directors, actions by minority shareholders and the fiduciary responsibilities of our directors to us under
Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived
in part from comparatively limited judicial precedent in the Cayman Islands as well as from English common law, the decisions of whose
courts are of persuasive authority, but are not binding on a court in the Cayman Islands. The rights of our shareholders and the fiduciary
responsibilities of our directors under Cayman Islands law are different from what they would be under statutes or judicial precedent
in some jurisdictions in the United States. In particular, the Cayman Islands has a different body of securities laws as compared to the
United States, and certain states, such as Delaware, may have more fully developed and judicially interpreted bodies of corporate law.
In addition, Cayman Islands companies may not have standing to initiate a shareholders derivative action in a Federal court of the United
States.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have been advised by Maples and Calder, our
Cayman Islands legal counsel, that the courts of the Cayman Islands are unlikely (i) to recognize or enforce against us judgments of courts
of the United States predicated upon the civil liability provisions of the federal securities laws of the United States or any state;
and (ii) in original actions brought in the Cayman Islands, to impose liabilities against us predicated upon the civil liability provisions
of the federal securities laws of the United States or any state, so far as the liabilities imposed by those provisions are penal in nature.
In those circumstances, although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the
courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without
retrial on the merits based on the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation
to pay the sum for which judgment has been given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman
Islands, such judgment must be final and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty,
inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner,
or be of a kind the enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands (awards of punitive
or multiple damages may well be held to be contrary to public policy). A Cayman Islands Court may stay enforcement proceedings if concurrent
proceedings are being brought elsewhere.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">As a result of all of the above, public shareholders
may have more difficulty in protecting their interests in the face of actions taken by management, members of the board of directors or
controlling shareholders than they would as public shareholders of a United States company.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">After our initial business combination, it is
possible that a majority of our directors and officers will live outside the United States and all of our assets will be located outside
the United States; therefore, investors may not be able to enforce federal securities laws or their other legal rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">It is possible that after our initial business
combination, a majority of our directors and officers will reside outside of the United States and all of our assets will be located outside
of the United States. As a result, it may be difficult, or in some cases not possible, for investors in the United States to enforce their
legal rights, to effect service of process upon all of our directors or officers or to enforce judgments of United States courts predicated
upon civil liabilities and criminal penalties on our directors and officers under United States laws.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Risks Associated with Conflicts of Interest</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Certain members of our management team may be
involved in and have a greater financial interest in the performance of other entities with which they are affiliated, and such activities
may create conflicts of interest in making decisions on our behalf.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Certain members of our management team may be
subject to a variety of conflicts of interest relating to their responsibilities to our sponsor and other entities with which they are
affiliated. Such individuals may serve as members of management or a board of directors (or in similar such capacity) to various other
affiliated entities. Such positions may create a conflict between the advice and investment opportunities provided to such entities and
the responsibilities owed to us. The other entities in which such individuals may become involved may have investment objectives that
overlap with ours. Furthermore, certain of our principals and employees may have a greater financial interest in the performance of such
other affiliated entities than our performance. Such involvement may create conflicts of interest in sourcing investment opportunities
on our behalf and on behalf of such other entities.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Our officers and directors will allocate their
time to other businesses, thereby causing conflicts of interest in their determination as to how much time to devote to our affairs. This
conflict of interest could have a negative impact on our ability to complete our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our officers and directors are not required to,
and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations
and our search for a business combination and their other businesses. Our officers may engage in other business endeavors for which he
or she may be entitled to, or otherwise expect to receive, substantial compensation or other economic benefit, and our officers are not
obligated to contribute any specific number of hours per week to our affairs. Our independent directors also serve as officers and board
members for other entities. If our officers&#8217; and directors&#8217; other business affairs require them to devote substantial amounts
of time to such affairs in excess of their current commitment levels, it could limit their ability to devote time to our affairs, which
may have a negative impact on our ability to complete our initial business combination. For a complete discussion of our officers&#8217;
and directors&#8217; other business affairs, please see &#8220;Item 10. Directors, Executive Officers and Corporate Governance &#8212;
Directors and Executive Officers.&#8221;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Our officers and directors presently have, and
any of them in the future may have additional, fiduciary or contractual obligations to other entities and, accordingly, may have conflicts
of interest in determining to which entity a particular business opportunity should be presented.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Until we consummate our initial business combination,
we intend to engage in the business of identifying and combining with one or more businesses. Certain of our officers and directors presently
have, and any of them in the future may have, additional fiduciary or contractual obligations to other entities, including NextG and other
entities affiliated with NextG, pursuant to which such officer or director is or will be required to present a business combination opportunity
to such entity. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should
be presented. These conflicts may not be resolved in our favor and a potential target business may be presented to another entity prior
to its presentation to us, subject to their fiduciary duties under Cayman Islands law. Our amended and restated memorandum and articles
of association provide that, to the fullest extent permitted by applicable law: (i) no individual serving as a director or an officer
shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same
or similar business activities or lines of business as us; and (ii) we renounce any interest or expectancy in, or in being offered an
opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any director or officer on
the one hand, and us, on the other.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In addition, our sponsor and our officers and
directors may sponsor, form, invest in or otherwise become involved with other special purpose acquisition companies similar to ours or
may pursue other business or investment ventures during the period in which we are seeking an initial business combination. Any such companies,
businesses or investments may present additional conflicts of interest in pursuing an initial business combination. However, we do not
believe that any such potential conflicts would materially affect our ability to complete our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">For a complete discussion of our officers&#8217;
and directors&#8217; business affiliations and the potential conflicts of interest that you should be aware of, please see &#8220;Item
10. Directors, Executive Officers and Corporate Governance &#8212; Directors and Executive Officers,&#8221; &#8220;Item 10. Directors,
Executive Officers and Corporate Governance &#8212; Conflicts of Interest&#8221; and &#8220;Item 13. Certain Relationships and Related
Party Transactions, and Director Independence.&#8221;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Our officers, directors, security holders and
their respective affiliates may have competitive pecuniary interests that conflict with our interests.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have not adopted a policy that expressly prohibits
our directors, officers, security holders or affiliates from having a direct or indirect pecuniary or financial interest in any investment
to be acquired or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may enter into a business
combination with a target business that is affiliated with our sponsor, our directors or officers. Nor do we have a policy that expressly
prohibits any such persons from engaging for their own account in business activities of the types conducted by us. Accordingly, such
persons or entities may have a conflict between their interests and ours.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The personal and financial interests of our directors
and officers may influence their motivation in timely identifying and selecting a target business and completing a business combination.
Consequently, our directors&#8217; and officers&#8217; discretion in identifying and selecting a suitable target business may result in
a conflict of interest when determining whether the terms, conditions and timing of a particular business combination are appropriate
and in our shareholders&#8217; best interest. If this were the case, it would be a breach of their fiduciary duties to us as a matter
of Cayman Islands law and we or our shareholders might have a claim against such individuals for infringing on our shareholders&#8217;
rights. However, we might not ultimately be successful in any claim we may make against them for such reason.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 52; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">We may engage in a business combination with
one or more target businesses that have relationships with entities that may be affiliated with our initial shareholders, officers, directors
or existing holders which may raise potential conflicts of interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In light of the involvement of our sponsor, officers
and directors with other entities, we may decide to acquire one or more businesses affiliated with our initial shareholders, officers,
directors or existing holders, including businesses affiliated with NextG. Our directors also serve as officers and board members for
other entities, including, without limitation, those described under &#8220;Item 10. Directors, Executive Officers and Corporate Governance
&#8212; Conflicts of Interest.&#8221; Such entities may compete with us for business combination opportunities. We may enter into a business
combination with an entity affiliated with our initial shareholders, officers, directors or existing holders if we determine that such
affiliated entity meets our criteria and guidelines for a business combination as set forth in &#8220;Item 1. Business&#8212;Effecting
our Initial Business Combination&#8212;Sources of Target Businesses&#8221; and such transaction is approved by a majority of our independent
and disinterested directors. Despite our agreement to obtain an opinion from an independent investment banking firm or a valuation or
appraisal firm regarding the fairness to our company from a financial point of view of a business combination with one or more domestic
or international businesses affiliated with our initial shareholders, officers, directors or existing holders, potential conflicts of
interest still may exist and, as a result, the terms of the business combination may not be as advantageous to our public shareholders
as they would be absent any conflicts of interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Moreover, we may, at our option, pursue an affiliated
joint acquisition opportunity with one or more affiliates of NextG or with other entities to which an officer or director has a fiduciary,
contractual or other obligation or duty. Any such parties may co-invest with us in the target business at the time of our initial business
combination, or we could raise additional proceeds to complete the acquisition by issuing equity to any such parties, which may give rise
to certain conflicts of interest.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Since our sponsor, officers and directors will
lose their entire investment in us if our initial business combination is not completed (other than with respect to public shares they
may acquire), a conflict of interest may arise in determining whether a particular business combination target is appropriate for our
initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">On December 30, 2020, our sponsor paid $25,000,
or approximately $0.003 per share, to cover certain offering costs in exchange for 8,625,000 founder shares (retroactively adjusting for
the issuance of 1,437,500 founder shares resulting from a share dividend effected by the Company on February 25, 2021). The purchase price
of the founder shares was determined by dividing the amount of cash contributed to the company by the number of founder shares issued.
Our initial shareholders collectively own approximately 20% of our issued and outstanding shares. Our sponsor currently owns 8,502,500
founder shares and the independent directors each received 25,000 founder shares. The founder shares will be worthless if we do not complete
an initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In addition, our sponsor has purchased an aggregate
of 6,266,667 private placement warrants for an aggregate purchase price of $9,400,000, or $1.50 per warrant. The private placement warrants
will also be worthless if we do not complete our initial business combination. The personal and financial interests of our officers and
directors may influence their motivation in identifying and selecting a target business combination, completing an initial business combination
and influencing the operation of the business following the initial business combination. This risk may become more acute as the deadline
nears for our completion of an initial business combination.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Our initial shareholders stand to make a substantial
profit on the founder shares even if an initial business combination subsequently declines in value or is unprofitable for our public
shareholders, and may have an incentive to recommend such an initial business combination to our shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our initial shareholders paid an aggregate of
$25,000, or approximately $0.003 per founder share. As a result of the low acquisition cost of our founder shares, our initial shareholders
could make a substantial profit even if we select and consummate an initial business combination with an acquisition target that subsequently
declines in value or is unprofitable for our public shareholders. Thus, they may have more of an economic incentive for us to enter into
an initial business combination with a riskier, weaker-performing or financially unstable business, or an entity lacking an established
record of revenues or earnings, than would be the case if such parties had paid the full offering price for their founder shares.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Risks Associated with Tax Matters</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">We believe that we were a passive foreign investment
company, or &#8220;PFIC,&#8221; which could result in adverse U.S. federal income tax consequences to U.S. investors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Because we are a blank check company, with no
current active business, we believe that we were a PFIC for our 2020, 2021 and 2022 taxable years. If we were a PFIC for any taxable year
(or portion thereof) that is included in the holding period of a U.S. investor that is a holder of our Class A ordinary shares or warrants,
the U.S. investor may be subject to adverse U.S. federal income tax consequences and may be subject to additional reporting requirements.
We will endeavor to provide to a U.S. investor such information as the Internal Revenue Service (&#8220;IRS&#8221;) may require, including
a PFIC annual information statement, in order to enable the U.S. investor to make and maintain a &#8220;qualified electing fund&#8221;
election, but there can be no assurance that we will timely provide such required information, and such election would be unavailable
with respect to our warrants in all cases. We urge U.S. investors to consult their own tax advisors regarding the possible application
of the PFIC rules. For a more detailed explanation, see the description under the caption &#8220;Taxation&#8212;United States Federal
Income Tax Considerations&#8212;Passive Foreign Investment Company Rules&#8221; in our final prospectus filed with the Securities and
Exchange Commission on March 1, 2021 pursuant to Rule 424(b)(4) under the Securities Act (File No. 333-252940).</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">We may reincorporate in another jurisdiction
in connection with our initial business combination and such reincorporation may result in taxes imposed on shareholders or warrant holders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We may, in connection with our initial business
combination and subject to requisite shareholder approval under the Companies Act, reincorporate in the jurisdiction in which the target
company or business is located or in another jurisdiction. The transaction may require a shareholder or warrant holder to recognize taxable
income in the jurisdiction in which the shareholder or warrant holder is a tax resident or in which its members are resident if it is
a tax transparent entity (or may otherwise result in adverse tax consequences). We do not intend to make any cash distributions to shareholders
or warrant holders to pay such taxes. Shareholders or warrant holders may be subject to withholding taxes or other taxes with respect
to their ownership of us after the reincorporation.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">There may be tax consequences to our business
combinations that may adversely affect us or our shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">While we expect to undertake any merger or acquisition
so as to minimize taxes both to the acquired business and/or asset and us, such business combination might not meet the statutory requirements
of a tax-free reorganization, or the parties might not obtain the intended tax-free treatment upon a transfer of shares or assets. A merger
or acquisition that does not qualify as a tax-free reorganization for U.S. tax purposes could result in the imposition of substantial
taxes.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Risks Associated with Acquiring and Operating a Business in Foreign
Countries</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">If we effect our initial business combination
with a company located outside of the United States, we would be subject to a variety of additional risks that may adversely affect us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">If we pursue a target company with operations
or opportunities outside of the United States for our initial business combination, we may face additional burdens in connection with
investigating, agreeing to and completing such initial business combination, and if we effect such initial business combination, we would
be subject to a variety of additional risks that may negatively impact our operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In addition, we would be subject to risks associated
with cross-border business combinations, including in connection with investigating, agreeing to and completing our initial business combination,
conducting due diligence in a foreign jurisdiction, having such transaction approved by any local governments, regulators or agencies
and changes in the purchase price based on fluctuations in foreign exchange rates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">If we effect our initial business combination
with such a company, we would be subject to any special considerations or risks associated with companies operating in an international
setting, including any of the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>costs and difficulties inherent in managing cross-border business operations;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                                                </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>rules and regulations regarding currency redemption;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                       </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>complex corporate withholding taxes on individuals;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                      </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>laws governing the manner in which future business combinations may be effected;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                                                   </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>exchange listing and/or delisting requirements;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                  </table><div>


</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>tariffs and trade barriers;</td></tr></table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 54; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>regulations related to customs and import/export matters;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                            </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>local or regional economic policies and market conditions;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                             </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>unexpected changes in regulatory requirements;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                 </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>challenges in managing and staffing international operations;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                                </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>longer payment cycles;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                         </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>tax issues, such as tax law changes and variations in tax laws as compared to the United States;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                                                                   </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>currency fluctuations and exchange controls;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                               </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>rates of inflation;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                      </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>challenges in collecting accounts receivable;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>cultural and language differences;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                     </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>employment regulations;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                          </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>underdeveloped or unpredictable legal or regulatory systems;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                               </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>corruption;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                              </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>protection of intellectual property;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                       </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>social unrest, crime, strikes, riots and civil disturbances;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                               </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>regime changes and political upheaval;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                         </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>terrorist attacks and wars, including the ongoing military conflict between Russia and Ukraine; and</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                                                                      </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>deterioration of political relations with the United States.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We may not be able to adequately address these
additional risks. If we were unable to do so, we may be unable to complete such initial business combination, or, if we complete such
initial business combination, our operations might suffer, either of which may adversely impact our business, financial condition and
results of operations.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">If our management following our initial business
combination is unfamiliar with United States securities laws, they may have to expend time and resources becoming familiar with such laws,
which could lead to various regulatory issues.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Following our initial business combination, our
management may resign from their positions as officers or directors of the company and the management of the target business at the time
of the business combination will remain in place. Management of the target business may not be familiar with United States securities
laws. If new management is unfamiliar with United States securities laws, they may have to expend time and resources becoming familiar
with such laws. This could be expensive and time-consuming and could lead to various regulatory issues which may adversely affect our
operations.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">After our initial business combination, substantially
all of our assets may be located in foreign countries and substantially all of our revenue will be derived from our operations in such
countries. Accordingly, our results of operations and prospects will be subject, to a significant extent, to the economic, political and
social conditions and government policies, developments and conditions in the countries in which we operate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The economic, political and social conditions,
as well as government policies, of the countries in which our operations are located could affect our business. Economic growth could
be uneven, both geographically and among various sectors of the economy and such growth may not be sustained in the future. If in the
future such countries&#8217; economies experience a downturn or grow at a slower rate than expected, there may be less demand for spending
in certain industries. A decrease in demand for spending in certain industries could materially and adversely affect our ability to find
an attractive target business with which to consummate our initial business combination and, if we effect our initial business combination,
the ability of that target business to become profitable.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 55; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">Exchange rate fluctuations and currency policies
may cause a target business&#8217;s ability to succeed in the international markets to be diminished.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In the event we acquire a non-U.S. target, all
revenues and income would likely be received in a foreign currency or several foreign currencies, and the dollar equivalent of our net
assets and distributions, if any, could be adversely affected by reductions in the value of such foreign currencies. The value of the
currencies in our target regions fluctuate and are affected by, among other things, changes in political and economic conditions. Any
change in the relative value of such currencies against our reporting currency may affect the attractiveness of any target business or,
following consummation of our initial business combination, our financial condition and results of operations. Additionally, if a currency
appreciates in value against the dollar prior to the consummation of our initial business combination, the cost of a target business as
measured in dollars will increase, which may make it less likely that we are able to consummate such transaction.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">We may reincorporate in another jurisdiction
in connection with our initial business combination, and the laws of such jurisdiction may govern some or all of our future material agreements
and we may not be able to enforce our legal rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In connection with our initial business combination,
we may relocate the home jurisdiction of our business from the Cayman Islands to another jurisdiction. If we determine to do this, the
laws of such jurisdiction may govern some or all of our future material agreements. The system of laws and the enforcement of existing
laws in such jurisdiction may not be as certain in implementation and interpretation as in the United States. The inability to enforce
or obtain a remedy under any of our future agreements could result in a significant loss of business, business opportunities or capital.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">We are subject to changing laws and regulations
regarding regulatory matters, corporate governance and public disclosure that have increased both our costs and the risk of non-compliance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We are subject to rules and regulations by various
governing bodies, including, for example, the Securities and Exchange Commission, which are charged with the protection of investors and
the oversight of companies whose securities are publicly traded, and to new and evolving regulatory measures under applicable law. Our
efforts to comply with new and changing laws and regulations have resulted in and are likely to continue to result in, increased general
and administrative expenses and a diversion of management time and attention from revenue-generating activities to compliance activities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Moreover, because these laws, regulations and
standards are subject to varying interpretations, their application in practice may evolve over time as new guidance becomes available.
This evolution may result in continuing uncertainty regarding compliance matters and additional costs necessitated by ongoing revisions
to our disclosure and governance practices. If we fail to address and comply with these regulations and any subsequent changes, we may
be subject to penalty and our business may be harmed.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9.35pt; padding-left: 0pt">We employ a mail forwarding service, which may
delay or disrupt our ability to receive mail in a timely manner.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Mail addressed to the Company and received at
its registered office will be forwarded unopened to the forwarding address supplied by the Company to be dealt with. None of the Company,
its directors, officers, advisors or service providers (including the organization which provides registered office services in the Cayman
Islands) will bear any responsibility for any delay howsoever caused in mail reaching the forwarding address, which may impair your ability
to communicate with us.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_005"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
1B. Unresolved Staff Comments</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">None.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_006"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
2. Property</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We currently maintain our executive offices at
14 Wall Street, 20<sup>th</sup> Floor, New York, NY 10005. The cost for the space is included in the up to $10,000 monthly fee that we
pay our sponsor for office space, administrative and support services. We consider our current office space adequate for our current operations.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_007"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
3. Legal Proceedings</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">To the knowledge of our management, there is no
material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their
capacity as such.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_008"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
4. Mine Safety Disclosures</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 56; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><div><a id="k_009"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center">PART II</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_010"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><span><b>(a) </b></span><b>Market
Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our units, Class A ordinary shares and warrants
are each traded on the NYSE under the symbols &#8220;FACT.U,&#8221; &#8220;FACT&#8221; and &#8220;FACT WS,&#8221; respectively. Our units
commenced public trading on February 26, 2021. Our Class A ordinary shares and warrants began separate trading on April 19, 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><span><b>(b) </b></span><b>Holders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">On April 3,
2023, there was 1 holder of record of our units, 2 holders of record of our Class A ordinary shares, 6 holders of record of our Class
B ordinary shares and 2 holders of record of our warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><span><b>(c) </b></span><b>Dividends</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have not paid any cash dividends on our ordinary
shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash
dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition
subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our initial business combination
will be within the discretion of our board of directors at such time. If we incur any indebtedness, our ability to declare dividends may
be limited by restrictive covenants we may agree to in connection therewith.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><span><b>(d) </b></span><b>Securities
Authorized for Issuance Under Equity Compensation Plans</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><span><b>(e) </b></span><b>Performance
Graph</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><span><b>(f) </b></span><b>Recent
Sales of Unregistered Securities; Use of Proceeds from Registered Offerings</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Unregistered Sales</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">On December 30, 2020, our sponsor paid $25,000,
or approximately $0.003 per share, to cover certain offering costs in exchange for 8,625,000 founder shares (retroactively adjusting for
the issuance of 1,437,500 founder shares resulting from a share dividend effected by the Company on February 25, 2021). Our sponsor transferred
25,000 founder shares each to Noreen Doyle, William Janetschek and David Poritz and an aggregate of 47,500 founder shares to certain employees
and consultants. On April 8, 2022, David Poritz resigned from our board of directors and returned his 25,000 founder shares to our sponsor.
On May 10, 2022, Nell Cady-Kruse was appointed to our board of directors, and our sponsor transferred 25,000 founder shares to her. As
a result, our sponsor now owns 8,502,500 founder shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The founder shares will automatically convert
into Class A ordinary shares concurrently with or immediately following the consummation of our initial business combination on a one-for-one
basis, subject to certain adjustments. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed
issued in connection with our initial business combination, the number of Class A ordinary shares issuable upon conversion of all founder
shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving
effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued,
or deemed issued or issuable upon conversion or exercise of any equity-linked securities issued or deemed issued, by the Company in connection
with the consummation of the initial business combination, excluding any Class A ordinary shares or equity-linked securities exercisable
for or convertible into Class A ordinary shares issued, deemed issued or to be issued, to any seller in the initial business combination
and any private placement warrants issued to our sponsor, officers or directors upon conversion of working capital loans; provided that
such conversion of founder shares will never occur on a less than one-for-one basis. The term &#8220;equity-linked securities&#8221; refers
to any debt or equity securities that are convertible, exercisable or exchangeable for our Class A ordinary shares issued in a financing
transaction in connection with our initial business combination, including but not limited to a private placement of equity or debt.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 57; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">With certain limited exceptions, the founder shares
are not transferable, assignable or salable (except to our officers and directors and other persons or entities affiliated with our sponsor,
each of whom are subject to the same transfer restrictions) until the earlier of (A) one year after the completion of our initial business
combination or (B) subsequent to our initial business combination, (x) if the last reported sale price of the ordinary shares equals or
exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination,
or (y) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange,
reorganization or other similar transaction that results in all of our public shareholders having the right to exchange their Class A
ordinary shares for cash, securities or other property.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our sponsor purchased 6,266,667 private placement
warrants at a price of $1.50 per warrant in a private placement that occurred concurrently with the closing of our initial public offering
and generated gross proceeds of $9,400,000. Each private placement warrant is exercisable for one Class A ordinary share at a price of
$11.50 per share. The proceeds from the sale of the private placement warrants were added to the net proceeds from the initial public
offering held in the trust account. If we do not complete a business combination during the Extension Period, the private placement warrants
will expire worthless. The private placement warrants are non-redeemable and exercisable on a cashless basis so long as they are held
by our sponsor or its permitted transferees. The sale of the private placement warrants was made pursuant to the exemption from registration
contained in Section 4(a)(2) of the Securities Act.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Use of Proceeds</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">On March 2, 2021, we consummated our initial public
offering of 34,500,000 units, at $10.00 per unit, generating gross proceeds of approximately $345.0 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In connection with our initial public offering,
we incurred offering costs of approximately $19.18 million, inclusive of approximately $12.08 million in deferred underwriting commissions.
Other incurred offering costs consisted principally of preparation fees related to our initial public offering. After deducting the underwriting
discounts and commissions (excluding the deferred portion, which amount will be payable upon consummation of the initial business combination,
if consummated) and our initial public offering expenses, $345.0 million of the net proceeds from our initial public offering and certain
of the proceeds from the private placement of the private placement warrants (or $10.00 per unit sold in our initial public offering)
was placed in the trust account. The net proceeds of our initial public offering and certain proceeds from the sale of the private placement
warrants are held in the trust account and invested as described elsewhere in this Annual Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">There has been no material change in the planned
use of the proceeds from our initial public offering and private placement as is described in the Company&#8217;s final prospectus (File
No. 333-252940) dated February 26, 2021, which was declared effective by the SEC on February 25, 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><span><b>(g) </b></span><b>Purchases
of Equity Securities by the Issuer and Affiliated Purchasers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">None.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_011"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
6. [Reserved]</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 58; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>


</div><div><a id="k_012"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The following discussion and analysis of the Company&#8217;s
financial condition and results of operations should be read in conjunction with our audited financial statements and the notes thereto
which are included in &#8220;Item 8. Financial Statements and Supplementary Data&#8221; of this Annual Report. Certain information contained
in the discussion and analysis set forth below includes forward-looking statements. Our actual results may differ materially from those
anticipated in these forward-looking statements as a result of many factors, including those set forth under &#8220;Cautionary Note Regarding
Forward-Looking Statements and Risk Factor Summary,&#8221; &#8220;Item 1A. Risk Factors&#8221; and elsewhere in this Annual Report.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Overview</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We are a blank check company incorporated as a
Cayman Islands exempted company on December 23, 2020 for the purpose of effecting a merger, share exchange, asset acquisition, share purchase,
reorganization or similar business combination with one or more businesses. Our sponsor is Freedom Acquisition I LLC, a Cayman Islands
limited liability company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The registration statement for our initial public
offering (the &#8220;Initial Public Offering&#8221;) became effective on February 25, 2021. On March 2, 2021, we consummated the Initial
Public Offering of 34,500,000 units, which included the exercise of the underwriters&#8217; option to purchase an additional 4,500,000
units at the Initial Public Offering price to cover over-allotments (the &#8220;Units&#8221;, and, with respect to the Class A ordinary
shares included in the Units, the &#8220;Public Shares&#8221; and, with respect to the one-fourth of one redeemable warrant included in
the Units, the &#8220;Public Warrants&#8221;), at $10.00 per Unit, generating gross proceeds of $345.0 million, and incurring offering
costs of approximately $19.18 million, inclusive of approximately $12.08 million in deferred underwriting commissions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Simultaneously with the closing of the Initial
Public Offering, we consummated the private placement (&#8220;Private Placement&#8221;) of 6,266,667 warrants (each, a &#8220;Private
Placement Warrant&#8221; and collectively, the &#8220;Private Placement Warrants&#8221; and, together with the Public Warrants, the &#8220;Warrants&#8221;),
at a price of $1.50 per Private Placement Warrant with the sponsor, generating gross proceeds of approximately $9.4 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Upon the closing of the Initial Public Offering
and the Private Placement, approximately $345.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain
of the proceeds of the Private Placement were placed in a trust account (&#8220;Trust Account&#8221;), located in the United States with
Continental Stock Transfer &amp; Trust Company acting as trustee, and, until the 24-month anniversary of the consummation of our initial
public offering, invested only in United States &#8220;government securities&#8221; within the meaning of Section 2(a)(16) of the Investment
Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule&#160;2a-7&#160;promulgated
under the&#160;Investment Company Act which invest only in direct U.S. government treasury obligations. To mitigate the risk of us being
deemed to have been operating as an unregistered investment company, prior to the&#160;24-month&#160;anniversary of the consummation of
our initial public offering, we instructed Continental to liquidate the U.S. government treasury obligations or money market funds held
in the trust account and to hold all the funds in the trust account in cash in a bank deposit account, until the earlier of: (i) the completion
of a business combination and (ii) the distribution of the Trust Account as described below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">If we have not completed a business combination
during the Extension Period, we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible
but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released
to us to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding
Public Shares, which redemption will completely extinguish Public Shareholders&#8217; rights as shareholders (including the right to receive
further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval
of the remaining shareholders and the board of directors, liquidate and dissolve, subject, in each case, to our obligations under Cayman
Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating
distributions with respect to our outstanding Warrants, which will expire worthless if we fail to consummate a business combination within
the Combination Period.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 59; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Recent Developments</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-weight: normal">&#160;</span></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in"><span style="font-weight: normal">Second Amendment
to the Business Combination Agreement</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">On January 17, 2023, the Company, Complete Solaria,
First Merger Sub and Second Merger Sub entered into that certain Second Amendment to Business Combination Agreement (the &#8220;Second
Amendment&#8221;) amending the Business Combination Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The Second Amendment provides that, if the Company
and Complete Solaria determine in good faith by January 1, 2023 that it is probable that the Business Combination will be consummated
after March 1, 2023, the Company will be required to prepare (with the reasonable cooperation of Complete Solaria) and file with the SEC
a proxy statement pursuant to which it will seek the approval of its shareholders for proposals to amend the Company&#8217;s organizational
documents to extend the time period for the Company to consummate its initial business combination for (x) up to an additional six (6)
months, from March 2, 2023 to September 2, 2023 (the original Business Combination Agreement provided for an extension from March 1, 2023
to September 2, 2023) or (y) such other period of time as the Company and Complete Solaria may mutually agree (the original Business Combination
Agreement contemplated no such prong (y)). In addition, the Second Amendment amends the Business Combination Agreement by changing the
latest permitted Agreement End Date (as defined in the Business Combination Agreement) from September 1, 2023 to September 2, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0in"><i>&#160;</i></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Amendment
to Amended and Restated Memorandum and Articles</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">On February 28, 2023, Freedom held the Extraordinary
General Meeting of shareholders, at which holders of 35,373,848 ordinary shares, comprised of 26,773,848 Class&#160;A ordinary shares
and 8,600,000 Class&#160;B ordinary shares, were present in person or by proxy, representing approximately 82.02% of the voting power
of the 43,125,000 Outstanding Shares of Freedom entitled to vote at the Extraordinary General Meeting at the close of business on January
23, 2023, which was the Record Date for the Extraordinary General Meeting. The Outstanding Shares on the Record Date were comprised of
34,500,000 Class A ordinary shares and 8,625,000 Class B ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">At the Extraordinary General Meeting, the shareholders
approved, by special resolution, the Extension Amendment Proposal, which extended the date by which Freedom must (i) consummate a merger,
amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination, which Freedom refers
to as its initial business combination, (ii) cease its operations except for the purpose of winding up if it fails to complete such initial
business combination, and (iii) redeem all of the Class A ordinary shares, included as part of the units sold in the initial public offering,
for an additional three months, from March 2, 2023 to June 2, 2023, and thereafter to up to three (3) times by an additional one month
each time (or up to September 2, 2023). The voting results for such proposal were as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><b>For</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Against</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Abstain</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 31%; text-align: center">35,047,305</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 31%; text-align: center">326,543</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 30%; text-align: center">0</td><td style="width: 1%; text-align: center">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In connection with the Extension Amendment, public
shareholders elected to redeem an aggregate of 23,256,504 Class&#160;A ordinary shares at a redemption price of $10.21 per share, representing
approximately 67.41% of the issued and outstanding Class A ordinary shares, for an aggregate redemption amount of approximately $237,372,952.
Following such redemptions, approximately $114,759,374 remained in the trust account and 11,243,496 Class A ordinary shares remain outstanding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">At the Extraordinary General Meeting, the public
shareholders also approved the proposal to amend the Trust Agreement, by and between Freedom and Continental, as trustee, to reflect the
Extension Amendment. The amendment to the Trust Agreement provides that Continental shall commence liquidation of the trust account only
and promptly (x) after its receipt of the applicable instruction letter delivered by Freedom in connection with either the consummation
of an initial business combination or Freedom&#8217;s inability to effect an initial business combination within the time frame specified
in Freedom&#8217;s amended and restated memorandum and articles of association or (y) upon the date that is the later of the end of the
Extension Period and such later date as may be approved by Freedom&#8217;s shareholders in accordance with the amended and restated memorandum
and articles of association, if the aforementioned termination letter has not been received by Continental prior to such date. The voting
results for such proposal were as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><b>For</b></p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Against</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Abstain</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 33%; text-align: center">35,047,305</td><td style="width: 1%">&#160;</td>
    <td style="width: 33%; text-align: center">326,543</td><td style="width: 1%">&#160;</td>
    <td style="width: 32%; text-align: center">0</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0in">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 60; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>


</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in"><span style="font-weight: normal">Promissory Note</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">On February 28, 2023, we issued an unsecured promissory
note in the amount of up to $2,100,000 to our sponsor. The proceeds of such promissory note, $1,600,000 of which was drawn down immediately, $400,000 of which may be drawn down, with the mutual consent of us and our sponsor, if we wish to extend the
date by which we will consummate a business combination beyond June 2, 2023, and $100,000 of which may be drawn down on an as-needed basis
at the discretion of our sponsor, will be used for general working capital purposes. Such promissory note bears no interest and is payable
in full upon the consummation of our business combination. A failure to pay the principal within five business days of the date specified
above or the commencement of a voluntary or involuntary bankruptcy action shall be deemed an event of default, in which case the promissory
note may be accelerated. The promissory note shall be forgiven by our sponsor if we are unable to consummate a business combination within
the time frame specified in our amended and restated memorandum and articles of association (as amended from time to time), except to
the extent of any funds held outside of the trust account established in connection with our initial public offering. The issuance of
the promissory note was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as
amended.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Results of Operations and Known Trends or Future
Events</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have neither engaged in any operations nor generated
any revenues to date. Our only activities since inception have been organizational activities, those necessary to prepare for our Initial
Public Offering and identifying a target company for our initial business combination. We do not expect to generate any operating revenues
until after completion of our initial business combination. We generate non-operating income in the form of interest income on cash and
cash equivalents held in the Trust Account and through changes in the fair value of our warrant liabilities. We incur expenses as a result
of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For the year ended December 31, 2022, we had
net income of $5,982,340, which consisted of an unrealized gain on change in fair value of our warrant liabilities of $5,509,917,
interest income of $4,821,632 on our amounts held in the Trust Account, reduction of transaction costs incurred in
connection with IPO of $271,687, offset by $4,407,058 of operating costs consisting mostly of general and administrative expenses,
foreign currency exchange loss of $17,638 and change in the fair value of convertible notes of $196,200.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">For the year ended December 31, 2021, we had
net income of $5,128,650, which consisted of an unrealized gain on change in fair value of our warrant liabilities of $9,381,750,
interest income of $105,681 on our amounts held in the Trust Account, offset by $3,782,028 of operating costs consisting mostly of
general and administrative expenses, foreign currency exchange loss of $1,475 and offering expenses related to warrant issuance of
$575,278.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We classify the Warrants issued in connection
with our Initial Public Offering and Private Placement as liabilities at their fair value and adjust the warrant instruments to fair
value at each reporting period. These liabilities are subject to remeasurement at each balance sheet date until exercised, and any
change in fair value is recognized in our consolidated statements of operations. As part of the reclassification to warrant
liability, we recorded a portion of the offering costs associated with the Initial Public Offering as expense in the consolidated
statements of operations in the amount of $575,278 based on a relative fair value basis. For the period from the Initial Public
Offering to December 31, 2022, the change in fair value of the Warrants was a decrease in the liability of $14,147,084.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Liquidity and Capital Resources</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">As of December 31, 2022, we had cash outside the Trust Account of $72,923
in its operating bank accounts, $349,927,313 in marketable securities held in the Trust Account to be used for a business combination,
or to repurchase or redeem its stock in connection therewith, and a working capital deficit of $5,493,215. As of December 31, 2022, none
of the amount in the Trust Account was available to be withdrawn as described above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">On each of April 1, 2022 and June 6, 2022, we
issued an unsecured promissory note in the amount of up to $500,000 to our sponsor (the &#8220;Sponsor Notes&#8221;). On December 14,
2022, we issued an unsecured promissory note in the amount of up to $325,000 to Tidjane Thiam, Adam Gishen, Edward Zeng, and Abhishek
Bhatia (collectively, the &#8220;Payees&#8221;) (such note, together with the Sponsor Notes, the &#8220;Convertible Notes&#8221;). The
proceeds of the Convertible Notes, which may be drawn down from time to time until we consummate our initial business combination, will
be used for general working capital purposes. The Convertible Notes bear no interest and are payable in full upon the earlier to occur
of (i) twenty-four (24) months from the closing of our initial public offering (or such later date as may be extended in accordance with
the terms of our amended and restated memorandum and articles of association) or (ii) the consummation of our business combination. A
failure to pay the principal within five business days of the date specified above or the commencement of a voluntary or involuntary bankruptcy
action shall be deemed an event of default, in which case the Convertible Notes may be accelerated. Prior to our first payment of all
or any portion of the principal balance of the Convertible Notes in cash, our sponsor and the Payees, as applicable, have the option to
convert all, but not less than all, of the principal balance of the Convertible Notes into private placement warrants (the &#8220;Conversion
Warrants&#8221;), each warrant exercisable for one of our ordinary shares at an exercise price of $1.50 per share. The terms of the Conversion
Warrants would be identical to the Private Placement Warrants. Our sponsor and the Payees shall be entitled to certain registration rights
relating to the Conversion Warrants. The issuances of the Convertible Notes were made pursuant to the exemption from registration contained
in Section 4(a)(2) of the Securities Act of 1933, as amended. As of December 31, 2022, the Company had drawn a total of $1,225,000 on
the Convertible Notes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 61; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In addition, on February 28, 2023, we issued an
additional unsecured promissory note in the amount of up to $2,100,000 to our sponsor, as further described under &#8220;&#8212;Recent
Developments&#8212;Promissory Note.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We may raise additional capital through loans
or additional investments from the sponsor or an affiliate of the sponsor or certain of its directors and officers. The sponsor may, but
is not obligated to, lend us funds, from time to time in whatever amounts it deems reasonable in its sole discretion, to meet our working
capital needs. There can be no assurance that we will be able to obtain additional financing, however. Moreover, we may need to obtain
additional financing either to complete our business combination or because we become obligated to redeem a significant number of its
public shares upon consummation of its business combination, in which case we may issue additional securities or incur debt in connection
with such business combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously
with the completion of its business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">If we are unable to raise additional capital,
it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing
operations, suspending the pursuit of a potential transaction and reducing overhead expenses. We cannot provide any assurance that new
financing will be available to it on commercially acceptable terms, if at all.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Going Concern</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In connection with our assessment of going concern
considerations in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 205-40, &#8220;Presentation of Financial Statements
&#8211; Going Concern,&#8221; pursuant to its Amended and Restated Certificate of Incorporation, we have until the end of the Extension Period
to consummate a business combination. If a business combination is not consummated during the Extension Period, we will have a mandatory
liquidation and subsequent dissolution. Although we intend to consummate a business combination during the Extension Period, it is uncertain
that we will be able to do so. This, as well as our liquidity condition, raise substantial doubt about our ability to continue as a going
concern. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate at the end
of the Extension Period.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Contractual Obligations</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We do not have any long-term debt obligations,
capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities other than described below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have an agreement to pay the sponsor a total
of up to $10,000 per month for office space, utilities and secretarial and administrative support services. We began incurring these fees
on February 25, 2021 and will continue to incur these fees monthly until the earlier of the completion of the business combination and
our liquidation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have an agreement to pay the underwriters
of our Initial Public Offering a deferred fee of $12,075,000 in the aggregate, which will become payable to them from the amounts
held in the Trust Account solely in the event that we complete a business combination, subject to the terms of the underwriting
agreement. As of October 25, 2022, and November 2, 2022, respectively, J.P. Morgan Securities LLC and Deutsche Bank Securities Inc.
have waived their portions of the deferred underwriting fee which is reflected in the consolidated statement of operations and the
consolidated statement of changes in shareholders&#8217; deficit as a reduction of transaction costs incurred in connection
with IPO. Therefore, the deferred underwriting fee was reduced by $9,056,250, of which $271,687 is shown in the consolidated statement of operations as a reduction of transaction
costs incurred in connection with the IPO and $8,784,563 is charged to additional paid-in capital in the consolidated statement of changes
in shareholders&#8217; deficit. As a result of the reductions, the outstanding deferred underwriting fee payable was reduced to $3,018,750.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 62; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Critical Accounting Policies</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">This management&#8217;s discussion and analysis
of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with
U.S. GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts
of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements. On
an ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued
expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable
under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities
that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
There have been no significant changes in our critical accounting policies as discussed in the Annual Report on Form 10-K filed by us
with the SEC on April 13, 2022.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our critical accounting policies are presented below:</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Class A Ordinary Shares Subject to Possible
Redemption</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We account for our Class A ordinary shares subject
to possible redemption in accordance with the guidance in ASC Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Class A
ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally
redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder
or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At
all other times, Class A ordinary shares are classified as shareholders&#8217; deficit. Our Class A ordinary shares feature certain redemption
rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, as of December
31, 2022 and 2021, 34,500,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity,
outside of the shareholders&#8217; deficit section of our consolidated balance sheets.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Derivative Warrant Liabilities</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We do not use derivative instruments to hedge
exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including issued share purchase
Warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480
and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or
as equity, is reassessed at the end of each reporting period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We account for our 14,891,667 Warrants issued
in connection with our Initial Public Offering (8,625,000) and Private Placement (6,266,667) as derivative warrant liabilities in accordance
with ASC 815-40. Accordingly, we recognize the warrant instruments as liabilities at fair value and adjust the instruments to fair value
at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in
fair value is recognized in our statements of operations. The fair value of the Private Placement Warrants has been estimated using binomial lattice simulations at each measurement date. The fair value of the Public Warrants was initially estimated using Monte Carlo simulations.
After the Public Warrants were separately traded, the measurement of the Public Warrants used an observable market quote in an active
market.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Net Income per Ordinary Share</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have two classes of shares, which are referred
to as Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares.
The 14,891,667 potential ordinary shares issuable upon the exercise of the Warrants were excluded from diluted earnings per share for
the year ended December 31, 2022 and 2021 because the Warrants are contingently exercisable, and the contingencies have not yet been met.
As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods presented.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Recent Accounting Pronouncements</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In August 2020, the Financial Accounting Standards
Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, Debt &#8212; Debt with Conversion and Other
Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;)
to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial
conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining
to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible
debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings
per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective
January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1,
2021. The guidance was adopted starting January 1, 2022. Adoption of the ASU did not impact our financial position, results of operations
or cash flows.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our consolidated
financial statements.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 63; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Off-Balance Sheet Arrangements</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">As of December 31, 2022 and 2021, we did not have
any off-balance sheet arrangements.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">JOBS Act</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The Jumpstart Our Business Startups Act of 2012
(the &#8220;JOBS Act&#8221;) contains provisions that, among other things, relax certain reporting requirements for qualifying public
companies. We qualify as an &#8220;emerging growth company&#8221; and under the JOBS Act are allowed to comply with new or revised accounting
pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or
revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which
adoption of such standards is required for non-emerging growth companies. As a result, the financial statements may not be comparable
to companies that comply with new or revised accounting pronouncements as of public company effective dates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Additionally, we are in the process of evaluating
the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth
in the JOBS Act, if, as an &#8220;emerging growth company,&#8221; we choose to rely on such exemptions we may not be required to, among
other things, (i) provide an auditor&#8217;s attestation report on our system of internal controls over financial reporting pursuant to
Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank
Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory
audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements
(auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive
compensation and performance and comparisons of the CEO&#8217;s compensation to median employee compensation. These exemptions will apply
for a period of five years following the completion of our Initial Public Offering or until we are no longer an &#8220;emerging growth
company,&#8221; whichever is earlier.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_013"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
7A. Quantitative and Qualitative Disclosures about Market Risk</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We are a smaller reporting company as defined
by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_014"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
8. Financial Statements and Supplementary Data</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">This information appears following Item 15 of
this Report and is included herein by reference.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_015"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">None.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_016"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
9A. Controls and Procedures</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Evaluation of Disclosure Controls and Procedures</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Disclosure controls and procedures are controls
and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the
Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure
controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed
in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our principal executive
officer and principal financial officer or persons performing similar functions, as appropriate, to allow timely decisions regarding required
disclosure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 64; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We determined that a material weakness exists in our internal control
over financial reporting related to the accounting for complex financial instruments, accrued expenses and accounts payable, and foreign
exchange transactions. A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial
reporting such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements
will not be prevented or detected on a timely basis. Notwithstanding the determination that our internal control over financial reporting
was not effective and that there was a material weakness as identified in this Annual Report, we believe that our consolidated financial
statements contained in this Annual Report fairly present our financial position, results of operations and cash flows for the years covered
hereby in all material respects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">As required by Rules 13a-15f and 15d-15 under
the Exchange Act, our principal executive officer and principal financial officer carried out an evaluation of the effectiveness of the
design and operation of our disclosure controls and procedures as of December 31, 2022. Based upon their evaluation, our principal executive
officer and principal financial officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15
(e) under the Exchange Act) were not effective as of December 31, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><i>Management&#8217;s Report on Internal Controls
Over Financial Reporting</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">As required by SEC rules and regulations implementing
Section 404 of the Sarbanes-Oxley Act, our management is responsible for establishing and maintaining adequate internal control over financial
reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of our financial statements for external reporting purposes in accordance with GAAP. Our internal control
over financial reporting includes those policies and procedures that:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: left">pertain to the maintenance of records that, in reasonable
detail, accurately and fairly reflect the transactions and dispositions of the assets of our company;</td>
</tr></table><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: left">provide reasonable assurance that transactions are recorded
as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being
made only in accordance with authorizations of our management and directors, and</td>
</tr></table><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: left">provide reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Because of its inherent limitations, internal
control over financial reporting may not prevent or detect errors or misstatements in our financial statements. Also, projections of any
evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions,
or that the degree or compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of our internal
control over financial reporting at December 31, 2022. In making these assessments, management used the criteria set forth by the Committee
of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control - Integrated Framework (2013). Based on our assessments
and those criteria, management determined that we did not maintain effective internal control over financial reporting as of December
31, 2022 due to the material weakness in our internal control over financial reporting described above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">To respond to this material weakness, management
has devoted, and plans to continue to devote, significant effort and resources to the remediation and improvement of our internal control
over financial reporting. While we have processes to identify and appropriately apply applicable accounting requirements, we are enhancing
our system of evaluating and implementing the accounting standards that apply to our financial statements, including through enhanced
analyses by our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of
our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the
intended effects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">This Annual Report does not include an attestation
report of our independent registered public accounting firm due to our status as an emerging growth company under the JOBS Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><i>Changes in Internal Control over Financial
Reporting</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Other than as discussed herein, there were no
changes in our internal control over financial reporting that occurred during the fourth fiscal quarter of 2022 that have materially affected,
or are reasonably likely to materially affect, our internal control over financial reporting.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_017"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
9B. Other Information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">None.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_018"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 65; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><div><a id="k_019"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center">PART III</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Item 10. Directors, Executive Officers and Corporate Governance</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Directors and Executive Officers</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; border-bottom: Black 1.5pt solid; width: 30%; text-indent: 0pt"><b>Name</b></td>
    <td style="padding: 0pt; width: 1%; text-indent: 0pt"><b>&#160;</b></td>
    <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: center; width: 10%; text-indent: 0pt"><b>Age</b></td>
    <td style="padding: 0pt; width: 1%; text-indent: 0pt"><b>&#160;</b></td>
    <td style="padding: 0pt; border-bottom: Black 1.5pt solid; width: 58%; text-indent: 0pt"><b>Position</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-indent: 0pt">Tidjane Thiam</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: center; text-indent: 0pt">60</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt">Executive Chairman</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0pt; text-indent: 0pt">Adam Gishen</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: center; text-indent: 0pt">48</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt">Chief Executive Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-indent: 0pt">Nell Cady-Kruse</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: center; text-indent: 0pt">61</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt">Director</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0pt; text-indent: 0pt">Noreen Doyle</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: center; text-indent: 0pt">73</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; text-indent: 0pt">William Janetschek</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: center; text-indent: 0pt">61</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt">Director</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0pt; text-indent: 0pt">Edward Zeng</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-align: center; text-indent: 0pt">60</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt">Director</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our directors and executive officers are as follows:</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Tidjane Thiam, Executive Chairman</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Tidjane Thiam has served as our Executive Chairman
since our inception in December 2020. Since June 2020, Mr. Thiam has been a Director and the Chair of the Audit Committee of Kering S.A.,
the French luxury group. From 2015 to 2020, Mr. Thiam was Chief Executive Officer of Credit Suisse Group AG. From 2014 to 2019, Mr. Thiam
was a Director of 21st Century Fox and served on its Nominating and Corporate Governance Committee. Mr. Thiam previously served at Prudential
plc, a global insurance company based on London, as the Group Chief Executive from 2009 to 2015, a Director from 2008 to 2015 and Group
Chief Financial Officer from 2008 to 2009. Mr. Thiam holds an MBA from INSEAD and graduated from Ecole Nationale Superieure des Mines
de Paris in 1986 and from Ecole Polytechnique in Paris in 1984. We believe Mr. Thiam&#8217;s extensive leadership experience, broad network
and deep understanding of the financial services sector make him a valuable addition to our board of directors.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Adam Gishen, Chief Executive Officer and Board
Observer</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Adam Gishen has served as our Chief Executive
Officer since February 2021 and serves as one of our initial board observers. From 2015 to 2020, Mr. Gishen served in several senior roles
at Credit Suisse Group AG, including Global Head of Investor Relations, Corporate Communications and Marketing and Branding. Prior to
2015, Mr. Gishen was a partner at Ondra Partners, a financial advisory firm and previous to this worked as a Managing Director at Nomura
and at Lehman Brothers in the area of Equity Capital Markets. Mr. Gishen graduated from the University of Leeds.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Nell Cady-Kruse, Director</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Nell Cady-Kruse has served on our board of directors
since May 2022. Ms. Cady-Kruse is non-executive director of Barclays US LLC and Barclays Bank Delaware (appointed in December 2017 and
September 2016, respectively) and serves as Chair of both Board Risk Committees. In 2022, Ms. Cady-Kruse joined as an Independent Director
of Varagon Capital Corporation, a business development company. She also serves as an Advisory Board member of FutureBank, a fintech startup.
Ms. Cady-Kruse&#8217;s executive career includes most recently the Global Chief Risk Officer, Wholesale Banking for Standard Chartered
Bank, based in Singapore. She retired from Standard Chartered in 2014. Prior to Standard Chartered, she spent nine years at Credit Suisse,
where her most recent role was Chief Risk Officer of the Asia Pacific region. Ms. Cady-Kruse received her MBA from Cornell SC Johnson
Graduate School of Management in 1985. She received her B.S. with Honors in Agricultural Economics from Cornell University. We believe
Ms. Cady-Kruse&#8217;s extensive leadership experience, global network, and deep expertise across the financial services sector make her
a valuable addition to our board of directors.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Noreen Doyle, Director</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Noreen Doyle has served on our board of directors
since our initial public offering. Ms. Doyle retired in April 2021 as Chair of the Board of Directors of Newmont Corporation, the world&#8217;s
largest gold producer. She joined the Newmont Board in 2005 and since 2016 served as Chair of the Board and of the Nominating and Corporate
Governance Committee. Previously she served as Chair of the Audit Committee. From 2004 to 2017, she served on the Board of Directors of
Credit Suisse Group AG, including as Vice Chair and Senior Independent Director from 2014 to 2017. Ms. Doyle has also served on the boards
of Rexam PLC and QinetiQ plc. In her executive career, Ms. Doyle was First Vice President of the European Bank for Reconstruction and
Development (EBRD) from 2001 to 2005, having previously served as head of Risk Management and of Syndications. Prior to EBRD, Ms. Doyle
was a senior officer at Bankers Trust Company (now Deutsche Bank) specializing in leveraged finance and natural resources. Ms. Doyle holds
an MBA from Tuck School at Dartmouth, where she served on its Board of Overseers, and a B.A. from the College of Mount Saint Vincent,
where she served on and chaired its Board of Trustees. We believe Ms. Doyle is well qualified to serve on our board of directors based
on her experience and network in the financial services industry.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 66; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">William Janetschek, Director</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">William Janetschek has served on our board of
directors since our initial public offering. Mr. Janetschek joined KKR in 1997 and retired in 2020 as a Partner and its Chief Financial
Officer. Mr. Janetschek was also a member of KKR&#8217;s Balance Sheet Committee, Global Valuation Committee and Risk and Operations Committee.
Prior to joining KKR, he was a Tax Partner at Deloitte &amp; Touche LLP. Mr. Janetschek serves on the board of directors of Bilander Acquisition
Corp. He also serves as a sponsor and member of a variety of non-profit organizations including Student Sponsor Partners and St. Brigid
Catholic Church. Mr. Janetschek holds a M.S. from Pace University and a B.S. from St. John&#8217;s University, where he is now the Chairman
of the Board of Trustees. We believe Mr. Janetschek&#8217;s finance and operations experience makes him well qualified to serve on our
board of directors.</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in">Edward Zeng, Director</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Edward Zeng has served on our board of directors
since June 2022. Mr. Zeng is the Managing Director of China Bridge Capital, an independent investment bank, focusing on China-based, integrated
financial bridge and emerging technologies, and with locations in China and the United States. Mr. Zeng has been a technological entrepreneur
in China and has founded several internet-related Chinese companies, including Sparkice Inc. and Qianlong.com. Mr. Zeng holds a B.A. in
Applied Mathematics and a M.A. in Economic Management from Tsinghua University and a M.A. in Financial Economics from University of Toronto.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Number and Terms of Office of Officers and Directors</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our board of directors consists of five members
and is divided into three classes with only one class of directors being appointed in each year, and with each class (except for those
directors appointed prior to our first general meeting) serving a three-year term.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In accordance with the NYSE corporate governance
requirements, we are not required to hold an annual general meeting until one year after our first fiscal year end following our listing
on the NYSE. The term of office of the first class of directors, consisting of Nell Cady-Kruse, will expire at our first annual general
meeting. The term of office of the second class of directors, consisting of Noreen Doyle and William Janetschek, will expire at the second
annual general meeting. The term of office of the third class of directors, consisting of Tidjane Thiam and Edward Zeng, will expire at
the third annual general meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Only holders of Class B ordinary shares will have
the right to appoint or remove directors in any general meeting held prior to or in connection with the completion of our initial business
combination. Holders of our public shares will not be entitled to vote on the appointment of directors during such time. These provisions
of our amended and restated memorandum and articles of association relating to the rights of holders of Class B ordinary shares to appoint
or remove directors may be amended by a special resolution passed by a majority of at least 90% of our ordinary shares voting in a general
meeting. Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific
terms of office. Our board of directors is authorized to appoint officers as it deems appropriate pursuant to our amended and restated
memorandum and articles of association.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Director Independence</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The rules of the NYSE require that a majority
of our board of directors be independent within one year of our initial public offering. An &#8220;independent director&#8221; is defined
generally as a person who, in the opinion of the company&#8217;s board of directors, has no material relationship with the listed company
(either directly or as a partner, shareholder, stockholder or officer of an organization that has a relationship with the company). Our
board of directors has determined that Nell Cady-Kruse, Noreen Doyle, and William Janetschek are &#8220;independent directors&#8221; as
defined in the NYSE listing standards and applicable SEC rules. Our independent directors have regularly scheduled meetings at which only
independent directors are present.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 67; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Committees of the Board of Directors</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our board of directors has three standing committees:
an audit committee, a compensation committee, and a nominating and corporate governance committee. Each of our audit committee, compensation
committee, and nominating and corporate governance committee is composed solely of independent directors. Subject to phase-in rules, the
rules of the NYSE and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of independent
directors, and the rules of the NYSE require that the compensation committee and the nominating and corporate governance committee of
a listed company be comprised solely of independent directors. Each committee operates under a charter that has been approved by our board
of directors and has the composition and responsibilities described below. The charter of each committee is available on our website at
https://freedomac1.com/investor-resources/#resources/.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Nell Cady-Kruse, Noreen Doyle, and William Janetschek
serve as the members and William Janetschek serves as chair of the audit committee. Nell Cady-Kruse, Noreen Doyle, and William Janetschek
are independent of and unaffiliated with our sponsor. Under the NYSE listing standards and applicable SEC rules, all the directors on
the audit committee must be independent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Nell Cady-Kruse, Noreen Doyle, and William Janetschek
are financially literate and our board of directors has determined that William Janetschek qualifies as an &#8220;audit committee financial
expert&#8221; as defined in applicable SEC rules and has accounting or related financial management expertise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have adopted an audit committee charter, which
details the purpose and principal functions of the audit committee, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>assisting board oversight of (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements,
(3) our independent registered public accounting firm&#8217;s qualifications and independence, and (4) the performance of our internal
audit function and independent registered public accounting firm; the appointment, compensation, retention, replacement, and oversight
of the work of the independent registered public accounting firm and any other independent registered public accounting firm engaged by
us;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
             </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>pre-approving all audit and non-audit services to be provided by the independent registered public accounting firm or any other registered
public accounting firm engaged by us, and establishing pre-approval policies and procedures; reviewing and discussing with the independent
registered public accounting firm all relationships the registered public accounting firm has with us in order to evaluate their continued
independence;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                       </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>setting clear hiring policies for employees or former employees of the independent registered public accounting firm;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                                                                                        </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>setting clear policies for audit partner rotation in compliance with applicable laws and regulations; obtaining and reviewing a report,
at least annually, from the independent registered public accounting firm describing (1) the independent registered public accounting
firm&#8217;s internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review,
or peer review, of the independent registered public accounting firm, or by any inquiry or investigation by governmental or professional
authorities, within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to
deal with such issues;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                </table><div>


</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>meeting to review and discuss our annual audited financial statements and quarterly financial statements with management and the independent
registered public accounting firm, including reviewing our specific disclosures under &#8220;Item 7. Management&#8217;s Discussion and
Analysis of Financial Condition and Results of Operations&#8221;; reviewing and approving any related party transaction required to be
disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and</td></tr></table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 68; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>reviewing with management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory
or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports
that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards
or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Nell Cady-Kruse, Noreen Doyle, and William Janetschek
serve as the members of the compensation committee, and Nell Cady-Kruse serves as chair of the compensation committee. Under the NYSE
listing standards, all the directors on the compensation committee must be independent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have adopted a compensation committee charter,
which details the purpose and responsibilities of the compensation committee, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>reviewing and approving on an annual basis the corporate goals and objectives relevant to our chief executive officer&#8217;s compensation,
evaluating our chief executive officer&#8217;s performance in light of such goals and objectives and determining and approving the remuneration
(if any) of our chief executive officer&#8217;s based on such evaluation;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                   </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>reviewing and making recommendations to our board of directors with respect to the compensation, and any incentive compensation and
equity based plans that are subject to board approval of all of our other officers;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                             </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>reviewing our executive compensation policies and plans;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                           </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>implementing and administering our incentive compensation equity-based remuneration plans;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                                                             </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>assisting management in complying with our proxy statement and annual report disclosure requirements;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                                                                        </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers
and employees;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                        </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>producing a report on executive compensation to be included in our annual proxy statement; and</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                                                                 </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Notwithstanding the foregoing, as indicated above,
other than the payment to an affiliate of our sponsor of up to $10,000 per month, for up to 24 months, for office space, utilities, secretarial
and administrative support, other expenses and obligations of our sponsor and reimbursement of expenses, no compensation of any kind,
including finders, consulting or other similar fees, will be paid to any of our existing shareholders, officers, directors or any of their
respective affiliates, prior to, or for any services they render in order to effectuate the consummation of an initial business combination.
Accordingly, it is likely that prior to the consummation of an initial business combination, the compensation committee will only be responsible
for the review and recommendation of any compensation arrangements to be entered into in connection with such initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The charter also provides that the compensation
committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, independent legal counsel or other advisor
and will be directly responsible for the appointment, compensation and oversight of the work of any such advisor. However, before engaging
or receiving advice from a compensation consultant, external legal counsel or any other advisor, the compensation committee will consider
the independence of each such advisor, including the factors required by the NYSE and the SEC.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 69; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Nominating and Corporate Governance Committee</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The members of our nominating and corporate governance
committee are Nell Cady-Kruse, Noreen Doyle, and William Janetschek. Noreen Doyle serves as chair of the nominating and corporate governance
committee. Under the NYSE listing standards, all the directors on the nominating and corporate governance committee must be independent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have adopted a nominating and corporate governance
committee charter, which details the purpose and responsibilities of the nominating and corporate governance committee, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>identifying, screening and reviewing individuals qualified to serve as directors, consistent with criteria approved by the board of
directors, and recommending to the board of directors candidates for nomination for appointment at the annual general meeting or to fill
vacancies on the board of directors;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                              </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>developing and recommending to the board of directors and overseeing implementation of our corporate governance guidelines;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                                                                                              </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>coordinating and overseeing the annual self-evaluation of the board of directors, its committees, individual directors and management
in the governance of the company; and</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                               </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>reviewing on a regular basis our overall corporate governance and recommending improvements as and when necessary.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The charter also provides that the nominating
and corporate governance committee may, in its sole discretion, retain or obtain the advice of, and terminate, any search firm to be used
to identify director candidates, and will be directly responsible for approving the search firm&#8217;s fees and other retention terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have not formally established any specific,
minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating
nominees for director, the board of directors considers educational background, diversity of professional experience, knowledge of our
business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our shareholders.
Prior to our initial business combination, holders of our public shares will not have the right to recommend director candidates for nomination
to our board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Compensation Committee Interlocks and Insider
Participation</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">None of our officers currently serves, or in the
past year has served, as a member of the compensation committee of any entity that has one or more officers serving on our board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Section 16(a) Beneficial Ownership Reporting
Compliance</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Section 16(a) of the Exchange Act requires our
officers, directors and persons who beneficially own more than ten percent of our ordinary shares to file reports of ownership and changes
in ownership with the SEC. These reporting persons are also required to furnish us with copies of all Section 16(a) forms they file. Based
solely upon a review of such forms, we believe that during the year ended December 31, 2022 there were no delinquent filers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Code of Business Conduct and Ethics</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have adopted a Code of Business Conduct and
Ethics applicable to our directors, officers and employees. You can review this document by accessing our public filings at the SEC&#8217;s
web site at www.sec.gov. In addition, a copy of the Code of Business Conduct and Ethics and the charters of the committees of our board
of directors are provided on our website at https://freedomac1.com/wp-content/uploads/2021/02/Freedom-Acquisition-I-Corp.-Code-of-Ethics.pdf.
If we make any amendments to our Code of Business Conduct and Ethics other than technical, administrative or other non-substantive amendments,
or grant any waiver, including any implicit waiver, from a provision of the Code of Business Conduct and Ethics applicable to our principal
executive officer, principal financial officer principal accounting officer or controller or persons performing similar functions requiring
disclosure under applicable SEC or NYSE rules, we will disclose the nature of such amendment or waiver on our website.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 70; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Conflicts of Interest</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Under Cayman Islands law, directors and officers
owe the following fiduciary duties:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -22.5pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 22.5pt">(i)</td><td>duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -22.5pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 22.5pt">(ii)</td><td>duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -22.5pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 22.5pt">(iii)</td><td>directors should not improperly fetter the exercise of future discretion;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -22.5pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 22.5pt">(iv)</td><td>duty to exercise powers fairly as between different sections of shareholders;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -22.5pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 22.5pt">(v)</td><td>duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests;
and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -22.5pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 22.5pt">(vi)</td><td>duty to exercise independent judgment.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In addition to the above, directors also owe a
duty of care which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having
both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried
out by that director in relation to the company and the general knowledge skill and experience of that director.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">As set out above, directors have a duty not to
put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of
their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance
by the shareholders provided that there is full disclosure by the directors. This can be done by way of permission granted in the memorandum
and articles of association or alternatively by shareholder approval at general meetings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Each of our officers and directors presently has,
and any of them in the future may have additional, fiduciary or contractual obligations to another entity pursuant to which such officer
or director is or will be required to present a business combination opportunity to such entity. Accordingly, if any of our officers or
directors becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary
or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such business combination
opportunity to such entity, subject to their fiduciary duties under Cayman Islands law. Our amended and restated memorandum and articles
of association provide that, to the fullest extent permitted by applicable law: (i) no individual serving as a director or an officer
shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same
or similar business activities or lines of business as us; and (ii) we renounce any interest or expectancy in, or in being offered an
opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any director or officer on
the one hand, and us, on the other. We do not believe, however, that the fiduciary duties or contractual obligations of our officers or
directors will materially affect our ability to complete our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Below is a table summarizing the other entities
to which our officers and directors currently have fiduciary duties or contractual obligations:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; width: 20%"><b>Individual</b></td>
    <td style="text-align: center; width: 1%"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 25%"><b>Entity/Organization</b></td>
    <td style="text-align: center; width: 1%"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 20%"><b>Entity&#8217;s Business</b></td>
    <td style="text-align: center; width: 1%"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 32%"><b>Affiliation</b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>Tidjane Thiam</td>
    <td>&#160;</td>
    <td>Kering S.A.</td>
    <td>&#160;</td>
    <td>Luxury goods</td>
    <td>&#160;</td>
    <td>Director and Chair of Audit Committee</td></tr>
  <tr style="vertical-align: top; ">
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap">Publicis Group</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap">Marketing and communications</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap">Director and Member of Audit Committee</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>Adam Gishen</td>
    <td>&#160;</td>
    <td>N/A</td>
    <td>&#160;</td>
    <td>N/A</td>
    <td>&#160;</td>
    <td>N/A</td></tr>
  <tr style="vertical-align: top; ">
    <td>Nell Cady-Kruse</td>
    <td>&#160;</td>
    <td>N/A</td>
    <td>&#160;</td>
    <td>N/A</td>
    <td>&#160;</td>
    <td>N/A</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>Noreen Doyle</td>
    <td>&#160;</td>
    <td>N/A</td>
    <td>&#160;</td>
    <td>N/A</td>
    <td>&#160;</td>
    <td>N/A</td></tr>
  <tr style="vertical-align: top; ">
    <td style="white-space: nowrap">William Janetschek</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap">Bilander Acquisition Corp.</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap">SPAC</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap">Director</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>Edward Zeng</td>
    <td>&#160;</td>
    <td>China Bridge Capital</td>
    <td>&#160;</td>
    <td>Investment Bank</td>
    <td>&#160;</td>
    <td>Managing Director</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">There are also other potential conflicts of interest:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>Our officers and directors are not required to, and will not commit their full time to our affairs, which may result in a conflict
of interest in allocating their time between our operations and our search for a business combination and their other businesses. Each
of our officers is engaged in several other business endeavors for which he may be entitled to substantial compensation, and our officers
are not obligated to contribute any specified amount of time to our affairs.</td></tr></table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 71; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>Our initial shareholders purchased founder shares and private placement warrants. Our initial shareholders, sponsor, officers and
directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect
to any founder shares and public shares held by them in connection with the completion of our initial business combination. Additionally,
our initial shareholders, sponsor, officers and directors have agreed to waive their rights to liquidating distributions from the trust
account with respect to any founder shares held by them if we fail to complete our initial business combination within the prescribed
time frame. If we do not complete our initial business combination within the prescribed time frame, the private placement warrants will
expire worthless. Furthermore, our initial shareholders, sponsor, officers and directors have agreed not to transfer, assign or sell any
of any founder shares (including the Class A ordinary shares issuable upon conversion thereof) until the earlier to occur of: (i) one
year after the completion of our initial business combination and (ii) the date following the completion of our initial business combination
on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having
the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the last reported
sales price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations,
reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days
after our initial business combination, the founder shares will be released from the lockup.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                      </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will
not be transferable until 30 days following the completion of our initial business combination. Because each of our officers and directors
will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular
target business is an appropriate business with which to effectuate our initial business combination.</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                               </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention
or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our
initial business combination.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We are not prohibited from pursuing an initial
business combination with a company that is affiliated with our sponsor, officers or directors, or completing the business combination
through a joint venture or other form of shared ownership with our sponsor, officers or directors. In the event we seek to complete an
initial business combination with a target that is affiliated with our sponsor, officers or directors, a committee of independent and
disinterested directors would consider, review and approve the transaction. Additionally, we, or a committee of independent and disinterested
directors, would obtain an opinion from an independent investment banking firm or a valuation or appraisal firm that such an initial business
combination is fair to our company from a financial point of view. We are not required to obtain such an opinion in any other context.
Furthermore, in no event will our sponsor or any of our existing officers or directors, or any of their respective affiliates, be paid
by the company any finder&#8217;s fee, consulting fee or other compensation prior to, or for any services they render in order to effectuate,
the completion of our initial business combination. Further, we have agreed to pay our sponsor or an affiliate thereof up to $10,000 per
month for office space, utilities, secretarial and administrative services provided to members of our management team and other expenses
and obligations of our sponsor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We cannot assure you that any of the above mentioned
conflicts will be resolved in our favor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In the event that we submit our initial business
combination to our public shareholders for a vote, our initial shareholders, sponsor, officers and directors have agreed to vote any founder
shares held by them, and they have agreed to vote any founder shares and public shares held by them in favor of our initial business combination.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Limitation on Liability and Indemnification of Officers and Directors</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Cayman Islands law does not limit the extent to
which a company&#8217;s memorandum and articles of association may provide for indemnification of officers and directors, except to the
extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification
against willful default, fraud or the consequences of committing a crime. Our amended and restated memorandum and articles of association
provide for indemnification of our officers and directors to the maximum extent permitted by law, including for any liability incurred
in their capacities as such, except through their own actual fraud, willful default or willful neglect. We have purchased a policy of
directors&#8217; and officers&#8217; liability insurance that insures our officers and directors against the cost of defense, settlement
or payment of a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors. We have
also entered into indemnity agreements with them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 72; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our officers and directors have agreed to waive
any right, title, interest or claim of any kind in or to any monies in the trust account, and have agreed to waive any right, title, interest
or claim of any kind they may have in the future as a result of, or arising out of, any services provided to us and will not seek recourse
against the trust account for any reason whatsoever. Accordingly, any indemnification provided will only be able to be satisfied by us
if (i) we have sufficient funds outside of the trust account or (ii) we consummate an initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our indemnification obligations may discourage
shareholders from bringing a lawsuit against our officers or directors for breach of their fiduciary duty. These provisions also may have
the effect of reducing the likelihood of derivative litigation against our officers and directors, even though such an action, if successful,
might otherwise benefit us and our shareholders. Furthermore, a shareholder&#8217;s investment may be adversely affected to the extent
we pay the costs of settlement and damage awards against our officers and directors pursuant to these indemnification provisions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We believe that these provisions, the insurance
and the indemnity agreements are necessary to attract and retain talented and experienced officers and directors.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_020"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
11. Executive Compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">None of our officers or directors have received
any cash compensation for services rendered to us. We pay our sponsor or an affiliate thereof up to $10,000 per month for office space,
utilities, secretarial and administrative support services provided to members of our management team and other expenses and obligations
of our sponsor. In addition, our sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket
expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence
on suitable business combinations. Our audit committee reviews on a quarterly basis all payments that were made by us to our sponsor,
officers or directors, or our or their affiliates. Any such payments prior to an initial business combination will be made from funds
held outside the trust account. Other than quarterly audit committee review of such reimbursements, we do not expect to have any additional
controls in place governing our reimbursement payments to our directors and officers for their out-of-pocket expenses incurred in connection
with our activities on our behalf in connection with identifying and consummating an initial business combination. Other than these payments
and reimbursements, no compensation of any kind, including finder&#8217;s and consulting fees, will be paid by the company to our sponsor,
officers and directors, or any of their respective affiliates, prior to completion of our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">After the completion of our initial business combination,
directors or members of our management team who remain with us may be paid consulting or management fees from the combined company. All
of these fees will be fully disclosed to shareholders, to the extent then known, in the proxy solicitation materials or tender offer materials
furnished to our shareholders in connection with a proposed initial business combination. We have not established any limit on the amount
of such fees that may be paid by the combined company to our directors or members of management. It is unlikely the amount of such compensation
will be known at the time of the proposed initial business combination, because the directors of the post-combination business will be
responsible for determining officer and director compensation. Any compensation to be paid to our officers will be determined, or recommended
to the board of directors for determination, either by a compensation committee constituted solely by independent directors or by a majority
of the independent directors on our board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We do not intend to take any action to ensure
that members of our management team maintain their positions with us after the consummation of our initial business combination, although
it is possible that some or all of our officers and directors may negotiate employment or consulting arrangements to remain with us after
our initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions with
us may influence our management&#8217;s motivation in identifying or selecting a target business but we do not believe that the ability
of our management to remain with us after the consummation of our initial business combination will be a determining factor in our decision
to proceed with any potential business combination. We are not party to any agreements with our officers and directors that provide for
benefits upon termination of employment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 73; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_021"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The following table sets forth information regarding
the beneficial ownership of our ordinary shares available to us at April 3, 2023, with respect
to our ordinary shares held by:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>each person known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares;</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                                                                                                    </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>each of our officers and directors; and</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
                                                                                                                                                                                          </table><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td>all our officers and directors as a group.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Unless otherwise indicated, we believe that all
persons named in the table have sole voting and investment power with respect to all of our ordinary shares beneficially owned by them.
The following table does not reflect record or beneficial ownership of the private placement warrants as these warrants are not exercisable
within 60 days of April 3, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">On December 30, 2020, our sponsor paid $25,000,
or approximately $0.003 per share, to cover certain offering costs in exchange for founder shares such that our sponsor owned 8,625,000
founder shares (retroactively adjusting for the issuance of 1,437,500 founder shares resulting from a share dividend effected by the Company
on February 25, 2021). Our sponsor transferred 25,000 founder shares each to Noreen Doyle, William Janetschek and David Poritz and an
aggregate of 47,500 founder shares to certain employees and consultants. On April 8, 2022, David Poritz resigned from our board of directors
and returned his 25,000 founder shares to our sponsor. On May 10, 2022, Nell Cady-Kruse was appointed to our board of directors, and our
sponsor transferred 25,000 founder shares to her. Prior to the initial investment in the company of $25,000 by the sponsor, the company
had no assets, tangible or intangible.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In connection with the Extension Amendment, 23,256,504
Class A ordinary shares were redeemed and 11,243,496 Class A ordinary shares remain outstanding after giving effect to such redemptions,
as further described in &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Recent
Developments&#8212;Amendment to Amended and Restated Memorandum and Articles.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class A ordinary shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class B ordinary shares(2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/>
 Shares<br/>
 Beneficially<br/>
 Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Approximate<br/>
 Percentage&#160;of <br/>
Class</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/>
 Shares<br/>
 Beneficially<br/>
 Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Approximate<br/>
 Percentage&#160;of <br/>
Class</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Approximate<br/>
 Percentage&#160;of <br/>
Ordinary<br/>
 Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Freedom Acquisition I LLC(3)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,502,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">98.6</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">42.8</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="white-space: nowrap; text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Entities affiliated with Glazer Capital, LLC(4)</td><td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right">1,244,800</td><td style="white-space: nowrap; text-align: left">&#160;</td><td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right">11.1</td><td style="white-space: nowrap; text-align: left">%</td><td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right">&#8212;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right">6.3</td><td style="white-space: nowrap; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Entities affiliated with Polar Asset Management Partners Inc.(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,961,121</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Tidjane Thiam</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Adam Gishen</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Nell Cady-Kruse</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Noreen Doyle</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">William Janetschek</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Edward Zeng</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">All directors and executive officers of FACT as a group (six individuals)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">*</td><td>Less than one percent.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">(1)</td><td>Unless otherwise noted, the business address of each of the following is 14 Wall Street, 20th Floor, New York, 10005.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">(2)</td><td>Interests shown consist solely of founder shares, classified as Class B ordinary shares. Such shares will automatically convert into
Class A ordinary shares concurrently with or immediately following the consummation of our initial business combination on a one-for-one
basis, subject to adjustment.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 74; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">(3)</td><td>Freedom Acquisition I LLC, our sponsor, is the record holder of such shares. Mr. Thiam, Mr. Gishen and Mr. Bhatia are the three managers
of our sponsor&#8217;s board of managers. Each manager of Freedom Acquisition I LLC has one vote, and the approval of a majority of the
members of the board of managers is required to approve an action of Freedom Acquisition I LLC. Under the so-called &#8220;rule of three,&#8221;
if voting and dispositive decisions regarding an entity&#8217;s securities are made by three or more individuals, and a voting and dispositive
decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity&#8217;s
securities. This is the situation with regard to Freedom Acquisition I LLC. Based upon the foregoing analysis, no individual manager of
Freedom Acquisition I LLC exercises voting or dispositive control over any of the securities held by Freedom Acquisition I LLC even those
in which he directly holds a pecuniary interest. Accordingly, none of them will be deemed to have or share beneficial ownership of such
shares and, for the avoidance of doubt, expressly disclaims any such beneficial interest to the extent of any pecuniary interest he may
have therein, directly or indirectly.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">(4)</td><td>The information in the table above is based solely on information contained in this shareholder&#8217;s Schedule&#160;13G/A under
the Exchange Act filed by such shareholder with the SEC on March 10, 2023. Glazer Capital, LLC (&#8220;Glazer Capital&#8221;) and Paul
J. Glazer, who serves as the managing member of Glazer Capital, have shared voting and dispositive power with respect to the Class A ordinary
shares held by certain funds and managed accounts to which Glazer Capital serves as investment manager (collectively, the &#8220;Glazer
Funds&#8221;). The address for the Glazer Funds and Paul J. Glazer is 250 West 55th Street, Suite 30A, New York, New York 10019.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">(5)</td><td>The information in the table above is based solely on information contained in this shareholder&#8217;s Schedule 13G under the Exchange
Act filed by such shareholder with the SEC on February 9, 2023, which was prior to the redemption of 23,256,504 Class A ordinary shares
in connection with the Extension Amendment, as further described in &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial
Condition and Results of Operations&#8212;Recent Developments&#8212;Amendment to Amended and Restated Memorandum and Articles.&#8221;
Polar Asset Management Partners Inc., a company incorporated under the laws of Ontario, Canada, serves as the investment advisor to Polar
Multi-Strategy Master Fund, a Cayman Islands exempted company, which holds 1,961,121 Class A ordinary shares, and has sole voting and
dispositive power with respect to such shares. The address for Polar Asset Management Partners Inc. is 16 York Street, Suite 2900, Toronto,
ON, Canada M5J 0E6.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our sponsor and our directors beneficially own
approximately 20% of the issued and outstanding ordinary shares. Only holders of Class B ordinary shares will have the right to appoint
and remove directors in any general meeting held prior to or in connection with the completion of our initial business combination. Holders
of our public shares will not have the right to appoint or remove any directors to our board of directors prior to our initial business
combination. Because of this ownership block, our sponsor and our directors may be able to effectively influence the outcome of all other
matters requiring approval by our shareholders, including amendments to our amended and restated memorandum and articles of association
and approval of significant corporate transactions including our initial business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In connection with our initial public offering,
our sponsor purchased an aggregate of 6,266,667 private placement warrants, each exercisable to purchase one Class A ordinary share at
$11.50 per share, subject to adjustment, at a price of $1.50 per warrant, $9,400,000 in the aggregate, in a private placement that occurred
simultaneously with the closing of our initial offering. The private placement warrants are identical to the warrants sold in our offering
except that the private placement warrants, so long as they are held by our sponsor or its permitted transferees, (i) will not be redeemable
by us (except as described in the registration statement for our initial public offering), (ii) will be subject to the transfer restrictions
described below, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. If we do
not complete our initial business combination during the Extension Period, the private placement warrants will expire worthless.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Freedom Acquisition I LLC, our sponsor, and our
officers and directors are deemed to be our &#8220;promoters&#8221; as such term is defined under the federal securities laws. See &#8220;Item
13. Certain Relationships and Related Transactions, and Director Independence&#8221; for additional information regarding our relationships
with our promoters.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 75; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Transfers of Founder Shares and Private Placement Warrants</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The founder shares, private placement warrants
and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up
provisions in the agreement entered into by our sponsor and management team. Those lock-up provisions provide that such securities are
not transferable or salable (i) in the case of the founder shares, until the earlier of (A) one year after the completion of our initial
business combination or earlier if, subsequent to our initial business combination, the last reported sales price of the Class A ordinary
shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination
and (B) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange
or other similar transaction that results in all of our shareholders having the right to exchange their Class A ordinary shares for cash,
securities or other property and (ii) in the case of the private placement warrants and any Class A ordinary shares issuable upon conversion
or exercise thereof, until 30 days after the completion of our initial business combination except in each case (a) to our officers or
directors, any affiliate or family member of any of our officers or directors, any affiliate of our sponsor or to any member of the sponsor
or any affiliates of such members and funds and accounts advised by such members, (b) in the case of an individual, as a gift to such
person&#8217;s immediate family or to a trust, the beneficiary of which is a member of such person&#8217;s immediate family, an affiliate
of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death
of such person; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers
made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination
at prices no greater than the price at which the shares or warrants were originally purchased; (f) by virtue of the laws of the Cayman
Islands or our sponsor&#8217;s limited liability company agreement upon dissolution of our sponsor, (g) in the event of our liquidation
prior to our consummation of our initial business combination; or (h) in the event that, subsequent to our consummation of an initial
business combination, we complete a liquidation, merger, share exchange or other similar transaction which results in all of our shareholders
having the right to exchange their Class A ordinary shares for cash, securities or other property; provided, however, that in the case
of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions
and the other restrictions contained in the letter agreements.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Registration Rights</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The holders of the (i) founder shares, which were
issued in a private placement prior to the closing of our initial public offering, (ii) private placement warrants, which were issued
in a private placement simultaneously with the closing of our initial public offering and the Class A ordinary shares underlying such
private placement warrants and (iii) private placement warrants that may be issued upon conversion of working capital loans are entitled
to registration rights to require us to register the resale of any of our securities held by them pursuant to a registration rights agreement.
The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities.
In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent
to our completion of our initial business combination. We will bear the expenses incurred in connection with the filing of any such registration
statements.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Equity Compensation Plans</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">As of December 31, 2022, we had no compensation
plans (including individual compensation arrangements) under which equity securities were authorized for issuance.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_022"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
13. Certain Relationships and Related Transactions, and Director Independence</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">On December 30, 2020, our sponsor paid $25,000,
or approximately $0.003 per share, to cover certain offering costs in exchange for founder shares such that our sponsor owned 8,625,000
founder shares (retroactively adjusting for the issuance of 1,437,500 founder shares resulting from a share dividend effected by the Company
on February 25, 2021). Our sponsor transferred 25,000 founder shares each to Noreen Doyle, William Janetschek and David Poritz and an
aggregate of 47,500 founder shares to certain employees and consultants. On April 8, 2022, David Poritz resigned from our board of directors
and returned his 25,000 founder shares to our sponsor. On May 10, 2022, Nell Cady-Kruse was appointed to our board of directors, and our
sponsor transferred 25,000 founder shares to her. As such, our sponsor now owns 8,502,500 founder shares. Our sponsor and our directors
collectively own approximately 20% of our issued and outstanding shares as of our initial public offering.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 76; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In connection with our initial public offering,
our sponsor purchased an aggregate of 6,266,667 private placement warrants, each exercisable to purchase one Class A ordinary share at
$11.50 per share, subject to adjustment, at a price of $1.50 per warrant, or $9,400,000 in the aggregate, in a private placement that
closed simultaneously with the closing of our initial public offering. The private placement warrants are identical to the warrants sold
in our initial public offering except that the private placement warrants, so long as they are held by our sponsor or its permitted transferees,
(i) will not be redeemable by us (except as described in the registration statement for our initial public offering), subject to certain
limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of our initial business combination,
(iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We currently utilize office space at 14 Wall Street,
20th Floor, New York, 10005 as our executive offices. We pay our sponsor or an affiliate thereof up to $10,000 per month for office space,
utilities, secretarial and administrative support services provided to members of our management team and other expenses and obligations
of our sponsor. Upon completion of our initial business combination or our liquidation, we will cease paying these monthly fees. Accordingly,
in the event the consummation of our initial business combination takes until 24 months after the closing of our initial public offering,
our sponsor will be paid an aggregate of up to approximately $240,000 ($10,000 per month) for office space, administrative and support
services, and other expenses and obligations of our sponsor and will be entitled to be reimbursed for any out-of-pocket expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">No compensation of any kind, including finder&#8217;s
and consulting fees, will be paid by the company to our sponsor, officers and directors, or any of their respective affiliates, for services
rendered prior to or in connection with the completion of an initial business combination. However, these individuals will be reimbursed
for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and
performing due diligence on suitable business combinations. Our audit committee reviews on a quarterly basis all payments that were made
by us to our sponsor, officers, directors or our or their affiliates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our sponsor agreed to loan us up to $300,000 under
an unsecured promissory note to be used for a portion of the expenses of our initial public offering. These loans were non-interest bearing
and unsecured, and were repaid upon completion of the initial public offering out of the offering proceeds that had been allocated for
the payment of offering expenses (other than underwriting commissions) not held in the trust account. The value of our sponsor&#8217;s
interest in this loan transaction corresponded to the principal amount outstanding under any such loan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">On each of April 1, 2022 and June 6, 2022, we
issued an unsecured promissory note in the amount of up to $500,000 to our sponsor (the &#8220;Sponsor Notes&#8221;). On December 14,
2022, we issued an unsecured promissory note in the amount of up to $325,000 to Tidjane Thiam, Adam Gishen, Edward Zeng, and Abhishek
Bhatia (collectively, the &#8220;Payees&#8221;) (such note, together with the Sponsor Notes, the &#8220;Convertible Notes&#8221;). The
proceeds of the Convertible Notes, which may be drawn down from time to time until we consummate our initial business combination, will
be used for general working capital purposes. The Convertible Notes bear no interest and are payable in full upon the earlier to occur
of (i) twenty-four (24) months from the closing of our initial public offering (or such later date as may be extended in accordance with
the terms of our amended and restated memorandum and articles of Association) or (ii) the consummation of our business combination. A
failure to pay the principal within five business days of the date specified above or the commencement of a voluntary or involuntary bankruptcy
action shall be deemed an event of default, in which case the Convertible Notes may be accelerated. Prior to the Company&#8217;s first
payment of all or any portion of the principal balance of the Convertible Notes in cash, our sponsor and the Payees, as applicable, have
the option to convert all, but not less than all, of the principal balance of the Convertible Notes into private placement warrants (the
&#8220;Conversion Warrants&#8221;), each warrant exercisable for one ordinary share of the Company at an exercise price of $1.50 per share.
The terms of the Conversion Warrants would be identical to the warrants issued by the Company to the sponsor in a private placement that
was consummated in connection with our initial public offering. Our sponsor and the Payees shall be entitled to certain registration rights
relating to the Conversion Warrants. The Convertible Notes were issued pursuant to the exemption from registration contained in Section
4(a)(2) of the Securities Act of 1933, as amended.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 77; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In addition, on February 28, 2023, we issued an
additional unsecured promissory note in the amount of up to $2,100,000 to our sponsor, as described under &#8220;Item 7. Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations&#8212;Recent Developments&#8212;Promissory Note.&#8221; The proceeds
of such promissory note, $1,600,000 of which was drawn down immediately, $400,000 of which may be drawn down, with
the mutual consent of us and our sponsor, if we wish to extend the date by which we will consummate a business combination beyond June
2, 2023, and $100,000 of which may be drawn down on an as-needed basis at the discretion of our sponsor, will be used for general working
capital purposes. Such promissory note bears no interest and is payable in full upon the consummation of our business combination. A failure
to pay the principal within five business days of the date specified above or the commencement of a voluntary or involuntary bankruptcy
action shall be deemed an event of default, in which case the promissory note may be accelerated. The promissory note shall be forgiven
by our sponsor if we are unable to consummate a business combination within the time frame specified in our amended and restated memorandum
and articles of association (as amended from time to time), except to the extent of any funds held outside of the trust account established
in connection with our initial public offering. The issuance of the promissory note was made pursuant to the exemption from registration
contained in Section 4(a)(2) of the Securities Act of 1933, as amended.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">In order to fund working capital deficiencies
or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or
certain of our officers and directors may, but are not obligated to, loan us additional funds as may be required on a non-interest basis.
If we complete an initial business combination, we would repay such loaned amounts. In the event that the initial business combination
does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds
from our trust account would be used for such repayment. Up to $675,000 of such loans may be convertible into private placement warrants
of the post business combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical
to the private placement warrants described above. Prior to the completion of our initial business combination, we do not expect to seek
loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to loan such
funds and provide a waiver against any and all rights to seek access to funds in our trust account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Any of the foregoing payments to our sponsor,
repayments of loans from our sponsor or repayments of working capital loans prior to our initial business combination will be made using
funds held outside the trust account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">After our initial business combination, members
of our management team who remain with us may be paid consulting, management or other fees from the combined company with any and all
amounts being fully disclosed to our shareholders, to the extent then known, in the proxy solicitation or tender offer materials, as applicable,
furnished to our shareholders. It is unlikely the amount of such compensation will be known at the time of distribution of such tender
offer materials or at the time of a general meeting held to consider our initial business combination, as applicable, as it will be up
to the directors of the post-combination business to determine executive and director compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We have entered into a registration rights agreement
with respect to the founder shares and private placement warrants, which is described under the heading &#8220;Item 12. Security Ownership
of Certain Beneficial Owners and Management and Related Stockholder Matters&#8212;Registration Rights.&#8221;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Policy for Approval of Related Party Transactions</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The audit committee of our board of directors
has adopted a policy setting forth the policies and procedures for its review and approval or ratification of &#8220;related party transactions.&#8221;
A &#8220;related party transaction&#8221; is any consummated or proposed transaction or series of transactions: (i) in which the company
was or is to be a participant; (ii) the amount of which exceeds (or is reasonably expected to exceed) the lesser of $120,000 or 1% of
the average of the company&#8217;s total assets at year end for the prior two completed fiscal years in the aggregate over the duration
of the transaction (without regard to profit or loss); and (iii) in which a &#8220;related party&#8221; had, has or will have a direct
or indirect material interest. &#8220;Related parties&#8221; under this policy will include: (i) our directors, nominees for director
or officers; (ii) any record or beneficial owner of more than 5% of any class of our voting securities; (iii) any immediate family member
of any of the foregoing if the foregoing person is a natural person; and (iv) any other person who maybe a &#8220;related person&#8221;
pursuant to Item 404 of Regulation S-K under the Exchange Act. Pursuant to the policy, the audit committee will consider (i) the relevant
facts and circumstances of each related party transaction, including if the transaction is on terms comparable to those that could be
obtained in arm&#8217;s-length dealings with an unrelated third party, (ii) the extent of the related party&#8217;s interest in the transaction,
(iii) whether the transaction contravenes our code of ethics or other policies, (iv) whether the audit committee believes the relationship
underlying the transaction to be in the best interests of the company and its shareholders and (v) the effect that the transaction may
have on a director&#8217;s status as an independent member of the board and on his or her eligibility to serve on the board&#8217;s committees.
Management will present to the audit committee each proposed related party transaction, including all relevant facts and circumstances
relating thereto. Under the policy, we may consummate related party transactions only if our audit committee approves or ratifies the
transaction in accordance with the guidelines set forth in the policy. The policy will not permit any director or officer to participate
in the discussion of, or decision concerning, a related person transaction in which he or she is the related party.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 78; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Director Independence</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The rules of the NYSE require that a majority
of our board of directors be independent within one year of our initial public offering. An &#8220;independent director&#8221; is defined
generally as a person who, in the opinion of the company&#8217;s board of directors, has no material relationship with the listed company
(either directly or as a partner, shareholder, stockholder or officer of an organization that has a relationship with the company). Our
board of directors has determined that Nell Cady-Kruse, Noreen Doyle and William Janetschek are &#8220;independent directors&#8221; as
defined in the NYSE listing standards and applicable SEC rules. Our independent directors have regularly scheduled meetings at which only
independent directors are present.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_023"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
14. Principal Accountant Fees and Services</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">The firm of Marcum LLP, or Marcum, acts as our
independent registered public accounting firm. The following is a summary of fees paid to Marcum for services rendered.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><i>Audit Fees.</i> During the years ended December
31, 2022 and 2021, fees for our independent registered public accounting firm were approximately $144,458 and $125,918, respectively,
for the services Marcum performed in connection with our Initial Public Offering and the audit of our December 31, 2022 financial statements
included in this Annual Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><i>Audit-Related Fees.</i> During the years ended
December 31, 2022 and 2021, our independent registered public accounting firm did not render assurance and related services related to
the performance of the audit or review of financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><i>Tax Fees</i>. During the years ended December
31, 2022 and 2021, our independent registered public accounting firm did not render services to us for tax compliance, tax advice and
tax planning.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><i>All Other Fees</i>. During the years ended
December 31, 2022 and 2021, there were no fees billed for products and services provided by our independent registered public accounting
firm other than those set forth above.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">Pre-Approval Policy</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Our audit committee was formed upon the consummation
of our Initial Public Offering. As a result, the audit committee did not pre-approve all of the foregoing services, although any services
rendered prior to the formation of our audit committee were approved by our board of directors. Since the formation of our audit committee,
and on a going-forward basis, the audit committee has and will pre-approve all auditing services and permitted non-audit services to be
performed for us by our auditors, including the fees and terms thereof (subject to the de minimis exceptions for non-audit services described
in the Exchange Act which are approved by the audit committee prior to the completion of the audit).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;&#160;</p><div>


</div><!-- Field: Page; Sequence: 79; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><div><a id="k_024"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center">PART IV</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -40.5pt">&#160;</p><div>

</div><div><a id="k_025"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Item
15. Exhibits, Financial Statement Schedules</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">(a) The following documents are filed as part
of this Annual Report:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0.25in">(1) Financial Statements:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 91%; padding-right: 2.9pt; padding-left: 2.9pt"><span style="font-family: Times New Roman, Times, Serif">&#160;
    &#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 9%; padding-right: 2.9pt; padding-left: 2.9pt"><span style="font-family: Times New Roman, Times, Serif">Page</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9.35pt; text-indent: -9.35pt"><span style="font-family: Times New Roman, Times, Serif"><a href="#f_001">Report
    of Independent Registered Public Accounting Firm</a></span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-2</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9.35pt; text-indent: -9.35pt"><span style="font-family: Times New Roman, Times, Serif"><a href="#f_002">Consolidated Balance Sheets</a></span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-3</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9.35pt; text-indent: -9.35pt"><a href="#f_003">Consolidated Statements of Operations</a></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-4</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9.35pt; text-indent: -9.35pt"><a href="#f_004">Consolidated Statements of Changes in Shareholders&#8217; Deficit</a></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-5</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9.35pt; text-indent: -9.35pt"><span style="font-family: Times New Roman, Times, Serif"><a href="#f_005">Statements
    of Cash Flows</a></span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-6</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9.35pt; text-indent: -9.35pt"><span style="font-family: Times New Roman, Times, Serif"><a href="#f_006">Notes
    to Financial Statements</a></span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-7&#160;&#8211;&#160;F-24</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0.25in">(2) Financial Statement Schedules:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0.25in">(3) Exhibits</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">We hereby file as part of this Report the exhibits
listed in the attached Exhibit Index. Exhibits which are incorporated herein by reference can be accessed on the SEC website at www.sec.gov.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; vertical-align: top; width: 9%; text-align: center"><b>Exhibit <br/>
    No.</b></td>
    <td style="padding: 0pt; vertical-align: top; width: 1%; text-align: center; text-indent: 0pt"><b>&#160;</b></td>
    <td style="padding: 0pt; border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 90%; text-align: center; text-indent: 0pt"><b>Description</b></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; text-align: center">2.1</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000121390022061524/ea166653ex2-1_freedom1.htm">Business Combination Agreement, dated October 3, 2022, by and among the Company, Jupiter Merger Sub I Corp., Jupiter Merger Sub II LLC, Complete Solaria Holding Corporation, and the Solaria Corporation (incorporated herein by reference to Exhibit 2.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on October 4, 2022).</a></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-align: center">2.2</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000121390022083036/ea170862ex2-1_freedom1.htm">First Amendment to Business Combination Agreement, dated December 26, 2022, by and among the Company, Jupiter Merger Sub I Corp., Jupiter Merger Sub II LLC, and Complete Solaria, Inc. (incorporated herein by reference to Exhibit 2.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 28, 2022).</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; text-align: center">2.3</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000119312523009586/d428780dex21.htm">Second Amendment to Business Combination Agreement, dated January 17, 2023, by and among the Company, Jupiter Merger Sub I Corp., Jupiter Merger Sub II LLC, and Complete Solaria, Inc. (incorporated herein by reference to Exhibit 2.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on January 17, 2023).</a></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-align: center">3.1</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000095010321003441/dp147251_ex0301.htm">Amended and Restated Memorandum and Articles of Association (incorporated herein by reference to Exhibit 3.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 2, 2021).</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; text-align: center">3.2</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000119312523056329/d465232dex31.htm">Amendment to Amended and Restated Memorandum and Articles of Association (incorporated herein by reference to Exhibit 3.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 1, 2023).</a></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-align: center">4.1</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="f10k2022ex4-1_freedomacq1.htm">Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended*</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; text-align: center">4.2</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000095010321003441/dp147251_ex0401.htm">Warrant Agreement, dated February 25, 2021, between the Company and Continental Stock Transfer &amp; Trust Company, as warrant agent (incorporated herein by reference to Exhibit 4.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 2, 2021).</a></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-align: center">10.1</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000095010321003441/dp147251_ex1001.htm">A Letter Agreement, dated February 25, 2021, among the Company and its officers and directors and Freedom Acquisition I, LLC (incorporated herein by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 2, 2021).</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; text-align: center">10.2</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000121390022031779/ea160879ex10-1_freedom1.htm">Amendment No. 1 to Letter Agreement dated February 25, 2021, dated June 6, 2022 (incorporated herein by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 8, 2022).</a></td></tr>
</table><div>

</div><p style="margin: 0">&#160;&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 80; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; vertical-align: top; text-align: center"><b>Exhibit <br/>
    No.</b></td>
    <td style="padding: 0pt; vertical-align: top; text-align: center; text-indent: 0pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; padding: 0pt; vertical-align: bottom; text-align: center; text-indent: 0pt"><b>Description</b></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; text-align: center; width: 9%">10.3</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt; width: 1%">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt; width: 90%"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000095010321003441/dp147251_ex1002.htm">Investment Management Trust Agreement, dated February 25, 2021, between the Company and Continental Stock Transfer &amp; Trust Company, as trustee (incorporated herein by reference to Exhibit 10.2 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 2, 2021).</a></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-align: center">10.4</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000119312523056329/d465232dex101.htm">Amendment to Investment Management Trust Agreement, dated February 28, 2023, between the Company and Continental Stock Transfer &amp; Trust Company, as trustee (incorporated herein by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 1, 2023).</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; text-align: center">10.5</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000095010321003441/dp147251_ex1003.htm">Registration Rights Agreement, dated February 25, 2021, between the Company and certain security holders (incorporated herein by reference to Exhibit 10.3 of the Company&#8217; s Current Report on Form 8-K filed with the SEC on March 2, 2021).</a></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-align: center">10.6</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000095010321003441/dp147251_ex1004.htm">Administrative Services Agreement, dated February 25, 2021, between the Company and Freedom Acquisition I LLC (incorporated herein by reference to Exhibit 10.4 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 2, 2021).</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; text-align: center">10.7</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000095010321003441/dp147251_ex1005.htm">Private Placement Warrants Purchase Agreement, dated December 2, 2020, between the Company and Freedom Acquisition I LLC (incorporated herein by reference to Exhibit 10.5 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 2, 2021).</a></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-align: center">10.8</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000121390022017467/ea153925ex10-1_freedom.htm">Promissory Note, dated April 1, 2022, issued to Freedom Acquisition I LLC (incorporated herein by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 1, 2022).</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; text-align: center">10.9</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000121390022031779/ea160879ex10-2_freedom1.htm">Promissory Note, dated June 6, 2022, issued to Freedom Acquisition I LLC (incorporated herein by reference to Exhibit 10.2 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 8, 2022).</a></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-align: center">10.10</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000121390022079792/ea169168ex10-1_freedom1.htm">Promissory Note, dated December 14, 2022, issued to Tidjane Thiam, Adam Gishen, Abhishek Bhatia, and Edward Zeng (incorporated herein by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 14, 2022).</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; text-align: center">10.11</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000119312523058254/d458401dex101.htm">Promissory Note, dated February 28, 2023, issued to Freedom Acquisition I LLC (incorporated herein by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 2, 2023).</a></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-align: center">10.12</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000121390022061524/ea166653ex10-1_freedom1.htm">Form of Company Subscription Agreement, dated October 3, 2022 (incorporated herein by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on October 4, 2022).</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; text-align: center">10.13</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000121390022061524/ea166653ex10-2_freedom1.htm">Sponsor Support Agreement, dated October 3, 2022 (incorporated herein by reference to Exhibit 10.2 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on October 4, 2022).</a></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-align: center">10.14</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="https://www.sec.gov/Archives/edgar/data/1838987/000121390022061524/ea166653ex10-3_freedom1.htm">Company Stockholder Support Agreement, dated October 3, 2022 (incorporated herein by reference to Exhibit 10.3 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on October 4, 2022).</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; text-align: center">31.1</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="f10k2022ex31-1_freedomacq1.htm">Certification of the Registrant&#8217;s Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*</a></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-align: center">31.2</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="f10k2022ex31-2_freedomacq1.htm">Certification of the Registrant&#8217;s Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding: 0pt; vertical-align: top; text-align: center">32.1</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="f10k2022ex32-1_freedomacq1.htm">Certification of the Registrant&#8217;s Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*</a></td></tr>
  <tr>
    <td style="padding: 0pt; vertical-align: top; text-align: center">32.2</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt"><a href="f10k2022ex32-2_freedomacq1.htm">Certification of the Registrant&#8217;s Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: center; padding: 0pt; vertical-align: bottom">101.INS*</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">Inline XBRL Instance Document.</td></tr>
  <tr>
    <td style="text-align: center; padding: 0pt; vertical-align: bottom">101.SCH*</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">Inline XBRL Taxonomy Extension Schema Document.</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: center; padding: 0pt; vertical-align: bottom">101.CAL*</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</td></tr>
  <tr>
    <td style="text-align: center; padding: 0pt; vertical-align: bottom">101.DEF*</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">Inline XBRL Taxonomy Extension Definition Linkbase Document.</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: center; padding: 0pt; vertical-align: bottom">101.LAB*</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">Inline XBRL Taxonomy Extension Label Linkbase Document.</td></tr>
  <tr>
    <td style="text-align: center; padding: 0pt; vertical-align: bottom">101.PRE*</td>
    <td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; vertical-align: bottom; text-indent: 0pt">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center; padding: 0pt">104*</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</td></tr>
  </table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">*</td><td>Filed herewith.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in">&#160;</p><div>

</div><div><a id="k_026"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> Item 16. Form 10-K Summary</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 81; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">SIGNATURES</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Pursuant to the requirements of Section 13 or 15(d)
of the Securities Act of 1934, as amended, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf
by the undersigned, thereunto duly authorized, on April 6, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3" style="padding-right: 5.75pt"><b>Freedom Acquisition I Corp.</b></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3" style="padding-right: 5.75pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding-right: 5.75pt">By:</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.75pt">/s/ Adam Gishen</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="padding-right: 5.75pt; width: 4%">&#160;</td>
    <td style="padding-right: 5.75pt; width: 5%">Name:</td>
    <td style="padding-right: 5.75pt; width: 31%">Adam Gishen</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding-right: 5.75pt">&#160;</td>
    <td style="padding-right: 5.75pt">Title:</td>
    <td style="padding-right: 5.75pt">Chief Executive Officer</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, this Annual Report on Form 10-K has been signed by the following persons in the capacity and on the
dates indicated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 25%"><b>Name</b></td>
    <td style="width: 1%"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 55%"><b>Position</b></td>
    <td style="width: 1%"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 18%"><b>Date</b></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: center">/s/ Tidjane Thiam</td>
    <td>&#160;</td>
    <td style="text-align: center">Executive Chairman</td>
    <td>&#160;</td>
    <td style="text-align: center">April 6, 2023</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Tidjane Thiam</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: center">/s/ Adam Gishen</td>
    <td>&#160;</td>
    <td style="text-align: center">Chief Executive Officer and Board</td>
    <td>&#160;</td>
    <td style="text-align: center">April 6, 2023</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Adam Gishen</td>
    <td>&#160;</td>
    <td style="text-align: center">Observer</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: center">/s/ Nell Cady-Kruse</td>
    <td>&#160;</td>
    <td style="text-align: center">Director</td>
    <td>&#160;</td>
    <td style="text-align: center">April 6, 2023</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Nell Cady-Kruse</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: center">/s/ Noreen Doyle</td>
    <td>&#160;</td>
    <td style="text-align: center">Director</td>
    <td>&#160;</td>
    <td style="text-align: center">April 6, 2023</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">Noreen Doyle</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: center">/s/ William Janetschek</td>
    <td>&#160;</td>
    <td style="text-align: center">Director</td>
    <td>&#160;</td>
    <td style="text-align: center">April 6, 2023</td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: center">William Janetschek</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: center">/s/ Edward Zeng</td>
    <td>&#160;</td>
    <td style="text-align: center">Director</td>
    <td>&#160;</td>
    <td style="text-align: center">April 6, 2023</td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: center">Edward Zeng</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 82; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FREEDOM ACQUISITION I CORP.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: top; width: 89%"> &#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 11%"><b>Page</b></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#f_001">Report of Independent Registered Public Accounting Firm (PCAOB ID Number <ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId">688</ix:nonNumeric>) </a></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-2</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; "> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#f_002">Consolidated Balance Sheets </a></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-3</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#f_003">Consolidated Statements of Operations </a></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-4</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; "> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#f_004">Consolidated Statements of Changes in Shareholders&#8217; Deficit </a></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-5</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#f_005">Consolidated Statements of Cash Flows </a></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-6</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; "> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#f_006">Notes to Consolidated Financial Statements </a></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-7 &#8211; F-24</td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 83; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_001"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the Shareholders and Board of Directors of</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Freedom Acquisition I Corp.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Opinion on the Consolidated Financial Statements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">We have audited the accompanying consolidated
balance sheet<b>s</b> of Freedom Acquisition I Corp. (the &#8220;Company&#8221;) as of December 31, 2022 and 2021, the related consolidated
statements of operations, changes in shareholders&#8217; (deficit) equity and cash flows for each of the two years in the period ended
December 31, 2022, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial
statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results
of its operations and its cash flows for each of the two years in the period ended December 31, 2022, in conformity with accounting principles
generally accepted in the United States of America.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Explanatory Paragraph &#8211; Going Concern</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The accompanying financial statements have been
prepared assuming that the Company will continue as a going concern. As more fully described in Note 1, the Company&#8217;s business plan
is dependent on the completion of a business combination and the Company&#8217;s cash and working capital as of December 31, 2022 are
not sufficient to complete its planned activities. These conditions raise substantial doubt about the Company&#8217;s ability to continue
as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 1. The financial statements do not
include any adjustments that might result from the outcome of this uncertainty.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis for Opinion</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">These financial statements are the responsibility
of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our
audit<b>s</b>. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;)
and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">We conducted our audits in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s
internal control over financial reporting. Accordingly, we express no such opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Our audits included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ <ix:nonNumeric contextRef="c0" name="dei:AuditorName">Marcum <span style="font-variant: small-caps">llp</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-variant: small-caps">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Marcum <span style="font-variant: small-caps">llp</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-variant: small-caps">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have served as the Company&#8217;s auditor since 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><ix:nonNumeric contextRef="c0" name="dei:AuditorLocation">New York, NY</ix:nonNumeric><br/>
April 6, 2023</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 84; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_002"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FREEDOM ACQUISITION I CORP.<br/>
CONSOLIDATED BALANCE SHEETS</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Current assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; width: 76%">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">72,923</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">277,583</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Prepaid expenses - short term</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="0" unitRef="usd">120,677</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="0" unitRef="usd">724,066</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Total current assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd">193,600</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd">1,001,649</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Prepaid expenses - long term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-1">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseNoncurrent" scale="0" unitRef="usd">113,073</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Cash and marketable securities held in Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd">349,927,313</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd">345,105,681</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Total Assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd">350,120,913</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd">346,220,403</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Liabilities, Redeemable Ordinary Shares and Shareholders&#8217; Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd">4,858,215</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd">2,579,641</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Convertible promissory note &#8211; related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="0" unitRef="usd">828,600</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-2">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Total current liabilities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd">5,686,815</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd">2,579,641</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd">2,978,333</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd">8,488,250</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Deferred underwriters&#8217; discount payable</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="0" unitRef="usd">3,018,750</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="0" unitRef="usd">12,075,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Total Liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">11,683,898</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">23,142,891</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Commitments and Contingencies (See Note 7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-3">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-4">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Class A Ordinary shares subject to possible redemption <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="fact:SharesSubjectToPossibleRedemption" scale="0" unitRef="shares"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="fact:SharesSubjectToPossibleRedemption" scale="0" unitRef="shares">34,500,000</ix:nonFraction></ix:nonFraction> shares subject to possible redemption at redemption value at December 31, 2022 and 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd">349,927,313</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd">345,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Shareholders&#8217; Deficit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Preference shares, $<ix:nonFraction contextRef="c4" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares">1,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <span style="-sec-ix-hidden: hidden-fact-7"><span style="-sec-ix-hidden: hidden-fact-8"><span style="-sec-ix-hidden: hidden-fact-9"><span style="-sec-ix-hidden: hidden-fact-10">none</span></span></span></span> issued or outstanding at December 31, 2022 and 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-5">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-6">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Class A ordinary shares, $<ix:nonFraction contextRef="c2" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c6" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">200,000,000</ix:nonFraction></ix:nonFraction> shares authorized at December 31, 2022 and 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-11">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Class B ordinary shares, $<ix:nonFraction contextRef="c3" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c7" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">20,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">8,625,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2022 and 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="fact:CommonStockValueOne" scale="0" unitRef="usd">863</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="fact:CommonStockValueOne" scale="0" unitRef="usd">863</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd">6,057,438</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-13">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd">17,548,599</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd">21,923,351</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Total Shareholders&#8217; Deficit</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(<b><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">11,490,298</ix:nonFraction></b></p>
</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">21,922,488</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Total Liabilities, Redeemable Ordinary Shares and Shareholders&#8217; Deficit</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd">350,120,913</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd">346,220,403</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral part
of the consolidated financial statements.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 85; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_003"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FREEDOM ACQUISITION I
CORP.<br/>
CONSOLIDATED STATEMENTS OF OPERATIONS</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Year Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Operating costs</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" unitRef="usd">4,407,058</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="0" unitRef="usd">3,782,028</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">4,407,058</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">3,782,028</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Other income (expense):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Foreign currency exchange loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="0" sign="-" unitRef="usd">17,638</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="0" sign="-" unitRef="usd">1,475</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest income on marketable securities held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd">4,821,632</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd">105,681</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Reduction
of transaction costs incurred in connection with IPO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:PartialReversalOfTransactionCosts" scale="0" unitRef="usd">271,687</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" sign="-" unitRef="usd">5,509,917</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" sign="-" unitRef="usd">9,381,750</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in fair value of convertible note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" scale="0" sign="-" unitRef="usd">196,200</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-14">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Offering expenses related to warrant issuance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-15">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NoninterestExpenseOfferingCost" scale="0" unitRef="usd">575,278</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total other income, net</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" unitRef="usd">10,389,398</ix:nonFraction></b></p>
</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" unitRef="usd">8,910,678</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Net income</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">5,982,340</ix:nonFraction></b></p>
</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">5,128,650</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Weighted average shares outstanding, Class A ordinary shares subject to possible redemption</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">34,500,000</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">28,828,767</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><div style="-sec-ix-hidden: hidden-fact-17; -sec-ix-hidden: hidden-fact-16">Basic and diluted net income per share, Class A ordinary shares subject to possible redemption</div></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.14</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c10" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.14</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">Weighted average shares outstanding, Class B ordinary shares</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">8,625,000</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">8,440,068</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><div style="-sec-ix-hidden: hidden-fact-19; -sec-ix-hidden: hidden-fact-18">Basic and diluted net income per share, Class B ordinary shares</div></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.14</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c12" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.14</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral part
of the consolidated financial statements.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 86; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="f_004"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FREEDOM ACQUISITION I CORP.<br/>
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; (DEFICIT) EQUITY<br/>
FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class A<br/> Ordinary Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class B<br/> Ordinary Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Additional<br/> Paid-in</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Total<br/> Shareholders&#8217;<br/>
 Equity</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Deficit)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 23%; font-weight: bold">Balance &#8211; December 31, 2020</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 8%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">&#8212;</div></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">&#8212;</div></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 8%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">8,625,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">863</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">24,137</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">5,494</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 8%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">19,506</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Sale of <ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="0" unitRef="shares">34,500,000</ix:nonFraction> Units on March 2, 2021 through public offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="0" unitRef="shares">34,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd">3,450</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-24">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-25">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd">3,450</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Excess of the fair value of private placement warrants over cash received</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-26">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-27">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="0" unitRef="usd">1,880,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-28">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="0" unitRef="usd">1,880,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Class A ordinary shares subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="0" sign="-" unitRef="shares">34,500,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityOther" scale="0" sign="-" unitRef="usd">3,450</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-29">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-30">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityOther" scale="0" sign="-" unitRef="usd">3,450</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt; text-indent: 0pt; text-align: left"><p style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Remeasurement of Class A ordinary shares subject to possible redemption</p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="0" sign="-" unitRef="usd">1,904,137</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="0" sign="-" unitRef="usd">27,046,507</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="0" sign="-" unitRef="usd">28,950,644</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">5,128,650</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">5,128,650</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 1.5pt">Balance &#8211; December 31, 2021</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">&#8212;</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">&#8212;</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">8,625,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">863</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">&#8212;</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">21,923,351</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">21,922,488</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Proceeds received on convertible note less than fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-39">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="0" unitRef="usd">592,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="0" unitRef="usd">592,600</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accretion portion net against additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="0" sign="-" unitRef="usd">592,600</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="0" sign="-" unitRef="usd">592,600</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accretion of Class A ordinary shares subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="0" sign="-" unitRef="usd">2,727,125</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="0" sign="-" unitRef="usd">1,607,588</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="0" sign="-" unitRef="usd">4,334,713</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt; text-indent: 0pt; text-align: left"><p style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Reduction of deferred underwriting fee payable</p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-47">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="0" unitRef="usd">8,784,563</ix:nonFraction></p>
</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="0" unitRef="usd">8,784,563</ix:nonFraction></p>
</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Net income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-51">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-52">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">5,982,340</ix:nonFraction></p>
</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">5,982,340</ix:nonFraction></p>
</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 4pt">Balance &#8211; December 31, 2022</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">&#8212;</div></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">&#8212;</div></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">8,625,000</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">863</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">6,057,438</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(<b><ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">17,548,599</ix:nonFraction></b></p>
</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">11,490,298</ix:nonFraction></b></p>
</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td></tr>
  </table><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral part
of the consolidated financial statements.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 87; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="f_005"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FREEDOM ACQUISITION I
CORP.<br/>
STATEMENTS OF CASH FLOWS</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<br/> December 31.</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Cash Flows from Operating Activities:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Net income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">5,982,340</ix:nonFraction></p>
</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">5,128,650</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Adjustments to reconcile net income to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Interest earned on marketable securities held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeOther" scale="0" unitRef="usd">4,821,632</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeOther" scale="0" unitRef="usd">105,681</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:ChangeInFairValueOfWarrantLiabilities" scale="0" sign="-" unitRef="usd">5,509,917</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:ChangeInFairValueOfWarrantLiabilities" scale="0" sign="-" unitRef="usd">9,381,750</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Change in fair value of convertible note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" scale="0" sign="-" unitRef="usd">196,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Change in deferred underwriting fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:ChangeInDeferredUnderwritingFee" scale="0" sign="-" unitRef="usd">271,687</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Offering costs allocated to warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:OfferingCostsAllocatedToWarrants" scale="0" sign="-" unitRef="usd">575,278</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Changes in current assets and current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left">Prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="0" sign="-" unitRef="usd">716,462</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="0" unitRef="usd">837,139</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-align: left">Accounts payable and accrued expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="0" unitRef="usd">2,278,574</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="0" unitRef="usd">2,579,641</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left"><b>Net cash used in operating activities</b></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">1,429,660</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">2,041,001</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash Flows from Investing Activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Investment of cash into Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:CashDepositedInTrustAccount" scale="0" sign="-" unitRef="usd">345,000,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left"><b>Net cash used in investing activities</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" sign="-" unitRef="usd">345,000,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash Flows from Financing Activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Proceeds from Initial Public Offering, net of underwriters&#8217; discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="0" unitRef="usd">338,595,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuance of Private Placement Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="0" unitRef="usd">9,400,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Proceeds from issuance of Convertible Promissory Note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="0" unitRef="usd">1,225,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Repayment of promissory note to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="0" unitRef="usd">90,996</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Payments of offering costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" unitRef="usd">585,420</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; font-weight: bold; text-align: left">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">1,225,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">347,318,584</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Change in Cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" sign="-" unitRef="usd">204,660</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" unitRef="usd">277,583</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Cash &#8211; Beginning</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd">277,583</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Cash &#8211; Ending</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd">72,923</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd">277,583</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental disclosure of noncash financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Initial value of Class A ordinary shares subject to possible redemption</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption" scale="0" unitRef="usd">345,000,000</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Initial value of warrant liabilities</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:InitialValueOfWarrantLiabilities" scale="0" unitRef="usd">17,870,000</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Deferred underwriters&#8217; discount payable charged to additional paid-in capital</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:DeferredOfferingCostsIncludedInAccruedExpenses" scale="0" unitRef="usd">12,075,000</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accretion of Class A ordinary shares subject to possible redemption</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares" scale="0" unitRef="usd">4,927,313</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares" scale="0" unitRef="usd">28,950,644</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Deferred offering costs paid under promissory note</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:DeferredOfferingCostsPaidUnderPromissoryNote" scale="0" unitRef="usd">90,996</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>




</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral part
of the consolidated financial statements.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 88; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="f_006"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FREEDOM ACQUISITION I CORP.<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 1 &#8212; Organization and Business Operations</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Organization and General</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_3" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Freedom Acquisition I Corp. (the &#8220;Company&#8221;
or &#8220;Freedom&#8221;) was incorporated in Cayman Islands on December 23, 2020. The Company was formed for the purpose of entering
into a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more
businesses (a &#8220;Business Combination&#8221;). The Company is not limited to a particular industry or geographic region for purposes
of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject
to all of the risks associated with early stage and emerging growth companies.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_4" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On October 3, 2022, the Company entered into a
Business Combination Agreement with Jupiter Merger Sub I Corp., a Delaware corporation and a wholly owned subsidiary of the Company, Jupiter
Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company, Complete Solar Holding Corporation,
a Delaware corporation, and The Solaria Corporation, a Delaware corporation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_5" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&#8217;s sponsor is Freedom Acquisition
I LLC, a Cayman Islands limited liability company (the &#8220;Sponsor&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_6" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022, the Company had not
yet commenced any operations. All activity through December 31, 2022, relates to the Company&#8217;s formation and the Initial
Public Offering (&#8220;IPO&#8221; or &#8220;Initial Public Offering&#8221;) described below. The Company will not generate any
operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO and changes
in the fair value of warrant liabilities.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_7" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_6"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financing</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_8" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The registration statement for the Company&#8217;s
IPO was declared effective on February 25, 2021 (the &#8220;Effective Date&#8221;). On March 2, 2021, the Company consummated the IPO
of&#160;<ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">34,500,000</ix:nonFraction>&#160;units (the &#8220;Units&#8221; and, with respect to the Class A ordinary shares included in the Units being offered,
the &#8220;public share&#8221;), at $<ix:nonFraction contextRef="c35" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">10.00</ix:nonFraction>&#160;per Unit, generating gross proceeds of $<ix:nonFraction contextRef="c36" decimals="0" format="ixt:num-dot-decimal" name="fact:GeneratingGrossProceeds" scale="0" unitRef="usd">345,000,000</ix:nonFraction>, which is discussed in Note 4.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_9" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Simultaneously with the closing of the IPO, the Company consummated
the sale&#160;of&#160;<ix:nonFraction contextRef="c37" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">6,266,667</ix:nonFraction>&#160;warrants (the &#8220;Private Placement Warrants&#8221;), at a price of $<ix:nonFraction contextRef="c38" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">1.50</ix:nonFraction>&#160;per Private Placement
Warrant, which is discussed in Note&#160;5.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_10" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Transaction costs amounted to $<ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" scale="0" unitRef="usd">19,175,922</ix:nonFraction>,&#160;consisting of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherUnderwritingExpense" scale="0" unitRef="usd">6,405,000</ix:nonFraction>&#160;of
underwriting fees, $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:DeferredUnderwritingFee" scale="0" unitRef="usd">12,075,000</ix:nonFraction>&#160;of deferred underwriting fees and $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherOwnershipInterestsOfferingCosts" scale="0" unitRef="usd">695,922</ix:nonFraction>&#160;of other offering costs. Of the total transaction
cost, $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:TotalTransactionCost" scale="0" unitRef="usd">575,278</ix:nonFraction>&#160;was expensed as non-operating expenses in the consolidated statement of operations with the rest of the offering cost
charged to shareholders&#8217; deficit for the year ended December 31, 2021. The transaction costs were allocated based on the relative
fair value basis, compared to the total offering proceeds, between the fair value of the public warrant liabilities and the Class A ordinary
shares.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_11" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_10"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Trust Account</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_12" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Following the closing of the IPO on March 2, 2021,
an amount of $<ix:nonFraction contextRef="c36" decimals="0" format="ixt:num-dot-decimal" name="fact:NetProceedsOfTheSaleOfTheUnits" scale="0" unitRef="usd">345,000,000</ix:nonFraction>&#160;from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants
was placed in a trust account (&#8220;Trust Account&#8221;). The funds in the Trust Account have, since the IPO and until the&#160;24-month&#160;anniversary
of the consummation of the IPO, been invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment
Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund
meeting the conditions of Rule&#160;2a-7&#160;of the&#160;Investment Company Act, as determined by the Company. To mitigate the risk of
the Company being deemed to have been operating as an unregistered investment company, prior to the&#160;24-month&#160;anniversary of
the consummation of the IPO, the Company instructed Continental, the trustee with respect to the Trust Account, to liquidate the U.S.
government treasury obligations or money market funds held in the Trust Account and to hold all the funds in the Trust Account in cash
in a bank deposit account. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company
to pay its tax obligations, the proceeds from the IPO and the sale of the private placement units will not be released from the Trust
Account until the earliest of (a) the completion of the Company&#8217;s initial Business Combination, (b) the redemption of any public
shares properly submitted in connection with a shareholder vote to amend the Company&#8217;s amended and restated certificate of incorporation,
and (c) the redemption of the Company&#8217;s public shares if the Company is unable to complete the initial Business Combination during
the Combination Period (as defined below), subject to applicable law. The proceeds deposited in the Trust Account could become subject
to the claims of the Company&#8217;s creditors, if any, which could have priority over the claims of the Company&#8217;s public shareholders.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 89; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_13" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_12"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Initial Business Combination</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_14" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&#8217;s management has broad discretion
with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to
be generally applied toward consummating a Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_15" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&#8217;s Business Combination must
be with one or more target businesses that together have a fair market value equal to at least&#160;<ix:nonFraction contextRef="c40" decimals="2" format="ixt:num-dot-decimal" name="fact:BusinessCombinationFairMarketValueEqualPercentage" scale="-2" unitRef="pure">80</ix:nonFraction>% of the balance in the Trust Account
(net of taxes payable) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete
a Business Combination if the post-Business Combination company owns or acquires&#160;<ix:nonFraction contextRef="c39" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" unitRef="pure">50</ix:nonFraction>% or more of the outstanding voting securities
of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment
company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_16" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company will provide its public shareholders
with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either
(i) in connection with a shareholder meeting called to approve the initial Business Combination or (ii) by means of a tender offer. The
decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer
will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their shares for a pro rata portion
of the amount then on deposit in the Trust Account (initially $<ix:nonFraction contextRef="c39" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" unitRef="usdPershares">10.00</ix:nonFraction>&#160;per share, plus any pro rata interest earned on the funds held
in the Trust Account and not previously released to the Company to pay its tax obligations).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_17" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Class A ordinary shares subject to
redemption are recorded at redemption value and classified as temporary equity upon the completion of the IPO, in accordance with
Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; In such case,
the Company will proceed with a Business Combination if the Company has net tangible assets of at least $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:NetTangibleAssets" scale="0" unitRef="usd">5,000,001</ix:nonFraction>&#160;either
immediately prior to or upon consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of
the issued and outstanding shares voted are voted in favor of the Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_18" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On February 28, 2023, the Company&#8217;s shareholders
approved an amendment to its amended and restated memorandum and articles of association to extend the date by which the Company must
complete a Business Combination from March 2, 2023 to June 2, 2023, and to thereafter further extend such period up to three times by
an additional one month each time (up to September 2, 2023) (such period, as may be extended, the &#8220;Combination Period&#8221;). However,
if the Company is unable to complete a Business Combination within the Combination Period, the Company will redeem&#160;<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="fact:RedeemPublicSharesPercentage" scale="-2" unitRef="pure">100</ix:nonFraction>% of the outstanding
public shares for a pro rata portion of the funds held in the Trust Account, equal to the aggregate amount then on deposit in the Trust
Account including interest earned on the funds held in the Trust Account and not previously released to the Company, divided by the number
of then outstanding public shares, subject to applicable law and as further described in the registration statement, and then seek to
dissolve and liquidate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_19" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&#8217;s Sponsor, officers and directors
have agreed to (i) waive their redemption rights with respect to their founder shares, private placement shares and public shares in connection
with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their founder shares and public
shares in connection with a shareholder vote to approve an amendment to the Company&#8217;s amended and restated certificate of incorporation,
and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares and private placement
shares if the Company fails to complete the initial Business Combination within the Combination Period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_20" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&#8217;s Sponsor has agreed that it
will be liable to the Company if and to the extent any claims by a third-party for services rendered or products sold to the Company,
or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement
or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="fact:PublicPerShare" scale="0" unitRef="usdPershares">10.00</ix:nonFraction>&#160;per public share
and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less
than $<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="fact:TrustAccountPerShare" scale="0" unitRef="usdPershares">10.00</ix:nonFraction>&#160;per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not
apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in
the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#8217;s indemnity of the
underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;). However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently
verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Company&#8217;s Sponsor&#8217;s
only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 90; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_21" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_20"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Liquidity</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_22" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022, the Company had cash outside the Trust Account
of $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrust" scale="0" unitRef="usd">72,923</ix:nonFraction> available for working capital needs. All remaining cash held in the Trust Account is generally unavailable for the Company&#8217;s
use prior to an initial Business Combination and is restricted for use either in a Business Combination or to redeem ordinary shares.
The Company may elect to withdraw from the interest income earned on the trust account to pay the Company&#8217;s tax obligations. As
of December 31, 2022, the Company had interest income earned on the trust account of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="0" unitRef="usd">4,821,632</ix:nonFraction>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_23" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company may raise additional capital through
loans or additional investments from the Sponsor or an affiliate of the Sponsor or certain of its directors and officers. The Sponsor
may, but is not obligated to, lend the Company funds, from time to time in whatever amounts it deems reasonable in its sole discretion,
to meet the Company&#8217;s working capital needs. There can be no assurance that the Company will be able to obtain additional financing,
however. Moreover, the Company may need to obtain additional financing either to complete its Business Combination or because the Company
becomes obligated to redeem a significant number of its public shares upon consummation of its Business Combination, in which case the
Company may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable
securities laws, the Company would only complete such financing simultaneously with the completion of its Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_24" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Company is unable to raise additional capital,
it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing
operations, suspending the pursuit of a potential transaction and reducing overhead expenses. The Company cannot provide any assurance
that new financing will be available to it on commercially acceptable terms, if at all.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_25" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_24"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Going Concern</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_26" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_25"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In connection with the Company&#8217;s
assessment of going concern considerations in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 205-40, &#8220;Presentation of Financial Statements &#8211; Going Concern,&#8221; pursuant to its Amended and Restated Certificate of Incorporation, the
Company has until the end of the Combination Period to consummate a Business Combination. If a Business Combination is not
consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Although the Company
intends to consummate a Business Combination during the Combination Period, it is uncertain that the Company will be able to do so.
This, as well as its liquidity condition, raise substantial doubt about the Company&#8217;s ability to continue as a going concern.
No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate at the
end of the Combination Period.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_27" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_26"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Risks and Uncertainties</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_28" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_27"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Management is currently evaluating the
impact of the COVID-19 pandemic and Russia-Ukraine war and has concluded that while it is reasonably possible that the virus and war
could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target
company, the specific impact is not readily determinable as of the date of these financial statements. The consolidated financial
statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_29" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_28"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Consideration of IR Act Excise Tax</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_30" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_29"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On August 16, 2022, the Inflation Reduction Act
of 2022 (the &#8220;IR Act&#8221;) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal <ix:nonFraction contextRef="c41" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure">1</ix:nonFraction>% excise
tax on certain repurchases of stock by publicly-traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly-traded
foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its
shareholders from which shares are repurchased. The amount of the excise tax is generally <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" unitRef="pure">1</ix:nonFraction>% of the fair market value of the shares repurchased
at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the
fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition,
certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the &#8220;Treasury&#8221;) has been given authority
to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_30"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any redemption or other repurchase that occurs
after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether
and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise
would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business
Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any &#8220;PIPE&#8221;
or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination
but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury.
In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment
of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business
Combination and in the Company&#8217;s ability to complete a Business Combination.</p></ix:continuation><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 91; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CondensedFinancialStatementsTextBlock-c0_cont_1" escape="true" name="srt:CondensedFinancialStatementsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 2 &#8212; Revision of Previously-Issued Financial Statements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_CondensedFinancialStatementsTextBlock-c0_cont_2" id="_CondensedFinancialStatementsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In connection with the preparation of the Company&#8217;s financial statements
as of December 31, 2022, the Company identified an error in amounts reported in certain of the Company&#8217;s previously-issued financial
statements related to accounts payable. The Company incorrectly recorded intercompany operating bank transfers as payables whereas Legal
and Professional Services was the accompanying debit in each transaction recorded. As a result, management determined that accounts payable
and operational costs as of June 30, 2022 and September 30, 2022 were overstated by $<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableOtherCurrent" scale="0" unitRef="usd"><ix:nonFraction contextRef="c42" decimals="0" format="ixt:num-dot-decimal" name="fact:OperationalCosts" scale="0" unitRef="usd">205,869</ix:nonFraction></ix:nonFraction>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CondensedFinancialStatementsTextBlock-c0_cont_3" id="_CondensedFinancialStatementsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following tables contain the revised financial information for
the affected periods previously reported. The revisions do not have an impact on the Company&#8217;s cash position and investments held
in the Trust Account established in connection with the Initial Public Offering. The Company has not amended its previously filed Quarterly
Reports on Form 10-Q for the two quarterly periods in 2022. The financial information that has been previously filed or otherwise reported
for these affected periods are superseded by the information below in this Annual Report on Form 10-K.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CondensedFinancialStatementsTextBlock-c0_cont_4" id="_CondensedFinancialStatementsTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The impact of the revision on the Company&#8217;s financial statements
is reflected in the following tables:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CondensedFinancialStatementsTextBlock-c0_cont_5" id="_CondensedFinancialStatementsTextBlock-c0_cont_4"><ix:nonNumeric contextRef="c0" escape="true" name="srt:ScheduleOfCondensedFinancialStatementsTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Revised</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><b>Balance Sheet as of June 30, 2022 (unaudited)</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left">Total Liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c43" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">19,737,596</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c44" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" sign="-" unitRef="usd">205,869</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">19,531,727</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Total Shareholders&#8217; Equity (Deficit)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c43" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">18,781,440</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c44" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">205,869</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">18,575,571</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Balance Sheet as of September 30, 2022 (unaudited)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Total Liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c46" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">17,298,967</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" sign="-" unitRef="usd">205,869</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c48" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">17,093,098</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Total Shareholders&#8217; Equity (Deficit)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c46" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">16,803,964</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">205,869</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c48" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">16,598,095</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table><p style="margin: 0">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CondensedFinancialStatementsTextBlock-c0_cont_6" id="_CondensedFinancialStatementsTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" escape="true" name="srt:ScheduleOfCondensedIncomeStatementTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; font-weight: bold; width: 64%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Previously<br/>
 Reported</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Revised</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><b>Condensed Statement of Operations for the Three Months
    Ended June 30, 2022 (unaudited)</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Operational Costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c49" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="0" unitRef="usd">824,081</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c50" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="0" sign="-" unitRef="usd">205,869</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c51" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="0" unitRef="usd">618,212</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c49" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">2,025,986</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c50" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">205,869</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c51" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">2,231,855</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-73; -sec-ix-hidden: hidden-fact-72; -sec-ix-hidden: hidden-fact-71">Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c52" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c54" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-77; -sec-ix-hidden: hidden-fact-76; -sec-ix-hidden: hidden-fact-75">Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c55" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c57" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.05</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Condensed Statement of Operations for the Six Months Ended June 30, 2022 (unaudited)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Operational Costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c58" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="0" unitRef="usd">2,022,164</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c59" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="0" sign="-" unitRef="usd">205,869</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c60" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="0" unitRef="usd">1,816,295</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c58" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">3,321,266</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c59" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">205,869</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c60" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">3,527,135</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-81; -sec-ix-hidden: hidden-fact-80; -sec-ix-hidden: hidden-fact-79">Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c61" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.08</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c63" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.08</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-85; -sec-ix-hidden: hidden-fact-84; -sec-ix-hidden: hidden-fact-83">Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c64" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.08</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c66" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.08</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Condensed Statement of Operations for the Nine Months Ended September 30, 2022 (unaudited)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Operational Costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c67" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="0" unitRef="usd">2,508,476</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c68" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="0" sign="-" unitRef="usd">205,869</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c69" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="0" unitRef="usd">2,302,607</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c67" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">6,726,111</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c68" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">205,869</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c69" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">6,931,980</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-89; -sec-ix-hidden: hidden-fact-88; -sec-ix-hidden: hidden-fact-87">Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c70" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c72" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.16</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-93; -sec-ix-hidden: hidden-fact-92; -sec-ix-hidden: hidden-fact-91">Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c73" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c75" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.16</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table><p style="margin: 0">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="_CondensedFinancialStatementsTextBlock-c0_cont_6"><ix:nonNumeric contextRef="c0" escape="true" name="srt:ScheduleOfCondensedCashFlowStatementTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; width: 64%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Previously<br/>
 Reported</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Revised</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><b>Condensed Statement of Cash Flows for the Six Months
    Ended June 30, 2022 (unaudited)</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c58" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">3,321,266</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c59" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">205,869</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c60" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">3,527,135</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c43" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd">884,539</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c44" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" sign="-" unitRef="usd">205,869</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd">678,670</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Condensed Statement of Cash Flows for the Nine Months Ended September 30, 2022 (unaudited)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c67" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">6,726,111</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c68" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">205,869</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c69" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">6,931,980</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c46" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd">226,411</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" sign="-" unitRef="usd">205,869</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c48" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd">20,542</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 92; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 3 &#8212; Significant Accounting Policies</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Basis of Presentation</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:continuation id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The accompanying financial statements are presented
in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules
and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" continuedAt="_ConsolidationPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Principles of Consolidation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_5" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><ix:continuation id="_ConsolidationPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The accompanying consolidated financial
statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions
have been eliminated in consolidation.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_6" id="_SignificantAccountingPoliciesTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" continuedAt="fact_EmergingGrowthCompanyStatusPolicyTextBlock-c0_cont_1" escape="true" name="fact:EmergingGrowthCompanyStatusPolicyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging Growth Company</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_7" id="_SignificantAccountingPoliciesTextBlock-c0_cont_6"><ix:continuation continuedAt="fact_EmergingGrowthCompanyStatusPolicyTextBlock-c0_cont_2" id="fact_EmergingGrowthCompanyStatusPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company is an &#8220;emerging growth company,&#8221;
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the &#8220;JOBS Act&#8221;),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements
of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and
proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder
approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_8" id="_SignificantAccountingPoliciesTextBlock-c0_cont_7"><ix:continuation id="fact_EmergingGrowthCompanyStatusPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth
companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that
have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange
Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to
opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election
to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard
is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company,
can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the
Company&#8217;s&#160;consolidated financial statements with another public company which is neither an emerging growth company nor an
emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences
in accounting standards used.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_9" id="_SignificantAccountingPoliciesTextBlock-c0_cont_8"><ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Use of Estimates</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_10" id="_SignificantAccountingPoliciesTextBlock-c0_cont_9"><ix:continuation continuedAt="_UseOfEstimates-c0_cont_2" id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The preparation of&#160;the&#160;consolidated financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the&#160;consolidated financial statements and the reported amounts
of expenses during the reporting period. Actual results could differ from those estimates.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_11" id="_SignificantAccountingPoliciesTextBlock-c0_cont_10"><ix:continuation id="_UseOfEstimates-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Estimates made in preparing these consolidated financial statements
include, among other things, the fair value measurement of the Private Warrant liabilities.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>



</div><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 93; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_12" id="_SignificantAccountingPoliciesTextBlock-c0_cont_11"><ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash and Cash Equivalents</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_13" id="_SignificantAccountingPoliciesTextBlock-c0_cont_12"><ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents.&#160;The Company did not have any cash equivalents
as of December 31, 2022 and 2021.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_14" id="_SignificantAccountingPoliciesTextBlock-c0_cont_13"><ix:nonNumeric contextRef="c0" continuedAt="_InvestmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:InvestmentPolicyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investments Held in Trust Account</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_15" id="_SignificantAccountingPoliciesTextBlock-c0_cont_14"><ix:continuation continuedAt="_InvestmentPolicyTextBlock-c0_cont_2" id="_InvestmentPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At December 31, 2022, the assets held in the Trust Account were held in a money market fund with a maturity of 180 days or less. At December 31, 2021, the assets held in the Trust Account
were held in cash and U.S. Treasury securities. The Company classifies its United States Treasury securities as&#160;held-to-maturity&#160;in
accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC Topic 320, &#8220;Investments&#8212;Debt and Equity Securities.&#8221;&#160;Held-to-maturity&#160;securities
are those securities which the Company has the ability and intent to hold until maturity.&#160;Held-to-maturity&#160;treasury securities
are recorded at amortized cost and adjusted for the amortization or remeasurement of premiums or discounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_16" id="_SignificantAccountingPoliciesTextBlock-c0_cont_15"><ix:continuation continuedAt="_InvestmentPolicyTextBlock-c0_cont_3" id="_InvestmentPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022, investment in the
Company&#8217;s Trust Account consisted of $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="0" unitRef="usd">349,927,313</ix:nonFraction> in a money market fund with a maturity of 180 days or less. Following the
maturity of the U.S. Treasury Securities on December 1, 2022, the Company immediately reinvested the entirety of the Trust Account
into a money market fund. The money market fund is disclosed at fair value on the consolidated balance sheet. As of December 31,
2021, investment in the Company&#8217;s Trust Account consisted of $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="0" unitRef="usd">484</ix:nonFraction>&#160;in cash and $<ix:nonFraction contextRef="c76" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="0" unitRef="usd">345,105,197</ix:nonFraction>&#160;in U.S. Treasury
Securities. All of the U.S. Treasury Securities (the &#8220;T-bills&#8221;) matured on March 3, 2022 and the Company purchased new
T-bills. The Company considers all investments with original maturities of more than three months but less than one year to be
short-term investments. The carrying value approximates the fair value due to its short-term maturity. The carrying value, excluding
gross unrealized holding losses and fair value of held to maturity securities on December 31, 2022 and 2021 are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_17" id="_SignificantAccountingPoliciesTextBlock-c0_cont_16"><ix:nonNumeric contextRef="c0" continuedAt="_MarketableSecuritiesTextBlock-c0_cont_1" escape="true" name="us-gaap:MarketableSecuritiesTextBlock"><ix:continuation continuedAt="_InvestmentPolicyTextBlock-c0_cont_4" id="_InvestmentPolicyTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Value<br/> as of<br/> December&#160;31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Money Market Funds</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c80" decimals="0" format="ixt:num-dot-decimal" name="fact:TradingSecuritiesFairValue" scale="0" unitRef="usd">349,927,313</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="fact:TradingSecuritiesFairValue" scale="0" unitRef="usd">349,927,313</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_18" id="_SignificantAccountingPoliciesTextBlock-c0_cont_17"><ix:continuation id="_MarketableSecuritiesTextBlock-c0_cont_1"><ix:continuation continuedAt="_InvestmentPolicyTextBlock-c0_cont_5" id="_InvestmentPolicyTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortized<br/> Cost&#160;and<br/> Carrying<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Unrealized<br/> Gains</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Unrealized<br/> Losses</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Value<br/> as&#160;of<br/> December&#160;31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-indent: -9.35pt; padding-left: 9.35pt">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c81" decimals="0" format="ixt:num-dot-decimal" name="fact:AmortizedCostAndCarryingValue" scale="0" unitRef="usd">484</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-95">&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-96">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c81" decimals="0" format="ixt:num-dot-decimal" name="fact:TradingSecuritiesFairValue" scale="0" unitRef="usd">484</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">U.S. Treasury Securities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c76" decimals="0" format="ixt:num-dot-decimal" name="fact:AmortizedCostAndCarryingValue" scale="0" unitRef="usd">345,105,197</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c83" decimals="0" format="ixt:num-dot-decimal" name="fact:GrossUnrealizedGainsAndLosses" scale="0" sign="-" unitRef="usd">6,065</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c76" decimals="0" format="ixt:num-dot-decimal" name="fact:TradingSecuritiesFairValue" scale="0" unitRef="usd">345,099,132</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="fact:AmortizedCostAndCarryingValue" scale="0" unitRef="usd">345,105,681</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-98">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:GrossUnrealizedGainsAndLosses" scale="0" sign="-" unitRef="usd">6,065</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="fact:TradingSecuritiesFairValue" scale="0" unitRef="usd">345,099,616</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_19" id="_SignificantAccountingPoliciesTextBlock-c0_cont_18"><ix:continuation continuedAt="_InvestmentPolicyTextBlock-c0_cont_6" id="_InvestmentPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A decline in the market value of held-to-maturity securities below
cost that is deemed to be other than temporary results in an impairment that reduces the carrying costs to such securities&#8217; fair
value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment
is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery
and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered
in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent
to&#160;year-end,&#160;forecasted performance of the investee, and the general market condition in the geographic area or industry the
investee operates in.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_20" id="_SignificantAccountingPoliciesTextBlock-c0_cont_19"><ix:continuation id="_InvestmentPolicyTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Premiums and discounts are amortized or accreted
over the life of the related&#160;held-to-maturity&#160;security as an adjustment to yield using the effective-interest method. Such amortization
and remeasurement are included in the &#8220;interest income&#8221; line item in the statements of operations. Interest income is recognized
when earned.&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 94; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_21" id="_SignificantAccountingPoliciesTextBlock-c0_cont_20"><ix:nonNumeric contextRef="c0" continuedAt="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock-c0_cont_1" escape="true" name="fact:ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Convertible Promissory Notes&#8212;Related Party&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_22" id="_SignificantAccountingPoliciesTextBlock-c0_cont_21"><ix:continuation id="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company accounts for its convertible promissory notes under ASC
815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). Under ASC 815-15-25, the election can be at the inception of a financial
instrument to account for the instrument under the fair value option under ASC 825. The Company has made such election for its convertible
promissory notes. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value
on the date of issuance, each drawdown date, and each balance sheet date thereafter. Differences between the face value of the note and
fair value at each drawdown date are recognized as either an expense in the consolidated statements of operations (if issued at a premium)
or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as non-cash gains
or losses in the consolidated statements of operations. Changes in the estimated fair value of the note are recognized as non-cash change
in the fair value of the convertible promissory notes in the consolidated statements of operations.&#160;&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_23" id="_SignificantAccountingPoliciesTextBlock-c0_cont_22"><ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskCreditRisk-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Concentration of Credit Risk&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_24" id="_SignificantAccountingPoliciesTextBlock-c0_cont_23"><ix:continuation id="_ConcentrationRiskCreditRisk-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal
Depository Insurance Coverage of&#8201;$<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashFDICInsuredAmount" scale="0" unitRef="usd">250,000</ix:nonFraction>. At December 31, 2022 and 2021, the Company has not experienced losses on this account.&#160;&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_25" id="_SignificantAccountingPoliciesTextBlock-c0_cont_24"><ix:nonNumeric contextRef="c0" continuedAt="_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ordinary Shares Subject to Possible Redemption</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_26" id="_SignificantAccountingPoliciesTextBlock-c0_cont_25"><ix:continuation id="_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company accounts for its Class A ordinary shares subject to possible
redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A ordinary shares
subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable
ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject
to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) are classified as temporary equity.
At all other times, ordinary shares are classified as shareholders&#8217; deficit. The Company&#8217;s ordinary shares feature certain
redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events.
Accordingly, as of December 31, 2022 and 2021,&#160;<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="fact:OrdinarySharesSubjectToPossibleRedemption" scale="0" unitRef="shares"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="fact:OrdinarySharesSubjectToPossibleRedemption" scale="0" unitRef="shares">34,500,000</ix:nonFraction></ix:nonFraction>&#160;Class A ordinary shares subject to possible redemption are presented
at redemption value as temporary equity, outside of the shareholders&#8217; deficit section of the Company&#8217;s consolidated balance
sheets, respectively.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_27" id="_SignificantAccountingPoliciesTextBlock-c0_cont_26"><ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net Income Per Ordinary Share</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_28" id="_SignificantAccountingPoliciesTextBlock-c0_cont_27"><ix:continuation continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_2" id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company has two classes of shares, which are referred to as Class
A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The&#160;<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:WarrantsPurchase" scale="0" unitRef="shares"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:WarrantsPurchase" scale="0" unitRef="shares">14,891,667</ix:nonFraction></ix:nonFraction>&#160;potential
ordinary shares for outstanding warrants to purchase the Company&#8217;s shares were excluded from diluted earnings per share for the
years ended December 31, 2022 and 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met.
As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods presented. The table
below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class
of ordinary share:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_29" id="_SignificantAccountingPoliciesTextBlock-c0_cont_28"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Basic and diluted net income per share:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Allocation of net income</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="fact:AllocationOfNetIncome" scale="0" unitRef="usd">4,785,872</ix:nonFraction></p>
</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="fact:AllocationOfNetIncome" scale="0" unitRef="usd">1,196,468</ix:nonFraction></p>
</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="fact:AllocationOfNetIncome" scale="0" unitRef="usd">3,967,193</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="fact:AllocationOfNetIncome" scale="0" unitRef="usd">1,161,457</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">34,500,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">8,625,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">28,828,767</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">8,440,068</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Basic and diluted net income per share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.14</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.14</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.14</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.14</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation></ix:nonNumeric></ix:continuation><div>



</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 95; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_30" id="_SignificantAccountingPoliciesTextBlock-c0_cont_29"><ix:nonNumeric contextRef="c0" continuedAt="_DeferredChargesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:DeferredChargesPolicyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Offering Costs</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_31" id="_SignificantAccountingPoliciesTextBlock-c0_cont_30"><ix:continuation id="_DeferredChargesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company complies with the requirements
of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#8220;SAB&#8221;) Topic 5A - &#8220;Expenses of Offering&#8221;.
Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to
the Public Offering and that were charged to temporary equity upon the completion of the IPO. Accordingly, on December 31, 2022,
offering costs totaling $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredOfferingCosts" scale="0" unitRef="usd">19,175,922</ix:nonFraction>&#160;have been charged to temporary equity (consisting of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherUnderwritingExpense" scale="0" unitRef="usd">6,405,000</ix:nonFraction>&#160;of underwriting fees,
$<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:DeferredUnderwritingFee" scale="0" unitRef="usd">12,075,000</ix:nonFraction>&#160;of deferred underwriting fees and $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherOwnershipInterestsOfferingCosts" scale="0" unitRef="usd">695,922</ix:nonFraction>&#160;of other offering costs). Of the total transaction cost,
$<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:TotalTransactionCost" scale="0" unitRef="usd">575,278</ix:nonFraction>&#160;was recorded as a non-operating expense in the consolidated statements of operations, with the rest of the offering
cost charged to temporary equity. The transaction costs were allocated based on the relative fair value basis, compared to the total
offering proceeds, between the fair value of the public warrant liabilities and the Class A ordinary shares. As of October 25, 2022,
and November 2, 2022, respectively, J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. have waived their portions of the
deferred underwriting fee which is reflected in the consolidated statement of operations and the consolidated statement of changes
in shareholders&#8217; deficit as a reduction of transaction costs incurred in connection with IPO. Therefore, the deferred underwriting fee was
reduced by $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" scale="0" unitRef="usd">9,056,250</ix:nonFraction>, of which $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:PartialReversalOfTransactionCosts" scale="0" unitRef="usd">271,687</ix:nonFraction> is shown in the consolidated statement of operations as a reduction of transaction
costs incurred in connection with the IPO and $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="0" unitRef="usd">8,784,563</ix:nonFraction> is charged to additional paid-in capital in the consolidated statement of changes in shareholders&#8217; deficit. As a result of the reductions, the outstanding deferred underwriting fee payable was reduced to
$<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="0" unitRef="usd">3,018,750</ix:nonFraction>.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_32" id="_SignificantAccountingPoliciesTextBlock-c0_cont_31"><ix:nonNumeric contextRef="c0" continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fair Value of Financial Instruments</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_33" id="_SignificantAccountingPoliciesTextBlock-c0_cont_32"><ix:continuation id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The fair value of the Company&#8217;s assets and liabilities, which
qualify as financial instruments under the Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 820, &#8220;Fair Value Measurements
and Disclosures,&#8221; approximates the carrying amounts represented in the consolidated balance sheets.&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_34" id="_SignificantAccountingPoliciesTextBlock-c0_cont_33"><ix:nonNumeric contextRef="c0" continuedAt="_DerivativesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:DerivativesPolicyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Derivative Warrant Liabilities</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_35" id="_SignificantAccountingPoliciesTextBlock-c0_cont_34"><ix:continuation continuedAt="_DerivativesPolicyTextBlock-c0_cont_2" id="_DerivativesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company does not use derivative instruments
to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including
issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives,
pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded
as liabilities or as equity, is re-assessed at the end of each reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_36" id="_SignificantAccountingPoliciesTextBlock-c0_cont_35"><ix:continuation id="_DerivativesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company accounts for its&#160;<ix:nonFraction contextRef="c38" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares">14,891,667</ix:nonFraction>&#160;ordinary shares warrants
issued in connection with its Initial Public Offering (<ix:nonFraction contextRef="c77" decimals="0" format="ixt:num-dot-decimal" name="fact:DerivativeWarrantLiabilities" scale="0" unitRef="shares">8,625,000</ix:nonFraction>) and Private Placement (<ix:nonFraction contextRef="c78" decimals="0" format="ixt:num-dot-decimal" name="fact:DerivativeWarrantLiabilities" scale="0" unitRef="shares">6,266,667</ix:nonFraction>) as derivative warrant liabilities
in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the
instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised,
and any change in fair value is recognized in the Company&#8217;s consolidated statements of operations. The fair value of the Private
Placement Warrants has been estimated using Monte Carlo simulations at each measurement date. The fair value of the Public Warrants was
initially estimated using Monte Carlo simulations. After the Public Warrants were separately traded, the measurement of the Public Warrants
used an observable market quote in an active market.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_37" id="_SignificantAccountingPoliciesTextBlock-c0_cont_36"><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Income Taxes</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_38" id="_SignificantAccountingPoliciesTextBlock-c0_cont_37"><ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_2" id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company follows the asset and liability method
of accounting for income taxes under ASC 740, &#8220;Income Taxes.&#8221; Deferred tax assets and liabilities are recognized for the estimated
future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities
and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are
established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_39" id="_SignificantAccountingPoliciesTextBlock-c0_cont_38"><ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_3" id="_IncomeTaxPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">ASC 740 prescribes a recognition threshold and
a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax
return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized
tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and December 31, 2021. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The
Company is subject to income tax examinations by major taxing authorities since inception.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 96; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_40" id="_SignificantAccountingPoliciesTextBlock-c0_cont_39"><ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There is currently no taxation imposed on income
by the Government of the Cayman Islands. In accordance with federal income tax regulations, income taxes are not levied on the Company,
but rather on the individual owners. United States (&#8220;U.S.&#8221;) taxation would occur on the individual owners if certain tax elections
are made by U.S. owners and the Company were treated as a passive foreign investment company. The Company believes that it was a passive
foreign investment company for the 2021 and 2022 taxable years. Additionally, U.S. taxation could occur to the Company itself if the Company
is engaged in a U.S. trade or business. The Company is not expected to be treated as engaged in a U.S. trade or business at this time.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_41" id="_SignificantAccountingPoliciesTextBlock-c0_cont_40"><ix:nonNumeric contextRef="c0" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Recent Accounting Standards</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_42" id="_SignificantAccountingPoliciesTextBlock-c0_cont_41"><ix:continuation continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_2" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;)
2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in
Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;)&#8221; to simplify accounting for certain financial instruments.
ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible
instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s
own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed
to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement
to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be applied on a full
or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The guidance was adopted starting January
1, 2022. Adoption of the ASU did not impact the Company&#8217;s financial position, results of operations or cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_42"><ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Management does not believe that any recently
issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#8217;s&#160;financial
statements.</p></ix:continuation></ix:continuation><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="fact_ProposedPublicOfferingDisclosureTextBlock-c0_cont_1" escape="true" name="fact:ProposedPublicOfferingDisclosureTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 4 &#8212; Initial Public Offering&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="fact_ProposedPublicOfferingDisclosureTextBlock-c0_cont_2" id="fact_ProposedPublicOfferingDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the Initial Public Offering, the Company
sold&#160;<ix:nonFraction contextRef="c77" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares">34,500,000</ix:nonFraction>&#160;Units, (at a price of $<ix:nonFraction contextRef="c84" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares">10.00</ix:nonFraction> per Unit. Each Unit consists of one share of Class A Ordinary shares, par value
$<ix:nonFraction contextRef="c2" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockNoParValue" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction>&#160;per share one-fourth of one redeemable warrant (&#8220;Public Warrant&#8221;). Each whole Public Warrant entitles the holder
to purchase one share of Class A Ordinary shares at a price of $<ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceIncrease" scale="0" unitRef="usdPershares">11.50</ix:nonFraction> per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="fact_ProposedPublicOfferingDisclosureTextBlock-c0_cont_3" id="fact_ProposedPublicOfferingDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">All of the <ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="fact:SaleOfOrdinarySharesRedemption" scale="0" unitRef="shares">34,500,000</ix:nonFraction> Class A ordinary share sold as part of the Units
in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with the Company&#8217;s liquidation,
if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to
the Company&#8217;s certificate of incorporation. In accordance with SEC and its staff&#8217;s guidance on redeemable equity instruments,
which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares
subject to redemption to be classified outside of permanent equity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="fact_ProposedPublicOfferingDisclosureTextBlock-c0_cont_4" id="fact_ProposedPublicOfferingDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Class A ordinary share is subject to SEC and its staff&#8217;s
guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will
become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance
(or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the
instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument
to equal the redemption value at the end of each reporting period. The Company recognizes changes in redemption value immediately as they
occur. Immediately upon the closing of the IPO, the Company recognized the remeasurement from initial book value to redemption amount
value. The change in the carrying value of redeemable ordinary shares resulted in charges against additional paid-in capital and accumulated
deficit.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="fact_ProposedPublicOfferingDisclosureTextBlock-c0_cont_5" id="fact_ProposedPublicOfferingDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022 and 2021, the ordinary share reflected on the
consolidated balance sheets are reconciled in the following table:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="fact_ProposedPublicOfferingDisclosureTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Gross proceeds from IPO</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:ProceedsFromGrossProceedsFromIPO" scale="0" unitRef="usd">345,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Proceeds allocated to Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="0" unitRef="usd">10,350,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Ordinary share issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" sign="-" unitRef="usd">18,600,644</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -8.65pt; padding-left: 17.3pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" scale="0" unitRef="usd">28,950,644</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-indent: -9.35pt; padding-left: 9.35pt">Contingently redeemable ordinary share as of December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd">345,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -8.65pt; padding-left: 17.3pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityOtherChanges" scale="0" unitRef="usd">4,927,313</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Contingently redeemable ordinary share as of December 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="0" unitRef="usd">349,927,313</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 97; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="fact_PrivatePlacementWarrantsDisclosureTextBlock-c0_cont_1" escape="true" name="fact:PrivatePlacementWarrantsDisclosureTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 5 &#8212; Private Placement Warrants</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="fact_PrivatePlacementWarrantsDisclosureTextBlock-c0_cont_2" id="fact_PrivatePlacementWarrantsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Simultaneously with the closing of the IPO,&#160;the
Sponsor purchased an aggregate of&#160;<ix:nonFraction contextRef="c85" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" unitRef="shares">6,266,667</ix:nonFraction>&#160;Private Placement Warrants at a price of $<ix:nonFraction contextRef="c85" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares">1.50</ix:nonFraction>&#160;per warrant ($<ix:nonFraction contextRef="c78" decimals="0" format="ixt:num-dot-decimal" name="fact:AggregatePurchasePrice" scale="0" unitRef="usd">9,400,000</ix:nonFraction>&#160;in
the aggregate), each Private Placement Warrant is exercisable to purchase one share of Class A ordinary shares at a price of $<ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares">11.50</ix:nonFraction>&#160;per
share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from our Initial Public Offering to
be held in the Trust Account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="fact_PrivatePlacementWarrantsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Private Placement Warrants are identical to the warrants sold in
the IPO except that the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not
be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to
certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business
Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights.</p></ix:continuation><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 6 &#8212; Related Party Transactions</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_2" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_1"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Founder Shares</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_3" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On December 31, 2020, the Sponsor paid $<ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="fact:StockIssuedDuringPeriodSponsorAmount" scale="0" unitRef="usd">25,000</ix:nonFraction>,
or approximately $<ix:nonFraction contextRef="c87" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares">0.003</ix:nonFraction>&#160;per share, to cover certain offering costs in consideration for&#160;<ix:nonFraction contextRef="c88" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="0" unitRef="shares">7,187,500</ix:nonFraction>&#160;Class&#160;B ordinary
shares, par value $<ix:nonFraction contextRef="c89" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction>&#160;per share (the &#8220;Founder Shares&#8221;). On February 25, 2021, the Company effected a share dividend
whereby the Company issued&#160;<ix:nonFraction contextRef="c90" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">1,437,500</ix:nonFraction>&#160;Class B ordinary shares, resulting in an aggregate of&#160;<ix:nonFraction contextRef="c90" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockOtherSharesOutstanding" scale="0" unitRef="shares">8,625,000</ix:nonFraction>&#160;Class B ordinary
shares outstanding. All share and per-share amounts have been retroactively restated to reflect the share dividend.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_4" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&#8217;s initial shareholders have
agreed not to transfer, assign or sell any of their Founder Shares and any Class A ordinary shares issuable upon conversion thereof until
the earlier to occur of:&#160;(i) one year after the completion of the initial Business Combination or (ii) the date on which the Company
completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all
of its shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; except to certain
permitted transferees and under certain circumstances (the &#8220;Lock-up&#8221;). Any permitted transferees will be subject to the same
restrictions and other agreements of the initial shareholders with respect to any Founder Shares. Notwithstanding the foregoing, if (1)
the closing price of the Company&#8217;s Class A ordinary shares equals or exceeds $<ix:nonFraction contextRef="c91" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" unitRef="usdPershares">12.00</ix:nonFraction>&#160;per share (as adjusted for share sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing
at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination
which results in its shareholders having the right to exchange their shares for cash, securities or other property, the Founder Shares
will be released from the Lock-up.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_5" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On May 16, 2022, the Sponsor transferred <ix:nonFraction contextRef="c92" decimals="0" format="ixt:num-dot-decimal" name="fact:SponsorShare" scale="0" unitRef="shares">25,000</ix:nonFraction>
shares to one of the Company&#8217;s directors following the departure of a previous director. The transfer of the Founders Shares is
in the scope of FASB ASC Topic 718, &#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC 718&#8221;). Under ASC 718, stock-based
compensation associated with equity-classified awards is measured at fair value upon the grant date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_6" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The transfer of Founders Shares to the Company&#8217;s
director, as described above, is within the scope of ASC 718, as such, the fair value of the <ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" scale="0" unitRef="shares">25,000</ix:nonFraction> shares transferred to the Company&#8217;s
director was $<ix:nonFraction contextRef="c93" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" scale="0" unitRef="shares">123,750</ix:nonFraction> or $<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ForwardContractIndexedToEquitySettlementShareFairValuePerShare" scale="0" unitRef="usdPershares">4.95</ix:nonFraction> per share. The transfer of the shares was granted subject to a performance condition (i.e., the occurrence
of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable
of occurrence under the applicable accounting literature in this circumstance. Stock-based compensation would be recognized at the date
a Business Combination is considered probable in an amount equal to the number of Founders Shares times the transfer date fair value per
share (unless subsequently modified). Founder Shares will automatically convert into Class A shares at a one-to-one ratio upon completion
of a Business Combination. The Founder Shares will receive no distributions if the Company is liquidated prior to a Business Combination.
In addition, the holders of the Founder Shares are restricted from transferring the Founder Shares and the Class A shares received upon
conversion until nine months to a year after a Business Combination.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 98; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_7" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_6"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Promissory Note &#8212; Related Party</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_8" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On December 30, 2020, the Sponsor agreed to loan
the Company up to $<ix:nonFraction contextRef="c94" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLongTermDebt" scale="0" unitRef="usd">300,000</ix:nonFraction>&#160;to cover expenses related to the IPO pursuant to a promissory note (the &#8220;Promissory Note&#8221;).
This loan is non-interest bearing and payable on the earlier of December 31, 2022 or the completion of the IPO.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_9" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022 and 2021, there was no
outstanding amount under the Promissory Note.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_10" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_9"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Working Capital Loans</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_11" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, in order to finance transaction costs
in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers
and directors, may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital Loans&#8221;). If the
Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination
does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans
but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. After giving effect to the Notes described
below, up to $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="fact:WorkingCapitalLoans" scale="0" unitRef="usd">675,000</ix:nonFraction>&#160;of additional Working Capital Loans may be convertible into Private Placement Warrants of the post Business
Combination entity at a price of $<ix:nonFraction contextRef="c85" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares">1.50</ix:nonFraction>&#160;per warrant at the option of the lender. Such warrants would be identical to the Private Placement
Warrants. Prior to the completion of the initial Business Combination, the Company does not expect to seek loans from parties other than
the Sponsor or an affiliate of the Sponsor as the Company does not believe third parties will be willing to loan such funds and provide
a waiver against any and all rights to seek access to funds in the Company&#8217;s Trust Account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_12" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On April 1, 2022 and June 6, 2022, the Company
issued unsecured promissory notes in the amounts of up to $<ix:nonFraction contextRef="c95" decimals="0" format="ixt:num-dot-decimal" name="fact:PromissioryNoteRelatedParty" scale="0" unitRef="usd">500,000</ix:nonFraction> and $<ix:nonFraction contextRef="c96" decimals="0" format="ixt:num-dot-decimal" name="fact:PromissioryNoteRelatedParty" scale="0" unitRef="usd">500,000</ix:nonFraction>, respectively, to the Sponsor. On December 14, 2022, the
Company issued an unsecured promissory note in the amount of up to $<ix:nonFraction contextRef="c97" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfUnsecuredDebt" scale="0" unitRef="usd">325,000</ix:nonFraction> to Tidjane Thiam, Adam Gishen, Abhishek Bhatia and Edward
Zeng (collectively, the &#8220;Payees&#8221;) (such promissory note, together with the unsecured promissory notes issued on April 1, 2022
and June 6, 2022, the &#8220;Notes&#8221;). The Notes bear no interest and are payable in full upon the earlier to occur of (i) twenty-four
(24) months from the closing of the Initial Public Offering (or such later date as may be extended in accordance with the terms of our
amended and restated memorandum and articles of association) or (ii) the consummation of the Business Combination. A failure to pay the
principal within five business days of the date specified above or the commencement of a voluntary or involuntary bankruptcy action shall
be deemed an event of default, in which case the Notes may be accelerated. Prior to the Company&#8217;s first payment of all or any portion
of the principal balance of the Notes in cash, the Sponsor and the Payees, as applicable, have the option to convert all, but not less
than all, of the principal balance of the Notes into private placement warrants (the &#8220;Conversion Warrants&#8221;), each warrant
exercisable for one ordinary share of the Company at an exercise price of $<ix:nonFraction contextRef="c95" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceDecrease" scale="0" unitRef="usdPershares">1.50</ix:nonFraction>&#160;per share. The terms of the Conversion Warrants would
be identical to the Private Placement Warrants. The Sponsor and the Payees shall be entitled to certain registration rights relating to
the Conversion Warrants. The issuances of the Notes were made pursuant to the exemption from registration contained in Section 4(a)(2)
of the Securities Act.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_13" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022 and 2021, the Company had an aggregate of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="0" unitRef="usd">1,225,000</ix:nonFraction>
and $<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="0" unitRef="usd">0</ix:nonFraction> borrowings, respectively, related to the Notes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_14" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On February 28, 2023, the Company issued an unsecured
promissory note in the amount of up to $<ix:nonFraction contextRef="c98" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="0" unitRef="usd">2,100,000</ix:nonFraction> to the Sponsor, as further described in Note 11.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_15" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_14"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Administrative Support Service</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Commencing on the date of the IPO, the Company
agreed to pay the Sponsor up to $<ix:nonFraction contextRef="c77" decimals="0" format="ixt:num-dot-decimal" name="fact:OfficeSpaceAndAdministrativeSupportServices" scale="0" unitRef="usd">10,000</ix:nonFraction>&#160;per month for office space and administrative support services. These were paid on a monthly
basis via invoices, and there was no amount due under the Administrative Services Agreement as of December 31, 2022.</p></ix:continuation><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 99; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 7 &#8212; Commitments &amp; Contingencies<i>&#160;</i></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_2" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Registration Rights</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_3" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The holders of the (i) Founder Shares, which were
issued in a private placement prior to the closing of the IPO, (ii) Private Placement Warrants, which will be issued in a private placement
simultaneously with the closing of the IPO and the Class A ordinary shares underlying such Private Placement Warrants and (iii) Private
Placement Warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to
register a sale of any of its securities held by them pursuant to a registration rights agreement. The holders of these securities are
entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders
have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the Company&#8217;s
completion of its initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such
registration statements.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_4" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_3"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Underwriters Agreement</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_5" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On March 2, 2021, the Company paid a fixed
underwriting discount of $<ix:nonFraction contextRef="c99" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherUnderwritingExpense" scale="0" unitRef="usd">6,405,000</ix:nonFraction>. Additionally, a deferred underwriting discount of $<ix:nonFraction contextRef="c99" decimals="2" format="ixt:num-dot-decimal" name="fact:DeferredUnderwritingDiscountPerUnit" scale="0" unitRef="usdPershares">0.35</ix:nonFraction>&#160;per Unit, or $<ix:nonFraction contextRef="c99" decimals="0" format="ixt:num-dot-decimal" name="fact:AggregateGrossProceeds" scale="0" unitRef="usd">12,075,000</ix:nonFraction>&#160;in
the aggregate, will be payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company
completes an initial Business Combination, subject to the terms of the underwriting agreement. As of October 25, 2022, and November
2, 2022, respectively, J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. have waived their portions of the deferred
underwriting fee which is reflected in the consolidated statement of operations and the consolidated statement of changes in
shareholders&#8217; deficit as a reduction of transaction costs incurred in connection with IPO. Therefore, the deferred
underwriting fee was reduced by $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" scale="0" unitRef="usd">9,056,250</ix:nonFraction>, of which $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:PartialReversalOfTransactionCosts" scale="0" unitRef="usd">271,687</ix:nonFraction> is shown in the consolidated statement of operations as a reduction of transaction costs incurred in connection with the IPO and $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="0" unitRef="usd">8,784,563</ix:nonFraction> is charged to additional paid-in capital in the
consolidated statement of changes in shareholders&#8217; deficit. As a result of the reductions, the outstanding deferred
underwriting fee payable was reduced to $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="0" unitRef="usd">3,018,750</ix:nonFraction>.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_6" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_5"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Business Combination Agreement</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_7" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On October 3, 2022, the Company entered into a
Business Combination Agreement (as amended from time to time, the &#8220;Business Combination Agreement&#8221;), with Jupiter Merger Sub
I Corp., a Delaware corporation and a wholly owned subsidiary of the Company (&#8220;First Merger Sub&#8221;), Jupiter Merger Sub II LLC,
a Delaware limited liability company and a wholly owned subsidiary of the Company (&#8220;Second Merger Sub&#8221;), Complete Solaria,
Inc. (formerly known as Complete Solar Holding Corporation), a Delaware corporation (&#8220;Complete Solaria&#8221;) and The Solaria Corporation,
a Delaware corporation (&#8220;Solaria&#8221;).</p><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_8" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_7"><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">The Mergers</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_9" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Business Combination Agreement provides that,
among other things and upon the terms and subject to the conditions thereof, the following transactions will occur (together with the
other agreements and transactions contemplated by the Business Combination Agreement, the &#8220;Business Combination&#8221;):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_10" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_9"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>at the closing of the transactions contemplated by the Business Combination Agreement (the &#8220;Closing&#8221;), upon the terms
and subject to the conditions thereof, and in accordance with the Delaware General Corporation Law, as amended (the &#8220;DGCL&#8221;),
(i) First Merger Sub will merge with and into Complete Solaria, with Complete Solaria surviving as a wholly owned subsidiary of the Company,
(ii) immediately thereafter and as part of the same overall transaction, Complete Solaria will merge with and into Second Merger Sub,
with Second Merger Sub surviving as a wholly owned subsidiary of the Company, and (iii) immediately after the consummation of the Second
Merger and as part of the same overall transaction, Solaria will merge with and into a newly formed Delaware limited liability company
and wholly-owned subsidiary of the Company (&#8220;Third Merger Sub&#8221;), with Third Merger Sub surviving as a wholly-owned subsidiary
of the Company (the &#8220;Additional Merger,&#8221; and together with the First Merger and the Second Merger, the &#8220;Mergers&#8221;);</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_11" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_10"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>at the Closing, all outstanding shares of capital stock of Complete Solaria (subject to certain restrictions) and all options and
warrants to acquire shares of capital stock of Complete Solaria will convert into the right to receive shares of common stock, par value
$<ix:nonFraction contextRef="c2" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction> per share, of the Company (&#8220;Freedom Common Stock&#8221;) or comparable equity awards that are settled or are exercisable
for shares of Freedom Common Stock; and</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_12" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_11"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>at the Closing, the Company will be renamed &#8220;Complete Solaria, Inc.&#8221;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 100; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_13" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On October 2, 2022 and October 3, 2022, respectively, a special committee (the &#8220;Freedom Special
Committee&#8221;) of the Board of Directors of the Company (the &#8220;Freedom Board&#8221;) and the Freedom Board have (i) approved the
Business Combination Agreement and the Business Combination and (ii) resolved to recommend that the shareholders of the Company approve
the Business Combination Agreement and the Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_14" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_13"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">First Amendment to the Business Combination Agreement</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_15" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On December 26, 2022, the Company, Complete Solaria,
First Merger Sub and Second Merger Sub entered into a letter agreement (the &#8220;First Amendment&#8221;) amending the Business Combination
Agreement, dated as of October 3, 2022, by and among the Company, Complete Solaria, First Merger Sub and Second Merger Sub.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>



</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_16" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">The Amendment deletes the following provisions in the Business Combination Agreement:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_17" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_16"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>The condition to the obligation of Complete Solaria to consummate the Business Combination that there be, as of the closing of the
Business Combination (the &#8220;Closing&#8221;), at least $<ix:nonFraction contextRef="c100" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DividendsCommonStockCash" scale="0" unitRef="usd">100,000,000</ix:nonFraction> in Available Acquiror Cash (as such term is defined in the Business
Combination Agreement);</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_18" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_17"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>The obligation of each of the Company and Complete Solaria to use reasonable best efforts to cause the Available Acquiror Cash to
equal or exceed $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DividendsCommonStockCash" scale="0" unitRef="usd">100,000,000</ix:nonFraction> as of immediately prior to the Closing;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_19" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_18"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>The right of Complete Solaria to terminate the Business Combination Agreement if:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_20" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_19"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>Complete Solaria has not consummated the issuances of convertible note investments in Complete Solaria for an aggregate purchase price
of at least $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SupplementalDeferredPurchasePrice" scale="0" unitRef="usd">10,000,000</ix:nonFraction> on or before January 16, 2023; or</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_21" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_20"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>at a meeting of shareholders of the Company to extend the deadline by which the Company is required to consummate the Business Combination
under its organizational documents, a number of shareholders of the Company elect to redeem their ordinary shares such that the amount
remaining in the Company&#8217;s trust account after processing such redemptions, when taken together with the amounts included in prongs
(ii), (iii), (iv) and (v) of the definition of Available Acquiror Cash (as described above) is less than $<ix:nonFraction contextRef="c101" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DividendsCommonStockCash" scale="6" unitRef="usd">100</ix:nonFraction> million;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_22" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_21"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>The obligation of the Company and Complete Solaria to make termination payments in certain circumstances.</td></tr></table><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_23" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_22"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Second Amendment to the Business Combination Agreement</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_24" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On January 17, 2023, the Company, Complete Solaria,
First Merger Sub and Second Merger Sub entered into that certain Second Amendment to Business Combination Agreement (the &#8220;Second
Amendment&#8221;) amending the Business Combination Agreement, dated as of October 3, 2022, by and among the Company, Complete Solaria,
First Merger Sub and Second Merger Sub, as amended by the First Amendment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_24"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Second Amendment provides that, if the Company
and Complete Solaria determine in good faith by January 1, 2023 that it is probable that the Business Combination will be consummated
after March 1, 2023, the Company will be required to prepare (with the reasonable cooperation of Complete Solaria) and file with the SEC
a proxy statement pursuant to which it will seek the approval of its shareholders for proposals to amend the Company&#8217;s organizational
documents to extend the time period for the Company to consummate its initial business combination for (x) up to an additional six (6)
months, from March 2, 2023 to September 2, 2023 (the original Business Combination Agreement provided for an extension from March 1, 2023
to September 2, 2023) or (y) such other period of time as the Company and Complete Solaria may mutually agree (the original Business Combination
Agreement contemplated no such prong (y)). In addition, the Second Amendment amends the Business Combination Agreement by changing the
latest permitted Agreement End Date (as defined in the Business Combination Agreement) from September 1, 2023 to September 2, 2023.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 101; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 8 &#8212; Shareholders&#8217; Deficit</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>&#160;</i></b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>Preference shares&#160;</i></b>&#8212; The
Company is authorized to issue a total of&#160;<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares">1,000,000</ix:nonFraction>&#160;preference shares at par value of $<ix:nonFraction contextRef="c4" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction>&#160;each. At December 31, 2022
and 2021, there were <span style="-sec-ix-hidden: hidden-fact-99"><span style="-sec-ix-hidden: hidden-fact-100"><span style="-sec-ix-hidden: hidden-fact-101"><span style="-sec-ix-hidden: hidden-fact-102">no</span></span></span></span> preference shares issued or outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>&#160;</i></b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>Class A Ordinary shares&#160;</i></b>&#8212;
The Company is authorized to issue a total of&#160;<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">200,000,000</ix:nonFraction>&#160;Class A ordinary shares at par value of $<ix:nonFraction contextRef="c2" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction>&#160;each. At December
31, 2022 and 2021, there were&#160;<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">34,500,000</ix:nonFraction></ix:nonFraction>&#160;Class&#160;A ordinary shares outstanding, all of which is subject to possible redemption.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>&#160;</i></b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>Class B Ordinary shares&#160;</i></b>&#8212;
The Company is authorized to issue a total of&#160;<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">20,000,000</ix:nonFraction>&#160;Class B ordinary shares at par value of $<ix:nonFraction contextRef="c3" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.0001</ix:nonFraction>&#160;each. At December
31, 2022 and 2021, there were&#160;<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">8,625,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;Class B ordinary shares issued and outstanding, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_5" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On December 31, 2020,&#160;<ix:nonNumeric contextRef="c17" name="fact:OrdinarySharesDescription">the Sponsor paid $25,000,
or approximately $0.003 per share, to cover certain offering costs in consideration for 7,187,500 Class B ordinary shares, par value $0.0001
per share. On February 25, 2021, the Company effected a share dividend whereby the Company issued 1,437,500 Class B ordinary shares, resulting
in an aggregate of 8,625,000 Class B ordinary shares outstanding.&#160;All share and per-share amounts have been retroactively restated
to reflect the share dividend.</ix:nonNumeric></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_6" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Holders of the Class&#160;A ordinary shares and
holders of the Class&#160;B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company&#8217;s
shareholders, except as required by law; provided that only holders of Class B ordinary shares will have the right to appoint and remove
directors in any general meeting held prior to or in connection with the completion of an initial Business Combination. Unless specified
in the Company&#8217;s amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies
Act or applicable stock exchange rules, the affirmative vote of a majority of the Company&#8217;s ordinary shares that are voted is required
to approve any such matter voted on by its shareholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Class&#160;B ordinary shares will automatically
convert into Class&#160;A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination
on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the
like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares or equity-linked securities
are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion
of all Founder Shares will equal, in the aggregate,&#160;<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="fact:TotalNumberOfOrdinarySharesOutstandingPercentage" scale="-2" unitRef="pure">20</ix:nonFraction>% of the total number of Class A ordinary shares outstanding after such conversion
(after giving effect to any redemptions of Class A ordinary shares by Public Shareholders), including the total number of Class A ordinary
shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued,
by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary
shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller
in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of
Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.</p></ix:continuation><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c102" continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_1" escape="true" name="fact:WarrantsDisclosureTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 9 &#8212; Warrants&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_2" id="fact_WarrantsDisclosureTextBlock-c102_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Public Warrants will become exercisable at
$<ix:nonFraction contextRef="c103" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares">11.50</ix:nonFraction>&#160;per share on the later of&#160;<ix:nonNumeric contextRef="c77" format="ixt-sec:durwordsen" name="fact:WarrantTerm">one year</ix:nonNumeric>&#160;from the closing of the IPO and 30 days after the completion of the initial Business
Combination; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class&#160;A
ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits
holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are
registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. The
warrants will expire&#160;<ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="fact:WarrantExpirationTerm">five years</ix:nonNumeric>&#160;after the completion of a Business Combination or earlier upon redemption or liquidation.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 102; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><ix:continuation continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_3" id="fact_WarrantsDisclosureTextBlock-c102_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company has agreed that as soon as practicable,
but in no event later than 15 business days after the closing of the initial Business Combination, it will use commercially reasonable
efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable
upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain
the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the
warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class&#160;A ordinary shares
issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant
holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to
maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section&#160;3(a)(9)
of the Securities Act or another exemption. Notwithstanding the above, if the Company&#8217;s Class A ordinary shares are at the time
of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221;
under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants
to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects,
it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will
use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is
not available. In such event, each holder would pay the exercise price by surrendering each such warrant for that number of Class&#160;A
ordinary shares equal to the lesser of (A)&#160;the quotient obtained by dividing (x)&#160;the product of the number of Class&#160;A ordinary
shares underlying the warrants, multiplied by the excess of the &#8220;fair market value&#8221; (defined below) less the exercise price
of the warrants by (y)&#160;the fair market value and (B) 0.361. The &#8220;fair market value&#8221; as used in this paragraph shall mean
the volume weighted average price of the Class&#160;A ordinary shares for the 10 trading days ending on the trading day prior to the date
on which the notice of exercise is received by the warrant agent.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_4" id="fact_WarrantsDisclosureTextBlock-c102_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The exercise price and number of shares issuable
upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend or recapitalization,
reorganization, merger or consolidation.&#160;<ix:nonNumeric contextRef="c40" name="us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity">In addition, if (x)&#160;the Company issues additional Class&#160;A ordinary shares or equity-linked
securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective
issue price of less than $9.20 per Class&#160;A ordinary share (with such issue price or effective issue price to be determined in good
faith by the Company&#8217;s board of directors and in the case of any such issuance to the Company&#8217;s Sponsors or their affiliates,
without taking into account any Founder Shares held by the Company&#8217;s initial shareholders or such affiliates, as applicable, prior
to such issuance (the &#8220;Newly Issued Price&#8221;), (y)&#160;the aggregate gross proceeds from such issuances represent more than
60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the
completion of the initial Business Combination (net of redemptions), and (z)&#160;the volume-weighted average trading price of the Company&#8217;s
Class&#160;A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates
its initial Business Combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, then the exercise price of the
warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and
the $10.00 and $18.00 per share redemption trigger prices described below under &#8220;Redemption of warrants when the price per Class
A ordinary share equals or exceeds $10.00&#8221; and &#8220;Redemption of warrants when the price per Class A ordinary share equals or
exceeds $18.00&#8221; will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly
Issued Price, respectively.</ix:nonNumeric></p><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_5" id="fact_WarrantsDisclosureTextBlock-c102_cont_4"><ix:nonNumeric contextRef="c9" continuedAt="fact_RedemptionsOfWarrantsDescription-c9_cont_1" name="fact:RedemptionsOfWarrantsDescription"><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Redemption of Warrants When the Price per Class&#160;A
Ordinary Share Equals or Exceeds $18.00</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_6" id="fact_WarrantsDisclosureTextBlock-c102_cont_5"><ix:continuation continuedAt="fact_RedemptionsOfWarrantsDescription-c9_cont_2" id="fact_RedemptionsOfWarrantsDescription-c9_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Once the warrants become exercisable, the Company
may redeem the outstanding warrants (except with respect to the Private Placement Warrants):&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_7" id="fact_WarrantsDisclosureTextBlock-c102_cont_6"><ix:continuation continuedAt="fact_RedemptionsOfWarrantsDescription-c9_cont_3" id="fact_RedemptionsOfWarrantsDescription-c9_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>in whole and not in part;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_8" id="fact_WarrantsDisclosureTextBlock-c102_cont_7"><ix:continuation continuedAt="fact_RedemptionsOfWarrantsDescription-c9_cont_4" id="fact_RedemptionsOfWarrantsDescription-c9_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>at a price of $0.01 per warrant;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_9" id="fact_WarrantsDisclosureTextBlock-c102_cont_8"><ix:continuation continuedAt="fact_RedemptionsOfWarrantsDescription-c9_cont_5" id="fact_RedemptionsOfWarrantsDescription-c9_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>upon not less than 30 days&#8217; prior written notice of redemption (the &#8220;30-day redemption period&#8221;) to each warrant
holder; and</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_10" id="fact_WarrantsDisclosureTextBlock-c102_cont_9"><ix:continuation continuedAt="fact_RedemptionsOfWarrantsDescription-c9_cont_6" id="fact_RedemptionsOfWarrantsDescription-c9_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a 30-trading day period
ending three business days before the Company sends to the notice of redemption to the warrant holders (the &#8220;Reference Value&#8221;)
equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and
the like).&#160;</td></tr></table><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 103; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p><div>

</div><ix:continuation continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_11" id="fact_WarrantsDisclosureTextBlock-c102_cont_10"><ix:continuation continuedAt="fact_RedemptionsOfWarrantsDescription-c9_cont_7" id="fact_RedemptionsOfWarrantsDescription-c9_cont_6"><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Redemption of Warrants When the Price per Class&#160;A
Ordinary Share Equals or Exceeds $10.00</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_12" id="fact_WarrantsDisclosureTextBlock-c102_cont_11"><ix:continuation continuedAt="fact_RedemptionsOfWarrantsDescription-c9_cont_8" id="fact_RedemptionsOfWarrantsDescription-c9_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Once the warrants become exercisable, the Company
may redeem the outstanding warrants:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_13" id="fact_WarrantsDisclosureTextBlock-c102_cont_12"><ix:continuation continuedAt="fact_RedemptionsOfWarrantsDescription-c9_cont_9" id="fact_RedemptionsOfWarrantsDescription-c9_cont_8"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>in whole and not in part;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_14" id="fact_WarrantsDisclosureTextBlock-c102_cont_13"><ix:continuation continuedAt="fact_RedemptionsOfWarrantsDescription-c9_cont_10" id="fact_RedemptionsOfWarrantsDescription-c9_cont_9"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>at $0.10 per warrant upon a minimum of 30 days&#8217; prior written notice of redemption provided that holders will be able to exercise
their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based
on the redemption date and the &#8220;fair market value&#8221; of the Class A ordinary shares;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="fact_WarrantsDisclosureTextBlock-c102_cont_15" id="fact_WarrantsDisclosureTextBlock-c102_cont_14"><ix:continuation continuedAt="fact_RedemptionsOfWarrantsDescription-c9_cont_11" id="fact_RedemptionsOfWarrantsDescription-c9_cont_10"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share sub-divisions, share capitalizations,
reorganizations, recapitalizations and the like); and</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation id="fact_WarrantsDisclosureTextBlock-c102_cont_15"><ix:continuation id="fact_RedemptionsOfWarrantsDescription-c9_cont_11"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>if the Reference Value is less than $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations,
recapitalizations and the like) the Private Placement Warrants must also be concurrently called for redemption on the same terms as the
outstanding public warrants, as described above.</td></tr></table></ix:continuation></ix:continuation><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_FairValueDisclosuresTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueDisclosuresTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 10 &#8212; Fair Value Measurements</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_2" id="_FairValueDisclosuresTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Fair value is defined as the price that would
be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement
date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives
the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the
lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_3" id="_FairValueDisclosuresTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_4" id="_FairValueDisclosuresTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
and</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_5" id="_FairValueDisclosuresTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own
assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers
are unobservable.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_6" id="_FairValueDisclosuresTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table presents information about
the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2022 and 2021 and indicates
the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_7" id="_FairValueDisclosuresTextBlock-c0_cont_6"><ix:nonNumeric contextRef="c0" continuedAt="_FairValueAssetsMeasuredOnRecurringBasisTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Quoted&#160;Prices In<br/> Active<br/> Markets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Description</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 53%; text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Investments held in trust account- U.S. Treasury Securities</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:InvestmentsHeldInTrustAccountUSTreasureSecurities" scale="0" unitRef="usd">349,927,313</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c104" decimals="0" format="ixt:num-dot-decimal" name="fact:InvestmentsHeldInTrustAccountUSTreasureSecurities" scale="0" unitRef="usd">349,927,313</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-103">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-104">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Total Investments held in Trust Account</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:InvestmentsHeldInTrustAccountNet" scale="0" unitRef="usd">349,927,313</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c104" decimals="0" format="ixt:num-dot-decimal" name="fact:InvestmentsHeldInTrustAccountNet" scale="0" unitRef="usd">349,927,313</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-105">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Warrant liabilities &#8211; Public warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:WarrantLiabilitiesPublicWarrants" scale="0" unitRef="usd">1,725,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c105" decimals="0" format="ixt:num-dot-decimal" name="fact:WarrantLiabilitiesPublicWarrants" scale="0" unitRef="usd">1,725,000</ix:nonFraction></td><td style="text-align: left"></td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-107">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Warrant liabilities &#8211; Private warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:WarrantLiabilitiesPrivateWarrants" scale="0" unitRef="usd">1,253,333</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-109">&#8212;</div></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c106" decimals="0" format="ixt:num-dot-decimal" name="fact:WarrantLiabilitiesPrivateWarrants" scale="0" unitRef="usd">1,253,333</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Convertible Note &#8211; April 1, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:ConvertibleNoteAmount" scale="0" unitRef="usd">338,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-111">&#8212;</div></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c106" decimals="0" format="ixt:num-dot-decimal" name="fact:ConvertibleNoteAmount" scale="0" unitRef="usd">338,200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Convertible Note &#8211; June 6, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:ConvertibleNoteone" scale="0" unitRef="usd">338,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">&#8212;</div></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c106" decimals="0" format="ixt:num-dot-decimal" name="fact:ConvertibleNoteone" scale="0" unitRef="usd">338,200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Convertible Note &#8211; December 14, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:ConvertibleNotesTwo" scale="0" unitRef="usd">152,200</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c106" decimals="0" format="ixt:num-dot-decimal" name="fact:ConvertibleNotesTwo" scale="0" unitRef="usd">152,200</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Total Warrant liabilities</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="fact:TotalWarrantLiabilities" scale="0" unitRef="usd">3,806,933</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c107" decimals="0" format="ixt:num-dot-decimal" name="fact:TotalWarrantLiabilities" scale="0" unitRef="usd">1,725,000</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left"></td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c108" decimals="0" format="ixt:num-dot-decimal" name="fact:TotalWarrantLiabilities" scale="0" unitRef="usd">2,081,933</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 104; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_8" id="_FairValueDisclosuresTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For the year ended December 31, 2022, as a result
of the recent decline in trading volume within the period, the public warrants were transferred to and are currently classified as Level
2 securities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_9" id="_FairValueDisclosuresTextBlock-c0_cont_8"><ix:continuation id="_FairValueAssetsMeasuredOnRecurringBasisTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Quoted&#160;Prices In<br/> Active<br/> Markets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Description</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Investments held in trust account- U.S. Money Market Fund</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:InvestmentsHeldInTrustAccountUSMoneyMarketFund" scale="0" unitRef="usd">484</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c109" decimals="0" format="ixt:num-dot-decimal" name="fact:InvestmentsHeldInTrustAccountUSMoneyMarketFund" scale="0" unitRef="usd">484</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Investments held in trust account- U.S. Treasury Securities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:InvestmentsHeldInTrustAccountUSTreasureSecurities" scale="0" unitRef="usd">345,105,197</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c109" decimals="0" format="ixt:num-dot-decimal" name="fact:InvestmentsHeldInTrustAccountUSTreasureSecurities" scale="0" unitRef="usd">345,105,197</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Total Investments held in Trust Account</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:InvestmentsHeldInTrustAccountNet" scale="0" unitRef="usd">345,105,681</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c109" decimals="0" format="ixt:num-dot-decimal" name="fact:InvestmentsHeldInTrustAccountNet" scale="0" unitRef="usd">345,105,681</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Warrant liabilities &#8211; Public warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:WarrantLiabilitiesPublicWarrants" scale="0" unitRef="usd">4,916,250</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c109" decimals="0" format="ixt:num-dot-decimal" name="fact:WarrantLiabilitiesPublicWarrants" scale="0" unitRef="usd">4,916,250</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Warrant liabilities &#8211; Private warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:WarrantLiabilitiesPrivateWarrants" scale="0" unitRef="usd">3,572,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c111" decimals="0" format="ixt:num-dot-decimal" name="fact:WarrantLiabilitiesPrivateWarrants" scale="0" unitRef="usd">3,572,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Total Warrant liabilities</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="fact:TotalWarrantLiabilities" scale="0" unitRef="usd">8,488,250</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c112" decimals="0" format="ixt:num-dot-decimal" name="fact:TotalWarrantLiabilities" scale="0" unitRef="usd">4,916,250</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c114" decimals="0" format="ixt:num-dot-decimal" name="fact:TotalWarrantLiabilities" scale="0" unitRef="usd">3,572,000</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_10" id="_FairValueDisclosuresTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company utilized a Monte Carlo simulation
model for the initial valuation of the Public Warrants. The subsequent measurement of the Public Warrants as of December 31, 2022 and
2021, is classified as Level 1 due to the use of an observable market quote in an active market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_11" id="_FairValueDisclosuresTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company utilizes a binomial lattice
simulation model to value the private placement warrants and the convertible promissory notes at each reporting period, with changes
in fair value recognized in the consolidated statements of operations. The estimated fair value of the warrant liability is
determined using Level&#160;3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price
volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares
based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the
U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The
expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the
historical rate, which the Company anticipates to remain at zero.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_12" id="_FairValueDisclosuresTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The aforementioned warrant liabilities are not
subject to qualified hedge accounting.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_13" id="_FairValueDisclosuresTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Transfers to/from Levels 1, 2, and 3 are
recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. The value of the
securities transferred from a Level 2 measurement to a Level 1 measurement during the year ended December 31, 2022 was
$<ix:nonFraction contextRef="c104" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3" scale="0" unitRef="usd">348,810,523</ix:nonFraction>. There was a transfer of $<ix:nonFraction contextRef="c105" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3" scale="0" unitRef="usd">1,725,000</ix:nonFraction> from Level 1 to Level 2 in the fair value hierarchy for Public Warrants during the
year ended December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_14" id="_FairValueDisclosuresTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table provides quantitative information
regarding Level&#160;3 fair value measurements:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_15" id="_FairValueDisclosuresTextBlock-c0_cont_14"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">At<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">At<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-indent: -9.35pt; padding-left: 9.35pt">Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares">10.10</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares">9.68</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="fact:FairValueMeasurementStrikePrice" scale="0" unitRef="usdPershares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="fact:FairValueMeasurementStrikePrice" scale="0" unitRef="usdPershares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">0.38</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c8" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">0.50</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c0" name="fact:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates">de minimis</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c8" continuedAt="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates-c8_cont_1" name="fact:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates">10.50</ix:nonNumeric></td><td style="text-align: left"><ix:continuation id="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates-c8_cont_1">%</ix:continuation></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure">3.98</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure">1.30</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure">0.00</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure">0.00</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 105; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_16" id="_FairValueDisclosuresTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table presents the changes in the
fair value of warrant liabilities:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_17" id="_FairValueDisclosuresTextBlock-c0_cont_16"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Public</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Private<br/> Placement</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrant<br/> Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of January 1, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c115" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">4,916,250</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c116" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">3,572,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c117" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">8,488,250</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Change in valuation inputs or other assumptions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c118" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" scale="0" sign="-" unitRef="usd">3,191,250</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c78" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" scale="0" sign="-" unitRef="usd">2,318,667</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c37" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" scale="0" sign="-" unitRef="usd">5,509,917</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of December 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c119" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">1,725,000</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c85" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">1,253,333</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c38" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">2,978,333</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_18" id="_FairValueDisclosuresTextBlock-c0_cont_17"><ix:continuation id="_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Public</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Private<br/> Placement</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrant<br/> Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of January 1, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-127">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-128">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-129">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt">Initial measurement on March 2, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c123" decimals="0" format="ixt:num-dot-decimal" name="fact:FairValueInitialMeasurement" scale="0" unitRef="usd">10,350,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c124" decimals="0" format="ixt:num-dot-decimal" name="fact:FairValueInitialMeasurement" scale="0" unitRef="usd">7,520,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c125" decimals="0" format="ixt:num-dot-decimal" name="fact:FairValueInitialMeasurement" scale="0" unitRef="usd">17,870,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Change in valuation inputs or other assumptions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c123" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" scale="0" sign="-" unitRef="usd">5,433,750</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c124" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" scale="0" sign="-" unitRef="usd">3,948,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c125" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" scale="0" sign="-" unitRef="usd">9,381,750</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of December 31, 2021</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c115" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">4,916,250</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c116" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">3,572,000</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c117" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">8,488,250</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_19" id="_FairValueDisclosuresTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company recognized gains in connection with
changes in the fair value of warrant liabilities of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="fact:FairValueWarrantLiabilities" scale="0" unitRef="usd">5,509,917</ix:nonFraction> within change in fair value of warrant liabilities in the consolidated statement of operations for the year ended December 31, 2022. The Company recognized gains in connection with changes in the fair value of warrant
liabilities of $<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="fact:FairValueWarrantLiabilities" scale="0" unitRef="usd">9,381,750</ix:nonFraction> within change in fair value of warrant liabilities in the consolidated statement of operations for the year ended December
31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_20" id="_FairValueDisclosuresTextBlock-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table presents a summary of the
changes in the fair value of Level 3 warrant liabilities:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_21" id="_FairValueDisclosuresTextBlock-c0_cont_20"><ix:nonNumeric contextRef="c0" continuedAt="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock-c0_cont_1" escape="true" name="fact:ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Private Placement</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Public</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> Warrant<br/> Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of January 1, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">3,572,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">3,572,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c129" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" scale="0" sign="-" unitRef="usd">2,318,667</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-131">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" scale="0" sign="-" unitRef="usd">2,318,667</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of December 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c132" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">1,253,333</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-132">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c134" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">1,253,333</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="_FairValueDisclosuresTextBlock-c0_cont_21"><ix:continuation id="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Private<br/> Placement</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Public</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> Warrant<br/> Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of January 1, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-133">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-135">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt">Initial measurement on March 2, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c138" decimals="0" format="ixt:num-dot-decimal" name="fact:FairValueInitialMeasurement" scale="0" unitRef="usd">7,520,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="fact:FairValueInitialMeasurement" scale="0" unitRef="usd">10,350,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c140" decimals="0" format="ixt:num-dot-decimal" name="fact:FairValueInitialMeasurement" scale="0" unitRef="usd">17,870,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Transfer to Level 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-136">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="fact:FairValueAssetsLevel1ToLevel2TransferAmount" scale="0" sign="-" unitRef="usd">10,350,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c140" decimals="0" format="ixt:num-dot-decimal" name="fact:FairValueAssetsLevel1ToLevel2TransferAmount" scale="0" sign="-" unitRef="usd">10,350,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c138" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" scale="0" sign="-" unitRef="usd">3,948,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-137">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c140" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" scale="0" sign="-" unitRef="usd">3,948,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of December 31, 2021</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">3,572,000</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-138">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="0" unitRef="usd">3,572,000</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SubsequentEventsTextBlock-c0_cont_1" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 11 &#8212; Subsequent Events</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_2" id="_SubsequentEventsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company evaluated subsequent events and
transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this
review, other than below, the Company did not identify any subsequent events that would have required adjustment or disclosure in
the consolidated financial statements.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_3" id="_SubsequentEventsTextBlock-c0_cont_2"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Second Amendment to the Business Combination Agreement</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_4" id="_SubsequentEventsTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On January 17, 2023, the Company, Complete Solaria,
First Merger Sub and Second Merger Sub entered into the Second Amendment amending the Business Combination Agreement, dated as of October
3, 2022, by and among the Company, Complete Solaria, First Merger Sub and Second Merger Sub, as amended by the First Amendment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_5" id="_SubsequentEventsTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Second Amendment provides that, if the Company
and Complete Solaria determine in good faith by January 1, 2023 that it is probable that the Business Combination will be consummated
after March 1, 2023, the Company will be required to prepare (with the reasonable cooperation of Complete Solaria) and file with the SEC
a proxy statement pursuant to which it will seek the approval of its shareholders for proposals to amend the Company&#8217;s organizational
documents to extend the time period for the Company to consummate its initial business combination for (x) up to an additional six (6)
months, from March 2, 2023 to September 2, 2023 (the original Business Combination Agreement provided for an extension from March 1, 2023
to September 2, 2023) or (y) such other period of time as the Company and Complete Solaria may mutually agree (the original Business Combination
Agreement contemplated no such prong (y)). In addition, the Second Amendment amends the Business Combination Agreement by changing the
latest permitted Agreement End Date (as defined in the Business Combination Agreement) from September 1, 2023 to September 2, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 106; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_6" id="_SubsequentEventsTextBlock-c0_cont_5"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Amendment to Amended and Restated Memorandum and Articles of Association</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_7" id="_SubsequentEventsTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On February 28, 2023, Freedom held an extraordinary
general meeting of shareholders (the &#8220;Extraordinary General Meeting&#8221;), at which holders of <ix:nonFraction contextRef="c141" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">35,373,848</ix:nonFraction> ordinary shares, comprised
of <ix:nonFraction contextRef="c142" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">26,773,848</ix:nonFraction> Class&#160;A ordinary shares and <ix:nonFraction contextRef="c143" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">8,600,000</ix:nonFraction> Class&#160;B ordinary shares, were present in person or by proxy, representing
approximately <ix:nonFraction contextRef="c144" decimals="4" format="ixt:num-dot-decimal" name="fact:VotingPowerPercentage" scale="-2" unitRef="pure">82.02</ix:nonFraction>% of the voting power of the <ix:nonFraction contextRef="c145" decimals="0" format="ixt:num-dot-decimal" name="fact:IssuedAndOutstandingShares" scale="0" unitRef="shares">43,125,000</ix:nonFraction> issued and outstanding ordinary shares of Freedom entitled to vote at the Extraordinary
General Meeting at the close of business on January 23, 2023, which was the record date (the &#8220;Record Date&#8221;) for the Extraordinary
General Meeting (such shares, the &#8220;Outstanding Shares&#8221;). The Outstanding Shares on the Record Date were comprised of <ix:nonFraction contextRef="c142" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonUnitOutstanding" scale="0" unitRef="shares">34,500,000</ix:nonFraction>
Class A ordinary shares and <ix:nonFraction contextRef="c143" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonUnitOutstanding" scale="0" unitRef="shares">8,625,000</ix:nonFraction> Class B ordinary shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_8" id="_SubsequentEventsTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At the Extraordinary General Meeting, the shareholders
approved, by special resolution, the proposal (the &#8220;Extension Amendment Proposal&#8221;) to amend the amended and restated memorandum
and articles of association to extend the date by which Freedom must (i) consummate a merger, amalgamation, share exchange, asset acquisition,
share purchase, reorganization or similar business combination, which Freedom refers to as its initial business combination, (ii) cease
its operations except for the purpose of winding up if it fails to complete such initial business combination, and (iii) redeem all of
the Class A ordinary shares, included as part of the units sold in the initial public offering, for an additional three months, from March
2, 2023 to June 2, 2023, and thereafter to up to three (3) times by an additional one month each time (or up to September 2, 2023) (the
&#8220;Extension Amendment,&#8221; and such period, as may be extended, the &#8220;Combination Period&#8221;). The voting results for
such proposal were as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_9" id="_SubsequentEventsTextBlock-c0_cont_8"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For</b></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Against</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Abstain</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: center">&#160;</td><td style="width: 31%; text-align: center"><ix:nonFraction contextRef="c146" decimals="0" format="ixt:num-dot-decimal" name="fact:ExtensionAmendmentProposalFor" scale="0" unitRef="shares">35,047,305</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td><td style="width: 31%; text-align: center"><ix:nonFraction contextRef="c146" decimals="0" format="ixt:num-dot-decimal" name="fact:ExtensionAmendmentProposalAgainst" scale="0" unitRef="shares">326,543</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td><td style="width: 30%; text-align: center"><ix:nonFraction contextRef="c146" decimals="0" format="ixt:num-dot-decimal" name="fact:ExtensionAmendmentProposalAbstain" scale="0" unitRef="shares">0</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_10" id="_SubsequentEventsTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In connection with the Extension Amendment, public
shareholders elected to redeem an aggregate of <ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="fact:AggregateSharesOfCommonStock" scale="0" unitRef="shares">23,256,504</ix:nonFraction> Class&#160;A ordinary shares at a redemption price of $<ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityRedemptionPricePerShare" scale="0" unitRef="usdPershares">10.21</ix:nonFraction> per share, representing
approximately <ix:nonFraction contextRef="c2" decimals="4" format="ixt:num-dot-decimal" name="fact:IssuedAndOutstandingInterestPercentage" scale="-2" unitRef="pure">67.41</ix:nonFraction>% of the issued and outstanding Class A ordinary shares, for an aggregate redemption amount of approximately $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" scale="0" unitRef="usd">237,372,952</ix:nonFraction>.
Following such redemptions, approximately $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockHeldInTrust" scale="0" unitRef="usd">114,759,374</ix:nonFraction> remained in the trust account and <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" scale="0" unitRef="shares">11,243,496</ix:nonFraction> Class A ordinary shares remain outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_11" id="_SubsequentEventsTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At the Extraordinary General Meeting, the public
shareholders also approved the proposal to amend the Investment Management Trust Agreement, dated as of February 25, 2021 (the &#8220;Trust
Agreement&#8221;), by and between Freedom and Continental Stock Transfer &amp; Trust Company, as trustee (&#8220;Continental&#8221;),
to reflect the Extension Amendment. The amendment to the Trust Agreement provides that Continental shall commence liquidation of the trust
account only and promptly (x) after its receipt of the applicable instruction letter delivered by Freedom in connection with either the
consummation of an initial business combination or Freedom&#8217;s inability to effect an initial business combination within the time
frame specified in Freedom&#8217;s amended and restated memorandum and articles of association or (y) upon the date that is the later
of the end of the Combination Period and such later date as may be approved by Freedom&#8217;s shareholders in accordance with the amended
and restated memorandum and articles of association, if the aforementioned termination letter has not been received by Continental prior
to such date. The voting results for such proposal were as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_12" id="_SubsequentEventsTextBlock-c0_cont_11"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Against</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Abstain</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: center">&#160;</td><td style="width: 31%; text-align: center"><ix:nonFraction contextRef="c147" decimals="0" format="ixt:num-dot-decimal" name="fact:InvestmentManagementTrustAgreementFor" scale="0" unitRef="shares">35,047,305</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td><td style="width: 31%; text-align: center"><ix:nonFraction contextRef="c147" decimals="0" format="ixt:num-dot-decimal" name="fact:InvestmentManagementTrustAgreementAgainst" scale="0" unitRef="shares">326,543</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td><td style="width: 30%; text-align: center"><ix:nonFraction contextRef="c147" decimals="0" format="ixt:num-dot-decimal" name="fact:InvestmentManagementTrustAgreementAbstain" scale="0" unitRef="shares">0</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_13" id="_SubsequentEventsTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><b>Promissory Note</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_SubsequentEventsTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On February 28, 2023, the Company issued an unsecured
promissory note in the amount of up to $<ix:nonFraction contextRef="c145" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfUnsecuredDebt" scale="0" unitRef="usd">2,100,000</ix:nonFraction> to the Sponsor. The proceeds of such promissory note, $<ix:nonFraction contextRef="c145" decimals="0" format="ixt:num-dot-decimal" name="fact:PromissoryNote" scale="0" unitRef="usd">1,600,000</ix:nonFraction> of which was drawn
down immediately, $<ix:nonFraction contextRef="c145" decimals="0" format="ixt:num-dot-decimal" name="fact:DrawnDownAmount" scale="0" unitRef="usd">400,000</ix:nonFraction> of which may be drawn down, with the mutual consent of the Company and the Sponsor, if the
Company wishes to extend the date by which it will consummate a business combination beyond June 2, 2023, and $<ix:nonFraction contextRef="c148" decimals="0" format="ixt:num-dot-decimal" name="fact:DrawnDownAmount" scale="0" unitRef="usd">100,000</ix:nonFraction> of which may be
drawn down on an as-needed basis at the discretion of our sponsor, will be used for general working capital purposes. Such promissory
note bears no interest and is payable in full upon the consummation of our business combination. A failure to pay the principal within
five business days of the date specified above or the commencement of a voluntary or involuntary bankruptcy action shall be deemed an
event of default, in which case the promissory note may be accelerated. The promissory note shall be forgiven by the Sponsor if the Company
is unable to consummate a business combination within the time frame specified in our amended and restated memorandum and articles of
association (as amended from time to time), except to the extent of any funds held outside of the trust account established in connection
with our initial public offering. The issuance of the promissory note was made pursuant to the exemption from registration contained in
Section 4(a)(2) of the Securities Act of 1933, as amended.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-24</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:EntityTaxIdentificationNumber">00-0000000</ix:nonNumeric>
<ix:nonFraction contextRef="c4" id="hidden-fact-1" name="us-gaap:PrepaidExpenseNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-2" name="us-gaap:ConvertibleNotesPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-3" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-4" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-5" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-6" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-7" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-8" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-9" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-10" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-11" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-12" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-13" name="us-gaap:AdditionalPaidInCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-14" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-15" name="us-gaap:NoninterestExpenseOfferingCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" decimals="2" id="hidden-fact-16" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.14</ix:nonFraction>
<ix:nonFraction contextRef="c10" decimals="2" id="hidden-fact-17" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.14</ix:nonFraction>
<ix:nonFraction contextRef="c11" decimals="2" id="hidden-fact-18" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.14</ix:nonFraction>
<ix:nonFraction contextRef="c12" decimals="2" id="hidden-fact-19" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.14</ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-20" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-21" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-22" name="us-gaap:StockIssuedDuringPeriodSharesOther" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-23" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-24" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-25" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-26" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-27" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-28" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-29" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-30" name="us-gaap:StockholdersEquityOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-31" name="us-gaap:StockholdersEquityOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-32" name="us-gaap:StockholdersEquityOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-33" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-34" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-35" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-36" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-37" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-38" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-39" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-40" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-41" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-42" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-43" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-44" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-45" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-46" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-47" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-48" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-49" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-50" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-51" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-52" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-53" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-54" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-55" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-56" name="fact:ChangeInDeferredUnderwritingFee" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-57" name="fact:OfferingCostsAllocatedToWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-58" name="fact:CashDepositedInTrustAccount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-59" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-60" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-61" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-62" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-63" name="us-gaap:RepaymentsOfRelatedPartyDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-64" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-65" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-66" name="fact:InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-67" name="fact:InitialValueOfWarrantLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-68" name="fact:DeferredOfferingCostsIncludedInAccruedExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-69" name="fact:DeferredOfferingCostsPaidUnderPromissoryNote" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-70" name="us-gaap:EarningsPerShareBasic" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" decimals="2" id="hidden-fact-71" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.05</ix:nonFraction>
<ix:nonFraction contextRef="c54" decimals="2" id="hidden-fact-72" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.05</ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-73" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c56" id="hidden-fact-74" name="us-gaap:EarningsPerShareBasic" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" decimals="2" id="hidden-fact-75" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.05</ix:nonFraction>
<ix:nonFraction contextRef="c57" decimals="2" id="hidden-fact-76" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.05</ix:nonFraction>
<ix:nonFraction contextRef="c56" id="hidden-fact-77" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c62" id="hidden-fact-78" name="us-gaap:EarningsPerShareBasic" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c61" decimals="2" id="hidden-fact-79" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.08</ix:nonFraction>
<ix:nonFraction contextRef="c63" decimals="2" id="hidden-fact-80" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.08</ix:nonFraction>
<ix:nonFraction contextRef="c62" id="hidden-fact-81" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c65" id="hidden-fact-82" name="us-gaap:EarningsPerShareBasic" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c64" decimals="2" id="hidden-fact-83" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.08</ix:nonFraction>
<ix:nonFraction contextRef="c66" decimals="2" id="hidden-fact-84" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.08</ix:nonFraction>
<ix:nonFraction contextRef="c65" id="hidden-fact-85" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c71" id="hidden-fact-86" name="us-gaap:EarningsPerShareBasic" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c70" decimals="2" id="hidden-fact-87" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.16</ix:nonFraction>
<ix:nonFraction contextRef="c72" decimals="2" id="hidden-fact-88" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.16</ix:nonFraction>
<ix:nonFraction contextRef="c71" id="hidden-fact-89" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c74" id="hidden-fact-90" name="us-gaap:EarningsPerShareBasic" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c73" decimals="2" id="hidden-fact-91" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.16</ix:nonFraction>
<ix:nonFraction contextRef="c75" decimals="2" id="hidden-fact-92" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.16</ix:nonFraction>
<ix:nonFraction contextRef="c74" id="hidden-fact-93" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c79" id="hidden-fact-94" name="fact:TradingSecuritiesFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c82" id="hidden-fact-95" name="fact:GrossUnrealizedGain" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c82" id="hidden-fact-96" name="fact:GrossUnrealizedGainsAndLosses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c83" id="hidden-fact-97" name="fact:GrossUnrealizedGain" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-98" name="fact:GrossUnrealizedGain" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-99" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-100" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-101" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-102" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c105" id="hidden-fact-103" name="fact:InvestmentsHeldInTrustAccountUSTreasureSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c106" id="hidden-fact-104" name="fact:InvestmentsHeldInTrustAccountUSTreasureSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c105" id="hidden-fact-105" name="fact:InvestmentsHeldInTrustAccountNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c106" id="hidden-fact-106" name="fact:InvestmentsHeldInTrustAccountNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c106" id="hidden-fact-107" name="fact:WarrantLiabilitiesPublicWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c104" id="hidden-fact-108" name="fact:WarrantLiabilitiesPrivateWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c105" id="hidden-fact-109" name="fact:WarrantLiabilitiesPrivateWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c104" id="hidden-fact-110" name="fact:ConvertibleNoteAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c105" id="hidden-fact-111" name="fact:ConvertibleNoteAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c104" id="hidden-fact-112" name="fact:ConvertibleNoteone" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c105" id="hidden-fact-113" name="fact:ConvertibleNoteone" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c104" id="hidden-fact-114" name="fact:ConvertibleNotesTwo" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c105" id="hidden-fact-115" name="fact:ConvertibleNotesTwo" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c110" id="hidden-fact-116" name="fact:InvestmentsHeldInTrustAccountUSMoneyMarketFund" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c111" id="hidden-fact-117" name="fact:InvestmentsHeldInTrustAccountUSMoneyMarketFund" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c110" id="hidden-fact-118" name="fact:InvestmentsHeldInTrustAccountUSTreasureSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c111" id="hidden-fact-119" name="fact:InvestmentsHeldInTrustAccountUSTreasureSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c110" id="hidden-fact-120" name="fact:InvestmentsHeldInTrustAccountNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c111" id="hidden-fact-121" name="fact:InvestmentsHeldInTrustAccountNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c110" id="hidden-fact-122" name="fact:WarrantLiabilitiesPublicWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c111" id="hidden-fact-123" name="fact:WarrantLiabilitiesPublicWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c109" id="hidden-fact-124" name="fact:WarrantLiabilitiesPrivateWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c110" id="hidden-fact-125" name="fact:WarrantLiabilitiesPrivateWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c113" id="hidden-fact-126" name="fact:TotalWarrantLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c120" id="hidden-fact-127" name="us-gaap:FairValueNetAssetLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c121" id="hidden-fact-128" name="us-gaap:FairValueNetAssetLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c122" id="hidden-fact-129" name="us-gaap:FairValueNetAssetLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c127" id="hidden-fact-130" name="us-gaap:FairValueNetAssetLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c130" id="hidden-fact-131" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c133" id="hidden-fact-132" name="us-gaap:FairValueNetAssetLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c135" id="hidden-fact-133" name="us-gaap:FairValueNetAssetLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c136" id="hidden-fact-134" name="us-gaap:FairValueNetAssetLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c137" id="hidden-fact-135" name="us-gaap:FairValueNetAssetLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c138" id="hidden-fact-136" name="fact:FairValueAssetsLevel1ToLevel2TransferAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-137" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c127" id="hidden-fact-138" name="us-gaap:FairValueNetAssetLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0001838987</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="fact-20221231.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources><xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-03-02</xbrli:startDate>
    <xbrli:endDate>2021-03-02</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-03-02</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-03-02</xbrli:startDate>
    <xbrli:endDate>2021-03-02</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-01</xbrli:startDate>
    <xbrli:endDate>2022-08-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZTEDkh6awj/BIIReKzb4sGTz1n4Qtz6doLW75LUrO5BZN95BNU5gyy58yAPWsdJIHcPZx1o6NM2CjhVzEFw7kOzrV8JjqYIRJQ4gEvu2u5sh+julvljtKtVlqFYmOCh9+g/cfz7LLZtgz2FLPFuCP/fwdCLWDj3vDJhSjrrMe+hNfAR6gadd95D99SFm84TXw4CoXgLsK04C+UgCJBlRkUi4O6r5HKCZ/Dfl/uU34KDA==] CSR-->
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fact:FounderSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-12-23</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fact:FounderSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-12-23</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-02-25</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fact:BusinessCombinationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-05-16</xbrli:startDate>
    <xbrli:endDate>2022-05-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-03-17</xbrli:startDate>
    <xbrli:endDate>2022-04-02</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-06-01</xbrli:startDate>
    <xbrli:endDate>2022-06-06</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-12-14</xbrli:startDate>
    <xbrli:endDate>2022-12-14</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-02-01</xbrli:startDate>
    <xbrli:endDate>2023-02-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-03-02</xbrli:startDate>
    <xbrli:endDate>2021-03-02</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fact:BusinessCombinationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c126">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c127">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c128">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c129">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c130">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c131">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c132">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c133">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c134">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c135">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c136">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c137">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c138">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c139">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c140">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c141">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-02-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c142">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-02-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c143">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-02-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c144">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-02-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c145">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-02-28</xbrli:startDate>
    <xbrli:endDate>2023-02-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c146">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-02</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c147">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-02-25</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c148">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838987</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fact:BusinessCombinationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-02-28</xbrli:startDate>
    <xbrli:endDate>2023-02-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>f10k2022ex4-1_freedomacq1.htm
<DESCRIPTION>DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 4.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Description of Securities Registered Pursuant
to Section 12 of the Securities Exchange Act of 1934, As Amended</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following description sets forth certain material
terms and provisions of the securities of Freedom Acquisition I Corp. (&ldquo;Freedom,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; or &ldquo;our&rdquo;)
that are registered under Section 12 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). The following
description of our securities is not complete and may not contain all the information you should consider before investing in our securities.
This description is summarized from, and qualified in its entirety by reference to, our amended and restated memorandum and articles of
association and our warrant agreement, which are incorporated herein by reference. The summary below is also qualified by reference to
the Companies Act and the common law of the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022, we had three classes
of securities registered under the Exchange Act: our Class A ordinary shares, $0.0001 par value per share (&ldquo;public shares&rdquo;)&#894;
warrants to purchase shares of our Class A ordinary shares&#894; and units consisting of one Class A ordinary share and one-fourth of
one redeemable warrant to purchase one Class A ordinary share. In addition, this Description of Securities also contains a description
of our Class B ordinary shares, par value $0.0001 per share (&ldquo;founder shares&rdquo;), which are not registered pursuant to Section
12 of the Exchange Act but are convertible into shares of the Class A ordinary shares. The description of the founder shares is necessary
to understand the material terms of the Class A ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Units</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Public Units</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each unit consists of one Class A ordinary share
and one-fourth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price
of $11.50 per share. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of the company&rsquo;s
Class A ordinary shares. This means only a whole warrant may be exercised at any given time by a warrant holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Class A ordinary shares and warrants began
separate trading on April 19, 2021 and holders have the option to continue to hold units or separate their units into the component securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Ordinary Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Ordinary shareholders of record are entitled to
one vote for each share held on all matters to be voted on by shareholders. Holders of Class A ordinary shares and holders of Class B
ordinary shares will vote together as a single class on all matters submitted to a vote of our shareholders except as required by law&#894;
provided that only holders of Class B ordinary shares will have the right to appoint and remove directors in any general meeting held
prior to or in connection with the completion of our initial business combination, meaning that holders of Class A ordinary shares will
not have the right to appoint and remove any directors until after the completion of our initial business combination. Unless specified
in our amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies Act or applicable
stock exchange rules, the affirmative vote of a majority of our ordinary shares that are voted is required to approve any such matter
voted on by our shareholders. Approval of certain actions will require a special resolution under Cayman Islands law, which requires the
affirmative vote of a majority of at least two-thirds of the shareholders who attend and vote at a general meeting of the company, and
pursuant to our amended and restated memorandum and articles of association&#894; such actions include amending our amended and restated
memorandum and articles of association and approving a statutory merger or consolidation with another company. Our board of directors
is divided into three classes, each of which will generally serve for a term of three years with only one class of directors being appointed
in each year. There is no cumulative voting with respect to the appointment of directors, with the result that the holders of more than
50% of the Class B ordinary shares voted for the appointment of directors can appoint all of the directors prior to our initial business
combination. Our shareholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds
legally available therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Because our amended and restated memorandum and
articles of association authorize the issuance of up to 200,000,000 Class A ordinary shares, if we were to enter into a business combination,
we may (depending on the terms of such a business combination) be required to increase the number of Class A ordinary shares which we
are authorized to issue at the same time as our shareholders vote on the business combination to the extent we seek shareholder approval
in connection with our initial business combination. Our board of directors is divided into three classes with only one class of directors
being appointed in each year and each class (except for those directors appointed prior to our first annual general meeting) serving a
three-year term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In accordance with the NYSE corporate governance
requirements, we are not required to hold an annual general meeting until one year after our first fiscal year end following our listing
on the NYSE. There is no requirement under the Companies Act for us to hold annual or extraordinary general meetings to appoint directors.
We may not hold an annual general meeting prior to the consummation of our initial business combination. We will provide our public shareholders
with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination at a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to
the consummation of our initial business combination, including interest earned on the funds held in the trust account and not previously
released to us to pay our taxes, divided by the number of then outstanding public shares, subject to the limitations and on the conditions
described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per-share amount we will
distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the
underwriters. Our initial shareholders, sponsor, officers and directors have entered into a letter agreement with us, pursuant to which
they have agreed to waive their redemption rights with respect to any founder shares and public shares held by them in connection with
the completion of our initial business combination. Unlike some special purpose acquisition companies that hold shareholder votes and
conduct proxy solicitations in conjunction with their initial business combinations and provide for related redemptions of public shares
for cash upon completion of such initial business combinations even when a vote is not required by law, if a shareholder vote is not required
by law and we do not decide to hold a shareholder vote for business or other reasons, we will, pursuant to our amended and restated memorandum
and articles of association, conduct the redemptions pursuant to the tender offer rules of the SEC, and file tender offer documents with
the SEC prior to completing our initial business combination. Our amended and restated memorandum and articles of association require
these tender offer documents to contain substantially the same financial and other information about our initial business combination
and the redemption rights as is required under the SEC&rsquo;s proxy rules. If, however, a shareholder approval of the transaction is
required by law, or we decide to obtain shareholder approval for business or other reasons, we will, like many special purpose acquisition
companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender
offer rules. If we seek shareholder approval, we will complete our initial business combination only if we receive an ordinary resolution
under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting
of the company. However, the participation of our sponsor, officers, directors, advisors or their affiliates in privately-negotiated transactions,
if any, could result in the approval of our initial business combination even if a majority of our public shareholders vote, or indicate
their intention to vote, against such initial business combination. For purposes of seeking approval of an ordinary resolution, non-votes
will have no effect on the approval of our initial business combination once a quorum is obtained. Our amended and restated memorandum
and articles of association require that at least five days&rsquo; notice will be given of any general meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If we seek shareholder approval of our initial
business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer
rules, our amended and restated memorandum and articles of association provide that a public shareholder, together with any affiliate
of such shareholder or any other person with whom such shareholder is acting in concert or as a &ldquo;group&rdquo; (as defined under
Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the ordinary
shares sold in our initial public offering, which we refer to as the &ldquo;Excess Shares,&rdquo; without our prior consent. However,
we would not be restricting our shareholders&rsquo; ability to vote all of their shares (including Excess Shares) for or against our initial
business combination. Our shareholders&rsquo; inability to redeem the Excess Shares will reduce their influence over our ability to complete
our initial business combination, and such shareholders could suffer a material loss in their investment if they sell such Excess Shares
on the open market. Additionally, such shareholders will not receive redemption distributions with respect to the Excess Shares if we
complete our initial business combination. And, as a result, such shareholders will continue to hold that number of shares exceeding 15%
and, in order to dispose such shares would be required to sell their shares in open market transactions, potentially at a loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If we seek shareholder approval in connection
with our initial business combination, our initial shareholders, sponsor, officers and directors have agreed to vote any founder shares
and public shares held by them in favor of our initial business combination. As a result, in addition to our initial shareholders&rsquo;
founder shares, we would need 1,309,249, or 11.6%, of the 11,243,496 public shares to be voted in favor of an initial business combination
in order to have our initial business combination approved (assuming all outstanding shares are voted). Additionally, each public shareholder
may elect to redeem their public shares without voting and, if they do vote, irrespective of whether they vote for or against the proposed
transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On February 28, 2023, Freedom held an extraordinary
general meeting of shareholders (the &ldquo;Extraordinary General Meeting&rdquo;), at which holders of 35,373,848 ordinary shares, comprised
of 26,773,848 Class&nbsp;A ordinary shares and 8,600,000 Class&nbsp;B ordinary shares, were present in person or by proxy, representing
approximately 82.02% of the voting power of the 43,125,000 issued and outstanding ordinary shares of Freedom entitled to vote at the Extraordinary
General Meeting at the close of business on January 23, 2023, which was the record date (the &ldquo;Record Date&rdquo;) for the Extraordinary
General Meeting (such shares, the &ldquo;Outstanding Shares&rdquo;). The Outstanding Shares on the Record Date were comprised of 34,500,000
Class A ordinary shares and 8,625,000 Class B ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At the Extraordinary General Meeting, the shareholders
approved, by special resolution, the proposal (the &ldquo;Extension Amendment Proposal&rdquo;) to amend our amended and restated memorandum
and articles of association to extend the date by which Freedom must (i) consummate a merger, amalgamation, share exchange, asset acquisition,
share purchase, reorganization or similar business combination, which Freedom refers to as its initial business combination, (ii) cease
its operations except for the purpose of winding up if it fails to complete such initial business combination, and (iii) redeem all of
the Class A ordinary shares, included as part of the units sold in the initial public offering, for an additional three months, from March
2, 2023 to June 2, 2023, and thereafter to up to three (3) times by an additional one month each time (or up to September 2, 2023) (the
&ldquo;Extension Amendment,&rdquo; and such period, as may be extended, the &ldquo;Extension Period&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In connection with the Extension Amendment, shareholders
elected to redeem an aggregate of 23,256,504 Class A ordinary shares. Following such redemptions, 11,243,496 Class A ordinary shares remain
outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If we have not completed our initial business
combination during the Extension Period, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably
possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the
aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (less taxes payable
and up to $100,000 of interest income to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption
will completely extinguish public shareholders&rsquo; rights as shareholders (including the right to receive further liquidation distributions,
if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders
and our board of directors, liquidate and dissolve, subject, in each case, to our obligations under Cayman Islands law to provide for
claims of creditors and in all cases subject to the other requirements of applicable law. Our initial shareholders, sponsor, officers
and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their rights to liquidating distributions
from the trust account with respect to any founder shares held by them if we fail to complete our initial business combination during
the Extension Period. However, if our sponsor or management team acquire public shares after our initial public offering, they will be
entitled to liquidating distributions from the trust account with respect to such public shares if we fail to complete our initial business
combination within the prescribed time period. In the event of a liquidation, dissolution or winding up of the company after a business
combination, our shareholders are entitled to share ratably in all assets remaining available for distribution to them after payment of
liabilities and after provision is made for each class of shares, if any, having preference over the ordinary shares. Our shareholders
have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the ordinary shares, except that we
will provide our public shareholders with the opportunity to redeem their public shares for cash at a per-share price equal to the aggregate
amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released
to us to pay our taxes, divided by the number of then outstanding public shares, upon the completion of our initial business combination,
subject to the limitations and on the conditions described herein.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Founder Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The founder shares are designated as Class B ordinary
shares and, except as described below, are identical to the Class A ordinary shares included in the units sold in our initial public offering,
and holders of founder shares have the same shareholder rights as public shareholders, except that (i) the founder shares are subject
to certain transfer restrictions, as described in more detail below, (ii) the founder shares are entitled to registration rights&#894;
(iii) our initial shareholders, sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have
agreed to (A) waive their redemption rights with respect to any founder shares and public shares held by them in connection with the completion
of our initial business combination, (B) waive their redemption rights with respect to any founder shares and public shares held by them
in connection with a shareholder vote to amend our amended and restated memorandum and articles of association (x) to modify the substance
or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public shares
if we have not consummated an initial business combination during the Extension Period or (y) with respect to any other material provisions
relating to shareholders&rsquo; rights or pre-initial business combination activity, (C) waive their rights to liquidating distributions
from the trust account with respect to any founder shares held by them if we fail to complete our initial business combination during
the Extension Period, although they will be entitled to liquidating distributions from the trust account with respect to any public shares
they hold if we fail to complete our initial business combination within such time period and (D) vote any founder shares and public shares
held by them in favor of our initial business combination, (iv) the founder shares are automatically convertible into Class A ordinary
shares concurrently with or immediately following the consummation of our initial business combination on a one-for-one basis, subject
to adjustment as described herein and in our amended and restated memorandum and articles of association, and (v) only holders of Class
B ordinary shares will have the right to appoint or remove directors in any general meeting held prior to or in connection with the completion
of our initial business combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The founder shares will automatically convert
into Class A ordinary shares concurrently with or immediately following the consummation of our initial business combination on a one-for-one
basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject
to further adjustment as provided herein. In the case that additional Class A ordinary shares or equity- linked securities are issued
or deemed issued in connection with our initial business combination, the number of Class A ordinary shares issuable upon conversion of
all founder shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion
(after giving effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary
shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities issued or deemed issued, by the
Company in connection with the consummation of the initial business combination, excluding any Class A ordinary shares or equity-linked
securities exercisable for or convertible into Class A ordinary shares issued, deemed issued or to be issued, to any seller in the initial
business combination and any private placement warrants issued to our sponsor, officers or directors upon conversion of working capital
loans&#894; provided that such conversion of founder shares will never occur on a less than one-for-one basis. The term &ldquo;equity-linked
securities&rdquo; refers to any debt or equity securities that are convertible, exercisable or exchangeable for our Class A ordinary shares
issued in a financing transaction in connection with our initial business combination, including but not limited to a private placement
of equity or debt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">With certain limited exceptions, the founder shares
are not transferable, assignable or salable (except to our officers and directors and other persons or entities affiliated with our sponsor,
each of whom will be subject to the same transfer restrictions) until the earlier of (A) one year after the completion of our initial
business combination or earlier if, subsequent to our initial business combination, the last reported sales price of the Class A ordinary
shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination,
and (B) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange
or other similar transaction that results in all of our shareholders having the right to exchange their Class A ordinary shares for cash,
securities or other property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Register of Members</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under Cayman Islands law, we must keep a register
of members and there will be entered therein:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">the names and addresses of the members, a statement of the
shares held by each member, and of the amount paid or agreed to be considered as paid, on the shares of each member and the voting rights
of shares of each member&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">the date on which the name of any person was entered on the
register as a member&#894; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">the date on which any person ceased to be a member.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under Cayman Islands law, the register of members
of our company is prima facie evidence of the matters set out therein (i.e., the register of members will raise a presumption of fact
on the matters referred to above unless rebutted) and a member registered in the register of members will be deemed as a matter of Cayman
Islands law to have legal title to the shares as set against its name in the register of members. The shareholders recorded in the register
of members will be deemed to have legal title to the shares set against their name. However, there are certain limited circumstances where
an application may be made to a Cayman Islands court for a determination on whether the register of members reflects the correct legal
position. Further, the Cayman Islands court has the power to order that the register of members maintained by a company should be rectified
where it considers that the register of members does not reflect the correct legal position. If an application for an order for rectification
of the register of members were made in respect of our ordinary shares, then the validity of such shares may be subject to re-examination
by a Cayman Islands court.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Preferred Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our amended and restated memorandum and articles
of association authorize 1,000,000 preferred shares and provide that preferred shares may be issued from time to time in one or more series.
Our board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating,
optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series.
Our board of directors will be able to, without shareholder approval, issue preferred shares with voting and other rights that could adversely
affect the voting power and other rights of the holders of the ordinary shares and could have anti-takeover effects. The ability of our
board of directors to issue preferred shares without shareholder approval could have the effect of delaying, deferring or preventing a
change of control of us or the removal of existing management. We have no preferred shares outstanding at the date hereof. Although we
do not currently intend to issue any preferred shares, we cannot assure you that we will not do so in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Warrants</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Public Shareholders&rsquo; Warrants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each whole warrant entitles the registered holder
to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing
on the later of one year from the closing of our initial public offering and 30 days after the completion of our initial business combination,
except as described below. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of Class
A ordinary shares. This means only a whole warrant may be exercised at a given time by a warrant holder. No fractional warrants will be
issued upon separation of the units and only whole warrants will trade. Accordingly, unless you purchase at least four units, you will
not be able to receive or trade a whole warrant. The warrants will expire five years after the completion of our initial business combination,
at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We will not be obligated to deliver any Class
A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration
statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a current
prospectus relating thereto is available (or we permit holders to exercise their warrants on a cashless basis under the circumstances
specified in the warrant agreement). No warrant will be exercisable and we will not be obligated to issue a Class A ordinary share upon
exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to
be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions
in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled
to exercise such warrant and such warrant may have no value and expire worthless. In no event will we be required to net cash settle any
warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such
warrant will have paid the full purchase price for the unit solely for the Class A ordinary share underlying such unit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have agreed that as soon as practicable, but
in no event later than fifteen (15) business days after the closing of our initial business combination, we will use our commercially
reasonable efforts to file with the SEC a registration statement covering the issuance, under the Securities Act, of the Class A ordinary
shares issuable upon exercise of the warrants. We will use our commercially reasonable efforts to cause the same to become effective within
60 business days following our initial business combination and to maintain the effectiveness of such registration statement, and a current
prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement.
If a registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is not effective
by the sixtieth (60th) business day after the closing of our initial business combination, warrant holders may, until such time as there
is an effective registration statement and during any period when we will have failed to maintain an effective registration statement,
exercise warrants on a &ldquo;cashless basis&rdquo; in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding
the above, if our Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such
that they satisfy the definition of a &ldquo;covered security&rdquo; under Section 18(b)(1) of the Securities Act, we may, at our option,
require holders of public warrants who exercise their warrants to do so on a &ldquo;cashless basis&rdquo; in accordance with Section 3(a)(9)
of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, and
in the event we do not so elect, we will use our commercially reasonable efforts to register or qualify the shares under applicable blue
sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering each such
warrant for that number of Class A ordinary shares equal to the lesser of (A) the quotient obtained by dividing (x) the product of the
number of Class A ordinary shares underlying the warrants, multiplied by the excess of the &ldquo;fair market value&rdquo; (as defined
below) less the exercise price of the warrants by (y) the fair market value and (B) 0.361 Class A ordinary shares per warrant (subject
to adjustment). The &ldquo;fair market value&rdquo; as used above shall mean the volume weighted average price of the Class A ordinary
shares for the 10 trading days ending on the trading day prior to the date on which the notice of exercise is received by the warrant
agent.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Redemption of Warrants When the Price per Class A
Ordinary Share Equals or Exceeds $18.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Once the warrants become exercisable, we may redeem
the outstanding warrants (except as described herein with respect to the private placement warrants):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">in whole and not in part&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">at a price of $0.01 per warrant&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">upon not less than 30 days&rsquo; prior written notice of
redemption (the &ldquo;30-day redemption period&rdquo;) to each warrant holder&#894; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">if, and only if, the last reported sale price of the Class
A ordinary shares for any 20 trading days within a 30-trading day period ending three business days before we send the notice of redemption
to the warrant holders (which we refer to as the &ldquo;Reference Value&rdquo;) equals or exceeds $18.00 per share (as adjusted for share
sub-divisions, share capitalizations, reorganizations, recapitalizations and the like and as described under the heading &ldquo;&mdash;Anti-dilution
Adjustments&rdquo; below).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If and when the warrants become redeemable by
us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable
state securities laws. However, we will not redeem the warrants unless an effective registration statement under the Securities Act covering
the issuance of the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those
Class A ordinary shares is available throughout the 30-day redemption period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have established the last of the redemption
criteria discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise
price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled
to exercise his, her or its warrant prior to the scheduled redemption date. Any such exercise would not be done on a &ldquo;cashless&rdquo;
basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised. However, the price of
the Class A ordinary shares may fall below the $18.00 redemption trigger price (as adjusted for share sub-divisions, share capitalizations,
reorganizations, recapitalizations and the like and as described under the heading &ldquo;&mdash;Anti-dilution Adjustments&rdquo; below)
as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Redemption of Warrants When the Price per Class A
Ordinary Share Equals or Exceeds $10.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Once the warrants become exercisable, we may redeem
the outstanding warrants:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">in whole and not in part&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">at $0.10 per warrant upon a minimum of 30 days&rsquo; prior
written notice of redemption&#894; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption
and receive that number of shares determined by reference to the table below, based on the redemption date and the &ldquo;fair market
value&rdquo; of our Class A ordinary shares (as defined below)&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">if, and only if, the Reference Value (as defined above under
&ldquo;&mdash;Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00&rdquo;) equals or exceeds $10.00
per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like and as described
under the heading &ldquo;&mdash;Anti-dilution Adjustments&rdquo; below)&#894; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">if the Reference Value is less than $18.00 per share (as
adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like and as described under the heading
&ldquo;&mdash;Anti-dilution Adjustments&rdquo; below) the private placement warrants must also be concurrently called for redemption
on the same terms as the outstanding public warrants, as described above.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The numbers in the table below represent the number
of Class A ordinary shares that a warrant holder will receive upon such cashless exercise in connection with a redemption by us pursuant
to this redemption feature, based on the &ldquo;fair market value&rdquo; of our Class A ordinary shares on the corresponding redemption
date (assuming holders elect to exercise their warrants and such warrants are not redeemed for $0.10 per warrant), determined for these
purposes based on volume-weighted average price of our Class A ordinary shares during the 10 trading days immediately following the date
on which the notice of redemption is sent to the holders of warrants, and the number of months that the corresponding redemption date
precedes the expiration date of the warrants, each as set forth in the table below. We will provide our warrant holders with the final
fair market value no later than one business day after the 10-trading day period described above ends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the warrant agreement, references
above to Class A ordinary shares shall include a security other than Class A ordinary shares into which the Class A ordinary shares have
been converted or exchanged for in the event we are not the surviving company in our initial business combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The numbers in the table below will not be adjusted
when determining the number of Class A ordinary shares to be issued upon exercise of the warrants if we are not the surviving entity following
our initial business combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The share prices set forth in the column headings
of the table below will be adjusted as of any date on which the number of shares issuable upon exercise of a warrant or the exercise price
of the warrant is adjusted as set forth under the heading &ldquo;&mdash;Anti-dilution Adjustments&rdquo; below. If the number of shares
issuable upon exercise of a warrant is adjusted, the adjusted share prices in the column headings will equal the share prices immediately
prior to such adjustment, multiplied by a fraction, the numerator of which is the exercise price of the warrant after such adjustment
and the denominator of which is the price of the warrant immediately prior to such adjustment. In such an event, the number of shares
in the table below shall be adjusted by multiplying such share amounts by a fraction, the numerator of which is the number of shares deliverable
upon exercise of a warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon
exercise of a warrant as so adjusted. If the exercise price of the warrant is adjusted as a result of the fifth paragraph under the heading
&ldquo;&mdash;Anti-dilution adjustments&rdquo; below, the adjusted share prices in the column headings will be multiplied by a fraction,
the numerator of which is the higher of the Market Value and the Newly Issued Price as set forth under the heading &ldquo;&mdash;Anti-dilution
Adjustments&rdquo; and the denominator of which is $10.00.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="34" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">Fair
    Market Value of Class A Ordinary Shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">Redemption Date (period
    to expiration of warrants)</FONT></TD><TD STYLE="white-space: nowrap; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">&le;$10.00</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">$11.00</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">$12.00</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">$13.00</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">$14.00</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">$15.00</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">$16.00</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">$17.00</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 9pt">&ge;$18.00</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 37%"><FONT STYLE="font-size: 9pt">60 months</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-size: 9pt">0.261</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-size: 9pt">0.281</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-size: 9pt">0.297</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-size: 9pt">0.311</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-size: 9pt">0.324</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-size: 9pt">0.337</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-size: 9pt">0.348</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-size: 9pt">0.358</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 9pt">57 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.257</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.277</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.294</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.310</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.324</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.337</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.348</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.358</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">54 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.252</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.272</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.291</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.307</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.322</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.335</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.347</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.357</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 9pt">51 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.246</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.268</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.287</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.304</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.320</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.333</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.346</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.357</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">48 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.241</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.263</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.283</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.301</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.317</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.332</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.344</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.356</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 9pt">45 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.235</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.258</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.279</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.298</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.315</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.330</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.343</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.356</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">42 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.228</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.252</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.274</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.294</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.312</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.328</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.342</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.355</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 9pt">39 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.221</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.246</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.269</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.290</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.309</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.325</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.340</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.354</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">36 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.213</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.239</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.263</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.285</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.305</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.323</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.339</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.353</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 9pt">33 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.205</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.232</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.257</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.280</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.301</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.320</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.337</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.352</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">30 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.196</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.224</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.250</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.274</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.297</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.316</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.335</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.351</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 9pt">27 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.185</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.214</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.242</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.268</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.291</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.313</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.332</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.350</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">24 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.173</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.204</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.233</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.260</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.285</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.308</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.329</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.348</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 9pt">21 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.161</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.193</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.223</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.252</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.279</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.304</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.326</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.347</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">18 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.146</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.179</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.211</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.242</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.271</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.298</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.322</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.345</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 9pt">15 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.130</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.164</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.197</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.230</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.262</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.291</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.317</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.342</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">12 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.111</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.146</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.181</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.216</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.250</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.282</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.312</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.339</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 9pt">9 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.090</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.125</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.162</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.199</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.237</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.272</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.305</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.336</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">6 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.065</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.099</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.137</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.178</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.219</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.259</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.296</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.331</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 9pt">3 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.034</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.065</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.104</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.150</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.197</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.243</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.286</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.326</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 9pt">0 months</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">&mdash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.042</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.115</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.179</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.233</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.281</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.323</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9pt">0.361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The exact fair market value and redemption date
may not be set forth in the table above, in which case, if the fair market value is between two values in the table or the redemption
date is between two redemption dates in the table, the number of Class A ordinary shares to be issued for each warrant exercised will
be determined by a straight-line interpolation between the number of shares set forth for the higher and lower fair market values and
the earlier and later redemption dates, as applicable, based on a 365 or 366-day year, as applicable. For example, if the volume-weighted
average price of our Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption
is sent to the holders of the warrants is $11.00 per share, and at such time there are 57 months until the expiration of the warrants,
holders may choose to, in connection with this redemption feature, exercise their warrants for 0.277 Class A ordinary shares for each
whole warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For an example where the exact fair market value
and redemption date are not as set forth in the table above, if the volume-weighted average price of our Class A ordinary shares during
the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of the warrants is $13.50
per share, and at such time there are 38 months until the expiration of the warrants, holders may choose to, in connection with this redemption
feature, exercise their warrants for 0.298 Class A ordinary shares for each whole warrant. In no event will the warrants be exercisable
in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This redemption feature is structured to allow
for all of the outstanding warrants to be redeemed when the Class A ordinary shares are trading at or above $10.00 per share, which may
be at a time when the trading price of our Class A ordinary shares is below the exercise price of the warrants. We have established this
redemption feature to provide us with the flexibility to redeem the warrants without the warrants having to reach the $18.00 per share
threshold set forth above under &ldquo;&mdash;Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00.&rdquo;
Holders choosing to exercise their warrants in connection with a redemption pursuant to this feature will, in effect, receive a number
of shares for their warrants based on an option pricing model with a fixed volatility input as of the date of our initial public offering.
This redemption right provides us with an additional mechanism by which to redeem all of the outstanding warrants, and therefore have
certainty as to our capital structure as the warrants would no longer be outstanding and would have been exercised or redeemed. We will
be required to pay the applicable redemption price to warrant holders if we choose to exercise this redemption right and it will allow
us to quickly proceed with a redemption of the warrants if we determine it is in our best interest to do so. As such, we would redeem
the warrants in this manner when we believe it is in our best interest to update our capital structure to remove the warrants and pay
the redemption price to the warrant holders. As stated above, we can redeem the warrants when the Class A ordinary shares are trading
at a price starting at $10.00, which is below the exercise price of $11.50, because it will provide certainty with respect to our capital
structure and cash position while providing warrant holders with the opportunity to exercise their warrants on a cashless basis for the
applicable number of shares. If we choose to redeem the warrants when the Class A ordinary shares are trading at a price below the exercise
price of the warrants, this could result in the warrant holders receiving fewer Class A ordinary shares than they would have received
if they had chosen to wait to exercise their warrants for Class A ordinary shares if and when such Class A ordinary shares were trading
at a price higher than the exercise price of $11.50.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">No fractional Class A ordinary shares will be
issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, we will round down to
the nearest whole number of the number of Class A ordinary shares to be issued to the holder. If, at the time of redemption, the warrants
are exercisable for a security other than the Class A ordinary shares pursuant to the warrant agreement (for instance, if we are not the
surviving company in our initial business combination), the warrants may be exercised for such security. At such time as the warrants
become exercisable for a security other than the Class A ordinary shares, the Company (or surviving company) will use its commercially
reasonable efforts to register under the Securities Act the security issuable upon the exercise of the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Redemption Procedures</I>. A holder of a warrant
may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such
warrant, to the extent that after giving effect to such exercise, such person (together with such person&rsquo;s affiliates), to the warrant
agent&rsquo;s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (as specified by the holder) of the Class A ordinary
shares outstanding immediately after giving effect to such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I></I></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Anti-dilution Adjustments</I>. If the number
of outstanding Class A ordinary shares is increased by a share capitalization payable in Class A ordinary shares, or by a split-up of
ordinary shares or other similar event, then, on the effective date of such share capitalization, split-up or similar event, the number
of Class A ordinary shares issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding ordinary
shares. A rights offering to holders of ordinary shares entitling holders to purchase Class A ordinary shares at a price less than the
&ldquo;historical fair market value&rdquo; (as defined below) will be deemed a share capitalization of a number of Class A ordinary shares
equal to the product of (i) the number of Class A ordinary shares actually sold in such rights offering (or issuable under any other equity
securities sold in such rights offering that are convertible into or exercisable for Class A ordinary shares) and (ii) one minus the quotient
of (x) the price per Class A ordinary share paid in such rights offering and (y) the historical fair market value. For these purposes
(i) if the rights offering is for securities convertible into or exercisable for Class A ordinary shares, in determining the price payable
for Class A ordinary shares, there will be taken into account any consideration received for such rights, as well as any additional amount
payable upon exercise or conversion and (ii) &ldquo;historical fair market value&rdquo; means the volume weighted average price of Class
A ordinary shares as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the Class
A ordinary shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, if we, at any time while the warrants
are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to the holders of Class A ordinary
shares on account of such Class A ordinary shares (or other securities into which the warrants are convertible), other than (a) as described
above, (b) any cash dividends or cash distributions which, when combined on a per share basis with all other cash dividends and cash distributions
paid on the Class A ordinary shares during the 365-day period ending on the date of declaration of such dividend or distribution does
not exceed $0.50 (as adjusted for share sub-divisions, share dividends, rights issuances, consolidations, reorganizations, recapitalizations
and other similar transactions) but only with respect to the amount of the aggregate cash dividends or cash distributions equal to or
less than $0.50 per share, (c) to satisfy the redemption rights of the holders of Class A ordinary shares in connection with a proposed
initial business combination or certain amendments to our amended and restated memorandum and articles of association, or (d) in connection
with the redemption of our public shares upon our failure to complete our initial business combination, then the warrant exercise price
will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of
any securities or other assets paid on each Class A ordinary share in respect of such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the number of outstanding Class A ordinary
shares is decreased by a consolidation, combination, reverse share split or reclassification of Class A ordinary shares or other similar
event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event, the number
of Class A ordinary shares issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding Class
A ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Whenever the number of Class A ordinary shares
purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying
the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of Class A
ordinary shares purchasable upon the exercise of the warrants immediately prior to such adjustment, and (y) the denominator of which will
be the number of Class A ordinary shares so purchasable immediately thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, if (x) we issue additional Class
A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination
at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price
to be determined in good faith by our board of directors and, in the case of any such issuance to our initial shareholders or their affiliates,
without taking into account any founder shares held by our initial shareholders or such affiliates, as applicable, prior to such issuance)
(the &ldquo;Newly Issued Price&rdquo;), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity
proceeds, and interest thereon, available for the funding of our initial business combination (net of redemptions), and (z) the volume-weighted
average trading price of our Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on
which we consummate our initial business combination (such price, the &ldquo;Market Value&rdquo;) is below $9.20 per share, then the exercise
price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued
Price, and the $10.00 and $18.00 per share redemption trigger prices described above under &ldquo;&mdash;Redemption of warrants when the
price per Class A ordinary share equals or exceeds $10.00&rdquo; and &ldquo;&mdash; Redemption of warrants when the price per Class A
ordinary share equals or exceeds $18.00&rdquo; will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the
Market Value and the Newly Issued Price, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In case of any reclassification or reorganization
of the outstanding Class A ordinary shares (other than those described above or that solely affects the par value of such Class A ordinary
shares), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in
which we are the continuing corporation and that does not result in any reclassification or reorganization of our issued and outstanding
Class A ordinary shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of
us as an entirety or substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter
have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the
Class A ordinary shares immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind
and amount of Class A ordinary shares or other securities or property (including cash) receivable upon such reclassification, reorganization,
merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received
if such holder had exercised their warrants immediately prior to such event. However, if such holders were entitled to exercise a right
of election as to the kind or amount of securities, cash or other assets receivable upon such merger or consolidation, then the kind and
amount of securities, cash or other assets for which each warrant will become exercisable will be deemed to be the weighted average of
the kind and amount received per share by such holders in such merger or consolidation that affirmatively make such election, and if a
tender, exchange or redemption offer has been made to and accepted by such holders (other than a tender, exchange or redemption offer
made by the company in connection with redemption rights held by shareholders of the company as provided for in the company&rsquo;s amended
and restated memorandum and articles of association or as a result of the redemption of Class A ordinary shares by the company if a proposed
initial business combination is presented to the shareholders of the company for approval) under circumstances in which, upon completion
of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under
the Exchange Act) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule
12b-2 under the Exchange Act) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within
the meaning of Rule 13d-3 under the Exchange Act) more than 50% of the issued and outstanding Class A ordinary shares, the holder of a
warrant will be entitled to receive the highest amount of cash, securities or other property to which such holder would actually have
been entitled as a shareholder if such warrant holder had exercised the warrant prior to the expiration of such tender or exchange offer,
accepted such offer and all of the Class A ordinary shares held by such holder had been purchased pursuant to such tender or exchange
offer, subject to adjustment (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the
adjustments provided for in the warrant agreement. Additionally, if less than 70% of the consideration receivable by the holders of Class
A ordinary shares in such a transaction is payable in the form of Class A ordinary shares in the successor entity that is listed for trading
on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted
immediately following such event, and if the registered holder of the warrant properly exercises the warrant within thirty days following
public disclosure of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement based on the Black-Scholes
Warrant Value (as defined in the warrant agreement) of the warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The purpose of such exercise price reduction is
to provide additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of the warrants
pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The warrants are issued in registered form under
a warrant agreement between Continental Stock Transfer &amp; Trust Company, as warrant agent, and us. The warrant agreement provides that
the terms of the warrants may be amended without the consent of any holder for the purpose of curing any ambiguity, or curing, correcting
or supplementing any defective provision contained in the warrant agreement or adding or changing any other provisions with respect to
matters or questions arising under such agreement as the warrant agent and us may deem necessary or desirable and that the warrant agent
and us deem shall not adversely affect the interest of the holders, but requires the approval by the holders of at least 65% of the then
outstanding public warrants to make any change that adversely affects the interests of the registered holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The warrant holders do not have the rights or
privileges of holders of ordinary shares and any voting rights until they exercise their warrants and receive Class A ordinary shares.
After the issuance of Class A ordinary shares upon exercise of the warrants, each holder will be entitled to one vote for each share held
of record on all matters to be voted on by shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">No fractional warrants will be issued upon separation
of the units and only whole warrants will trade. No fractional shares will be issued upon exercise of the warrants. If, upon exercise
of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest
whole number, the number of Class A ordinary shares to be issued to the warrant holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Exclusive Forum Provision</I>. Our warrant
agreement provides that, subject to applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way
to the warrant agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or the
United States District Court for the Southern District of New York, and (ii) that we irrevocably submit to such jurisdiction, which jurisdiction
will be the exclusive forum for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that
such courts represent an inconvenient forum. This provision does not apply to claims under the Exchange Act or any claim for which the
federal district courts of the United States of America are the sole and exclusive forum.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Private Placement Warrants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The private placement warrants (including the
Class A ordinary shares issuable upon exercise of such warrants) will not be transferable, assignable or salable until 30 days after the
completion of our initial business combination (except, as described under &ldquo;Principal Shareholders&mdash;Transfers of Founder Shares
and Private Placement Warrants,&rdquo; including to our officers and directors and other persons or entities affiliated with our sponsor)
and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as described above
under &ldquo;&mdash; Public Shareholders&rsquo; Warrants&mdash;Redemption of Warrants When the Price per Class A Ordinary Share Equals
or Exceeds $18.00&rdquo;). The sponsor or its permitted transferees, have the option to exercise the private placement warrants on a cashless
basis. If the private placement warrants are held by holders other than the sponsor or its permitted transferees, the private placement
warrants will be redeemable by us and exercisable by the holders on the same basis as the warrants included in the units being sold in
our initial public offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Except as described under &ldquo;&mdash;Redemption
of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00,&rdquo; if holders of the private placement warrants elect
to exercise them on a cashless basis, they would pay the exercise price by surrendering his, her or its warrants for that number of Class
A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants,
multiplied by the excess of the &ldquo;historical fair market value&rdquo; of our Class A ordinary shares (defined below) over the exercise
price of the warrants by (y) the historical fair market value. For these purposes, the &ldquo;historical fair market value&rdquo; will
mean the average reported last reported sales price of the Class A ordinary shares for the 10 trading days ending on the third trading
day prior to the date on which the notice of warrant exercise is sent to the warrant agent. The reason that we have agreed that these
warrants will be exercisable on a cashless basis so long as they are held by the sponsor or its permitted transferees is because it is
not known at this time whether they will be affiliated with us following a business combination. If they remain affiliated with us, their
ability to sell our securities in the open market will be significantly limited. We expect to have policies in place that prohibit insiders
from selling our securities except during specific periods of time. Even during such periods of time when insiders will be permitted to
sell our securities, an insider cannot trade in our securities if he or she is in possession of material non-public information. Accordingly,
unlike public shareholders who could exercise their warrants and sell the Class A ordinary shares received upon such exercise freely in
the open market in order to recoup the cost of such exercise, the insiders could be significantly restricted from selling such securities.
As a result, we believe that allowing the holders to exercise such warrants on a cashless basis is appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Except as described above, the private placement
warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in our initial public offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dividends</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have not paid any cash dividends on our ordinary
shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash
dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition
subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our initial business combination
will be within the discretion of our board of directors at such time. If we incur any indebtedness, our ability to declare dividends may
be limited by restrictive covenants we may agree to in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Our Transfer Agent and Warrant Agent</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The transfer agent for our ordinary shares and
warrant agent for our warrants is Continental Stock Transfer &amp; Trust Company. We have agreed to indemnify Continental Stock Transfer
&amp; Trust Company in its roles as transfer agent and warrant agent, its agents and each of its shareholders, directors, officers and
employees against all claims and losses that may arise out of acts performed or omitted for its activities in that capacity, except for
any liability due to any gross negligence or intentional misconduct of the indemnified person or entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Certain Differences in Corporate Law</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Cayman Islands companies are governed by the Companies
Act. The Companies Act is modeled on English Law but does not follow recent English Law statutory enactments, and differs from laws applicable
to United States corporations and their shareholders. Set forth below is a summary of the material differences between the provisions
of the Companies Act applicable to us and the laws applicable to companies incorporated in the United States and their shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Mergers and Similar Arrangements</I>. In certain
circumstances, the Companies Act allows for mergers or consolidations between two Cayman Islands companies, or between a Cayman Islands
exempted company and a company incorporated in another jurisdiction (provided that is facilitated by the laws of that other jurisdiction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Where the merger or consolidation is between two
Cayman Islands companies, the directors of each company must approve a written plan of merger or consolidation containing certain prescribed
information. That plan or merger or consolidation must then be authorized by either (a) a special resolution (usually a majority of 662/3%
in value of the voting shares voted at a general meeting) of the shareholders of each company&#894; or (b) such other authorization, if
any, as may be specified in such constituent company&rsquo;s articles of association. No shareholder resolution is required for a merger
between a parent company (i.e., a company that owns at least 90% of the issued shares of each class in a subsidiary company) and its subsidiary
company. The consent of each holder of a fixed or floating security interest of a constituent company must be obtained, unless the court
waives such requirement. If the Cayman Islands Registrar of Companies is satisfied that the requirements of the Companies Act (which includes
certain other formalities) have been complied with, the Registrar of Companies will register the plan of merger or consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Where the merger or consolidation involves a foreign
company, the procedure is similar, save that with respect to the foreign company, the directors of the Cayman Islands exempted company
are required to make a declaration to the effect that, having made due enquiry, they are of the opinion that the requirements set out
below have been met: (i) that the merger or consolidation is permitted or not prohibited by the constitutional documents of the foreign
company and by the laws of the jurisdiction in which the foreign company is incorporated, and that those laws and any requirements of
those constitutional documents have been or will be complied with&#894; (ii) that no petition or other similar proceeding has been filed
and remains outstanding or order made or resolution adopted to wind up or liquidate the foreign company in any jurisdictions&#894; (iii)
that no receiver, trustee, administrator or other similar person has been appointed in any jurisdiction and is acting in respect of the
foreign company, its affairs or its property or any part thereof&#894; (iv) that no scheme, order, compromise or other similar arrangement
has been entered into or made in any jurisdiction whereby the rights of creditors of the foreign company are and continue to be suspended
or restricted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Where the surviving company is the Cayman Islands
exempted company, the directors of the Cayman Islands exempted company are further required to make a declaration to the effect that,
having made due enquiry, they are of the opinion that the requirements set out below have been met: (i) that the foreign company is able
to pay its debts as they fall due and that the merger or consolidated is bona fide and not intended to defraud unsecured creditors of
the foreign company&#894; (ii) that in respect of the transfer of any security interest granted by the foreign company to the surviving
or consolidated company (a) consent or approval to the transfer has been obtained, released or waived&#894; (b) the transfer is permitted
by and has been approved in accordance with the constitutional documents of the foreign company&#894; and (c) the laws of the jurisdiction
of the foreign company with respect to the transfer have been or will be complied with&#894; (iii) that the foreign company will, upon
the merger or consolidation becoming effective, cease to be incorporated, registered or exist under the laws of the relevant foreign jurisdiction&#894;
and (iv) that there is no other reason why it would be against the public interest to permit the merger or consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Where the above procedures are adopted, the Companies
Act provides for a right of dissenting shareholders to be paid a payment of the fair value of his shares upon their dissenting to the
merger or consolidation if they follow a prescribed procedure. In essence, that procedure is as follows (a) the shareholder must give
his written objection to the merger or consolidation to the constituent company before the vote on the merger or consolidation, including
a statement that the shareholder proposes to demand payment for his shares if the merger or consolidation is authorized by the vote&#894;
(b) within 20 days following the date on which the merger or consolidation is approved by the shareholders, the constituent company must
give written notice to each shareholder who made a written objection&#894; (c) a shareholder must within 20 days following receipt of
such notice from the constituent company, give the constituent company a written notice of his intention to dissent including, among other
details, a demand for payment of the fair value of his shares&#894; (d) within seven days following the date of the expiration of the
period set out in paragraph (b) above or seven days following the date on which the plan of merger or consolidation is filed, whichever
is later, the constituent company, the surviving company or the consolidated company must make a written offer to each dissenting shareholder
to purchase his shares at a price that the company determines is the fair value and if the company and the shareholder agree the price
within 30 days following the date on which the offer was made, the company must pay the shareholder such amount&#894; and (e) if the company
and the shareholder fail to agree a price within such 30 day period, within 20 days following the date on which such 30 day period expires,
the company (and any dissenting shareholder) must file a petition with the Cayman Islands Grand Court to determine the fair value and
such petition must be accompanied by a list of the names and addresses of the dissenting shareholders with whom agreements as to the fair
value of their shares have not been reached by the company. At the hearing of that petition, the court has the power to determine the
fair value of the shares together with a fair rate of interest, if any, to be paid by the company upon the amount determined to be the
fair value. Any dissenting shareholder whose name appears on the list filed by the company may participate fully in all proceedings until
the determination of fair value is reached. These rights of a dissenting shareholder are not available in certain circumstances, for example,
to dissenters holding shares of any class in respect of which an open market exists on a recognized stock exchange or recognized interdealer
quotation system at the relevant date or where the consideration for such shares to be contributed are shares of any company listed on
a national securities exchange or shares of the surviving or consolidated company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Moreover, Cayman Islands law has separate statutory
provisions that facilitate the reconstruction or amalgamation of companies in certain circumstances, schemes of arrangement will generally
be more suited for complex mergers or other transactions involving widely held companies, commonly referred to in the Cayman Islands as
a &ldquo;scheme of arrangement&rdquo; which may be tantamount to a merger. In the event that a merger was sought pursuant to a scheme
of arrangement (the procedures for which are more rigorous and take longer to complete than the procedures typically required to consummate
a merger in the United States), the arrangement in question must be approved by a majority in number of each class of shareholders and
creditors with whom the arrangement is to be made and who must in addition represent three-fourths in value of each such class of shareholders
or creditors, as the case may be, that are present and voting either in person or by proxy at a meeting, or meeting summoned for that
purpose. The convening of the meetings and subsequently the terms of the arrangement must be sanctioned by the Grand Court of the Cayman
Islands. While a dissenting shareholder would have the right to express to the court the view that the transaction should not be approved,
the court can be expected to approve the arrangement if it satisfies itself that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">we are not proposing to act illegally or beyond the scope
of our corporate authority and the statutory provisions as to majority vote have been complied with&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">the shareholders have been fairly represented at the meeting
in question&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">the arrangement is such as a businessman would reasonably
approve&#894; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">the arrangement is not one that would more properly be sanctioned
under some other provision of the Companies Act or that would amount to a &ldquo;fraud on the minority.&rdquo;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If a scheme of arrangement or takeover offer (as
described below) is approved, any dissenting shareholder would have no rights comparable to appraisal rights (providing rights to receive
payment in cash for the judicially determined value of the shares), which would otherwise ordinarily be available to dissenting shareholders
of United States corporations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Squeeze-out Provisions</I>. When a takeover
offer is made and accepted by holders of 90% of the shares to whom the offer relates is made within four months, the offeror may, within
a two-month period, require the holders of the remaining shares to transfer such shares on the terms of the offer. An objection can be
made to the Grand Court of the Cayman Islands but this is unlikely to succeed unless there is evidence of fraud, bad faith, collusion
or inequitable treatment of the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Further, transactions similar to a merger, reconstruction
and/or an amalgamation may in some circumstances be achieved through means other than these statutory provisions, such as a share capital
exchange, asset acquisition or control, or through contractual arrangements, of an operating business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Shareholders&rsquo; Suits</I>. Maples and Calder,
our Cayman Islands legal counsel, is not aware of any reported class action having been brought in a Cayman Islands court. Derivative
actions have been brought in the Cayman Islands courts, and the Cayman Islands courts have confirmed the availability for such actions.
In most cases, we will be the proper plaintiff in any claim based on a breach of duty owed to us, and a claim against (for example) our
officers or directors usually may not be brought by a shareholder. However, based both on Cayman Islands authorities and on English authorities,
which would in all likelihood be of persuasive authority and be applied by a court in the Cayman Islands, exceptions to the foregoing
principle apply in circumstances in which:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">a company is acting, or proposing to act, illegally or beyond
the scope of its authority&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">the act complained of, although not beyond the scope of the
authority, could be effected if duly authorized by more than the number of votes which have actually been obtained&#894; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">those who control the company are perpetrating a &ldquo;fraud
on the minority.&rdquo;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A shareholder may have a direct right of action
against us where the individual rights of that shareholder have been infringed or are about to be infringed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Enforcement of Civil Liabilities</I>. The Cayman
Islands has a different body of securities laws as compared to the United States and provides less protection to investors. Additionally,
Cayman Islands companies may not have standing to sue before the Federal courts of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have been advised by Maples and Calder, our
Cayman Islands legal counsel, that the courts of the Cayman Islands are unlikely (i) to recognize or enforce against us judgments of courts
of the United States predicated upon the civil liability provisions of the federal securities laws of the United States or any state&#894;
and (ii) in original actions brought in the Cayman Islands, to impose liabilities against us predicated upon the civil liability provisions
of the federal securities laws of the United States or any state, so far as the liabilities imposed by those provisions are penal in nature.
In those circumstances, although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the
courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without
retrial on the merits based on the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation
to pay the sum for which judgment has been given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman
Islands, such judgment must be final and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty,
inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner,
and or be of a kind the enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands (awards of punitive
or multiple damages may well be held to be contrary to public policy). A Cayman Islands Court may stay enforcement proceedings if concurrent
proceedings are being brought elsewhere.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Special Considerations for Exempted Companies</I>.
We are an exempted company with limited liability under the Companies Act. The Companies Act distinguishes between ordinary resident companies
and exempted companies. Any company that is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands
may apply to be registered as an exempted company. The requirements for an exempted company are essentially the same as for an ordinary
company except for the exemptions and privileges listed below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">an exempted company does not have to file an annual return
of its shareholders with the Registrar of Companies&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">an exempted company&rsquo;s register of members is not open
to inspection&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>an exempted company does not have to hold an annual general meeting&#894;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">an exempted company may issue shares with no par value&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">an exempted company may obtain an undertaking against the
imposition of any future taxation (such undertakings are usually given for 20 years in the first instance)&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">an exempted company may register by way of continuation in
another jurisdiction and be deregistered in the Cayman Islands&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">an exempted company may register as a limited duration company&#894;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">an exempted company may register as a segregated portfolio
company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;Limited liability&rdquo; means that the
liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company (except in exceptional circumstances,
such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances in which
a court may be prepared to pierce or lift the corporate veil).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Our Amended and Restated Memorandum and Articles
of Association</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Business Combination Article of our amended
and restated memorandum and articles of association contains provisions designed to provide certain rights and protections relating to
our initial public offering that will apply to us until the completion of our initial business combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">These provisions cannot be amended without a special
resolution. As a matter of Cayman Islands law, a resolution is deemed to be a special resolution where it has been approved by either
(i) at least two-thirds (or any higher threshold specified in a company&rsquo;s articles of association) of a company&rsquo;s shareholders
at a general meeting for which notice specifying the intention to propose the resolution as a special resolution has been given&#894;
or (ii) if so authorized by a company&rsquo;s articles of association, by a unanimous written resolution of all of the company&rsquo;s
shareholders. Our amended and restated memorandum and articles of association provide that special resolutions must be approved either
by at least two-thirds of our shareholders (i.e., the lowest threshold permissible under Cayman Islands law) (other than amendments relating
to the rights of holders of Class B ordinary shares to appoint or remove directors, which may be amended by a special resolution passed
by a majority of at least 90% of our ordinary shares voting in a general meeting), or by a unanimous written resolution of all of our
shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our initial shareholders, who collectively beneficially
own approximately 20% of our ordinary shares, may participate in any vote to amend our amended and restated memorandum and articles of
association and will have the discretion to vote in any manner they choose. Specifically, our amended and restated memorandum and articles
of association provide, among other things, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">If we have not completed our initial business combination
during the Extension Period, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible
but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the trust account, including interest income earned on the funds held in the trust account (less taxes payable
and up to $100,000 of interest income to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption
will completely extinguish public shareholders&rsquo; rights as shareholders (including the right to receive further liquidation distributions,
if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders
and our board of directors, liquidate and dissolve, subject, in each case, to our obligations under Cayman Islands law to provide for
claims of creditors and in all cases subject to the other requirements of applicable law&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">Prior to our initial business combination, we may not issue
additional securities that would entitle the holders thereof to (i) receive funds from the trust account or (ii) vote on our initial
business combination&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">In the event that we enter into a business combination with
a target business that is affiliated with our sponsor, our directors or our officers, we, or a committee of independent and disinterested
directors, will obtain an opinion from an independent investment banking firm or a valuation or appraisal firm that such a business combination
is fair to our company from a financial point of view&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">If a shareholder vote on our initial business combination
is not required by law and we do not decide to hold a shareholder vote for business or other reasons, we will offer to redeem our public
shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and will file tender offer documents with the SEC prior to completing
our initial business combination which contain substantially the same financial and other information about our initial business combination
and the redemption rights as is required under Regulation 14A of the Exchange Act&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">We must complete one or more business combinations having
an aggregate fair market value of at least 80% of the assets held in the trust account (excluding the deferred underwriting commissions
and taxes payable on the income earned on the trust account)&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">If our shareholders approve an amendment to our amended and
restated memorandum and articles of association (A) to modify the substance or timing of our obligation to allow redemption in connection
with our initial business combination or to redeem 100% of our public shares if we have not consummated an initial business combination
during the Extension Period or (B) with respect to any other material provisions relating to shareholders&rsquo; rights or pre-initial
business combination activity, we will provide our public shareholders with the opportunity to redeem all or a portion of their Class
A ordinary shares upon such approval at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust
account, including interest earned on the funds held in the trust account and not previously released to us to pay our taxes, divided
by the number of then outstanding public shares, subject to the limitations and on the conditions described herein&#894; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">We will not effectuate our initial business combination solely
with another blank check company or a similar company with nominal operations.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, our amended and restated memorandum
and articles of association provide we will not redeem our public shares in an amount that would cause our net tangible assets to be less
than $5,000,001. We may, however, raise funds through the issuance of equity or equity-linked securities or through loans, advances or
other indebtedness in connection with our initial business combination, including pursuant to forward purchase agreements or backstop
arrangements we may enter into following our initial public offering, in order to, among other reasons, satisfy such net tangible assets
requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Companies Act permits a company incorporated
in the Cayman Islands to amend its memorandum and articles of association with the approval of a special resolution. A company&rsquo;s
articles of association may specify that the approval of a higher majority is required but, provided the approval of the required majority
is obtained, any Cayman Islands exempted company may amend its memorandum and articles of association regardless of whether its memorandum
and articles of association provides otherwise. Accordingly, although we could amend any of the provisions relating to our proposed offering,
structure and business plan which are contained in our amended and restated memorandum and articles of association, we view all of these
provisions as binding obligations to our shareholders and neither we, nor our officers or directors, will take any action to amend or
waive any of these provisions unless we provide dissenting public shareholders with the opportunity to redeem their public shares.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain Anti-Takeover Provisions of Our Amended and Restated Memorandum
and Articles of Association</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our authorized but unissued Class A ordinary shares
and preferred shares are available for future issuances without shareholder approval and could be utilized for a variety of corporate
purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized
but unissued and unreserved Class A ordinary shares and preferred shares could render more difficult or discourage an attempt to obtain
control of us by means of a proxy contest, tender offer, merger or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Securities Eligible for Future Sale</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022, we had 43,125,000 ordinary
shares issued and outstanding. After giving effect to the redemption of 23,256,504 Class A ordinary shares in connection with the Extension
Amendment described above, 19,868,496 ordinary shares remain issued and outstanding. Of these shares, the 11,243,496 Class A ordinary
shares are freely tradable without restriction or further registration under the Securities Act, except for any shares purchased by one
of our affiliates within the meaning of Rule 144 under the Securities Act. All of the remaining 8,625,000 founder shares and all 6,266,667
private placement warrants are restricted securities under Rule 144, in that they were issued in private transactions not involving a
public offering, and are subject to transfer restrictions as set forth in the prospectus for our initial public offering.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rule 144</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to Rule 144, a person who has beneficially
owned restricted shares or warrants for at least six months would be entitled to sell their securities provided that (i) such person is
not deemed to have been one of our affiliates at the time of, or at any time during the three months preceding, a sale and (ii) we are
subject to the Exchange Act periodic reporting requirements for at least three months before the sale and have filed all required reports
under Section 13 or 15(d) of the Exchange Act during the 12 months (or such shorter period as we were required to file reports) preceding
the sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Persons who have beneficially owned restricted
shares or warrants for at least six months but who are our affiliates at the time of, or at any time during the three months preceding,
a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three-month period only
a number of securities that does not exceed the greater of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">1% of the total number of Class A ordinary shares then outstanding,
which is currently equal to 112,434 Class A ordinary shares&#894; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">the average weekly reported trading volume of the Class A
ordinary shares during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Sales by our affiliates under Rule 144 are also
limited by manner of sale provisions and notice requirements and to the availability of current public information about us.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Restrictions on the Use of Rule 144 by Shell Companies or Former
Shell Companies</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Rule 144 is not available for the resale of securities
initially issued by shell companies (other than business combination related shell companies) or issuers that have been at any time previously
a shell company. However, Rule 144 also includes an important exception to this prohibition if the following conditions are met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">the issuer of the securities that was formerly a shell company
has ceased to be a shell company&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">the issuer of the securities is subject to the reporting
requirements of Section 13 or 15(d) of the Exchange Act&#894;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">the issuer of the securities has filed all Exchange Act reports
and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required
to file such reports and materials), other than Current Reports on Form 8-K&#894; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: left">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">at least one year has elapsed from the time that the issuer
filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As a result, our initial shareholders will be
able to sell their founder shares and private placement warrants, as applicable, pursuant to Rule 144 without registration one year after
we have completed our initial business combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registration Rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The holders of the founder shares, private placement
warrants and any warrants that may be issued on conversion of working capital loans are entitled to registration rights pursuant to a
registration rights agreement requiring us to register such securities for resale. The holders of these securities are entitled to make
up to three demands, excluding short form registration demands, that we register such securities. In addition, the holders have certain
&ldquo;piggy-back&rdquo; registration rights with respect to registration statements filed subsequent to our completion of our initial
business combination. However, the registration rights agreement provides that we will not permit any registration statement filed under
the Securities Act to become effective until termination of the applicable lock-up period, which occurs (1) in the case of the founder
shares, on the earlier of (A) one year after the completion of our initial business combination or (B) subsequent to our initial business
combination, (x) if the last reported sale price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share
splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within
any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date following the completion
of our initial business combination on which we complete a liquidation, merger, amalgamation, share exchange, reorganization or other
similar transaction that results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash,
securities or other property, and (2) in the case of the private placement warrants and the respective Class A ordinary shares underlying
such warrants, 30 days after the completion of our initial business combination. We will bear the expenses incurred in connection with
the filing of any such registration statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Listing of Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our units, Class A ordinary shares and warrants
are listed on NYSE under the symbols &ldquo;FACT U,&rdquo; &ldquo;FACT&rdquo; and &ldquo;FACT WS,&rdquo; respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">19</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>f10k2022ex31-1_freedomacq1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.1 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO RULE 13a-14(a) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Adam Gishen, certify that:</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in; font-size: 10pt">1.</TD>
    <TD STYLE="text-align: left; font-size: 10pt">I have reviewed this annual report on Form 10-K of Freedom Acquisition I Corp. (the &ldquo;Company&rdquo;);</TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in; font-size: 10pt">2.</TD>
    <TD STYLE="text-align: left; font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in; font-size: 10pt">3.</TD>
    <TD STYLE="text-align: left; font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;</TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in; font-size: 10pt">4.</TD>
    <TD STYLE="text-align: left; font-size: 10pt">The Company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and&nbsp;internal control over financial reporting&nbsp;(as defined in&nbsp;Exchange Act&nbsp;Rules 13a-15(f) and 15d-15(f)) for the Company and have:</TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a.</TD><TD STYLE="text-align: left">Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which
this report is being prepared;</TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b.</TD><TD STYLE="text-align: left">Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;</TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">c.</TD><TD STYLE="text-align: left">Evaluated the effectiveness of the Company&rsquo;s disclosure
controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation; and</TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 24px">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 24px; font-size: 10pt">d.</TD>
    <TD STYLE="text-align: left; font-size: 10pt">Disclosed in this report any change in the Company&rsquo;s internal control over financial reporting that occurred during the Company&rsquo;s most recent fiscal quarter (the Company&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal control over financial reporting; and</TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in; font-size: 10pt">5.</TD>
    <TD STYLE="text-align: left; font-size: 10pt">The Company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company&rsquo;s auditors and the audit committee of the Company&rsquo;s board of directors (or persons performing the equivalent functions):</TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a.</TD><TD STYLE="text-align: left">All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company&rsquo;s
ability to record, process, summarize and report financial information; and</TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b.</TD><TD STYLE="text-align: left">Any fraud, whether or not material, that involves management
or other employees who have a significant role in the Company&rsquo;s internal control over financial reporting.</TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: April 6, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 40%; font-size: 10pt">/s/ Adam Gishen</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Adam Gishen</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">(Principal Executive Officer)</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>f10k2022ex31-2_freedomacq1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.2 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO RULE 13a-14(a) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Adam Gishen, certify that:</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in; font-size: 10pt">1.</TD>
    <TD STYLE="text-align: left; font-size: 10pt">I have reviewed this annual report on Form 10-K of Freedom Acquisition I Corp. (the &ldquo;Company&rdquo;);</TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in; font-size: 10pt">2.</TD>
    <TD STYLE="text-align: left; font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in; font-size: 10pt">3.</TD>
    <TD STYLE="text-align: left; font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;</TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in; font-size: 10pt">4.</TD>
    <TD STYLE="text-align: left; font-size: 10pt">The Company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and&nbsp;internal control over financial reporting&nbsp;(as defined in&nbsp;Exchange Act&nbsp;Rules 13a-15(f) and 15d-15(f)) for the Company and have:</TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a.</TD><TD STYLE="text-align: left">Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which
this report is being prepared;</TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b.</TD><TD STYLE="text-align: left">Designed such&nbsp;internal control over financial reporting,
or caused such&nbsp;internal control over financial reporting&nbsp;to be designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;</TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">c.</TD><TD STYLE="text-align: left">Evaluated the effectiveness of the Company&rsquo;s disclosure
controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation; and</TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">d.</TD><TD STYLE="text-align: left">Disclosed in this report any change in the Company&rsquo;s
internal control over financial reporting that occurred during the Company&rsquo;s most recent fiscal quarter (the Company&rsquo;s fourth
fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s
internal control over financial reporting; and</TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 0.25in; font-size: 10pt">5.</TD>
    <TD STYLE="text-align: left; font-size: 10pt">The Company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company&rsquo;s auditors and the audit committee of the Company&rsquo;s board of directors (or persons performing the equivalent functions):</TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a.</TD><TD STYLE="text-align: left">All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company&rsquo;s
ability to record, process, summarize and report financial information; and</TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b.</TD><TD STYLE="text-align: left">Any fraud, whether or not material, that involves management
or other employees who have a significant role in the Company&rsquo;s internal control over financial reporting.</TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: April 6, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 40%; font-size: 10pt">/s/ Adam Gishen</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Adam Gishen</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt">Chief Executive Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt">(Principal Financial Officer)</P></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>f10k2022ex32-1_freedomacq1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.1 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO 18 U.S.C. &sect; 1350 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">I, Adam Gishen, Chief Executive Officer of Freedom Acquisition I Corp.
(the &ldquo;Company&rdquo;), certify, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that, to my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: left">The Annual Report of the Company on Form 10-K for the fiscal
year ended December 31, 2022 (the &ldquo;Annual Report&rdquo;) fully complies with the requirements of Section 13(a) or Section 15(d)
of the Securities Exchange Act of 1934; and</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: left">The information contained in the Annual Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Date: April 6, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: left; width: 40%; font-size: 10pt">/s/ Adam Gishen</TD>
    <TD STYLE="text-align: left; width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt">Adam Gishen</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt">Chief Executive Officer</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt">(Principal Executive Officer)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">This certification accompanies the Report pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). Such certification will not be deemed
to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent
that the Company specifically incorporates it by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">A signed original of this written statement required by Section 906
has been provided to the Company and will be retained by the Company and furnished to the U.S. Securities and Exchange Commission or its
staff upon request.</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>f10k2022ex32-2_freedomacq1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.2 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO 18 U.S.C. &sect; 1350 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Adam Gishen, Chief Executive Officer (Principal Financial Officer)
of Freedom Acquisition I Corp. (the &ldquo;Company&rdquo;), certify, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 24px">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 24px; font-size: 10pt">1.</TD>
    <TD STYLE="text-align: left; font-size: 10pt">The Annual Report of the Company on Form 10-K for the fiscal year ended December 31, 2022 (the &ldquo;Annual Report&rdquo;) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and</TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 24px">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 24px; font-size: 10pt">2.</TD>
    <TD STYLE="text-align: left; font-size: 10pt">The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: April 6, 2023</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; border-bottom: black 1.5pt solid; width: 40%; font-size: 10pt">/s/ Adam Gishen</TD>
    <TD STYLE="text-align: left; width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt">Adam Gishen</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">
    <P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt">Chief Executive Officer</P>
    <P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt">(Principal Financial Officer)</P></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This certification accompanies the Report pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). Such certification will not be deemed
to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent
that the Company specifically incorporates it by reference.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A signed original of this written statement required by Section 906
has been provided to the Company and will be retained by the Company and furnished to the U.S. Securities and Exchange Commission or its
staff upon request.</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>fact-20221231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Apr 06 13:36:39 UTC 2023 -->
<xs:schema xmlns:fact="http://www.FreedomAcquisitionICorp.com/20221231" elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2022" targetNamespace="http://www.FreedomAcquisitionICorp.com/20221231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="fact-20221231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="fact-20221231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="fact-20221231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="fact-20221231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet" id="fact_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals" id="fact_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement" id="fact_r_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals" id="fact_r_ConsolidatedIncomeStatement_Parentheticals">
        <link:definition>004 - Statement - Consolidated Statements of Operations (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3" id="fact_r_ShareholdersEquityType2or3">
        <link:definition>005 - Statement - Consolidated Statements of Changes in Shareholders&#8217; (Deficit) Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3_Parentheticals" id="fact_r_ShareholdersEquityType2or3_Parentheticals">
        <link:definition>006 - Statement - Consolidated Statements of Changes in Shareholders&#8217; (Deficit) Equity (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow" id="fact_r_ConsolidatedCashFlow">
        <link:definition>007 - Statement - Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperations" id="fact_r_OrganizationandBusinessOperations">
        <link:definition>008 - Disclosure - Organization and Business Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatements" id="fact_r_RevisionofPreviouslyIssuedFinancialStatements">
        <link:definition>009 - Disclosure - Revision of Previously Issued Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPolicies" id="fact_r_SignificantAccountingPolicies">
        <link:definition>010 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOffering" id="fact_r_InitialPublicOffering">
        <link:definition>011 - Disclosure - Initial Public Offering</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrants" id="fact_r_PrivatePlacementWarrants">
        <link:definition>012 - Disclosure - Private Placement Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactions" id="fact_r_RelatedPartyTransactions">
        <link:definition>013 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingencies" id="fact_r_CommitmentsContingencies">
        <link:definition>014 - Disclosure - Commitments &amp; Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficit" id="fact_r_ShareholdersDeficit">
        <link:definition>015 - Disclosure - Shareholders&#8217; Deficit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/Warrants" id="fact_r_Warrants">
        <link:definition>016 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurements" id="fact_r_FairValueMeasurements">
        <link:definition>017 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/SubsequentEvents" id="fact_r_SubsequentEvents">
        <link:definition>018 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy" id="fact_r_AccountingPoliciesByPolicy">
        <link:definition>019 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables" id="fact_r_RevisionofPreviouslyIssuedFinancialStatementsTables">
        <link:definition>020 - Disclosure - Revision of Previously Issued Financial Statements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesTables" id="fact_r_SignificantAccountingPoliciesTables">
        <link:definition>021 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingTables" id="fact_r_InitialPublicOfferingTables">
        <link:definition>022 - Disclosure - Initial Public Offering (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables" id="fact_r_FairValueMeasurementsTables">
        <link:definition>023 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails" id="fact_r_OrganizationandBusinessOperationsDetails">
        <link:definition>024 - Disclosure - Organization and Business Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsDetails" id="fact_r_RevisionofPreviouslyIssuedFinancialStatementsDetails">
        <link:definition>025 - Disclosure - Revision of Previously Issued Financial Statements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable" id="fact_r_ScheduleofrestatementoffinancialstatementsTable">
        <link:definition>026 - Disclosure - Revision of Previously Issued Financial Statements (Details) - Schedule of restatement of financial statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable" id="fact_r_ScheduleofcondensedstatementofoperationsTable">
        <link:definition>027 - Disclosure - Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals" id="fact_r_ScheduleofcondensedstatementofoperationsTable_Parentheticals">
        <link:definition>028 - Disclosure - Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of operations (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable" id="fact_r_ScheduleofcondensedstatementofcashflowsTable">
        <link:definition>029 - Disclosure - Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of cash flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails" id="fact_r_SignificantAccountingPoliciesDetails">
        <link:definition>030 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable" id="fact_r_ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable">
        <link:definition>031 - Disclosure - Significant Accounting Policies (Details) - Schedule of unrealized holding losses and fair value of held to maturity securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable" id="fact_r_ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable">
        <link:definition>032 - Disclosure - Significant Accounting Policies (Details) - Schedule of basic and diluted net income per share for each class of ordinary share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails" id="fact_r_InitialPublicOfferingDetails">
        <link:definition>033 - Disclosure - Initial Public Offering (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable" id="fact_r_ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable">
        <link:definition>034 - Disclosure - Initial Public Offering (Details) - Schedule of the ordinary share reflected on the balance sheet are reconciled</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails" id="fact_r_PrivatePlacementWarrantsDetails">
        <link:definition>035 - Disclosure - Private Placement Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZTEDkh6awj/BIIReKzb4sGTz1n4Qtz6doLW75LUrO5BZN95BNU5gyy58yAPWsdJIHcPZx1o6NM2CjhVzEFw7kOzrV8JjqYIRJQ4gEvu2u5sh+julvljtKtVlqFYmOCh9+g/cfz7LLZtgz2FLPFuCP/fwdCLWDj3vDJhSjrrMe+hNfAR6gadd95D99SFm84TXw4CoXgLsK04OqvAfemc+b2AsLF3TSCgZLPtkF3zwXjYA==] CSR-->
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails" id="fact_r_RelatedPartyTransactionsDetails">
        <link:definition>036 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails" id="fact_r_CommitmentsContingenciesDetails">
        <link:definition>037 - Disclosure - Commitments &amp; Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails" id="fact_r_ShareholdersDeficitDetails">
        <link:definition>038 - Disclosure - Shareholders&#8217; Deficit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails" id="fact_r_WarrantsDetails">
        <link:definition>039 - Disclosure - Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails" id="fact_r_FairValueMeasurementsDetails">
        <link:definition>040 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable" id="fact_r_ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable">
        <link:definition>041 - Disclosure - Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable" id="fact_r_ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable">
        <link:definition>042 - Disclosure - Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable" id="fact_r_ScheduleofchangesinthefairvalueofwarrantliabilitiesTable">
        <link:definition>043 - Disclosure - Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" id="fact_r_Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable">
        <link:definition>044 - Disclosure - Fair Value Measurements (Details) - Schedule of changes in the fair value of level 3 warrant liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails" id="fact_r_SubsequentEventsDetails">
        <link:definition>045 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <xs:element name="ScheduleOfRestatementOfFinancialStatementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ScheduleOfRestatementOfFinancialStatementsAbstract"/>
  <xs:element name="ScheduleOfCondensedStatementOfOperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ScheduleOfCondensedStatementOfOperationsAbstract"/>
  <xs:element name="ScheduleOfCondensedStatementOfCashFlowsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ScheduleOfCondensedStatementOfCashFlowsAbstract"/>
  <xs:element name="ScheduleOfUnrealizedHoldingLossesAndFairValueOfHeldToMaturitySecuritiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ScheduleOfUnrealizedHoldingLossesAndFairValueOfHeldToMaturitySecuritiesAbstract"/>
  <xs:element name="ScheduleOfBasicAndDilutedNetIncomePerShareForEachClassOfOrdinaryShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ScheduleOfBasicAndDilutedNetIncomePerShareForEachClassOfOrdinaryShareAbstract"/>
  <xs:element name="ProposedPublicOfferingDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ProposedPublicOfferingDisclosureAbstract"/>
  <xs:element name="ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract"/>
  <xs:element name="PrivatePlacementWarrantsDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_PrivatePlacementWarrantsDisclosureAbstract"/>
  <xs:element name="WarrantsDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_WarrantsDisclosureAbstract"/>
  <xs:element name="ScheduleOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ScheduleOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisAbstract"/>
  <xs:element name="ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract"/>
  <xs:element name="ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesAbstract"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract"/>
  <xs:element name="LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract0"/>
  <xs:element name="UnlabeledAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract1"/>
  <xs:element name="ShareholdersDeficitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ShareholdersDeficitAbstract"/>
  <xs:element name="UnlabeledAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract2"/>
  <xs:element name="UnlabeledAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract3"/>
  <xs:element name="UnlabeledAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract4"/>
  <xs:element name="UnlabeledAbstract5" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract5"/>
  <xs:element name="UnlabeledAbstract6" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract6"/>
  <xs:element name="BalanceSheetAsOfSeptember302022UnauditedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_BalanceSheetAsOfSeptember302022UnauditedAbstract"/>
  <xs:element name="UnlabeledAbstract7" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract7"/>
  <xs:element name="UnlabeledAbstract8" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract8"/>
  <xs:element name="CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract"/>
  <xs:element name="UnlabeledAbstract9" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract9"/>
  <xs:element name="CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract"/>
  <xs:element name="UnlabeledAbstract10" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract10"/>
  <xs:element name="UnlabeledAbstract11" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract11"/>
  <xs:element name="CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract"/>
  <xs:element name="BasicAndDilutedNetIncomePerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_BasicAndDilutedNetIncomePerShareAbstract"/>
  <xs:element name="NumeratorAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_NumeratorAbstract"/>
  <xs:element name="DenominatorAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_DenominatorAbstract"/>
  <xs:element name="LessAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_LessAbstract"/>
  <xs:element name="PlusAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_PlusAbstract"/>
  <xs:element name="PlusAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_PlusAbstract0"/>
  <xs:element name="DescriptionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_DescriptionAbstract"/>
  <xs:element name="UnlabeledAbstract12" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract12"/>
  <xs:element name="DescriptionAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_DescriptionAbstract0"/>
  <xs:element name="UnlabeledAbstract13" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_UnlabeledAbstract13"/>
  <xs:element name="CommonStockValueOne" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_CommonStockValueOne"/>
  <xs:element name="SharesSubjectToPossibleRedemption" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_SharesSubjectToPossibleRedemption"/>
  <xs:element name="PartialReversalOfTransactionCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_PartialReversalOfTransactionCosts"/>
  <xs:element name="ChangeInFairValueOfWarrantLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_ChangeInFairValueOfWarrantLiabilities"/>
  <xs:element name="ChangeInDeferredUnderwritingFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_ChangeInDeferredUnderwritingFee"/>
  <xs:element name="OfferingCostsAllocatedToWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_OfferingCostsAllocatedToWarrants"/>
  <xs:element name="CashDepositedInTrustAccount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_CashDepositedInTrustAccount"/>
  <xs:element name="InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption"/>
  <xs:element name="InitialValueOfWarrantLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_InitialValueOfWarrantLiabilities"/>
  <xs:element name="DeferredOfferingCostsIncludedInAccruedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_DeferredOfferingCostsIncludedInAccruedExpenses"/>
  <xs:element name="AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares"/>
  <xs:element name="DeferredOfferingCostsPaidUnderPromissoryNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_DeferredOfferingCostsPaidUnderPromissoryNote"/>
  <xs:element name="ProposedPublicOfferingDisclosureTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ProposedPublicOfferingDisclosureTextBlock"/>
  <xs:element name="PrivatePlacementWarrantsDisclosureTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_PrivatePlacementWarrantsDisclosureTextBlock"/>
  <xs:element name="WarrantsDisclosureTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_WarrantsDisclosureTextBlock"/>
  <xs:element name="EmergingGrowthCompanyStatusPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_EmergingGrowthCompanyStatusPolicyTextBlock"/>
  <xs:element name="ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock"/>
  <xs:element name="ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock"/>
  <xs:element name="TradingSecuritiesFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_TradingSecuritiesFairValue"/>
  <xs:element name="AmortizedCostAndCarryingValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_AmortizedCostAndCarryingValue"/>
  <xs:element name="GrossUnrealizedGain" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_GrossUnrealizedGain"/>
  <xs:element name="GrossUnrealizedGainsAndLosses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_GrossUnrealizedGainsAndLosses"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems"/>
  <xs:element name="AllocationOfNetIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_AllocationOfNetIncome"/>
  <xs:element name="ProceedsFromGrossProceedsFromIPO" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_ProceedsFromGrossProceedsFromIPO"/>
  <xs:element name="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"/>
  <xs:element name="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems"/>
  <xs:element name="InvestmentsHeldInTrustAccountUSTreasureSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_InvestmentsHeldInTrustAccountUSTreasureSecurities"/>
  <xs:element name="InvestmentsHeldInTrustAccountNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_InvestmentsHeldInTrustAccountNet"/>
  <xs:element name="WarrantLiabilitiesPublicWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_WarrantLiabilitiesPublicWarrants"/>
  <xs:element name="WarrantLiabilitiesPrivateWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_WarrantLiabilitiesPrivateWarrants"/>
  <xs:element name="ConvertibleNoteAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_ConvertibleNoteAmount"/>
  <xs:element name="ConvertibleNoteone" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_ConvertibleNoteone"/>
  <xs:element name="ConvertibleNotesTwo" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_ConvertibleNotesTwo"/>
  <xs:element name="TotalWarrantLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_TotalWarrantLiabilities"/>
  <xs:element name="InvestmentsHeldInTrustAccountUSMoneyMarketFund" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund"/>
  <xs:element name="FairValueMeasurementStrikePrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_FairValueMeasurementStrikePrice"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates"/>
  <xs:element name="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable"/>
  <xs:element name="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems"/>
  <xs:element name="FairValueInitialMeasurement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_FairValueInitialMeasurement"/>
  <xs:element name="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable"/>
  <xs:element name="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems"/>
  <xs:element name="FairValueAssetsLevel1ToLevel2TransferAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_FairValueAssetsLevel1ToLevel2TransferAmount"/>
  <xs:element name="OrganizationandBusinessOperationsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="fact_OrganizationandBusinessOperationsDetailsTable"/>
  <xs:element name="OrganizationandBusinessOperationsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_OrganizationandBusinessOperationsDetailsLineItems"/>
  <xs:element name="GeneratingGrossProceeds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_GeneratingGrossProceeds"/>
  <xs:element name="DeferredUnderwritingFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_DeferredUnderwritingFee"/>
  <xs:element name="TotalTransactionCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_TotalTransactionCost"/>
  <xs:element name="NetProceedsOfTheSaleOfTheUnits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_NetProceedsOfTheSaleOfTheUnits"/>
  <xs:element name="BusinessCombinationFairMarketValueEqualPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_BusinessCombinationFairMarketValueEqualPercentage"/>
  <xs:element name="NetTangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_NetTangibleAssets"/>
  <xs:element name="RedeemPublicSharesPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_RedeemPublicSharesPercentage"/>
  <xs:element name="PublicPerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_PublicPerShare"/>
  <xs:element name="TrustAccountPerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_TrustAccountPerShare"/>
  <xs:element name="OperationalCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_OperationalCosts"/>
  <xs:element name="SignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="fact_SignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_SignificantAccountingPoliciesDetailsLineItems"/>
  <xs:element name="OrdinarySharesSubjectToPossibleRedemption" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_OrdinarySharesSubjectToPossibleRedemption"/>
  <xs:element name="WarrantsPurchase" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_WarrantsPurchase"/>
  <xs:element name="DerivativeWarrantLiabilities" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_DerivativeWarrantLiabilities"/>
  <xs:element name="InitialPublicOfferingDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="fact_InitialPublicOfferingDetailsTable"/>
  <xs:element name="InitialPublicOfferingDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_InitialPublicOfferingDetailsLineItems"/>
  <xs:element name="SaleOfOrdinarySharesRedemption" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_SaleOfOrdinarySharesRedemption"/>
  <xs:element name="PrivatePlacementWarrantsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="fact_PrivatePlacementWarrantsDetailsTable"/>
  <xs:element name="PrivatePlacementWarrantsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_PrivatePlacementWarrantsDetailsLineItems"/>
  <xs:element name="AggregatePurchasePrice" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_AggregatePurchasePrice"/>
  <xs:element name="RelatedPartyTransactionsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="fact_RelatedPartyTransactionsDetailsTable"/>
  <xs:element name="RelatedPartyTransactionsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_RelatedPartyTransactionsDetailsLineItems"/>
  <xs:element name="StockIssuedDuringPeriodSponsorAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_StockIssuedDuringPeriodSponsorAmount"/>
  <xs:element name="SponsorShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_SponsorShare"/>
  <xs:element name="WorkingCapitalLoans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="fact_WorkingCapitalLoans"/>
  <xs:element name="PromissioryNoteRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_PromissioryNoteRelatedParty"/>
  <xs:element name="OfficeSpaceAndAdministrativeSupportServices" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_OfficeSpaceAndAdministrativeSupportServices"/>
  <xs:element name="CommitmentsContingenciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="fact_CommitmentsContingenciesDetailsTable"/>
  <xs:element name="CommitmentsContingenciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_CommitmentsContingenciesDetailsLineItems"/>
  <xs:element name="DeferredUnderwritingDiscountPerUnit" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_DeferredUnderwritingDiscountPerUnit"/>
  <xs:element name="AggregateGrossProceeds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_AggregateGrossProceeds"/>
  <xs:element name="ShareholdersDeficitDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="fact_ShareholdersDeficitDetailsTable"/>
  <xs:element name="ShareholdersDeficitDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_ShareholdersDeficitDetailsLineItems"/>
  <xs:element name="OrdinarySharesDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_OrdinarySharesDescription"/>
  <xs:element name="TotalNumberOfOrdinarySharesOutstandingPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_TotalNumberOfOrdinarySharesOutstandingPercentage"/>
  <xs:element name="WarrantsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="fact_WarrantsDetailsTable"/>
  <xs:element name="WarrantsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_WarrantsDetailsLineItems"/>
  <xs:element name="WarrantTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_WarrantTerm"/>
  <xs:element name="WarrantExpirationTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_WarrantExpirationTerm"/>
  <xs:element name="RedemptionsOfWarrantsDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_RedemptionsOfWarrantsDescription"/>
  <xs:element name="FairValueMeasurementsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="fact_FairValueMeasurementsDetailsTable"/>
  <xs:element name="FairValueMeasurementsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_FairValueMeasurementsDetailsLineItems"/>
  <xs:element name="FairValueWarrantLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_FairValueWarrantLiabilities"/>
  <xs:element name="SubsequentEventsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="fact_SubsequentEventsDetailsTable"/>
  <xs:element name="SubsequentEventsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_SubsequentEventsDetailsLineItems"/>
  <xs:element name="VotingPowerPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_VotingPowerPercentage"/>
  <xs:element name="IssuedAndOutstandingShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_IssuedAndOutstandingShares"/>
  <xs:element name="ExtensionAmendmentProposalFor" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_ExtensionAmendmentProposalFor"/>
  <xs:element name="ExtensionAmendmentProposalAgainst" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_ExtensionAmendmentProposalAgainst"/>
  <xs:element name="ExtensionAmendmentProposalAbstain" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_ExtensionAmendmentProposalAbstain"/>
  <xs:element name="AggregateSharesOfCommonStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_AggregateSharesOfCommonStock"/>
  <xs:element name="IssuedAndOutstandingInterestPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_IssuedAndOutstandingInterestPercentage"/>
  <xs:element name="InvestmentManagementTrustAgreementFor" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_InvestmentManagementTrustAgreementFor"/>
  <xs:element name="InvestmentManagementTrustAgreementAgainst" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_InvestmentManagementTrustAgreementAgainst"/>
  <xs:element name="InvestmentManagementTrustAgreementAbstain" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="fact_InvestmentManagementTrustAgreementAbstain"/>
  <xs:element name="PromissoryNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_PromissoryNote"/>
  <xs:element name="DrawnDownAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="fact_DrawnDownAmount"/>
  <xs:element name="AsRestatedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_AsRestatedMember"/>
  <xs:element name="BusinessCombinationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_BusinessCombinationMember"/>
  <xs:element name="FounderSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_FounderSharesMember"/>
  <xs:element name="PublicMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_PublicMember"/>
  <xs:element name="PublicWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_PublicWarrantsMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="fact_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>fact-20221231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Apr 06 13:36:39 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ConsolidatedBalanceSheet" roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ConsolidatedIncomeStatement" roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ConsolidatedCashFlow" roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PrepaidExpenseNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="fact_CommonStockValueOne" xlink:href="fact-20221231.xsd#fact_CommonStockValueOne"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="fact_CommonStockValueOne" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="3" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingCostsAndExpenses" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZTEDkh6awj/BIIReKzb4sGTz1n4Qtz6doLW75LUrO5BZN95BNU5gyy58yAPWsdJIHcPZx1o6NM2CjhVzEFw7kOzrV8JjqYIRJQ4gEvu2u5sh+julvljtKtVlqFYmOCh9+g/cfz7LLZtgz2FLPFuCP/fwdCLWDj3vDJhSjrrMe+hNfAR6gadd95D99SFm84TXw4CoXgLsK04JoP5ZJBhbgYd/fJ+nURwnAZ2HfP5hfJJw==] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterest" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="fact_PartialReversalOfTransactionCosts" xlink:href="fact-20221231.xsd#fact_PartialReversalOfTransactionCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="fact_PartialReversalOfTransactionCosts" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseOfferingCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoninterestExpenseOfferingCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NoninterestExpenseOfferingCost" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="fact_ChangeInFairValueOfWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_ChangeInFairValueOfWarrantLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="fact_ChangeInFairValueOfWarrantLiabilities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="fact_ChangeInDeferredUnderwritingFee" xlink:href="fact-20221231.xsd#fact_ChangeInDeferredUnderwritingFee"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="fact_ChangeInDeferredUnderwritingFee" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOther"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InterestIncomeOther" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="fact_OfferingCostsAllocatedToWarrants" xlink:href="fact-20221231.xsd#fact_OfferingCostsAllocatedToWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="fact_OfferingCostsAllocatedToWarrants" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="fact_CashDepositedInTrustAccount" xlink:href="fact-20221231.xsd#fact_CashDepositedInTrustAccount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="fact_CashDepositedInTrustAccount" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>fact-20221231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Apr 06 13:36:39 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ConsolidatedBalanceSheet" roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ConsolidatedIncomeStatement" roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ShareholdersEquityType2or3" roleURI="http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ConsolidatedCashFlow" roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_OrganizationandBusinessOperations" roleURI="http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperations"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_RevisionofPreviouslyIssuedFinancialStatements" roleURI="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatements"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_SignificantAccountingPolicies" roleURI="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_InitialPublicOffering" roleURI="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOffering"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_PrivatePlacementWarrants" roleURI="http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrants"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_RelatedPartyTransactions" roleURI="http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_CommitmentsContingencies" roleURI="http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingencies"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ShareholdersDeficit" roleURI="http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficit"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_Warrants" roleURI="http://www.FreedomAcquisitionICorp.com/role/Warrants"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_FairValueMeasurements" roleURI="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurements"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_SubsequentEvents" roleURI="http://www.FreedomAcquisitionICorp.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_AccountingPoliciesByPolicy" roleURI="http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_RevisionofPreviouslyIssuedFinancialStatementsTables" roleURI="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_SignificantAccountingPoliciesTables" roleURI="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_InitialPublicOfferingTables" roleURI="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingTables"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_FairValueMeasurementsTables" roleURI="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofrestatementoffinancialstatementsTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofcondensedstatementofoperationsTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofcondensedstatementofoperationsTable_Parentheticals" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofcondensedstatementofcashflowsTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofchangesinthefairvalueofwarrantliabilitiesTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_OrganizationandBusinessOperationsDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_RevisionofPreviouslyIssuedFinancialStatementsDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_SignificantAccountingPoliciesDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_InitialPublicOfferingDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_PrivatePlacementWarrantsDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_RelatedPartyTransactionsDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_CommitmentsContingenciesDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ShareholdersDeficitDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_WarrantsDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_FairValueMeasurementsDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_SubsequentEventsDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#DocumentAndEntityInformation" roleURI="http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseNoncurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Assets" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract" xlink:href="fact-20221231.xsd#fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_ShareholdersDeficitAbstract" xlink:href="fact-20221231.xsd#fact_ShareholdersDeficitAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="fact_ShareholdersDeficitAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ShareholdersDeficitAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ShareholdersDeficitAbstract" xlink:to="us-gaap_CommonStockValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_CommonStockValueOne" xlink:href="fact-20221231.xsd#fact_CommonStockValueOne"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ShareholdersDeficitAbstract" xlink:to="fact_CommonStockValueOne" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquity" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_SharesSubjectToPossibleRedemption" xlink:href="fact-20221231.xsd#fact_SharesSubjectToPossibleRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="fact_SharesSubjectToPossibleRedemption" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpenses" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_PartialReversalOfTransactionCosts" xlink:href="fact-20221231.xsd#fact_PartialReversalOfTransactionCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="fact_PartialReversalOfTransactionCosts" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseOfferingCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoninterestExpenseOfferingCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NoninterestExpenseOfferingCost" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_EarningsPerShareBasic" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityOther" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InterestIncomeOther" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_ChangeInFairValueOfWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_ChangeInFairValueOfWarrantLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="fact_ChangeInFairValueOfWarrantLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_ChangeInDeferredUnderwritingFee" xlink:href="fact-20221231.xsd#fact_ChangeInDeferredUnderwritingFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="fact_ChangeInDeferredUnderwritingFee" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_OfferingCostsAllocatedToWarrants" xlink:href="fact-20221231.xsd#fact_OfferingCostsAllocatedToWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="fact_OfferingCostsAllocatedToWarrants" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_CashDepositedInTrustAccount" xlink:href="fact-20221231.xsd#fact_CashDepositedInTrustAccount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="fact_CashDepositedInTrustAccount" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption" xlink:href="fact-20221231.xsd#fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_InitialValueOfWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_InitialValueOfWarrantLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="fact_InitialValueOfWarrantLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_DeferredOfferingCostsIncludedInAccruedExpenses" xlink:href="fact-20221231.xsd#fact_DeferredOfferingCostsIncludedInAccruedExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="fact_DeferredOfferingCostsIncludedInAccruedExpenses" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares" xlink:href="fact-20221231.xsd#fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_DeferredOfferingCostsPaidUnderPromissoryNote" xlink:href="fact-20221231.xsd#fact_DeferredOfferingCostsPaidUnderPromissoryNote"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="fact_DeferredOfferingCostsPaidUnderPromissoryNote" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperations">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatements">
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialStatementsTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="srt_CondensedFinancialStatementsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOffering">
    <loc xlink:type="locator" xlink:label="fact_ProposedPublicOfferingDisclosureAbstract" xlink:href="fact-20221231.xsd#fact_ProposedPublicOfferingDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="fact_ProposedPublicOfferingDisclosureTextBlock" xlink:href="fact-20221231.xsd#fact_ProposedPublicOfferingDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ProposedPublicOfferingDisclosureAbstract" xlink:to="fact_ProposedPublicOfferingDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrants">
    <loc xlink:type="locator" xlink:label="fact_PrivatePlacementWarrantsDisclosureAbstract" xlink:href="fact-20221231.xsd#fact_PrivatePlacementWarrantsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="fact_PrivatePlacementWarrantsDisclosureTextBlock" xlink:href="fact-20221231.xsd#fact_PrivatePlacementWarrantsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_PrivatePlacementWarrantsDisclosureAbstract" xlink:to="fact_PrivatePlacementWarrantsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactions">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingencies">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficit">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/Warrants">
    <loc xlink:type="locator" xlink:label="fact_WarrantsDisclosureAbstract" xlink:href="fact-20221231.xsd#fact_WarrantsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantsDisclosureTextBlock" xlink:href="fact-20221231.xsd#fact_WarrantsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_WarrantsDisclosureAbstract" xlink:to="fact_WarrantsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurements">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:href="fact-20221231.xsd#fact_EmergingGrowthCompanyStatusPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="fact_EmergingGrowthCompanyStatusPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock" xlink:href="fact-20221231.xsd#fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredChargesPolicyTextBlock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables">
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingTables">
    <loc xlink:type="locator" xlink:label="fact_ProposedPublicOfferingDisclosureAbstract" xlink:href="fact-20221231.xsd#fact_ProposedPublicOfferingDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ProposedPublicOfferingDisclosureAbstract" xlink:to="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock" xlink:href="fact-20221231.xsd#fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable">
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="srt_RestatementAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementAdjustmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_AsRestatedMember" xlink:href="fact-20221231.xsd#fact_AsRestatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="fact_AsRestatedMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="us-gaap_Liabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="us-gaap_StockholdersEquity" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_BalanceSheetAsOfSeptember302022UnauditedAbstract" xlink:href="fact-20221231.xsd#fact_BalanceSheetAsOfSeptember302022UnauditedAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="fact_BalanceSheetAsOfSeptember302022UnauditedAbstract" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable">
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedIncomeStatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="srt_CondensedIncomeStatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_RestatementAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementAdjustmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_AsRestatedMember" xlink:href="fact-20221231.xsd#fact_AsRestatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="fact_AsRestatedMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_OperatingLeaseCost" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract" xlink:href="fact-20221231.xsd#fact_CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="fact_CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract" xlink:href="fact-20221231.xsd#fact_CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="fact_CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedIncomeStatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="srt_CondensedIncomeStatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_RestatementAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementAdjustmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_AsRestatedMember" xlink:href="fact-20221231.xsd#fact_AsRestatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="fact_AsRestatedMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable">
    <loc xlink:type="locator" xlink:label="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedCashFlowStatementTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedCashFlowStatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="srt_CondensedCashFlowStatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_CondensedCashFlowStatementTable" xlink:to="srt_RestatementAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementAdjustmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_AsRestatedMember" xlink:href="fact-20221231.xsd#fact_AsRestatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="fact_AsRestatedMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract" xlink:href="fact-20221231.xsd#fact_CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="fact_CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CashMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_TradingSecuritiesFairValue" xlink:href="fact-20221231.xsd#fact_TradingSecuritiesFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="fact_TradingSecuritiesFairValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_AmortizedCostAndCarryingValue" xlink:href="fact-20221231.xsd#fact_AmortizedCostAndCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="fact_AmortizedCostAndCarryingValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_GrossUnrealizedGain" xlink:href="fact-20221231.xsd#fact_GrossUnrealizedGain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="fact_GrossUnrealizedGain" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_GrossUnrealizedGainsAndLosses" xlink:href="fact-20221231.xsd#fact_GrossUnrealizedGainsAndLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="fact_GrossUnrealizedGainsAndLosses" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable">
    <loc xlink:type="locator" xlink:label="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems" xlink:href="fact-20221231.xsd#fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems"/>
    <loc xlink:type="locator" xlink:label="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable" xlink:href="fact-20221231.xsd#fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems" xlink:to="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_NumeratorAbstract" xlink:href="fact-20221231.xsd#fact_NumeratorAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems" xlink:to="fact_NumeratorAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_AllocationOfNetIncome" xlink:href="fact-20221231.xsd#fact_AllocationOfNetIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_NumeratorAbstract" xlink:to="fact_AllocationOfNetIncome" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_DenominatorAbstract" xlink:href="fact-20221231.xsd#fact_DenominatorAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems" xlink:to="fact_DenominatorAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_DenominatorAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable">
    <loc xlink:type="locator" xlink:label="fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract"/>
    <loc xlink:type="locator" xlink:label="fact_ProceedsFromGrossProceedsFromIPO" xlink:href="fact-20221231.xsd#fact_ProceedsFromGrossProceedsFromIPO"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract" xlink:to="fact_ProceedsFromGrossProceedsFromIPO" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_LessAbstract" xlink:href="fact-20221231.xsd#fact_LessAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract" xlink:to="fact_LessAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_LessAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_LessAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_PlusAbstract" xlink:href="fact-20221231.xsd#fact_PlusAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract" xlink:to="fact_PlusAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_PlusAbstract" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_PlusAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_PlusAbstract0" xlink:href="fact-20221231.xsd#fact_PlusAbstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract" xlink:to="fact_PlusAbstract0" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityOtherChanges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityOtherChanges"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_PlusAbstract0" xlink:to="us-gaap_TemporaryEquityOtherChanges" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable">
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_InvestmentsHeldInTrustAccountUSTreasureSecurities" xlink:href="fact-20221231.xsd#fact_InvestmentsHeldInTrustAccountUSTreasureSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="fact_InvestmentsHeldInTrustAccountUSTreasureSecurities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_InvestmentsHeldInTrustAccountNet" xlink:href="fact-20221231.xsd#fact_InvestmentsHeldInTrustAccountNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="fact_InvestmentsHeldInTrustAccountNet" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantLiabilitiesPublicWarrants" xlink:href="fact-20221231.xsd#fact_WarrantLiabilitiesPublicWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="fact_WarrantLiabilitiesPublicWarrants" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantLiabilitiesPrivateWarrants" xlink:href="fact-20221231.xsd#fact_WarrantLiabilitiesPrivateWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="fact_WarrantLiabilitiesPrivateWarrants" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_ConvertibleNoteAmount" xlink:href="fact-20221231.xsd#fact_ConvertibleNoteAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="fact_ConvertibleNoteAmount" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_ConvertibleNoteone" xlink:href="fact-20221231.xsd#fact_ConvertibleNoteone"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="fact_ConvertibleNoteone" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_ConvertibleNotesTwo" xlink:href="fact-20221231.xsd#fact_ConvertibleNotesTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="fact_ConvertibleNotesTwo" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_TotalWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_TotalWarrantLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="fact_TotalWarrantLiabilities" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund" xlink:href="fact-20221231.xsd#fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable">
    <loc xlink:type="locator" xlink:label="fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:to="us-gaap_SharePrice" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementStrikePrice" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementStrikePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:to="fact_FairValueMeasurementStrikePrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates" xlink:href="fact-20221231.xsd#fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:to="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable">
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems" xlink:to="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZTEDkh6awj/BIIReKzb4sGTz1n4Qtz6doLW75LUrO5BZN95BNU5gyy58yAPWsdJIHcPZx1o6NM2CjhVzEFw7kOzrV8JjqYIRJQ4gEvu2u5sh+julvljtKtVlqFYmOCh9+g/cfz7LLZtgz2FLPFuCP/fwdCLWDj3vDJhSjrrMe+hNfAR6gadd95D99SFm84TXw4CoXgLsK04GTpia2mIWRl5+fDZjSODvE=] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_PublicMember" xlink:href="fact-20221231.xsd#fact_PublicMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="fact_PublicMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueNetAssetLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems" xlink:to="us-gaap_FairValueNetAssetLiability" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueInitialMeasurement" xlink:href="fact-20221231.xsd#fact_FairValueInitialMeasurement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems" xlink:to="fact_FairValueInitialMeasurement" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable">
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" xlink:to="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_PublicMember" xlink:href="fact-20221231.xsd#fact_PublicMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="fact_PublicMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueNetAssetLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" xlink:to="us-gaap_FairValueNetAssetLiability" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueInitialMeasurement" xlink:href="fact-20221231.xsd#fact_FairValueInitialMeasurement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" xlink:to="fact_FairValueInitialMeasurement" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueAssetsLevel1ToLevel2TransferAmount" xlink:href="fact-20221231.xsd#fact_FairValueAssetsLevel1ToLevel2TransferAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" xlink:to="fact_FairValueAssetsLevel1ToLevel2TransferAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails">
    <loc xlink:type="locator" xlink:label="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_OrganizationandBusinessOperationsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="fact_OrganizationandBusinessOperationsDetailsTable" xlink:href="fact-20221231.xsd#fact_OrganizationandBusinessOperationsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="fact_OrganizationandBusinessOperationsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_OrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_OrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_OrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_OrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_GeneratingGrossProceeds" xlink:href="fact-20221231.xsd#fact_GeneratingGrossProceeds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="fact_GeneratingGrossProceeds" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherUnderwritingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherUnderwritingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_OtherUnderwritingExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_DeferredUnderwritingFee" xlink:href="fact-20221231.xsd#fact_DeferredUnderwritingFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="fact_DeferredUnderwritingFee" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOwnershipInterestsOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOwnershipInterestsOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_OtherOwnershipInterestsOfferingCosts" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_TotalTransactionCost" xlink:href="fact-20221231.xsd#fact_TotalTransactionCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="fact_TotalTransactionCost" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_NetProceedsOfTheSaleOfTheUnits" xlink:href="fact-20221231.xsd#fact_NetProceedsOfTheSaleOfTheUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="fact_NetProceedsOfTheSaleOfTheUnits" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_BusinessCombinationFairMarketValueEqualPercentage" xlink:href="fact-20221231.xsd#fact_BusinessCombinationFairMarketValueEqualPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="fact_BusinessCombinationFairMarketValueEqualPercentage" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_NetTangibleAssets" xlink:href="fact-20221231.xsd#fact_NetTangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="fact_NetTangibleAssets" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_RedeemPublicSharesPercentage" xlink:href="fact-20221231.xsd#fact_RedeemPublicSharesPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="fact_RedeemPublicSharesPercentage" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_PublicPerShare" xlink:href="fact-20221231.xsd#fact_PublicPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="fact_PublicPerShare" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_TrustAccountPerShare" xlink:href="fact-20221231.xsd#fact_TrustAccountPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="fact_TrustAccountPerShare" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_AssetsHeldInTrust" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="20" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsDetails">
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="us-gaap_AccountsPayableOtherCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_OperationalCosts" xlink:href="fact-20221231.xsd#fact_OperationalCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="fact_OperationalCosts" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:href="fact-20221231.xsd#fact_SignificantAccountingPoliciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="fact_SignificantAccountingPoliciesDetailsTable" xlink:href="fact-20221231.xsd#fact_SignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="fact_SignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_Cash" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_CashFDICInsuredAmount" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_OrdinarySharesSubjectToPossibleRedemption" xlink:href="fact-20221231.xsd#fact_OrdinarySharesSubjectToPossibleRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="fact_OrdinarySharesSubjectToPossibleRedemption" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantsPurchase" xlink:href="fact-20221231.xsd#fact_WarrantsPurchase"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="fact_WarrantsPurchase" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DeferredOfferingCosts" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherUnderwritingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherUnderwritingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_OtherUnderwritingExpense" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_DeferredUnderwritingFee" xlink:href="fact-20221231.xsd#fact_DeferredUnderwritingFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="fact_DeferredUnderwritingFee" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOwnershipInterestsOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOwnershipInterestsOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_OtherOwnershipInterestsOfferingCosts" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_TotalTransactionCost" xlink:href="fact-20221231.xsd#fact_TotalTransactionCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="fact_TotalTransactionCost" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_PartialReversalOfTransactionCosts" xlink:href="fact-20221231.xsd#fact_PartialReversalOfTransactionCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="fact_PartialReversalOfTransactionCosts" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_DerivativeWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_DerivativeWarrantLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="fact_DerivativeWarrantLiabilities" order="15" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails">
    <loc xlink:type="locator" xlink:label="fact_InitialPublicOfferingDetailsLineItems" xlink:href="fact-20221231.xsd#fact_InitialPublicOfferingDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="fact_InitialPublicOfferingDetailsTable" xlink:href="fact-20221231.xsd#fact_InitialPublicOfferingDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="fact_InitialPublicOfferingDetailsLineItems" xlink:to="fact_InitialPublicOfferingDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_InitialPublicOfferingDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_InitialPublicOfferingDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_CommonStockNoParValue" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceIncrease" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_SaleOfOrdinarySharesRedemption" xlink:href="fact-20221231.xsd#fact_SaleOfOrdinarySharesRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_InitialPublicOfferingDetailsLineItems" xlink:to="fact_SaleOfOrdinarySharesRedemption" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails">
    <loc xlink:type="locator" xlink:label="fact_PrivatePlacementWarrantsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_PrivatePlacementWarrantsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="fact_PrivatePlacementWarrantsDetailsTable" xlink:href="fact-20221231.xsd#fact_PrivatePlacementWarrantsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="fact_PrivatePlacementWarrantsDetailsLineItems" xlink:to="fact_PrivatePlacementWarrantsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_PrivatePlacementWarrantsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_PrivatePlacementWarrantsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_PrivatePlacementWarrantsDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_PrivatePlacementWarrantsDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_AggregatePurchasePrice" xlink:href="fact-20221231.xsd#fact_AggregatePurchasePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_PrivatePlacementWarrantsDetailsLineItems" xlink:to="fact_AggregatePurchasePrice" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails">
    <loc xlink:type="locator" xlink:label="fact_RelatedPartyTransactionsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_RelatedPartyTransactionsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="fact_RelatedPartyTransactionsDetailsTable" xlink:href="fact-20221231.xsd#fact_RelatedPartyTransactionsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="fact_RelatedPartyTransactionsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_RelatedPartyTransactionsDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_BusinessCombinationMember" xlink:href="fact-20221231.xsd#fact_BusinessCombinationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="fact_BusinessCombinationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_FounderSharesMember" xlink:href="fact-20221231.xsd#fact_FounderSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="fact_FounderSharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_StockIssuedDuringPeriodSponsorAmount" xlink:href="fact-20221231.xsd#fact_StockIssuedDuringPeriodSponsorAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="fact_StockIssuedDuringPeriodSponsorAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SharePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SharesIssued" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockOtherSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockOtherSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_CommonStockOtherSharesOutstanding" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_SponsorShare" xlink:href="fact-20221231.xsd#fact_SponsorShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="fact_SponsorShare" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_OtherLongTermDebt" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_WorkingCapitalLoans" xlink:href="fact-20221231.xsd#fact_WorkingCapitalLoans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="fact_WorkingCapitalLoans" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_PromissioryNoteRelatedParty" xlink:href="fact-20221231.xsd#fact_PromissioryNoteRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="fact_PromissioryNoteRelatedParty" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfUnsecuredDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceDecrease" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_OfficeSpaceAndAdministrativeSupportServices" xlink:href="fact-20221231.xsd#fact_OfficeSpaceAndAdministrativeSupportServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="fact_OfficeSpaceAndAdministrativeSupportServices" order="18" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails">
    <loc xlink:type="locator" xlink:label="fact_CommitmentsContingenciesDetailsLineItems" xlink:href="fact-20221231.xsd#fact_CommitmentsContingenciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="fact_CommitmentsContingenciesDetailsTable" xlink:href="fact-20221231.xsd#fact_CommitmentsContingenciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="fact_CommitmentsContingenciesDetailsLineItems" xlink:to="fact_CommitmentsContingenciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_CommitmentsContingenciesDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_CommitmentsContingenciesDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_CommitmentsContingenciesDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_BusinessCombinationMember" xlink:href="fact-20221231.xsd#fact_BusinessCombinationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="fact_BusinessCombinationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherUnderwritingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherUnderwritingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_CommitmentsContingenciesDetailsLineItems" xlink:to="us-gaap_OtherUnderwritingExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_DeferredUnderwritingDiscountPerUnit" xlink:href="fact-20221231.xsd#fact_DeferredUnderwritingDiscountPerUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_CommitmentsContingenciesDetailsLineItems" xlink:to="fact_DeferredUnderwritingDiscountPerUnit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_AggregateGrossProceeds" xlink:href="fact-20221231.xsd#fact_AggregateGrossProceeds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_CommitmentsContingenciesDetailsLineItems" xlink:to="fact_AggregateGrossProceeds" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_CommitmentsContingenciesDetailsLineItems" xlink:to="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_PartialReversalOfTransactionCosts" xlink:href="fact-20221231.xsd#fact_PartialReversalOfTransactionCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_CommitmentsContingenciesDetailsLineItems" xlink:to="fact_PartialReversalOfTransactionCosts" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_CommitmentsContingenciesDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_CommitmentsContingenciesDetailsLineItems" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_CommitmentsContingenciesDetailsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_CommitmentsContingenciesDetailsLineItems" xlink:to="us-gaap_DividendsCommonStockCash" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalDeferredPurchasePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalDeferredPurchasePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_CommitmentsContingenciesDetailsLineItems" xlink:to="us-gaap_SupplementalDeferredPurchasePrice" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails">
    <loc xlink:type="locator" xlink:label="fact_ShareholdersDeficitDetailsLineItems" xlink:href="fact-20221231.xsd#fact_ShareholdersDeficitDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="fact_ShareholdersDeficitDetailsTable" xlink:href="fact-20221231.xsd#fact_ShareholdersDeficitDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="fact_ShareholdersDeficitDetailsLineItems" xlink:to="fact_ShareholdersDeficitDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_ShareholdersDeficitDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_OrdinarySharesDescription" xlink:href="fact-20221231.xsd#fact_OrdinarySharesDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ShareholdersDeficitDetailsLineItems" xlink:to="fact_OrdinarySharesDescription" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_TotalNumberOfOrdinarySharesOutstandingPercentage" xlink:href="fact-20221231.xsd#fact_TotalNumberOfOrdinarySharesOutstandingPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_ShareholdersDeficitDetailsLineItems" xlink:to="fact_TotalNumberOfOrdinarySharesOutstandingPercentage" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails">
    <loc xlink:type="locator" xlink:label="fact_WarrantsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_WarrantsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantsDetailsTable" xlink:href="fact-20221231.xsd#fact_WarrantsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="fact_WarrantsDetailsLineItems" xlink:to="fact_WarrantsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_WarrantsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_WarrantsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_WarrantsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_PublicWarrantsMember" xlink:href="fact-20221231.xsd#fact_PublicWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="fact_PublicWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_WarrantsDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantTerm" xlink:href="fact-20221231.xsd#fact_WarrantTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_WarrantsDetailsLineItems" xlink:to="fact_WarrantTerm" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantExpirationTerm" xlink:href="fact-20221231.xsd#fact_WarrantExpirationTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_WarrantsDetailsLineItems" xlink:to="fact_WarrantExpirationTerm" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_WarrantsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_RedemptionsOfWarrantsDescription" xlink:href="fact-20221231.xsd#fact_RedemptionsOfWarrantsDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_WarrantsDetailsLineItems" xlink:to="fact_RedemptionsOfWarrantsDescription" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails">
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsTable" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="fact_FairValueMeasurementsDetailsLineItems" xlink:to="fact_FairValueMeasurementsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_FairValueMeasurementsDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsLineItems" xlink:to="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_FairValueWarrantLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_FairValueMeasurementsDetailsLineItems" xlink:to="fact_FairValueWarrantLiabilities" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails">
    <loc xlink:type="locator" xlink:label="fact_SubsequentEventsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_SubsequentEventsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="fact_SubsequentEventsDetailsTable" xlink:href="fact-20221231.xsd#fact_SubsequentEventsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="fact_SubsequentEventsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_SubsequentEventsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_SubsequentEventsDetailsTable" xlink:to="srt_StatementScenarioAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_SubsequentEventsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="fact_SubsequentEventsDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_BusinessCombinationMember" xlink:href="fact-20221231.xsd#fact_BusinessCombinationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="fact_BusinessCombinationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_SharesIssued" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_VotingPowerPercentage" xlink:href="fact-20221231.xsd#fact_VotingPowerPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="fact_VotingPowerPercentage" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_IssuedAndOutstandingShares" xlink:href="fact-20221231.xsd#fact_IssuedAndOutstandingShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="fact_IssuedAndOutstandingShares" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonUnitOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_CommonUnitOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_ExtensionAmendmentProposalFor" xlink:href="fact-20221231.xsd#fact_ExtensionAmendmentProposalFor"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="fact_ExtensionAmendmentProposalFor" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_ExtensionAmendmentProposalAgainst" xlink:href="fact-20221231.xsd#fact_ExtensionAmendmentProposalAgainst"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="fact_ExtensionAmendmentProposalAgainst" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_ExtensionAmendmentProposalAbstain" xlink:href="fact-20221231.xsd#fact_ExtensionAmendmentProposalAbstain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="fact_ExtensionAmendmentProposalAbstain" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_AggregateSharesOfCommonStock" xlink:href="fact-20221231.xsd#fact_AggregateSharesOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="fact_AggregateSharesOfCommonStock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_IssuedAndOutstandingInterestPercentage" xlink:href="fact-20221231.xsd#fact_IssuedAndOutstandingInterestPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="fact_IssuedAndOutstandingInterestPercentage" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockHeldInTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockHeldInTrust"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_CommonStockHeldInTrust" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_InvestmentManagementTrustAgreementFor" xlink:href="fact-20221231.xsd#fact_InvestmentManagementTrustAgreementFor"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="fact_InvestmentManagementTrustAgreementFor" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_InvestmentManagementTrustAgreementAgainst" xlink:href="fact-20221231.xsd#fact_InvestmentManagementTrustAgreementAgainst"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="fact_InvestmentManagementTrustAgreementAgainst" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_InvestmentManagementTrustAgreementAbstain" xlink:href="fact-20221231.xsd#fact_InvestmentManagementTrustAgreementAbstain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="fact_InvestmentManagementTrustAgreementAbstain" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfUnsecuredDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_RepaymentsOfUnsecuredDebt" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_PromissoryNote" xlink:href="fact-20221231.xsd#fact_PromissoryNote"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="fact_PromissoryNote" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="fact_DrawnDownAmount" xlink:href="fact-20221231.xsd#fact_DrawnDownAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="fact_DrawnDownAmount" order="19" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="38" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>fact-20221231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Apr 06 13:36:39 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Total Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Shareholders&#8217; Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Total Shareholders&#8217; Equity (Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities, Redeemable Ordinary Shares and Shareholders&#8217; Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US">Net Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Net Change in Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash &#8211; Beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Cash &#8211; Ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAxis_lbl" xml:lang="en-US">Revision of Prior Period [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xml:lang="en-US">Cash and Cash Equivalents [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ProposedPublicOfferingDisclosureAbstract" xlink:href="fact-20221231.xsd#fact_ProposedPublicOfferingDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ProposedPublicOfferingDisclosureAbstract_lbl" xml:lang="en-US">Initial Public Offering [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ProposedPublicOfferingDisclosureAbstract" xlink:to="fact_ProposedPublicOfferingDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract_lbl" xml:lang="en-US">Schedule of the Ordinary Share Reflected on the Balance Sheet are Reconciled [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract" xlink:to="fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US">Contingently redeemable ordinary share as of December 31, 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl0" xml:lang="en-US">Contingently redeemable ordinary share as of December 31, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl1" xml:lang="en-US">Class A Ordinary shares subject to possible redemption 34,500,000 shares subject to possible redemption at redemption value at December 31, 2022 and 2021, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract_lbl" xml:lang="en-US">Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:to="fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueNetAssetLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueNetAssetLiability_lbl" xml:lang="en-US">Fair value as of beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetAssetLiability" xlink:to="us-gaap_FairValueNetAssetLiability_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueNetAssetLiability_lbl0" xml:lang="en-US">Fair value as of ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetAssetLiability" xlink:to="us-gaap_FairValueNetAssetLiability_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses - short term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseNoncurrent_lbl" xml:lang="en-US">Prepaid expenses - long term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseNoncurrent" xlink:to="us-gaap_PrepaidExpenseNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xml:lang="en-US">Cash and marketable securities held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract" xlink:to="fact_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract" xlink:href="fact-20221231.xsd#fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract_lbl" xml:lang="en-US">Liabilities, Redeemable Ordinary Shares and Shareholders&#8217; Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract" xlink:to="fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl" xml:lang="en-US">Convertible promissory note &#8211; related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_lbl" xml:lang="en-US">Deferred underwriters&#8217; discount payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_lbl0" xml:lang="en-US">Underwriting fee payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_lbl1" xml:lang="en-US">underwriting fee payableU</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_lbl1"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract0" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract0" xlink:to="fact_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies (See Note 7)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_SharesSubjectToPossibleRedemption" xlink:href="fact-20221231.xsd#fact_SharesSubjectToPossibleRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_SharesSubjectToPossibleRedemption_lbl" xml:lang="en-US">Ordinary shares subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SharesSubjectToPossibleRedemption" xlink:to="fact_SharesSubjectToPossibleRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract1" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract1_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract1" xlink:to="fact_UnlabeledAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ShareholdersDeficitAbstract" xlink:href="fact-20221231.xsd#fact_ShareholdersDeficitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_ShareholdersDeficitAbstract_lbl" xml:lang="en-US">Shareholders&#8217; Deficit:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ShareholdersDeficitAbstract" xlink:to="fact_ShareholdersDeficitAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at December 31, 2022 and 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preference shares, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Preferred stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preference shares, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl0" xml:lang="en-US">Preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preference shares, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preference shares, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized at December 31, 2022 and 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Ordinary shares, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Common stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Ordinary shares, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_CommonStockValueOne" xlink:href="fact-20221231.xsd#fact_CommonStockValueOne"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_CommonStockValueOne_lbl" xml:lang="en-US">Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding at December 31, 2022 and 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_CommonStockValueOne" xlink:to="fact_CommonStockValueOne_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Ordinary shares, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Ordinary shares, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Operating costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Foreign currency exchange loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest income on marketable securities held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentIncomeInterest_lbl0" xml:lang="en-US">Interest income earned</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_PartialReversalOfTransactionCosts" xlink:href="fact-20221231.xsd#fact_PartialReversalOfTransactionCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_PartialReversalOfTransactionCosts_lbl" xml:lang="en-US">Reduction of transaction costs incurred in connection with IPO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PartialReversalOfTransactionCosts" xlink:to="fact_PartialReversalOfTransactionCosts_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="fact_PartialReversalOfTransactionCosts_lbl0" xml:lang="en-US">Partial reversal of transaction costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PartialReversalOfTransactionCosts" xlink:to="fact_PartialReversalOfTransactionCosts_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl" xml:lang="en-US">Change in fair value of convertible note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl0" xml:lang="en-US">Change in fair value of convertible note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average shares outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0" xml:lang="en-US">Weighted average shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic net income per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl0" xml:lang="en-US">Basic and Diluted Net Income (Loss) per shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl1" xml:lang="en-US">Basic and diluted net income per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net income per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl0" xml:lang="en-US">Diluted Net Income (Loss) per shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Sale of 34,500,000 Units on March 2, 2021 through public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Sale of 34,500,000 Units on March 2, 2021 through public offering (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0" xml:lang="en-US">Sale of Units through public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Excess of the fair value of private placement warrants over cash received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityOther_lbl" xml:lang="en-US">Class A ordinary shares subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityOther" xlink:to="us-gaap_StockholdersEquityOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xml:lang="en-US">Class A ordinary shares subject to possible redemption (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xml:lang="en-US">Remeasurement of Class A ordinary shares subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xml:lang="en-US">Proceeds received on convertible note less than fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xml:lang="en-US">Accretion portion net against additional paid-in-capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_lbl" xml:lang="en-US">Accretion of Class A ordinary shares subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:to="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Reduction of deferred underwriting fee payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl0" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ChangeInFairValueOfWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_ChangeInFairValueOfWarrantLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_ChangeInFairValueOfWarrantLiabilities_lbl" xml:lang="en-US">Change in fair value of warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ChangeInFairValueOfWarrantLiabilities" xlink:to="fact_ChangeInFairValueOfWarrantLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ChangeInDeferredUnderwritingFee" xlink:href="fact-20221231.xsd#fact_ChangeInDeferredUnderwritingFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_ChangeInDeferredUnderwritingFee_lbl" xml:lang="en-US">Change in deferred underwriting fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ChangeInDeferredUnderwritingFee" xlink:to="fact_ChangeInDeferredUnderwritingFee_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in current assets and current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract2" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract2_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract2" xlink:to="fact_UnlabeledAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing Activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_CashDepositedInTrustAccount" xlink:href="fact-20221231.xsd#fact_CashDepositedInTrustAccount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_CashDepositedInTrustAccount_lbl" xml:lang="en-US">Investment of cash into Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_CashDepositedInTrustAccount" xlink:to="fact_CashDepositedInTrustAccount_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract3" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract3_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract3" xlink:to="fact_UnlabeledAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Proceeds from Initial Public Offering, net of underwriters&#8217; discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Proceeds from issuance of Private Placement Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from issuance of Convertible Promissory Note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract4" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract4_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract4" xlink:to="fact_UnlabeledAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract5" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract5_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract5" xlink:to="fact_UnlabeledAbstract5_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of noncash financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption" xlink:href="fact-20221231.xsd#fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption_lbl" xml:lang="en-US">Initial value of Class A ordinary shares subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption" xlink:to="fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_InitialValueOfWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_InitialValueOfWarrantLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_InitialValueOfWarrantLiabilities_lbl" xml:lang="en-US">Initial value of warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InitialValueOfWarrantLiabilities" xlink:to="fact_InitialValueOfWarrantLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_DeferredOfferingCostsIncludedInAccruedExpenses" xlink:href="fact-20221231.xsd#fact_DeferredOfferingCostsIncludedInAccruedExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_DeferredOfferingCostsIncludedInAccruedExpenses_lbl" xml:lang="en-US">Deferred underwriters&#8217; discount payable charged to additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DeferredOfferingCostsIncludedInAccruedExpenses" xlink:to="fact_DeferredOfferingCostsIncludedInAccruedExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares" xlink:href="fact-20221231.xsd#fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares_lbl" xml:lang="en-US">Accretion of Class A ordinary shares subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares" xlink:to="fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_DeferredOfferingCostsPaidUnderPromissoryNote" xlink:href="fact-20221231.xsd#fact_DeferredOfferingCostsPaidUnderPromissoryNote"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_DeferredOfferingCostsPaidUnderPromissoryNote_lbl" xml:lang="en-US">Deferred offering costs paid under promissory note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DeferredOfferingCostsPaidUnderPromissoryNote" xlink:to="fact_DeferredOfferingCostsPaidUnderPromissoryNote_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Change in fair value of warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseOfferingCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoninterestExpenseOfferingCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NoninterestExpenseOfferingCost_lbl" xml:lang="en-US">Offering expenses related to warrant issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoninterestExpenseOfferingCost" xlink:to="us-gaap_NoninterestExpenseOfferingCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestIncomeOther_lbl" xml:lang="en-US">Interest earned on marketable securities held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOther" xlink:to="us-gaap_InterestIncomeOther_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_OfferingCostsAllocatedToWarrants" xlink:href="fact-20221231.xsd#fact_OfferingCostsAllocatedToWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="fact_OfferingCostsAllocatedToWarrants_lbl" xml:lang="en-US">Offering costs allocated to warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OfferingCostsAllocatedToWarrants" xlink:to="fact_OfferingCostsAllocatedToWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Repayment of promissory note to related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payments of offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Class A Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonClassAMember_lbl0" xml:lang="en-US">Class A</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonClassAMember_lbl1" xml:lang="en-US">Class A Ordinary Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl2" xml:lang="en-US">Class A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Class B Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonClassBMember_lbl0" xml:lang="en-US">Class B</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonClassBMember_lbl1" xml:lang="en-US">Class B Ordinary Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl2" xml:lang="en-US">Class B [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Ordinary Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-In Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">Organization and Business Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialStatementsTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_CondensedFinancialStatementsTextBlock_lbl" xml:lang="en-US">Revision of Previously Issued Financial Statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedFinancialStatementsTextBlock" xlink:to="srt_CondensedFinancialStatementsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock_lbl" xml:lang="en-US">Schedule of restatement of financial statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract6" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract6"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract6_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract6" xlink:to="fact_UnlabeledAbstract6_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_BalanceSheetAsOfSeptember302022UnauditedAbstract" xlink:href="fact-20221231.xsd#fact_BalanceSheetAsOfSeptember302022UnauditedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_BalanceSheetAsOfSeptember302022UnauditedAbstract_lbl" xml:lang="en-US">Balance Sheet as of September 30, 2022 (unaudited)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_BalanceSheetAsOfSeptember302022UnauditedAbstract" xlink:to="fact_BalanceSheetAsOfSeptember302022UnauditedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract7" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract7"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract7_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract7" xlink:to="fact_UnlabeledAbstract7_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl" xml:lang="en-US">Schedule of condensed statement of operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operational Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract8" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract8"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract8_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract8" xlink:to="fact_UnlabeledAbstract8_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract" xlink:href="fact-20221231.xsd#fact_CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract_lbl" xml:lang="en-US">Condensed Statement of Operations for the Six Months Ended June 30, 2022 (unaudited)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract" xlink:to="fact_CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract9" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract9"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract9_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract9" xlink:to="fact_UnlabeledAbstract9_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract" xlink:href="fact-20221231.xsd#fact_CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract_lbl" xml:lang="en-US">Condensed Statement of Operations for the Nine Months Ended September 30, 2022 (unaudited)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract" xlink:to="fact_CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract10" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract10"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract10_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract10" xlink:to="fact_UnlabeledAbstract10_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_lbl" xml:lang="en-US">Schedule of condensed statement of cash flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract11" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract11"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract11_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract11" xlink:to="fact_UnlabeledAbstract11_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract" xlink:href="fact-20221231.xsd#fact_CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract_lbl" xml:lang="en-US">Condensed Statement of Cash Flows for the Nine Months Ended September 30, 2022 (unaudited)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract" xlink:to="fact_CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl" xml:lang="en-US">Schedule of unrealized holding losses and fair value of held to maturity securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTextBlock" xlink:to="us-gaap_MarketableSecuritiesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_TradingSecuritiesFairValue" xlink:href="fact-20221231.xsd#fact_TradingSecuritiesFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_TradingSecuritiesFairValue_lbl" xml:lang="en-US">Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TradingSecuritiesFairValue" xlink:to="fact_TradingSecuritiesFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_AmortizedCostAndCarryingValue" xlink:href="fact-20221231.xsd#fact_AmortizedCostAndCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_AmortizedCostAndCarryingValue_lbl" xml:lang="en-US">Amortized Cost and Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AmortizedCostAndCarryingValue" xlink:to="fact_AmortizedCostAndCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_GrossUnrealizedGain" xlink:href="fact-20221231.xsd#fact_GrossUnrealizedGain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_GrossUnrealizedGain_lbl" xml:lang="en-US">Gross Unrealized Gains</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_GrossUnrealizedGain" xlink:to="fact_GrossUnrealizedGain_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_GrossUnrealizedGainsAndLosses" xlink:href="fact-20221231.xsd#fact_GrossUnrealizedGainsAndLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_GrossUnrealizedGainsAndLosses_lbl" xml:lang="en-US">Gross Unrealized Gains (Losses)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_GrossUnrealizedGainsAndLosses" xlink:to="fact_GrossUnrealizedGainsAndLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of basic and diluted net income per share for each class of ordinary share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_BasicAndDilutedNetIncomePerShareAbstract" xlink:href="fact-20221231.xsd#fact_BasicAndDilutedNetIncomePerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_BasicAndDilutedNetIncomePerShareAbstract_lbl" xml:lang="en-US">Basic and diluted net income per share:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_BasicAndDilutedNetIncomePerShareAbstract" xlink:to="fact_BasicAndDilutedNetIncomePerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_NumeratorAbstract" xlink:href="fact-20221231.xsd#fact_NumeratorAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_NumeratorAbstract_lbl" xml:lang="en-US">Numerator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_NumeratorAbstract" xlink:to="fact_NumeratorAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_AllocationOfNetIncome" xlink:href="fact-20221231.xsd#fact_AllocationOfNetIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_AllocationOfNetIncome_lbl" xml:lang="en-US">Allocation of net income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AllocationOfNetIncome" xlink:to="fact_AllocationOfNetIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_DenominatorAbstract" xlink:href="fact-20221231.xsd#fact_DenominatorAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_DenominatorAbstract_lbl" xml:lang="en-US">Denominator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DenominatorAbstract" xlink:to="fact_DenominatorAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ProposedPublicOfferingDisclosureTextBlock" xlink:href="fact-20221231.xsd#fact_ProposedPublicOfferingDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_ProposedPublicOfferingDisclosureTextBlock_lbl" xml:lang="en-US">Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ProposedPublicOfferingDisclosureTextBlock" xlink:to="fact_ProposedPublicOfferingDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_lbl" xml:lang="en-US">Schedule of the ordinary share reflected on the balance sheet are reconciled</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ProceedsFromGrossProceedsFromIPO" xlink:href="fact-20221231.xsd#fact_ProceedsFromGrossProceedsFromIPO"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_ProceedsFromGrossProceedsFromIPO_lbl" xml:lang="en-US">Gross proceeds from IPO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ProceedsFromGrossProceedsFromIPO" xlink:to="fact_ProceedsFromGrossProceedsFromIPO_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_LessAbstract" xlink:href="fact-20221231.xsd#fact_LessAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_LessAbstract_lbl" xml:lang="en-US">Less:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_LessAbstract" xlink:to="fact_LessAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Ordinary share issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_PlusAbstract" xlink:href="fact-20221231.xsd#fact_PlusAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_PlusAbstract_lbl" xml:lang="en-US">Plus:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PlusAbstract" xlink:to="fact_PlusAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl" xml:lang="en-US">Accretion of carrying value to redemption value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_PlusAbstract0" xlink:href="fact-20221231.xsd#fact_PlusAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_PlusAbstract0_lbl" xml:lang="en-US">Plus:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PlusAbstract0" xlink:to="fact_PlusAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityOtherChanges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityOtherChanges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityOtherChanges_lbl" xml:lang="en-US">Accretion of carrying value to redemption value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityOtherChanges" xlink:to="us-gaap_TemporaryEquityOtherChanges_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_PrivatePlacementWarrantsDisclosureTextBlock" xlink:href="fact-20221231.xsd#fact_PrivatePlacementWarrantsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_PrivatePlacementWarrantsDisclosureTextBlock_lbl" xml:lang="en-US">Private Placement Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PrivatePlacementWarrantsDisclosureTextBlock" xlink:to="fact_PrivatePlacementWarrantsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments &amp; Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Shareholders&#8217; Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantsDisclosureTextBlock" xlink:href="fact-20221231.xsd#fact_WarrantsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_WarrantsDisclosureTextBlock_lbl" xml:lang="en-US">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantsDisclosureTextBlock" xlink:to="fact_WarrantsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Schedule of assets that are measured at fair value on a recurring basis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_DescriptionAbstract" xlink:href="fact-20221231.xsd#fact_DescriptionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_DescriptionAbstract_lbl" xml:lang="en-US">Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DescriptionAbstract" xlink:to="fact_DescriptionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_InvestmentsHeldInTrustAccountUSTreasureSecurities" xlink:href="fact-20221231.xsd#fact_InvestmentsHeldInTrustAccountUSTreasureSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_InvestmentsHeldInTrustAccountUSTreasureSecurities_lbl" xml:lang="en-US">Investments held in trust account- U.S. Treasury Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentsHeldInTrustAccountUSTreasureSecurities" xlink:to="fact_InvestmentsHeldInTrustAccountUSTreasureSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_InvestmentsHeldInTrustAccountNet" xlink:href="fact-20221231.xsd#fact_InvestmentsHeldInTrustAccountNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_InvestmentsHeldInTrustAccountNet_lbl" xml:lang="en-US">Total Investments held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentsHeldInTrustAccountNet" xlink:to="fact_InvestmentsHeldInTrustAccountNet_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract12" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract12"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract12_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract12" xlink:to="fact_UnlabeledAbstract12_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantLiabilitiesPublicWarrants" xlink:href="fact-20221231.xsd#fact_WarrantLiabilitiesPublicWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_WarrantLiabilitiesPublicWarrants_lbl" xml:lang="en-US">Warrant liabilities &#8211; Public warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantLiabilitiesPublicWarrants" xlink:to="fact_WarrantLiabilitiesPublicWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantLiabilitiesPrivateWarrants" xlink:href="fact-20221231.xsd#fact_WarrantLiabilitiesPrivateWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_WarrantLiabilitiesPrivateWarrants_lbl" xml:lang="en-US">Warrant liabilities &#8211; Private warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantLiabilitiesPrivateWarrants" xlink:to="fact_WarrantLiabilitiesPrivateWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ConvertibleNoteAmount" xlink:href="fact-20221231.xsd#fact_ConvertibleNoteAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_ConvertibleNoteAmount_lbl" xml:lang="en-US">Convertible Note &#8211; April 1, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ConvertibleNoteAmount" xlink:to="fact_ConvertibleNoteAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ConvertibleNoteone" xlink:href="fact-20221231.xsd#fact_ConvertibleNoteone"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_ConvertibleNoteone_lbl" xml:lang="en-US">Convertible Note &#8211; June 6, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ConvertibleNoteone" xlink:to="fact_ConvertibleNoteone_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ConvertibleNotesTwo" xlink:href="fact-20221231.xsd#fact_ConvertibleNotesTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_ConvertibleNotesTwo_lbl" xml:lang="en-US">Convertible Note &#8211; December 14, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ConvertibleNotesTwo" xlink:to="fact_ConvertibleNotesTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_TotalWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_TotalWarrantLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_TotalWarrantLiabilities_lbl" xml:lang="en-US">Total Warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TotalWarrantLiabilities" xlink:to="fact_TotalWarrantLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_DescriptionAbstract0" xlink:href="fact-20221231.xsd#fact_DescriptionAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_DescriptionAbstract0_lbl" xml:lang="en-US">Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DescriptionAbstract0" xlink:to="fact_DescriptionAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund" xlink:href="fact-20221231.xsd#fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund_lbl" xml:lang="en-US">Investments held in trust account- U.S. Money Market Fund</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund" xlink:to="fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_UnlabeledAbstract13" xlink:href="fact-20221231.xsd#fact_UnlabeledAbstract13"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_UnlabeledAbstract13_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract13" xlink:to="fact_UnlabeledAbstract13_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">Schedule of quantitative information regarding Level 3 fair value measurements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_lbl0" xml:lang="en-US">Common stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementStrikePrice" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementStrikePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_FairValueMeasurementStrikePrice_lbl" xml:lang="en-US">Strike price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueMeasurementStrikePrice" xlink:to="fact_FairValueMeasurementStrikePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Term (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates" xlink:href="fact-20221231.xsd#fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates_lbl" xml:lang="en-US">Volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates" xlink:to="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of changes in the fair value of warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_lbl" xml:lang="en-US">Change in valuation inputs or other assumptions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_lbl0" xml:lang="en-US">Change in fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueInitialMeasurement" xlink:href="fact-20221231.xsd#fact_FairValueInitialMeasurement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_FairValueInitialMeasurement_lbl" xml:lang="en-US">Initial measurement on March 2, 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueInitialMeasurement" xlink:to="fact_FairValueInitialMeasurement_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock" xlink:href="fact-20221231.xsd#fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of changes in the fair value of level 3 warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock" xlink:to="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueAssetsLevel1ToLevel2TransferAmount" xlink:href="fact-20221231.xsd#fact_FairValueAssetsLevel1ToLevel2TransferAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_FairValueAssetsLevel1ToLevel2TransferAmount_lbl" xml:lang="en-US">Transfer to Level 1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueAssetsLevel1ToLevel2TransferAmount" xlink:to="fact_FairValueAssetsLevel1ToLevel2TransferAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Proceeds allocated to Public Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">As Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl0" xml:lang="en-US">Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_RestatementAdjustmentMember_lbl" xml:lang="en-US">Adjustment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAdjustmentMember" xlink:to="srt_RestatementAdjustmentMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_RestatementAdjustmentMember_lbl0" xml:lang="en-US">Adjusted [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAdjustmentMember" xlink:to="srt_RestatementAdjustmentMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_AsRestatedMember" xlink:href="fact-20221231.xsd#fact_AsRestatedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_AsRestatedMember_lbl" xml:lang="en-US">As Restated [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AsRestatedMember" xlink:to="fact_AsRestatedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashMember_lbl" xml:lang="en-US">Cash [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashMember" xlink:to="us-gaap_CashMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US">Money Market Funds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xml:lang="en-US">U.S. Treasury Securities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Quoted Prices In Active Markets (Level 1) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Significant Other Observable Inputs (Level 2) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Significant Other Unobservable Inputs (Level 3) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_PublicMember" xlink:href="fact-20221231.xsd#fact_PublicMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_PublicMember_lbl" xml:lang="en-US">Public [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PublicMember" xlink:to="fact_PublicMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PrivatePlacementMember_lbl0" xml:lang="en-US">Private Placement Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantMember_lbl0" xml:lang="en-US">Total Warrant Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_WarrantMember_lbl1" xml:lang="en-US">Private Placement Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl2" xml:lang="en-US">Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Consummated share units (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Price per unit (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_GeneratingGrossProceeds" xlink:href="fact-20221231.xsd#fact_GeneratingGrossProceeds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_GeneratingGrossProceeds_lbl" xml:lang="en-US">Generating gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_GeneratingGrossProceeds" xlink:to="fact_GeneratingGrossProceeds_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xml:lang="en-US">Transaction costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherUnderwritingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherUnderwritingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherUnderwritingExpense_lbl" xml:lang="en-US">Underwriting fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherUnderwritingExpense" xlink:to="us-gaap_OtherUnderwritingExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherUnderwritingExpense_lbl0" xml:lang="en-US">Underwriting discount amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherUnderwritingExpense" xlink:to="us-gaap_OtherUnderwritingExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_DeferredUnderwritingFee" xlink:href="fact-20221231.xsd#fact_DeferredUnderwritingFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_DeferredUnderwritingFee_lbl" xml:lang="en-US">Deferred underwriting fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DeferredUnderwritingFee" xlink:to="fact_DeferredUnderwritingFee_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOwnershipInterestsOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOwnershipInterestsOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherOwnershipInterestsOfferingCosts_lbl" xml:lang="en-US">Other offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOwnershipInterestsOfferingCosts" xlink:to="us-gaap_OtherOwnershipInterestsOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_TotalTransactionCost" xlink:href="fact-20221231.xsd#fact_TotalTransactionCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_TotalTransactionCost_lbl" xml:lang="en-US">Total transaction cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TotalTransactionCost" xlink:to="fact_TotalTransactionCost_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_NetProceedsOfTheSaleOfTheUnits" xlink:href="fact-20221231.xsd#fact_NetProceedsOfTheSaleOfTheUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_NetProceedsOfTheSaleOfTheUnits_lbl" xml:lang="en-US">Net proceeds of the sale of the units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_NetProceedsOfTheSaleOfTheUnits" xlink:to="fact_NetProceedsOfTheSaleOfTheUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_BusinessCombinationFairMarketValueEqualPercentage" xlink:href="fact-20221231.xsd#fact_BusinessCombinationFairMarketValueEqualPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_BusinessCombinationFairMarketValueEqualPercentage_lbl" xml:lang="en-US">Business combination fair market value equal percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_BusinessCombinationFairMarketValueEqualPercentage" xlink:to="fact_BusinessCombinationFairMarketValueEqualPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Percentage of outstanding voting securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xml:lang="en-US">Trust account price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl0" xml:lang="en-US">Class A ordinary shares equals or exceeds (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_NetTangibleAssets" xlink:href="fact-20221231.xsd#fact_NetTangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_NetTangibleAssets_lbl" xml:lang="en-US">Net tangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_NetTangibleAssets" xlink:to="fact_NetTangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_RedeemPublicSharesPercentage" xlink:href="fact-20221231.xsd#fact_RedeemPublicSharesPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_RedeemPublicSharesPercentage_lbl" xml:lang="en-US">Redeem public shares, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_RedeemPublicSharesPercentage" xlink:to="fact_RedeemPublicSharesPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_PublicPerShare" xlink:href="fact-20221231.xsd#fact_PublicPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_PublicPerShare_lbl" xml:lang="en-US">Public per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PublicPerShare" xlink:to="fact_PublicPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_TrustAccountPerShare" xlink:href="fact-20221231.xsd#fact_TrustAccountPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_TrustAccountPerShare_lbl" xml:lang="en-US">Trust account per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TrustAccountPerShare" xlink:to="fact_TrustAccountPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsHeldInTrust_lbl" xml:lang="en-US">Cash outside the trust account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrust" xlink:to="us-gaap_AssetsHeldInTrust_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal excise tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">Excise tax percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableOtherCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_OperationalCosts" xlink:href="fact-20221231.xsd#fact_OperationalCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_OperationalCosts_lbl" xml:lang="en-US">Operational costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OperationalCosts" xlink:to="fact_OperationalCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash in trust account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">Federal depository insurance coverage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_OrdinarySharesSubjectToPossibleRedemption" xlink:href="fact-20221231.xsd#fact_OrdinarySharesSubjectToPossibleRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_OrdinarySharesSubjectToPossibleRedemption_lbl" xml:lang="en-US">Ordinary shares subject to possible redemption (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OrdinarySharesSubjectToPossibleRedemption" xlink:to="fact_OrdinarySharesSubjectToPossibleRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantsPurchase" xlink:href="fact-20221231.xsd#fact_WarrantsPurchase"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_WarrantsPurchase_lbl" xml:lang="en-US">Warrants purchase (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantsPurchase" xlink:to="fact_WarrantsPurchase_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xml:lang="en-US">Offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_lbl" xml:lang="en-US">Underwriting fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:to="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Ordinary shares warrants issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_DerivativeWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_DerivativeWarrantLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_DerivativeWarrantLiabilities_lbl" xml:lang="en-US">Derivative warrant liabilities (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DerivativeWarrantLiabilities" xlink:to="fact_DerivativeWarrantLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Sale of unit (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl0" xml:lang="en-US">Price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockNoParValue_lbl" xml:lang="en-US">Ordinary share, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNoParValue" xlink:to="us-gaap_CommonStockNoParValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl" xml:lang="en-US">Warrant price, per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_SaleOfOrdinarySharesRedemption" xlink:href="fact-20221231.xsd#fact_SaleOfOrdinarySharesRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_SaleOfOrdinarySharesRedemption_lbl" xml:lang="en-US">Sale of ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SaleOfOrdinarySharesRedemption" xlink:to="fact_SaleOfOrdinarySharesRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Purchase of warrants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0" xml:lang="en-US">Price per warrant (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" xml:lang="en-US">Warrant exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1"/>
    <loc xlink:type="locator" xlink:label="fact_AggregatePurchasePrice" xlink:href="fact-20221231.xsd#fact_AggregatePurchasePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_AggregatePurchasePrice_lbl" xml:lang="en-US">Aggregate purchase price (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AggregatePurchasePrice" xlink:to="fact_AggregatePurchasePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_StockIssuedDuringPeriodSponsorAmount" xlink:href="fact-20221231.xsd#fact_StockIssuedDuringPeriodSponsorAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_StockIssuedDuringPeriodSponsorAmount_lbl" xml:lang="en-US">Sponsor amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_StockIssuedDuringPeriodSponsorAmount" xlink:to="fact_StockIssuedDuringPeriodSponsorAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Consideration shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssued_lbl0" xml:lang="en-US">Shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockOtherSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockOtherSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockOtherSharesOutstanding_lbl" xml:lang="en-US">Ordinary shares outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockOtherSharesOutstanding" xlink:to="us-gaap_CommonStockOtherSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_SponsorShare" xlink:href="fact-20221231.xsd#fact_SponsorShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_SponsorShare_lbl" xml:lang="en-US">Sponsor share (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SponsorShare" xlink:to="fact_SponsorShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_lbl" xml:lang="en-US">Fair value of shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:to="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare_lbl" xml:lang="en-US">Fair value per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare" xlink:to="us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLongTermDebt_lbl" xml:lang="en-US">Agreed to loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermDebt" xlink:to="us-gaap_OtherLongTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_WorkingCapitalLoans" xlink:href="fact-20221231.xsd#fact_WorkingCapitalLoans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_WorkingCapitalLoans_lbl" xml:lang="en-US">Working capital loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WorkingCapitalLoans" xlink:to="fact_WorkingCapitalLoans_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_PromissioryNoteRelatedParty" xlink:href="fact-20221231.xsd#fact_PromissioryNoteRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_PromissioryNoteRelatedParty_lbl" xml:lang="en-US">Promissory note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PromissioryNoteRelatedParty" xlink:to="fact_PromissioryNoteRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfUnsecuredDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt_lbl" xml:lang="en-US">Issued unsecured promissory note amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantExercisePriceDecrease_lbl" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceDecrease" xlink:to="us-gaap_WarrantExercisePriceDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xml:lang="en-US">Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_OfficeSpaceAndAdministrativeSupportServices" xlink:href="fact-20221231.xsd#fact_OfficeSpaceAndAdministrativeSupportServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_OfficeSpaceAndAdministrativeSupportServices_lbl" xml:lang="en-US">Sponsor amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OfficeSpaceAndAdministrativeSupportServices" xlink:to="fact_OfficeSpaceAndAdministrativeSupportServices_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_DeferredUnderwritingDiscountPerUnit" xlink:href="fact-20221231.xsd#fact_DeferredUnderwritingDiscountPerUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_DeferredUnderwritingDiscountPerUnit_lbl" xml:lang="en-US">Deferred underwriting discount, per unit (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DeferredUnderwritingDiscountPerUnit" xlink:to="fact_DeferredUnderwritingDiscountPerUnit_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_AggregateGrossProceeds" xlink:href="fact-20221231.xsd#fact_AggregateGrossProceeds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_AggregateGrossProceeds_lbl" xml:lang="en-US">Aggregate amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AggregateGrossProceeds" xlink:to="fact_AggregateGrossProceeds_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DividendsCommonStockCash_lbl" xml:lang="en-US">Acquiror Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCommonStockCash" xlink:to="us-gaap_DividendsCommonStockCash_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalDeferredPurchasePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalDeferredPurchasePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalDeferredPurchasePrice_lbl" xml:lang="en-US">Aggregate purchase price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalDeferredPurchasePrice" xlink:to="us-gaap_SupplementalDeferredPurchasePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_OrdinarySharesDescription" xlink:href="fact-20221231.xsd#fact_OrdinarySharesDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_OrdinarySharesDescription_lbl" xml:lang="en-US">Ordinary shares, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OrdinarySharesDescription" xlink:to="fact_OrdinarySharesDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_TotalNumberOfOrdinarySharesOutstandingPercentage" xlink:href="fact-20221231.xsd#fact_TotalNumberOfOrdinarySharesOutstandingPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_TotalNumberOfOrdinarySharesOutstandingPercentage_lbl" xml:lang="en-US">Total number of ordinary shares outstanding percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TotalNumberOfOrdinarySharesOutstandingPercentage" xlink:to="fact_TotalNumberOfOrdinarySharesOutstandingPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantTerm" xlink:href="fact-20221231.xsd#fact_WarrantTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_WarrantTerm_lbl" xml:lang="en-US">Warrant term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantTerm" xlink:to="fact_WarrantTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantExpirationTerm" xlink:href="fact-20221231.xsd#fact_WarrantExpirationTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_WarrantExpirationTerm_lbl" xml:lang="en-US">Warrant expiration term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantExpirationTerm" xlink:to="fact_WarrantExpirationTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl" xml:lang="en-US">Business combination, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_RedemptionsOfWarrantsDescription" xlink:href="fact-20221231.xsd#fact_RedemptionsOfWarrantsDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_RedemptionsOfWarrantsDescription_lbl" xml:lang="en-US">Redemptions of warrants, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_RedemptionsOfWarrantsDescription" xlink:to="fact_RedemptionsOfWarrantsDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3_lbl" xml:lang="en-US">Transferred amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3" xlink:to="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_FairValueWarrantLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_FairValueWarrantLiabilities_lbl" xml:lang="en-US">Fair value warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueWarrantLiabilities" xlink:to="fact_FairValueWarrantLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_VotingPowerPercentage" xlink:href="fact-20221231.xsd#fact_VotingPowerPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_VotingPowerPercentage_lbl" xml:lang="en-US">Voting power percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_VotingPowerPercentage" xlink:to="fact_VotingPowerPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_IssuedAndOutstandingShares" xlink:href="fact-20221231.xsd#fact_IssuedAndOutstandingShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_IssuedAndOutstandingShares_lbl" xml:lang="en-US">Issued and outstanding ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_IssuedAndOutstandingShares" xlink:to="fact_IssuedAndOutstandingShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonUnitOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonUnitOutstanding_lbl" xml:lang="en-US">Outstanding shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitOutstanding" xlink:to="us-gaap_CommonUnitOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ExtensionAmendmentProposalFor" xlink:href="fact-20221231.xsd#fact_ExtensionAmendmentProposalFor"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_ExtensionAmendmentProposalFor_lbl" xml:lang="en-US">Extension amendment proposal for</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ExtensionAmendmentProposalFor" xlink:to="fact_ExtensionAmendmentProposalFor_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ExtensionAmendmentProposalAgainst" xlink:href="fact-20221231.xsd#fact_ExtensionAmendmentProposalAgainst"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_ExtensionAmendmentProposalAgainst_lbl" xml:lang="en-US">Extension amendment proposal against</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ExtensionAmendmentProposalAgainst" xlink:to="fact_ExtensionAmendmentProposalAgainst_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ExtensionAmendmentProposalAbstain" xlink:href="fact-20221231.xsd#fact_ExtensionAmendmentProposalAbstain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_ExtensionAmendmentProposalAbstain_lbl" xml:lang="en-US">Extension amendment proposal abstain</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ExtensionAmendmentProposalAbstain" xlink:to="fact_ExtensionAmendmentProposalAbstain_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_AggregateSharesOfCommonStock" xlink:href="fact-20221231.xsd#fact_AggregateSharesOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_AggregateSharesOfCommonStock_lbl" xml:lang="en-US">Aggregate ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AggregateSharesOfCommonStock" xlink:to="fact_AggregateSharesOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US">Redemption price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_IssuedAndOutstandingInterestPercentage" xlink:href="fact-20221231.xsd#fact_IssuedAndOutstandingInterestPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_IssuedAndOutstandingInterestPercentage_lbl" xml:lang="en-US">Issued and outstanding interest percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_IssuedAndOutstandingInterestPercentage" xlink:to="fact_IssuedAndOutstandingInterestPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl" xml:lang="en-US">Redemption amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockHeldInTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockHeldInTrust"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockHeldInTrust_lbl" xml:lang="en-US">Trust account (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockHeldInTrust" xlink:to="us-gaap_CommonStockHeldInTrust_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_lbl" xml:lang="en-US">Remaining shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_InvestmentManagementTrustAgreementFor" xlink:href="fact-20221231.xsd#fact_InvestmentManagementTrustAgreementFor"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_InvestmentManagementTrustAgreementFor_lbl" xml:lang="en-US">Investment management trust agreement for</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentManagementTrustAgreementFor" xlink:to="fact_InvestmentManagementTrustAgreementFor_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_InvestmentManagementTrustAgreementAgainst" xlink:href="fact-20221231.xsd#fact_InvestmentManagementTrustAgreementAgainst"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_InvestmentManagementTrustAgreementAgainst_lbl" xml:lang="en-US">Investment management trust agreement against</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentManagementTrustAgreementAgainst" xlink:to="fact_InvestmentManagementTrustAgreementAgainst_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_InvestmentManagementTrustAgreementAbstain" xlink:href="fact-20221231.xsd#fact_InvestmentManagementTrustAgreementAbstain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_InvestmentManagementTrustAgreementAbstain_lbl" xml:lang="en-US">Investment management trust agreement against</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentManagementTrustAgreementAbstain" xlink:to="fact_InvestmentManagementTrustAgreementAbstain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfUnsecuredDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt_lbl" xml:lang="en-US">Unsecured promissory note (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfUnsecuredDebt" xlink:to="us-gaap_RepaymentsOfUnsecuredDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_PromissoryNote" xlink:href="fact-20221231.xsd#fact_PromissoryNote"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_PromissoryNote_lbl" xml:lang="en-US">Promissory note (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PromissoryNote" xlink:to="fact_PromissoryNote_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_DrawnDownAmount" xlink:href="fact-20221231.xsd#fact_DrawnDownAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_DrawnDownAmount_lbl" xml:lang="en-US">Drawn down amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DrawnDownAmount" xlink:to="fact_DrawnDownAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:href="fact-20221231.xsd#fact_EmergingGrowthCompanyStatusPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_EmergingGrowthCompanyStatusPolicyTextBlock_lbl" xml:lang="en-US">Emerging Growth Company</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZTEDkh6awj/BIIReKzb4sGTz1n4Qtz6doLW75LUrO5BZN95BNU5gyy58yAPWsdJIHcPZx1o6NM2CjhVzEFw7kOzrV8JjqYIRJQ4gEvu2u5sh+julvljtKtVlqFYmOCh9+g/cfz7LLZtgz2FLPFuCP/fwdCLWDj3vDJhSjrrMe+hNfAR6gadd95D99SFm84TXw4CoXgLsK04ATVN75KpzRVmlBZd3juEGKPGRtorCEHVQ==] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:to="fact_EmergingGrowthCompanyStatusPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investments Held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock" xlink:href="fact-20221231.xsd#fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock_lbl" xml:lang="en-US">Convertible Promissory Notes&#8212;Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock" xlink:to="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl" xml:lang="en-US">Ordinary Shares Subject to Possible Redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Income Per Ordinary Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xml:lang="en-US">Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Derivative Warrant Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IPOMember_lbl0" xml:lang="en-US">Initial Public Offering [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xml:lang="en-US">Business Combination [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl0" xml:lang="en-US">Business Acquisition [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_FounderSharesMember" xlink:href="fact-20221231.xsd#fact_FounderSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_FounderSharesMember_lbl" xml:lang="en-US">Founder Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FounderSharesMember" xlink:to="fact_FounderSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_BusinessCombinationMember" xlink:href="fact-20221231.xsd#fact_BusinessCombinationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_BusinessCombinationMember_lbl" xml:lang="en-US">Business Combination [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_BusinessCombinationMember" xlink:to="fact_BusinessCombinationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_PublicWarrantsMember" xlink:href="fact-20221231.xsd#fact_PublicWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="fact_PublicWarrantsMember_lbl" xml:lang="en-US">Public Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PublicWarrantsMember" xlink:to="fact_PublicWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementDomain_lbl" xml:lang="en-US">Revision of Prior Period [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTable_lbl" xml:lang="en-US">Condensed Financial Statements [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedFinancialStatementsCaptionsLineItems_lbl" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="srt_CondensedFinancialStatementsCaptionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedIncomeStatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedIncomeStatementTable_lbl" xml:lang="en-US">Condensed Income Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_CondensedIncomeStatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems_lbl" xml:lang="en-US">Condensed Income Statements, Captions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="srt_CondensedIncomeStatementsCaptionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedCashFlowStatementTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedCashFlowStatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedCashFlowStatementTable_lbl" xml:lang="en-US">Condensed Cash Flow Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedCashFlowStatementTable" xlink:to="srt_CondensedCashFlowStatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedCashFlowStatementsCaptionsLineItems_lbl" xml:lang="en-US">Condensed Cash Flow Statements, Captions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="srt_CondensedCashFlowStatementsCaptionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xml:lang="en-US">Cash and Cash Equivalents [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesTable_lbl" xml:lang="en-US">Marketable Securities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesLineItems_lbl" xml:lang="en-US">Marketable Securities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable" xlink:href="fact-20221231.xsd#fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of basic and diluted net income per share for each class of ordinary share [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable" xlink:to="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems" xlink:href="fact-20221231.xsd#fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of basic and diluted net income per share for each class of ordinary share [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems" xlink:to="fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable_lbl" xml:lang="en-US">Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable" xlink:to="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems_lbl" xml:lang="en-US">Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US">Sale of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable_lbl" xml:lang="en-US">Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable" xlink:to="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems_lbl" xml:lang="en-US">Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems" xlink:to="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable_lbl" xml:lang="en-US">Fair Value Measurements (Details) - Schedule of changes in the fair value of level 3 warrant liabilities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" xlink:to="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems_lbl" xml:lang="en-US">Fair Value Measurements (Details) - Schedule of changes in the fair value of level 3 warrant liabilities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" xlink:to="fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_OrganizationandBusinessOperationsDetailsTable" xlink:href="fact-20221231.xsd#fact_OrganizationandBusinessOperationsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_OrganizationandBusinessOperationsDetailsTable_lbl" xml:lang="en-US">Organization and Business Operations (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OrganizationandBusinessOperationsDetailsTable" xlink:to="fact_OrganizationandBusinessOperationsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_OrganizationandBusinessOperationsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_OrganizationandBusinessOperationsDetailsLineItems_lbl" xml:lang="en-US">Organization and Business Operations (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OrganizationandBusinessOperationsDetailsLineItems" xlink:to="fact_OrganizationandBusinessOperationsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_SignificantAccountingPoliciesDetailsTable" xlink:href="fact-20221231.xsd#fact_SignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_SignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SignificantAccountingPoliciesDetailsTable" xlink:to="fact_SignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:href="fact-20221231.xsd#fact_SignificantAccountingPoliciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_SignificantAccountingPoliciesDetailsLineItems_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SignificantAccountingPoliciesDetailsLineItems" xlink:to="fact_SignificantAccountingPoliciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_InitialPublicOfferingDetailsTable" xlink:href="fact-20221231.xsd#fact_InitialPublicOfferingDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_InitialPublicOfferingDetailsTable_lbl" xml:lang="en-US">Initial Public Offering (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InitialPublicOfferingDetailsTable" xlink:to="fact_InitialPublicOfferingDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_InitialPublicOfferingDetailsLineItems" xlink:href="fact-20221231.xsd#fact_InitialPublicOfferingDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_InitialPublicOfferingDetailsLineItems_lbl" xml:lang="en-US">Initial Public Offering (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InitialPublicOfferingDetailsLineItems" xlink:to="fact_InitialPublicOfferingDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_PrivatePlacementWarrantsDetailsTable" xlink:href="fact-20221231.xsd#fact_PrivatePlacementWarrantsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_PrivatePlacementWarrantsDetailsTable_lbl" xml:lang="en-US">Private Placement Warrants (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PrivatePlacementWarrantsDetailsTable" xlink:to="fact_PrivatePlacementWarrantsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_PrivatePlacementWarrantsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_PrivatePlacementWarrantsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_PrivatePlacementWarrantsDetailsLineItems_lbl" xml:lang="en-US">Private Placement Warrants (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PrivatePlacementWarrantsDetailsLineItems" xlink:to="fact_PrivatePlacementWarrantsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US">Title of Individual [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_RelatedPartyTransactionsDetailsTable" xlink:href="fact-20221231.xsd#fact_RelatedPartyTransactionsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_RelatedPartyTransactionsDetailsTable_lbl" xml:lang="en-US">Related Party Transactions (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_RelatedPartyTransactionsDetailsTable" xlink:to="fact_RelatedPartyTransactionsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_RelatedPartyTransactionsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_RelatedPartyTransactionsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_RelatedPartyTransactionsDetailsLineItems_lbl" xml:lang="en-US">Related Party Transactions (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_RelatedPartyTransactionsDetailsLineItems" xlink:to="fact_RelatedPartyTransactionsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_CommitmentsContingenciesDetailsTable" xlink:href="fact-20221231.xsd#fact_CommitmentsContingenciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_CommitmentsContingenciesDetailsTable_lbl" xml:lang="en-US">Commitments &amp; Contingencies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_CommitmentsContingenciesDetailsTable" xlink:to="fact_CommitmentsContingenciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_CommitmentsContingenciesDetailsLineItems" xlink:href="fact-20221231.xsd#fact_CommitmentsContingenciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_CommitmentsContingenciesDetailsLineItems_lbl" xml:lang="en-US">Commitments &amp; Contingencies (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_CommitmentsContingenciesDetailsLineItems" xlink:to="fact_CommitmentsContingenciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ShareholdersDeficitDetailsTable" xlink:href="fact-20221231.xsd#fact_ShareholdersDeficitDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ShareholdersDeficitDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Deficit (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ShareholdersDeficitDetailsTable" xlink:to="fact_ShareholdersDeficitDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_ShareholdersDeficitDetailsLineItems" xlink:href="fact-20221231.xsd#fact_ShareholdersDeficitDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ShareholdersDeficitDetailsLineItems_lbl" xml:lang="en-US">Shareholders&#8217; Deficit (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ShareholdersDeficitDetailsLineItems" xlink:to="fact_ShareholdersDeficitDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantsDetailsTable" xlink:href="fact-20221231.xsd#fact_WarrantsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_WarrantsDetailsTable_lbl" xml:lang="en-US">Warrants (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantsDetailsTable" xlink:to="fact_WarrantsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_WarrantsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_WarrantsDetailsLineItems_lbl" xml:lang="en-US">Warrants (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantsDetailsLineItems" xlink:to="fact_WarrantsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsTable" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_FairValueMeasurementsDetailsTable_lbl" xml:lang="en-US">Fair Value Measurements (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueMeasurementsDetailsTable" xlink:to="fact_FairValueMeasurementsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_FairValueMeasurementsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_FairValueMeasurementsDetailsLineItems_lbl" xml:lang="en-US">Fair Value Measurements (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueMeasurementsDetailsLineItems" xlink:to="fact_FairValueMeasurementsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_SubsequentEventsDetailsTable" xlink:href="fact-20221231.xsd#fact_SubsequentEventsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_SubsequentEventsDetailsTable_lbl" xml:lang="en-US">Subsequent Events (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SubsequentEventsDetailsTable" xlink:to="fact_SubsequentEventsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="fact_SubsequentEventsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_SubsequentEventsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_SubsequentEventsDetailsLineItems_lbl" xml:lang="en-US">Subsequent Events (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SubsequentEventsDetailsLineItems" xlink:to="fact_SubsequentEventsDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares_lbl0" xml:lang="en-US">The amount of accretion of Class A ordinary shares subject to possible redemption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares" xlink:to="fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_AggregateGrossProceeds_lbl0" xml:lang="en-US">Aggregate gross proceeds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AggregateGrossProceeds" xlink:to="fact_AggregateGrossProceeds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_AggregatePurchasePrice_lbl0" xml:lang="en-US">The amount of aggregate purchase price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AggregatePurchasePrice" xlink:to="fact_AggregatePurchasePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_AggregateSharesOfCommonStock_lbl0" xml:lang="en-US">Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AggregateSharesOfCommonStock" xlink:to="fact_AggregateSharesOfCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_AllocationOfNetIncome_lbl0" xml:lang="en-US">The amount of net income.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AllocationOfNetIncome" xlink:to="fact_AllocationOfNetIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_AmortizedCostAndCarryingValue_lbl0" xml:lang="en-US">Amortized cost and carrying value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AmortizedCostAndCarryingValue" xlink:to="fact_AmortizedCostAndCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_BusinessCombinationFairMarketValueEqualPercentage_lbl0" xml:lang="en-US">Business combination fair market value equal percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_BusinessCombinationFairMarketValueEqualPercentage" xlink:to="fact_BusinessCombinationFairMarketValueEqualPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_CashDepositedInTrustAccount_lbl0" xml:lang="en-US">Cash deposited in Trust Account.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_CashDepositedInTrustAccount" xlink:to="fact_CashDepositedInTrustAccount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_ChangeInDeferredUnderwritingFee_lbl0" xml:lang="en-US">Change in deferred underwriting fee.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ChangeInDeferredUnderwritingFee" xlink:to="fact_ChangeInDeferredUnderwritingFee_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_ChangeInFairValueOfWarrantLiabilities_lbl0" xml:lang="en-US">Change in fair value of warrant liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ChangeInFairValueOfWarrantLiabilities" xlink:to="fact_ChangeInFairValueOfWarrantLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_CommonStockValueOne_lbl0" xml:lang="en-US">Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders&apos; equity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_CommonStockValueOne" xlink:to="fact_CommonStockValueOne_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_ConvertibleNoteAmount_lbl0" xml:lang="en-US">The amount of convertible note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ConvertibleNoteAmount" xlink:to="fact_ConvertibleNoteAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_ConvertibleNoteone_lbl0" xml:lang="en-US">The amount of convertible note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ConvertibleNoteone" xlink:to="fact_ConvertibleNoteone_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_ConvertibleNotesTwo_lbl0" xml:lang="en-US">The amount of convertible note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ConvertibleNotesTwo" xlink:to="fact_ConvertibleNotesTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy related to convertible promissory note related party.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock" xlink:to="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_DeferredOfferingCostsIncludedInAccruedExpenses_lbl0" xml:lang="en-US">The amount is deferred offering costs included in accrued expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DeferredOfferingCostsIncludedInAccruedExpenses" xlink:to="fact_DeferredOfferingCostsIncludedInAccruedExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_DeferredOfferingCostsPaidUnderPromissoryNote_lbl0" xml:lang="en-US">The amount of deferred offering costs paid under promissory note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DeferredOfferingCostsPaidUnderPromissoryNote" xlink:to="fact_DeferredOfferingCostsPaidUnderPromissoryNote_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_DeferredUnderwritingDiscountPerUnit_lbl0" xml:lang="en-US">Deferred underwriting discount, per unit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DeferredUnderwritingDiscountPerUnit" xlink:to="fact_DeferredUnderwritingDiscountPerUnit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_DeferredUnderwritingFee_lbl0" xml:lang="en-US">Deferred underwriting fee.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DeferredUnderwritingFee" xlink:to="fact_DeferredUnderwritingFee_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_DerivativeWarrantLiabilities_lbl0" xml:lang="en-US">Derivative warrant liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DerivativeWarrantLiabilities" xlink:to="fact_DerivativeWarrantLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_DrawnDownAmount_lbl0" xml:lang="en-US">Amount of decrease in liability for separate account from withdrawal of funds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DrawnDownAmount" xlink:to="fact_DrawnDownAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_EmergingGrowthCompanyStatusPolicyTextBlock_lbl0" xml:lang="en-US">The entire policy disclosure of Emerging Growth Company Status.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:to="fact_EmergingGrowthCompanyStatusPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_ExtensionAmendmentProposalAbstain_lbl0" xml:lang="en-US">Extension amendment proposal abstain.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ExtensionAmendmentProposalAbstain" xlink:to="fact_ExtensionAmendmentProposalAbstain_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_ExtensionAmendmentProposalAgainst_lbl0" xml:lang="en-US">Extension amendment proposal against.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ExtensionAmendmentProposalAgainst" xlink:to="fact_ExtensionAmendmentProposalAgainst_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_ExtensionAmendmentProposalFor_lbl0" xml:lang="en-US">Extension Amendment Proposal For.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ExtensionAmendmentProposalFor" xlink:to="fact_ExtensionAmendmentProposalFor_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_FairValueAssetsLevel1ToLevel2TransferAmount_lbl0" xml:lang="en-US">Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueAssetsLevel1ToLevel2TransferAmount" xlink:to="fact_FairValueAssetsLevel1ToLevel2TransferAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_FairValueInitialMeasurement_lbl0" xml:lang="en-US">Fair value initial measurement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueInitialMeasurement" xlink:to="fact_FairValueInitialMeasurement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_FairValueMeasurementStrikePrice_lbl0" xml:lang="en-US">Strike price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueMeasurementStrikePrice" xlink:to="fact_FairValueMeasurementStrikePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_FairValueWarrantLiabilities_lbl0" xml:lang="en-US">The amount of the fair value warrant liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueWarrantLiabilities" xlink:to="fact_FairValueWarrantLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_GeneratingGrossProceeds_lbl0" xml:lang="en-US">The cash inflow associated with the amount received from entity&apos;s first offering of stock to the public.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_GeneratingGrossProceeds" xlink:to="fact_GeneratingGrossProceeds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_GrossUnrealizedGain_lbl0" xml:lang="en-US">Gross Unrealized Gains</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_GrossUnrealizedGain" xlink:to="fact_GrossUnrealizedGain_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_GrossUnrealizedGainsAndLosses_lbl0" xml:lang="en-US">Amount of gross unrealized gains and losses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_GrossUnrealizedGainsAndLosses" xlink:to="fact_GrossUnrealizedGainsAndLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption_lbl0" xml:lang="en-US">Change in value of Class A ordinary shares subject to possible redemption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption" xlink:to="fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_InitialValueOfWarrantLiabilities_lbl0" xml:lang="en-US">The amount of  initial value of warrant liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InitialValueOfWarrantLiabilities" xlink:to="fact_InitialValueOfWarrantLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_InvestmentManagementTrustAgreementAbstain_lbl0" xml:lang="en-US">Investment management trust agreement against.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentManagementTrustAgreementAbstain" xlink:to="fact_InvestmentManagementTrustAgreementAbstain_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_InvestmentManagementTrustAgreementAgainst_lbl0" xml:lang="en-US">Investment management trust agreement against.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentManagementTrustAgreementAgainst" xlink:to="fact_InvestmentManagementTrustAgreementAgainst_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_InvestmentManagementTrustAgreementFor_lbl0" xml:lang="en-US">Investment management trust agreement for.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentManagementTrustAgreementFor" xlink:to="fact_InvestmentManagementTrustAgreementFor_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_InvestmentsHeldInTrustAccountNet_lbl0" xml:lang="en-US">Total Investments held in Trust Account.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentsHeldInTrustAccountNet" xlink:to="fact_InvestmentsHeldInTrustAccountNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund_lbl0" xml:lang="en-US">The amount of investments held in trust account.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund" xlink:to="fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_InvestmentsHeldInTrustAccountUSTreasureSecurities_lbl0" xml:lang="en-US">The amount of investments held in trust account US treasure securities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentsHeldInTrustAccountUSTreasureSecurities" xlink:to="fact_InvestmentsHeldInTrustAccountUSTreasureSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_IssuedAndOutstandingInterestPercentage_lbl0" xml:lang="en-US">Issued and outstanding interest percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_IssuedAndOutstandingInterestPercentage" xlink:to="fact_IssuedAndOutstandingInterestPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_IssuedAndOutstandingShares_lbl0" xml:lang="en-US">Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_IssuedAndOutstandingShares" xlink:to="fact_IssuedAndOutstandingShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_NetProceedsOfTheSaleOfTheUnits_lbl0" xml:lang="en-US">Net proceeds of the sale of the Units.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_NetProceedsOfTheSaleOfTheUnits" xlink:to="fact_NetProceedsOfTheSaleOfTheUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_NetTangibleAssets_lbl0" xml:lang="en-US">Net tangible assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_NetTangibleAssets" xlink:to="fact_NetTangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_OfferingCostsAllocatedToWarrants_lbl0" xml:lang="en-US">Offering costs allocated to warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OfferingCostsAllocatedToWarrants" xlink:to="fact_OfferingCostsAllocatedToWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_OfficeSpaceAndAdministrativeSupportServices_lbl0" xml:lang="en-US">The amount of expenses for office space and administrative support services.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OfficeSpaceAndAdministrativeSupportServices" xlink:to="fact_OfficeSpaceAndAdministrativeSupportServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_OperationalCosts_lbl0" xml:lang="en-US">The adjustment to expense previously capitalized costs of operational costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OperationalCosts" xlink:to="fact_OperationalCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_OrdinarySharesDescription_lbl0" xml:lang="en-US">Ordinary shares, description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OrdinarySharesDescription" xlink:to="fact_OrdinarySharesDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_OrdinarySharesSubjectToPossibleRedemption_lbl0" xml:lang="en-US">Ordinary shares subject to possible redemption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OrdinarySharesSubjectToPossibleRedemption" xlink:to="fact_OrdinarySharesSubjectToPossibleRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_PartialReversalOfTransactionCosts_lbl1" xml:lang="en-US">Partial reversal of transaction costs incurred in connection with IPO.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PartialReversalOfTransactionCosts" xlink:to="fact_PartialReversalOfTransactionCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_PrivatePlacementWarrantsDisclosureTextBlock_lbl0" xml:lang="en-US">The entire disclosure of Private Placement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PrivatePlacementWarrantsDisclosureTextBlock" xlink:to="fact_PrivatePlacementWarrantsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_ProceedsFromGrossProceedsFromIPO_lbl0" xml:lang="en-US">The amonut is gross proceeds from IPO.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ProceedsFromGrossProceedsFromIPO" xlink:to="fact_ProceedsFromGrossProceedsFromIPO_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_PromissioryNoteRelatedParty_lbl0" xml:lang="en-US">The amount is related party promissiory note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PromissioryNoteRelatedParty" xlink:to="fact_PromissioryNoteRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_PromissoryNote_lbl0" xml:lang="en-US">Promissory notes may also be referred to as an IOU, a loan agreement, or just a note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PromissoryNote" xlink:to="fact_PromissoryNote_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_ProposedPublicOfferingDisclosureTextBlock_lbl0" xml:lang="en-US">Disclosure of initial public offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ProposedPublicOfferingDisclosureTextBlock" xlink:to="fact_ProposedPublicOfferingDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_PublicPerShare_lbl0" xml:lang="en-US">Public per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PublicPerShare" xlink:to="fact_PublicPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_RedeemPublicSharesPercentage_lbl0" xml:lang="en-US">Redeem public shares, percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_RedeemPublicSharesPercentage" xlink:to="fact_RedeemPublicSharesPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_RedemptionsOfWarrantsDescription_lbl0" xml:lang="en-US">Redemptions of warrants, description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_RedemptionsOfWarrantsDescription" xlink:to="fact_RedemptionsOfWarrantsDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_SaleOfOrdinarySharesRedemption_lbl0" xml:lang="en-US">Number of ordinary share sale of redemption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SaleOfOrdinarySharesRedemption" xlink:to="fact_SaleOfOrdinarySharesRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates_lbl0" xml:lang="en-US">The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates" xlink:to="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_SharesSubjectToPossibleRedemption_lbl0" xml:lang="en-US">Shares subject to possible redemption.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SharesSubjectToPossibleRedemption" xlink:to="fact_SharesSubjectToPossibleRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_SponsorShare_lbl0" xml:lang="en-US">The shares for sponsor.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SponsorShare" xlink:to="fact_SponsorShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_StockIssuedDuringPeriodSponsorAmount_lbl0" xml:lang="en-US">Sponsor amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_StockIssuedDuringPeriodSponsorAmount" xlink:to="fact_StockIssuedDuringPeriodSponsorAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_TotalNumberOfOrdinarySharesOutstandingPercentage_lbl0" xml:lang="en-US">Total number of ordinary shares outstanding percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TotalNumberOfOrdinarySharesOutstandingPercentage" xlink:to="fact_TotalNumberOfOrdinarySharesOutstandingPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_TotalTransactionCost_lbl0" xml:lang="en-US">Total transaction cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TotalTransactionCost" xlink:to="fact_TotalTransactionCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_TotalWarrantLiabilities_lbl0" xml:lang="en-US">Total warrant liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TotalWarrantLiabilities" xlink:to="fact_TotalWarrantLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_TradingSecuritiesFairValue_lbl0" xml:lang="en-US">The amount of trading securities fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TradingSecuritiesFairValue" xlink:to="fact_TradingSecuritiesFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_TrustAccountPerShare_lbl0" xml:lang="en-US">Trust account per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TrustAccountPerShare" xlink:to="fact_TrustAccountPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_VotingPowerPercentage_lbl0" xml:lang="en-US">Percentage of voting equity interests acquired at the acquisition date in the business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_VotingPowerPercentage" xlink:to="fact_VotingPowerPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_WarrantExpirationTerm_lbl0" xml:lang="en-US">Warrant expiration term.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantExpirationTerm" xlink:to="fact_WarrantExpirationTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_WarrantLiabilitiesPrivateWarrants_lbl0" xml:lang="en-US">Warrant liabilities private warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantLiabilitiesPrivateWarrants" xlink:to="fact_WarrantLiabilitiesPrivateWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_WarrantLiabilitiesPublicWarrants_lbl0" xml:lang="en-US">Warrant liabilities public warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantLiabilitiesPublicWarrants" xlink:to="fact_WarrantLiabilitiesPublicWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_WarrantTerm_lbl0" xml:lang="en-US">Warrant term.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantTerm" xlink:to="fact_WarrantTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_WarrantsDisclosureTextBlock_lbl0" xml:lang="en-US">Disclosure of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantsDisclosureTextBlock" xlink:to="fact_WarrantsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_WarrantsPurchase_lbl0" xml:lang="en-US">Warrants purchase.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantsPurchase" xlink:to="fact_WarrantsPurchase_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="fact_WorkingCapitalLoans_lbl0" xml:lang="en-US">Working capital loans.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WorkingCapitalLoans" xlink:to="fact_WorkingCapitalLoans_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule Of Changes In The Fair Value Of Warrant Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract" xlink:to="fact_ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_lbl" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl0" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_SponsorShare_lbl1" xml:lang="en-US">Sponsor Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SponsorShare" xlink:to="fact_SponsorShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund_lbl1" xml:lang="en-US">Investments Held In Trust Account USMoney Market Fund</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund" xlink:to="fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ShareholdersDeficitAbstract_lbl0" xml:lang="en-US">Shareholders Deficit Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ShareholdersDeficitAbstract" xlink:to="fact_ShareholdersDeficitAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOwnershipInterestsOfferingCosts_lbl0" xml:lang="en-US">Other Ownership Interests, Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOwnershipInterestsOfferingCosts" xlink:to="us-gaap_OtherOwnershipInterestsOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl0" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_AmortizedCostAndCarryingValue_lbl1" xml:lang="en-US">Amortized Cost And Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AmortizedCostAndCarryingValue" xlink:to="fact_AmortizedCostAndCarryingValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_InvestmentManagementTrustAgreementAbstain_lbl1" xml:lang="en-US">Investment Management Trust Agreement Abstain</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentManagementTrustAgreementAbstain" xlink:to="fact_InvestmentManagementTrustAgreementAbstain_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl0" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl0" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl0" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl1" xml:lang="en-US">Shares Issued, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_PublicMember_lbl0" xml:lang="en-US">Public Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PublicMember" xlink:to="fact_PublicMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl1" xml:lang="en-US">Investment Income, Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl2" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1"/>
    <loc xlink:type="locator" xlink:label="fact_PrivatePlacementWarrantsDisclosureAbstract" xlink:href="fact-20221231.xsd#fact_PrivatePlacementWarrantsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_PrivatePlacementWarrantsDisclosureAbstract_lbl" xml:lang="en-US">Private Placement Warrants Disclosure Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PrivatePlacementWarrantsDisclosureAbstract" xlink:to="fact_PrivatePlacementWarrantsDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_WarrantExpirationTerm_lbl1" xml:lang="en-US">Warrant Expiration Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantExpirationTerm" xlink:to="fact_WarrantExpirationTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl0" xml:lang="en-US">Warrants and Rights Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption_lbl1" xml:lang="en-US">Initial Value Of Class AOrdinary Share Subject To Possible Redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption" xlink:to="fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_PublicPerShare_lbl1" xml:lang="en-US">Public Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PublicPerShare" xlink:to="fact_PublicPerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_GrossUnrealizedGain_lbl1" xml:lang="en-US">Gross Unrealized Gain</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_GrossUnrealizedGain" xlink:to="fact_GrossUnrealizedGain_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_PublicWarrantsMember_lbl0" xml:lang="en-US">Public Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PublicWarrantsMember" xlink:to="fact_PublicWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_IssuedAndOutstandingInterestPercentage_lbl1" xml:lang="en-US">Issued And Outstanding Interest Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_IssuedAndOutstandingInterestPercentage" xlink:to="fact_IssuedAndOutstandingInterestPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl0" xml:lang="en-US">Prepaid Expense, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl0" xml:lang="en-US">Business Acquisition, Transaction Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl1" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_TotalWarrantLiabilities_lbl1" xml:lang="en-US">Total Warrant Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TotalWarrantLiabilities" xlink:to="fact_TotalWarrantLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_BusinessCombinationFairMarketValueEqualPercentage_lbl1" xml:lang="en-US">Business Combination Fair Market Value Equal Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_BusinessCombinationFairMarketValueEqualPercentage" xlink:to="fact_BusinessCombinationFairMarketValueEqualPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_SaleOfOrdinarySharesRedemption_lbl1" xml:lang="en-US">Sale Of Ordinary Shares Redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SaleOfOrdinarySharesRedemption" xlink:to="fact_SaleOfOrdinarySharesRedemption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl1" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_lbl2" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl0" xml:lang="en-US">Preferred Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_WarrantsPurchase_lbl1" xml:lang="en-US">Warrants Purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantsPurchase" xlink:to="fact_WarrantsPurchase_lbl1"/>
    <loc xlink:type="locator" xlink:label="fact_ScheduleOfCondensedStatementOfOperationsAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfCondensedStatementOfOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ScheduleOfCondensedStatementOfOperationsAbstract_lbl" xml:lang="en-US">Schedule Of Condensed Statement Of Operations Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ScheduleOfCondensedStatementOfOperationsAbstract" xlink:to="fact_ScheduleOfCondensedStatementOfOperationsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl0" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_DenominatorAbstract_lbl0" xml:lang="en-US">Denominator Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DenominatorAbstract" xlink:to="fact_DenominatorAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_InvestmentsHeldInTrustAccountUSTreasureSecurities_lbl1" xml:lang="en-US">Investments Held In Trust Account USTreasure Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentsHeldInTrustAccountUSTreasureSecurities" xlink:to="fact_InvestmentsHeldInTrustAccountUSTreasureSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseNoncurrent_lbl0" xml:lang="en-US">Prepaid Expense, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseNoncurrent" xlink:to="us-gaap_PrepaidExpenseNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl0" xml:lang="en-US">Business Acquisition, Description of Acquired Entity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl0" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_RedeemPublicSharesPercentage_lbl1" xml:lang="en-US">Redeem Public Shares Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_RedeemPublicSharesPercentage" xlink:to="fact_RedeemPublicSharesPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_ScheduleOfCondensedStatementOfCashFlowsAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfCondensedStatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ScheduleOfCondensedStatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Schedule Of Condensed Statement Of Cash Flows Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ScheduleOfCondensedStatementOfCashFlowsAbstract" xlink:to="fact_ScheduleOfCondensedStatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl0" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl0" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_GeneratingGrossProceeds_lbl1" xml:lang="en-US">Generating Gross Proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_GeneratingGrossProceeds" xlink:to="fact_GeneratingGrossProceeds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_FairValueWarrantLiabilities_lbl1" xml:lang="en-US">Fair Value Warrant Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueWarrantLiabilities" xlink:to="fact_FairValueWarrantLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_FairValueMeasurementStrikePrice_lbl1" xml:lang="en-US">Fair Value Measurement Strike Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueMeasurementStrikePrice" xlink:to="fact_FairValueMeasurementStrikePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockHeldInTrust_lbl0" xml:lang="en-US">Common Stock Held in Trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockHeldInTrust" xlink:to="us-gaap_CommonStockHeldInTrust_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_LessAbstract_lbl0" xml:lang="en-US">Less Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_LessAbstract" xlink:to="fact_LessAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl0" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl1" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3_lbl0" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers out of Level 3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3" xlink:to="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_lbl0" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_OfficeSpaceAndAdministrativeSupportServices_lbl1" xml:lang="en-US">Office Space And Administrative Support Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OfficeSpaceAndAdministrativeSupportServices" xlink:to="fact_OfficeSpaceAndAdministrativeSupportServices_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl0" xml:lang="en-US">Convertible Notes Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl0" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates" xlink:to="fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl1" xml:lang="en-US">Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_AllocationOfNetIncome_lbl1" xml:lang="en-US">Allocation Of Net Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AllocationOfNetIncome" xlink:to="fact_AllocationOfNetIncome_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract_lbl0" xml:lang="en-US">Condensed Statement Of Cash Flows For The Nine Months Ended September302022 Unaudited Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract" xlink:to="fact_CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl0" xml:lang="en-US">Stock Redeemed or Called During Period, Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_OfferingCostsAllocatedToWarrants_lbl1" xml:lang="en-US">Offering Costs Allocated To Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OfferingCostsAllocatedToWarrants" xlink:to="fact_OfferingCostsAllocatedToWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract10_lbl0" xml:lang="en-US">Unlabeled Abstract10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract10" xlink:to="fact_UnlabeledAbstract10_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract11_lbl0" xml:lang="en-US">Unlabeled Abstract11</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract11" xlink:to="fact_UnlabeledAbstract11_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Changes In The Fair Value Of Level3 Warrant Liabilities Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock" xlink:to="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract12_lbl0" xml:lang="en-US">Unlabeled Abstract12</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract12" xlink:to="fact_UnlabeledAbstract12_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract13_lbl0" xml:lang="en-US">Unlabeled Abstract13</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract13" xlink:to="fact_UnlabeledAbstract13_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl0" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_StockIssuedDuringPeriodSponsorAmount_lbl1" xml:lang="en-US">Stock Issued During Period Sponsor Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_StockIssuedDuringPeriodSponsorAmount" xlink:to="fact_StockIssuedDuringPeriodSponsorAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl0" xml:lang="en-US">Warrant, Exercise Price, Increase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_PlusAbstract0_lbl0" xml:lang="en-US">Plus Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PlusAbstract0" xlink:to="fact_PlusAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract2_lbl0" xml:lang="en-US">Unlabeled Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract2" xlink:to="fact_UnlabeledAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract1_lbl0" xml:lang="en-US">Unlabeled Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract1" xlink:to="fact_UnlabeledAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract4_lbl0" xml:lang="en-US">Unlabeled Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract4" xlink:to="fact_UnlabeledAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract3_lbl0" xml:lang="en-US">Unlabeled Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract3" xlink:to="fact_UnlabeledAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl0" xml:lang="en-US">Payments of Stock Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract0" xlink:to="fact_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract9_lbl0" xml:lang="en-US">Unlabeled Abstract9</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract9" xlink:to="fact_UnlabeledAbstract9_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_OrdinarySharesDescription_lbl1" xml:lang="en-US">Ordinary Shares Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OrdinarySharesDescription" xlink:to="fact_OrdinarySharesDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract6_lbl0" xml:lang="en-US">Unlabeled Abstract6</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract6" xlink:to="fact_UnlabeledAbstract6_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract5_lbl0" xml:lang="en-US">Unlabeled Abstract5</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract5" xlink:to="fact_UnlabeledAbstract5_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ConvertibleNoteAmount_lbl1" xml:lang="en-US">Convertible Note Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ConvertibleNoteAmount" xlink:to="fact_ConvertibleNoteAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract8_lbl0" xml:lang="en-US">Unlabeled Abstract8</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract8" xlink:to="fact_UnlabeledAbstract8_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract7_lbl0" xml:lang="en-US">Unlabeled Abstract7</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract7" xlink:to="fact_UnlabeledAbstract7_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ChangeInDeferredUnderwritingFee_lbl1" xml:lang="en-US">Change In Deferred Underwriting Fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ChangeInDeferredUnderwritingFee" xlink:to="fact_ChangeInDeferredUnderwritingFee_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrust_lbl0" xml:lang="en-US">Assets Held-in-trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrust" xlink:to="us-gaap_AssetsHeldInTrust_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_DerivativeWarrantLiabilities_lbl1" xml:lang="en-US">Derivative Warrant Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DerivativeWarrantLiabilities" xlink:to="fact_DerivativeWarrantLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_PartialReversalOfTransactionCosts_lbl2" xml:lang="en-US">Partial Reversal Of Transaction Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PartialReversalOfTransactionCosts" xlink:to="fact_PartialReversalOfTransactionCosts_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl0" xml:lang="en-US">Temporary Equity, Aggregate Amount of Redemption Requirement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl0" xml:lang="en-US">Fair Value Adjustment of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl1" xml:lang="en-US">Business Acquisition, Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_UnlabeledAbstract" xlink:to="fact_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_lbl0" xml:lang="en-US">Condensed Cash Flow Statement [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl0" xml:lang="en-US">Assets Held-in-trust, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract_lbl0" xml:lang="en-US">Condensed Statement Of Operations For The Nine Months Ended September302022 Unaudited Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract" xlink:to="fact_CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAdjustmentMember_lbl1" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAdjustmentMember" xlink:to="srt_RestatementAdjustmentMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares_lbl1" xml:lang="en-US">Accretion Of Class AOrdinary Shares Subject To Possible Redemptionin Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares" xlink:to="fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt_lbl0" xml:lang="en-US">Proceeds from Issuance of Unsecured Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock_lbl0" xml:lang="en-US">Condensed Financial Statements [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl3" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_AggregateGrossProceeds_lbl1" xml:lang="en-US">Aggregate Gross Proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AggregateGrossProceeds" xlink:to="fact_AggregateGrossProceeds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableOtherCurrent_lbl0" xml:lang="en-US">Accounts Payable, Other, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock_lbl1" xml:lang="en-US">Convertible Promissory Note Related Party Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock" xlink:to="fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_DeferredUnderwritingFee_lbl1" xml:lang="en-US">Deferred Underwriting Fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DeferredUnderwritingFee" xlink:to="fact_DeferredUnderwritingFee_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare_lbl0" xml:lang="en-US">Forward Contract Indexed to Equity, Settlement, Share, Fair Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare" xlink:to="us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_DrawnDownAmount_lbl1" xml:lang="en-US">Drawn Down Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DrawnDownAmount" xlink:to="fact_DrawnDownAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_FounderSharesMember_lbl0" xml:lang="en-US">Founder Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FounderSharesMember" xlink:to="fact_FounderSharesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl1" xml:lang="en-US">Stock Issued During Period, Value, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_OrdinarySharesSubjectToPossibleRedemption_lbl1" xml:lang="en-US">Ordinary Shares Subject To Possible Redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OrdinarySharesSubjectToPossibleRedemption" xlink:to="fact_OrdinarySharesSubjectToPossibleRedemption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl0" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ChangeInFairValueOfWarrantLiabilities_lbl1" xml:lang="en-US">Change In Fair Value Of Warrant Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ChangeInFairValueOfWarrantLiabilities" xlink:to="fact_ChangeInFairValueOfWarrantLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_NetProceedsOfTheSaleOfTheUnits_lbl1" xml:lang="en-US">Net Proceeds Of The Sale Of The Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_NetProceedsOfTheSaleOfTheUnits" xlink:to="fact_NetProceedsOfTheSaleOfTheUnits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_AsRestatedMember_lbl0" xml:lang="en-US">As Restated Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AsRestatedMember" xlink:to="fact_AsRestatedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl0" xml:lang="en-US">Director [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockNoParValue_lbl0" xml:lang="en-US">Common Stock, No Par Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNoParValue" xlink:to="us-gaap_CommonStockNoParValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_PromissoryNote_lbl1" xml:lang="en-US">Promissory Note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PromissoryNote" xlink:to="fact_PromissoryNote_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_NumeratorAbstract_lbl0" xml:lang="en-US">Numerator Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_NumeratorAbstract" xlink:to="fact_NumeratorAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_WorkingCapitalLoans_lbl1" xml:lang="en-US">Working Capital Loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WorkingCapitalLoans" xlink:to="fact_WorkingCapitalLoans_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_InvestmentManagementTrustAgreementFor_lbl1" xml:lang="en-US">Investment Management Trust Agreement For</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentManagementTrustAgreementFor" xlink:to="fact_InvestmentManagementTrustAgreementFor_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_TotalTransactionCost_lbl1" xml:lang="en-US">Total Transaction Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TotalTransactionCost" xlink:to="fact_TotalTransactionCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl0" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract_lbl0" xml:lang="en-US">Condensed Statement Of Operations For The Six Months Ended June302022 Unaudited Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract" xlink:to="fact_CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl1" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_PromissioryNoteRelatedParty_lbl1" xml:lang="en-US">Promissiory Note Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PromissioryNoteRelatedParty" xlink:to="fact_PromissioryNoteRelatedParty_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl2" xml:lang="en-US">Earnings Per Share, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl0" xml:lang="en-US">US Treasury Securities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_DescriptionAbstract_lbl0" xml:lang="en-US">Description Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DescriptionAbstract" xlink:to="fact_DescriptionAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl1" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders&apos; Equity Note [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl0" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_ScheduleOfBasicAndDilutedNetIncomePerShareForEachClassOfOrdinaryShareAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfBasicAndDilutedNetIncomePerShareForEachClassOfOrdinaryShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ScheduleOfBasicAndDilutedNetIncomePerShareForEachClassOfOrdinaryShareAbstract_lbl" xml:lang="en-US">Schedule Of Basic And Diluted Net Income Per Share For Each Class Of Ordinary Share Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ScheduleOfBasicAndDilutedNetIncomePerShareForEachClassOfOrdinaryShareAbstract" xlink:to="fact_ScheduleOfBasicAndDilutedNetIncomePerShareForEachClassOfOrdinaryShareAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_InvestmentsHeldInTrustAccountNet_lbl1" xml:lang="en-US">Investments Held In Trust Account Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentsHeldInTrustAccountNet" xlink:to="fact_InvestmentsHeldInTrustAccountNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl0" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_ScheduleOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ScheduleOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisAbstract_lbl" xml:lang="en-US">Schedule Of Assets That Are Measured At Fair Value On ARecurring Basis Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ScheduleOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisAbstract" xlink:to="fact_ScheduleOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl0" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl0" xml:lang="en-US">Proceeds from Issuance of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl0" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantExercisePriceDecrease_lbl0" xml:lang="en-US">Warrant, Exercise Price, Decrease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceDecrease" xlink:to="us-gaap_WarrantExercisePriceDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedFinancialStatementsTextBlock_lbl0" xml:lang="en-US">Condensed Financial Statements [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedFinancialStatementsTextBlock" xlink:to="srt_CondensedFinancialStatementsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl0" xml:lang="en-US">Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl1" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl0" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_lbl0" xml:lang="en-US">Expense Related to Distribution or Servicing and Underwriting Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:to="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_GrossUnrealizedGainsAndLosses_lbl1" xml:lang="en-US">Gross Unrealized Gains And Losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_GrossUnrealizedGainsAndLosses" xlink:to="fact_GrossUnrealizedGainsAndLosses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract_lbl0" xml:lang="en-US">Liabilities Redeemable Ordinary Shares And Shareholders Deficit Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract" xlink:to="fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ExtensionAmendmentProposalFor_lbl1" xml:lang="en-US">Extension Amendment Proposal For</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ExtensionAmendmentProposalFor" xlink:to="fact_ExtensionAmendmentProposalFor_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl0" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_TradingSecuritiesFairValue_lbl1" xml:lang="en-US">Trading Securities Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TradingSecuritiesFairValue" xlink:to="fact_TradingSecuritiesFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_BalanceSheetAsOfSeptember302022UnauditedAbstract_lbl0" xml:lang="en-US">Balance Sheet As Of September302022 Unaudited Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_BalanceSheetAsOfSeptember302022UnauditedAbstract" xlink:to="fact_BalanceSheetAsOfSeptember302022UnauditedAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_lbl0" xml:lang="en-US">Option Contract Indexed to Equity, Settlement, Number of Shares, Effect of Change in Fair Value of Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:to="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl0" xml:lang="en-US">Stock Redeemed or Called During Period, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_CashDepositedInTrustAccount_lbl1" xml:lang="en-US">Cash Deposited In Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_CashDepositedInTrustAccount" xlink:to="fact_CashDepositedInTrustAccount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl0" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_DeferredUnderwritingDiscountPerUnit_lbl1" xml:lang="en-US">Deferred Underwriting Discount Per Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DeferredUnderwritingDiscountPerUnit" xlink:to="fact_DeferredUnderwritingDiscountPerUnit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl1" xml:lang="en-US">Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonUnitOutstanding_lbl0" xml:lang="en-US">Common Unit, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitOutstanding" xlink:to="us-gaap_CommonUnitOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_InvestmentManagementTrustAgreementAgainst_lbl1" xml:lang="en-US">Investment Management Trust Agreement Against</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InvestmentManagementTrustAgreementAgainst" xlink:to="fact_InvestmentManagementTrustAgreementAgainst_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLongTermDebt_lbl0" xml:lang="en-US">Other Long-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermDebt" xlink:to="us-gaap_OtherLongTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl0" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_CommonStockValueOne_lbl1" xml:lang="en-US">Common Stock Value One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_CommonStockValueOne" xlink:to="fact_CommonStockValueOne_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt_lbl0" xml:lang="en-US">Repayments of Unsecured Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfUnsecuredDebt" xlink:to="us-gaap_RepaymentsOfUnsecuredDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl1" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl1" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashMember_lbl0" xml:lang="en-US">Cash [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashMember" xlink:to="us-gaap_CashMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_BusinessCombinationMember_lbl0" xml:lang="en-US">Business Combination Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_BusinessCombinationMember" xlink:to="fact_BusinessCombinationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_FairValueInitialMeasurement_lbl1" xml:lang="en-US">Fair Value Initial Measurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueInitialMeasurement" xlink:to="fact_FairValueInitialMeasurement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockOtherSharesOutstanding_lbl0" xml:lang="en-US">Common Stock, Other Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockOtherSharesOutstanding" xlink:to="us-gaap_CommonStockOtherSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl0" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl0" xml:lang="en-US">Temporary Equity, Redemption Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl0" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl0" xml:lang="en-US">Repayments of Related Party Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoninterestExpenseOfferingCost_lbl0" xml:lang="en-US">Noninterest Expense Offering Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoninterestExpenseOfferingCost" xlink:to="us-gaap_NoninterestExpenseOfferingCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_NetTangibleAssets_lbl1" xml:lang="en-US">Net Tangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_NetTangibleAssets" xlink:to="fact_NetTangibleAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_TotalNumberOfOrdinarySharesOutstandingPercentage_lbl1" xml:lang="en-US">Total Number Of Ordinary Shares Outstanding Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TotalNumberOfOrdinarySharesOutstandingPercentage" xlink:to="fact_TotalNumberOfOrdinarySharesOutstandingPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl0" xml:lang="en-US">Sale of Stock, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_WarrantsDisclosureTextBlock_lbl1" xml:lang="en-US">Warrants Disclosure Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantsDisclosureTextBlock" xlink:to="fact_WarrantsDisclosureTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_VotingPowerPercentage_lbl1" xml:lang="en-US">Voting Power Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_VotingPowerPercentage" xlink:to="fact_VotingPowerPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Treasury Stock Reissued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:to="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ExtensionAmendmentProposalAgainst_lbl1" xml:lang="en-US">Extension Amendment Proposal Against</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ExtensionAmendmentProposalAgainst" xlink:to="fact_ExtensionAmendmentProposalAgainst_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ConvertibleNoteone_lbl1" xml:lang="en-US">Convertible Noteone</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ConvertibleNoteone" xlink:to="fact_ConvertibleNoteone_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_WarrantTerm_lbl1" xml:lang="en-US">Warrant Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantTerm" xlink:to="fact_WarrantTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl0" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl0" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_InitialValueOfWarrantLiabilities_lbl1" xml:lang="en-US">Initial Value Of Warrant Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_InitialValueOfWarrantLiabilities" xlink:to="fact_InitialValueOfWarrantLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl0" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_FairValueAssetsLevel1ToLevel2TransferAmount_lbl1" xml:lang="en-US">Fair Value Assets Level1 To Level2 Transfer Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_FairValueAssetsLevel1ToLevel2TransferAmount" xlink:to="fact_FairValueAssetsLevel1ToLevel2TransferAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_AggregatePurchasePrice_lbl1" xml:lang="en-US">Aggregate Purchase Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AggregatePurchasePrice" xlink:to="fact_AggregatePurchasePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl0" xml:lang="en-US">Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_OperationalCosts_lbl1" xml:lang="en-US">Operational Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_OperationalCosts" xlink:to="fact_OperationalCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_TrustAccountPerShare_lbl1" xml:lang="en-US">Trust Account Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_TrustAccountPerShare" xlink:to="fact_TrustAccountPerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ProceedsFromGrossProceedsFromIPO_lbl1" xml:lang="en-US">Proceeds From Gross Proceeds From IPO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ProceedsFromGrossProceedsFromIPO" xlink:to="fact_ProceedsFromGrossProceedsFromIPO_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueNetAssetLiability_lbl1" xml:lang="en-US">Fair Value, Net Asset (Liability)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetAssetLiability" xlink:to="us-gaap_FairValueNetAssetLiability_lbl1"/>
    <loc xlink:type="locator" xlink:label="fact_ScheduleOfUnrealizedHoldingLossesAndFairValueOfHeldToMaturitySecuritiesAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfUnrealizedHoldingLossesAndFairValueOfHeldToMaturitySecuritiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ScheduleOfUnrealizedHoldingLossesAndFairValueOfHeldToMaturitySecuritiesAbstract_lbl" xml:lang="en-US">Schedule Of Unrealized Holding Losses And Fair Value Of Held To Maturity Securities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ScheduleOfUnrealizedHoldingLossesAndFairValueOfHeldToMaturitySecuritiesAbstract" xlink:to="fact_ScheduleOfUnrealizedHoldingLossesAndFairValueOfHeldToMaturitySecuritiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_lbl0" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_DescriptionAbstract0_lbl0" xml:lang="en-US">Description Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DescriptionAbstract0" xlink:to="fact_DescriptionAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsMember_lbl0" xml:lang="en-US">Money Market Funds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl0" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl1" xml:lang="en-US">Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_WarrantLiabilitiesPublicWarrants_lbl1" xml:lang="en-US">Warrant Liabilities Public Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantLiabilitiesPublicWarrants" xlink:to="fact_WarrantLiabilitiesPublicWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_SharesSubjectToPossibleRedemption_lbl1" xml:lang="en-US">Shares Subject To Possible Redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_SharesSubjectToPossibleRedemption" xlink:to="fact_SharesSubjectToPossibleRedemption_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ConvertibleNotesTwo_lbl1" xml:lang="en-US">Convertible Notes Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ConvertibleNotesTwo" xlink:to="fact_ConvertibleNotesTwo_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_DeferredOfferingCostsPaidUnderPromissoryNote_lbl1" xml:lang="en-US">Deferred Offering Costs Paid Under Promissory Note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DeferredOfferingCostsPaidUnderPromissoryNote" xlink:to="fact_DeferredOfferingCostsPaidUnderPromissoryNote_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl0" xml:lang="en-US">Operating Lease, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalDeferredPurchasePrice_lbl0" xml:lang="en-US">Supplemental Deferred Purchase Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalDeferredPurchasePrice" xlink:to="us-gaap_SupplementalDeferredPurchasePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_lbl1" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl0" xml:lang="en-US">Operating Costs and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl0" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ExtensionAmendmentProposalAbstain_lbl1" xml:lang="en-US">Extension Amendment Proposal Abstain</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ExtensionAmendmentProposalAbstain" xlink:to="fact_ExtensionAmendmentProposalAbstain_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_PlusAbstract_lbl0" xml:lang="en-US">Plus Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PlusAbstract" xlink:to="fact_PlusAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_WarrantLiabilitiesPrivateWarrants_lbl1" xml:lang="en-US">Warrant Liabilities Private Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantLiabilitiesPrivateWarrants" xlink:to="fact_WarrantLiabilitiesPrivateWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_EmergingGrowthCompanyStatusPolicyTextBlock_lbl1" xml:lang="en-US">Emerging Growth Company Status Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:to="fact_EmergingGrowthCompanyStatusPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_DeferredOfferingCostsIncludedInAccruedExpenses_lbl1" xml:lang="en-US">Deferred Offering Costs Included In Accrued Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_DeferredOfferingCostsIncludedInAccruedExpenses" xlink:to="fact_DeferredOfferingCostsIncludedInAccruedExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl0" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_RedemptionsOfWarrantsDescription_lbl1" xml:lang="en-US">Redemptions Of Warrants Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_RedemptionsOfWarrantsDescription" xlink:to="fact_RedemptionsOfWarrantsDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl0" xml:lang="en-US">Marketable Securities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTextBlock" xlink:to="us-gaap_MarketableSecuritiesTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_WarrantsDisclosureAbstract" xlink:href="fact-20221231.xsd#fact_WarrantsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_WarrantsDisclosureAbstract_lbl" xml:lang="en-US">Warrants Disclosure Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_WarrantsDisclosureAbstract" xlink:to="fact_WarrantsDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeOther_lbl0" xml:lang="en-US">Interest Income, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOther" xlink:to="us-gaap_InterestIncomeOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl0" xml:lang="en-US">Condensed Income Statement [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsCommonStockCash_lbl0" xml:lang="en-US">Dividends, Common Stock, Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCommonStockCash" xlink:to="us-gaap_DividendsCommonStockCash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl0" xml:lang="en-US">Proceeds from Issuance of Private Placement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl0" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl2" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ProposedPublicOfferingDisclosureTextBlock_lbl1" xml:lang="en-US">Proposed Public Offering Disclosure Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ProposedPublicOfferingDisclosureTextBlock" xlink:to="fact_ProposedPublicOfferingDisclosureTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl1" xml:lang="en-US">Fair Value, Option, Changes in Fair Value, Gain (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl1" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl0" xml:lang="en-US">Cash, FDIC Insured Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_IssuedAndOutstandingShares_lbl1" xml:lang="en-US">Issued And Outstanding Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_IssuedAndOutstandingShares" xlink:to="fact_IssuedAndOutstandingShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl0" xml:lang="en-US">Additional Paid in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl0"/>
    <loc xlink:type="locator" xlink:label="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule Of Changes In The Fair Value Of Level3 Warrant Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesAbstract" xlink:to="fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl1" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl0" xml:lang="en-US">Proceeds from Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl0" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl2" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl0" xml:lang="en-US">Preferred Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredOfferingCosts_lbl0" xml:lang="en-US">Deferred Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityOther_lbl0" xml:lang="en-US">Stockholders&apos; Equity, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityOther" xlink:to="us-gaap_StockholdersEquityOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_AggregateSharesOfCommonStock_lbl1" xml:lang="en-US">Aggregate Shares Of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_AggregateSharesOfCommonStock" xlink:to="fact_AggregateSharesOfCommonStock_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl0" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_PrivatePlacementWarrantsDisclosureTextBlock_lbl1" xml:lang="en-US">Private Placement Warrants Disclosure Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_PrivatePlacementWarrantsDisclosureTextBlock" xlink:to="fact_PrivatePlacementWarrantsDisclosureTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl0" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1"/>
    <loc xlink:type="locator" xlink:label="fact_ScheduleOfRestatementOfFinancialStatementsAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfRestatementOfFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_ScheduleOfRestatementOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Schedule Of Restatement Of Financial Statements Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_ScheduleOfRestatementOfFinancialStatementsAbstract" xlink:to="fact_ScheduleOfRestatementOfFinancialStatementsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl0" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="fact_BasicAndDilutedNetIncomePerShareAbstract_lbl0" xml:lang="en-US">Basic And Diluted Net Income Per Share Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fact_BasicAndDilutedNetIncomePerShareAbstract" xlink:to="fact_BasicAndDilutedNetIncomePerShareAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherUnderwritingExpense_lbl1" xml:lang="en-US">Other Underwriting Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherUnderwritingExpense" xlink:to="us-gaap_OtherUnderwritingExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityOtherChanges_lbl0" xml:lang="en-US">Temporary Equity, Other Changes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityOtherChanges" xlink:to="us-gaap_TemporaryEquityOtherChanges_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>fact-20221231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Apr 06 13:36:39 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ConsolidatedBalanceSheet" roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ConsolidatedIncomeStatement" roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ShareholdersEquityType2or3" roleURI="http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ConsolidatedCashFlow" roleURI="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_OrganizationandBusinessOperations" roleURI="http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperations"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_RevisionofPreviouslyIssuedFinancialStatements" roleURI="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatements"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_SignificantAccountingPolicies" roleURI="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_InitialPublicOffering" roleURI="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOffering"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_PrivatePlacementWarrants" roleURI="http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrants"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_RelatedPartyTransactions" roleURI="http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_CommitmentsContingencies" roleURI="http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingencies"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ShareholdersDeficit" roleURI="http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficit"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_Warrants" roleURI="http://www.FreedomAcquisitionICorp.com/role/Warrants"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_FairValueMeasurements" roleURI="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurements"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_SubsequentEvents" roleURI="http://www.FreedomAcquisitionICorp.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_AccountingPoliciesByPolicy" roleURI="http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_RevisionofPreviouslyIssuedFinancialStatementsTables" roleURI="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_SignificantAccountingPoliciesTables" roleURI="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_InitialPublicOfferingTables" roleURI="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingTables"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_FairValueMeasurementsTables" roleURI="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofrestatementoffinancialstatementsTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofcondensedstatementofoperationsTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofcondensedstatementofoperationsTable_Parentheticals" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofcondensedstatementofcashflowsTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ScheduleofchangesinthefairvalueofwarrantliabilitiesTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" roleURI="http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_OrganizationandBusinessOperationsDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_RevisionofPreviouslyIssuedFinancialStatementsDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_SignificantAccountingPoliciesDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_InitialPublicOfferingDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_PrivatePlacementWarrantsDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_RelatedPartyTransactionsDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_CommitmentsContingenciesDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_ShareholdersDeficitDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_WarrantsDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_FairValueMeasurementsDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#fact_r_SubsequentEventsDetails" roleURI="http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="fact-20221231.xsd#DocumentAndEntityInformation" roleURI="http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Assets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract" xlink:href="fact-20221231.xsd#fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareholdersDeficitAbstract" xlink:href="fact-20221231.xsd#fact_ShareholdersDeficitAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="ShareholdersDeficitAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitAbstract" xlink:to="us-gaap_CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockValueOne" xlink:href="fact-20221231.xsd#fact_CommonStockValueOne"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitAbstract" xlink:to="CommonStockValueOne" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SharesSubjectToPossibleRedemption" xlink:href="fact-20221231.xsd#fact_SharesSubjectToPossibleRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="SharesSubjectToPossibleRedemption" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PartialReversalOfTransactionCosts" xlink:href="fact-20221231.xsd#fact_PartialReversalOfTransactionCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="PartialReversalOfTransactionCosts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseOfferingCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoninterestExpenseOfferingCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NoninterestExpenseOfferingCost" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_EarningsPerShareBasic" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityOther" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_0" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InterestIncomeOther" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInFairValueOfWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_ChangeInFairValueOfWarrantLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ChangeInFairValueOfWarrantLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInDeferredUnderwritingFee" xlink:href="fact-20221231.xsd#fact_ChangeInDeferredUnderwritingFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ChangeInDeferredUnderwritingFee" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfferingCostsAllocatedToWarrants" xlink:href="fact-20221231.xsd#fact_OfferingCostsAllocatedToWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="OfferingCostsAllocatedToWarrants" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashDepositedInTrustAccount" xlink:href="fact-20221231.xsd#fact_CashDepositedInTrustAccount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="CashDepositedInTrustAccount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption" xlink:href="fact-20221231.xsd#fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InitialValueOfWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_InitialValueOfWarrantLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="InitialValueOfWarrantLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredOfferingCostsIncludedInAccruedExpenses" xlink:href="fact-20221231.xsd#fact_DeferredOfferingCostsIncludedInAccruedExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="DeferredOfferingCostsIncludedInAccruedExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares" xlink:href="fact-20221231.xsd#fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredOfferingCostsPaidUnderPromissoryNote" xlink:href="fact-20221231.xsd#fact_DeferredOfferingCostsPaidUnderPromissoryNote"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="DeferredOfferingCostsPaidUnderPromissoryNote" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperations">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatements">
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialStatementsTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="srt_CondensedFinancialStatementsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOffering">
    <loc xlink:type="locator" xlink:label="ProposedPublicOfferingDisclosureAbstract" xlink:href="fact-20221231.xsd#fact_ProposedPublicOfferingDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="ProposedPublicOfferingDisclosureTextBlock" xlink:href="fact-20221231.xsd#fact_ProposedPublicOfferingDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProposedPublicOfferingDisclosureAbstract" xlink:to="ProposedPublicOfferingDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrants">
    <loc xlink:type="locator" xlink:label="PrivatePlacementWarrantsDisclosureAbstract" xlink:href="fact-20221231.xsd#fact_PrivatePlacementWarrantsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementWarrantsDisclosureTextBlock" xlink:href="fact-20221231.xsd#fact_PrivatePlacementWarrantsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementWarrantsDisclosureAbstract" xlink:to="PrivatePlacementWarrantsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactions">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingencies">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficit">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/Warrants">
    <loc xlink:type="locator" xlink:label="WarrantsDisclosureAbstract" xlink:href="fact-20221231.xsd#fact_WarrantsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="WarrantsDisclosureTextBlock" xlink:href="fact-20221231.xsd#fact_WarrantsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsDisclosureAbstract" xlink:to="WarrantsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurements">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EmergingGrowthCompanyStatusPolicyTextBlock" xlink:href="fact-20221231.xsd#fact_EmergingGrowthCompanyStatusPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="EmergingGrowthCompanyStatusPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock" xlink:href="fact-20221231.xsd#fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredChargesPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables">
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingTables">
    <loc xlink:type="locator" xlink:label="ProposedPublicOfferingDisclosureAbstract" xlink:href="fact-20221231.xsd#fact_ProposedPublicOfferingDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProposedPublicOfferingDisclosureAbstract" xlink:to="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock" xlink:href="fact-20221231.xsd#fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfRestatementOfFinancialStatementsAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfRestatementOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRestatementOfFinancialStatementsAbstract" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="srt_RestatementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAdjustmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AsRestatedMember" xlink:href="fact-20221231.xsd#fact_AsRestatedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="AsRestatedMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="srt_CondensedFinancialStatementsCaptionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="us-gaap_Liabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="us-gaap_StockholdersEquity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BalanceSheetAsOfSeptember302022UnauditedAbstract" xlink:href="fact-20221231.xsd#fact_BalanceSheetAsOfSeptember302022UnauditedAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="BalanceSheetAsOfSeptember302022UnauditedAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfCondensedStatementOfOperationsAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfCondensedStatementOfOperationsAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedIncomeStatementTable"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCondensedStatementOfOperationsAbstract" xlink:to="srt_CondensedIncomeStatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_RestatementAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAdjustmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="AsRestatedMember" xlink:href="fact-20221231.xsd#fact_AsRestatedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="AsRestatedMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_CondensedIncomeStatementsCaptionsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_OperatingLeaseCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <loc xlink:type="locator" xlink:label="CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract" xlink:href="fact-20221231.xsd#fact_CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract" xlink:href="fact-20221231.xsd#fact_CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="ScheduleOfCondensedStatementOfOperationsAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfCondensedStatementOfOperationsAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedIncomeStatementTable"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCondensedStatementOfOperationsAbstract" xlink:to="srt_CondensedIncomeStatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_RestatementAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAdjustmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="AsRestatedMember" xlink:href="fact-20221231.xsd#fact_AsRestatedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="AsRestatedMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_CondensedIncomeStatementsCaptionsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfCondensedStatementOfCashFlowsAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfCondensedStatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedCashFlowStatementTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedCashFlowStatementTable"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCondensedStatementOfCashFlowsAbstract" xlink:to="srt_CondensedCashFlowStatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedCashFlowStatementTable" xlink:to="srt_RestatementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAdjustmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="AsRestatedMember" xlink:href="fact-20221231.xsd#fact_AsRestatedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="AsRestatedMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedCashFlowStatementTable" xlink:to="srt_CondensedCashFlowStatementsCaptionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract" xlink:href="fact-20221231.xsd#fact_CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfUnrealizedHoldingLossesAndFairValueOfHeldToMaturitySecuritiesAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfUnrealizedHoldingLossesAndFairValueOfHeldToMaturitySecuritiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfUnrealizedHoldingLossesAndFairValueOfHeldToMaturitySecuritiesAbstract" xlink:to="us-gaap_MarketableSecuritiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_MoneyMarketFundsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_USTreasurySecuritiesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TradingSecuritiesFairValue" xlink:href="fact-20221231.xsd#fact_TradingSecuritiesFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="TradingSecuritiesFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmortizedCostAndCarryingValue" xlink:href="fact-20221231.xsd#fact_AmortizedCostAndCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="AmortizedCostAndCarryingValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrossUnrealizedGain" xlink:href="fact-20221231.xsd#fact_GrossUnrealizedGain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="GrossUnrealizedGain" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrossUnrealizedGainsAndLosses" xlink:href="fact-20221231.xsd#fact_GrossUnrealizedGainsAndLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="GrossUnrealizedGainsAndLosses" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfBasicAndDilutedNetIncomePerShareForEachClassOfOrdinaryShareAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfBasicAndDilutedNetIncomePerShareForEachClassOfOrdinaryShareAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable" xlink:href="fact-20221231.xsd#fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems" xlink:href="fact-20221231.xsd#fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedNetIncomePerShareForEachClassOfOrdinaryShareAbstract" xlink:to="SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable" xlink:to="SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NumeratorAbstract" xlink:href="fact-20221231.xsd#fact_NumeratorAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems" xlink:to="NumeratorAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AllocationOfNetIncome" xlink:href="fact-20221231.xsd#fact_AllocationOfNetIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumeratorAbstract" xlink:to="AllocationOfNetIncome" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DenominatorAbstract" xlink:href="fact-20221231.xsd#fact_DenominatorAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems" xlink:to="DenominatorAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DenominatorAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromGrossProceedsFromIPO" xlink:href="fact-20221231.xsd#fact_ProceedsFromGrossProceedsFromIPO"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract" xlink:to="ProceedsFromGrossProceedsFromIPO" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LessAbstract" xlink:href="fact-20221231.xsd#fact_LessAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract" xlink:to="LessAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LessAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LessAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PlusAbstract" xlink:href="fact-20221231.xsd#fact_PlusAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract" xlink:to="PlusAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlusAbstract" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlusAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="PlusAbstract0" xlink:href="fact-20221231.xsd#fact_PlusAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract" xlink:to="PlusAbstract0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityOtherChanges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityOtherChanges"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlusAbstract0" xlink:to="us-gaap_TemporaryEquityOtherChanges" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlusAbstract0" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisAbstract" xlink:to="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable" xlink:to="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="InvestmentsHeldInTrustAccountUSTreasureSecurities" xlink:href="fact-20221231.xsd#fact_InvestmentsHeldInTrustAccountUSTreasureSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="InvestmentsHeldInTrustAccountUSTreasureSecurities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentsHeldInTrustAccountNet" xlink:href="fact-20221231.xsd#fact_InvestmentsHeldInTrustAccountNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="InvestmentsHeldInTrustAccountNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantLiabilitiesPublicWarrants" xlink:href="fact-20221231.xsd#fact_WarrantLiabilitiesPublicWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="WarrantLiabilitiesPublicWarrants" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantLiabilitiesPrivateWarrants" xlink:href="fact-20221231.xsd#fact_WarrantLiabilitiesPrivateWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="WarrantLiabilitiesPrivateWarrants" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNoteAmount" xlink:href="fact-20221231.xsd#fact_ConvertibleNoteAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="ConvertibleNoteAmount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNoteone" xlink:href="fact-20221231.xsd#fact_ConvertibleNoteone"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="ConvertibleNoteone" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesTwo" xlink:href="fact-20221231.xsd#fact_ConvertibleNotesTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="ConvertibleNotesTwo" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_TotalWarrantLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="TotalWarrantLiabilities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentsHeldInTrustAccountUSMoneyMarketFund" xlink:href="fact-20221231.xsd#fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems" xlink:to="InvestmentsHeldInTrustAccountUSMoneyMarketFund" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:to="us-gaap_SharePrice" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementStrikePrice" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementStrikePrice"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZTEDkh6awj/BIIReKzb4sGTz1n4Qtz6doLW75LUrO5BZN95BNU5gyy58yAPWsdJIHcPZx1o6NM2CjhVzEFw7kOzrV8JjqYIRJQ4gEvu2u5sh+julvljtKtVlqFYmOCh9+g/cfz7LLZtgz2FLPFuCP/fwdCLWDj3vDJhSjrrMe+hNfAR6gadd95D99SFm84TXw4CoXgLsK04Nw5QXd7n5l6AnnmQpdNXIo=] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:to="FairValueMeasurementStrikePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates" xlink:href="fact-20221231.xsd#fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract" xlink:to="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PublicMember" xlink:href="fact-20221231.xsd#fact_PublicMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="PublicMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable" xlink:to="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueNetAssetLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems" xlink:to="us-gaap_FairValueNetAssetLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueInitialMeasurement" xlink:href="fact-20221231.xsd#fact_FairValueInitialMeasurement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems" xlink:to="FairValueInitialMeasurement" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueNetAssetLiability_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems" xlink:to="us-gaap_FairValueNetAssetLiability_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesAbstract" xlink:href="fact-20221231.xsd#fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesAbstract" xlink:to="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicMember" xlink:href="fact-20221231.xsd#fact_PublicMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="PublicMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable" xlink:to="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueNetAssetLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" xlink:to="us-gaap_FairValueNetAssetLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueInitialMeasurement" xlink:href="fact-20221231.xsd#fact_FairValueInitialMeasurement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" xlink:to="FairValueInitialMeasurement" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueAssetsLevel1ToLevel2TransferAmount" xlink:href="fact-20221231.xsd#fact_FairValueAssetsLevel1ToLevel2TransferAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" xlink:to="FairValueAssetsLevel1ToLevel2TransferAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueNetAssetLiability_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems" xlink:to="us-gaap_FairValueNetAssetLiability_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="OrganizationandBusinessOperationsDetailsTable" xlink:href="fact-20221231.xsd#fact_OrganizationandBusinessOperationsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="OrganizationandBusinessOperationsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_OrganizationandBusinessOperationsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="OrganizationandBusinessOperationsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsTable" xlink:to="OrganizationandBusinessOperationsDetailsLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GeneratingGrossProceeds" xlink:href="fact-20221231.xsd#fact_GeneratingGrossProceeds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="GeneratingGrossProceeds" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherUnderwritingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherUnderwritingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_OtherUnderwritingExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredUnderwritingFee" xlink:href="fact-20221231.xsd#fact_DeferredUnderwritingFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="DeferredUnderwritingFee" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOwnershipInterestsOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOwnershipInterestsOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_OtherOwnershipInterestsOfferingCosts" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalTransactionCost" xlink:href="fact-20221231.xsd#fact_TotalTransactionCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="TotalTransactionCost" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetProceedsOfTheSaleOfTheUnits" xlink:href="fact-20221231.xsd#fact_NetProceedsOfTheSaleOfTheUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="NetProceedsOfTheSaleOfTheUnits" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationFairMarketValueEqualPercentage" xlink:href="fact-20221231.xsd#fact_BusinessCombinationFairMarketValueEqualPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="BusinessCombinationFairMarketValueEqualPercentage" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetTangibleAssets" xlink:href="fact-20221231.xsd#fact_NetTangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="NetTangibleAssets" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RedeemPublicSharesPercentage" xlink:href="fact-20221231.xsd#fact_RedeemPublicSharesPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="RedeemPublicSharesPercentage" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicPerShare" xlink:href="fact-20221231.xsd#fact_PublicPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="PublicPerShare" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TrustAccountPerShare" xlink:href="fact-20221231.xsd#fact_TrustAccountPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="TrustAccountPerShare" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_AssetsHeldInTrust" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationandBusinessOperationsDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsDetails">
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="us-gaap_AccountsPayableOtherCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OperationalCosts" xlink:href="fact-20221231.xsd#fact_OperationalCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="OperationalCosts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsTable" xlink:href="fact-20221231.xsd#fact_SignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsLineItems" xlink:href="fact-20221231.xsd#fact_SignificantAccountingPoliciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_USTreasurySecuritiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="SignificantAccountingPoliciesDetailsLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_CashFDICInsuredAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesSubjectToPossibleRedemption" xlink:href="fact-20221231.xsd#fact_OrdinarySharesSubjectToPossibleRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="OrdinarySharesSubjectToPossibleRedemption" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsPurchase" xlink:href="fact-20221231.xsd#fact_WarrantsPurchase"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="WarrantsPurchase" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DeferredOfferingCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherUnderwritingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherUnderwritingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_OtherUnderwritingExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredUnderwritingFee" xlink:href="fact-20221231.xsd#fact_DeferredUnderwritingFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="DeferredUnderwritingFee" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOwnershipInterestsOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOwnershipInterestsOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_OtherOwnershipInterestsOfferingCosts" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalTransactionCost" xlink:href="fact-20221231.xsd#fact_TotalTransactionCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="TotalTransactionCost" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PartialReversalOfTransactionCosts" xlink:href="fact-20221231.xsd#fact_PartialReversalOfTransactionCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="PartialReversalOfTransactionCosts" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DerivativeWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_DerivativeWarrantLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="DerivativeWarrantLiabilities" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails">
    <loc xlink:type="locator" xlink:label="ProposedPublicOfferingDisclosureAbstract" xlink:href="fact-20221231.xsd#fact_ProposedPublicOfferingDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingDetailsTable" xlink:href="fact-20221231.xsd#fact_InitialPublicOfferingDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingDetailsLineItems" xlink:href="fact-20221231.xsd#fact_InitialPublicOfferingDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProposedPublicOfferingDisclosureAbstract" xlink:to="InitialPublicOfferingDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsTable" xlink:to="InitialPublicOfferingDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_CommonStockNoParValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceIncrease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SaleOfOrdinarySharesRedemption" xlink:href="fact-20221231.xsd#fact_SaleOfOrdinarySharesRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InitialPublicOfferingDetailsLineItems" xlink:to="SaleOfOrdinarySharesRedemption" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails">
    <loc xlink:type="locator" xlink:label="PrivatePlacementWarrantsDisclosureAbstract" xlink:href="fact-20221231.xsd#fact_PrivatePlacementWarrantsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementWarrantsDetailsTable" xlink:href="fact-20221231.xsd#fact_PrivatePlacementWarrantsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementWarrantsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_PrivatePlacementWarrantsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementWarrantsDisclosureAbstract" xlink:to="PrivatePlacementWarrantsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementWarrantsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementWarrantsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementWarrantsDetailsTable" xlink:to="PrivatePlacementWarrantsDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementWarrantsDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementWarrantsDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregatePurchasePrice" xlink:href="fact-20221231.xsd#fact_AggregatePurchasePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementWarrantsDetailsLineItems" xlink:to="AggregatePurchasePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsDetailsTable" xlink:href="fact-20221231.xsd#fact_RelatedPartyTransactionsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_RelatedPartyTransactionsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="RelatedPartyTransactionsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FounderSharesMember" xlink:href="fact-20221231.xsd#fact_FounderSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="FounderSharesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationMember" xlink:href="fact-20221231.xsd#fact_BusinessCombinationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="BusinessCombinationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_DirectorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="RelatedPartyTransactionsDetailsLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSponsorAmount" xlink:href="fact-20221231.xsd#fact_StockIssuedDuringPeriodSponsorAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="StockIssuedDuringPeriodSponsorAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SharePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_SharesIssued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockOtherSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockOtherSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_CommonStockOtherSharesOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="SponsorShare" xlink:href="fact-20221231.xsd#fact_SponsorShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="SponsorShare" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_OtherLongTermDebt" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WorkingCapitalLoans" xlink:href="fact-20221231.xsd#fact_WorkingCapitalLoans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="WorkingCapitalLoans" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PromissioryNoteRelatedParty" xlink:href="fact-20221231.xsd#fact_PromissioryNoteRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="PromissioryNoteRelatedParty" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfUnsecuredDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceDecrease" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfficeSpaceAndAdministrativeSupportServices" xlink:href="fact-20221231.xsd#fact_OfficeSpaceAndAdministrativeSupportServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsLineItems" xlink:to="OfficeSpaceAndAdministrativeSupportServices" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="CommitmentsContingenciesDetailsTable" xlink:href="fact-20221231.xsd#fact_CommitmentsContingenciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="CommitmentsContingenciesDetailsLineItems" xlink:href="fact-20221231.xsd#fact_CommitmentsContingenciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsContingenciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsContingenciesDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationMember" xlink:href="fact-20221231.xsd#fact_BusinessCombinationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="BusinessCombinationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsContingenciesDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsContingenciesDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsContingenciesDetailsTable" xlink:to="CommitmentsContingenciesDetailsLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherUnderwritingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherUnderwritingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsContingenciesDetailsLineItems" xlink:to="us-gaap_OtherUnderwritingExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredUnderwritingDiscountPerUnit" xlink:href="fact-20221231.xsd#fact_DeferredUnderwritingDiscountPerUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsContingenciesDetailsLineItems" xlink:to="DeferredUnderwritingDiscountPerUnit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateGrossProceeds" xlink:href="fact-20221231.xsd#fact_AggregateGrossProceeds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsContingenciesDetailsLineItems" xlink:to="AggregateGrossProceeds" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsContingenciesDetailsLineItems" xlink:to="us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PartialReversalOfTransactionCosts" xlink:href="fact-20221231.xsd#fact_PartialReversalOfTransactionCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsContingenciesDetailsLineItems" xlink:to="PartialReversalOfTransactionCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsContingenciesDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsContingenciesDetailsLineItems" xlink:to="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsContingenciesDetailsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsContingenciesDetailsLineItems" xlink:to="us-gaap_DividendsCommonStockCash" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalDeferredPurchasePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalDeferredPurchasePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsContingenciesDetailsLineItems" xlink:to="us-gaap_SupplementalDeferredPurchasePrice" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersDeficitDetailsTable" xlink:href="fact-20221231.xsd#fact_ShareholdersDeficitDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersDeficitDetailsLineItems" xlink:href="fact-20221231.xsd#fact_ShareholdersDeficitDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="ShareholdersDeficitDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsTable" xlink:to="ShareholdersDeficitDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesDescription" xlink:href="fact-20221231.xsd#fact_OrdinarySharesDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsLineItems" xlink:to="OrdinarySharesDescription" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalNumberOfOrdinarySharesOutstandingPercentage" xlink:href="fact-20221231.xsd#fact_TotalNumberOfOrdinarySharesOutstandingPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersDeficitDetailsLineItems" xlink:to="TotalNumberOfOrdinarySharesOutstandingPercentage" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails">
    <loc xlink:type="locator" xlink:label="WarrantsDisclosureAbstract" xlink:href="fact-20221231.xsd#fact_WarrantsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="WarrantsDetailsTable" xlink:href="fact-20221231.xsd#fact_WarrantsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="WarrantsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_WarrantsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsDisclosureAbstract" xlink:to="WarrantsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PublicWarrantsMember" xlink:href="fact-20221231.xsd#fact_PublicWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="PublicWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsDetailsTable" xlink:to="WarrantsDetailsLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantTerm" xlink:href="fact-20221231.xsd#fact_WarrantTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsDetailsLineItems" xlink:to="WarrantTerm" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantExpirationTerm" xlink:href="fact-20221231.xsd#fact_WarrantExpirationTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsDetailsLineItems" xlink:to="WarrantExpirationTerm" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsDetailsLineItems" xlink:to="us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RedemptionsOfWarrantsDescription" xlink:href="fact-20221231.xsd#fact_RedemptionsOfWarrantsDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsDetailsLineItems" xlink:to="RedemptionsOfWarrantsDescription" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementsDetailsTable" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_FairValueMeasurementsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="FairValueMeasurementsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsTable" xlink:to="FairValueMeasurementsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsLineItems" xlink:to="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueWarrantLiabilities" xlink:href="fact-20221231.xsd#fact_FairValueWarrantLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsDetailsLineItems" xlink:to="FairValueWarrantLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsTable" xlink:href="fact-20221231.xsd#fact_SubsequentEventsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsLineItems" xlink:href="fact-20221231.xsd#fact_SubsequentEventsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SubsequentEventsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationMember" xlink:href="fact-20221231.xsd#fact_BusinessCombinationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="BusinessCombinationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="srt_StatementScenarioAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="SubsequentEventsDetailsLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_SharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="VotingPowerPercentage" xlink:href="fact-20221231.xsd#fact_VotingPowerPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="VotingPowerPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuedAndOutstandingShares" xlink:href="fact-20221231.xsd#fact_IssuedAndOutstandingShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="IssuedAndOutstandingShares" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonUnitOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_CommonUnitOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExtensionAmendmentProposalFor" xlink:href="fact-20221231.xsd#fact_ExtensionAmendmentProposalFor"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="ExtensionAmendmentProposalFor" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExtensionAmendmentProposalAgainst" xlink:href="fact-20221231.xsd#fact_ExtensionAmendmentProposalAgainst"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="ExtensionAmendmentProposalAgainst" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExtensionAmendmentProposalAbstain" xlink:href="fact-20221231.xsd#fact_ExtensionAmendmentProposalAbstain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="ExtensionAmendmentProposalAbstain" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateSharesOfCommonStock" xlink:href="fact-20221231.xsd#fact_AggregateSharesOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="AggregateSharesOfCommonStock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuedAndOutstandingInterestPercentage" xlink:href="fact-20221231.xsd#fact_IssuedAndOutstandingInterestPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="IssuedAndOutstandingInterestPercentage" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockHeldInTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockHeldInTrust"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_CommonStockHeldInTrust" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentManagementTrustAgreementFor" xlink:href="fact-20221231.xsd#fact_InvestmentManagementTrustAgreementFor"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="InvestmentManagementTrustAgreementFor" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentManagementTrustAgreementAgainst" xlink:href="fact-20221231.xsd#fact_InvestmentManagementTrustAgreementAgainst"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="InvestmentManagementTrustAgreementAgainst" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentManagementTrustAgreementAbstain" xlink:href="fact-20221231.xsd#fact_InvestmentManagementTrustAgreementAbstain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="InvestmentManagementTrustAgreementAbstain" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfUnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfUnsecuredDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_RepaymentsOfUnsecuredDebt" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PromissoryNote" xlink:href="fact-20221231.xsd#fact_PromissoryNote"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="PromissoryNote" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DrawnDownAmount" xlink:href="fact-20221231.xsd#fact_DrawnDownAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="DrawnDownAmount" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="fact-20221231.xsd#fact_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassBMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925632248800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FREEDOM
ACQUISITION I CORP.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FACT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 339,256,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001838987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">14
Wall Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">20th Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">618-1798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A ordinary shares, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Marcum llp<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">34,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925632271248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 72,923<span></span>
</td>
<td class="nump">$ 277,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses - short term</a></td>
<td class="nump">120,677<span></span>
</td>
<td class="nump">724,066<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">193,600<span></span>
</td>
<td class="nump">1,001,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Prepaid expenses - long term</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">113,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Cash and marketable securities held in Trust Account</a></td>
<td class="nump">349,927,313<span></span>
</td>
<td class="nump">345,105,681<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">350,120,913<span></span>
</td>
<td class="nump">346,220,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">4,858,215<span></span>
</td>
<td class="nump">2,579,641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible promissory note &#8211; related party</a></td>
<td class="nump">828,600<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">5,686,815<span></span>
</td>
<td class="nump">2,579,641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">2,978,333<span></span>
</td>
<td class="nump">8,488,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred underwriters&#8217; discount payable</a></td>
<td class="nump">3,018,750<span></span>
</td>
<td class="nump">12,075,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">11,683,898<span></span>
</td>
<td class="nump">23,142,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (See Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A Ordinary shares subject to possible redemption 34,500,000 shares subject to possible redemption at redemption value at December 31, 2022 and 2021, respectively</a></td>
<td class="nump">349,927,313<span></span>
</td>
<td class="nump">345,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ShareholdersDeficitAbstract', window );"><strong>Shareholders&#8217; Deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at December 31, 2022 and 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized at December 31, 2022 and 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_CommonStockValueOne', window );">Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding at December 31, 2022 and 2021</a></td>
<td class="nump">863<span></span>
</td>
<td class="nump">863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">6,057,438<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(17,548,599)<span></span>
</td>
<td class="num">(21,923,351)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Deficit</a></td>
<td class="num">(11,490,298)<span></span>
</td>
<td class="num">(21,922,488)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities, Redeemable Ordinary Shares and Shareholders&#8217; Deficit</a></td>
<td class="nump">$ 350,120,913<span></span>
</td>
<td class="nump">$ 346,220,403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_CommonStockValueOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_CommonStockValueOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ShareholdersDeficitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ShareholdersDeficitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925632181088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preference shares, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preference shares, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preference shares, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preference shares, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SharesSubjectToPossibleRedemption', window );">Ordinary shares subject to possible redemption</a></td>
<td class="nump">34,500,000<span></span>
</td>
<td class="nump">34,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding</a></td>
<td class="nump">34,500,000<span></span>
</td>
<td class="nump">34,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued</a></td>
<td class="nump">8,625,000<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding</a></td>
<td class="nump">8,625,000<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_SharesSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_SharesSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925632151248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Operating costs</a></td>
<td class="nump">$ 4,407,058<span></span>
</td>
<td class="nump">$ 3,782,028<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(4,407,058)<span></span>
</td>
<td class="num">(3,782,028)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency exchange loss</a></td>
<td class="num">(17,638)<span></span>
</td>
<td class="num">(1,475)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income on marketable securities held in Trust Account</a></td>
<td class="nump">4,821,632<span></span>
</td>
<td class="nump">105,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_PartialReversalOfTransactionCosts', window );">Reduction of transaction costs incurred in connection with IPO</a></td>
<td class="nump">271,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">5,509,917<span></span>
</td>
<td class="nump">9,381,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Change in fair value of convertible note</a></td>
<td class="num">(196,200)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoninterestExpenseOfferingCost', window );">Offering expenses related to warrant issuance</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(575,278)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income, net</a></td>
<td class="nump">10,389,398<span></span>
</td>
<td class="nump">8,910,678<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 5,982,340<span></span>
</td>
<td class="nump">$ 5,128,650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding (in Shares)</a></td>
<td class="nump">34,500,000<span></span>
</td>
<td class="nump">28,828,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share (in Dollars per share)</a></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding (in Shares)</a></td>
<td class="nump">8,625,000<span></span>
</td>
<td class="nump">8,440,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share (in Dollars per share)</a></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_PartialReversalOfTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Partial reversal of transaction costs incurred in connection with IPO.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_PartialReversalOfTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14172-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoninterestExpenseOfferingCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Includes offering costs of open-end investment companies, and closed-end funds with a continuous offering period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoninterestExpenseOfferingCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925632376560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share</a></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share</a></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925561971536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders&#8217; (Deficit) Equity - USD ($)<br></strong></div></th>
<th class="th">
<div>Class A </div>
<div>Ordinary Shares</div>
</th>
<th class="th">
<div>Class B </div>
<div>Ordinary Shares</div>
</th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
<td class="nump">$ 24,137<span></span>
</td>
<td class="num">$ (5,494)<span></span>
</td>
<td class="nump">$ 19,506<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Sale of 34,500,000 Units on March 2, 2021 through public offering</a></td>
<td class="nump">$ 3,450<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Sale of 34,500,000 Units on March 2, 2021 through public offering (in Shares)</a></td>
<td class="nump">34,500,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Excess of the fair value of private placement warrants over cash received</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,880,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,880,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Class A ordinary shares subject to possible redemption</a></td>
<td class="num">$ (3,450)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Class A ordinary shares subject to possible redemption (in Shares)</a></td>
<td class="num">(34,500,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Remeasurement of Class A ordinary shares subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,904,137)<span></span>
</td>
<td class="num">(27,046,507)<span></span>
</td>
<td class="num">(28,950,644)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,128,650<span></span>
</td>
<td class="nump">5,128,650<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(21,923,351)<span></span>
</td>
<td class="num">(21,922,488)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(21,923,351)<span></span>
</td>
<td class="num">(21,922,488)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(21,923,351)<span></span>
</td>
<td class="num">(21,922,488)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Proceeds received on convertible note less than fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">592,600<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">592,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Accretion portion net against additional paid-in-capital</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(592,600)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(592,600)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Accretion of Class A ordinary shares subject to possible redemption</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,727,125)<span></span>
</td>
<td class="num">(1,607,588)<span></span>
</td>
<td class="num">(4,334,713)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Reduction of deferred underwriting fee payable</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,784,563<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,784,563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,982,340<span></span>
</td>
<td class="nump">5,982,340<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
<td class="nump">$ 6,057,438<span></span>
</td>
<td class="num">$ (17,548,599)<span></span>
</td>
<td class="num">$ (11,490,298)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925636443696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders&#8217; (Deficit) Equity (Parentheticals)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Sale of Units through public offering</a></td>
<td class="nump">34,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925634409696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 5,982,340<span></span>
</td>
<td class="nump">$ 5,128,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest earned on marketable securities held in Trust Account</a></td>
<td class="num">(4,821,632)<span></span>
</td>
<td class="num">(105,681)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ChangeInFairValueOfWarrantLiabilities', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(5,509,917)<span></span>
</td>
<td class="num">(9,381,750)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Change in fair value of convertible note</a></td>
<td class="nump">196,200<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ChangeInDeferredUnderwritingFee', window );">Change in deferred underwriting fee</a></td>
<td class="num">(271,687)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_OfferingCostsAllocatedToWarrants', window );">Offering costs allocated to warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">575,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in current assets and current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="nump">716,462<span></span>
</td>
<td class="num">(837,139)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">2,278,574<span></span>
</td>
<td class="nump">2,579,641<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(1,429,660)<span></span>
</td>
<td class="num">(2,041,001)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_CashDepositedInTrustAccount', window );">Investment of cash into Trust Account</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(345,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(345,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from Initial Public Offering, net of underwriters&#8217; discount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">338,595,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of Private Placement Warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of Convertible Promissory Note</a></td>
<td class="nump">1,225,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of promissory note to related party</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(90,996)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(585,420)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">1,225,000<span></span>
</td>
<td class="nump">347,318,584<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net Change in Cash</a></td>
<td class="num">(204,660)<span></span>
</td>
<td class="nump">277,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; Beginning</a></td>
<td class="nump">277,583<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; Ending</a></td>
<td class="nump">72,923<span></span>
</td>
<td class="nump">277,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of noncash financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption', window );">Initial value of Class A ordinary shares subject to possible redemption</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">345,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InitialValueOfWarrantLiabilities', window );">Initial value of warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">17,870,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_DeferredOfferingCostsIncludedInAccruedExpenses', window );">Deferred underwriters&#8217; discount payable charged to additional paid-in capital</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">12,075,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares', window );">Accretion of Class A ordinary shares subject to possible redemption</a></td>
<td class="nump">4,927,313<span></span>
</td>
<td class="nump">28,950,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_DeferredOfferingCostsPaidUnderPromissoryNote', window );">Deferred offering costs paid under promissory note</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 90,996<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accretion of Class A ordinary shares subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_CashDepositedInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash deposited in Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_CashDepositedInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ChangeInDeferredUnderwritingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in deferred underwriting fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ChangeInDeferredUnderwritingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ChangeInFairValueOfWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ChangeInFairValueOfWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_DeferredOfferingCostsIncludedInAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is deferred offering costs included in accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_DeferredOfferingCostsIncludedInAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_DeferredOfferingCostsPaidUnderPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred offering costs paid under promissory note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_DeferredOfferingCostsPaidUnderPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in value of Class A ordinary shares subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_InitialValueOfWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of  initial value of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_InitialValueOfWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_OfferingCostsAllocatedToWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Offering costs allocated to warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_OfferingCostsAllocatedToWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14172-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925632177760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Business Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Business Operations</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 1 &#8212; Organization and Business Operations</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Organization and General</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Freedom Acquisition I Corp. (the &#8220;Company&#8221;
or &#8220;Freedom&#8221;) was incorporated in Cayman Islands on December 23, 2020. The Company was formed for the purpose of entering
into a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more
businesses (a &#8220;Business Combination&#8221;). The Company is not limited to a particular industry or geographic region for purposes
of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject
to all of the risks associated with early stage and emerging growth companies.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On October 3, 2022, the Company entered into a
Business Combination Agreement with Jupiter Merger Sub I Corp., a Delaware corporation and a wholly owned subsidiary of the Company, Jupiter
Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company, Complete Solar Holding Corporation,
a Delaware corporation, and The Solaria Corporation, a Delaware corporation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&#8217;s sponsor is Freedom Acquisition
I LLC, a Cayman Islands limited liability company (the &#8220;Sponsor&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022, the Company had not
yet commenced any operations. All activity through December 31, 2022, relates to the Company&#8217;s formation and the Initial
Public Offering (&#8220;IPO&#8221; or &#8220;Initial Public Offering&#8221;) described below. The Company will not generate any
operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO and changes
in the fair value of warrant liabilities.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financing</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The registration statement for the Company&#8217;s
IPO was declared effective on February 25, 2021 (the &#8220;Effective Date&#8221;). On March 2, 2021, the Company consummated the IPO
of&#160;34,500,000&#160;units (the &#8220;Units&#8221; and, with respect to the Class A ordinary shares included in the Units being offered,
the &#8220;public share&#8221;), at $10.00&#160;per Unit, generating gross proceeds of $345,000,000, which is discussed in Note 4.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Simultaneously with the closing of the IPO, the Company consummated
the sale&#160;of&#160;6,266,667&#160;warrants (the &#8220;Private Placement Warrants&#8221;), at a price of $1.50&#160;per Private Placement
Warrant, which is discussed in Note&#160;5.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Transaction costs amounted to $19,175,922,&#160;consisting of $6,405,000&#160;of
underwriting fees, $12,075,000&#160;of deferred underwriting fees and $695,922&#160;of other offering costs. Of the total transaction
cost, $575,278&#160;was expensed as non-operating expenses in the consolidated statement of operations with the rest of the offering cost
charged to shareholders&#8217; deficit for the year ended December 31, 2021. The transaction costs were allocated based on the relative
fair value basis, compared to the total offering proceeds, between the fair value of the public warrant liabilities and the Class A ordinary
shares.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Trust Account</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Following the closing of the IPO on March 2, 2021,
an amount of $345,000,000&#160;from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants
was placed in a trust account (&#8220;Trust Account&#8221;). The funds in the Trust Account have, since the IPO and until the&#160;24-month&#160;anniversary
of the consummation of the IPO, been invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment
Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund
meeting the conditions of Rule&#160;2a-7&#160;of the&#160;Investment Company Act, as determined by the Company. To mitigate the risk of
the Company being deemed to have been operating as an unregistered investment company, prior to the&#160;24-month&#160;anniversary of
the consummation of the IPO, the Company instructed Continental, the trustee with respect to the Trust Account, to liquidate the U.S.
government treasury obligations or money market funds held in the Trust Account and to hold all the funds in the Trust Account in cash
in a bank deposit account. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company
to pay its tax obligations, the proceeds from the IPO and the sale of the private placement units will not be released from the Trust
Account until the earliest of (a) the completion of the Company&#8217;s initial Business Combination, (b) the redemption of any public
shares properly submitted in connection with a shareholder vote to amend the Company&#8217;s amended and restated certificate of incorporation,
and (c) the redemption of the Company&#8217;s public shares if the Company is unable to complete the initial Business Combination during
the Combination Period (as defined below), subject to applicable law. The proceeds deposited in the Trust Account could become subject
to the claims of the Company&#8217;s creditors, if any, which could have priority over the claims of the Company&#8217;s public shareholders.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Initial Business Combination</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&#8217;s management has broad discretion
with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to
be generally applied toward consummating a Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&#8217;s Business Combination must
be with one or more target businesses that together have a fair market value equal to at least&#160;80% of the balance in the Trust Account
(net of taxes payable) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete
a Business Combination if the post-Business Combination company owns or acquires&#160;50% or more of the outstanding voting securities
of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment
company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company will provide its public shareholders
with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either
(i) in connection with a shareholder meeting called to approve the initial Business Combination or (ii) by means of a tender offer. The
decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer
will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their shares for a pro rata portion
of the amount then on deposit in the Trust Account (initially $10.00&#160;per share, plus any pro rata interest earned on the funds held
in the Trust Account and not previously released to the Company to pay its tax obligations).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Class A ordinary shares subject to
redemption are recorded at redemption value and classified as temporary equity upon the completion of the IPO, in accordance with
Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; In such case,
the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001&#160;either
immediately prior to or upon consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of
the issued and outstanding shares voted are voted in favor of the Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On February 28, 2023, the Company&#8217;s shareholders
approved an amendment to its amended and restated memorandum and articles of association to extend the date by which the Company must
complete a Business Combination from March 2, 2023 to June 2, 2023, and to thereafter further extend such period up to three times by
an additional one month each time (up to September 2, 2023) (such period, as may be extended, the &#8220;Combination Period&#8221;). However,
if the Company is unable to complete a Business Combination within the Combination Period, the Company will redeem&#160;100% of the outstanding
public shares for a pro rata portion of the funds held in the Trust Account, equal to the aggregate amount then on deposit in the Trust
Account including interest earned on the funds held in the Trust Account and not previously released to the Company, divided by the number
of then outstanding public shares, subject to applicable law and as further described in the registration statement, and then seek to
dissolve and liquidate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&#8217;s Sponsor, officers and directors
have agreed to (i) waive their redemption rights with respect to their founder shares, private placement shares and public shares in connection
with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their founder shares and public
shares in connection with a shareholder vote to approve an amendment to the Company&#8217;s amended and restated certificate of incorporation,
and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares and private placement
shares if the Company fails to complete the initial Business Combination within the Combination Period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&#8217;s Sponsor has agreed that it
will be liable to the Company if and to the extent any claims by a third-party for services rendered or products sold to the Company,
or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement
or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00&#160;per public share
and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less
than $10.00&#160;per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not
apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in
the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#8217;s indemnity of the
underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;). However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently
verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Company&#8217;s Sponsor&#8217;s
only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Liquidity</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022, the Company had cash outside the Trust Account
of $72,923 available for working capital needs. All remaining cash held in the Trust Account is generally unavailable for the Company&#8217;s
use prior to an initial Business Combination and is restricted for use either in a Business Combination or to redeem ordinary shares.
The Company may elect to withdraw from the interest income earned on the trust account to pay the Company&#8217;s tax obligations. As
of December 31, 2022, the Company had interest income earned on the trust account of $4,821,632.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company may raise additional capital through
loans or additional investments from the Sponsor or an affiliate of the Sponsor or certain of its directors and officers. The Sponsor
may, but is not obligated to, lend the Company funds, from time to time in whatever amounts it deems reasonable in its sole discretion,
to meet the Company&#8217;s working capital needs. There can be no assurance that the Company will be able to obtain additional financing,
however. Moreover, the Company may need to obtain additional financing either to complete its Business Combination or because the Company
becomes obligated to redeem a significant number of its public shares upon consummation of its Business Combination, in which case the
Company may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable
securities laws, the Company would only complete such financing simultaneously with the completion of its Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Company is unable to raise additional capital,
it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing
operations, suspending the pursuit of a potential transaction and reducing overhead expenses. The Company cannot provide any assurance
that new financing will be available to it on commercially acceptable terms, if at all.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Going Concern</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In connection with the Company&#8217;s
assessment of going concern considerations in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 205-40, &#8220;Presentation of Financial Statements &#8211; Going Concern,&#8221; pursuant to its Amended and Restated Certificate of Incorporation, the
Company has until the end of the Combination Period to consummate a Business Combination. If a Business Combination is not
consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Although the Company
intends to consummate a Business Combination during the Combination Period, it is uncertain that the Company will be able to do so.
This, as well as its liquidity condition, raise substantial doubt about the Company&#8217;s ability to continue as a going concern.
No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate at the
end of the Combination Period.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Risks and Uncertainties</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Management is currently evaluating the
impact of the COVID-19 pandemic and Russia-Ukraine war and has concluded that while it is reasonably possible that the virus and war
could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target
company, the specific impact is not readily determinable as of the date of these financial statements. The consolidated financial
statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Consideration of IR Act Excise Tax</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On August 16, 2022, the Inflation Reduction Act
of 2022 (the &#8220;IR Act&#8221;) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise
tax on certain repurchases of stock by publicly-traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly-traded
foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its
shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased
at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the
fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition,
certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the &#8220;Treasury&#8221;) has been given authority
to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Any redemption or other repurchase that occurs
after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether
and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise
would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business
Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any &#8220;PIPE&#8221;
or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination
but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury.
In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment
of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business
Combination and in the Company&#8217;s ability to complete a Business Combination.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925652578384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revision of Previously Issued Financial Statements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsTextBlock', window );">Revision of Previously Issued Financial Statements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 2 &#8212; Revision of Previously-Issued Financial Statements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In connection with the preparation of the Company&#8217;s financial statements
as of December 31, 2022, the Company identified an error in amounts reported in certain of the Company&#8217;s previously-issued financial
statements related to accounts payable. The Company incorrectly recorded intercompany operating bank transfers as payables whereas Legal
and Professional Services was the accompanying debit in each transaction recorded. As a result, management determined that accounts payable
and operational costs as of June 30, 2022 and September 30, 2022 were overstated by $205,869.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following tables contain the revised financial information for
the affected periods previously reported. The revisions do not have an impact on the Company&#8217;s cash position and investments held
in the Trust Account established in connection with the Initial Public Offering. The Company has not amended its previously filed Quarterly
Reports on Form 10-Q for the two quarterly periods in 2022. The financial information that has been previously filed or otherwise reported
for these affected periods are superseded by the information below in this Annual Report on Form 10-K.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The impact of the revision on the Company&#8217;s financial statements
is reflected in the following tables:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Revised</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><b>Balance Sheet as of June 30, 2022 (unaudited)</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left">Total Liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,737,596</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(205,869</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,531,727</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Total Shareholders&#8217; Equity (Deficit)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(18,781,440</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(18,575,571</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Balance Sheet as of September 30, 2022 (unaudited)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Total Liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,298,967</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(205,869</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,093,098</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Total Shareholders&#8217; Equity (Deficit)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(16,803,964</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(16,598,095</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table><p style="margin: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; font-weight: bold; width: 64%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Previously<br/>
 Reported</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Revised</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><b>Condensed Statement of Operations for the Three Months
    Ended June 30, 2022 (unaudited)</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Operational Costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">824,081</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(205,869</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">618,212</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,025,986</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,231,855</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-73; -sec-ix-hidden: hidden-fact-72; -sec-ix-hidden: hidden-fact-71">Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.05</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.05</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-77; -sec-ix-hidden: hidden-fact-76; -sec-ix-hidden: hidden-fact-75">Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.05</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.05</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Condensed Statement of Operations for the Six Months Ended June 30, 2022 (unaudited)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Operational Costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,022,164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(205,869</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,816,295</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,321,266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,527,135</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-81; -sec-ix-hidden: hidden-fact-80; -sec-ix-hidden: hidden-fact-79">Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.08</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.08</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-85; -sec-ix-hidden: hidden-fact-84; -sec-ix-hidden: hidden-fact-83">Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.08</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.08</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Condensed Statement of Operations for the Nine Months Ended September 30, 2022 (unaudited)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Operational Costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,508,476</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(205,869</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,302,607</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,726,111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,931,980</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-89; -sec-ix-hidden: hidden-fact-88; -sec-ix-hidden: hidden-fact-87">Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.16</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.16</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-93; -sec-ix-hidden: hidden-fact-92; -sec-ix-hidden: hidden-fact-91">Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.16</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.16</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table><p style="margin: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; width: 64%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Previously<br/>
 Reported</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Revised</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><b>Condensed Statement of Cash Flows for the Six Months
    Ended June 30, 2022 (unaudited)</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,321,266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,527,135</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">884,539</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(205,869</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">678,670</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Condensed Statement of Cash Flows for the Nine Months Ended September 30, 2022 (unaudited)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,726,111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,931,980</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">226,411</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(205,869</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,542</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for condensed financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph a<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925636630368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 3 &#8212; Significant Accounting Policies</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Basis of Presentation</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The accompanying financial statements are presented
in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules
and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Principles of Consolidation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The accompanying consolidated financial
statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions
have been eliminated in consolidation.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging Growth Company</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company is an &#8220;emerging growth company,&#8221;
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the &#8220;JOBS Act&#8221;),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements
of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and
proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder
approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth
companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that
have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange
Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to
opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election
to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard
is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company,
can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the
Company&#8217;s&#160;consolidated financial statements with another public company which is neither an emerging growth company nor an
emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences
in accounting standards used.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Use of Estimates</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The preparation of&#160;the&#160;consolidated financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the&#160;consolidated financial statements and the reported amounts
of expenses during the reporting period. Actual results could differ from those estimates.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Estimates made in preparing these consolidated financial statements
include, among other things, the fair value measurement of the Private Warrant liabilities.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash and Cash Equivalents</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents.&#160;The Company did not have any cash equivalents
as of December 31, 2022 and 2021.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investments Held in Trust Account</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At December 31, 2022, the assets held in the Trust Account were held in a money market fund with a maturity of 180 days or less. At December 31, 2021, the assets held in the Trust Account
were held in cash and U.S. Treasury securities. The Company classifies its United States Treasury securities as&#160;held-to-maturity&#160;in
accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC Topic 320, &#8220;Investments&#8212;Debt and Equity Securities.&#8221;&#160;Held-to-maturity&#160;securities
are those securities which the Company has the ability and intent to hold until maturity.&#160;Held-to-maturity&#160;treasury securities
are recorded at amortized cost and adjusted for the amortization or remeasurement of premiums or discounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022, investment in the
Company&#8217;s Trust Account consisted of $349,927,313 in a money market fund with a maturity of 180 days or less. Following the
maturity of the U.S. Treasury Securities on December 1, 2022, the Company immediately reinvested the entirety of the Trust Account
into a money market fund. The money market fund is disclosed at fair value on the consolidated balance sheet. As of December 31,
2021, investment in the Company&#8217;s Trust Account consisted of $484&#160;in cash and $345,105,197&#160;in U.S. Treasury
Securities. All of the U.S. Treasury Securities (the &#8220;T-bills&#8221;) matured on March 3, 2022 and the Company purchased new
T-bills. The Company considers all investments with original maturities of more than three months but less than one year to be
short-term investments. The carrying value approximates the fair value due to its short-term maturity. The carrying value, excluding
gross unrealized holding losses and fair value of held to maturity securities on December 31, 2022 and 2021 are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Value<br/> as of<br/> December&#160;31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Money Market Funds</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">349,927,313</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">349,927,313</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortized<br/> Cost&#160;and<br/> Carrying<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Unrealized<br/> Gains</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Unrealized<br/> Losses</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Value<br/> as&#160;of<br/> December&#160;31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-indent: -9.35pt; padding-left: 9.35pt">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">484</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-95">&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-96">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">484</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">U.S. Treasury Securities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">345,105,197</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,065</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">345,099,132</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">345,105,681</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-98">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(6,065</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">345,099,616</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A decline in the market value of held-to-maturity securities below
cost that is deemed to be other than temporary results in an impairment that reduces the carrying costs to such securities&#8217; fair
value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment
is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery
and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered
in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent
to&#160;year-end,&#160;forecasted performance of the investee, and the general market condition in the geographic area or industry the
investee operates in.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Premiums and discounts are amortized or accreted
over the life of the related&#160;held-to-maturity&#160;security as an adjustment to yield using the effective-interest method. Such amortization
and remeasurement are included in the &#8220;interest income&#8221; line item in the statements of operations. Interest income is recognized
when earned.&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Convertible Promissory Notes&#8212;Related Party&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company accounts for its convertible promissory notes under ASC
815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). Under ASC 815-15-25, the election can be at the inception of a financial
instrument to account for the instrument under the fair value option under ASC 825. The Company has made such election for its convertible
promissory notes. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value
on the date of issuance, each drawdown date, and each balance sheet date thereafter. Differences between the face value of the note and
fair value at each drawdown date are recognized as either an expense in the consolidated statements of operations (if issued at a premium)
or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as non-cash gains
or losses in the consolidated statements of operations. Changes in the estimated fair value of the note are recognized as non-cash change
in the fair value of the convertible promissory notes in the consolidated statements of operations.&#160;&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Concentration of Credit Risk&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal
Depository Insurance Coverage of&#8201;$250,000. At December 31, 2022 and 2021, the Company has not experienced losses on this account.&#160;&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ordinary Shares Subject to Possible Redemption</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company accounts for its Class A ordinary shares subject to possible
redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A ordinary shares
subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable
ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject
to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) are classified as temporary equity.
At all other times, ordinary shares are classified as shareholders&#8217; deficit. The Company&#8217;s ordinary shares feature certain
redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events.
Accordingly, as of December 31, 2022 and 2021,&#160;34,500,000&#160;Class A ordinary shares subject to possible redemption are presented
at redemption value as temporary equity, outside of the shareholders&#8217; deficit section of the Company&#8217;s consolidated balance
sheets, respectively.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net Income Per Ordinary Share</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company has two classes of shares, which are referred to as Class
A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The&#160;14,891,667&#160;potential
ordinary shares for outstanding warrants to purchase the Company&#8217;s shares were excluded from diluted earnings per share for the
years ended December 31, 2022 and 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met.
As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods presented. The table
below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class
of ordinary share:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Basic and diluted net income per share:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Allocation of net income</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4,785,872</p>
</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1,196,468</p>
</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">3,967,193</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,161,457</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">34,500,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,625,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">28,828,767</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,440,068</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Basic and diluted net income per share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Offering Costs</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company complies with the requirements
of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#8220;SAB&#8221;) Topic 5A - &#8220;Expenses of Offering&#8221;.
Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to
the Public Offering and that were charged to temporary equity upon the completion of the IPO. Accordingly, on December 31, 2022,
offering costs totaling $19,175,922&#160;have been charged to temporary equity (consisting of $6,405,000&#160;of underwriting fees,
$12,075,000&#160;of deferred underwriting fees and $695,922&#160;of other offering costs). Of the total transaction cost,
$575,278&#160;was recorded as a non-operating expense in the consolidated statements of operations, with the rest of the offering
cost charged to temporary equity. The transaction costs were allocated based on the relative fair value basis, compared to the total
offering proceeds, between the fair value of the public warrant liabilities and the Class A ordinary shares. As of October 25, 2022,
and November 2, 2022, respectively, J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. have waived their portions of the
deferred underwriting fee which is reflected in the consolidated statement of operations and the consolidated statement of changes
in shareholders&#8217; deficit as a reduction of transaction costs incurred in connection with IPO. Therefore, the deferred underwriting fee was
reduced by $9,056,250, of which $271,687 is shown in the consolidated statement of operations as a reduction of transaction
costs incurred in connection with the IPO and $8,784,563 is charged to additional paid-in capital in the consolidated statement of changes in shareholders&#8217; deficit. As a result of the reductions, the outstanding deferred underwriting fee payable was reduced to
$3,018,750.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fair Value of Financial Instruments</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The fair value of the Company&#8217;s assets and liabilities, which
qualify as financial instruments under the Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 820, &#8220;Fair Value Measurements
and Disclosures,&#8221; approximates the carrying amounts represented in the consolidated balance sheets.&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Derivative Warrant Liabilities</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company does not use derivative instruments
to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including
issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives,
pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded
as liabilities or as equity, is re-assessed at the end of each reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company accounts for its&#160;14,891,667&#160;ordinary shares warrants
issued in connection with its Initial Public Offering (8,625,000) and Private Placement (6,266,667) as derivative warrant liabilities
in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the
instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised,
and any change in fair value is recognized in the Company&#8217;s consolidated statements of operations. The fair value of the Private
Placement Warrants has been estimated using Monte Carlo simulations at each measurement date. The fair value of the Public Warrants was
initially estimated using Monte Carlo simulations. After the Public Warrants were separately traded, the measurement of the Public Warrants
used an observable market quote in an active market.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Income Taxes</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company follows the asset and liability method
of accounting for income taxes under ASC 740, &#8220;Income Taxes.&#8221; Deferred tax assets and liabilities are recognized for the estimated
future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities
and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are
established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">ASC 740 prescribes a recognition threshold and
a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax
return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized
tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and December 31, 2021. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The
Company is subject to income tax examinations by major taxing authorities since inception.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There is currently no taxation imposed on income
by the Government of the Cayman Islands. In accordance with federal income tax regulations, income taxes are not levied on the Company,
but rather on the individual owners. United States (&#8220;U.S.&#8221;) taxation would occur on the individual owners if certain tax elections
are made by U.S. owners and the Company were treated as a passive foreign investment company. The Company believes that it was a passive
foreign investment company for the 2021 and 2022 taxable years. Additionally, U.S. taxation could occur to the Company itself if the Company
is engaged in a U.S. trade or business. The Company is not expected to be treated as engaged in a U.S. trade or business at this time.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Recent Accounting Standards</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;)
2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in
Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;)&#8221; to simplify accounting for certain financial instruments.
ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible
instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s
own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed
to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement
to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be applied on a full
or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The guidance was adopted starting January
1, 2022. Adoption of the ASU did not impact the Company&#8217;s financial position, results of operations or cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Management does not believe that any recently
issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#8217;s&#160;financial
statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925636529840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ProposedPublicOfferingDisclosureAbstract', window );"><strong>Initial Public Offering [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ProposedPublicOfferingDisclosureTextBlock', window );">Initial Public Offering</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 4 &#8212; Initial Public Offering&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the Initial Public Offering, the Company
sold&#160;34,500,000&#160;Units, (at a price of $10.00 per Unit. Each Unit consists of one share of Class A Ordinary shares, par value
$0.0001&#160;per share one-fourth of one redeemable warrant (&#8220;Public Warrant&#8221;). Each whole Public Warrant entitles the holder
to purchase one share of Class A Ordinary shares at a price of $11.50 per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">All of the 34,500,000 Class A ordinary share sold as part of the Units
in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with the Company&#8217;s liquidation,
if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to
the Company&#8217;s certificate of incorporation. In accordance with SEC and its staff&#8217;s guidance on redeemable equity instruments,
which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares
subject to redemption to be classified outside of permanent equity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Class A ordinary share is subject to SEC and its staff&#8217;s
guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will
become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance
(or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the
instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument
to equal the redemption value at the end of each reporting period. The Company recognizes changes in redemption value immediately as they
occur. Immediately upon the closing of the IPO, the Company recognized the remeasurement from initial book value to redemption amount
value. The change in the carrying value of redeemable ordinary shares resulted in charges against additional paid-in capital and accumulated
deficit.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022 and 2021, the ordinary share reflected on the
consolidated balance sheets are reconciled in the following table:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Gross proceeds from IPO</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">345,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Proceeds allocated to Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,350,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Ordinary share issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18,600,644</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -8.65pt; padding-left: 17.3pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">28,950,644</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-indent: -9.35pt; padding-left: 9.35pt">Contingently redeemable ordinary share as of December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">345,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -8.65pt; padding-left: 17.3pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,927,313</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Contingently redeemable ordinary share as of December 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">349,927,313</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ProposedPublicOfferingDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ProposedPublicOfferingDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ProposedPublicOfferingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ProposedPublicOfferingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925636688048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_PrivatePlacementWarrantsDisclosureAbstract', window );"><strong>Private Placement Warrants Disclosure Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_PrivatePlacementWarrantsDisclosureTextBlock', window );">Private Placement Warrants</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 5 &#8212; Private Placement Warrants</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Simultaneously with the closing of the IPO,&#160;the
Sponsor purchased an aggregate of&#160;6,266,667&#160;Private Placement Warrants at a price of $1.50&#160;per warrant ($9,400,000&#160;in
the aggregate), each Private Placement Warrant is exercisable to purchase one share of Class A ordinary shares at a price of $11.50&#160;per
share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from our Initial Public Offering to
be held in the Trust Account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Private Placement Warrants are identical to the warrants sold in
the IPO except that the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not
be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to
certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business
Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_PrivatePlacementWarrantsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_PrivatePlacementWarrantsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_PrivatePlacementWarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of Private Placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_PrivatePlacementWarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925636612480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 6 &#8212; Related Party Transactions</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Founder Shares</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On December 31, 2020, the Sponsor paid $25,000,
or approximately $0.003&#160;per share, to cover certain offering costs in consideration for&#160;7,187,500&#160;Class&#160;B ordinary
shares, par value $0.0001&#160;per share (the &#8220;Founder Shares&#8221;). On February 25, 2021, the Company effected a share dividend
whereby the Company issued&#160;1,437,500&#160;Class B ordinary shares, resulting in an aggregate of&#160;8,625,000&#160;Class B ordinary
shares outstanding. All share and per-share amounts have been retroactively restated to reflect the share dividend.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company&#8217;s initial shareholders have
agreed not to transfer, assign or sell any of their Founder Shares and any Class A ordinary shares issuable upon conversion thereof until
the earlier to occur of:&#160;(i) one year after the completion of the initial Business Combination or (ii) the date on which the Company
completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all
of its shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; except to certain
permitted transferees and under certain circumstances (the &#8220;Lock-up&#8221;). Any permitted transferees will be subject to the same
restrictions and other agreements of the initial shareholders with respect to any Founder Shares. Notwithstanding the foregoing, if (1)
the closing price of the Company&#8217;s Class A ordinary shares equals or exceeds $12.00&#160;per share (as adjusted for share sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing
at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination
which results in its shareholders having the right to exchange their shares for cash, securities or other property, the Founder Shares
will be released from the Lock-up.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On May 16, 2022, the Sponsor transferred 25,000
shares to one of the Company&#8217;s directors following the departure of a previous director. The transfer of the Founders Shares is
in the scope of FASB ASC Topic 718, &#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC 718&#8221;). Under ASC 718, stock-based
compensation associated with equity-classified awards is measured at fair value upon the grant date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The transfer of Founders Shares to the Company&#8217;s
director, as described above, is within the scope of ASC 718, as such, the fair value of the 25,000 shares transferred to the Company&#8217;s
director was $123,750 or $4.95 per share. The transfer of the shares was granted subject to a performance condition (i.e., the occurrence
of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable
of occurrence under the applicable accounting literature in this circumstance. Stock-based compensation would be recognized at the date
a Business Combination is considered probable in an amount equal to the number of Founders Shares times the transfer date fair value per
share (unless subsequently modified). Founder Shares will automatically convert into Class A shares at a one-to-one ratio upon completion
of a Business Combination. The Founder Shares will receive no distributions if the Company is liquidated prior to a Business Combination.
In addition, the holders of the Founder Shares are restricted from transferring the Founder Shares and the Class A shares received upon
conversion until nine months to a year after a Business Combination.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Promissory Note &#8212; Related Party</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On December 30, 2020, the Sponsor agreed to loan
the Company up to $300,000&#160;to cover expenses related to the IPO pursuant to a promissory note (the &#8220;Promissory Note&#8221;).
This loan is non-interest bearing and payable on the earlier of December 31, 2022 or the completion of the IPO.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022 and 2021, there was no
outstanding amount under the Promissory Note.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Working Capital Loans</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, in order to finance transaction costs
in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers
and directors, may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital Loans&#8221;). If the
Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination
does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans
but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. After giving effect to the Notes described
below, up to $675,000&#160;of additional Working Capital Loans may be convertible into Private Placement Warrants of the post Business
Combination entity at a price of $1.50&#160;per warrant at the option of the lender. Such warrants would be identical to the Private Placement
Warrants. Prior to the completion of the initial Business Combination, the Company does not expect to seek loans from parties other than
the Sponsor or an affiliate of the Sponsor as the Company does not believe third parties will be willing to loan such funds and provide
a waiver against any and all rights to seek access to funds in the Company&#8217;s Trust Account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On April 1, 2022 and June 6, 2022, the Company
issued unsecured promissory notes in the amounts of up to $500,000 and $500,000, respectively, to the Sponsor. On December 14, 2022, the
Company issued an unsecured promissory note in the amount of up to $325,000 to Tidjane Thiam, Adam Gishen, Abhishek Bhatia and Edward
Zeng (collectively, the &#8220;Payees&#8221;) (such promissory note, together with the unsecured promissory notes issued on April 1, 2022
and June 6, 2022, the &#8220;Notes&#8221;). The Notes bear no interest and are payable in full upon the earlier to occur of (i) twenty-four
(24) months from the closing of the Initial Public Offering (or such later date as may be extended in accordance with the terms of our
amended and restated memorandum and articles of association) or (ii) the consummation of the Business Combination. A failure to pay the
principal within five business days of the date specified above or the commencement of a voluntary or involuntary bankruptcy action shall
be deemed an event of default, in which case the Notes may be accelerated. Prior to the Company&#8217;s first payment of all or any portion
of the principal balance of the Notes in cash, the Sponsor and the Payees, as applicable, have the option to convert all, but not less
than all, of the principal balance of the Notes into private placement warrants (the &#8220;Conversion Warrants&#8221;), each warrant
exercisable for one ordinary share of the Company at an exercise price of $1.50&#160;per share. The terms of the Conversion Warrants would
be identical to the Private Placement Warrants. The Sponsor and the Payees shall be entitled to certain registration rights relating to
the Conversion Warrants. The issuances of the Notes were made pursuant to the exemption from registration contained in Section 4(a)(2)
of the Securities Act.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022 and 2021, the Company had an aggregate of $1,225,000
and $0 borrowings, respectively, related to the Notes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On February 28, 2023, the Company issued an unsecured
promissory note in the amount of up to $2,100,000 to the Sponsor, as further described in Note 11.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Administrative Support Service</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Commencing on the date of the IPO, the Company
agreed to pay the Sponsor up to $10,000&#160;per month for office space and administrative support services. These were paid on a monthly
basis via invoices, and there was no amount due under the Administrative Services Agreement as of December 31, 2022.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925636613296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments &amp; Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments &amp; Contingencies</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 7 &#8212; Commitments &amp; Contingencies<i>&#160;</i></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Registration Rights</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The holders of the (i) Founder Shares, which were
issued in a private placement prior to the closing of the IPO, (ii) Private Placement Warrants, which will be issued in a private placement
simultaneously with the closing of the IPO and the Class A ordinary shares underlying such Private Placement Warrants and (iii) Private
Placement Warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to
register a sale of any of its securities held by them pursuant to a registration rights agreement. The holders of these securities are
entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders
have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the Company&#8217;s
completion of its initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such
registration statements.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Underwriters Agreement</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On March 2, 2021, the Company paid a fixed
underwriting discount of $6,405,000. Additionally, a deferred underwriting discount of $0.35&#160;per Unit, or $12,075,000&#160;in
the aggregate, will be payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company
completes an initial Business Combination, subject to the terms of the underwriting agreement. As of October 25, 2022, and November
2, 2022, respectively, J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. have waived their portions of the deferred
underwriting fee which is reflected in the consolidated statement of operations and the consolidated statement of changes in
shareholders&#8217; deficit as a reduction of transaction costs incurred in connection with IPO. Therefore, the deferred
underwriting fee was reduced by $9,056,250, of which $271,687 is shown in the consolidated statement of operations as a reduction of transaction costs incurred in connection with the IPO and $8,784,563 is charged to additional paid-in capital in the
consolidated statement of changes in shareholders&#8217; deficit. As a result of the reductions, the outstanding deferred
underwriting fee payable was reduced to $3,018,750.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Business Combination Agreement</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On October 3, 2022, the Company entered into a
Business Combination Agreement (as amended from time to time, the &#8220;Business Combination Agreement&#8221;), with Jupiter Merger Sub
I Corp., a Delaware corporation and a wholly owned subsidiary of the Company (&#8220;First Merger Sub&#8221;), Jupiter Merger Sub II LLC,
a Delaware limited liability company and a wholly owned subsidiary of the Company (&#8220;Second Merger Sub&#8221;), Complete Solaria,
Inc. (formerly known as Complete Solar Holding Corporation), a Delaware corporation (&#8220;Complete Solaria&#8221;) and The Solaria Corporation,
a Delaware corporation (&#8220;Solaria&#8221;).</p><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">The Mergers</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Business Combination Agreement provides that,
among other things and upon the terms and subject to the conditions thereof, the following transactions will occur (together with the
other agreements and transactions contemplated by the Business Combination Agreement, the &#8220;Business Combination&#8221;):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>at the closing of the transactions contemplated by the Business Combination Agreement (the &#8220;Closing&#8221;), upon the terms
and subject to the conditions thereof, and in accordance with the Delaware General Corporation Law, as amended (the &#8220;DGCL&#8221;),
(i) First Merger Sub will merge with and into Complete Solaria, with Complete Solaria surviving as a wholly owned subsidiary of the Company,
(ii) immediately thereafter and as part of the same overall transaction, Complete Solaria will merge with and into Second Merger Sub,
with Second Merger Sub surviving as a wholly owned subsidiary of the Company, and (iii) immediately after the consummation of the Second
Merger and as part of the same overall transaction, Solaria will merge with and into a newly formed Delaware limited liability company
and wholly-owned subsidiary of the Company (&#8220;Third Merger Sub&#8221;), with Third Merger Sub surviving as a wholly-owned subsidiary
of the Company (the &#8220;Additional Merger,&#8221; and together with the First Merger and the Second Merger, the &#8220;Mergers&#8221;);</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>at the Closing, all outstanding shares of capital stock of Complete Solaria (subject to certain restrictions) and all options and
warrants to acquire shares of capital stock of Complete Solaria will convert into the right to receive shares of common stock, par value
$0.0001 per share, of the Company (&#8220;Freedom Common Stock&#8221;) or comparable equity awards that are settled or are exercisable
for shares of Freedom Common Stock; and</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>at the Closing, the Company will be renamed &#8220;Complete Solaria, Inc.&#8221;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On October 2, 2022 and October 3, 2022, respectively, a special committee (the &#8220;Freedom Special
Committee&#8221;) of the Board of Directors of the Company (the &#8220;Freedom Board&#8221;) and the Freedom Board have (i) approved the
Business Combination Agreement and the Business Combination and (ii) resolved to recommend that the shareholders of the Company approve
the Business Combination Agreement and the Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">First Amendment to the Business Combination Agreement</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On December 26, 2022, the Company, Complete Solaria,
First Merger Sub and Second Merger Sub entered into a letter agreement (the &#8220;First Amendment&#8221;) amending the Business Combination
Agreement, dated as of October 3, 2022, by and among the Company, Complete Solaria, First Merger Sub and Second Merger Sub.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">The Amendment deletes the following provisions in the Business Combination Agreement:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>The condition to the obligation of Complete Solaria to consummate the Business Combination that there be, as of the closing of the
Business Combination (the &#8220;Closing&#8221;), at least $100,000,000 in Available Acquiror Cash (as such term is defined in the Business
Combination Agreement);</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>The obligation of each of the Company and Complete Solaria to use reasonable best efforts to cause the Available Acquiror Cash to
equal or exceed $100,000,000 as of immediately prior to the Closing;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>The right of Complete Solaria to terminate the Business Combination Agreement if:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>Complete Solaria has not consummated the issuances of convertible note investments in Complete Solaria for an aggregate purchase price
of at least $10,000,000 on or before January 16, 2023; or</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>at a meeting of shareholders of the Company to extend the deadline by which the Company is required to consummate the Business Combination
under its organizational documents, a number of shareholders of the Company elect to redeem their ordinary shares such that the amount
remaining in the Company&#8217;s trust account after processing such redemptions, when taken together with the amounts included in prongs
(ii), (iii), (iv) and (v) of the definition of Available Acquiror Cash (as described above) is less than $100 million;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>The obligation of the Company and Complete Solaria to make termination payments in certain circumstances.</td></tr></table><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Second Amendment to the Business Combination Agreement</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On January 17, 2023, the Company, Complete Solaria,
First Merger Sub and Second Merger Sub entered into that certain Second Amendment to Business Combination Agreement (the &#8220;Second
Amendment&#8221;) amending the Business Combination Agreement, dated as of October 3, 2022, by and among the Company, Complete Solaria,
First Merger Sub and Second Merger Sub, as amended by the First Amendment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Second Amendment provides that, if the Company
and Complete Solaria determine in good faith by January 1, 2023 that it is probable that the Business Combination will be consummated
after March 1, 2023, the Company will be required to prepare (with the reasonable cooperation of Complete Solaria) and file with the SEC
a proxy statement pursuant to which it will seek the approval of its shareholders for proposals to amend the Company&#8217;s organizational
documents to extend the time period for the Company to consummate its initial business combination for (x) up to an additional six (6)
months, from March 2, 2023 to September 2, 2023 (the original Business Combination Agreement provided for an extension from March 1, 2023
to September 2, 2023) or (y) such other period of time as the Company and Complete Solaria may mutually agree (the original Business Combination
Agreement contemplated no such prong (y)). In addition, the Second Amendment amends the Business Combination Agreement by changing the
latest permitted Agreement End Date (as defined in the Business Combination Agreement) from September 1, 2023 to September 2, 2023.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925636566096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Deficit<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders&#8217; Deficit</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 8 &#8212; Shareholders&#8217; Deficit</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>&#160;</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>Preference shares&#160;</i></b>&#8212; The
Company is authorized to issue a total of&#160;1,000,000&#160;preference shares at par value of $0.0001&#160;each. At December 31, 2022
and 2021, there were <span style="-sec-ix-hidden: hidden-fact-99"><span style="-sec-ix-hidden: hidden-fact-100"><span style="-sec-ix-hidden: hidden-fact-101"><span style="-sec-ix-hidden: hidden-fact-102">no</span></span></span></span> preference shares issued or outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>&#160;</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>Class A Ordinary shares&#160;</i></b>&#8212;
The Company is authorized to issue a total of&#160;200,000,000&#160;Class A ordinary shares at par value of $0.0001&#160;each. At December
31, 2022 and 2021, there were&#160;34,500,000&#160;Class&#160;A ordinary shares outstanding, all of which is subject to possible redemption.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>&#160;</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>Class B Ordinary shares&#160;</i></b>&#8212;
The Company is authorized to issue a total of&#160;20,000,000&#160;Class B ordinary shares at par value of $0.0001&#160;each. At December
31, 2022 and 2021, there were&#160;8,625,000&#160;Class B ordinary shares issued and outstanding, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On December 31, 2020,&#160;the Sponsor paid $25,000,
or approximately $0.003 per share, to cover certain offering costs in consideration for 7,187,500 Class B ordinary shares, par value $0.0001
per share. On February 25, 2021, the Company effected a share dividend whereby the Company issued 1,437,500 Class B ordinary shares, resulting
in an aggregate of 8,625,000 Class B ordinary shares outstanding.&#160;All share and per-share amounts have been retroactively restated
to reflect the share dividend.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Holders of the Class&#160;A ordinary shares and
holders of the Class&#160;B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company&#8217;s
shareholders, except as required by law; provided that only holders of Class B ordinary shares will have the right to appoint and remove
directors in any general meeting held prior to or in connection with the completion of an initial Business Combination. Unless specified
in the Company&#8217;s amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies
Act or applicable stock exchange rules, the affirmative vote of a majority of the Company&#8217;s ordinary shares that are voted is required
to approve any such matter voted on by its shareholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Class&#160;B ordinary shares will automatically
convert into Class&#160;A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination
on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the
like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares or equity-linked securities
are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion
of all Founder Shares will equal, in the aggregate,&#160;20% of the total number of Class A ordinary shares outstanding after such conversion
(after giving effect to any redemptions of Class A ordinary shares by Public Shareholders), including the total number of Class A ordinary
shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued,
by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary
shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller
in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of
Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925636494528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantsDisclosureAbstract', window );"><strong>Warrants Disclosure Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantsDisclosureTextBlock', window );">Warrants</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 9 &#8212; Warrants&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Public Warrants will become exercisable at
$11.50&#160;per share on the later of&#160;one year&#160;from the closing of the IPO and 30 days after the completion of the initial Business
Combination; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class&#160;A
ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits
holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are
registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. The
warrants will expire&#160;five years&#160;after the completion of a Business Combination or earlier upon redemption or liquidation.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company has agreed that as soon as practicable,
but in no event later than 15 business days after the closing of the initial Business Combination, it will use commercially reasonable
efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable
upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain
the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the
warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class&#160;A ordinary shares
issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant
holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to
maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section&#160;3(a)(9)
of the Securities Act or another exemption. Notwithstanding the above, if the Company&#8217;s Class A ordinary shares are at the time
of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221;
under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants
to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects,
it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will
use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is
not available. In such event, each holder would pay the exercise price by surrendering each such warrant for that number of Class&#160;A
ordinary shares equal to the lesser of (A)&#160;the quotient obtained by dividing (x)&#160;the product of the number of Class&#160;A ordinary
shares underlying the warrants, multiplied by the excess of the &#8220;fair market value&#8221; (defined below) less the exercise price
of the warrants by (y)&#160;the fair market value and (B) 0.361. The &#8220;fair market value&#8221; as used in this paragraph shall mean
the volume weighted average price of the Class&#160;A ordinary shares for the 10 trading days ending on the trading day prior to the date
on which the notice of exercise is received by the warrant agent.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The exercise price and number of shares issuable
upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend or recapitalization,
reorganization, merger or consolidation.&#160;In addition, if (x)&#160;the Company issues additional Class&#160;A ordinary shares or equity-linked
securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective
issue price of less than $9.20 per Class&#160;A ordinary share (with such issue price or effective issue price to be determined in good
faith by the Company&#8217;s board of directors and in the case of any such issuance to the Company&#8217;s Sponsors or their affiliates,
without taking into account any Founder Shares held by the Company&#8217;s initial shareholders or such affiliates, as applicable, prior
to such issuance (the &#8220;Newly Issued Price&#8221;), (y)&#160;the aggregate gross proceeds from such issuances represent more than
60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the
completion of the initial Business Combination (net of redemptions), and (z)&#160;the volume-weighted average trading price of the Company&#8217;s
Class&#160;A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates
its initial Business Combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, then the exercise price of the
warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and
the $10.00 and $18.00 per share redemption trigger prices described below under &#8220;Redemption of warrants when the price per Class
A ordinary share equals or exceeds $10.00&#8221; and &#8220;Redemption of warrants when the price per Class A ordinary share equals or
exceeds $18.00&#8221; will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly
Issued Price, respectively.</p><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Redemption of Warrants When the Price per Class&#160;A
Ordinary Share Equals or Exceeds $18.00</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Once the warrants become exercisable, the Company
may redeem the outstanding warrants (except with respect to the Private Placement Warrants):&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>in whole and not in part;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>at a price of $0.01 per warrant;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>upon not less than 30 days&#8217; prior written notice of redemption (the &#8220;30-day redemption period&#8221;) to each warrant
holder; and</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a 30-trading day period
ending three business days before the Company sends to the notice of redemption to the warrant holders (the &#8220;Reference Value&#8221;)
equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and
the like).&#160;</td></tr></table><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Redemption of Warrants When the Price per Class&#160;A
Ordinary Share Equals or Exceeds $10.00</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Once the warrants become exercisable, the Company
may redeem the outstanding warrants:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>in whole and not in part;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>at $0.10 per warrant upon a minimum of 30 days&#8217; prior written notice of redemption provided that holders will be able to exercise
their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based
on the redemption date and the &#8220;fair market value&#8221; of the Class A ordinary shares;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share sub-divisions, share capitalizations,
reorganizations, recapitalizations and the like); and</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>if the Reference Value is less than $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations,
recapitalizations and the like) the Private Placement Warrants must also be concurrently called for redemption on the same terms as the
outstanding public warrants, as described above.</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_WarrantsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_WarrantsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925636558800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 10 &#8212; Fair Value Measurements</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Fair value is defined as the price that would
be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement
date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives
the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the
lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
and</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td>Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own
assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers
are unobservable.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table presents information about
the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2022 and 2021 and indicates
the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Quoted&#160;Prices In<br/> Active<br/> Markets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Description</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 53%; text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Investments held in trust account- U.S. Treasury Securities</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">349,927,313</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">349,927,313</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-103">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-104">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Total Investments held in Trust Account</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">349,927,313</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">349,927,313</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-105">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Warrant liabilities &#8211; Public warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,725,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,725,000</td><td style="text-align: left"/>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-107">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Warrant liabilities &#8211; Private warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,253,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-109">&#8212;</div></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,253,333</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Convertible Note &#8211; April 1, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-111">&#8212;</div></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Convertible Note &#8211; June 6, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">&#8212;</div></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Convertible Note &#8211; December 14, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">152,200</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">152,200</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Total Warrant liabilities</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,806,933</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,725,000</td><td style="padding-bottom: 4pt; text-align: left"/>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,081,933</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For the year ended December 31, 2022, as a result
of the recent decline in trading volume within the period, the public warrants were transferred to and are currently classified as Level
2 securities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Quoted&#160;Prices In<br/> Active<br/> Markets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Description</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Investments held in trust account- U.S. Money Market Fund</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">484</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">484</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Investments held in trust account- U.S. Treasury Securities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">345,105,197</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">345,105,197</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Total Investments held in Trust Account</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">345,105,681</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">345,105,681</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Warrant liabilities &#8211; Public warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,916,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,916,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Warrant liabilities &#8211; Private warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,572,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,572,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Total Warrant liabilities</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">8,488,250</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,916,250</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,572,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company utilized a Monte Carlo simulation
model for the initial valuation of the Public Warrants. The subsequent measurement of the Public Warrants as of December 31, 2022 and
2021, is classified as Level 1 due to the use of an observable market quote in an active market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company utilizes a binomial lattice
simulation model to value the private placement warrants and the convertible promissory notes at each reporting period, with changes
in fair value recognized in the consolidated statements of operations. The estimated fair value of the warrant liability is
determined using Level&#160;3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price
volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares
based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the
U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The
expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the
historical rate, which the Company anticipates to remain at zero.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The aforementioned warrant liabilities are not
subject to qualified hedge accounting.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Transfers to/from Levels 1, 2, and 3 are
recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. The value of the
securities transferred from a Level 2 measurement to a Level 1 measurement during the year ended December 31, 2022 was
$348,810,523. There was a transfer of $1,725,000 from Level 1 to Level 2 in the fair value hierarchy for Public Warrants during the
year ended December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table provides quantitative information
regarding Level&#160;3 fair value measurements:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">At<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">At<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-indent: -9.35pt; padding-left: 9.35pt">Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.10</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9.68</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">de minimis</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.50</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.98</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.30</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.00</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.00</td><td style="text-align: left">%</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table presents the changes in the
fair value of warrant liabilities:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Public</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Private<br/> Placement</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrant<br/> Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of January 1, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,916,250</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,572,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,488,250</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Change in valuation inputs or other assumptions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,191,250</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,318,667</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,509,917</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of December 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,725,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,253,333</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,978,333</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Public</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Private<br/> Placement</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrant<br/> Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of January 1, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-127">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-128">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-129">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt">Initial measurement on March 2, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,350,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,520,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,870,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Change in valuation inputs or other assumptions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,433,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,948,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,381,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of December 31, 2021</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,916,250</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,572,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">8,488,250</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company recognized gains in connection with
changes in the fair value of warrant liabilities of $5,509,917 within change in fair value of warrant liabilities in the consolidated statement of operations for the year ended December 31, 2022. The Company recognized gains in connection with changes in the fair value of warrant
liabilities of $9,381,750 within change in fair value of warrant liabilities in the consolidated statement of operations for the year ended December
31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table presents a summary of the
changes in the fair value of Level 3 warrant liabilities:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Private Placement</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Public</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> Warrant<br/> Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of January 1, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,572,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,572,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,318,667</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-131">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,318,667</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of December 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,253,333</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-132">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,253,333</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Private<br/> Placement</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Public</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> Warrant<br/> Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of January 1, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-133">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-135">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt">Initial measurement on March 2, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,520,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,350,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,870,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Transfer to Level 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-136">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,350,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,350,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,948,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-137">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,948,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of December 31, 2021</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,572,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-138">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,572,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925636552688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 11 &#8212; Subsequent Events</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company evaluated subsequent events and
transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this
review, other than below, the Company did not identify any subsequent events that would have required adjustment or disclosure in
the consolidated financial statements.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Second Amendment to the Business Combination Agreement</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On January 17, 2023, the Company, Complete Solaria,
First Merger Sub and Second Merger Sub entered into the Second Amendment amending the Business Combination Agreement, dated as of October
3, 2022, by and among the Company, Complete Solaria, First Merger Sub and Second Merger Sub, as amended by the First Amendment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Second Amendment provides that, if the Company
and Complete Solaria determine in good faith by January 1, 2023 that it is probable that the Business Combination will be consummated
after March 1, 2023, the Company will be required to prepare (with the reasonable cooperation of Complete Solaria) and file with the SEC
a proxy statement pursuant to which it will seek the approval of its shareholders for proposals to amend the Company&#8217;s organizational
documents to extend the time period for the Company to consummate its initial business combination for (x) up to an additional six (6)
months, from March 2, 2023 to September 2, 2023 (the original Business Combination Agreement provided for an extension from March 1, 2023
to September 2, 2023) or (y) such other period of time as the Company and Complete Solaria may mutually agree (the original Business Combination
Agreement contemplated no such prong (y)). In addition, the Second Amendment amends the Business Combination Agreement by changing the
latest permitted Agreement End Date (as defined in the Business Combination Agreement) from September 1, 2023 to September 2, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Amendment to Amended and Restated Memorandum and Articles of Association</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On February 28, 2023, Freedom held an extraordinary
general meeting of shareholders (the &#8220;Extraordinary General Meeting&#8221;), at which holders of 35,373,848 ordinary shares, comprised
of 26,773,848 Class&#160;A ordinary shares and 8,600,000 Class&#160;B ordinary shares, were present in person or by proxy, representing
approximately 82.02% of the voting power of the 43,125,000 issued and outstanding ordinary shares of Freedom entitled to vote at the Extraordinary
General Meeting at the close of business on January 23, 2023, which was the record date (the &#8220;Record Date&#8221;) for the Extraordinary
General Meeting (such shares, the &#8220;Outstanding Shares&#8221;). The Outstanding Shares on the Record Date were comprised of 34,500,000
Class A ordinary shares and 8,625,000 Class B ordinary shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At the Extraordinary General Meeting, the shareholders
approved, by special resolution, the proposal (the &#8220;Extension Amendment Proposal&#8221;) to amend the amended and restated memorandum
and articles of association to extend the date by which Freedom must (i) consummate a merger, amalgamation, share exchange, asset acquisition,
share purchase, reorganization or similar business combination, which Freedom refers to as its initial business combination, (ii) cease
its operations except for the purpose of winding up if it fails to complete such initial business combination, and (iii) redeem all of
the Class A ordinary shares, included as part of the units sold in the initial public offering, for an additional three months, from March
2, 2023 to June 2, 2023, and thereafter to up to three (3) times by an additional one month each time (or up to September 2, 2023) (the
&#8220;Extension Amendment,&#8221; and such period, as may be extended, the &#8220;Combination Period&#8221;). The voting results for
such proposal were as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>For</b></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Against</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Abstain</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: center">&#160;</td><td style="width: 31%; text-align: center">35,047,305</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td><td style="width: 31%; text-align: center">326,543</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td><td style="width: 30%; text-align: center">0</td><td style="width: 1%; text-align: left">&#160;</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In connection with the Extension Amendment, public
shareholders elected to redeem an aggregate of 23,256,504 Class&#160;A ordinary shares at a redemption price of $10.21 per share, representing
approximately 67.41% of the issued and outstanding Class A ordinary shares, for an aggregate redemption amount of approximately $237,372,952.
Following such redemptions, approximately $114,759,374 remained in the trust account and 11,243,496 Class A ordinary shares remain outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At the Extraordinary General Meeting, the public
shareholders also approved the proposal to amend the Investment Management Trust Agreement, dated as of February 25, 2021 (the &#8220;Trust
Agreement&#8221;), by and between Freedom and Continental Stock Transfer &amp; Trust Company, as trustee (&#8220;Continental&#8221;),
to reflect the Extension Amendment. The amendment to the Trust Agreement provides that Continental shall commence liquidation of the trust
account only and promptly (x) after its receipt of the applicable instruction letter delivered by Freedom in connection with either the
consummation of an initial business combination or Freedom&#8217;s inability to effect an initial business combination within the time
frame specified in Freedom&#8217;s amended and restated memorandum and articles of association or (y) upon the date that is the later
of the end of the Combination Period and such later date as may be approved by Freedom&#8217;s shareholders in accordance with the amended
and restated memorandum and articles of association, if the aforementioned termination letter has not been received by Continental prior
to such date. The voting results for such proposal were as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Against</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Abstain</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: center">&#160;</td><td style="width: 31%; text-align: center">35,047,305</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td><td style="width: 31%; text-align: center">326,543</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td><td style="width: 30%; text-align: center">0</td><td style="width: 1%; text-align: left">&#160;</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><b>Promissory Note</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On February 28, 2023, the Company issued an unsecured
promissory note in the amount of up to $2,100,000 to the Sponsor. The proceeds of such promissory note, $1,600,000 of which was drawn
down immediately, $400,000 of which may be drawn down, with the mutual consent of the Company and the Sponsor, if the
Company wishes to extend the date by which it will consummate a business combination beyond June 2, 2023, and $100,000 of which may be
drawn down on an as-needed basis at the discretion of our sponsor, will be used for general working capital purposes. Such promissory
note bears no interest and is payable in full upon the consummation of our business combination. A failure to pay the principal within
five business days of the date specified above or the commencement of a voluntary or involuntary bankruptcy action shall be deemed an
event of default, in which case the promissory note may be accelerated. The promissory note shall be forgiven by the Sponsor if the Company
is unable to consummate a business combination within the time frame specified in our amended and restated memorandum and articles of
association (as amended from time to time), except to the extent of any funds held outside of the trust account established in connection
with our initial public offering. The issuance of the promissory note was made pursuant to the exemption from registration contained in
Section 4(a)(2) of the Securities Act of 1933, as amended.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925632193168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Basis of Presentation</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The accompanying financial statements are presented
in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules
and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Principles of Consolidation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The accompanying consolidated financial
statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions
have been eliminated in consolidation.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_EmergingGrowthCompanyStatusPolicyTextBlock', window );">Emerging Growth Company</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging Growth Company</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company is an &#8220;emerging growth company,&#8221;
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the &#8220;JOBS Act&#8221;),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements
of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and
proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder
approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth
companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that
have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange
Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to
opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election
to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard
is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company,
can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the
Company&#8217;s&#160;consolidated financial statements with another public company which is neither an emerging growth company nor an
emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences
in accounting standards used.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Use of Estimates</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The preparation of&#160;the&#160;consolidated financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the&#160;consolidated financial statements and the reported amounts
of expenses during the reporting period. Actual results could differ from those estimates.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Estimates made in preparing these consolidated financial statements
include, among other things, the fair value measurement of the Private Warrant liabilities.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash and Cash Equivalents</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents.&#160;The Company did not have any cash equivalents
as of December 31, 2022 and 2021.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments Held in Trust Account</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investments Held in Trust Account</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">At December 31, 2022, the assets held in the Trust Account were held in a money market fund with a maturity of 180 days or less. At December 31, 2021, the assets held in the Trust Account
were held in cash and U.S. Treasury securities. The Company classifies its United States Treasury securities as&#160;held-to-maturity&#160;in
accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC Topic 320, &#8220;Investments&#8212;Debt and Equity Securities.&#8221;&#160;Held-to-maturity&#160;securities
are those securities which the Company has the ability and intent to hold until maturity.&#160;Held-to-maturity&#160;treasury securities
are recorded at amortized cost and adjusted for the amortization or remeasurement of premiums or discounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As of December 31, 2022, investment in the
Company&#8217;s Trust Account consisted of $349,927,313 in a money market fund with a maturity of 180 days or less. Following the
maturity of the U.S. Treasury Securities on December 1, 2022, the Company immediately reinvested the entirety of the Trust Account
into a money market fund. The money market fund is disclosed at fair value on the consolidated balance sheet. As of December 31,
2021, investment in the Company&#8217;s Trust Account consisted of $484&#160;in cash and $345,105,197&#160;in U.S. Treasury
Securities. All of the U.S. Treasury Securities (the &#8220;T-bills&#8221;) matured on March 3, 2022 and the Company purchased new
T-bills. The Company considers all investments with original maturities of more than three months but less than one year to be
short-term investments. The carrying value approximates the fair value due to its short-term maturity. The carrying value, excluding
gross unrealized holding losses and fair value of held to maturity securities on December 31, 2022 and 2021 are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Value<br/> as of<br/> December&#160;31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Money Market Funds</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">349,927,313</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">349,927,313</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortized<br/> Cost&#160;and<br/> Carrying<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Unrealized<br/> Gains</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Unrealized<br/> Losses</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Value<br/> as&#160;of<br/> December&#160;31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-indent: -9.35pt; padding-left: 9.35pt">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">484</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-95">&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-96">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">484</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">U.S. Treasury Securities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">345,105,197</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,065</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">345,099,132</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">345,105,681</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-98">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(6,065</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">345,099,616</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A decline in the market value of held-to-maturity securities below
cost that is deemed to be other than temporary results in an impairment that reduces the carrying costs to such securities&#8217; fair
value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment
is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery
and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered
in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent
to&#160;year-end,&#160;forecasted performance of the investee, and the general market condition in the geographic area or industry the
investee operates in.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Premiums and discounts are amortized or accreted
over the life of the related&#160;held-to-maturity&#160;security as an adjustment to yield using the effective-interest method. Such amortization
and remeasurement are included in the &#8220;interest income&#8221; line item in the statements of operations. Interest income is recognized
when earned.&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock', window );">Convertible Promissory Notes&#8212;Related Party</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Convertible Promissory Notes&#8212;Related Party&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company accounts for its convertible promissory notes under ASC
815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). Under ASC 815-15-25, the election can be at the inception of a financial
instrument to account for the instrument under the fair value option under ASC 825. The Company has made such election for its convertible
promissory notes. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value
on the date of issuance, each drawdown date, and each balance sheet date thereafter. Differences between the face value of the note and
fair value at each drawdown date are recognized as either an expense in the consolidated statements of operations (if issued at a premium)
or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as non-cash gains
or losses in the consolidated statements of operations. Changes in the estimated fair value of the note are recognized as non-cash change
in the fair value of the convertible promissory notes in the consolidated statements of operations.&#160;&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Concentration of Credit Risk&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal
Depository Insurance Coverage of&#8201;$250,000. At December 31, 2022 and 2021, the Company has not experienced losses on this account.&#160;&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock', window );">Ordinary Shares Subject to Possible Redemption</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ordinary Shares Subject to Possible Redemption</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company accounts for its Class A ordinary shares subject to possible
redemption in accordance with the guidance in ASC Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221; Class A ordinary shares
subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable
ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject
to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) are classified as temporary equity.
At all other times, ordinary shares are classified as shareholders&#8217; deficit. The Company&#8217;s ordinary shares feature certain
redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events.
Accordingly, as of December 31, 2022 and 2021,&#160;34,500,000&#160;Class A ordinary shares subject to possible redemption are presented
at redemption value as temporary equity, outside of the shareholders&#8217; deficit section of the Company&#8217;s consolidated balance
sheets, respectively.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income Per Ordinary Share</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net Income Per Ordinary Share</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company has two classes of shares, which are referred to as Class
A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The&#160;14,891,667&#160;potential
ordinary shares for outstanding warrants to purchase the Company&#8217;s shares were excluded from diluted earnings per share for the
years ended December 31, 2022 and 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met.
As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods presented. The table
below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class
of ordinary share:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Basic and diluted net income per share:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Allocation of net income</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4,785,872</p>
</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1,196,468</p>
</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">3,967,193</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,161,457</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">34,500,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,625,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">28,828,767</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,440,068</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Basic and diluted net income per share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Offering Costs</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Offering Costs</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company complies with the requirements
of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#8220;SAB&#8221;) Topic 5A - &#8220;Expenses of Offering&#8221;.
Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to
the Public Offering and that were charged to temporary equity upon the completion of the IPO. Accordingly, on December 31, 2022,
offering costs totaling $19,175,922&#160;have been charged to temporary equity (consisting of $6,405,000&#160;of underwriting fees,
$12,075,000&#160;of deferred underwriting fees and $695,922&#160;of other offering costs). Of the total transaction cost,
$575,278&#160;was recorded as a non-operating expense in the consolidated statements of operations, with the rest of the offering
cost charged to temporary equity. The transaction costs were allocated based on the relative fair value basis, compared to the total
offering proceeds, between the fair value of the public warrant liabilities and the Class A ordinary shares. As of October 25, 2022,
and November 2, 2022, respectively, J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. have waived their portions of the
deferred underwriting fee which is reflected in the consolidated statement of operations and the consolidated statement of changes
in shareholders&#8217; deficit as a reduction of transaction costs incurred in connection with IPO. Therefore, the deferred underwriting fee was
reduced by $9,056,250, of which $271,687 is shown in the consolidated statement of operations as a reduction of transaction
costs incurred in connection with the IPO and $8,784,563 is charged to additional paid-in capital in the consolidated statement of changes in shareholders&#8217; deficit. As a result of the reductions, the outstanding deferred underwriting fee payable was reduced to
$3,018,750.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fair Value of Financial Instruments</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The fair value of the Company&#8217;s assets and liabilities, which
qualify as financial instruments under the Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 820, &#8220;Fair Value Measurements
and Disclosures,&#8221; approximates the carrying amounts represented in the consolidated balance sheets.&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Warrant Liabilities</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Derivative Warrant Liabilities</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company does not use derivative instruments
to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including
issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives,
pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded
as liabilities or as equity, is re-assessed at the end of each reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company accounts for its&#160;14,891,667&#160;ordinary shares warrants
issued in connection with its Initial Public Offering (8,625,000) and Private Placement (6,266,667) as derivative warrant liabilities
in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the
instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised,
and any change in fair value is recognized in the Company&#8217;s consolidated statements of operations. The fair value of the Private
Placement Warrants has been estimated using Monte Carlo simulations at each measurement date. The fair value of the Public Warrants was
initially estimated using Monte Carlo simulations. After the Public Warrants were separately traded, the measurement of the Public Warrants
used an observable market quote in an active market.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Income Taxes</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company follows the asset and liability method
of accounting for income taxes under ASC 740, &#8220;Income Taxes.&#8221; Deferred tax assets and liabilities are recognized for the estimated
future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities
and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are
established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">ASC 740 prescribes a recognition threshold and
a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax
return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized
tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and December 31, 2021. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The
Company is subject to income tax examinations by major taxing authorities since inception.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There is currently no taxation imposed on income
by the Government of the Cayman Islands. In accordance with federal income tax regulations, income taxes are not levied on the Company,
but rather on the individual owners. United States (&#8220;U.S.&#8221;) taxation would occur on the individual owners if certain tax elections
are made by U.S. owners and the Company were treated as a passive foreign investment company. The Company believes that it was a passive
foreign investment company for the 2021 and 2022 taxable years. Additionally, U.S. taxation could occur to the Company itself if the Company
is engaged in a U.S. trade or business. The Company is not expected to be treated as engaged in a U.S. trade or business at this time.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Recent Accounting Standards</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;)
2020-06, &#8220;Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in
Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;)&#8221; to simplify accounting for certain financial instruments.
ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible
instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s
own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed
to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement
to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be applied on a full
or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The guidance was adopted starting January
1, 2022. Adoption of the ASU did not impact the Company&#8217;s financial position, results of operations or cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Management does not believe that any recently
issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#8217;s&#160;financial
statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to convertible promissory note related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_EmergingGrowthCompanyStatusPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire policy disclosure of Emerging Growth Company Status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_EmergingGrowthCompanyStatusPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925636868272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revision of Previously Issued Financial Statements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedFinancialStatementsTableTextBlock', window );">Schedule of restatement of financial statements</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Revised</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><b>Balance Sheet as of June 30, 2022 (unaudited)</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left">Total Liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,737,596</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(205,869</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,531,727</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Total Shareholders&#8217; Equity (Deficit)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(18,781,440</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(18,575,571</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Balance Sheet as of September 30, 2022 (unaudited)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Total Liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,298,967</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(205,869</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,093,098</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Total Shareholders&#8217; Equity (Deficit)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(16,803,964</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(16,598,095</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table><p style="margin: 0">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock', window );">Schedule of condensed statement of operations</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; font-weight: bold; width: 64%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Previously<br/>
 Reported</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Revised</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><b>Condensed Statement of Operations for the Three Months
    Ended June 30, 2022 (unaudited)</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Operational Costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">824,081</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(205,869</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">618,212</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,025,986</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,231,855</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-73; -sec-ix-hidden: hidden-fact-72; -sec-ix-hidden: hidden-fact-71">Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.05</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.05</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-77; -sec-ix-hidden: hidden-fact-76; -sec-ix-hidden: hidden-fact-75">Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.05</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.05</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Condensed Statement of Operations for the Six Months Ended June 30, 2022 (unaudited)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Operational Costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,022,164</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(205,869</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,816,295</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,321,266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,527,135</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-81; -sec-ix-hidden: hidden-fact-80; -sec-ix-hidden: hidden-fact-79">Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.08</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.08</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-85; -sec-ix-hidden: hidden-fact-84; -sec-ix-hidden: hidden-fact-83">Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.08</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.08</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Condensed Statement of Operations for the Nine Months Ended September 30, 2022 (unaudited)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Operational Costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,508,476</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(205,869</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,302,607</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,726,111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,931,980</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-89; -sec-ix-hidden: hidden-fact-88; -sec-ix-hidden: hidden-fact-87">Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.16</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.16</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><div style="-sec-ix-hidden: hidden-fact-93; -sec-ix-hidden: hidden-fact-92; -sec-ix-hidden: hidden-fact-91">Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares</div></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.16</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">&#8212;</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.16</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table><p style="margin: 0">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock', window );">Schedule of condensed statement of cash flows</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; width: 64%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Previously<br/>
 Reported</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Revised</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><b>Condensed Statement of Cash Flows for the Six Months
    Ended June 30, 2022 (unaudited)</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,321,266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,527,135</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">884,539</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(205,869</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">678,670</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Condensed Statement of Cash Flows for the Nine Months Ended September 30, 2022 (unaudited)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,726,111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,931,980</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">226,411</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(205,869</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,542</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph (a)<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedCashFlowStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedFinancialStatementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph (a)<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedFinancialStatementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Paragraph (a)<br> -Subsection 04<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedIncomeStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925636506720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of unrealized holding losses and fair value of held to maturity securities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Value<br/> as of<br/> December&#160;31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Cash</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Money Market Funds</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">349,927,313</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">349,927,313</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortized<br/> Cost&#160;and<br/> Carrying<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Unrealized<br/> Gains</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Unrealized<br/> Losses</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Value<br/> as&#160;of<br/> December&#160;31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-indent: -9.35pt; padding-left: 9.35pt">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">484</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-95">&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-96">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">484</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">U.S. Treasury Securities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">345,105,197</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,065</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">345,099,132</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">345,105,681</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-98">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(6,065</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">345,099,616</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of basic and diluted net income per share for each class of ordinary share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Basic and diluted net income per share:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Allocation of net income</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4,785,872</p>
</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1,196,468</p>
</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">3,967,193</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,161,457</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">34,500,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,625,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">28,828,767</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,440,068</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Basic and diluted net income per share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925636529840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ProposedPublicOfferingDisclosureAbstract', window );"><strong>Initial Public Offering [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Schedule of the ordinary share reflected on the balance sheet are reconciled</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Gross proceeds from IPO</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">345,000,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Proceeds allocated to Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,350,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt">Ordinary share issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18,600,644</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -8.65pt; padding-left: 17.3pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">28,950,644</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-indent: -9.35pt; padding-left: 9.35pt">Contingently redeemable ordinary share as of December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">345,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -8.65pt; padding-left: 17.3pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,927,313</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Contingently redeemable ordinary share as of December 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">349,927,313</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ProposedPublicOfferingDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ProposedPublicOfferingDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925632203600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of assets that are measured at fair value on a recurring basis</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Quoted&#160;Prices In<br/> Active<br/> Markets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Description</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 53%; text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Investments held in trust account- U.S. Treasury Securities</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">349,927,313</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">349,927,313</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-103">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-104">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Total Investments held in Trust Account</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">349,927,313</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">349,927,313</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-105">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Warrant liabilities &#8211; Public warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,725,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,725,000</td><td style="text-align: left"/>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-107">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Warrant liabilities &#8211; Private warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,253,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-109">&#8212;</div></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,253,333</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Convertible Note &#8211; April 1, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-111">&#8212;</div></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Convertible Note &#8211; June 6, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">&#8212;</div></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Convertible Note &#8211; December 14, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">152,200</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">152,200</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Total Warrant liabilities</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,806,933</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,725,000</td><td style="padding-bottom: 4pt; text-align: left"/>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,081,933</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Quoted&#160;Prices In<br/> Active<br/> Markets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Description</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Investments held in trust account- U.S. Money Market Fund</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">484</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">484</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Investments held in trust account- U.S. Treasury Securities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">345,105,197</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">345,105,197</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Total Investments held in Trust Account</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">345,105,681</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">345,105,681</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Warrant liabilities &#8211; Public warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,916,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,916,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Warrant liabilities &#8211; Private warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,572,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,572,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Total Warrant liabilities</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">8,488,250</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,916,250</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,572,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of quantitative information regarding Level 3 fair value measurements</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">At<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">At<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-indent: -9.35pt; padding-left: 9.35pt">Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.10</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9.68</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">de minimis</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.50</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.98</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.30</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.00</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.00</td><td style="text-align: left">%</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">Schedule of changes in the fair value of warrant liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Public</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Private<br/> Placement</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrant<br/> Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of January 1, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,916,250</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,572,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,488,250</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Change in valuation inputs or other assumptions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,191,250</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,318,667</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,509,917</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of December 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,725,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,253,333</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,978,333</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Public</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Private<br/> Placement</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrant<br/> Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of January 1, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-127">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-128">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-129">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt">Initial measurement on March 2, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,350,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,520,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,870,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Change in valuation inputs or other assumptions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,433,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,948,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,381,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of December 31, 2021</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,916,250</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,572,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">8,488,250</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock', window );">Schedule of changes in the fair value of level 3 warrant liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Private Placement</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Public</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> Warrant<br/> Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of January 1, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,572,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,572,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,318,667</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-131">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,318,667</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of December 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,253,333</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-132">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,253,333</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Private<br/> Placement</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Public</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> Warrant<br/> Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of January 1, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-133">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-135">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt">Initial measurement on March 2, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,520,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,350,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,870,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt">Transfer to Level 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-136">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,350,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,350,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,948,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-137">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,948,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt">Fair value as of December 31, 2021</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,572,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-138">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,572,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925631380112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Business Operations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 02, 2021</div></th>
<th class="th"><div>Aug. 16, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_OrganizationandBusinessOperationsDetailsLineItems', window );"><strong>Organization and Business Operations (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherUnderwritingExpense', window );">Underwriting fee</a></td>
<td class="nump">$ 6,405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_DeferredUnderwritingFee', window );">Deferred underwriting fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,075,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsOfferingCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">695,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_TotalTransactionCost', window );">Total transaction cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">575,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_NetTangibleAssets', window );">Net tangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_RedeemPublicSharesPercentage', window );">Redeem public shares, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_PublicPerShare', window );">Public per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_TrustAccountPerShare', window );">Trust account per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrust', window );">Cash outside the trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,821,632<span></span>
</td>
<td class="nump">$ 105,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal excise tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">Excise tax percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_OrganizationandBusinessOperationsDetailsLineItems', window );"><strong>Organization and Business Operations (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Consummated share units (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,266,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per unit (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_OrganizationandBusinessOperationsDetailsLineItems', window );"><strong>Organization and Business Operations (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per unit (in Dollars per share)</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_GeneratingGrossProceeds', window );">Generating gross proceeds</a></td>
<td class="nump">$ 345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_NetProceedsOfTheSaleOfTheUnits', window );">Net proceeds of the sale of the units</a></td>
<td class="nump">$ 345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member] | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_OrganizationandBusinessOperationsDetailsLineItems', window );"><strong>Organization and Business Operations (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Consummated share units (in Shares)</a></td>
<td class="nump">34,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_OrganizationandBusinessOperationsDetailsLineItems', window );"><strong>Organization and Business Operations (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,175,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_BusinessCombinationFairMarketValueEqualPercentage', window );">Business combination fair market value equal percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of outstanding voting securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Trust account price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_BusinessCombinationFairMarketValueEqualPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination fair market value equal percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_BusinessCombinationFairMarketValueEqualPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_DeferredUnderwritingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriting fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_DeferredUnderwritingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_GeneratingGrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_GeneratingGrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_NetProceedsOfTheSaleOfTheUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net proceeds of the sale of the Units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_NetProceedsOfTheSaleOfTheUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_NetTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net tangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_NetTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_OrganizationandBusinessOperationsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_OrganizationandBusinessOperationsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_PublicPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_PublicPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_RedeemPublicSharesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redeem public shares, percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_RedeemPublicSharesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_TotalTransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total transaction cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_TotalTransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_TrustAccountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trust account per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_TrustAccountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOwnershipInterestsOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of offering costs allocated to the other unit holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB TOPIC 4.F)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187171-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOwnershipInterestsOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 720<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=35755714&amp;loc=d3e28434-158551<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925562029312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revision of Previously Issued Financial Statements (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 205,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_OperationalCosts', window );">Operational costs</a></td>
<td class="nump">$ 205,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_OperationalCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The adjustment to expense previously capitalized costs of operational costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_OperationalCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925632196048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revision of Previously Issued Financial Statements (Details) - Schedule of restatement of financial statements - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">$ 17,298,967<span></span>
</td>
<td class="nump">$ 19,737,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Equity (Deficit)</a></td>
<td class="num">(16,803,964)<span></span>
</td>
<td class="num">(18,781,440)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="num">(205,869)<span></span>
</td>
<td class="num">(205,869)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Equity (Deficit)</a></td>
<td class="nump">205,869<span></span>
</td>
<td class="nump">205,869<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=fact_AsRestatedMember', window );">As Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">17,093,098<span></span>
</td>
<td class="nump">19,531,727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Equity (Deficit)</a></td>
<td class="num">$ (16,598,095)<span></span>
</td>
<td class="num">$ (18,575,571)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=fact_AsRestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=fact_AsRestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925631908016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of operations - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operational Costs</a></td>
<td class="nump">$ 824,081<span></span>
</td>
<td class="nump">$ 2,022,164<span></span>
</td>
<td class="nump">$ 2,508,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">2,025,986<span></span>
</td>
<td class="nump">3,321,266<span></span>
</td>
<td class="nump">6,726,111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjusted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operational Costs</a></td>
<td class="num">(205,869)<span></span>
</td>
<td class="num">(205,869)<span></span>
</td>
<td class="num">(205,869)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">205,869<span></span>
</td>
<td class="nump">205,869<span></span>
</td>
<td class="nump">205,869<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=fact_AsRestatedMember', window );">As Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operational Costs</a></td>
<td class="nump">618,212<span></span>
</td>
<td class="nump">1,816,295<span></span>
</td>
<td class="nump">2,302,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 2,231,855<span></span>
</td>
<td class="nump">$ 3,527,135<span></span>
</td>
<td class="nump">$ 6,931,980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member] | As Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and Diluted Net Income (Loss) per shares</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member] | Adjusted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and Diluted Net Income (Loss) per shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member] | As Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and Diluted Net Income (Loss) per shares</a></td>
<td class="nump">0.05<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
<td class="nump">0.16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares [Member] | As Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and Diluted Net Income (Loss) per shares</a></td>
<td class="nump">0.05<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
<td class="nump">0.16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares [Member] | Adjusted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and Diluted Net Income (Loss) per shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares [Member] | As Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and Diluted Net Income (Loss) per shares</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedIncomeStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedIncomeStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=fact_AsRestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=fact_AsRestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925634438736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of operations (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member] | As Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income (Loss) per shares</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member] | Adjusted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income (Loss) per shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member] | As Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income (Loss) per shares</a></td>
<td class="nump">0.05<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
<td class="nump">0.16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares [Member] | As Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income (Loss) per shares</a></td>
<td class="nump">0.05<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
<td class="nump">0.16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares [Member] | Adjusted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income (Loss) per shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares [Member] | As Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Condensed Income Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income (Loss) per shares</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedIncomeStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedIncomeStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=fact_AsRestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=fact_AsRestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925559714112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of cash flows - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 2,025,986<span></span>
</td>
<td class="nump">$ 3,321,266<span></span>
</td>
<td class="nump">$ 6,726,111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">884,539<span></span>
</td>
<td class="nump">884,539<span></span>
</td>
<td class="nump">226,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjusted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">205,869<span></span>
</td>
<td class="nump">205,869<span></span>
</td>
<td class="nump">205,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(205,869)<span></span>
</td>
<td class="num">(205,869)<span></span>
</td>
<td class="num">(205,869)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=fact_AsRestatedMember', window );">As Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Condensed Cash Flow Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">2,231,855<span></span>
</td>
<td class="nump">3,527,135<span></span>
</td>
<td class="nump">6,931,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">$ 678,670<span></span>
</td>
<td class="nump">$ 678,670<span></span>
</td>
<td class="nump">$ 20,542<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedCashFlowStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedCashFlowStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=fact_AsRestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=fact_AsRestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925559588416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 02, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 349,927,313<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Federal depository insurance coverage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantsPurchase', window );">Warrants purchase (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,891,667<span></span>
</td>
<td class="nump">14,891,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,175,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherUnderwritingExpense', window );">Underwriting fee</a></td>
<td class="nump">$ 6,405,000<span></span>
</td>
<td class="nump">6,405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_DeferredUnderwritingFee', window );">Deferred underwriting fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,075,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsOfferingCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">695,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_TotalTransactionCost', window );">Total transaction cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">575,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees', window );">Underwriting fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,056,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_PartialReversalOfTransactionCosts', window );">Partial reversal of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,784,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Underwriting fee payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,018,750<span></span>
</td>
<td class="nump">$ 12,075,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Ordinary shares warrants issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,891,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_DerivativeWarrantLiabilities', window );">Derivative warrant liabilities (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_DerivativeWarrantLiabilities', window );">Derivative warrant liabilities (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,266,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_OrdinarySharesSubjectToPossibleRedemption', window );">Ordinary shares subject to possible redemption (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,500,000<span></span>
</td>
<td class="nump">34,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash in trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345,105,197<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_DeferredUnderwritingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriting fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_DeferredUnderwritingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_DerivativeWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_DerivativeWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_OrdinarySharesSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ordinary shares subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_OrdinarySharesSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_PartialReversalOfTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Partial reversal of transaction costs incurred in connection with IPO.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_PartialReversalOfTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_SignificantAccountingPoliciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_SignificantAccountingPoliciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_TotalTransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total transaction cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_TotalTransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_WarrantsPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_WarrantsPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense related to distribution, servicing and underwriting fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOwnershipInterestsOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of offering costs allocated to the other unit holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB TOPIC 4.F)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187171-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOwnershipInterestsOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 720<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=35755714&amp;loc=d3e28434-158551<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925634518224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - Schedule of unrealized holding losses and fair value of held to maturity securities - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_TradingSecuritiesFairValue', window );">Fair Value</a></td>
<td class="nump">$ 345,099,616<span></span>
</td>
<td class="nump">$ 349,927,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_AmortizedCostAndCarryingValue', window );">Amortized Cost and Carrying Value</a></td>
<td class="nump">345,105,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_GrossUnrealizedGain', window );">Gross Unrealized Gains</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_GrossUnrealizedGainsAndLosses', window );">Gross Unrealized Gains (Losses)</a></td>
<td class="num">(6,065)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember', window );">Cash [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_TradingSecuritiesFairValue', window );">Fair Value</a></td>
<td class="nump">484<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_AmortizedCostAndCarryingValue', window );">Amortized Cost and Carrying Value</a></td>
<td class="nump">484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_GrossUnrealizedGain', window );">Gross Unrealized Gains</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_GrossUnrealizedGainsAndLosses', window );">Gross Unrealized Gains (Losses)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_TradingSecuritiesFairValue', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 349,927,313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_TradingSecuritiesFairValue', window );">Fair Value</a></td>
<td class="nump">345,099,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_AmortizedCostAndCarryingValue', window );">Amortized Cost and Carrying Value</a></td>
<td class="nump">345,105,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_GrossUnrealizedGain', window );">Gross Unrealized Gains</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_GrossUnrealizedGainsAndLosses', window );">Gross Unrealized Gains (Losses)</a></td>
<td class="num">$ (6,065)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_AmortizedCostAndCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost and carrying value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_AmortizedCostAndCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_GrossUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross Unrealized Gains</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_GrossUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_GrossUnrealizedGainsAndLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross unrealized gains and losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_GrossUnrealizedGainsAndLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_TradingSecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trading securities fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_TradingSecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925631234720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - Schedule of basic and diluted net income per share for each class of ordinary share - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_AllocationOfNetIncome', window );">Allocation of net income</a></td>
<td class="nump">$ 4,785,872<span></span>
</td>
<td class="nump">$ 3,967,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding</a></td>
<td class="nump">34,500,000<span></span>
</td>
<td class="nump">28,828,767<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and diluted net income per share</a></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_AllocationOfNetIncome', window );">Allocation of net income</a></td>
<td class="nump">$ 1,196,468<span></span>
</td>
<td class="nump">$ 1,161,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding</a></td>
<td class="nump">8,625,000<span></span>
</td>
<td class="nump">8,440,068<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and diluted net income per share</a></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_AllocationOfNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_AllocationOfNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_DenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_DenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925562122192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InitialPublicOfferingDetailsLineItems', window );"><strong>Initial Public Offering (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SaleOfOrdinarySharesRedemption', window );">Sale of ordinary shares (in Shares) | shares</a></td>
<td class="nump">34,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InitialPublicOfferingDetailsLineItems', window );"><strong>Initial Public Offering (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of unit (in Shares) | shares</a></td>
<td class="nump">34,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InitialPublicOfferingDetailsLineItems', window );"><strong>Initial Public Offering (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Ordinary share, par value</a></td>
<td class="nump">0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceIncrease', window );">Warrant price, per share</a></td>
<td class="nump">$ 11.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_InitialPublicOfferingDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_InitialPublicOfferingDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_SaleOfOrdinarySharesRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of ordinary share sale of redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_SaleOfOrdinarySharesRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925559561792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering (Details) - Schedule of the ordinary share reflected on the balance sheet are reconciled<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract', window );"><strong>Schedule of the Ordinary Share Reflected on the Balance Sheet are Reconciled [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ProceedsFromGrossProceedsFromIPO', window );">Gross proceeds from IPO</a></td>
<td class="nump">$ 345,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_LessAbstract', window );"><strong>Less:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds allocated to Public Warrants</a></td>
<td class="num">(10,350,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Ordinary share issuance costs</a></td>
<td class="num">(18,600,644)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_PlusAbstract', window );"><strong>Plus:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Accretion of carrying value to redemption value</a></td>
<td class="nump">28,950,644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Contingently redeemable ordinary share as of December 31, 2021</a></td>
<td class="nump">345,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_PlusAbstract0', window );"><strong>Plus:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityOtherChanges', window );">Accretion of carrying value to redemption value</a></td>
<td class="nump">4,927,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Contingently redeemable ordinary share as of December 31, 2022</a></td>
<td class="nump">$ 349,927,313<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_LessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_LessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_PlusAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_PlusAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_PlusAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_PlusAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ProceedsFromGrossProceedsFromIPO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amonut is gross proceeds from IPO.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ProceedsFromGrossProceedsFromIPO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityOtherChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in temporary equity from changes classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityOtherChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925559539088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement Warrants (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_PrivatePlacementWarrantsDetailsLineItems', window );"><strong>Private Placement Warrants (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Purchase of warrants (in Shares) | shares</a></td>
<td class="nump">6,266,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant price per share</a></td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_AggregatePurchasePrice', window );">Aggregate purchase price (in Dollars) | $</a></td>
<td class="nump">$ 9,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_PrivatePlacementWarrantsDetailsLineItems', window );"><strong>Private Placement Warrants (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant price per share</a></td>
<td class="nump">$ 11.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_AggregatePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of aggregate purchase price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_AggregatePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_PrivatePlacementWarrantsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_PrivatePlacementWarrantsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925630318720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 14, 2022</div></th>
<th class="th"><div>Jun. 06, 2022</div></th>
<th class="th"><div>May 16, 2022</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Apr. 02, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 25, 2021</div></th>
<th class="th"><div>Dec. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="nump">$ 9.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SponsorShare', window );">Sponsor share (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare', window );">Fair value of shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare', window );">Fair value per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Agreed to loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WorkingCapitalLoans', window );">Working capital loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 675,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_PromissioryNoteRelatedParty', window );">Promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfUnsecuredDebt', window );">Issued unsecured promissory note amount</a></td>
<td class="nump">$ 325,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceDecrease', window );">Exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,225,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Price per warrant (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_OfficeSpaceAndAdministrativeSupportServices', window );">Sponsor amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Consideration shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,187,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,437,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockOtherSharesOutstanding', window );">Ordinary shares outstanding (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare', window );">Fair value of shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=fact_BusinessCombinationMember', window );">Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Class A ordinary shares equals or exceeds (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=fact_FounderSharesMember', window );">Founder Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_RelatedPartyTransactionsDetailsLineItems', window );"><strong>Related Party Transactions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_StockIssuedDuringPeriodSponsorAmount', window );">Sponsor amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_OfficeSpaceAndAdministrativeSupportServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses for office space and administrative support services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_OfficeSpaceAndAdministrativeSupportServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_PromissioryNoteRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is related party promissiory note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_PromissioryNoteRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_RelatedPartyTransactionsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_RelatedPartyTransactionsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_SponsorShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The shares for sponsor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_SponsorShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_StockIssuedDuringPeriodSponsorAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sponsor amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_StockIssuedDuringPeriodSponsorAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_WorkingCapitalLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_WorkingCapitalLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockOtherSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockOtherSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value per share that would be issued upon settlement of forward contract indexed to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in number of shares that would be issued upon settlement from change in fair value of share for option contract indexed to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfUnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfUnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantExercisePriceDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantExercisePriceDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=fact_BusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=fact_BusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=fact_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=fact_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925559764176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments &amp; Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 02, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_CommitmentsContingenciesDetailsLineItems', window );"><strong>Commitments &amp; Contingencies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherUnderwritingExpense', window );">Underwriting discount amount</a></td>
<td class="nump">$ 6,405,000<span></span>
</td>
<td class="nump">$ 6,405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_DeferredUnderwritingDiscountPerUnit', window );">Deferred underwriting discount, per unit (in Dollars per share)</a></td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_AggregateGrossProceeds', window );">Aggregate amount</a></td>
<td class="nump">$ 12,075,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees', window );">Underwriting fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,056,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_PartialReversalOfTransactionCosts', window );">Partial reversal of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,784,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">underwriting fee payableU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,018,750<span></span>
</td>
<td class="nump">$ 12,075,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Acquiror Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalDeferredPurchasePrice', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_CommitmentsContingenciesDetailsLineItems', window );"><strong>Commitments &amp; Contingencies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Acquiror Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_CommitmentsContingenciesDetailsLineItems', window );"><strong>Commitments &amp; Contingencies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member] | Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_CommitmentsContingenciesDetailsLineItems', window );"><strong>Commitments &amp; Contingencies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=fact_BusinessCombinationMember', window );">Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_CommitmentsContingenciesDetailsLineItems', window );"><strong>Commitments &amp; Contingencies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Acquiror Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_AggregateGrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate gross proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_AggregateGrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_CommitmentsContingenciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_CommitmentsContingenciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_DeferredUnderwritingDiscountPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriting discount, per unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_DeferredUnderwritingDiscountPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_PartialReversalOfTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Partial reversal of transaction costs incurred in connection with IPO.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_PartialReversalOfTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense related to distribution, servicing and underwriting fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 720<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=35755714&amp;loc=d3e28434-158551<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalDeferredPurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalDeferredPurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=fact_BusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=fact_BusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925631290080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Deficit (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ShareholdersDeficitDetailsLineItems', window );"><strong>Shareholders&#8217; Deficit (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preference shares, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preference shares, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_OrdinarySharesDescription', window );">Ordinary shares, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Sponsor paid $25,000,
or approximately $0.003 per share, to cover certain offering costs in consideration for 7,187,500 Class B ordinary shares, par value $0.0001
per share. On February 25, 2021, the Company effected a share dividend whereby the Company issued 1,437,500 Class B ordinary shares, resulting
in an aggregate of 8,625,000 Class B ordinary shares outstanding.&#160;All share and per-share amounts have been retroactively restated
to reflect the share dividend.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_TotalNumberOfOrdinarySharesOutstandingPercentage', window );">Total number of ordinary shares outstanding percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ShareholdersDeficitDetailsLineItems', window );"><strong>Shareholders&#8217; Deficit (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding</a></td>
<td class="nump">34,500,000<span></span>
</td>
<td class="nump">34,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ShareholdersDeficitDetailsLineItems', window );"><strong>Shareholders&#8217; Deficit (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding</a></td>
<td class="nump">8,625,000<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued</a></td>
<td class="nump">8,625,000<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_OrdinarySharesDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ordinary shares, description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_OrdinarySharesDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ShareholdersDeficitDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ShareholdersDeficitDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_TotalNumberOfOrdinarySharesOutstandingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of ordinary shares outstanding percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_TotalNumberOfOrdinarySharesOutstandingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925634349664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantsDetailsLineItems', window );"><strong>Warrants (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantExpirationTerm', window );">Warrant expiration term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=fact_PublicWarrantsMember', window );">Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantsDetailsLineItems', window );"><strong>Warrants (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 11.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantsDetailsLineItems', window );"><strong>Warrants (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantTerm', window );">Warrant term</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantsDetailsLineItems', window );"><strong>Warrants (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 11.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_RedemptionsOfWarrantsDescription', window );">Redemptions of warrants, description</a></td>
<td class="text">Redemption of Warrants When the Price per Class&#160;A
Ordinary Share Equals or Exceeds $18.00&#160;Once the warrants become exercisable, the Company
may redeem the outstanding warrants (except with respect to the Private Placement Warrants):&#160;&#160;
&#9679;in whole and not in part;&#160;
&#9679;at a price of $0.01 per warrant;&#160;
&#9679;upon not less than 30 days&#8217; prior written notice of redemption (the &#8220;30-day redemption period&#8221;) to each warrant
holder; and&#160;
&#9679;if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a 30-trading day period
ending three business days before the Company sends to the notice of redemption to the warrant holders (the &#8220;Reference Value&#8221;)
equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and
the like).&#160;&#160;Redemption of Warrants When the Price per Class&#160;A
Ordinary Share Equals or Exceeds $10.00&#160;Once the warrants become exercisable, the Company
may redeem the outstanding warrants:&#160;
&#9679;in whole and not in part;&#160;
&#9679;at $0.10 per warrant upon a minimum of 30 days&#8217; prior written notice of redemption provided that holders will be able to exercise
their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based
on the redemption date and the &#8220;fair market value&#8221; of the Class A ordinary shares;&#160;
&#9679;if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share sub-divisions, share capitalizations,
reorganizations, recapitalizations and the like); and&#160;
&#9679;if the Reference Value is less than $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations,
recapitalizations and the like) the Private Placement Warrants must also be concurrently called for redemption on the same terms as the
outstanding public warrants, as described above.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Business Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantsDetailsLineItems', window );"><strong>Warrants (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity', window );">Business combination, description</a></td>
<td class="text">In addition, if (x)&#160;the Company issues additional Class&#160;A ordinary shares or equity-linked
securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective
issue price of less than $9.20 per Class&#160;A ordinary share (with such issue price or effective issue price to be determined in good
faith by the Company&#8217;s board of directors and in the case of any such issuance to the Company&#8217;s Sponsors or their affiliates,
without taking into account any Founder Shares held by the Company&#8217;s initial shareholders or such affiliates, as applicable, prior
to such issuance (the &#8220;Newly Issued Price&#8221;), (y)&#160;the aggregate gross proceeds from such issuances represent more than
60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the
completion of the initial Business Combination (net of redemptions), and (z)&#160;the volume-weighted average trading price of the Company&#8217;s
Class&#160;A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates
its initial Business Combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, then the exercise price of the
warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and
the $10.00 and $18.00 per share redemption trigger prices described below under &#8220;Redemption of warrants when the price per Class
A ordinary share equals or exceeds $10.00&#8221; and &#8220;Redemption of warrants when the price per Class A ordinary share equals or
exceeds $18.00&#8221; will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly
Issued Price, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_RedemptionsOfWarrantsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemptions of warrants, description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_RedemptionsOfWarrantsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_WarrantExpirationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant expiration term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_WarrantExpirationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_WarrantTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_WarrantTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_WarrantsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_WarrantsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=fact_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=fact_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925634596544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueMeasurementsDetailsLineItems', window );"><strong>Fair Value Measurements (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueWarrantLiabilities', window );">Fair value warrant liabilities</a></td>
<td class="nump">$ 5,509,917<span></span>
</td>
<td class="nump">$ 9,381,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueMeasurementsDetailsLineItems', window );"><strong>Fair Value Measurements (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3', window );">Transferred amount</a></td>
<td class="nump">348,810,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueMeasurementsDetailsLineItems', window );"><strong>Fair Value Measurements (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3', window );">Transferred amount</a></td>
<td class="nump">$ 1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_FairValueMeasurementsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_FairValueMeasurementsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_FairValueWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the fair value warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_FairValueWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset) out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925634457120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentsHeldInTrustAccountUSTreasureSecurities', window );">Investments held in trust account- U.S. Treasury Securities</a></td>
<td class="nump">$ 349,927,313<span></span>
</td>
<td class="nump">$ 345,105,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentsHeldInTrustAccountNet', window );">Total Investments held in Trust Account</a></td>
<td class="nump">349,927,313<span></span>
</td>
<td class="nump">345,105,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantLiabilitiesPublicWarrants', window );">Warrant liabilities &#8211; Public warrants</a></td>
<td class="nump">1,725,000<span></span>
</td>
<td class="nump">4,916,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantLiabilitiesPrivateWarrants', window );">Warrant liabilities &#8211; Private warrants</a></td>
<td class="nump">1,253,333<span></span>
</td>
<td class="nump">3,572,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ConvertibleNoteAmount', window );">Convertible Note &#8211; April 1, 2022</a></td>
<td class="nump">338,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ConvertibleNoteone', window );">Convertible Note &#8211; June 6, 2022</a></td>
<td class="nump">338,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ConvertibleNotesTwo', window );">Convertible Note &#8211; December 14, 2022</a></td>
<td class="nump">152,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_TotalWarrantLiabilities', window );">Total Warrant liabilities</a></td>
<td class="nump">3,806,933<span></span>
</td>
<td class="nump">8,488,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund', window );">Investments held in trust account- U.S. Money Market Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices In Active Markets (Level 1) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentsHeldInTrustAccountUSTreasureSecurities', window );">Investments held in trust account- U.S. Treasury Securities</a></td>
<td class="nump">349,927,313<span></span>
</td>
<td class="nump">345,105,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentsHeldInTrustAccountNet', window );">Total Investments held in Trust Account</a></td>
<td class="nump">349,927,313<span></span>
</td>
<td class="nump">345,105,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantLiabilitiesPublicWarrants', window );">Warrant liabilities &#8211; Public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,916,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantLiabilitiesPrivateWarrants', window );">Warrant liabilities &#8211; Private warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ConvertibleNoteAmount', window );">Convertible Note &#8211; April 1, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ConvertibleNoteone', window );">Convertible Note &#8211; June 6, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ConvertibleNotesTwo', window );">Convertible Note &#8211; December 14, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_TotalWarrantLiabilities', window );">Total Warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,916,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund', window );">Investments held in trust account- U.S. Money Market Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level 2) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentsHeldInTrustAccountUSTreasureSecurities', window );">Investments held in trust account- U.S. Treasury Securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentsHeldInTrustAccountNet', window );">Total Investments held in Trust Account</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantLiabilitiesPublicWarrants', window );">Warrant liabilities &#8211; Public warrants</a></td>
<td class="nump">1,725,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantLiabilitiesPrivateWarrants', window );">Warrant liabilities &#8211; Private warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ConvertibleNoteAmount', window );">Convertible Note &#8211; April 1, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ConvertibleNoteone', window );">Convertible Note &#8211; June 6, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ConvertibleNotesTwo', window );">Convertible Note &#8211; December 14, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_TotalWarrantLiabilities', window );">Total Warrant liabilities</a></td>
<td class="nump">1,725,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund', window );">Investments held in trust account- U.S. Money Market Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Other Unobservable Inputs (Level 3) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentsHeldInTrustAccountUSTreasureSecurities', window );">Investments held in trust account- U.S. Treasury Securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentsHeldInTrustAccountNet', window );">Total Investments held in Trust Account</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantLiabilitiesPublicWarrants', window );">Warrant liabilities &#8211; Public warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_WarrantLiabilitiesPrivateWarrants', window );">Warrant liabilities &#8211; Private warrants</a></td>
<td class="nump">1,253,333<span></span>
</td>
<td class="nump">3,572,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ConvertibleNoteAmount', window );">Convertible Note &#8211; April 1, 2022</a></td>
<td class="nump">338,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ConvertibleNoteone', window );">Convertible Note &#8211; June 6, 2022</a></td>
<td class="nump">338,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ConvertibleNotesTwo', window );">Convertible Note &#8211; December 14, 2022</a></td>
<td class="nump">152,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_TotalWarrantLiabilities', window );">Total Warrant liabilities</a></td>
<td class="nump">$ 2,081,933<span></span>
</td>
<td class="nump">3,572,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund', window );">Investments held in trust account- U.S. Money Market Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ConvertibleNoteAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ConvertibleNoteAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ConvertibleNoteone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ConvertibleNoteone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ConvertibleNotesTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ConvertibleNotesTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_InvestmentsHeldInTrustAccountNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Investments held in Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_InvestmentsHeldInTrustAccountNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments held in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_InvestmentsHeldInTrustAccountUSTreasureSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments held in trust account US treasure securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_InvestmentsHeldInTrustAccountUSTreasureSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_TotalWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_TotalWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_WarrantLiabilitiesPrivateWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant liabilities private warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_WarrantLiabilitiesPrivateWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_WarrantLiabilitiesPublicWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant liabilities public warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_WarrantLiabilitiesPublicWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925632002304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract', window );"><strong>Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="nump">$ 9.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueMeasurementStrikePrice', window );">Strike price</a></td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (in years)</a></td>
<td class="text">4 months 17 days<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates', window );">Volatility</a></td>
<td class="text">de minimis<span></span>
</td>
<td class="text">10.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">3.98%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_FairValueMeasurementStrikePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Strike price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_FairValueMeasurementStrikePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925561911952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems', window );"><strong>Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Fair value as of beginning</a></td>
<td class="nump">$ 8,488,250<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueInitialMeasurement', window );">Initial measurement on March 2, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,870,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease', window );">Change in valuation inputs or other assumptions</a></td>
<td class="num">(5,509,917)<span></span>
</td>
<td class="num">(9,381,750)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Fair value as of ending</a></td>
<td class="nump">2,978,333<span></span>
</td>
<td class="nump">8,488,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=fact_PublicMember', window );">Public [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems', window );"><strong>Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Fair value as of beginning</a></td>
<td class="nump">4,916,250<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueInitialMeasurement', window );">Initial measurement on March 2, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,350,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease', window );">Change in valuation inputs or other assumptions</a></td>
<td class="num">(3,191,250)<span></span>
</td>
<td class="num">(5,433,750)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Fair value as of ending</a></td>
<td class="nump">1,725,000<span></span>
</td>
<td class="nump">4,916,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems', window );"><strong>Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Fair value as of beginning</a></td>
<td class="nump">3,572,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueInitialMeasurement', window );">Initial measurement on March 2, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,520,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease', window );">Change in valuation inputs or other assumptions</a></td>
<td class="num">(2,318,667)<span></span>
</td>
<td class="num">(3,948,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Fair value as of ending</a></td>
<td class="nump">$ 1,253,333<span></span>
</td>
<td class="nump">$ 3,572,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_FairValueInitialMeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value initial measurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_FairValueInitialMeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset after deduction of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=fact_PublicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=fact_PublicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925630099376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - Schedule of changes in the fair value of level 3 warrant liabilities - Fair Value, Inputs, Level 3 [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Total Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems', window );"><strong>Fair Value Measurements (Details) - Schedule of changes in the fair value of level 3 warrant liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Fair value as of beginning</a></td>
<td class="nump">$ 3,572,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueInitialMeasurement', window );">Initial measurement on March 2, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,870,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueAssetsLevel1ToLevel2TransferAmount', window );">Transfer to Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,350,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease', window );">Change in fair value</a></td>
<td class="num">(2,318,667)<span></span>
</td>
<td class="num">(3,948,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Fair value as of ending</a></td>
<td class="nump">1,253,333<span></span>
</td>
<td class="nump">3,572,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems', window );"><strong>Fair Value Measurements (Details) - Schedule of changes in the fair value of level 3 warrant liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Fair value as of beginning</a></td>
<td class="nump">3,572,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueInitialMeasurement', window );">Initial measurement on March 2, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,520,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueAssetsLevel1ToLevel2TransferAmount', window );">Transfer to Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease', window );">Change in fair value</a></td>
<td class="num">(2,318,667)<span></span>
</td>
<td class="num">(3,948,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Fair value as of ending</a></td>
<td class="nump">1,253,333<span></span>
</td>
<td class="nump">3,572,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Public [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems', window );"><strong>Fair Value Measurements (Details) - Schedule of changes in the fair value of level 3 warrant liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Fair value as of beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueInitialMeasurement', window );">Initial measurement on March 2, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,350,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_FairValueAssetsLevel1ToLevel2TransferAmount', window );">Transfer to Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,350,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease', window );">Change in fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Fair value as of ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_FairValueAssetsLevel1ToLevel2TransferAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_FairValueAssetsLevel1ToLevel2TransferAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_FairValueInitialMeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value initial measurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_FairValueInitialMeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset after deduction of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=fact_PublicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=fact_PublicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139925562040432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 02, 2023</div></th>
<th class="th"><div>Feb. 25, 2023</div></th>
<th class="th"><div>Feb. 25, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_AggregateSharesOfCommonStock', window );">Aggregate ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,256,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Redemption price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_IssuedAndOutstandingInterestPercentage', window );">Issued and outstanding interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Redemption amount (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 237,372,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockHeldInTrust', window );">Trust account (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114,759,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Remaining shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,243,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,437,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_VotingPowerPercentage', window );">Voting power percentage</a></td>
<td class="nump">82.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_IssuedAndOutstandingShares', window );">Issued and outstanding ordinary shares</a></td>
<td class="nump">43,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentManagementTrustAgreementFor', window );">Investment management trust agreement for</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,047,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentManagementTrustAgreementAgainst', window );">Investment management trust agreement against</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_InvestmentManagementTrustAgreementAbstain', window );">Investment management trust agreement against</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfUnsecuredDebt', window );">Unsecured promissory note (in Dollars)</a></td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_PromissoryNote', window );">Promissory note (in Dollars)</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_DrawnDownAmount', window );">Drawn down amount (in Dollars)</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued</a></td>
<td class="nump">35,373,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued</a></td>
<td class="nump">26,773,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonUnitOutstanding', window );">Outstanding shares</a></td>
<td class="nump">34,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Class B Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued</a></td>
<td class="nump">8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonUnitOutstanding', window );">Outstanding shares</a></td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ExtensionAmendmentProposalFor', window );">Extension amendment proposal for</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,047,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ExtensionAmendmentProposalAgainst', window );">Extension amendment proposal against</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_ExtensionAmendmentProposalAbstain', window );">Extension amendment proposal abstain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=fact_BusinessCombinationMember', window );">Business Combination [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fact_DrawnDownAmount', window );">Drawn down amount (in Dollars)</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_AggregateSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_AggregateSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_DrawnDownAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in liability for separate account from withdrawal of funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_DrawnDownAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ExtensionAmendmentProposalAbstain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extension amendment proposal abstain.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ExtensionAmendmentProposalAbstain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ExtensionAmendmentProposalAgainst">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extension amendment proposal against.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ExtensionAmendmentProposalAgainst</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_ExtensionAmendmentProposalFor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extension Amendment Proposal For.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_ExtensionAmendmentProposalFor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_InvestmentManagementTrustAgreementAbstain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment management trust agreement against.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_InvestmentManagementTrustAgreementAbstain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_InvestmentManagementTrustAgreementAgainst">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment management trust agreement against.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_InvestmentManagementTrustAgreementAgainst</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_InvestmentManagementTrustAgreementFor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment management trust agreement for.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_InvestmentManagementTrustAgreementFor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_IssuedAndOutstandingInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issued and outstanding interest percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_IssuedAndOutstandingInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_IssuedAndOutstandingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_IssuedAndOutstandingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_PromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Promissory notes may also be referred to as an IOU, a loan agreement, or just a note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_PromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_SubsequentEventsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_SubsequentEventsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fact_VotingPowerPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fact_VotingPowerPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fact_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of common stock held in trust.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonUnitOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common units of ownership outstanding of a limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonUnitOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfUnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfUnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=fact_BusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=fact_BusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>f10k2022_freedomacq1_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:fact="http://www.FreedomAcquisitionICorp.com/20221231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fact-20221231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-02</startDate>
            <endDate>2021-03-02</endDate>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-02</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-02</startDate>
            <endDate>2021-03-02</endDate>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-16</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">fact:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fact:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-23</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">fact:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-23</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-25</instant>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fact:BusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <startDate>2022-05-16</startDate>
            <endDate>2022-05-16</endDate>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <instant>2020-12-30</instant>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <startDate>2022-03-17</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-06</endDate>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <startDate>2022-12-14</startDate>
            <endDate>2022-12-14</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <startDate>2021-03-02</startDate>
            <endDate>2021-03-02</endDate>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fact:BusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fact:PublicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-28</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-02</instant>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-25</instant>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838987</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fact:BusinessCombinationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-28</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="c0">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c0">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0">001-40117</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0">FREEDOM ACQUISITION I CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c0">14 Wall Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0">20th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressStateOrProvince contextRef="c0">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCityOrTown contextRef="c0">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="c0">10005</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0">618-1798</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c0">Class A ordinary shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0">FACT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="c0">true</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c1" decimals="0" unitRef="usd">339256450</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c2" decimals="INF" unitRef="shares">34500000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding contextRef="c3" decimals="INF" unitRef="shares">8625000</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorFirmId contextRef="c0">688</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c0">Marcum llp</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0">New York, NY</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c4" decimals="0" unitRef="usd">72923</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c5" decimals="0" unitRef="usd">277583</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent contextRef="c4" decimals="0" unitRef="usd">120677</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c5" decimals="0" unitRef="usd">724066</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent contextRef="c4" decimals="0" unitRef="usd">193600</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c5" decimals="0" unitRef="usd">1001649</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseNoncurrent contextRef="c5" decimals="0" unitRef="usd">113073</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c4" decimals="0" unitRef="usd">349927313</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c5" decimals="0" unitRef="usd">345105681</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets contextRef="c4" decimals="0" unitRef="usd">350120913</us-gaap:Assets>
    <us-gaap:Assets contextRef="c5" decimals="0" unitRef="usd">346220403</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c4" decimals="0" unitRef="usd">4858215</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c5" decimals="0" unitRef="usd">2579641</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c4" decimals="0" unitRef="usd">828600</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c4" decimals="0" unitRef="usd">5686815</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c5" decimals="0" unitRef="usd">2579641</us-gaap:LiabilitiesCurrent>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c4" decimals="0" unitRef="usd">2978333</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c5" decimals="0" unitRef="usd">8488250</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent contextRef="c4" decimals="0" unitRef="usd">3018750</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent contextRef="c5" decimals="0" unitRef="usd">12075000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:Liabilities contextRef="c4" decimals="0" unitRef="usd">11683898</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c5" decimals="0" unitRef="usd">23142891</us-gaap:Liabilities>
    <fact:SharesSubjectToPossibleRedemption contextRef="c2" decimals="0" unitRef="shares">34500000</fact:SharesSubjectToPossibleRedemption>
    <fact:SharesSubjectToPossibleRedemption contextRef="c6" decimals="0" unitRef="shares">34500000</fact:SharesSubjectToPossibleRedemption>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c4" decimals="0" unitRef="usd">349927313</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c5" decimals="0" unitRef="usd">345000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c4" decimals="4" unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c5" decimals="4" unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c4" decimals="0" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c5" decimals="0" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c2" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c6" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c2" decimals="0" unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c6" decimals="0" unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c3" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c7" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c3" decimals="0" unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c7" decimals="0" unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c3" decimals="0" unitRef="shares">8625000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c7" decimals="0" unitRef="shares">8625000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c3" decimals="0" unitRef="shares">8625000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c7" decimals="0" unitRef="shares">8625000</us-gaap:CommonStockSharesOutstanding>
    <fact:CommonStockValueOne contextRef="c4" decimals="0" unitRef="usd">863</fact:CommonStockValueOne>
    <fact:CommonStockValueOne contextRef="c5" decimals="0" unitRef="usd">863</fact:CommonStockValueOne>
    <us-gaap:AdditionalPaidInCapital contextRef="c4" decimals="0" unitRef="usd">6057438</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c4" decimals="0" unitRef="usd">-17548599</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c5" decimals="0" unitRef="usd">-21923351</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="0" unitRef="usd">-11490298</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c5" decimals="0" unitRef="usd">-21922488</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c4" decimals="0" unitRef="usd">350120913</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c5" decimals="0" unitRef="usd">346220403</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingCostsAndExpenses contextRef="c0" decimals="0" unitRef="usd">4407058</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses contextRef="c8" decimals="0" unitRef="usd">3782028</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="0" unitRef="usd">-4407058</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c8" decimals="0" unitRef="usd">-3782028</us-gaap:OperatingIncomeLoss>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c0" decimals="0" unitRef="usd">-17638</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c8" decimals="0" unitRef="usd">-1475</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:InvestmentIncomeInterest contextRef="c0" decimals="0" unitRef="usd">4821632</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c8" decimals="0" unitRef="usd">105681</us-gaap:InvestmentIncomeInterest>
    <fact:PartialReversalOfTransactionCosts contextRef="c0" decimals="0" unitRef="usd">271687</fact:PartialReversalOfTransactionCosts>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c0" decimals="0" unitRef="usd">-5509917</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c8" decimals="0" unitRef="usd">-9381750</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="c0" decimals="0" unitRef="usd">-196200</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:NoninterestExpenseOfferingCost contextRef="c8" decimals="0" unitRef="usd">575278</us-gaap:NoninterestExpenseOfferingCost>
    <us-gaap:NonoperatingIncomeExpense contextRef="c0" decimals="0" unitRef="usd">10389398</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c8" decimals="0" unitRef="usd">8910678</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" unitRef="usd">5982340</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="0" unitRef="usd">5128650</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c9" decimals="0" unitRef="shares">34500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c10" decimals="0" unitRef="shares">28828767</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c9" decimals="2" unitRef="usdPershares">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c10" decimals="2" unitRef="usdPershares">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c11" decimals="0" unitRef="shares">8625000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c12" decimals="0" unitRef="shares">8440068</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c11" decimals="2" unitRef="usdPershares">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c12" decimals="2" unitRef="usdPershares">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:SharesOutstanding contextRef="c14" decimals="0" unitRef="shares">8625000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c14" decimals="0" unitRef="usd">863</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c15" decimals="0" unitRef="usd">24137</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c16" decimals="0" unitRef="usd">-5494</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c17" decimals="0" unitRef="usd">19506</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c8" decimals="INF" unitRef="shares">34500000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="c18" decimals="0" unitRef="shares">34500000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c18" decimals="0" unitRef="usd">3450</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c8" decimals="0" unitRef="usd">3450</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c20" decimals="0" unitRef="usd">1880000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c8" decimals="0" unitRef="usd">1880000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares contextRef="c18" decimals="0" unitRef="shares">-34500000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockholdersEquityOther contextRef="c18" decimals="0" unitRef="usd">-3450</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther contextRef="c8" decimals="0" unitRef="usd">-3450</us-gaap:StockholdersEquityOther>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c20" decimals="0" unitRef="usd">-1904137</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c21" decimals="0" unitRef="usd">-27046507</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c8" decimals="0" unitRef="usd">-28950644</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:NetIncomeLoss contextRef="c21" decimals="0" unitRef="usd">5128650</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="0" unitRef="usd">5128650</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c23" decimals="0" unitRef="shares">8625000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c23" decimals="0" unitRef="usd">863</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c25" decimals="0" unitRef="usd">-21923351</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c5" decimals="0" unitRef="usd">-21922488</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c28" decimals="0" unitRef="usd">592600</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c0" decimals="0" unitRef="usd">592600</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="c28" decimals="0" unitRef="usd">-592600</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="c0" decimals="0" unitRef="usd">-592600</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="c28" decimals="0" unitRef="usd">-2727125</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="c29" decimals="0" unitRef="usd">-1607588</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="c0" decimals="0" unitRef="usd">-4334713</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c28" decimals="0" unitRef="usd">8784563</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c0" decimals="0" unitRef="usd">8784563</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:NetIncomeLoss contextRef="c29" decimals="0" unitRef="usd">5982340</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" unitRef="usd">5982340</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c31" decimals="0" unitRef="shares">8625000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c31" decimals="0" unitRef="usd">863</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c32" decimals="0" unitRef="usd">6057438</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c33" decimals="0" unitRef="usd">-17548599</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="0" unitRef="usd">-11490298</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" unitRef="usd">5982340</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="0" unitRef="usd">5128650</us-gaap:NetIncomeLoss>
    <us-gaap:InterestIncomeOther contextRef="c0" decimals="0" unitRef="usd">4821632</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther contextRef="c8" decimals="0" unitRef="usd">105681</us-gaap:InterestIncomeOther>
    <fact:ChangeInFairValueOfWarrantLiabilities contextRef="c0" decimals="0" unitRef="usd">-5509917</fact:ChangeInFairValueOfWarrantLiabilities>
    <fact:ChangeInFairValueOfWarrantLiabilities contextRef="c8" decimals="0" unitRef="usd">-9381750</fact:ChangeInFairValueOfWarrantLiabilities>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="c0" decimals="0" unitRef="usd">-196200</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <fact:ChangeInDeferredUnderwritingFee contextRef="c0" decimals="0" unitRef="usd">-271687</fact:ChangeInDeferredUnderwritingFee>
    <fact:OfferingCostsAllocatedToWarrants contextRef="c8" decimals="0" unitRef="usd">-575278</fact:OfferingCostsAllocatedToWarrants>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c0" decimals="0" unitRef="usd">-716462</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c8" decimals="0" unitRef="usd">837139</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c0" decimals="0" unitRef="usd">2278574</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c8" decimals="0" unitRef="usd">2579641</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="0" unitRef="usd">-1429660</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c8" decimals="0" unitRef="usd">-2041001</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <fact:CashDepositedInTrustAccount contextRef="c8" decimals="0" unitRef="usd">-345000000</fact:CashDepositedInTrustAccount>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c8" decimals="0" unitRef="usd">-345000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c8" decimals="0" unitRef="usd">338595000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c8" decimals="0" unitRef="usd">9400000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c0" decimals="0" unitRef="usd">1225000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c8" decimals="0" unitRef="usd">90996</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c8" decimals="0" unitRef="usd">585420</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="0" unitRef="usd">1225000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c8" decimals="0" unitRef="usd">347318584</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c0" decimals="0" unitRef="usd">-204660</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c8" decimals="0" unitRef="usd">277583</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c5" decimals="0" unitRef="usd">277583</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c4" decimals="0" unitRef="usd">72923</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c5" decimals="0" unitRef="usd">277583</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <fact:InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption contextRef="c8" decimals="0" unitRef="usd">345000000</fact:InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption>
    <fact:InitialValueOfWarrantLiabilities contextRef="c8" decimals="0" unitRef="usd">17870000</fact:InitialValueOfWarrantLiabilities>
    <fact:DeferredOfferingCostsIncludedInAccruedExpenses contextRef="c8" decimals="0" unitRef="usd">12075000</fact:DeferredOfferingCostsIncludedInAccruedExpenses>
    <fact:AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares contextRef="c0" decimals="0" unitRef="usd">4927313</fact:AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares>
    <fact:AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares contextRef="c8" decimals="0" unitRef="usd">28950644</fact:AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares>
    <fact:DeferredOfferingCostsPaidUnderPromissoryNote contextRef="c8" decimals="0" unitRef="usd">90996</fact:DeferredOfferingCostsPaidUnderPromissoryNote>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Note 1 &#x2014; Organization and Business Operations&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Organization and General&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Freedom Acquisition I Corp. (the &#x201c;Company&#x201d;
or &#x201c;Freedom&#x201d;) was incorporated in Cayman Islands on December 23, 2020. The Company was formed for the purpose of entering
into a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more
businesses (a &#x201c;Business Combination&#x201d;). The Company is not limited to a particular industry or geographic region for purposes
of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject
to all of the risks associated with early stage and emerging growth companies.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On October 3, 2022, the Company entered into a
Business Combination Agreement with Jupiter Merger Sub I Corp., a Delaware corporation and a wholly owned subsidiary of the Company, Jupiter
Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company, Complete Solar Holding Corporation,
a Delaware corporation, and The Solaria Corporation, a Delaware corporation.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company&#x2019;s sponsor is Freedom Acquisition
I LLC, a Cayman Islands limited liability company (the &#x201c;Sponsor&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;As of December 31, 2022, the Company had not
yet commenced any operations. All activity through December 31, 2022, relates to the Company&#x2019;s formation and the Initial
Public Offering (&#x201c;IPO&#x201d; or &#x201c;Initial Public Offering&#x201d;) described below. The Company will not generate any
operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO and changes
in the fair value of warrant liabilities.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Financing&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The registration statement for the Company&#x2019;s
IPO was declared effective on February 25, 2021 (the &#x201c;Effective Date&#x201d;). On March 2, 2021, the Company consummated the IPO
of&#160;34,500,000&#160;units (the &#x201c;Units&#x201d; and, with respect to the Class A ordinary shares included in the Units being offered,
the &#x201c;public share&#x201d;), at $10.00&#160;per Unit, generating gross proceeds of $345,000,000, which is discussed in Note 4.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Simultaneously with the closing of the IPO, the Company consummated
the sale&#160;of&#160;6,266,667&#160;warrants (the &#x201c;Private Placement Warrants&#x201d;), at a price of $1.50&#160;per Private Placement
Warrant, which is discussed in Note&#160;5.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Transaction costs amounted to $19,175,922,&#160;consisting of $6,405,000&#160;of
underwriting fees, $12,075,000&#160;of deferred underwriting fees and $695,922&#160;of other offering costs. Of the total transaction
cost, $575,278&#160;was expensed as non-operating expenses in the consolidated statement of operations with the rest of the offering cost
charged to shareholders&#x2019; deficit for the year ended December 31, 2021. The transaction costs were allocated based on the relative
fair value basis, compared to the total offering proceeds, between the fair value of the public warrant liabilities and the Class A ordinary
shares.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Trust Account&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Following the closing of the IPO on March 2, 2021,
an amount of $345,000,000&#160;from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants
was placed in a trust account (&#x201c;Trust Account&#x201d;). The funds in the Trust Account have, since the IPO and until the&#160;24-month&#160;anniversary
of the consummation of the IPO, been invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment
Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund
meeting the conditions of Rule&#160;2a-7&#160;of the&#160;Investment Company Act, as determined by the Company. To mitigate the risk of
the Company being deemed to have been operating as an unregistered investment company, prior to the&#160;24-month&#160;anniversary of
the consummation of the IPO, the Company instructed Continental, the trustee with respect to the Trust Account, to liquidate the U.S.
government treasury obligations or money market funds held in the Trust Account and to hold all the funds in the Trust Account in cash
in a bank deposit account. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company
to pay its tax obligations, the proceeds from the IPO and the sale of the private placement units will not be released from the Trust
Account until the earliest of (a) the completion of the Company&#x2019;s initial Business Combination, (b) the redemption of any public
shares properly submitted in connection with a shareholder vote to amend the Company&#x2019;s amended and restated certificate of incorporation,
and (c) the redemption of the Company&#x2019;s public shares if the Company is unable to complete the initial Business Combination during
the Combination Period (as defined below), subject to applicable law. The proceeds deposited in the Trust Account could become subject
to the claims of the Company&#x2019;s creditors, if any, which could have priority over the claims of the Company&#x2019;s public shareholders.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Initial Business Combination&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company&#x2019;s management has broad discretion
with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to
be generally applied toward consummating a Business Combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company&#x2019;s Business Combination must
be with one or more target businesses that together have a fair market value equal to at least&#160;80% of the balance in the Trust Account
(net of taxes payable) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete
a Business Combination if the post-Business Combination company owns or acquires&#160;50% or more of the outstanding voting securities
of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment
company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company will provide its public shareholders
with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either
(i) in connection with a shareholder meeting called to approve the initial Business Combination or (ii) by means of a tender offer. The
decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer
will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their shares for a pro rata portion
of the amount then on deposit in the Trust Account (initially $10.00&#160;per share, plus any pro rata interest earned on the funds held
in the Trust Account and not previously released to the Company to pay its tax obligations).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Class A ordinary shares subject to
redemption are recorded at redemption value and classified as temporary equity upon the completion of the IPO, in accordance with
Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 480, &#x201c;Distinguishing Liabilities from Equity.&#x201d; In such case,
the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001&#160;either
immediately prior to or upon consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of
the issued and outstanding shares voted are voted in favor of the Business Combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On February 28, 2023, the Company&#x2019;s shareholders
approved an amendment to its amended and restated memorandum and articles of association to extend the date by which the Company must
complete a Business Combination from March 2, 2023 to June 2, 2023, and to thereafter further extend such period up to three times by
an additional one month each time (up to September 2, 2023) (such period, as may be extended, the &#x201c;Combination Period&#x201d;). However,
if the Company is unable to complete a Business Combination within the Combination Period, the Company will redeem&#160;100% of the outstanding
public shares for a pro rata portion of the funds held in the Trust Account, equal to the aggregate amount then on deposit in the Trust
Account including interest earned on the funds held in the Trust Account and not previously released to the Company, divided by the number
of then outstanding public shares, subject to applicable law and as further described in the registration statement, and then seek to
dissolve and liquidate.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company&#x2019;s Sponsor, officers and directors
have agreed to (i) waive their redemption rights with respect to their founder shares, private placement shares and public shares in connection
with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their founder shares and public
shares in connection with a shareholder vote to approve an amendment to the Company&#x2019;s amended and restated certificate of incorporation,
and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares and private placement
shares if the Company fails to complete the initial Business Combination within the Combination Period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company&#x2019;s Sponsor has agreed that it
will be liable to the Company if and to the extent any claims by a third-party for services rendered or products sold to the Company,
or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement
or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00&#160;per public share
and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less
than $10.00&#160;per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not
apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in
the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#x2019;s indemnity of the
underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#x201c;Securities
Act&#x201d;). However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently
verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Company&#x2019;s Sponsor&#x2019;s
only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Liquidity&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;As of December 31, 2022, the Company had cash outside the Trust Account
of $72,923 available for working capital needs. All remaining cash held in the Trust Account is generally unavailable for the Company&#x2019;s
use prior to an initial Business Combination and is restricted for use either in a Business Combination or to redeem ordinary shares.
The Company may elect to withdraw from the interest income earned on the trust account to pay the Company&#x2019;s tax obligations. As
of December 31, 2022, the Company had interest income earned on the trust account of $4,821,632.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company may raise additional capital through
loans or additional investments from the Sponsor or an affiliate of the Sponsor or certain of its directors and officers. The Sponsor
may, but is not obligated to, lend the Company funds, from time to time in whatever amounts it deems reasonable in its sole discretion,
to meet the Company&#x2019;s working capital needs. There can be no assurance that the Company will be able to obtain additional financing,
however. Moreover, the Company may need to obtain additional financing either to complete its Business Combination or because the Company
becomes obligated to redeem a significant number of its public shares upon consummation of its Business Combination, in which case the
Company may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable
securities laws, the Company would only complete such financing simultaneously with the completion of its Business Combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;If the Company is unable to raise additional capital,
it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing
operations, suspending the pursuit of a potential transaction and reducing overhead expenses. The Company cannot provide any assurance
that new financing will be available to it on commercially acceptable terms, if at all.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Going Concern&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;In connection with the Company&#x2019;s
assessment of going concern considerations in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 205-40, &#x201c;Presentation of Financial Statements &#x2013; Going Concern,&#x201d; pursuant to its Amended and Restated Certificate of Incorporation, the
Company has until the end of the Combination Period to consummate a Business Combination. If a Business Combination is not
consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Although the Company
intends to consummate a Business Combination during the Combination Period, it is uncertain that the Company will be able to do so.
This, as well as its liquidity condition, raise substantial doubt about the Company&#x2019;s ability to continue as a going concern.
No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate at the
end of the Combination Period.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Risks and Uncertainties&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Management is currently evaluating the
impact of the COVID-19 pandemic and Russia-Ukraine war and has concluded that while it is reasonably possible that the virus and war
could have a negative effect on the Company&#x2019;s financial position, results of its operations and/or search for a target
company, the specific impact is not readily determinable as of the date of these financial statements. The consolidated financial
statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Consideration of IR Act Excise Tax&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On August 16, 2022, the Inflation Reduction Act
of 2022 (the &#x201c;IR Act&#x201d;) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise
tax on certain repurchases of stock by publicly-traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly-traded
foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its
shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased
at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the
fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition,
certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the &#x201c;Treasury&#x201d;) has been given authority
to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Any redemption or other repurchase that occurs
after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether
and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise
would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business
Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any &#x201c;PIPE&#x201d;
or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination
but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury.
In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment
of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business
Combination and in the Company&#x2019;s ability to complete a Business Combination.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c34" decimals="0" unitRef="shares">34500000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare contextRef="c35" decimals="2" unitRef="usdPershares">10</us-gaap:SaleOfStockPricePerShare>
    <fact:GeneratingGrossProceeds contextRef="c36" decimals="0" unitRef="usd">345000000</fact:GeneratingGrossProceeds>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c37" decimals="0" unitRef="shares">6266667</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare contextRef="c38" decimals="2" unitRef="usdPershares">1.5</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts contextRef="c39" decimals="0" unitRef="usd">19175922</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:OtherUnderwritingExpense contextRef="c0" decimals="0" unitRef="usd">6405000</us-gaap:OtherUnderwritingExpense>
    <fact:DeferredUnderwritingFee contextRef="c0" decimals="0" unitRef="usd">12075000</fact:DeferredUnderwritingFee>
    <us-gaap:OtherOwnershipInterestsOfferingCosts contextRef="c4" decimals="0" unitRef="usd">695922</us-gaap:OtherOwnershipInterestsOfferingCosts>
    <fact:TotalTransactionCost contextRef="c0" decimals="0" unitRef="usd">575278</fact:TotalTransactionCost>
    <fact:NetProceedsOfTheSaleOfTheUnits contextRef="c36" decimals="0" unitRef="usd">345000000</fact:NetProceedsOfTheSaleOfTheUnits>
    <fact:BusinessCombinationFairMarketValueEqualPercentage contextRef="c40" decimals="2" unitRef="pure">0.80</fact:BusinessCombinationFairMarketValueEqualPercentage>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c39" decimals="2" unitRef="pure">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionSharePrice contextRef="c39" decimals="2" unitRef="usdPershares">10</us-gaap:BusinessAcquisitionSharePrice>
    <fact:NetTangibleAssets contextRef="c0" decimals="0" unitRef="usd">5000001</fact:NetTangibleAssets>
    <fact:RedeemPublicSharesPercentage contextRef="c0" decimals="2" unitRef="pure">1</fact:RedeemPublicSharesPercentage>
    <fact:PublicPerShare contextRef="c4" decimals="2" unitRef="usdPershares">10</fact:PublicPerShare>
    <fact:TrustAccountPerShare contextRef="c4" decimals="2" unitRef="usdPershares">10</fact:TrustAccountPerShare>
    <us-gaap:AssetsHeldInTrust contextRef="c4" decimals="0" unitRef="usd">72923</us-gaap:AssetsHeldInTrust>
    <us-gaap:InvestmentIncomeInterest contextRef="c0" decimals="0" unitRef="usd">4821632</us-gaap:InvestmentIncomeInterest>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c41" decimals="2" unitRef="pure">0.01</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c0" decimals="2" unitRef="pure">0.01</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <srt:CondensedFinancialStatementsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 2 &#x2014; Revision of Previously-Issued Financial Statements&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;In connection with the preparation of the Company&#x2019;s financial statements
as of December 31, 2022, the Company identified an error in amounts reported in certain of the Company&#x2019;s previously-issued financial
statements related to accounts payable. The Company incorrectly recorded intercompany operating bank transfers as payables whereas Legal
and Professional Services was the accompanying debit in each transaction recorded. As a result, management determined that accounts payable
and operational costs as of June 30, 2022 and September 30, 2022 were overstated by $205,869.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The following tables contain the revised financial information for
the affected periods previously reported. The revisions do not have an impact on the Company&#x2019;s cash position and investments held
in the Trust Account established in connection with the Initial Public Offering. The Company has not amended its previously filed Quarterly
Reports on Form 10-Q for the two quarterly periods in 2022. The financial information that has been previously filed or otherwise reported
for these affected periods are superseded by the information below in this Annual Report on Form 10-K.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The impact of the revision on the Company&#x2019;s financial statements
is reflected in the following tables:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Revised&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;Balance Sheet as of June 30, 2022 (unaudited)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left"&gt;Total Liabilities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;19,737,596&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(205,869&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;19,531,727&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Total Shareholders&#x2019; Equity (Deficit)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,781,440&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,575,571&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;Balance Sheet as of September 30, 2022 (unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Total Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;17,298,967&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;17,093,098&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Total Shareholders&#x2019; Equity (Deficit)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(16,803,964&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(16,598,095&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; font-weight: bold; width: 64%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As Previously&lt;br/&gt;
 Reported&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjusted&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As Revised&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;Condensed Statement of Operations for the Three Months
    Ended June 30, 2022 (unaudited)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Operational Costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;824,081&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;618,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,025,986&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,231,855&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-73; -sec-ix-hidden: hidden-fact-72; -sec-ix-hidden: hidden-fact-71"&gt;Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-70"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-77; -sec-ix-hidden: hidden-fact-76; -sec-ix-hidden: hidden-fact-75"&gt;Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-74"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Condensed Statement of Operations for the Six Months Ended June 30, 2022 (unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Operational Costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,022,164&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,816,295&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,321,266&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,527,135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-81; -sec-ix-hidden: hidden-fact-80; -sec-ix-hidden: hidden-fact-79"&gt;Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-78"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-85; -sec-ix-hidden: hidden-fact-84; -sec-ix-hidden: hidden-fact-83"&gt;Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-82"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;Condensed Statement of Operations for the Nine Months Ended September 30, 2022 (unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Operational Costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,508,476&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,302,607&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,726,111&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,931,980&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-89; -sec-ix-hidden: hidden-fact-88; -sec-ix-hidden: hidden-fact-87"&gt;Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-86"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-93; -sec-ix-hidden: hidden-fact-92; -sec-ix-hidden: hidden-fact-91"&gt;Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-90"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; width: 64%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As Previously&lt;br/&gt;
 Reported&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjusted&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As Revised&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;Condensed Statement of Cash Flows for the Six Months
    Ended June 30, 2022 (unaudited)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,321,266&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,527,135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Accounts payable and accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;884,539&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;678,670&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;Condensed Statement of Cash Flows for the Nine Months Ended September 30, 2022 (unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,726,111&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,931,980&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Accounts payable and accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;226,411&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;20,542&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</srt:CondensedFinancialStatementsTextBlock>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c1" decimals="0" unitRef="usd">205869</us-gaap:AccountsPayableOtherCurrent>
    <fact:OperationalCosts contextRef="c42" decimals="0" unitRef="usd">205869</fact:OperationalCosts>
    <srt:ScheduleOfCondensedFinancialStatementsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Revised&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;Balance Sheet as of June 30, 2022 (unaudited)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left"&gt;Total Liabilities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;19,737,596&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(205,869&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;19,531,727&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Total Shareholders&#x2019; Equity (Deficit)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,781,440&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,575,571&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;Balance Sheet as of September 30, 2022 (unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Total Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;17,298,967&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;17,093,098&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Total Shareholders&#x2019; Equity (Deficit)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(16,803,964&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(16,598,095&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;</srt:ScheduleOfCondensedFinancialStatementsTableTextBlock>
    <us-gaap:Liabilities contextRef="c43" decimals="0" unitRef="usd">19737596</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c44" decimals="0" unitRef="usd">-205869</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c45" decimals="0" unitRef="usd">19531727</us-gaap:Liabilities>
    <us-gaap:StockholdersEquity contextRef="c43" decimals="0" unitRef="usd">-18781440</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c44" decimals="0" unitRef="usd">205869</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c45" decimals="0" unitRef="usd">-18575571</us-gaap:StockholdersEquity>
    <us-gaap:Liabilities contextRef="c46" decimals="0" unitRef="usd">17298967</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c47" decimals="0" unitRef="usd">-205869</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c48" decimals="0" unitRef="usd">17093098</us-gaap:Liabilities>
    <us-gaap:StockholdersEquity contextRef="c46" decimals="0" unitRef="usd">-16803964</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c47" decimals="0" unitRef="usd">205869</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c48" decimals="0" unitRef="usd">-16598095</us-gaap:StockholdersEquity>
    <srt:ScheduleOfCondensedIncomeStatementTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; font-weight: bold; width: 64%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As Previously&lt;br/&gt;
 Reported&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjusted&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As Revised&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;Condensed Statement of Operations for the Three Months
    Ended June 30, 2022 (unaudited)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Operational Costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;824,081&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;618,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,025,986&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,231,855&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-73; -sec-ix-hidden: hidden-fact-72; -sec-ix-hidden: hidden-fact-71"&gt;Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-70"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-77; -sec-ix-hidden: hidden-fact-76; -sec-ix-hidden: hidden-fact-75"&gt;Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-74"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Condensed Statement of Operations for the Six Months Ended June 30, 2022 (unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Operational Costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,022,164&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,816,295&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,321,266&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,527,135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-81; -sec-ix-hidden: hidden-fact-80; -sec-ix-hidden: hidden-fact-79"&gt;Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-78"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-85; -sec-ix-hidden: hidden-fact-84; -sec-ix-hidden: hidden-fact-83"&gt;Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-82"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;Condensed Statement of Operations for the Nine Months Ended September 30, 2022 (unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Operational Costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,508,476&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,302,607&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,726,111&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,931,980&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-89; -sec-ix-hidden: hidden-fact-88; -sec-ix-hidden: hidden-fact-87"&gt;Basic and Diluted Net Income (Loss) per shares, Class A Ordinary Shares&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-86"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-93; -sec-ix-hidden: hidden-fact-92; -sec-ix-hidden: hidden-fact-91"&gt;Basic and Diluted Net Income (Loss) per shares, Class B Ordinary Shares&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-90"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;</srt:ScheduleOfCondensedIncomeStatementTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c49" decimals="0" unitRef="usd">824081</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c50" decimals="0" unitRef="usd">-205869</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c51" decimals="0" unitRef="usd">618212</us-gaap:OperatingLeaseCost>
    <us-gaap:NetIncomeLoss contextRef="c49" decimals="0" unitRef="usd">2025986</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c50" decimals="0" unitRef="usd">205869</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c51" decimals="0" unitRef="usd">2231855</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic contextRef="c52" decimals="2" unitRef="usdPershares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c54" decimals="2" unitRef="usdPershares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c55" decimals="2" unitRef="usdPershares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c57" decimals="2" unitRef="usdPershares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:OperatingLeaseCost contextRef="c58" decimals="0" unitRef="usd">2022164</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c59" decimals="0" unitRef="usd">-205869</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c60" decimals="0" unitRef="usd">1816295</us-gaap:OperatingLeaseCost>
    <us-gaap:NetIncomeLoss contextRef="c58" decimals="0" unitRef="usd">3321266</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c59" decimals="0" unitRef="usd">205869</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c60" decimals="0" unitRef="usd">3527135</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic contextRef="c61" decimals="2" unitRef="usdPershares">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c63" decimals="2" unitRef="usdPershares">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c64" decimals="2" unitRef="usdPershares">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c66" decimals="2" unitRef="usdPershares">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:OperatingLeaseCost contextRef="c67" decimals="0" unitRef="usd">2508476</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c68" decimals="0" unitRef="usd">-205869</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c69" decimals="0" unitRef="usd">2302607</us-gaap:OperatingLeaseCost>
    <us-gaap:NetIncomeLoss contextRef="c67" decimals="0" unitRef="usd">6726111</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c68" decimals="0" unitRef="usd">205869</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c69" decimals="0" unitRef="usd">6931980</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic contextRef="c70" decimals="2" unitRef="usdPershares">0.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c72" decimals="2" unitRef="usdPershares">0.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c73" decimals="2" unitRef="usdPershares">0.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c75" decimals="2" unitRef="usdPershares">0.16</us-gaap:EarningsPerShareBasic>
    <srt:ScheduleOfCondensedCashFlowStatementTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; width: 64%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As Previously&lt;br/&gt;
 Reported&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjusted&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 9%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As Revised&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;b&gt;Condensed Statement of Cash Flows for the Six Months
    Ended June 30, 2022 (unaudited)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,321,266&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,527,135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Accounts payable and accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;884,539&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;678,670&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;Condensed Statement of Cash Flows for the Nine Months Ended September 30, 2022 (unaudited)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,726,111&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,931,980&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Accounts payable and accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;226,411&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(205,869&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;20,542&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</srt:ScheduleOfCondensedCashFlowStatementTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c58" decimals="0" unitRef="usd">3321266</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c59" decimals="0" unitRef="usd">205869</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c60" decimals="0" unitRef="usd">3527135</us-gaap:NetIncomeLoss>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c43" decimals="0" unitRef="usd">884539</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c44" decimals="0" unitRef="usd">-205869</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c45" decimals="0" unitRef="usd">678670</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:NetIncomeLoss contextRef="c67" decimals="0" unitRef="usd">6726111</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c68" decimals="0" unitRef="usd">205869</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c69" decimals="0" unitRef="usd">6931980</us-gaap:NetIncomeLoss>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c46" decimals="0" unitRef="usd">226411</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c47" decimals="0" unitRef="usd">-205869</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c48" decimals="0" unitRef="usd">20542</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Note 3 &#x2014; Significant Accounting Policies&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Basis of Presentation&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The accompanying financial statements are presented
in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and pursuant to the rules
and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;).&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The accompanying consolidated financial
statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions
have been eliminated in consolidation.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Emerging Growth Company&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company is an &#x201c;emerging growth company,&#x201d;
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the &#x201c;JOBS Act&#x201d;),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements
of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and
proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder
approval of any golden parachute payments not previously approved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Further, Section 102(b)(1) of the JOBS Act exempts emerging growth
companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that
have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange
Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to
opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election
to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard
is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company,
can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the
Company&#x2019;s&#160;consolidated financial statements with another public company which is neither an emerging growth company nor an
emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences
in accounting standards used.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Use of Estimates&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The preparation of&#160;the&#160;consolidated financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the&#160;consolidated financial statements and the reported amounts
of expenses during the reporting period. Actual results could differ from those estimates.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Estimates made in preparing these consolidated financial statements
include, among other things, the fair value measurement of the Private Warrant liabilities.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Cash and Cash Equivalents&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents.&#160;The Company did not have any cash equivalents
as of December 31, 2022 and 2021.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Investments Held in Trust Account&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;At December 31, 2022, the assets held in the Trust Account were held in a money market fund with a maturity of 180 days or less. At December 31, 2021, the assets held in the Trust Account
were held in cash and U.S. Treasury securities. The Company classifies its United States Treasury securities as&#160;held-to-maturity&#160;in
accordance with Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC Topic 320, &#x201c;Investments&#x2014;Debt and Equity Securities.&#x201d;&#160;Held-to-maturity&#160;securities
are those securities which the Company has the ability and intent to hold until maturity.&#160;Held-to-maturity&#160;treasury securities
are recorded at amortized cost and adjusted for the amortization or remeasurement of premiums or discounts.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;As of December 31, 2022, investment in the
Company&#x2019;s Trust Account consisted of $349,927,313 in a money market fund with a maturity of 180 days or less. Following the
maturity of the U.S. Treasury Securities on December 1, 2022, the Company immediately reinvested the entirety of the Trust Account
into a money market fund. The money market fund is disclosed at fair value on the consolidated balance sheet. As of December 31,
2021, investment in the Company&#x2019;s Trust Account consisted of $484&#160;in cash and $345,105,197&#160;in U.S. Treasury
Securities. All of the U.S. Treasury Securities (the &#x201c;T-bills&#x201d;) matured on March 3, 2022 and the Company purchased new
T-bills. The Company considers all investments with original maturities of more than three months but less than one year to be
short-term investments. The carrying value approximates the fair value due to its short-term maturity. The carrying value, excluding
gross unrealized holding losses and fair value of held to maturity securities on December 31, 2022 and 2021 are as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair Value&lt;br/&gt; as of&lt;br/&gt; December&#160;31,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Cash&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-94"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 88%; text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Money Market Funds&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amortized&lt;br/&gt; Cost&#160;and&lt;br/&gt; Carrying&lt;br/&gt; Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Unrealized&lt;br/&gt; Gains&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Unrealized&lt;br/&gt; Losses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair Value&lt;br/&gt; as&#160;of&lt;br/&gt; December&#160;31,&lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-95"&gt;&#160;&#160;&#160;&#160;&#160;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-96"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;U.S. Treasury Securities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;345,105,197&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-97"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,065&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;345,099,132&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;345,105,681&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-98"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(6,065&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;345,099,616&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;A decline in the market value of held-to-maturity securities below
cost that is deemed to be other than temporary results in an impairment that reduces the carrying costs to such securities&#x2019; fair
value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment
is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery
and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered
in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent
to&#160;year-end,&#160;forecasted performance of the investee, and the general market condition in the geographic area or industry the
investee operates in.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Premiums and discounts are amortized or accreted
over the life of the related&#160;held-to-maturity&#160;security as an adjustment to yield using the effective-interest method. Such amortization
and remeasurement are included in the &#x201c;interest income&#x201d; line item in the statements of operations. Interest income is recognized
when earned.&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Convertible Promissory Notes&#x2014;Related Party&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company accounts for its convertible promissory notes under ASC
815, &#x201c;Derivatives and Hedging&#x201d; (&#x201c;ASC 815&#x201d;). Under ASC 815-15-25, the election can be at the inception of a financial
instrument to account for the instrument under the fair value option under ASC 825. The Company has made such election for its convertible
promissory notes. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value
on the date of issuance, each drawdown date, and each balance sheet date thereafter. Differences between the face value of the note and
fair value at each drawdown date are recognized as either an expense in the consolidated statements of operations (if issued at a premium)
or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as non-cash gains
or losses in the consolidated statements of operations. Changes in the estimated fair value of the note are recognized as non-cash change
in the fair value of the convertible promissory notes in the consolidated statements of operations.&#160;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Concentration of Credit Risk&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal
Depository Insurance Coverage of&#x2009;$250,000. At December 31, 2022 and 2021, the Company has not experienced losses on this account.&#160;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Ordinary Shares Subject to Possible Redemption&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company accounts for its Class A ordinary shares subject to possible
redemption in accordance with the guidance in ASC Topic 480, &#x201c;Distinguishing Liabilities from Equity.&#x201d; Class A ordinary shares
subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable
ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject
to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) are classified as temporary equity.
At all other times, ordinary shares are classified as shareholders&#x2019; deficit. The Company&#x2019;s ordinary shares feature certain
redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence of uncertain future events.
Accordingly, as of December 31, 2022 and 2021,&#160;34,500,000&#160;Class A ordinary shares subject to possible redemption are presented
at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s consolidated balance
sheets, respectively.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Net Income Per Ordinary Share&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company has two classes of shares, which are referred to as Class
A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The&#160;14,891,667&#160;potential
ordinary shares for outstanding warrants to purchase the Company&#x2019;s shares were excluded from diluted earnings per share for the
years ended December 31, 2022 and 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met.
As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods presented. The table
below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class
of ordinary share:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;For the Years Ended&lt;br/&gt; December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class A&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class B&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class A&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class B&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Basic and diluted net income per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Allocation of net income&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;4,785,872&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;1,196,468&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;3,967,193&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;1,161,457&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;34,500,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,625,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;28,828,767&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,440,068&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Basic and diluted net income per share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Offering Costs&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company complies with the requirements
of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic 5A - &#x201c;Expenses of Offering&#x201d;.
Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to
the Public Offering and that were charged to temporary equity upon the completion of the IPO. Accordingly, on December 31, 2022,
offering costs totaling $19,175,922&#160;have been charged to temporary equity (consisting of $6,405,000&#160;of underwriting fees,
$12,075,000&#160;of deferred underwriting fees and $695,922&#160;of other offering costs). Of the total transaction cost,
$575,278&#160;was recorded as a non-operating expense in the consolidated statements of operations, with the rest of the offering
cost charged to temporary equity. The transaction costs were allocated based on the relative fair value basis, compared to the total
offering proceeds, between the fair value of the public warrant liabilities and the Class A ordinary shares. As of October 25, 2022,
and November 2, 2022, respectively, J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. have waived their portions of the
deferred underwriting fee which is reflected in the consolidated statement of operations and the consolidated statement of changes
in shareholders&#x2019; deficit as a reduction of transaction costs incurred in connection with IPO. Therefore, the deferred underwriting fee was
reduced by $9,056,250, of which $271,687 is shown in the consolidated statement of operations as a reduction of transaction
costs incurred in connection with the IPO and $8,784,563 is charged to additional paid-in capital in the consolidated statement of changes in shareholders&#x2019; deficit. As a result of the reductions, the outstanding deferred underwriting fee payable was reduced to
$3,018,750.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Fair Value of Financial Instruments&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The fair value of the Company&#x2019;s assets and liabilities, which
qualify as financial instruments under the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC 820, &#x201c;Fair Value Measurements
and Disclosures,&#x201d; approximates the carrying amounts represented in the consolidated balance sheets.&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Derivative Warrant Liabilities&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company does not use derivative instruments
to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including
issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives,
pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded
as liabilities or as equity, is re-assessed at the end of each reporting period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company accounts for its&#160;14,891,667&#160;ordinary shares warrants
issued in connection with its Initial Public Offering (8,625,000) and Private Placement (6,266,667) as derivative warrant liabilities
in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the
instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised,
and any change in fair value is recognized in the Company&#x2019;s consolidated statements of operations. The fair value of the Private
Placement Warrants has been estimated using Monte Carlo simulations at each measurement date. The fair value of the Public Warrants was
initially estimated using Monte Carlo simulations. After the Public Warrants were separately traded, the measurement of the Public Warrants
used an observable market quote in an active market.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Income Taxes&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company follows the asset and liability method
of accounting for income taxes under ASC 740, &#x201c;Income Taxes.&#x201d; Deferred tax assets and liabilities are recognized for the estimated
future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities
and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are
established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;ASC 740 prescribes a recognition threshold and
a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax
return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized
tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and December 31, 2021. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The
Company is subject to income tax examinations by major taxing authorities since inception.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;There is currently no taxation imposed on income
by the Government of the Cayman Islands. In accordance with federal income tax regulations, income taxes are not levied on the Company,
but rather on the individual owners. United States (&#x201c;U.S.&#x201d;) taxation would occur on the individual owners if certain tax elections
are made by U.S. owners and the Company were treated as a passive foreign investment company. The Company believes that it was a passive
foreign investment company for the 2021 and 2022 taxable years. Additionally, U.S. taxation could occur to the Company itself if the Company
is engaged in a U.S. trade or business. The Company is not expected to be treated as engaged in a U.S. trade or business at this time.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Recent Accounting Standards&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;In August 2020, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;)
2020-06, &#x201c;Debt &#x2014; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2014; Contracts in
Entity&#x2019;s Own Equity (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;)&#x201d; to simplify accounting for certain financial instruments.
ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible
instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#x2019;s
own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed
to and settled in an entity&#x2019;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement
to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be applied on a full
or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The guidance was adopted starting January
1, 2022. Adoption of the ASU did not impact the Company&#x2019;s financial position, results of operations or cash flows.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Management does not believe that any recently
issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s&#160;financial
statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Basis of Presentation&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The accompanying financial statements are presented
in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and pursuant to the rules
and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;).&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The accompanying consolidated financial
statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions
have been eliminated in consolidation.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <fact:EmergingGrowthCompanyStatusPolicyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Emerging Growth Company&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company is an &#x201c;emerging growth company,&#x201d;
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the &#x201c;JOBS Act&#x201d;),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements
of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and
proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder
approval of any golden parachute payments not previously approved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Further, Section 102(b)(1) of the JOBS Act exempts emerging growth
companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that
have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange
Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to
opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election
to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard
is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company,
can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the
Company&#x2019;s&#160;consolidated financial statements with another public company which is neither an emerging growth company nor an
emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences
in accounting standards used.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</fact:EmergingGrowthCompanyStatusPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Use of Estimates&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The preparation of&#160;the&#160;consolidated financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the&#160;consolidated financial statements and the reported amounts
of expenses during the reporting period. Actual results could differ from those estimates.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Estimates made in preparing these consolidated financial statements
include, among other things, the fair value measurement of the Private Warrant liabilities.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Cash and Cash Equivalents&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents.&#160;The Company did not have any cash equivalents
as of December 31, 2022 and 2021.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Investments Held in Trust Account&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;At December 31, 2022, the assets held in the Trust Account were held in a money market fund with a maturity of 180 days or less. At December 31, 2021, the assets held in the Trust Account
were held in cash and U.S. Treasury securities. The Company classifies its United States Treasury securities as&#160;held-to-maturity&#160;in
accordance with Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC Topic 320, &#x201c;Investments&#x2014;Debt and Equity Securities.&#x201d;&#160;Held-to-maturity&#160;securities
are those securities which the Company has the ability and intent to hold until maturity.&#160;Held-to-maturity&#160;treasury securities
are recorded at amortized cost and adjusted for the amortization or remeasurement of premiums or discounts.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;As of December 31, 2022, investment in the
Company&#x2019;s Trust Account consisted of $349,927,313 in a money market fund with a maturity of 180 days or less. Following the
maturity of the U.S. Treasury Securities on December 1, 2022, the Company immediately reinvested the entirety of the Trust Account
into a money market fund. The money market fund is disclosed at fair value on the consolidated balance sheet. As of December 31,
2021, investment in the Company&#x2019;s Trust Account consisted of $484&#160;in cash and $345,105,197&#160;in U.S. Treasury
Securities. All of the U.S. Treasury Securities (the &#x201c;T-bills&#x201d;) matured on March 3, 2022 and the Company purchased new
T-bills. The Company considers all investments with original maturities of more than three months but less than one year to be
short-term investments. The carrying value approximates the fair value due to its short-term maturity. The carrying value, excluding
gross unrealized holding losses and fair value of held to maturity securities on December 31, 2022 and 2021 are as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair Value&lt;br/&gt; as of&lt;br/&gt; December&#160;31,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Cash&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-94"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 88%; text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Money Market Funds&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amortized&lt;br/&gt; Cost&#160;and&lt;br/&gt; Carrying&lt;br/&gt; Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Unrealized&lt;br/&gt; Gains&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Unrealized&lt;br/&gt; Losses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair Value&lt;br/&gt; as&#160;of&lt;br/&gt; December&#160;31,&lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-95"&gt;&#160;&#160;&#160;&#160;&#160;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-96"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;U.S. Treasury Securities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;345,105,197&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-97"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,065&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;345,099,132&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;345,105,681&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-98"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(6,065&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;345,099,616&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;A decline in the market value of held-to-maturity securities below
cost that is deemed to be other than temporary results in an impairment that reduces the carrying costs to such securities&#x2019; fair
value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment
is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery
and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered
in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent
to&#160;year-end,&#160;forecasted performance of the investee, and the general market condition in the geographic area or industry the
investee operates in.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Premiums and discounts are amortized or accreted
over the life of the related&#160;held-to-maturity&#160;security as an adjustment to yield using the effective-interest method. Such amortization
and remeasurement are included in the &#x201c;interest income&#x201d; line item in the statements of operations. Interest income is recognized
when earned.&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:Cash contextRef="c4" decimals="0" unitRef="usd">349927313</us-gaap:Cash>
    <us-gaap:Cash contextRef="c5" decimals="0" unitRef="usd">484</us-gaap:Cash>
    <us-gaap:Cash contextRef="c76" decimals="0" unitRef="usd">345105197</us-gaap:Cash>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair Value&lt;br/&gt; as of&lt;br/&gt; December&#160;31,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Cash&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-94"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 88%; text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Money Market Funds&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amortized&lt;br/&gt; Cost&#160;and&lt;br/&gt; Carrying&lt;br/&gt; Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Unrealized&lt;br/&gt; Gains&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br/&gt; Unrealized&lt;br/&gt; Losses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair Value&lt;br/&gt; as&#160;of&lt;br/&gt; December&#160;31,&lt;br/&gt; 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-95"&gt;&#160;&#160;&#160;&#160;&#160;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-96"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;U.S. Treasury Securities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;345,105,197&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-97"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,065&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;345,099,132&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;345,105,681&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-98"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(6,065&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;345,099,616&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <fact:TradingSecuritiesFairValue contextRef="c80" decimals="0" unitRef="usd">349927313</fact:TradingSecuritiesFairValue>
    <fact:TradingSecuritiesFairValue contextRef="c4" decimals="0" unitRef="usd">349927313</fact:TradingSecuritiesFairValue>
    <fact:AmortizedCostAndCarryingValue contextRef="c81" decimals="0" unitRef="usd">484</fact:AmortizedCostAndCarryingValue>
    <fact:TradingSecuritiesFairValue contextRef="c81" decimals="0" unitRef="usd">484</fact:TradingSecuritiesFairValue>
    <fact:AmortizedCostAndCarryingValue contextRef="c76" decimals="0" unitRef="usd">345105197</fact:AmortizedCostAndCarryingValue>
    <fact:GrossUnrealizedGainsAndLosses contextRef="c83" decimals="0" unitRef="usd">-6065</fact:GrossUnrealizedGainsAndLosses>
    <fact:TradingSecuritiesFairValue contextRef="c76" decimals="0" unitRef="usd">345099132</fact:TradingSecuritiesFairValue>
    <fact:AmortizedCostAndCarryingValue contextRef="c5" decimals="0" unitRef="usd">345105681</fact:AmortizedCostAndCarryingValue>
    <fact:GrossUnrealizedGainsAndLosses contextRef="c8" decimals="0" unitRef="usd">-6065</fact:GrossUnrealizedGainsAndLosses>
    <fact:TradingSecuritiesFairValue contextRef="c5" decimals="0" unitRef="usd">345099616</fact:TradingSecuritiesFairValue>
    <fact:ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Convertible Promissory Notes&#x2014;Related Party&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company accounts for its convertible promissory notes under ASC
815, &#x201c;Derivatives and Hedging&#x201d; (&#x201c;ASC 815&#x201d;). Under ASC 815-15-25, the election can be at the inception of a financial
instrument to account for the instrument under the fair value option under ASC 825. The Company has made such election for its convertible
promissory notes. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value
on the date of issuance, each drawdown date, and each balance sheet date thereafter. Differences between the face value of the note and
fair value at each drawdown date are recognized as either an expense in the consolidated statements of operations (if issued at a premium)
or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as non-cash gains
or losses in the consolidated statements of operations. Changes in the estimated fair value of the note are recognized as non-cash change
in the fair value of the convertible promissory notes in the consolidated statements of operations.&#160;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</fact:ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Concentration of Credit Risk&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal
Depository Insurance Coverage of&#x2009;$250,000. At December 31, 2022 and 2021, the Company has not experienced losses on this account.&#160;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount contextRef="c4" decimals="0" unitRef="usd">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Ordinary Shares Subject to Possible Redemption&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company accounts for its Class A ordinary shares subject to possible
redemption in accordance with the guidance in ASC Topic 480, &#x201c;Distinguishing Liabilities from Equity.&#x201d; Class A ordinary shares
subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable
ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject
to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) are classified as temporary equity.
At all other times, ordinary shares are classified as shareholders&#x2019; deficit. The Company&#x2019;s ordinary shares feature certain
redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence of uncertain future events.
Accordingly, as of December 31, 2022 and 2021,&#160;34,500,000&#160;Class A ordinary shares subject to possible redemption are presented
at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s consolidated balance
sheets, respectively.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <fact:OrdinarySharesSubjectToPossibleRedemption contextRef="c2" decimals="0" unitRef="shares">34500000</fact:OrdinarySharesSubjectToPossibleRedemption>
    <fact:OrdinarySharesSubjectToPossibleRedemption contextRef="c6" decimals="0" unitRef="shares">34500000</fact:OrdinarySharesSubjectToPossibleRedemption>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Net Income Per Ordinary Share&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company has two classes of shares, which are referred to as Class
A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The&#160;14,891,667&#160;potential
ordinary shares for outstanding warrants to purchase the Company&#x2019;s shares were excluded from diluted earnings per share for the
years ended December 31, 2022 and 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met.
As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods presented. The table
below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class
of ordinary share:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;For the Years Ended&lt;br/&gt; December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class A&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class B&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class A&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class B&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Basic and diluted net income per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Allocation of net income&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;4,785,872&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;1,196,468&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;3,967,193&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;1,161,457&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;34,500,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,625,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;28,828,767&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,440,068&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Basic and diluted net income per share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <fact:WarrantsPurchase contextRef="c0" decimals="0" unitRef="shares">14891667</fact:WarrantsPurchase>
    <fact:WarrantsPurchase contextRef="c8" decimals="0" unitRef="shares">14891667</fact:WarrantsPurchase>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;For the Years Ended&lt;br/&gt; December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class A&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class B&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class A&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Class B&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Basic and diluted net income per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Allocation of net income&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;4,785,872&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;1,196,468&lt;/p&gt;
&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;3,967,193&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;1,161,457&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;34,500,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,625,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;28,828,767&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,440,068&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Basic and diluted net income per share&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <fact:AllocationOfNetIncome contextRef="c9" decimals="0" unitRef="usd">4785872</fact:AllocationOfNetIncome>
    <fact:AllocationOfNetIncome contextRef="c11" decimals="0" unitRef="usd">1196468</fact:AllocationOfNetIncome>
    <fact:AllocationOfNetIncome contextRef="c10" decimals="0" unitRef="usd">3967193</fact:AllocationOfNetIncome>
    <fact:AllocationOfNetIncome contextRef="c12" decimals="0" unitRef="usd">1161457</fact:AllocationOfNetIncome>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c9" decimals="INF" unitRef="shares">34500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c11" decimals="INF" unitRef="shares">8625000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c10" decimals="INF" unitRef="shares">28828767</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c12" decimals="INF" unitRef="shares">8440068</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c9" decimals="2" unitRef="usdPershares">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c11" decimals="2" unitRef="usdPershares">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c10" decimals="2" unitRef="usdPershares">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c12" decimals="2" unitRef="usdPershares">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Offering Costs&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company complies with the requirements
of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic 5A - &#x201c;Expenses of Offering&#x201d;.
Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to
the Public Offering and that were charged to temporary equity upon the completion of the IPO. Accordingly, on December 31, 2022,
offering costs totaling $19,175,922&#160;have been charged to temporary equity (consisting of $6,405,000&#160;of underwriting fees,
$12,075,000&#160;of deferred underwriting fees and $695,922&#160;of other offering costs). Of the total transaction cost,
$575,278&#160;was recorded as a non-operating expense in the consolidated statements of operations, with the rest of the offering
cost charged to temporary equity. The transaction costs were allocated based on the relative fair value basis, compared to the total
offering proceeds, between the fair value of the public warrant liabilities and the Class A ordinary shares. As of October 25, 2022,
and November 2, 2022, respectively, J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. have waived their portions of the
deferred underwriting fee which is reflected in the consolidated statement of operations and the consolidated statement of changes
in shareholders&#x2019; deficit as a reduction of transaction costs incurred in connection with IPO. Therefore, the deferred underwriting fee was
reduced by $9,056,250, of which $271,687 is shown in the consolidated statement of operations as a reduction of transaction
costs incurred in connection with the IPO and $8,784,563 is charged to additional paid-in capital in the consolidated statement of changes in shareholders&#x2019; deficit. As a result of the reductions, the outstanding deferred underwriting fee payable was reduced to
$3,018,750.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredOfferingCosts contextRef="c4" decimals="0" unitRef="usd">19175922</us-gaap:DeferredOfferingCosts>
    <us-gaap:OtherUnderwritingExpense contextRef="c0" decimals="0" unitRef="usd">6405000</us-gaap:OtherUnderwritingExpense>
    <fact:DeferredUnderwritingFee contextRef="c0" decimals="0" unitRef="usd">12075000</fact:DeferredUnderwritingFee>
    <us-gaap:OtherOwnershipInterestsOfferingCosts contextRef="c4" decimals="0" unitRef="usd">695922</us-gaap:OtherOwnershipInterestsOfferingCosts>
    <fact:TotalTransactionCost contextRef="c0" decimals="0" unitRef="usd">575278</fact:TotalTransactionCost>
    <us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees contextRef="c0" decimals="0" unitRef="usd">9056250</us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees>
    <fact:PartialReversalOfTransactionCosts contextRef="c0" decimals="0" unitRef="usd">271687</fact:PartialReversalOfTransactionCosts>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c0" decimals="0" unitRef="usd">8784563</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent contextRef="c4" decimals="0" unitRef="usd">3018750</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Fair Value of Financial Instruments&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The fair value of the Company&#x2019;s assets and liabilities, which
qualify as financial instruments under the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC 820, &#x201c;Fair Value Measurements
and Disclosures,&#x201d; approximates the carrying amounts represented in the consolidated balance sheets.&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Derivative Warrant Liabilities&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company does not use derivative instruments
to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including
issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives,
pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded
as liabilities or as equity, is re-assessed at the end of each reporting period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company accounts for its&#160;14,891,667&#160;ordinary shares warrants
issued in connection with its Initial Public Offering (8,625,000) and Private Placement (6,266,667) as derivative warrant liabilities
in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the
instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised,
and any change in fair value is recognized in the Company&#x2019;s consolidated statements of operations. The fair value of the Private
Placement Warrants has been estimated using Monte Carlo simulations at each measurement date. The fair value of the Public Warrants was
initially estimated using Monte Carlo simulations. After the Public Warrants were separately traded, the measurement of the Public Warrants
used an observable market quote in an active market.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c38" decimals="0" unitRef="shares">14891667</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <fact:DerivativeWarrantLiabilities contextRef="c77" decimals="0" unitRef="shares">8625000</fact:DerivativeWarrantLiabilities>
    <fact:DerivativeWarrantLiabilities contextRef="c78" decimals="0" unitRef="shares">6266667</fact:DerivativeWarrantLiabilities>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Income Taxes&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company follows the asset and liability method
of accounting for income taxes under ASC 740, &#x201c;Income Taxes.&#x201d; Deferred tax assets and liabilities are recognized for the estimated
future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities
and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are
established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;ASC 740 prescribes a recognition threshold and
a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax
return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized
tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and December 31, 2021. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The
Company is subject to income tax examinations by major taxing authorities since inception.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;There is currently no taxation imposed on income
by the Government of the Cayman Islands. In accordance with federal income tax regulations, income taxes are not levied on the Company,
but rather on the individual owners. United States (&#x201c;U.S.&#x201d;) taxation would occur on the individual owners if certain tax elections
are made by U.S. owners and the Company were treated as a passive foreign investment company. The Company believes that it was a passive
foreign investment company for the 2021 and 2022 taxable years. Additionally, U.S. taxation could occur to the Company itself if the Company
is engaged in a U.S. trade or business. The Company is not expected to be treated as engaged in a U.S. trade or business at this time.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Recent Accounting Standards&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;In August 2020, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;)
2020-06, &#x201c;Debt &#x2014; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2014; Contracts in
Entity&#x2019;s Own Equity (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;)&#x201d; to simplify accounting for certain financial instruments.
ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible
instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#x2019;s
own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed
to and settled in an entity&#x2019;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement
to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be applied on a full
or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The guidance was adopted starting January
1, 2022. Adoption of the ASU did not impact the Company&#x2019;s financial position, results of operations or cash flows.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Management does not believe that any recently
issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s&#160;financial
statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <fact:ProposedPublicOfferingDisclosureTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Note 4 &#x2014; Initial Public Offering&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Pursuant to the Initial Public Offering, the Company
sold&#160;34,500,000&#160;Units, (at a price of $10.00 per Unit. Each Unit consists of one share of Class A Ordinary shares, par value
$0.0001&#160;per share one-fourth of one redeemable warrant (&#x201c;Public Warrant&#x201d;). Each whole Public Warrant entitles the holder
to purchase one share of Class A Ordinary shares at a price of $11.50 per share.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;All of the 34,500,000 Class A ordinary share sold as part of the Units
in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with the Company&#x2019;s liquidation,
if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to
the Company&#x2019;s certificate of incorporation. In accordance with SEC and its staff&#x2019;s guidance on redeemable equity instruments,
which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares
subject to redemption to be classified outside of permanent equity.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Class A ordinary share is subject to SEC and its staff&#x2019;s
guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will
become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance
(or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the
instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument
to equal the redemption value at the end of each reporting period. The Company recognizes changes in redemption value immediately as they
occur. Immediately upon the closing of the IPO, the Company recognized the remeasurement from initial book value to redemption amount
value. The change in the carrying value of redeemable ordinary shares resulted in charges against additional paid-in capital and accumulated
deficit.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;As of December 31, 2022 and 2021, the ordinary share reflected on the
consolidated balance sheets are reconciled in the following table:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Gross proceeds from IPO&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;345,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Proceeds allocated to Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,350,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt"&gt;Ordinary share issuance costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,600,644&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -8.65pt; padding-left: 17.3pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;28,950,644&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Contingently redeemable ordinary share as of December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;345,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -8.65pt; padding-left: 17.3pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,927,313&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Contingently redeemable ordinary share as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</fact:ProposedPublicOfferingDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c77" decimals="0" unitRef="shares">34500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare contextRef="c84" decimals="2" unitRef="usdPershares">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:CommonStockNoParValue contextRef="c2" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockNoParValue>
    <us-gaap:WarrantExercisePriceIncrease contextRef="c9" decimals="2" unitRef="usdPershares">11.5</us-gaap:WarrantExercisePriceIncrease>
    <fact:SaleOfOrdinarySharesRedemption contextRef="c4" decimals="0" unitRef="shares">34500000</fact:SaleOfOrdinarySharesRedemption>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Gross proceeds from IPO&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;345,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Proceeds allocated to Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,350,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -8.65pt; padding-left: 17.3pt"&gt;Ordinary share issuance costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,600,644&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -8.65pt; padding-left: 17.3pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;28,950,644&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Contingently redeemable ordinary share as of December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;345,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -8.65pt; padding-left: 17.3pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,927,313&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Contingently redeemable ordinary share as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <fact:ProceedsFromGrossProceedsFromIPO contextRef="c0" decimals="0" unitRef="usd">345000000</fact:ProceedsFromGrossProceedsFromIPO>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c0" decimals="0" unitRef="usd">10350000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c0" decimals="0" unitRef="usd">-18600644</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue contextRef="c0" decimals="0" unitRef="usd">28950644</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c5" decimals="0" unitRef="usd">345000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityOtherChanges contextRef="c0" decimals="0" unitRef="usd">4927313</us-gaap:TemporaryEquityOtherChanges>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c4" decimals="0" unitRef="usd">349927313</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <fact:PrivatePlacementWarrantsDisclosureTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Note 5 &#x2014; Private Placement Warrants&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Simultaneously with the closing of the IPO,&#160;the
Sponsor purchased an aggregate of&#160;6,266,667&#160;Private Placement Warrants at a price of $1.50&#160;per warrant ($9,400,000&#160;in
the aggregate), each Private Placement Warrant is exercisable to purchase one share of Class A ordinary shares at a price of $11.50&#160;per
share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from our Initial Public Offering to
be held in the Trust Account.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Private Placement Warrants are identical to the warrants sold in
the IPO except that the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not
be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to
certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business
Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights.&lt;/p&gt;</fact:PrivatePlacementWarrantsDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="c85" decimals="0" unitRef="shares">6266667</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="c85" decimals="2" unitRef="usdPershares">1.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <fact:AggregatePurchasePrice contextRef="c78" decimals="0" unitRef="usd">9400000</fact:AggregatePurchasePrice>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="c2" decimals="2" unitRef="usdPershares">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Note 6 &#x2014; Related Party Transactions&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Founder Shares&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On December 31, 2020, the Sponsor paid $25,000,
or approximately $0.003&#160;per share, to cover certain offering costs in consideration for&#160;7,187,500&#160;Class&#160;B ordinary
shares, par value $0.0001&#160;per share (the &#x201c;Founder Shares&#x201d;). On February 25, 2021, the Company effected a share dividend
whereby the Company issued&#160;1,437,500&#160;Class B ordinary shares, resulting in an aggregate of&#160;8,625,000&#160;Class B ordinary
shares outstanding. All share and per-share amounts have been retroactively restated to reflect the share dividend.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company&#x2019;s initial shareholders have
agreed not to transfer, assign or sell any of their Founder Shares and any Class A ordinary shares issuable upon conversion thereof until
the earlier to occur of:&#160;(i) one year after the completion of the initial Business Combination or (ii) the date on which the Company
completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all
of its shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; except to certain
permitted transferees and under certain circumstances (the &#x201c;Lock-up&#x201d;). Any permitted transferees will be subject to the same
restrictions and other agreements of the initial shareholders with respect to any Founder Shares. Notwithstanding the foregoing, if (1)
the closing price of the Company&#x2019;s Class A ordinary shares equals or exceeds $12.00&#160;per share (as adjusted for share sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing
at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination
which results in its shareholders having the right to exchange their shares for cash, securities or other property, the Founder Shares
will be released from the Lock-up.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On May 16, 2022, the Sponsor transferred 25,000
shares to one of the Company&#x2019;s directors following the departure of a previous director. The transfer of the Founders Shares is
in the scope of FASB ASC Topic 718, &#x201c;Compensation-Stock Compensation&#x201d; (&#x201c;ASC 718&#x201d;). Under ASC 718, stock-based
compensation associated with equity-classified awards is measured at fair value upon the grant date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The transfer of Founders Shares to the Company&#x2019;s
director, as described above, is within the scope of ASC 718, as such, the fair value of the 25,000 shares transferred to the Company&#x2019;s
director was $123,750 or $4.95 per share. The transfer of the shares was granted subject to a performance condition (i.e., the occurrence
of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable
of occurrence under the applicable accounting literature in this circumstance. Stock-based compensation would be recognized at the date
a Business Combination is considered probable in an amount equal to the number of Founders Shares times the transfer date fair value per
share (unless subsequently modified). Founder Shares will automatically convert into Class A shares at a one-to-one ratio upon completion
of a Business Combination. The Founder Shares will receive no distributions if the Company is liquidated prior to a Business Combination.
In addition, the holders of the Founder Shares are restricted from transferring the Founder Shares and the Class A shares received upon
conversion until nine months to a year after a Business Combination.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Promissory Note &#x2014; Related Party&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On December 30, 2020, the Sponsor agreed to loan
the Company up to $300,000&#160;to cover expenses related to the IPO pursuant to a promissory note (the &#x201c;Promissory Note&#x201d;).
This loan is non-interest bearing and payable on the earlier of December 31, 2022 or the completion of the IPO.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;As of December 31, 2022 and 2021, there was no
outstanding amount under the Promissory Note.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Working Capital Loans&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;In addition, in order to finance transaction costs
in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers
and directors, may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital Loans&#x201d;). If the
Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination
does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans
but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. After giving effect to the Notes described
below, up to $675,000&#160;of additional Working Capital Loans may be convertible into Private Placement Warrants of the post Business
Combination entity at a price of $1.50&#160;per warrant at the option of the lender. Such warrants would be identical to the Private Placement
Warrants. Prior to the completion of the initial Business Combination, the Company does not expect to seek loans from parties other than
the Sponsor or an affiliate of the Sponsor as the Company does not believe third parties will be willing to loan such funds and provide
a waiver against any and all rights to seek access to funds in the Company&#x2019;s Trust Account.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On April 1, 2022 and June 6, 2022, the Company
issued unsecured promissory notes in the amounts of up to $500,000 and $500,000, respectively, to the Sponsor. On December 14, 2022, the
Company issued an unsecured promissory note in the amount of up to $325,000 to Tidjane Thiam, Adam Gishen, Abhishek Bhatia and Edward
Zeng (collectively, the &#x201c;Payees&#x201d;) (such promissory note, together with the unsecured promissory notes issued on April 1, 2022
and June 6, 2022, the &#x201c;Notes&#x201d;). The Notes bear no interest and are payable in full upon the earlier to occur of (i) twenty-four
(24) months from the closing of the Initial Public Offering (or such later date as may be extended in accordance with the terms of our
amended and restated memorandum and articles of association) or (ii) the consummation of the Business Combination. A failure to pay the
principal within five business days of the date specified above or the commencement of a voluntary or involuntary bankruptcy action shall
be deemed an event of default, in which case the Notes may be accelerated. Prior to the Company&#x2019;s first payment of all or any portion
of the principal balance of the Notes in cash, the Sponsor and the Payees, as applicable, have the option to convert all, but not less
than all, of the principal balance of the Notes into private placement warrants (the &#x201c;Conversion Warrants&#x201d;), each warrant
exercisable for one ordinary share of the Company at an exercise price of $1.50&#160;per share. The terms of the Conversion Warrants would
be identical to the Private Placement Warrants. The Sponsor and the Payees shall be entitled to certain registration rights relating to
the Conversion Warrants. The issuances of the Notes were made pursuant to the exemption from registration contained in Section 4(a)(2)
of the Securities Act.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;As of December 31, 2022 and 2021, the Company had an aggregate of $1,225,000
and $0 borrowings, respectively, related to the Notes.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On February 28, 2023, the Company issued an unsecured
promissory note in the amount of up to $2,100,000 to the Sponsor, as further described in Note 11.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Administrative Support Service&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Commencing on the date of the IPO, the Company
agreed to pay the Sponsor up to $10,000&#160;per month for office space and administrative support services. These were paid on a monthly
basis via invoices, and there was no amount due under the Administrative Services Agreement as of December 31, 2022.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <fact:StockIssuedDuringPeriodSponsorAmount contextRef="c86" decimals="0" unitRef="usd">25000</fact:StockIssuedDuringPeriodSponsorAmount>
    <us-gaap:SharesIssuedPricePerShare contextRef="c87" decimals="3" unitRef="usdPershares">0.003</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="c88" decimals="0" unitRef="shares">7187500</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:SharePrice contextRef="c89" decimals="4" unitRef="usdPershares">0.0001</us-gaap:SharePrice>
    <us-gaap:SharesIssued contextRef="c90" decimals="0" unitRef="shares">1437500</us-gaap:SharesIssued>
    <us-gaap:CommonStockOtherSharesOutstanding contextRef="c90" decimals="0" unitRef="shares">8625000</us-gaap:CommonStockOtherSharesOutstanding>
    <us-gaap:BusinessAcquisitionSharePrice contextRef="c91" decimals="2" unitRef="usdPershares">12</us-gaap:BusinessAcquisitionSharePrice>
    <fact:SponsorShare contextRef="c92" decimals="0" unitRef="shares">25000</fact:SponsorShare>
    <us-gaap:OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare contextRef="c4" decimals="0" unitRef="shares">25000</us-gaap:OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare>
    <us-gaap:OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare contextRef="c93" decimals="0" unitRef="shares">123750</us-gaap:OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare>
    <us-gaap:ForwardContractIndexedToEquitySettlementShareFairValuePerShare contextRef="c4" decimals="2" unitRef="usdPershares">4.95</us-gaap:ForwardContractIndexedToEquitySettlementShareFairValuePerShare>
    <us-gaap:OtherLongTermDebt contextRef="c94" decimals="0" unitRef="usd">300000</us-gaap:OtherLongTermDebt>
    <fact:WorkingCapitalLoans contextRef="c4" decimals="0" unitRef="usd">675000</fact:WorkingCapitalLoans>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="c85" decimals="2" unitRef="usdPershares">1.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <fact:PromissioryNoteRelatedParty contextRef="c95" decimals="0" unitRef="usd">500000</fact:PromissioryNoteRelatedParty>
    <fact:PromissioryNoteRelatedParty contextRef="c96" decimals="0" unitRef="usd">500000</fact:PromissioryNoteRelatedParty>
    <us-gaap:ProceedsFromIssuanceOfUnsecuredDebt contextRef="c97" decimals="0" unitRef="usd">325000</us-gaap:ProceedsFromIssuanceOfUnsecuredDebt>
    <us-gaap:WarrantExercisePriceDecrease contextRef="c95" decimals="2" unitRef="usdPershares">1.5</us-gaap:WarrantExercisePriceDecrease>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c0" decimals="0" unitRef="usd">1225000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c8" decimals="0" unitRef="usd">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c98" decimals="0" unitRef="usd">2100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <fact:OfficeSpaceAndAdministrativeSupportServices contextRef="c77" decimals="0" unitRef="usd">10000</fact:OfficeSpaceAndAdministrativeSupportServices>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Note 7 &#x2014; Commitments &amp;amp; Contingencies&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Registration Rights&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The holders of the (i) Founder Shares, which were
issued in a private placement prior to the closing of the IPO, (ii) Private Placement Warrants, which will be issued in a private placement
simultaneously with the closing of the IPO and the Class A ordinary shares underlying such Private Placement Warrants and (iii) Private
Placement Warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to
register a sale of any of its securities held by them pursuant to a registration rights agreement. The holders of these securities are
entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders
have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent to the Company&#x2019;s
completion of its initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such
registration statements.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Underwriters Agreement&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On March 2, 2021, the Company paid a fixed
underwriting discount of $6,405,000. Additionally, a deferred underwriting discount of $0.35&#160;per Unit, or $12,075,000&#160;in
the aggregate, will be payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company
completes an initial Business Combination, subject to the terms of the underwriting agreement. As of October 25, 2022, and November
2, 2022, respectively, J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. have waived their portions of the deferred
underwriting fee which is reflected in the consolidated statement of operations and the consolidated statement of changes in
shareholders&#x2019; deficit as a reduction of transaction costs incurred in connection with IPO. Therefore, the deferred
underwriting fee was reduced by $9,056,250, of which $271,687 is shown in the consolidated statement of operations as a reduction of transaction costs incurred in connection with the IPO and $8,784,563 is charged to additional paid-in capital in the
consolidated statement of changes in shareholders&#x2019; deficit. As a result of the reductions, the outstanding deferred
underwriting fee payable was reduced to $3,018,750.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Business Combination Agreement&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On October 3, 2022, the Company entered into a
Business Combination Agreement (as amended from time to time, the &#x201c;Business Combination Agreement&#x201d;), with Jupiter Merger Sub
I Corp., a Delaware corporation and a wholly owned subsidiary of the Company (&#x201c;First Merger Sub&#x201d;), Jupiter Merger Sub II LLC,
a Delaware limited liability company and a wholly owned subsidiary of the Company (&#x201c;Second Merger Sub&#x201d;), Complete Solaria,
Inc. (formerly known as Complete Solar Holding Corporation), a Delaware corporation (&#x201c;Complete Solaria&#x201d;) and The Solaria Corporation,
a Delaware corporation (&#x201c;Solaria&#x201d;).&lt;/p&gt;&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;The Mergers&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Business Combination Agreement provides that,
among other things and upon the terms and subject to the conditions thereof, the following transactions will occur (together with the
other agreements and transactions contemplated by the Business Combination Agreement, the &#x201c;Business Combination&#x201d;):&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;at the closing of the transactions contemplated by the Business Combination Agreement (the &#x201c;Closing&#x201d;), upon the terms
and subject to the conditions thereof, and in accordance with the Delaware General Corporation Law, as amended (the &#x201c;DGCL&#x201d;),
(i) First Merger Sub will merge with and into Complete Solaria, with Complete Solaria surviving as a wholly owned subsidiary of the Company,
(ii) immediately thereafter and as part of the same overall transaction, Complete Solaria will merge with and into Second Merger Sub,
with Second Merger Sub surviving as a wholly owned subsidiary of the Company, and (iii) immediately after the consummation of the Second
Merger and as part of the same overall transaction, Solaria will merge with and into a newly formed Delaware limited liability company
and wholly-owned subsidiary of the Company (&#x201c;Third Merger Sub&#x201d;), with Third Merger Sub surviving as a wholly-owned subsidiary
of the Company (the &#x201c;Additional Merger,&#x201d; and together with the First Merger and the Second Merger, the &#x201c;Mergers&#x201d;);&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;at the Closing, all outstanding shares of capital stock of Complete Solaria (subject to certain restrictions) and all options and
warrants to acquire shares of capital stock of Complete Solaria will convert into the right to receive shares of common stock, par value
$0.0001 per share, of the Company (&#x201c;Freedom Common Stock&#x201d;) or comparable equity awards that are settled or are exercisable
for shares of Freedom Common Stock; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;at the Closing, the Company will be renamed &#x201c;Complete Solaria, Inc.&#x201d;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On October 2, 2022 and October 3, 2022, respectively, a special committee (the &#x201c;Freedom Special
Committee&#x201d;) of the Board of Directors of the Company (the &#x201c;Freedom Board&#x201d;) and the Freedom Board have (i) approved the
Business Combination Agreement and the Business Combination and (ii) resolved to recommend that the shareholders of the Company approve
the Business Combination Agreement and the Business Combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;First Amendment to the Business Combination Agreement&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On December 26, 2022, the Company, Complete Solaria,
First Merger Sub and Second Merger Sub entered into a letter agreement (the &#x201c;First Amendment&#x201d;) amending the Business Combination
Agreement, dated as of October 3, 2022, by and among the Company, Complete Solaria, First Merger Sub and Second Merger Sub.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;The Amendment deletes the following provisions in the Business Combination Agreement:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;The condition to the obligation of Complete Solaria to consummate the Business Combination that there be, as of the closing of the
Business Combination (the &#x201c;Closing&#x201d;), at least $100,000,000 in Available Acquiror Cash (as such term is defined in the Business
Combination Agreement);&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;The obligation of each of the Company and Complete Solaria to use reasonable best efforts to cause the Available Acquiror Cash to
equal or exceed $100,000,000 as of immediately prior to the Closing;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;The right of Complete Solaria to terminate the Business Combination Agreement if:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;o&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Complete Solaria has not consummated the issuances of convertible note investments in Complete Solaria for an aggregate purchase price
of at least $10,000,000 on or before January 16, 2023; or&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;o&lt;/span&gt;&lt;/td&gt;&lt;td&gt;at a meeting of shareholders of the Company to extend the deadline by which the Company is required to consummate the Business Combination
under its organizational documents, a number of shareholders of the Company elect to redeem their ordinary shares such that the amount
remaining in the Company&#x2019;s trust account after processing such redemptions, when taken together with the amounts included in prongs
(ii), (iii), (iv) and (v) of the definition of Available Acquiror Cash (as described above) is less than $100 million;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;The obligation of the Company and Complete Solaria to make termination payments in certain circumstances.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Second Amendment to the Business Combination Agreement&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On January 17, 2023, the Company, Complete Solaria,
First Merger Sub and Second Merger Sub entered into that certain Second Amendment to Business Combination Agreement (the &#x201c;Second
Amendment&#x201d;) amending the Business Combination Agreement, dated as of October 3, 2022, by and among the Company, Complete Solaria,
First Merger Sub and Second Merger Sub, as amended by the First Amendment.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Second Amendment provides that, if the Company
and Complete Solaria determine in good faith by January 1, 2023 that it is probable that the Business Combination will be consummated
after March 1, 2023, the Company will be required to prepare (with the reasonable cooperation of Complete Solaria) and file with the SEC
a proxy statement pursuant to which it will seek the approval of its shareholders for proposals to amend the Company&#x2019;s organizational
documents to extend the time period for the Company to consummate its initial business combination for (x) up to an additional six (6)
months, from March 2, 2023 to September 2, 2023 (the original Business Combination Agreement provided for an extension from March 1, 2023
to September 2, 2023) or (y) such other period of time as the Company and Complete Solaria may mutually agree (the original Business Combination
Agreement contemplated no such prong (y)). In addition, the Second Amendment amends the Business Combination Agreement by changing the
latest permitted Agreement End Date (as defined in the Business Combination Agreement) from September 1, 2023 to September 2, 2023.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OtherUnderwritingExpense contextRef="c99" decimals="0" unitRef="usd">6405000</us-gaap:OtherUnderwritingExpense>
    <fact:DeferredUnderwritingDiscountPerUnit contextRef="c99" decimals="2" unitRef="usdPershares">0.35</fact:DeferredUnderwritingDiscountPerUnit>
    <fact:AggregateGrossProceeds contextRef="c99" decimals="0" unitRef="usd">12075000</fact:AggregateGrossProceeds>
    <us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees contextRef="c0" decimals="0" unitRef="usd">9056250</us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees>
    <fact:PartialReversalOfTransactionCosts contextRef="c0" decimals="0" unitRef="usd">271687</fact:PartialReversalOfTransactionCosts>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c0" decimals="0" unitRef="usd">8784563</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent contextRef="c4" decimals="0" unitRef="usd">3018750</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c2" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:DividendsCommonStockCash contextRef="c100" decimals="0" unitRef="usd">100000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c0" decimals="0" unitRef="usd">100000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SupplementalDeferredPurchasePrice contextRef="c0" decimals="0" unitRef="usd">10000000</us-gaap:SupplementalDeferredPurchasePrice>
    <us-gaap:DividendsCommonStockCash contextRef="c101" decimals="-6" unitRef="usd">100000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Note 8 &#x2014; Shareholders&#x2019; Deficit&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;b&gt;&lt;i&gt;Preference shares&#160;&lt;/i&gt;&lt;/b&gt;&#x2014; The
Company is authorized to issue a total of&#160;1,000,000&#160;preference shares at par value of $0.0001&#160;each. At December 31, 2022
and 2021, there were &lt;span style="-sec-ix-hidden: hidden-fact-99"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-100"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-101"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-102"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; preference shares issued or outstanding.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;b&gt;&lt;i&gt;Class A Ordinary shares&#160;&lt;/i&gt;&lt;/b&gt;&#x2014;
The Company is authorized to issue a total of&#160;200,000,000&#160;Class A ordinary shares at par value of $0.0001&#160;each. At December
31, 2022 and 2021, there were&#160;34,500,000&#160;Class&#160;A ordinary shares outstanding, all of which is subject to possible redemption.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&lt;b&gt;&lt;i&gt;Class B Ordinary shares&#160;&lt;/i&gt;&lt;/b&gt;&#x2014;
The Company is authorized to issue a total of&#160;20,000,000&#160;Class B ordinary shares at par value of $0.0001&#160;each. At December
31, 2022 and 2021, there were&#160;8,625,000&#160;Class B ordinary shares issued and outstanding, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On December 31, 2020,&#160;the Sponsor paid $25,000,
or approximately $0.003 per share, to cover certain offering costs in consideration for 7,187,500 Class B ordinary shares, par value $0.0001
per share. On February 25, 2021, the Company effected a share dividend whereby the Company issued 1,437,500 Class B ordinary shares, resulting
in an aggregate of 8,625,000 Class B ordinary shares outstanding.&#160;All share and per-share amounts have been retroactively restated
to reflect the share dividend.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Holders of the Class&#160;A ordinary shares and
holders of the Class&#160;B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company&#x2019;s
shareholders, except as required by law; provided that only holders of Class B ordinary shares will have the right to appoint and remove
directors in any general meeting held prior to or in connection with the completion of an initial Business Combination. Unless specified
in the Company&#x2019;s amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies
Act or applicable stock exchange rules, the affirmative vote of a majority of the Company&#x2019;s ordinary shares that are voted is required
to approve any such matter voted on by its shareholders.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Class&#160;B ordinary shares will automatically
convert into Class&#160;A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination
on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the
like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares or equity-linked securities
are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion
of all Founder Shares will equal, in the aggregate,&#160;20% of the total number of Class A ordinary shares outstanding after such conversion
(after giving effect to any redemptions of Class A ordinary shares by Public Shareholders), including the total number of Class A ordinary
shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued,
by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary
shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller
in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of
Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c4" decimals="0" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c4" decimals="4" unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c2" decimals="0" unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c2" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding contextRef="c2" decimals="0" unitRef="shares">34500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c6" decimals="0" unitRef="shares">34500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized contextRef="c3" decimals="0" unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c3" decimals="4" unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="c3" decimals="0" unitRef="shares">8625000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c7" decimals="0" unitRef="shares">8625000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c3" decimals="0" unitRef="shares">8625000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c7" decimals="0" unitRef="shares">8625000</us-gaap:CommonStockSharesOutstanding>
    <fact:OrdinarySharesDescription contextRef="c17">the Sponsor paid $25,000,
or approximately $0.003 per share, to cover certain offering costs in consideration for 7,187,500 Class B ordinary shares, par value $0.0001
per share. On February 25, 2021, the Company effected a share dividend whereby the Company issued 1,437,500 Class B ordinary shares, resulting
in an aggregate of 8,625,000 Class B ordinary shares outstanding.&#160;All share and per-share amounts have been retroactively restated
to reflect the share dividend.</fact:OrdinarySharesDescription>
    <fact:TotalNumberOfOrdinarySharesOutstandingPercentage contextRef="c0" decimals="2" unitRef="pure">0.20</fact:TotalNumberOfOrdinarySharesOutstandingPercentage>
    <fact:WarrantsDisclosureTextBlock contextRef="c102">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Note 9 &#x2014; Warrants&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Public Warrants will become exercisable at
$11.50&#160;per share on the later of&#160;one year&#160;from the closing of the IPO and 30 days after the completion of the initial Business
Combination; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class&#160;A
ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits
holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are
registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. The
warrants will expire&#160;five years&#160;after the completion of a Business Combination or earlier upon redemption or liquidation.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company has agreed that as soon as practicable,
but in no event later than 15 business days after the closing of the initial Business Combination, it will use commercially reasonable
efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable
upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain
the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the
warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class&#160;A ordinary shares
issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant
holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to
maintain an effective registration statement, exercise warrants on a &#x201c;cashless basis&#x201d; in accordance with Section&#160;3(a)(9)
of the Securities Act or another exemption. Notwithstanding the above, if the Company&#x2019;s Class A ordinary shares are at the time
of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#x201c;covered security&#x201d;
under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants
to do so on a &#x201c;cashless basis&#x201d; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects,
it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will
use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is
not available. In such event, each holder would pay the exercise price by surrendering each such warrant for that number of Class&#160;A
ordinary shares equal to the lesser of (A)&#160;the quotient obtained by dividing (x)&#160;the product of the number of Class&#160;A ordinary
shares underlying the warrants, multiplied by the excess of the &#x201c;fair market value&#x201d; (defined below) less the exercise price
of the warrants by (y)&#160;the fair market value and (B) 0.361. The &#x201c;fair market value&#x201d; as used in this paragraph shall mean
the volume weighted average price of the Class&#160;A ordinary shares for the 10 trading days ending on the trading day prior to the date
on which the notice of exercise is received by the warrant agent.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The exercise price and number of shares issuable
upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend or recapitalization,
reorganization, merger or consolidation.&#160;In addition, if (x)&#160;the Company issues additional Class&#160;A ordinary shares or equity-linked
securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective
issue price of less than $9.20 per Class&#160;A ordinary share (with such issue price or effective issue price to be determined in good
faith by the Company&#x2019;s board of directors and in the case of any such issuance to the Company&#x2019;s Sponsors or their affiliates,
without taking into account any Founder Shares held by the Company&#x2019;s initial shareholders or such affiliates, as applicable, prior
to such issuance (the &#x201c;Newly Issued Price&#x201d;), (y)&#160;the aggregate gross proceeds from such issuances represent more than
60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the
completion of the initial Business Combination (net of redemptions), and (z)&#160;the volume-weighted average trading price of the Company&#x2019;s
Class&#160;A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates
its initial Business Combination (such price, the &#x201c;Market Value&#x201d;) is below $9.20 per share, then the exercise price of the
warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and
the $10.00 and $18.00 per share redemption trigger prices described below under &#x201c;Redemption of warrants when the price per Class
A ordinary share equals or exceeds $10.00&#x201d; and &#x201c;Redemption of warrants when the price per Class A ordinary share equals or
exceeds $18.00&#x201d; will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly
Issued Price, respectively.&lt;/p&gt;&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;Redemption of Warrants When the Price per Class&#160;A
Ordinary Share Equals or Exceeds $18.00&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Once the warrants become exercisable, the Company
may redeem the outstanding warrants (except with respect to the Private Placement Warrants):&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;in whole and not in part;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;at a price of $0.01 per warrant;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;upon not less than 30 days&#x2019; prior written notice of redemption (the &#x201c;30-day redemption period&#x201d;) to each warrant
holder; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a 30-trading day period
ending three business days before the Company sends to the notice of redemption to the warrant holders (the &#x201c;Reference Value&#x201d;)
equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and
the like).&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;Redemption of Warrants When the Price per Class&#160;A
Ordinary Share Equals or Exceeds $10.00&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Once the warrants become exercisable, the Company
may redeem the outstanding warrants:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;in whole and not in part;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;at $0.10 per warrant upon a minimum of 30 days&#x2019; prior written notice of redemption provided that holders will be able to exercise
their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based
on the redemption date and the &#x201c;fair market value&#x201d; of the Class A ordinary shares;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share sub-divisions, share capitalizations,
reorganizations, recapitalizations and the like); and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;if the Reference Value is less than $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations,
recapitalizations and the like) the Private Placement Warrants must also be concurrently called for redemption on the same terms as the
outstanding public warrants, as described above.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</fact:WarrantsDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="c103" decimals="2" unitRef="usdPershares">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <fact:WarrantTerm contextRef="c77">P1Y</fact:WarrantTerm>
    <fact:WarrantExpirationTerm contextRef="c0">P5Y</fact:WarrantExpirationTerm>
    <us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity contextRef="c40">In addition, if (x)&#160;the Company issues additional Class&#160;A ordinary shares or equity-linked
securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective
issue price of less than $9.20 per Class&#160;A ordinary share (with such issue price or effective issue price to be determined in good
faith by the Company&#x2019;s board of directors and in the case of any such issuance to the Company&#x2019;s Sponsors or their affiliates,
without taking into account any Founder Shares held by the Company&#x2019;s initial shareholders or such affiliates, as applicable, prior
to such issuance (the &#x201c;Newly Issued Price&#x201d;), (y)&#160;the aggregate gross proceeds from such issuances represent more than
60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the
completion of the initial Business Combination (net of redemptions), and (z)&#160;the volume-weighted average trading price of the Company&#x2019;s
Class&#160;A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates
its initial Business Combination (such price, the &#x201c;Market Value&#x201d;) is below $9.20 per share, then the exercise price of the
warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and
the $10.00 and $18.00 per share redemption trigger prices described below under &#x201c;Redemption of warrants when the price per Class
A ordinary share equals or exceeds $10.00&#x201d; and &#x201c;Redemption of warrants when the price per Class A ordinary share equals or
exceeds $18.00&#x201d; will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly
Issued Price, respectively.</us-gaap:BusinessAcquisitionDescriptionOfAcquiredEntity>
    <fact:RedemptionsOfWarrantsDescription contextRef="c9">Redemption of Warrants When the Price per Class&#160;A
Ordinary Share Equals or Exceeds $18.00&#160;Once the warrants become exercisable, the Company
may redeem the outstanding warrants (except with respect to the Private Placement Warrants):&#160;&#160;
&#x25cf;in whole and not in part;&#160;
&#x25cf;at a price of $0.01 per warrant;&#160;
&#x25cf;upon not less than 30 days&#x2019; prior written notice of redemption (the &#x201c;30-day redemption period&#x201d;) to each warrant
holder; and&#160;
&#x25cf;if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a 30-trading day period
ending three business days before the Company sends to the notice of redemption to the warrant holders (the &#x201c;Reference Value&#x201d;)
equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and
the like).&#160;&#160;Redemption of Warrants When the Price per Class&#160;A
Ordinary Share Equals or Exceeds $10.00&#160;Once the warrants become exercisable, the Company
may redeem the outstanding warrants:&#160;
&#x25cf;in whole and not in part;&#160;
&#x25cf;at $0.10 per warrant upon a minimum of 30 days&#x2019; prior written notice of redemption provided that holders will be able to exercise
their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based
on the redemption date and the &#x201c;fair market value&#x201d; of the Class A ordinary shares;&#160;
&#x25cf;if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share sub-divisions, share capitalizations,
reorganizations, recapitalizations and the like); and&#160;
&#x25cf;if the Reference Value is less than $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations,
recapitalizations and the like) the Private Placement Warrants must also be concurrently called for redemption on the same terms as the
outstanding public warrants, as described above.</fact:RedemptionsOfWarrantsDescription>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Note 10 &#x2014; Fair Value Measurements&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Fair value is defined as the price that would
be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement
date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives
the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the
lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td&gt;Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own
assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers
are unobservable.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The following table presents information about
the Company&#x2019;s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2022 and 2021 and indicates
the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Quoted&#160;Prices In&lt;br/&gt; Active&lt;br/&gt; Markets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Observable&lt;br/&gt; Inputs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Unobservable&lt;br/&gt; Inputs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;(Level 1)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;(Level 2)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;(Level 3)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Description&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 53%; text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Investments held in trust account- U.S. Treasury Securities&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-103"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-104"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Total Investments held in Trust Account&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-105"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-106"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Warrant liabilities &#x2013; Public warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,725,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,725,000&lt;/td&gt;&lt;td style="text-align: left"/&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-107"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Warrant liabilities &#x2013; Private warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,253,333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-108"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-109"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,253,333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Convertible Note &#x2013; April 1, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;338,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-110"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-111"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;338,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Convertible Note &#x2013; June 6, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;338,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-112"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-113"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;338,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Convertible Note &#x2013; December 14, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;152,200&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-114"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-115"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;152,200&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Total Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,806,933&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,725,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"/&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,081,933&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;For the year ended December 31, 2022, as a result
of the recent decline in trading volume within the period, the public warrants were transferred to and are currently classified as Level
2 securities.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Quoted&#160;Prices In&lt;br/&gt; Active&lt;br/&gt; Markets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Observable&lt;br/&gt; Inputs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Unobservable&lt;br/&gt; Inputs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;(Level 1)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;(Level 2)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;(Level 3)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Description&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Investments held in trust account- U.S. Money Market Fund&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-116"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-117"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Investments held in trust account- U.S. Treasury Securities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;345,105,197&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;345,105,197&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-118"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-119"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Total Investments held in Trust Account&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;345,105,681&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;345,105,681&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-120"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-121"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Warrant liabilities &#x2013; Public warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,916,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,916,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-122"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-123"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Warrant liabilities &#x2013; Private warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-124"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-125"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Total Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;8,488,250&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,916,250&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-126"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company utilized a Monte Carlo simulation
model for the initial valuation of the Public Warrants. The subsequent measurement of the Public Warrants as of December 31, 2022 and
2021, is classified as Level 1 due to the use of an observable market quote in an active market.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company utilizes a binomial lattice
simulation model to value the private placement warrants and the convertible promissory notes at each reporting period, with changes
in fair value recognized in the consolidated statements of operations. The estimated fair value of the warrant liability is
determined using Level&#160;3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price
volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares
based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the
U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The
expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the
historical rate, which the Company anticipates to remain at zero.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The aforementioned warrant liabilities are not
subject to qualified hedge accounting.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;Transfers to/from Levels 1, 2, and 3 are
recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. The value of the
securities transferred from a Level 2 measurement to a Level 1 measurement during the year ended December 31, 2022 was
$348,810,523. There was a transfer of $1,725,000 from Level 1 to Level 2 in the fair value hierarchy for Public Warrants during the
year ended December 31, 2022.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The following table provides quantitative information
regarding Level&#160;3 fair value measurements:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;At&lt;br/&gt; December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;At&lt;br/&gt; December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10.10&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9.68&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Strike price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;de minimis&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10.50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.98&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.30&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The following table presents the changes in the
fair value of warrant liabilities:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Public&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Private&lt;br/&gt; Placement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Warrant&lt;br/&gt; Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of January 1, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,916,250&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,488,250&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Change in valuation inputs or other assumptions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,191,250&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,318,667&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(5,509,917&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,725,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,253,333&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,978,333&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Public&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Private&lt;br/&gt; Placement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Warrant&lt;br/&gt; Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of January 1, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-127"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-128"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-129"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Initial measurement on March 2, 2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,350,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,520,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,870,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Change in valuation inputs or other assumptions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(5,433,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,948,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(9,381,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,916,250&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;8,488,250&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company recognized gains in connection with
changes in the fair value of warrant liabilities of $5,509,917 within change in fair value of warrant liabilities in the consolidated statement of operations for the year ended December 31, 2022. The Company recognized gains in connection with changes in the fair value of warrant
liabilities of $9,381,750 within change in fair value of warrant liabilities in the consolidated statement of operations for the year ended December
31, 2021.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The following table presents a summary of the
changes in the fair value of Level 3 warrant liabilities:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Private Placement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Public&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;br/&gt; Warrant&lt;br/&gt; Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of January 1, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-130"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,318,667&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-131"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,318,667&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,253,333&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-132"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,253,333&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Private&lt;br/&gt; Placement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Public&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;br/&gt; Warrant&lt;br/&gt; Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of January 1, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-133"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-134"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-135"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Initial measurement on March 2, 2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,520,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,350,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,870,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Transfer to Level 1&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-136"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,350,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,350,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,948,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-137"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,948,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-138"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Quoted&#160;Prices In&lt;br/&gt; Active&lt;br/&gt; Markets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Observable&lt;br/&gt; Inputs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Unobservable&lt;br/&gt; Inputs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;(Level 1)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;(Level 2)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;(Level 3)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Description&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 53%; text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Investments held in trust account- U.S. Treasury Securities&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-103"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-104"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Total Investments held in Trust Account&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;349,927,313&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-105"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-106"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Warrant liabilities &#x2013; Public warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,725,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,725,000&lt;/td&gt;&lt;td style="text-align: left"/&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-107"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Warrant liabilities &#x2013; Private warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,253,333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-108"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-109"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,253,333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Convertible Note &#x2013; April 1, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;338,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-110"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-111"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;338,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Convertible Note &#x2013; June 6, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;338,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-112"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-113"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;338,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Convertible Note &#x2013; December 14, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;152,200&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-114"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-115"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;152,200&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Total Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,806,933&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,725,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"/&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,081,933&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Quoted&#160;Prices In&lt;br/&gt; Active&lt;br/&gt; Markets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Observable&lt;br/&gt; Inputs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Unobservable&lt;br/&gt; Inputs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;(Level 1)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;(Level 2)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;(Level 3)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Description&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Investments held in trust account- U.S. Money Market Fund&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;484&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-116"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-117"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Investments held in trust account- U.S. Treasury Securities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;345,105,197&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;345,105,197&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-118"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-119"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Total Investments held in Trust Account&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;345,105,681&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;345,105,681&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-120"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-121"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Warrant liabilities &#x2013; Public warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,916,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,916,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-122"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-123"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Warrant liabilities &#x2013; Private warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-124"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-125"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Total Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;8,488,250&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,916,250&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-126"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <fact:InvestmentsHeldInTrustAccountUSTreasureSecurities contextRef="c0" decimals="0" unitRef="usd">349927313</fact:InvestmentsHeldInTrustAccountUSTreasureSecurities>
    <fact:InvestmentsHeldInTrustAccountUSTreasureSecurities contextRef="c104" decimals="0" unitRef="usd">349927313</fact:InvestmentsHeldInTrustAccountUSTreasureSecurities>
    <fact:InvestmentsHeldInTrustAccountNet contextRef="c0" decimals="0" unitRef="usd">349927313</fact:InvestmentsHeldInTrustAccountNet>
    <fact:InvestmentsHeldInTrustAccountNet contextRef="c104" decimals="0" unitRef="usd">349927313</fact:InvestmentsHeldInTrustAccountNet>
    <fact:WarrantLiabilitiesPublicWarrants contextRef="c0" decimals="0" unitRef="usd">1725000</fact:WarrantLiabilitiesPublicWarrants>
    <fact:WarrantLiabilitiesPublicWarrants contextRef="c105" decimals="0" unitRef="usd">1725000</fact:WarrantLiabilitiesPublicWarrants>
    <fact:WarrantLiabilitiesPrivateWarrants contextRef="c0" decimals="0" unitRef="usd">1253333</fact:WarrantLiabilitiesPrivateWarrants>
    <fact:WarrantLiabilitiesPrivateWarrants contextRef="c106" decimals="0" unitRef="usd">1253333</fact:WarrantLiabilitiesPrivateWarrants>
    <fact:ConvertibleNoteAmount contextRef="c0" decimals="0" unitRef="usd">338200</fact:ConvertibleNoteAmount>
    <fact:ConvertibleNoteAmount contextRef="c106" decimals="0" unitRef="usd">338200</fact:ConvertibleNoteAmount>
    <fact:ConvertibleNoteone contextRef="c0" decimals="0" unitRef="usd">338200</fact:ConvertibleNoteone>
    <fact:ConvertibleNoteone contextRef="c106" decimals="0" unitRef="usd">338200</fact:ConvertibleNoteone>
    <fact:ConvertibleNotesTwo contextRef="c0" decimals="0" unitRef="usd">152200</fact:ConvertibleNotesTwo>
    <fact:ConvertibleNotesTwo contextRef="c106" decimals="0" unitRef="usd">152200</fact:ConvertibleNotesTwo>
    <fact:TotalWarrantLiabilities contextRef="c4" decimals="0" unitRef="usd">3806933</fact:TotalWarrantLiabilities>
    <fact:TotalWarrantLiabilities contextRef="c107" decimals="0" unitRef="usd">1725000</fact:TotalWarrantLiabilities>
    <fact:TotalWarrantLiabilities contextRef="c108" decimals="0" unitRef="usd">2081933</fact:TotalWarrantLiabilities>
    <fact:InvestmentsHeldInTrustAccountUSMoneyMarketFund contextRef="c8" decimals="0" unitRef="usd">484</fact:InvestmentsHeldInTrustAccountUSMoneyMarketFund>
    <fact:InvestmentsHeldInTrustAccountUSMoneyMarketFund contextRef="c109" decimals="0" unitRef="usd">484</fact:InvestmentsHeldInTrustAccountUSMoneyMarketFund>
    <fact:InvestmentsHeldInTrustAccountUSTreasureSecurities contextRef="c8" decimals="0" unitRef="usd">345105197</fact:InvestmentsHeldInTrustAccountUSTreasureSecurities>
    <fact:InvestmentsHeldInTrustAccountUSTreasureSecurities contextRef="c109" decimals="0" unitRef="usd">345105197</fact:InvestmentsHeldInTrustAccountUSTreasureSecurities>
    <fact:InvestmentsHeldInTrustAccountNet contextRef="c8" decimals="0" unitRef="usd">345105681</fact:InvestmentsHeldInTrustAccountNet>
    <fact:InvestmentsHeldInTrustAccountNet contextRef="c109" decimals="0" unitRef="usd">345105681</fact:InvestmentsHeldInTrustAccountNet>
    <fact:WarrantLiabilitiesPublicWarrants contextRef="c8" decimals="0" unitRef="usd">4916250</fact:WarrantLiabilitiesPublicWarrants>
    <fact:WarrantLiabilitiesPublicWarrants contextRef="c109" decimals="0" unitRef="usd">4916250</fact:WarrantLiabilitiesPublicWarrants>
    <fact:WarrantLiabilitiesPrivateWarrants contextRef="c8" decimals="0" unitRef="usd">3572000</fact:WarrantLiabilitiesPrivateWarrants>
    <fact:WarrantLiabilitiesPrivateWarrants contextRef="c111" decimals="0" unitRef="usd">3572000</fact:WarrantLiabilitiesPrivateWarrants>
    <fact:TotalWarrantLiabilities contextRef="c5" decimals="0" unitRef="usd">8488250</fact:TotalWarrantLiabilities>
    <fact:TotalWarrantLiabilities contextRef="c112" decimals="0" unitRef="usd">4916250</fact:TotalWarrantLiabilities>
    <fact:TotalWarrantLiabilities contextRef="c114" decimals="0" unitRef="usd">3572000</fact:TotalWarrantLiabilities>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3 contextRef="c104" decimals="0" unitRef="usd">348810523</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3 contextRef="c105" decimals="0" unitRef="usd">1725000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;At&lt;br/&gt; December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;At&lt;br/&gt; December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10.10&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9.68&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Strike price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;de minimis&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10.50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.98&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.30&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:SharePrice contextRef="c4" decimals="2" unitRef="usdPershares">10.1</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="c5" decimals="2" unitRef="usdPershares">9.68</us-gaap:SharePrice>
    <fact:FairValueMeasurementStrikePrice contextRef="c4" decimals="2" unitRef="usdPershares">11.5</fact:FairValueMeasurementStrikePrice>
    <fact:FairValueMeasurementStrikePrice contextRef="c5" decimals="2" unitRef="usdPershares">11.5</fact:FairValueMeasurementStrikePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c0">P0Y4M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c8">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <fact:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates contextRef="c0">de minimis</fact:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates>
    <fact:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates contextRef="c8">10.50%</fact:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c0" decimals="4" unitRef="pure">0.0398</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c8" decimals="4" unitRef="pure">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c0" decimals="4" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c8" decimals="4" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Public&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Private&lt;br/&gt; Placement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Warrant&lt;br/&gt; Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of January 1, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,916,250&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,488,250&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Change in valuation inputs or other assumptions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,191,250&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,318,667&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(5,509,917&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,725,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,253,333&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,978,333&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Public&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Private&lt;br/&gt; Placement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Warrant&lt;br/&gt; Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of January 1, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-127"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-128"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-129"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Initial measurement on March 2, 2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,350,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,520,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,870,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Change in valuation inputs or other assumptions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(5,433,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,948,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(9,381,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,916,250&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;8,488,250&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:FairValueNetAssetLiability contextRef="c115" decimals="0" unitRef="usd">4916250</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability contextRef="c116" decimals="0" unitRef="usd">3572000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability contextRef="c117" decimals="0" unitRef="usd">8488250</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease contextRef="c118" decimals="0" unitRef="usd">-3191250</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease contextRef="c78" decimals="0" unitRef="usd">-2318667</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease contextRef="c37" decimals="0" unitRef="usd">-5509917</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueNetAssetLiability contextRef="c119" decimals="0" unitRef="usd">1725000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability contextRef="c85" decimals="0" unitRef="usd">1253333</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability contextRef="c38" decimals="0" unitRef="usd">2978333</us-gaap:FairValueNetAssetLiability>
    <fact:FairValueInitialMeasurement contextRef="c123" decimals="0" unitRef="usd">10350000</fact:FairValueInitialMeasurement>
    <fact:FairValueInitialMeasurement contextRef="c124" decimals="0" unitRef="usd">7520000</fact:FairValueInitialMeasurement>
    <fact:FairValueInitialMeasurement contextRef="c125" decimals="0" unitRef="usd">17870000</fact:FairValueInitialMeasurement>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease contextRef="c123" decimals="0" unitRef="usd">-5433750</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease contextRef="c124" decimals="0" unitRef="usd">-3948000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease contextRef="c125" decimals="0" unitRef="usd">-9381750</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueNetAssetLiability contextRef="c115" decimals="0" unitRef="usd">4916250</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability contextRef="c116" decimals="0" unitRef="usd">3572000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability contextRef="c117" decimals="0" unitRef="usd">8488250</us-gaap:FairValueNetAssetLiability>
    <fact:FairValueWarrantLiabilities contextRef="c0" decimals="0" unitRef="usd">5509917</fact:FairValueWarrantLiabilities>
    <fact:FairValueWarrantLiabilities contextRef="c8" decimals="0" unitRef="usd">9381750</fact:FairValueWarrantLiabilities>
    <fact:ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Private Placement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Public&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;br/&gt; Warrant&lt;br/&gt; Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of January 1, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-130"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,318,667&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-131"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,318,667&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,253,333&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-132"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,253,333&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Private&lt;br/&gt; Placement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Public&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;br/&gt; Warrant&lt;br/&gt; Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of January 1, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-133"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-134"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-135"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 64%; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Initial measurement on March 2, 2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,520,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,350,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,870,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Transfer to Level 1&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-136"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,350,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,350,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,948,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-137"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,948,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-indent: -9.35pt; padding-left: 9.35pt"&gt;Fair value as of December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-138"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,572,000&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</fact:ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock>
    <us-gaap:FairValueNetAssetLiability contextRef="c126" decimals="0" unitRef="usd">3572000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability contextRef="c128" decimals="0" unitRef="usd">3572000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease contextRef="c129" decimals="0" unitRef="usd">-2318667</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease contextRef="c131" decimals="0" unitRef="usd">-2318667</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueNetAssetLiability contextRef="c132" decimals="0" unitRef="usd">1253333</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability contextRef="c134" decimals="0" unitRef="usd">1253333</us-gaap:FairValueNetAssetLiability>
    <fact:FairValueInitialMeasurement contextRef="c138" decimals="0" unitRef="usd">7520000</fact:FairValueInitialMeasurement>
    <fact:FairValueInitialMeasurement contextRef="c139" decimals="0" unitRef="usd">10350000</fact:FairValueInitialMeasurement>
    <fact:FairValueInitialMeasurement contextRef="c140" decimals="0" unitRef="usd">17870000</fact:FairValueInitialMeasurement>
    <fact:FairValueAssetsLevel1ToLevel2TransferAmount contextRef="c139" decimals="0" unitRef="usd">-10350000</fact:FairValueAssetsLevel1ToLevel2TransferAmount>
    <fact:FairValueAssetsLevel1ToLevel2TransferAmount contextRef="c140" decimals="0" unitRef="usd">-10350000</fact:FairValueAssetsLevel1ToLevel2TransferAmount>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease contextRef="c138" decimals="0" unitRef="usd">-3948000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease contextRef="c140" decimals="0" unitRef="usd">-3948000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueNetAssetLiability contextRef="c126" decimals="0" unitRef="usd">3572000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability contextRef="c128" decimals="0" unitRef="usd">3572000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Note 11 &#x2014; Subsequent Events&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Company evaluated subsequent events and
transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this
review, other than below, the Company did not identify any subsequent events that would have required adjustment or disclosure in
the consolidated financial statements.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Second Amendment to the Business Combination Agreement&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On January 17, 2023, the Company, Complete Solaria,
First Merger Sub and Second Merger Sub entered into the Second Amendment amending the Business Combination Agreement, dated as of October
3, 2022, by and among the Company, Complete Solaria, First Merger Sub and Second Merger Sub, as amended by the First Amendment.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;The Second Amendment provides that, if the Company
and Complete Solaria determine in good faith by January 1, 2023 that it is probable that the Business Combination will be consummated
after March 1, 2023, the Company will be required to prepare (with the reasonable cooperation of Complete Solaria) and file with the SEC
a proxy statement pursuant to which it will seek the approval of its shareholders for proposals to amend the Company&#x2019;s organizational
documents to extend the time period for the Company to consummate its initial business combination for (x) up to an additional six (6)
months, from March 2, 2023 to September 2, 2023 (the original Business Combination Agreement provided for an extension from March 1, 2023
to September 2, 2023) or (y) such other period of time as the Company and Complete Solaria may mutually agree (the original Business Combination
Agreement contemplated no such prong (y)). In addition, the Second Amendment amends the Business Combination Agreement by changing the
latest permitted Agreement End Date (as defined in the Business Combination Agreement) from September 1, 2023 to September 2, 2023.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Amendment to Amended and Restated Memorandum and Articles of Association&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On February 28, 2023, Freedom held an extraordinary
general meeting of shareholders (the &#x201c;Extraordinary General Meeting&#x201d;), at which holders of 35,373,848 ordinary shares, comprised
of 26,773,848 Class&#160;A ordinary shares and 8,600,000 Class&#160;B ordinary shares, were present in person or by proxy, representing
approximately 82.02% of the voting power of the 43,125,000 issued and outstanding ordinary shares of Freedom entitled to vote at the Extraordinary
General Meeting at the close of business on January 23, 2023, which was the record date (the &#x201c;Record Date&#x201d;) for the Extraordinary
General Meeting (such shares, the &#x201c;Outstanding Shares&#x201d;). The Outstanding Shares on the Record Date were comprised of 34,500,000
Class A ordinary shares and 8,625,000 Class B ordinary shares.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;At the Extraordinary General Meeting, the shareholders
approved, by special resolution, the proposal (the &#x201c;Extension Amendment Proposal&#x201d;) to amend the amended and restated memorandum
and articles of association to extend the date by which Freedom must (i) consummate a merger, amalgamation, share exchange, asset acquisition,
share purchase, reorganization or similar business combination, which Freedom refers to as its initial business combination, (ii) cease
its operations except for the purpose of winding up if it fails to complete such initial business combination, and (iii) redeem all of
the Class A ordinary shares, included as part of the units sold in the initial public offering, for an additional three months, from March
2, 2023 to June 2, 2023, and thereafter to up to three (3) times by an additional one month each time (or up to September 2, 2023) (the
&#x201c;Extension Amendment,&#x201d; and such period, as may be extended, the &#x201c;Combination Period&#x201d;). The voting results for
such proposal were as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;For&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Against&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Abstain&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 31%; text-align: center"&gt;35,047,305&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 31%; text-align: center"&gt;326,543&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 30%; text-align: center"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;In connection with the Extension Amendment, public
shareholders elected to redeem an aggregate of 23,256,504 Class&#160;A ordinary shares at a redemption price of $10.21 per share, representing
approximately 67.41% of the issued and outstanding Class A ordinary shares, for an aggregate redemption amount of approximately $237,372,952.
Following such redemptions, approximately $114,759,374 remained in the trust account and 11,243,496 Class A ordinary shares remain outstanding.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;At the Extraordinary General Meeting, the public
shareholders also approved the proposal to amend the Investment Management Trust Agreement, dated as of February 25, 2021 (the &#x201c;Trust
Agreement&#x201d;), by and between Freedom and Continental Stock Transfer &amp;amp; Trust Company, as trustee (&#x201c;Continental&#x201d;),
to reflect the Extension Amendment. The amendment to the Trust Agreement provides that Continental shall commence liquidation of the trust
account only and promptly (x) after its receipt of the applicable instruction letter delivered by Freedom in connection with either the
consummation of an initial business combination or Freedom&#x2019;s inability to effect an initial business combination within the time
frame specified in Freedom&#x2019;s amended and restated memorandum and articles of association or (y) upon the date that is the later
of the end of the Combination Period and such later date as may be approved by Freedom&#x2019;s shareholders in accordance with the amended
and restated memorandum and articles of association, if the aforementioned termination letter has not been received by Continental prior
to such date. The voting results for such proposal were as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Against&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Abstain&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 31%; text-align: center"&gt;35,047,305&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 31%; text-align: center"&gt;326,543&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 30%; text-align: center"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"&gt;&lt;b&gt;Promissory Note&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;On February 28, 2023, the Company issued an unsecured
promissory note in the amount of up to $2,100,000 to the Sponsor. The proceeds of such promissory note, $1,600,000 of which was drawn
down immediately, $400,000 of which may be drawn down, with the mutual consent of the Company and the Sponsor, if the
Company wishes to extend the date by which it will consummate a business combination beyond June 2, 2023, and $100,000 of which may be
drawn down on an as-needed basis at the discretion of our sponsor, will be used for general working capital purposes. Such promissory
note bears no interest and is payable in full upon the consummation of our business combination. A failure to pay the principal within
five business days of the date specified above or the commencement of a voluntary or involuntary bankruptcy action shall be deemed an
event of default, in which case the promissory note may be accelerated. The promissory note shall be forgiven by the Sponsor if the Company
is unable to consummate a business combination within the time frame specified in our amended and restated memorandum and articles of
association (as amended from time to time), except to the extent of any funds held outside of the trust account established in connection
with our initial public offering. The issuance of the promissory note was made pursuant to the exemption from registration contained in
Section 4(a)(2) of the Securities Act of 1933, as amended.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SharesIssued contextRef="c141" decimals="0" unitRef="shares">35373848</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="c142" decimals="0" unitRef="shares">26773848</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="c143" decimals="0" unitRef="shares">8600000</us-gaap:SharesIssued>
    <fact:VotingPowerPercentage contextRef="c144" decimals="4" unitRef="pure">0.8202</fact:VotingPowerPercentage>
    <fact:IssuedAndOutstandingShares contextRef="c145" decimals="0" unitRef="shares">43125000</fact:IssuedAndOutstandingShares>
    <us-gaap:CommonUnitOutstanding contextRef="c142" decimals="0" unitRef="shares">34500000</us-gaap:CommonUnitOutstanding>
    <us-gaap:CommonUnitOutstanding contextRef="c143" decimals="0" unitRef="shares">8625000</us-gaap:CommonUnitOutstanding>
    <fact:ExtensionAmendmentProposalFor contextRef="c146" decimals="0" unitRef="shares">35047305</fact:ExtensionAmendmentProposalFor>
    <fact:ExtensionAmendmentProposalAgainst contextRef="c146" decimals="0" unitRef="shares">326543</fact:ExtensionAmendmentProposalAgainst>
    <fact:ExtensionAmendmentProposalAbstain contextRef="c146" decimals="0" unitRef="shares">0</fact:ExtensionAmendmentProposalAbstain>
    <fact:AggregateSharesOfCommonStock contextRef="c9" decimals="0" unitRef="shares">23256504</fact:AggregateSharesOfCommonStock>
    <us-gaap:TemporaryEquityRedemptionPricePerShare contextRef="c2" decimals="2" unitRef="usdPershares">10.21</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <fact:IssuedAndOutstandingInterestPercentage contextRef="c2" decimals="4" unitRef="pure">0.6741</fact:IssuedAndOutstandingInterestPercentage>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement contextRef="c2" decimals="0" unitRef="usd">237372952</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:CommonStockHeldInTrust contextRef="c2" decimals="0" unitRef="usd">114759374</us-gaap:CommonStockHeldInTrust>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased contextRef="c2" decimals="0" unitRef="shares">11243496</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <fact:InvestmentManagementTrustAgreementFor contextRef="c147" decimals="0" unitRef="shares">35047305</fact:InvestmentManagementTrustAgreementFor>
    <fact:InvestmentManagementTrustAgreementAgainst contextRef="c147" decimals="0" unitRef="shares">326543</fact:InvestmentManagementTrustAgreementAgainst>
    <fact:InvestmentManagementTrustAgreementAbstain contextRef="c147" decimals="0" unitRef="shares">0</fact:InvestmentManagementTrustAgreementAbstain>
    <us-gaap:RepaymentsOfUnsecuredDebt contextRef="c145" decimals="0" unitRef="usd">2100000</us-gaap:RepaymentsOfUnsecuredDebt>
    <fact:PromissoryNote contextRef="c145" decimals="0" unitRef="usd">1600000</fact:PromissoryNote>
    <fact:DrawnDownAmount contextRef="c145" decimals="0" unitRef="usd">400000</fact:DrawnDownAmount>
    <fact:DrawnDownAmount contextRef="c148" decimals="0" unitRef="usd">100000</fact:DrawnDownAmount>
    <dei:EntityTaxIdentificationNumber contextRef="c0" id="hidden-fact-0">00-0000000</dei:EntityTaxIdentificationNumber>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="c4"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="c5"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c4"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c5"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c4"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c5"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c4"
      id="hidden-fact-7"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c5"
      id="hidden-fact-8"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c4"
      id="hidden-fact-9"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c5"
      id="hidden-fact-10"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="c4"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="c5"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c5"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="c8"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NoninterestExpenseOfferingCost
      contextRef="c0"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c9"
      decimals="2"
      id="hidden-fact-16"
      unitRef="usdPershares">0.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c10"
      decimals="2"
      id="hidden-fact-17"
      unitRef="usdPershares">0.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c11"
      decimals="2"
      id="hidden-fact-18"
      unitRef="usdPershares">0.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c12"
      decimals="2"
      id="hidden-fact-19"
      unitRef="usdPershares">0.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SharesOutstanding
      contextRef="c13"
      id="hidden-fact-20"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c13"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c19"
      id="hidden-fact-22"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c19"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20"
      id="hidden-fact-24"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c21"
      id="hidden-fact-25"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="c18"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="c19"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="c21"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c19"
      id="hidden-fact-29"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityOther
      contextRef="c19"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityOther
      contextRef="c20"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityOther
      contextRef="c21"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c18"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c19"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c20"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c22"
      id="hidden-fact-36"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c22"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c24"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c26"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c27"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c29"
      id="hidden-fact-41"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="c26"
      id="hidden-fact-42"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="c27"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="c29"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="c26"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="c27"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c26"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c27"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c29"
      id="hidden-fact-49"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c26"
      id="hidden-fact-50"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c27"
      id="hidden-fact-51"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c28"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c30"
      id="hidden-fact-53"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c30"
      id="hidden-fact-54"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="c8"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:ChangeInDeferredUnderwritingFee
      contextRef="c8"
      id="hidden-fact-56"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:OfferingCostsAllocatedToWarrants
      contextRef="c0"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:CashDepositedInTrustAccount
      contextRef="c0"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c0"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="c0"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="c0"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c8"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="c0"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="c0"
      id="hidden-fact-64"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c17"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption
      contextRef="c0"
      id="hidden-fact-66"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:InitialValueOfWarrantLiabilities
      contextRef="c0"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:DeferredOfferingCostsIncludedInAccruedExpenses
      contextRef="c0"
      id="hidden-fact-68"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:DeferredOfferingCostsPaidUnderPromissoryNote
      contextRef="c0"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="c53"
      id="hidden-fact-70"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c52"
      decimals="2"
      id="hidden-fact-71"
      unitRef="usdPershares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c54"
      decimals="2"
      id="hidden-fact-72"
      unitRef="usdPershares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c53"
      id="hidden-fact-73"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="c56"
      id="hidden-fact-74"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c55"
      decimals="2"
      id="hidden-fact-75"
      unitRef="usdPershares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c57"
      decimals="2"
      id="hidden-fact-76"
      unitRef="usdPershares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c56"
      id="hidden-fact-77"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="c62"
      id="hidden-fact-78"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c61"
      decimals="2"
      id="hidden-fact-79"
      unitRef="usdPershares">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c63"
      decimals="2"
      id="hidden-fact-80"
      unitRef="usdPershares">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c62"
      id="hidden-fact-81"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="c65"
      id="hidden-fact-82"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c64"
      decimals="2"
      id="hidden-fact-83"
      unitRef="usdPershares">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c66"
      decimals="2"
      id="hidden-fact-84"
      unitRef="usdPershares">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c65"
      id="hidden-fact-85"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="c71"
      id="hidden-fact-86"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c70"
      decimals="2"
      id="hidden-fact-87"
      unitRef="usdPershares">0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c72"
      decimals="2"
      id="hidden-fact-88"
      unitRef="usdPershares">0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c71"
      id="hidden-fact-89"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="c74"
      id="hidden-fact-90"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c73"
      decimals="2"
      id="hidden-fact-91"
      unitRef="usdPershares">0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c75"
      decimals="2"
      id="hidden-fact-92"
      unitRef="usdPershares">0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c74"
      id="hidden-fact-93"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <fact:TradingSecuritiesFairValue
      contextRef="c79"
      id="hidden-fact-94"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:GrossUnrealizedGain
      contextRef="c82"
      id="hidden-fact-95"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:GrossUnrealizedGainsAndLosses
      contextRef="c82"
      id="hidden-fact-96"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:GrossUnrealizedGain
      contextRef="c83"
      id="hidden-fact-97"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:GrossUnrealizedGain
      contextRef="c8"
      id="hidden-fact-98"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c4"
      id="hidden-fact-99"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c5"
      id="hidden-fact-100"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c4"
      id="hidden-fact-101"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c5"
      id="hidden-fact-102"
      unitRef="shares"
      xsi:nil="true"/>
    <fact:InvestmentsHeldInTrustAccountUSTreasureSecurities
      contextRef="c105"
      id="hidden-fact-103"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:InvestmentsHeldInTrustAccountUSTreasureSecurities
      contextRef="c106"
      id="hidden-fact-104"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:InvestmentsHeldInTrustAccountNet
      contextRef="c105"
      id="hidden-fact-105"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:InvestmentsHeldInTrustAccountNet
      contextRef="c106"
      id="hidden-fact-106"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:WarrantLiabilitiesPublicWarrants
      contextRef="c106"
      id="hidden-fact-107"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:WarrantLiabilitiesPrivateWarrants
      contextRef="c104"
      id="hidden-fact-108"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:WarrantLiabilitiesPrivateWarrants
      contextRef="c105"
      id="hidden-fact-109"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:ConvertibleNoteAmount
      contextRef="c104"
      id="hidden-fact-110"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:ConvertibleNoteAmount
      contextRef="c105"
      id="hidden-fact-111"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:ConvertibleNoteone
      contextRef="c104"
      id="hidden-fact-112"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:ConvertibleNoteone
      contextRef="c105"
      id="hidden-fact-113"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:ConvertibleNotesTwo
      contextRef="c104"
      id="hidden-fact-114"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:ConvertibleNotesTwo
      contextRef="c105"
      id="hidden-fact-115"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:InvestmentsHeldInTrustAccountUSMoneyMarketFund
      contextRef="c110"
      id="hidden-fact-116"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:InvestmentsHeldInTrustAccountUSMoneyMarketFund
      contextRef="c111"
      id="hidden-fact-117"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:InvestmentsHeldInTrustAccountUSTreasureSecurities
      contextRef="c110"
      id="hidden-fact-118"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:InvestmentsHeldInTrustAccountUSTreasureSecurities
      contextRef="c111"
      id="hidden-fact-119"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:InvestmentsHeldInTrustAccountNet
      contextRef="c110"
      id="hidden-fact-120"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:InvestmentsHeldInTrustAccountNet
      contextRef="c111"
      id="hidden-fact-121"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:WarrantLiabilitiesPublicWarrants
      contextRef="c110"
      id="hidden-fact-122"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:WarrantLiabilitiesPublicWarrants
      contextRef="c111"
      id="hidden-fact-123"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:WarrantLiabilitiesPrivateWarrants
      contextRef="c109"
      id="hidden-fact-124"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:WarrantLiabilitiesPrivateWarrants
      contextRef="c110"
      id="hidden-fact-125"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:TotalWarrantLiabilities
      contextRef="c113"
      id="hidden-fact-126"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueNetAssetLiability
      contextRef="c120"
      id="hidden-fact-127"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueNetAssetLiability
      contextRef="c121"
      id="hidden-fact-128"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueNetAssetLiability
      contextRef="c122"
      id="hidden-fact-129"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueNetAssetLiability
      contextRef="c127"
      id="hidden-fact-130"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="c130"
      id="hidden-fact-131"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueNetAssetLiability
      contextRef="c133"
      id="hidden-fact-132"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueNetAssetLiability
      contextRef="c135"
      id="hidden-fact-133"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueNetAssetLiability
      contextRef="c136"
      id="hidden-fact-134"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueNetAssetLiability
      contextRef="c137"
      id="hidden-fact-135"
      unitRef="usd"
      xsi:nil="true"/>
    <fact:FairValueAssetsLevel1ToLevel2TransferAmount
      contextRef="c138"
      id="hidden-fact-136"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="c139"
      id="hidden-fact-137"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueNetAssetLiability
      contextRef="c127"
      id="hidden-fact-138"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c0">0001838987</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>59
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ,^#AE8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #/@X96^OFFB^X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M3L,P#(9?!>7>.FUAAZCK91,GD)"8!.(6)=X6K6FBQ*C=VY.&K1."!^ 8^\_G
MSY);Y85R 5^"\QC(8+R;;#]$H?R:'8F\ (CJB%;&,B6&U-R[8"6E9SB E^HD
M#P@UYRNP2%)+DC #"[\06==J)51 22Y<\%HM>/\9^@S3"K!'BP-%J,H*6#=/
M].>I;^$&F&&$P<;O NJ%F*M_8G,'V"4Y1;.DQG$LQR;GT@X5O#\_O>9U"S-$
MDH/"]"L:06>/:W:=_-9LMKM'UM6\;@I^7_#5KN:BX:)Z^)A=?_C=A*W39F_^
ML?%5L&OAUUUT7U!+ P04    " #/@X96F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M ,^#AE8/QYLX4P<  +<K   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MM9I=<]HX%(;O^RLT;&>GG0G!E@TAW809XH1=MBUA0]I.]DZQ!7AB6ZPLA^3?
MK_R!1;KRP>O!O6CX.B]Z+%E^9'2Q9?PI7E,JT$L81/%E9RW$YE.O%[MK&I+X
ME&UH)-]9,AX2(9_R52_><$J\K"@,>M@P!KV0^%%G=)&]-N>C"Y:(P(_HG*,X
M"4/"7Z]HP+:7';.S>^'.7ZU%^D)O=+$A*[J@XMMFSN6S7IGB^2&-8I]%B-/E
M96=L?G+L05J0?>*[3[?QWF.4HCPR]I0^F7J7'2-M$0VH*](((O\\4X<&09HD
MV_%/$=HIOS,MW'^\2Y]D\!+FD<348<$/WQ/KR\ZP@SRZ)$D@[MCV#UH ]=,\
MEP5Q]C_:YI^U[0YRDUBPL"B6+0C]*/]+7HH#L5?0MRH*<%& ?RHPJ[[!*@JL
M##1O689U300977"V13S]M$Q+'V3')JN6-'Z4=N-"</FN+^O$Z)JYB>P5@<:1
MAVXBX8M7-(WRX9$>YB[ZMKA&']Y_O.@)^75I4<\MHJ_R:%P1;6+TE45B'<M<
MCWIO WJRG65C\:ZQ5QA,O*;N*;+,$X0-C#4-<N#R/Y-(EANZ\C?-L<IC9V5Y
MUJ%CMW_ OL@/H:F@8:P[8GF@K0],3]E/\8:X]+(CS\F8\F?:&?WZBSDP?M/1
M'BGL#;M=LMM0^J@8*G=TY<>"$WD09B2D.F0X9W)W<W-]^_7=V/GKVW0QO9_>
MSM 4.;=W\U,=,AC6$+E?(O?!IMYSXOG1"BU>PT<6Z%#A^LG8N=<Q@54-F08E
MTP!L4SF$[U\WVMZ#RTVC^UF'!%8U1#HKD<[ -CD)YRG1Q(]=$J '2G@Z 2$Y
M/6H)X;1NU\1=R]1!@H4-(8<EY+#.Z3=/'@/?19. $:%C T/^[W23A_6SL-0.
MGD>6=8[[ [MO7/2>-3#G)<PY"#.6(]#+1N$D("L=!UR_)$&LZUH'+&O80Z:A
MKJQ&G3YR)!B7 W$J+X(OZ#-]U5Y)X2C#,,RA-3P?GNDPX>*FG'L&8=;B+,Z[
M.[IA7&03I2 BT5X&#R0^4%V5 U<UY<2*$]?A_,Z")!)2>>4,$U"NYX.39DR+
M!Q8UQ5,R8X*^L,/+H) C)\L5X_JQ"N?,6-0EKBM%G<L0+P_4\K;A+Z82&+.6
MP?R0*XCN4\2V$5I0$K-(-GD:QXFVS5<',BLZM@UK,96VF+!WE-?X.>4^\\"+
MX:&HG8!7&C@<T)15Z8Q9TV?VK_X3^:+^-(7#*AG;T!M3^8T)*\G/C$6W5E/"
M<9,'+6,;=F,JO3%K^<TB)$& KI)8OAWKX> <P1.M&<!E3?&4\)BPL11X-R'E
MJ_1*^;M,$&ODL'!#(OVD"P=6<K:A0%@I$*ZE0(NUG&0AN@,Q571P65,Z)3ZX
MEOC<O""Y-(QB/UO_YV>C%A).J[18N*XII=(>#,O*U)G<H7'B^8)Q-!:"QB*_
MTU$EZP?RJCG;\!^L_ ?#WK)W)RQ*Y+2:>ZP6$ ZJ'*UM^ Y6OH-A-U%+?358
M 48XK+H3VW =K%P'PX*R)[%HEH2/>HL[$"(76UW;,$WM8@NN;0JH! ?#3E+>
MHG49EWV7G8DGV4J+(GE^.DRN3>32Q&&>UN\.I9]KD=OP':Q\!\."4B#?DQ<T
M]>0 ]I>^F\] 0 _#D8;1-?)_6MXVW <K]\&UW&?L>3(]/MD]R.\LWT;Z?H4C
M3?O=C]2DY&N4ZLYW!PYHRJR$"-<2(CWS_5:WK+HZ$(D-:523@#'MXA,N;LAK
M*3&R:HE1R5N>P'/.GOW(U7;R@<R95N3AHJ:@RI&L6HY4@CKI,\EY+Q?<6D8X
M;D:WZ('Q)RUI&YYD*4^R:MT>*DGG3(I2@/[V-Y6S\8%$4\Y/?2UI&Z9D[?WL
M!0M.UH=C3DDU&!R 3>VZ&JYJBJ4$R8*=Y@O+5M-K%D'N<"!D8 Z[YMGY4,O7
MAAM9RHVL []?^4):$5LB$W]X_(@6U$VX[$DM))SD!$3.S6-Y'GM^E-X)C==$
MMO@$;0A'SR1(*'IOG*8WK=&&\OQ=[0%IPZ4LY5(6;#N[(R!7<.Z:1"M:^1OF
M@:#9P^)&R]>&.%E*G*Q:XC2-!.7Y=HGTOA_9W:G7@L*)%3?FX:JFG$J8+-AN
M=HO3B<]#-+W6<L$)@Z'^A&U#BBPE1=:!W\4*KLI1"9=_)5RN^% 0;+1L;0B0
MK03(AF5EQY9.NJG+:W<.'/"=P@5.D-Y\X/*FA,I\;%A5=I/D[6Z27&23I!;T
M2.92<+?A0;;R(!L?>U>,?22?*?C;L"-;V9%=ZW<TAX6A!%\(YLH1FO<]NDV$
ME,(HW4:B/0YY\F#_)W:[7ZQ3G]\PMK+W9V_S#VPY^=B^JC6VCR0]!7<;"F4K
MA;+[1Q_;1W*<@K\-8[*5,=FU[CXU&MN#_XSMX0#W-4/[J-+4V]L:F?[:DNT8
MC9&;WB?+=TF6KY:[4L?97LR>^GB^I55>3U=^%*. +F6I<7HF^X+GNT3S)X)M
MLHV6CTP(%F8/UY1XE*<?D.\O&1.[)^D7E'MU1_\"4$L#!!0    ( ,^#AE:8
M$B"BNP4  -$7   8    >&PO=V]R:W-H965T<R]S:&5E=#(N>&ULK5AM;]LV
M$/XKA%<4'>#$(O6>. 82!\,&["6HV_4S+3$Q5TG42#IN]NMWE!Q)MBC%:?,E
ML:2[T_,<[U7SG9!?U88QC;[E6:&N)ANMRXO93"4;EE-U+DI6P)-[(7.JX5(^
MS%0I&4TKI3R;$<<)9CGEQ60QK^[=R<5<;'7&"W8GD=KF.95/-RP3NZL)GCS?
M^,@?-MK<F"WF)7U@*Z8_EW<2KF:-E93GK%!<%$BR^ZO)-;Y8$M\H5!)_<[93
MG=_(4%D+\=5<_)9>31R#B&4LT<8$A7^/;,FRS%@"'/_NC4Z:=QK%[N]GZ[]4
MY(',FBJV%-D7GNK-U22:H)3=TVVF/XK=KVQ/J *8B$Q5?]%N+^M,4+)56N1[
M94"0\Z+^3[_M'=%1P-Z  MDKD%,5W+V"6Q&MD56T;JFFB[D4.R2--%@S/RK?
M5-K AA?F&%=:PE,.>GJQ%(42&4^I9BFZH1DM$H96QIQ"9^CSZA9]>/?S?*;A
M549AENS-WM1FR8#96Y:<(Q=/$7$(L:@O3U?'A^HS(-BP) U+4MESAUANI62%
M1E0I('9AXU,;\.P&3#)=J)(F[&H"V:*8?&23Q?N?<.!<VMB]D;$#KF[#U1VS
MOEA2M;$1K+7\2LLD]^,B)#%QY[/'+O*^% E#/VK%#C!Y#29O%-.=9"7E*6+?
MH/PH9D)+;8342#.9V\#6YH(.#$R<( R/T/;%0N(Y06!'ZS=H_5&TGX2F&21?
M-V9L(/T^R-@-'.<(I$7,<7#@Q7:408,R>*U/,U$\#+ITU)H])I$MMH,^'>PZ
MX4"$A V;\,6H1;1(H;;)KTS3=<:08G &7'/@MF%9BGB!/DDHB>@Z2<2VT#:6
M80^=Z\4Q"5U\'.DV21\[?A!A.Y6HH1*=$#[7@V$3]5_L.Q#><0^B1=(+"'$\
M9\#;<0,Q/JD>9IRN>5:YV%H4X[<LBF]D[( P=MH^YXR>RCYF%"KI4Q5=)MAH
MDL@M:W/(VNB<WBEXD1\1[!^=ED60^&$<> /QA#L]&H\GAR@>F=3<P"ZER+E2
M0CZA0FB&WO\$4/ EC%19U<-+*O63E0?NP8M(U"]7XUA.*A2'--LFC4?[XE'=
M[<2FE0[IT8'4A>3M'4M?</Q8VD:+QSOM%RHE/0&IVP<0AY'K'J>[13#RHHCX
MS@#2MOWB\?Y[R^X9>#5%VR)E<@=%E4E514YXB5*NJM1XS@PKAWZG=1T<A7XO
M>JR=&^2<(1)M5\:GM.7?7W"VI=OB('*C.#I&VI<D+O9(% \%1MN9\7AK7HH\
MYQJ6'2@WILQ _FI>/+ B,;WLPXHQ]*?)W= ^6;]5IWX#0X<.:)LY?J&;9S U
MH6OTETQY =LA3'L47@'+XOH?V-^0%J@42E4%#<*2Y66UT[G>% )E"K%RH@+5
MW:M'FFV9N0?K \O73#8;2'4*9I>8@KPJ6;4[9O8R>?H$814UD3X<[.T,@:/1
M#KTR_#<B2SN)"EG,$ZZMG1J/SB2O;=5O9>V0?#N=X-%9P(RV4*^8647K.)BB
M=\XY>!6;]E:?\R7")E"ZP4*W&I8*_A]++Z$W%@Q!GS3=74@DMEII" +(PO$
ML?KV.R87>T+^N*'#];>=?LCX]/.<D.(P(:U^);57[9Y]O??&D;W">V]@Z-![
M[?Q%7IB_*N_=G.B]L;",I@'QNP_W(6H<^$,Q2BS377!<L%X0.O1.Y]O*^-AV
MG:;<U%]HSF8A/8,U+:$EAV9M!=H?QP+'#SWWN#^/O_4[CKN=Z\CX7 >KPC;?
MUN-T6M=<*Y/^N':&0Q^6@S@^YF(1)3@FKNL/#!NDG>W(^&Q7CT4C_<**O3^F
MG6'LQ0[IS4DV48.=P&@Z@+T=Z<@K1[HI^@C]G.75AM9,#ZM](D'\OY:GW_N>
M-;1LVT0'MNU9YWNK^=C]!Y4/O% H8_>@ZYR'8$36WX_K"RW*ZA/L6F@M\NKG
MAE'@8 3@^;V <7!_8;[J-E_Q%_\#4$L#!!0    ( ,^#AE;PH7#T2P,  *,.
M   8    >&PO=V]R:W-H965T<R]S:&5E=#,N>&ULK9==;YLP%(;_BL6FJ9.Z
M@,EGNP2I235M%].B5MNN'3@)7@UFMDFZ_?K90 FLA)"TO2A?Y[Q^'\*QCZ<[
M+AYD"*#08\1B.;-"I9)KVY9^"!&1/9Y K)^LN8B(TI=B8\M$  FRI(C9KN.,
M[(C0V/*FV;VE\*8\58S&L!1(IE%$Q)\Y,+Z;6=AZNG%'-Z$R-VQOFI -W(/Z
MGBR%OK)+E8!&$$O*8R1@/;-N\/4"#TU"%O&#PDY6SI%!67'^8"Z^!#/+,8Z
M@:^,!-&'+2R ,:.D??PN1*UR3)-8/7]2_Y3!:Y@5D;#@["<-5#BS)A8*8$U2
MIN[X[C,40)E!GS.9_4>[/':H@_U4*AX5R=I!1./\2!Z+%U%)P(,#"6Z1X'9-
MZ!<)_0PT=Y9AW1)%O*G@.R1,M%8S)]F[R;(U#8W-SWBOA'Y*=9[R%CR6G-&
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MLMA/_;3$%P^T<\#]E5)VMW ']&]H]A=02P,$%     @ SX.&5FP+SC!I!@
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MV-1P='=#B>X&K3-0-;ZY-PKMJ/AM9=\FT"[ GA=*X<%P%PRO7?H74$L#!!0
M   ( ,^#AE:@4?QRU 8   0?   8    >&PO=V]R:W-H965T<R]S:&5E=#@N
M>&ULK9EM<YLX$,>_BL:]Z=S--#42CTX3SR1..]<7;3W-]?I: 3FFQ8B39+OY
M]K<2!&PCY"1U7L0&2\O^=Y?5#W2QY>*G7#*FT*]54<K+T5*IZGP\ENF2K:A\
MRRM6PB\++E94P:&X'\M*,)J92:MB3#PO&J]H7HZF%^;<7$PO^%H5><GF LGU
M:D7%PS4K^/9RA$>/)[[F]TNE3XRG%Q6]9[=,?:OF H[&K94L7[%2YKQ$@BTN
M1U?X?.;[>H(9\6_.MG+G.])2[CC_J0\^9I<C3WO$"I8J;8+"QX;-6%%H2^#'
M?XW147M-/7'W^Z/U#T8\B+FCDLUX\3W/U/)RE(Q0QA9T7:BO?/LW:P2%VE[*
M"VG^HVT]-H;!Z5HJOFHF@P>KO*P_Z:\F$#L3<#0P@303R.&$8&""WTPPD1O7
MGAE9-U31Z87@6R3T:+"FOYC8F-F@)B]U&F^5@%]SF*>FMXHJ!FE1$O$%FE&Y
M1!\@M1*=H6^W-^C//_ZZ&"NXCAX]3AN;U[5-,F 3$_2)EVHIT?LR8]F^@3$X
MV'I)'KV\)DZ+-RQ]BWS\!A&/$(M#LZ=/QPYW_#9HOK'G#]C;"=-"\!7Z4C%!
M55[>HRM=E;G*F3RWQ:TV&]C-ZCOV7%8T99<CN"4E$QLVFKY^A2/OG4WSB8SM
M12!H(Q"XK$\_0X/)RY2OF$UF/3<T<W4?V4S#24+\P+L8;W856,9ADD1A-V[/
MN;!U+G2FYRK[ 3=.7=2*0[-)>9GF!4-EZ[4^KX]2G<FU9!F<1[Q-(W6G,3QE
M&D]D;"]241NIR)G&CZ5B8%4A1D4)08"^"LW\)U/T#L(E6;H6)@IHR0H3HG\$
M1!:J/.7K4ME"4U\OVDGI69 0'/GD(/>6@=@+HP3;<Q^WBF*GHMF2EO=,N[J@
MN4 ;6JR9[FQ;*@0M%2IR>I<71I3-_;CO51AZDPF.#]RW#)SX"8Z':C=I_4]>
MY#^4\(8)E>N\E%Q9;[NDYQ.>1+">'[CN=,!><,A1:Y-6V>2)RF"594) N:UA
M>1!;76)PSRV85=2D'V@2XR@Y3(CSXL]7A;UN ?6<NKXL0(T6D'()#8<6!4]A
M3<UTBVFJSEIJ;K-/\KA6WAC:#5$8AR1.[)6(=]  NY<YDS&I4P:-0$ _151*
MID6667MJYXZR-LOF(B?JEJ>RMA\2TH6$.),]%ZRB>8;8+^!H:>\AC8G=?$#!
M!M%A![2,.TO\&/N3@<1U>(*=:_^TZ<\25?3!='*=+YJF8LV.N.[W7")02&$<
M'/IN&1C&DR@8:-^X PM\G"R.KLI6WP/+BA*0210=-D#;2.(%V/.&O._( [O1
MXY ,/T+7ED\A0WQ2ICB5M?TH=%2!CV&%5JT!S"Q=.B9Y">WP*#VX[3ZG)UKP
MP@]"S_P-)+E##.QFC%Z)YFV6CY2HT^YSY%GPXYB\CD!P\JP:_I"7%/CY"37\
M K)PU/")K.U'H:,5[,:5N> I8UE['X-L6J#Y^J[(4_2XYK\Q#Q%0XRW),"%?
MOP+@C=^A+)?#A?[[N-)$J<]'OI^$DW"P$$A'-L1--OLAR*5<0QT8&IV+? .,
M@^8%^&CN\^\.TG%?YAEB29]T)H&CYDF'.L3)#0ZILQWPAE$K^(V+!_1Y@,&;
MZ^Q!."%[V6BTO !D7,!*.H8A;H;Y"@CS\-B<JTZ2?JRHGY<+PZ\5%>K!JM%I
M_SGYM!#0!)ZVHH%T=@!$W  TKP6:=UI\C\^M>E[P)L6NIT]%9V$2!F2H/CLJ
M(D^D(LC7)L\@.W</:-$V9O>R0_J\,U"3_8%^$/LX"9-@0$%'1L3)'$9!]PBH
MUQBKJZ$5S?H,9QE(XCA,_ $_.W8A;G8QJY]IX?@=NF;W>5E"A*V^]AGCP(7&
MU=^'FGTM':B0(R]#=K6\+[,A(7V:B,F$]'3TASE#W@$'<0/'[;JJ"K.,P JK
M5\V"R[4PW;?DI2E[6ZE;&82<E$%.96T_,!V#$#>#/%)'^Q9H5L #.+I"7$ N
M*?1LN:1P8237=S]8JG3WKKB49K$2+&.K2N^56.-T*@ A%@!QDZC? 8CO!I">
M_B>^Q7.;?88XOP\<.$YBA[:..'PW<=ST7H)9T+%]@$\AS_?U.R6:9;G.*L1%
MOXHXTV]G:)7#O6,-Q>]C1A,*&]AX\3!G^AV0^&X@@0="P<RFWDE+W._313 A
ML)P=-C;+0)( 04?!P*KG[VP4N4&DS?(^A9C,U9D_)#"KDE,!2F-H=\?%QEOC
MG?W$%8/"T]NL$IF2K#?MVK/M5NZ5V< \.'^-SV?UAFQGIMX?_@3UG)<2%6P!
M)KVW,?@DZBW7^D#QRNQ:WG&E^,I\73(* =,#X/<%AV U!_H"[<;W]']02P,$
M%     @ SX.&5H[C=2V/%P  7D<  !@   !X;"]W;W)K<VAE971S+W-H965T
M.2YX;6RM7%MSVT:R?L>O0&F]6W(5+(G4Q7;LN,I1G(U2\=IE)9N'4^=A" S)
MB4& BQF(YO[ZTU_W## @05H^NP]Q)&(PT]W3EZ\OU.M-W7RV2ZU=^F555O;[
MDZ5SZ^_.SVV^U"MES^JUKNC)O&Y6RM&OS>+<KANM"GYI59Y/+RYNSE?*5"=O
M7O-G'YLWK^O6E:;2'YO4MJN5:K8_Z++>?'\R.0D??#*+I<,'YV]>K]5"WVOW
M^_IC0[^==[L49J4K:^HJ;?3\^Y.WD^]^N,)Z7O!/HS<V^CD%)[.Z_HQ?[HKO
M3RY D"YU[K"#HO\]Z%M=EMB(R/B7W_.D.Q(OQC^'W7]BWHF7F;+ZMB[_,(5;
M?G_RXB0M]%RUI?M4;W[6GI]K[)?7I>5_TXU?>W&2YJUU]<J_3!2L3"7_5U^\
M'![SPM2_,&6ZY2"F\D?EU)O73;U)&ZRFW? #L\IO$W&FPJ7<NX:>&GK/O?G0
M+%1E_JU$1%61_M!:6F)M^F&M&_[8OCYW=!+6G^=^UQ]DU^F!72?3]'U=N:5-
MWU6%+H8;G!.)'9W30.</TZ,[_JCSL_1RDJ73B^GTR'Z7'=^7O-_E(_C.TEOB
MLBY-T8OA8Z.MKIQ\4,_3GTREJMRH,KVG#S6II;/I_[R=6=>08OWOF(B$@*MQ
M F!LW]FURO7W)VN<U3SHDS=_^\ODYN+5$?:N.O:NCNW^_[[6X[O^HW8ZG:1_
M^\N+Z63Z*GW,(?N+_JXK>EBF/S5:%_4J?9O_JS76\/,[NHEF?9:>NJ7F8Z87
MKV[KU5I56_YM\BJIF_# ;^ ?/$TWRJ:FRFF#F@[7!?V2WJKM2M&^MJ2C;4I'
MD"+IU4PWZ?22E>GB+/V-#O.G\"9P=?0Z_2\%'>N6=K0:6D"WKAM3+1)3N3I5
MZ4HW"]UD::[6QA%/=JD:G>HO^5)5"YVEREKRJZKG,/-+:$]:8VE)H^M80G2F
M-2M3*G(V09IYO9J1^O'SC7%+8D-CX:IN=!)6:9N>JB":[B)N^U>#G(;\&IM6
MM4M+.A,B8Z[6JG$F;T&#J0KR0<T6QRUTO6C4>FE(5?0"Q$!"7CHV(?'D=.%P
M[HY$1/N,4;%W.MV.5DVY3:VC(, :HB%6;+$@K2=V<[^:GD&D%$#R9<97$^UC
MV]F?Y.D3<%"6N"PL:(S];'$--=DN&&3Y/>Y H^U9^J%*/^2NAL*(ODR')[-&
ML*[AX&2,Y?3M@C05'D-._Z4E9:']WK/RI/?M+.@]<4?Z6:H-5"0H<K ;E6Z6
M=4ETUYN*#B1^K2F,PMW,8Y*R<$ 2'W"7_OKK[6#_<.6E43-3&K>-Y?P-I^&'
M4I-CN*^A,3_790%1WO;D9\DX6QF?!'W@5XT:O'1 %@,%8D_T_!7=_AH>O($B
MC/B5I.-^QQ\<ED'L@>YE\]Z WEI(H?,D(2P--6.I"IA6LB4/0+O2_>=T$I[4
MG7>DK4A7&9G@<+=LZG:Q'-NY(5$XLG'2,C?"OZ"SH"I8<5<1ZZI,/K:SDBSV
MPWS.GBL]]4S=??S@&4I[E^I?2G=>ZEQLH6W>F!GQ,0.<VW&=AGB!,UFPAW>P
MK6WBF:63&_V@JY9X:"MGB.LYC "DYJ)!/M(:!S<N=(R9$UVCX]=@Q62C;H2*
M0$%2U=6SG@)$AY5&7,#[D!D?R"9L77A,9.3*+EF2_(,F17I0)8?\>4.JQ5&A
MJ7-2-$LR:0A7%OT3DJR\RT' )N$X99J4MFDYDI!:-ZIRG>:QL_$@@R@%1W"R
M@!<L&!M01Q>6=E0@P;&(7H7.R9B(($VWQY@7'/VD9TT+\YU>LTI-!AK^KEM*
M(%+WBD[>[[VB2)5.Y:6AAG?N7A>!<42!RZOL^N(BN[BXH)O&;<8G_8Y/@N*Q
M0V>?2/)?$P6=>I?DLM.WI)GD2T U1TT.[V5;2&C'.MZ-=!$BJZ&LNLB2Z+2U
MZ#&_';AB_7DRN3@C^D@S>(\L:(P/ G1X=[_$T9/+JVOPP_^18S0D$?(TA;&$
MT*V0P]CHZBR]-RM*"%2EZ]:66^&.E;RLK9 99'50F,R!)87#XIML>G.3W=P\
M#RHSE.='4CZ8VL>2H"3KQQ]^V8!?"NJ-R7G#)Y.S:^%\[]W$OWN4QVNR-UID
ME:15>6V))+6JR:H%0#R9O,PFSZ^SE_!;8(NTV'/^Y":[NF!1TF])2[E!LVD,
M/YUK;3-Z=YI=/ \KD%[I!KJ\MY0M[,G-2SX&2VL22B-*@#5,%BFP2-O50&>N
M)SO!<SKNFLZ:/G_!AJ._4*8+3A4P4>PW_!,;U"[OT@6$QLXR044/?+N;9]_B
MKWU 7T(>@B(T"XU5E"(NL6F]28-[DYO>XK?D\0AP0/]W(\1$G*#;NY@-V00
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M]PK?_J><1\_IU8NSY]<GTH@*O[AZS7]!958[5Z_X1]0B=(,%]'Q>D__PO^"
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M5L4[I-[A34B B(@1FVY;*B!H9)==B.,B.(BDI@RA4M7:!Y4PG@42!R*2!-\
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M64D8GE,^]0?%'1\DY+TC>G2-VU905C^6(CI2$Q)R6!-NO1\%+):WRMJW:)N
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MN<\KA:OOXAKT!/:F4D&@U5;6[;'L$%+HAW?3?*76W#$18R2T)W]P>)(,1W3
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M]QJ7,QNO;_'%FSI<F6;&XP(6'A>X\9)E :P7!B>3]H45K._0EW\#4$L#!!0
M   ( ,^#AE;]_?FXZP,   $)   9    >&PO=V]R:W-H965T<R]S:&5E=#$S
M+GAM;)56VV[;.!!]]U<,U*)H <.2%<?)IK8!.]G%YJ%;H^ENGREJ)'%+D5J2
MBN._WR%UJ8LF+@H$,2\S9\X9#CE:';3Y:BM$!T^U5'8=5<XU-W%L>84ULS/=
MH**=0IN:.9J:,K:-098'IUK&:9(LXYH)%6U686UO-BO=.BD4[@W8MJZ9.>Y0
MZL,ZFD?#PB=15LXOQ)M5PTI\0/=WLS<TBT>47-2HK- *#!;K:#N_V2V\?3#X
M1^#!GHS!*\FT_NHG]_DZ2CPAE,B=1V#T\XBW**4'(AK_]9C1&-([GHX']#^"
M=M*2,8NW6GX1N:O6T74$.1:LE>Z3/OR)O9Y+C\>UM.$_'#K;Q54$O+5.U[TS
M,:B%ZG[94Y^'$X?KY 6'M'=( ^\N4&!YQQS;K(P^@/'6A.8'06KP)G)"^4-Y
M<(9V!?FYS=Z(1^80]I)QI&0[^,*,8<K95>P(WUO%O,?:=5CI"UCS%#YHY2H+
MOZL<\^\!8B(VLDL'=KOT+.(=\AE<S*>0)FEZ!N]B5'L1\"Y^62W<"<NEMJU!
MV&;6&2J7YS+0X2^>Q_<WZ,8VA+V.Z(I8-(\8;=Z\FB^3]V?8+T;VBW/HOWA6
MY['^T@1T"6]>7:?S]#V<2<R#J*G"F4+=6GFD\G05N K!9TNH$G01IO?[CU,_
MF#PT6EEMH&D-K^B^Y,#H\I6EP=)'(//E-%TNI\OEU;FPS &#Q@@>7%[/9Y<)
M-&C@T!G V]>_31=),DV2!(2:> ICD'=30,:KE^%!6, G-%Q8EDD$IT>ZH!6"
MK9@)<6\ELQ:VH$TN%#U:W<Z/[ 9ZD[ _(X]&F_#L].D9X4<GOWI&_X%1E)RN
MD2<7$(SFB+F%PN@:=&O@7@DGF(1]FTG!X6-1H/$GXO0D0ZA0YI29X/O9T$L"
M6\YUJ]P,/I\/[;6+G)8$)_0^_&'8M3K@3OI#ISQR;!S9,/<335/R!:F)(6DC
MTV.(%'AFQ^ [U []"0I%":V%<SX'!&!)'B*AO!7OJ RE!*6=5VHP1VI5_B![
MG%M=-TP=O2G9UNSH36FBN&SSD")O],+9"FO; -82FZ%,AB.SWS)!56;;[%]J
M+S[C'(VC'@A2$&5BW*6%*H ($\=! '&=DGPK2D5&I#.DLZ==T1B-!3HD(>$B
M@9P=Z3@*1W4?KAS)DGA:5J(O@5U+=Q&MG9#RC-1XFZ"^ET\,!B$_1/.]$3BS
ME20 W^+H<C"5D_=CGV?O392<[*J1+IGP+V0@8GS;L[/GGK?XI"W5:,K0?"V$
M(NPZU+@Z]O=MU]:^F7<?!Q^8*86R(+$@UV1V=1EUD8>)TTUH<IEVU#+#L*)O
M%#3>@/8+30]>/_$!QJ^>S?]02P,$%     @ SX.&5K'3%><G#0  O",  !D
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M*P27I05XOC0P>+B@ YH/=J[_!U!+ P04    " #/@X96PX8D7<4,  ">)P
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M87KV[IR, ^1;5%]FF+^I3UP.]]^EY^_>IJ=G)R0+#*JG'K1YEZ<NR;\E.J%
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M!<J%3&M$KA? 4.5B62",T_L'VMK[!KKCP<'^=V#A QT&[O7@F,3??.YHCN#
M;W$\>)$BMVV]0"/V0580SH?BPI@6'"0<T[WVJ;1-A= 5<D%B2L3]-CB;6B:2
M $,!.^8]Q!ZLX)8:O7GHZ%"\34QB9-'9EBR/,6'S7O&4ZB;\I0;D!9,VV#E!
M$_SP'&+X8TBHN(R[.]3 F, F?3,M=>!4 *Y,JU?;I/"W5/<]O\;_@: [177@
M#1RA-3A80-J,7)X(4)*=A,E"!FR(H*QYL!-]#"IO[GA"1$QU;7458A(<E2!S
M+\=N*E@7Z<L$F5,%_L(I=';F=D$&&7,:7(8%?"::5^UT6^I0Q$T4/#0490 &
MONA*!PU#EPUB1H")&$R!DE6&XE-E6.9K4GJFD6&8?2)08 AQ2V\A)S8 6VD=
M)$T9Y=(%K0S%B" >5NFXR8#1/HHI(F"TDE.D,$:69[Q_F"1-OG<!GJ6.L-+V
MW, Y486LY@AI8[A&>)6<S32/:3"V2[D$)[Y8QTW^:0)L9"RFETG-)G*4:0>[
MEQ('M!03Y!M5M)1KE1%RN*911^NT&HK?O\=OV6#, [D"B^][R"JZ6T#B@MU:
M0E!2C4-W#F!B3#Y3HBPIUZEOSJS!@8N9DUA1Q6/7BA<LVT6,'I<4'*(]-,\]
M?//11R/2J*TOL?H1C/P+SB?@18@=-O4"O-_C?A 3.FB%2M8Z2*/_CK9C3\,Q
M$BE>$SS2B80"RI[1M^CY_+2V]:QQJ15\@P""=37*_5:#W.\2EQ5.;6UB\URS
M>7B]+;#PA.*Q8 ^C\Q;&/"'06 4ZLB]MXX9:3E1&BD3!EG+<%>3$VZJ)P['K
M(IN0>(=(_@8C4R1Z^)BD6>Q[;]"\P;0TS%M*P0=I!J*MYFYF\.#Z846 8!'P
M?['_V@A!E3'?(_?7@/R<Q',D'CII$D:*5#P[<BKKL"KP;9N@<JZ;*<K\P9GD
M%W9!F29?$?E[F'MK,:-\L)DG+I,M\8RYOR.GM$_=@Z?Z%BZP;NSG?ALC!KW'
M(W^3(:F-.S*I,!&Q_U.L<7"U,>*-ML5D![57?L>P<#7CK^U#FD4[>]%:K*$U
MI4[0,@!W,$-N-5EV>9+&")9<.[W@(\ZUP:DZUO=GZ3!JOH6[C55[BASP(5"K
M.(Z1AVZ8;F1XUON,6R)'ZBHU'/&KE95_/. ?$9RS\%255<3G4*L0QG@($7&8
MPD*UV3N'3UT%1FLWMY+</-Y/N;OC.)8N<9VTNP)?I)O?-_5T?WXOW5RCQ@S-
ML#0;'AWV$T-7#\'6\1XXM0'C)OXL<(TGQPIX/[.88NT#;]#]8^#\'U!+ P04
M    " #/@X968[9"J4D+  !L(@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q
M-RYX;6RU6EMSV[82?N>OP"@Y'6E&L2DY<>SX,I.DZ30/;3QQ3_,,D:"$8Y)@
M -"R^NO/[N)"4I9\R30/<402E[U\^^TNR/.UTC=F)81E=U59FXO1RMKFW>&A
MR5:BXN9 -:*&)X72%;=PJ9>'IM&"YS2I*@_G:7I\6'%9CR[/Z=Z5OCQ7K2UE
M+:XT,VU5<;WY($JUOAC-1N'&5[E<6;QQ>'G>\*6X%O:_S96&J\.X2BXK41NI
M:J9%<3%Z/WOWX36.IP%_2[$VO=\,-5DH=8,7G_.+48H"B5)D%E?@\-^M^"C*
M$A<",;[[-4=Q2YS8_QU6_XUT!UT6W(B/JOPF<[NZ&)V,6"X*WI;VJUK_+KP^
M;W"]3)6&_K*U&SL_';&L-595?C)(4,G:_<_OO!UZ$T[2/1/F?L*<Y'8;D92_
M<LLOS[5:,XVC837\0:K2;!!.UNB4:ZOAJ81Y]O(;UYK7UIP?6E@-[QUF?N8'
M-W.^9^8I^T/5=F78ISH7^7#^(4@119D'43[,'USP6C0'["B=LGDZGS^PWE%4
M[8C6.WI$-?:K-%FI3*L%>[\P5@,2=JGK5GN]>S4,CG>FX9FX& 'ZC="W8G3Y
MRXO9<7KV@*ROHZRO'UK]03<\//-/904[9;^\.)G/YF<L*OW72K"K=E'*K+NW
MEF7)%B)3E6#B3NA,&KXH!>,V>3F;';Q)62,@8%<<+ 418V&)DENXI0JX%FPC
MN&:%5A4]0IO*>HD/\?+SU1?&ZQP\R'*^,8P7.),&JJHI!06A'RMK:24OV8<6
M5A#&)!]5M9 UQS%GK-'J5@*F8!@3/%NQ#,(.YG%+DV%LP^L-6W'8!$84A:#0
M!HY82G0O[60L2 [L85D+^'2"7(NLU;"S,.Q]9D&N6Z%1 UJUY 9N)TKG((C>
M.#,8)HUIR4AM ZMZJXF@R#J8%C7G$+!:XY:@@6E JM: 4&!"VD3AC H69/R6
MRY(6'2L]T GL7TEKDI4J06B#D^*6,$[J;D>D-+3,J@0#(C/!PIVJF=196X$1
MZ@R40&%D(9U)>W(SOM2"K#0A#4P+UO:*PY_$651HD4_9]Y:7;@V0&82J&NNP
M,#![)X&)QI[BC$79PKV;S10@M3;!?N0EO( =P>4@;'CB+'" .$[6 P"+NT8"
M0 MT.2)R/]1X!!CK 8SDY[J4,(><"NJA-OY1*;^W,J>1M/L0;VBOW&$1+HU"
M+QCP-V:7#%TZ31:M13/7X+I;!(,+(9A2L]D;M@@2;0?),)JV(Z2OP)1)ZTS1
M&E*Y0H3PLMR *MRH&N5(("Z4M@2A0@+4UM*N7!1\^@B6V1,LA0=D__%T;PA-
M@[@^>MB^Z$D>C)ZAG:-F$ C[M&,][3+>NNA@A@.QP9U <9$9$-MP'XL4"_\2
M'!R?DGE!(@+_;K-,GQ+?*X@3J]!85I8D#R$U8JX/,]*_P[7$\B0#XV&X=IXB
M(L3RQVQ9K(O; _:YV._-70RW[:/DB0P']%(KVS/J8D,#CE.0%L#\HUCV&T3*
MJ_@FV) \8J$&Q!@C^Q)[/H'ST5UY2ZI[6I4J9^N5J =T2U!;<5BG $;&P%9)
M ,E3]IEVYAKR,J;C>7HVI&>Z.3O;Y>UK7Z0>C?ED?#I)O.6V$A: B(,/P!">
M@(FCH + -9#K\^!KO@#/ T\4?76I1GA[9O9&*^9]GV31ZB@%6JD/"1XAB& H
M,3OD3F7G3W!S1_PP,P/:6PKO29_!83\8:PJ''RBA"2"!LH/I$+JPME]MXXV7
M."H*]IJ=C!>3\6S"=AIL.G V 0LD0%I1C0.?%D#V.F0;"K/&%4U=SEGMS<$)
M<$JN( O\*T[?K0-">1K2MDLH?:5@;^IPS#0)20$=LQ!!M3PF $!/Q+8,V-[+
M'8[R]NZ;*^'X( @0DU+R#.H.]07*YNH+APF/1^=KWC2ERZVQB' UA*NHP#G6
MA7P7%$ 3"0H7"RV@R=J!D%29NKK2>1WZQK;,6<,W?CGOZT;+C%C.$.OGCDEI
M(JT4 L&E3 !6W58+5RSO*R8%*AGD1HRXX>/W$[KSO57@=EA2+=!+X#O8/9=0
M#./.X[M)R IYBVS@X')OUQC62=^,Y29P0T#OE%70NDHPKMO(*9_Y;(A7'M#
MC0@=?2,LN^7@@H#I,<4NSL;F?D(:[;!ALIU*8+/QQBES;VV"W?C#A*4'1\<S
M5QD\)@=D!P"=1RMDB(9K2)"\H5H6(J(2W.7\6U6VD$W6U*O#!&!^&!E<_4@M
M$TJC6<H@6L@E5,,)1[N^8>H]PF5QCG,WE)1@B1KX1&8NO0-"_;;17A(+BDQ
MQHDNZ5(^I?N_[D,4+=:AX%F5%Y(BD@7/_]<2E8,),Z&)(X8MA*RSLB7-!IQ
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MFB;@^4*AD0P7M$'S7P+._@-02P,$%     @ SX.&5GYJ>RO'"P  )2   !D
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M/'%%E<<I%E0>IC)@&YVI#G=?LO-8^Q+_K_8%[ED Z0W A >]A^^.P\M_UQ=
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M\/A'@!ZY/7&A_[>%_IX.#X>9*:-OB^RO-*F6KX^F1V&BYZK.JL_%YE<M![I
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MN 4A=;W291JK\.3?_YJ.Q\.7OUQ?W]&?HY?/0I4GX;HN3:WR*JP*@E#6L$.
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MK/$'%=(F/SUL"%#[$1=3Q\O09@D!VA?!!^QQ6L*Q"[(\@Y:M7H(UI36 )[+
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M5 2[E#MQLRQ[1"7]G&LJM?C8ECBDZDW6B,]!LC;&K2H+5^+A$0X,JYV&%S[
M>BT>MX@A?"8?20W0W,W\/+C)#C":6EKW!RI6LGD7,9N\6#/C E!7K/I(%LFF
M8)<.^W"\P127%N,D59Q6K>#'X;0+TE)5#ACT4+=)[&R>7U?XQ<[TW.[Q>8"F
MD;L^\LYK0H:I##0A50&)R+BWW]NCB<*S\^AB2-;O1]33YW][^)/K$O:9A#_[
MO(MV"='#%,S+_ 2V=Q1 XKB XCB#PU5FS7E:MNTWQ,W(\*AWQO?-'Q @?N#$
MZ@Z(VK:0G7;W)V:&>S?9"]&K3<%"SN5-9ISX28F%('P5*51BB8-]5E.#DL3@
M9O?9('SG5X1LO;$4UB48*X7@Y54K/NY$C+5L=!Y-KT;19'+9A!%[!@Y=!TH*
M]H70RFVX_4L5+EL=[A0*64^=+RZ?8K"(5C])LQHEQ16XP'_SSVW>%&#= Z)Q
MFMKH*9#:,0W<WR$F6B^M_PSC$EW&J4'[W=1'W"]HXMP-A&UUQ;.N*UV!*J,#
MX1I@Y-#.M4OKUV26?8)AID_:I%:D=EBLBY]88I-%'@\PC2XSFRIR/%2^M(\8
M+0SLP+.U:DLY^+=2T5PD5FAT7M#$+GRN33-;A@-_C!G7<3H/UB!'J1,)$<XX
MM+%_$;P7]/^'>$;W# )B$[(HL#;-"O7.Y^#FN]!X$?QA#_8BN,ZR(G:G]GY^
M')Y'E].+:'HYAK]'T>AJ$IU/IEA%CJXFE_#YC+^?C*+SBTN(3AUY7@1_T>41
M=% 2G8H ^\+OV>II-!E?T%_C:32%?R]!C:;1^3D\GDR_\UB S7 P.N_^7Y^I
M;.XKC/HO+'S"K!E1O\6R=*=M_(FK"FVH.^V@U3JC1FW7=& @8HKAXMGY\'0T
M/+V_NCH=$:7NW]UB_WD^]QO2-W66:?C+E7+NKYM&-$><%]?AJ8TXW]D!'-C(
M8BD_'P0.;:[1V]1'+D10J$<MVF*NZ0Z"XC"@-0\ZUSS 7+,Q7Y9%O>!S=A8P
M) JQ%<^JH.SLCH?A'#YLE)0,*G@]@%VOW<1Z1&?MJ_Z'NT^#L!5\='67(F!!
MBPI54:D,/QZ/KJ+1Y45T!:K;S/SW(7,B%*3H=QX>@[8-62<H/H)(8H.]#[RT
M E2+@N/1.!I>NE\DUB7N_93;H9,K1@9M#@68;<R?#8" [./P"/ZE!?H!['<!
MFXTOI^ ;C%>Z,CQ2?2J% IKK_O%B3^1+>-./L#ARIZF'>F+<=Y 6AZG8Q%$X
M9;A1ZPKG.'CL%4VH'13)P*9L96G2\!J$&I-SO%C6*I[MUEYD3'.S/^35](:[
MHU3;)O\45P4*'!946>!PX1^0\Y,<CNT<@!\71N%O@[M!^+$H%RKW>XF__WY+
M^[[58(5CV/Q&Y=_\'T"$-F!IW2@ E4A5DB;NFOM&P4%1:P91(4"38>)>*=BI
M^'GAQ($?2X<'RUU](;9BGY[43:2])QK.[/#<92Y1.<DA:?\7+)ABIX@K)3VG
M5B:PMQYFV_#X*AI>3"*LPN#.3)/C\24$A]-+)(Y98M'TAPC3=Y[@Z?.(16-+
M -YU"JYW<K;3(E6)S=+#M4J34YJFX KKD[AZG;?>?-2+ 9O^E1Q+!B?]$.$P
MS==J2WU)-D9,>_ 'QV?1< 0'O!CV9T?-W;91_^6VII&/^#:UPP]-[; S#OB)
M6V[?L159N7T[LYLM= _H2@(5_%.#BYI36W#>60MMFBO_W53;U)MG\P[WL>D;
M\J#Q6S=H;.QUL/V9$S<28(>72^U"^T[Y;$403U2OFSMUH_Y+=4V'S(WN>G6X
M3DGXB<MU_;NT!UL+S;4HS-R29IW'3RQP+76RP,QQS62FU 7+TW/(@R)I:V.Q
MB3KCZ0(TGXLS6ZIK[PPI:10^GCCGT2FLAG:*4M3<3@ND*<.ANDMV;:(9(4K-
MB$4J=TY\L<1UB=>A!&PQ[Z2B$9>PI%+E"3BZR03C%&]A%/BW:U%0SZ=#4I:F
M@RF#2U)H:_*C;@I[QW3C%GOH@]7'R72O[X<SQWY,P'TM6U$B+WK*<Q.N1XA9
M/.)!2>3^+'QOO=JK4.S6)2P7+),Z7 A"^"#MR=V(^\3E;WQ[V4ZWWV4@V.0B
M3L ?3B:X][.0;GHZ,G8$1T%'B=RRYGRX$Y;[30S7(C-^$:,M1&;WSH+?V'13
MJ$;&-KP&41%VM$"[6=#:H=1^R1%8VIJ;J [V:WG&1\HM.N'(CY)"OMV-8M\@
MU)J).#0_^9U]OFXG(TP-&J;^98M$6+/C.\VND<F3)?BZ!$!#E5D1FG3E+J[;
M8_ND0*P.[LT"YS;$B$MZY5B2^KY=07"P^]T-$/,$PY=VL*0/X14H*$M7U_6-
M]O*@YNML83%#"TZ!B8P*_5-C_Y8GWOB%'?*DWR$UEYI&_;>:I*CZ13T><#\_
M<:7)A]DR*3([R<-J&&.T0HRM3 QA6<*[RD7FAR%6!+&9S[@\]P?>FTU=#^NM
MJ_.JQX/7CMJ]<5O_<T(12$<!0: "T#P8W<VO>&K 7L-.#@U%=-U;V@M'Z+Z2
MI.\]EZHXHVK2-4(+TU(0S^\]K>NSL;CK7%&FA:MXN PS</ZJ:"Z/PF.J?=HA
M*CX<UX;A@[T*0-=Z77;MTX3::Q[DF1LYY#$UP+?*;)V5Y\DPU4ZZ3Q6T/!_U
MRYU=:TZR9];:V,O%0QY!M>-G[":!)IY9^9,B%NKOH @K>Z# F_*,^&(1>#WP
MN#RY64ANT7D(J0VP .Q3AB>:!U;0J=H<@\!I6V]>Y#Q#B#/;AJ8\D2PJ;/L'
MEM&FKMTAC2UH*#"[%@MPILD!OA6HOFFZ3K&#,7]/<PJP !):T)H<;RN4(A4S
MG4,:QP>?^3H7\1*W1[C",?V9YKGT+/U&%A6G8N5F\0Q=HL'(#85X31?O%=6.
M<36^RT$]DA[5L+.,Z0=?NAT]#D=RR")#@O3Z%.!_)O?%;:V0QLR=*)':V0,I
MXUDH6[^2 @"[AKR]/&@OS_%RF;,$%B,V?)U8]34R]VY%M<,ZS-DI-J^R;8#T
M5!O%-S3Y*<1OUL3BM62]8>W@:Y&2>6.6[KVZQ+ZM(&+454:A*!K/DF[I A@I
MUV+#B5[.()PFU (/-2_2:5'4<=<@>U?J;Y2J/28#5CP!(>.!E@7^F9'2:,IX
ME@(O&7-%C[<+Y$4@OZ!9RGV7?0N'! G\8"#02FBH="_&G/.<C8^Y][:=J.W%
M[(LY,B2RJRG::^@!WKT $T:%UERF%Y/T(4WPKBJ^3:;$B<+6[3.;1^-= )='
MNZ-NB('4-3\($=,FVT<GNLN (U^_HL%'H _=-9 %NU=42-CQ_E9E:[MK3($>
MM$L,O1%QN3/>EL^9SE+]8%.QM*(*C0,3' ;C+!S?UN"NY-BZ+7948$V39I0D
MXJ,X$L4>B<0X.]&LC,[F2!_O6QS9U_E"+;1<961P&/JA LSD]3%[^F?GI'SC
MV9#L.R!R,H?-S72E^P/!YL+OJ/_&[V>-<VF==9K.N/"GH:'F7-<+-/' H"''
MR%C[L6.7G8N^KBFI:4:(OUH1Q_;F\'0X\::09Y6[OD(?2#MY.MI8'_>)=.N3
M7'4_N:]G%4],70Y/QY*''IAG=L!OZ>I"3,73X!V@7#6YTJ=-;F]:-L Y WWF
M'R,4].UQ;.A:4>ZQYD)$.QIVHRY=)9-!X %M7A(E13"V@OC>(YV)BDE'T&8O
M4JA@YT3 XS;A>&JT^<[53LBZ^R/0K;P9)WCX/*D@XR7Q)H;\D486>5#&#;.M
M^:@T.%W83M=^627V&$'SPBU>!%@N]_L\>'NG>5='9M#95&7!]X>\,G;S!@.N
M@OBSL(F]3CLOM78%Y[V14+[8D$ :GF =C<C <6XGJJ&/JL](!3 3H=OAB0U+
M-[^@M-/U12SLE$8Z/Y4CZ422+SHGEN7\L_KBU<(*#:![_\YO*J\QYN>PXUS>
M>F2+5O1>%G9T*IS7&0ZW-._?@FBQ+%Q.(UTT4ELX);[X*)'A_#46^"JJSVK0
M19(,^+J]MX0\3HK(A23\0A)ZO1>NDB6!Q$[H&@IWJ8#;XE_=O7^\)21OP=@M
MBC1::*.:R-U4:W=A4()LT10(^;%Y%X>KPHKW$]GA2)5#-3:.S3NZ'-VCSO>>
M1.3+7= CIX\D#) 7)+D0K<FV>D_HO01OT.5TGGNOW<3WP]#+1>F5&GG%;^!T
MW[H7F%[S:SN;G_/;3S\J?+V,@?!H#DN'@\N+(YXFM!_ H-)+/&=%514K^G.I
MP4^6^ -X/B^*RG[ #=QK7=_\/U!+ P04    " #/@X963%DE7'0$  !3#@
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M=@:TOE7*/@Y<@/YOPO)?4$L#!!0    ( ,^#AE:D,]B4W (  )<&   9
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MTV$_(+IM@^W"JMJWGDQ9;&1^6N*7 [0SP/-"*;M9N #;;U'Z$U!+ P04
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M.%N1)4!;&0K"*">8,>-N-AYZ(\_SCOMWNPH[,W55^(5)0Z2DEGBC2KR14[P
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M*F=5XIPJ<4[!U]O#=R:V\S6!C'&I,O;C&I(9\)]-_EH)=;^>B@S/86"HAA3
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M)'SSD;%92)85<_J,237U%X=+]6$&7 >HZPO&Y,-"C_[5I][P#U!+ P04
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M+J>R\L!<>:/$NCA"=BN4$DEQN>(LY%DNH-_?":&>;_(!ZF.+L_\!4$L#!!0
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M-Q](*<B5?"%-N/I%FS+6T%!8<$'3$@PS2.-L^X^?2B-J .!I!U@EP#H78)<
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M@;J_9DP^GE0.VNU?\_\ 4$L#!!0    ( ,^#AE80>1_S-P0  "P6   9
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M=51#S4!G%-$V0*<95WH%&O5 FSIJ1CR'^B6D"JRT"C2+%:E$R0[DE0@\9&G
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M5 B:Z,N0X( P-4$^7U(JW@9J@;)!//L/4$L#!!0    ( ,^#AE90=,PCDP,
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M+ZOG0C70(B^OZ*70YL(ONZEY8J&T&\QZ(H3>#JR#YM$6_@%02P,$%     @
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M(O@>A)FMU4S#AFJM-1PMS*JLE-!OJ;93T5+0'5$(2T9BU-E6<$>$((62<+I
M12B39Q-7:4]FOAO7JO-*-7A!U0_@FA<JD_"A2#!Y+N!JQ(8S.'#.@T[%!<8]
MZ/OO(/"" &Y7"S@].8,3<$%F1*"L'QV>^DU&^M;3X,\S<G^-^1K%M[:$=(J:
MLW4A2RTX=?3AD2AVZ$1OW_BA][X#>= @#ZQZ_Q\6$>X_:RNX4IC+U@ &KQ#
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M,!/T^PWGZM Q#IJ/D>@74$L#!!0    ( ,^#AE8"J34%@PD   )Y   9
M>&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;+W=6V_B2!H&X+]28E>K'FD6L V$
M9!.D3GSVMB;J[$Q?C/:B I7$:A^8*I-T_OV4#\$4F J>>;MONH'P/66"W[B,
M/^S+EYQ_%4^,%>1;FF3B:O!4%.N+T4@LGUA*Q3!?LTS^Y"'G*2WD7?XX$FO.
MZ*HJ2I.1.1[/1BF-L\'BLGKLEB\N\TV1Q!F[Y41LTI3RUVN6Y"]7 V/P]L#G
M^/&I*!\8+2[7])'=L>+7]2V7]T9;916G+!-QGA'.'JX&'XV+R)J5!=4S?HO9
MB]BY3<J7<I_G7\L[P>IJ,"Z7B"5L690$E?\]LQN6)*4DE^./!AULQRP+=V^_
MZ6[UXN6+N:>"W>3)EWA5/%T-Y@.R8@]TDQ2?\Q>?-2]H6GK+/!'5O^2E?NYL
M.B#+C2CRM"F62Y#&6?T__=;\(G8*C,F1 K,I,$\ML)H":[_ .E(P:0HFIXXP
M;0JF^P7'7O2L*9B=.L)94W"V7S [4C!O"N:GCG#>%)R?6F",W]ZY\<DEVS>[
M7NGJM:1:Q6Q:T,4ESU\(+Y\OO?)&M9Y6]7+-BK,R4G<%ES^-95VQ^,P26K 5
MN:6\>"7_XS03M%K9!?E@LX+&B?B)_)O\>F>3#__\Z7)4R#'+RM&R\=W:-X_X
M!OF49\63($ZV8JN.>O^=>E,#C.2+W;YB\^T57YM:T6;+(3$F/Q-S;)H="W2C
M+P\WV9",9T?+;7WY)_I*C./5S@G+;AE5^;CKS="7N^Q^2,QY56YUE'OZ\H]K
M+E^Z>73A_=,7OJL\.+W<Z"@/3WGMTZ/ET2FCC[M^\\I::&US9U6>]7=R]_M_
M914)"I:*_W<L\G4]Q*1[B')C?"'6=,FN!G)K*QA_9H/%O_YAS,;_Z5KMD9B-
MQ!PDYB(Q#XGY2"Q 8B$2BT"8DKK)-G43G;ZXR=-4SN/D=G7Y]6>RIIP\TV3#
MR(<X(W:>))0+LF9RQOE$.>O:VEUK_;Z10V(V$G.0F(O$/"3FUU@Y#9-:N??Q
MO##&0[EY>-[-4OVL^<Z3SH>SN?JD$+E<$0A3,C+=9F2JS<C=6FZ$\B8#53+N
MRENB,PY:JF\<D)A=8[.=-\V<CL=C]5USD$.Z2,Q#8CX2"Y!8B,0B$*;$9K:-
MS4P;&Y?&;UN3_*$.CW@O/5JQ;WJ0F(W$'"3F(C$/B?FS4_[B!,@A0R06@3 E
M/6?;])R=FI[M_*O'K$R+]PT2$K.1F(/$7"3F(3'_[&"^-1F>3_=RA!PQ1&(1
M"%-R--_F:*[-T<='SMB*%#E)<IIU145;WS<J2,Q&8@X2<Y&8A\1\)!8@L1")
M134VW?F+8(W'N]M6)2SGV["<:\/R)>=?X^R1+.DZ+FA2149T94;+],T,$K.1
MF(/$7"3F(3'__&!EFIUU3-208X9(+ )A2F:,<7O :*Q-S2W/TUB(G+^2+"]8
M5U[T0M_ --KN&S95TU]G 3JJ ]5<J.:=^!OQH:,&4"V$:A%*4S.Q<Q#5T&8B
M$&(CIUV;3+#EALM;:S4DA*;Y)BLZLV(<;MLZ]AMO]$O0=[L!U1RHYD(U#ZKY
M4"V :B%4BU":FBBS392I393SC?%E+)A,4KSL\U& WNV][4%J-E1SH)H+U;Q&
M4X^L#*?[VR?DF %4"Z%:A-+4-+7-!H;VJ.KB.N>R1N[K=.[>Z(M[1P;:2 #5
M'*CF-MKNIMLT.N9A'G18OV-8P^SZJ+GCB7M/":%+%J$T=2UO#^X;^J/[MSQ^
MIG*R=9O(,5*6%>0+Y9QFA2"_?V+I/>.=731ZM??J#SVH#]4<J.9"-0^J^5 M
M@&HA5(M0FIJYMEG J ^J?M<^-@/:1@#5;*CF0#47JGE0S8=J 50+H5J$TM0$
MMGT'AK[QX+;:02IWBE[JK5V?G25H!P)4LZ&: ]5<J.9!-;_1]+M> 73,$*I%
M*$T-5-N*8.A[$8+;7_3S16BW 52SH9H#U5RHYD$U'ZH%4"V$:A%*4\/5]B<8
M\Q\P7X0V,4 U&ZHY4,V%:AY4\Z%: -5"J!:A-#6!;=.#H>]Z:.>+?;OL]'#O
MV$$;(:": ]5<J.9!-=\X[(8P#CY'A+9"0+4(I:E?)6V;(4Q],\3;ER6.']_5
M WU# ]5LJ.9 -1>J>5#--P_[+XS#C_T#Z* A5(M0FIJ;MF'"U#=,W"14"')-
M?N&K.*/\M?F6A':_2T_V3A*TGP*J.5#-A6H>5/.A6@#50J@6H30U<&T_A6E^
M__TN$]I; =5LJ.9 -1>J>5#-AVH!5 NA6H32U 2V/1BFO@?C1F8M7C%.JU,)
MG?8%03W9.W#0S@RHYC3:[K?GSHQYV9>M3JI<Z+ >5/.A6@#50J@6H30U2VVG
MAZGO]/C[YW'0#] [6="F#ZCF--K9;A?04.ZL&/O!@K9S0#4?J@50+81J$4I3
M@]6V<YCOG/RAWBS%=3_[>ULG:-L&5+.AF@/57*CF034?J@50+30/S^EA3*S#
M.4*$&E8-4=N18>H[,K8?:C23O'Q3B()FJ_*[AN]%"MJ0 =5LJ.9 -1>J>5#-
MAVH!5 O-PY-6S&<=O<01:E@U4FU/AJGOR;!CSI9%SO4?$$(;,Z":#=4<J.9"
M-0^J^5 M@&HA5(M0FIJPMC'#_ &-&2:T,0.JV5#-@6HN5/.@F@_5 J@60K4(
MI:D);!LS3'UCQE\Y@YB>[!TX:$L&5'.@F@O5/*CF-YJRFV.6NSG[AY>A;1E0
M+4)IZKF5V[8,2]^6<;T1\A$AR$V>WLM]L>HC=]W44>_US1%4LZ&: ]5<J.9!
M-1^J!5 MA&H12E/3UC9S6,;WGSI:T.X.J&9#-0>JN5#-@VH^5 N@6@C5(I2F
M)K#M[K#T9\NHVZD^DGSODT?VQX8F0CY,V+<E8RO1XPB9?LC>@80V>T U!ZJY
M4,V#:GZCJ:<.V)M60D<,H5J$TM28[5RS0]_"X>:;;"5#<T*SHE[JG1[LQ3FP
M5^? 7IX#>WT.[ 4ZL%?HP%ZB WN-CN_1WF&U[1W6Y =,**$='E#-AFH.5'.A
MF@?5?*@60+40JD4H34U@VP=BG781D./?:]$#O>,%;?Z :DZC*:=Y.CQ"ZD('
M]:":#]4"J!9"M0BEJ;EI6S^L4T_&T??+E7JX=YZ@G1]0S6DTP]H)5-F1:.T'
M"MK3 =5\J!9 M1"J12BM#M1HYTJE*>./U<5T!5F66YGZXHG;1[<7[/U87:9V
M[W'7N/",CL=]XR*HKXS:\O75@3]1_AC+&63"'N10X^&9_$O!ZPONUG>*?%U=
M)_4^+XH\K6X^,2KW]\HGR)\_Y'GQ=J<<8'O9X\6?4$L#!!0    ( ,^#AE:^
M=@PP]P0  ! ?   9    >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;+V9;6_;
M-A#'OPJA#44*M)%(V[*3V@82:\4*+%C0(-N+8B\8Z6P3D425I.T6V(<?]1#)
MLA7&ZMCD1:P'WO]X/^GH.W.ZX^)1K@$4^I;$J9PY:Z6R2]>5X1H2*L]Y!JF^
ML^0BH4J?BI4K,P$T*HR2V"6>Y[L)9:DSGQ;7;L5\RC<J9BG<"B0W24+%]VN(
M^6[F8.?IPF>V6JO\@CN?9G0%=Z#NLUNAS]Q:)6()I)+Q% E8SIPK?!F086Y0
MC/B+P4[N':,\E ?.'_.33]',\?(900RARB6H_MC" N(X5]+S^%J).K7/W'#_
M^$G]8Q&\#N:!2ECP^&\6J?7,F3@H@B7=Q.HSW_T.54"C7"_DL2S^HUTYUA\Z
M*-Q(Q9/*6,\@86GY2;]5(/8,\',&I#(@AP;^,P:#RF!PJH=A95"@=LM0"@X!
M570^%7R'1#Y:J^4'!<S"6H?/TORYWRFA[S)MI^8+GB1,Z0>I)'I#D^P#6O!4
ML70%:<A HK, %&6Q?(O>H_N[ )W]^G;J*NTX-W?#RLFB=$*><8()NM&J:XE^
M2R.(V@*NGG$];?(T[6MB5+RAXAQYY!TB'L%=$S*;!Q">HP$NS$F'>7"Z.39$
M,Z@?PJ#0&_SOA_#E#VV*/BE(Y#\=\[XN_0R[_>1KR*7,: @S1R\2$L06G/F;
M7[#O?>AB:%,LL"36XCNL^0Y-ZO-[_=:)G6 Y4A0Q&?)-JA!-\H\NBJ7:J%#+
M%\[MW!]Z(\_SINYV']")XP+C['XP]E$=^\@8>P!+$ (BM.F"\ YE(/0MIM 9
M2U' XY@*65R4:RJ@*]FO2X>3O;"]\\'H@(UQ5GU?'DMB+8!^#= W KQ:K02L
MJ +#"^,?O0B8>...-\;HJB\52V(M*N.:ROCTE%H"=%$Q*O1=C$HQ?P_QA3?R
MR>@PURPY;4&9U% F1BBW5"A&8UT/;4%(?<"72 F:2EH6.2&72G:1,LKV)34Y
M(D7&V)^,#T!9\MD"=5&#NC#G5!2QG(A&E%$6O==+3T@SIFC<1<>HU9?.Q1&=
MR7@R'/F# SR6G+;P8*^IRCPCH,U!>FE,W^E##/==?,Q:?0%5:ON$!AZ>C(\R
MK1IH7/7:X>\5I=C\?H1?-TQP@194KCM#-MKW#AD?A8R]ZN\P:$N.VV!( X:<
M^&64;42XU@T/R@0+.Y=?LU1O1N191H>(+/EM(VIJ:6PL)>=_BHBENH5%=WD!
M(]&7&T@>0'26RV:IWHBL%LRVU-H8FY(9#U^I)\&6RM\*LDVUP)9:&W)3FV-S
M<?[R.F>SC%Y4:J-3UKF?47+CIN;&YJ)[$5,IT17JE<PVB^N%5;7 EEH;9U.L
MX_%K);/5HMZJ6F!+K0VY*?ZQN?K/(>LB7RH>/NJ^F@JTI?$&>C369@>]X99J
MXU:?KC,='Z;ZB^/:0)HB'YNK_)>2&/W;+[^M]@%6U0);:NT?0YMV@7BOE-_$
M:B]A52VPI=:&W#0EY(6FI%?3:A;K#?('U% GPY_1OY"F?R'F_N5Z(_45O2KH
M-_9!9W[QLX@IZ<UZO3':5 MLJ;59-HT.>:U= V*U#;*J%MA2:T-NVB!BWCIX
ML4(WV_=F=[RE\%R%;LMQ"<;=VT),0*R*K5B)BDV"<C>QOEIO]UX5FYQN,[S<
M*[ZA8L52B6)8:E/O?*RC$>7V:WFB>%9L2#YPI7A2'*Z!1B#R ?K^DG/U=)([
MJ#?!Y_\!4$L#!!0    ( ,^#AE8=SA5=.P4  #@;   9    >&PO=V]R:W-H
M965T<R]S:&5E=#,Y+GAM;+U9VV[;.!!]SU<0:E"T@&M=?$WJ&$BB+;; !@V:
MO3P4^T!+8TN()&I)VD[VZW<H*9+MR(RL%1H$L2C/G)DY)(<SX6S+^*,( "1Y
MBJ-$7!F!E.FE:0HO@)B*/DLAP6^6C,=4XI"O3)%RH'ZF%$>F8UEC,Z9A8LQG
MV;M[/I^QM8S"!.XY$>LXIOSY!B*VO3)LX^7%]W 52/7"G,]2NH('D'^D]QQ'
M9HGBAS$D(F0)X;"\,J[M2]>QE$(F\6<(6['S3%0H"\8>U>"K?V58RB.(P),*
M@N+'!FXABA02^O%/ 6J4-I7B[O,+^I<L> QF007<LNBOT)?!E3$UB ]+NH[D
M=[;]%8J 1@K/8Y'(_I)M+CL:&<1;"\GB0AD]B,,D_Z1/!1$["O;XB()3*#B'
M"L,C"H-"87"@,+6.* P+A6'&3!Y*QH-+)9W/.-L2KJ0133UD9&;:&'Z8J'E_
MD!R_#5%/SA\"RB%@D0]<O'\W=>S)9^+",O1"23ZX(&D8B8_D$SDG)A%*5LQ,
MB7:5MND5-FYR&\X1&[9#[E@B T%^27SP]P%,=+CTVGGQ^L;1(KK@]<G [A''
M<IP:AVZ;J]LUZFYS=4L3S:"<@T&&-_A?<_#C-U0C7R7$XN^Z.<AM#.MMJ/1Q
M*5+JP96!^4$ WX Q?__.'EN?Z_CK$LSM"&R/VV')[5"'/K_'- *<@T]P*WF/
MO6(1$[J6 >/AOX?+,><RQQQGF"IS;N:VE?W,S,TN30WE7*V/+1D8E0R,3F,@
MI9QL:+0&\B%,B,NBB')!4N Y-Q_K",E-3'8"M?H8IGW 1S,Q5^MP2SK&)1WC
M!G1 XD&Q%,HE$0JQKE\.6L1Z?TG=KNH(QVV!\R9_DY*_24O^L*H0DB9^F*SJ
M2-3"GD!B1SAN"YPW29R6)$ZU)'[CR!*6626%/@B/AZDJA>JXTZ*=FMN[!'/U
M<<H R$/*$L$XIIW0)^?.J(<)H7>&+VB:<O848NT&T3,Y5YEB4*6A'I&,>&R#
M8P\XGH$)84M<>;BZ\+60N%\3?, "%(]-FM606 632<^>3GHCRR*W$16"W!!V
MR'65_\[S['16&NV3;PGY @N^5@KH:U8AH"L8QRV+4YH\$T O/(GIE.8ZQ \W
MZ$/BDVV &V/QO">=)Q5B]X:#-]S"/UBK8GAG&!C%W]6*PPK)P;C)M#?.F3NF
MO[O[^OET74=1X2&^5L1^*D8Q6R?(7T W0!8 JGZ7G.45.,X$HDDTZY_A!.!F
M5Q5Z%M)^M'W--K@HM\&%=GG\SB2-2+*.%S@!&*4F)N6_!XG$7J1N@^1V+O8.
M'N?@<-+Z<NJZ[PALCS;;JHIV2TM<O@BN29E''G+"?MR!XK*V/M1#GII$.D5S
MNT+;IW.G![)_0@%>&.F*X"[1W*[0]@EV*H(=_7IE<8P)^I02O$#<K:T=RZJM
MPIN+NGH_V_)0-7JVMM=Y?>ZWJ<4+&V\6XPWE7+W/;3FI&C1;WZ&]XJ19.6F_
M[KT&PU'M\F@JZ>H];<M$U:C9^D[MY6@_*:MWU$L55'6)YG:%MD]GU>C9XY^1
MU3MJM@J"NT1SNT+;)[CJ!&U]*]@FJT^.INK#7=M4TM5[V9:%JI6S3^SE6N7T
M:<.<WDS.U?O<EI.JKK?UA7W;G'[Q:LZGV/?4+(Z&@J[>SY8\.%6=[NCK]&,\
M'/]74P'X-@5-!5V]BZ=28.Y<-<3 5]F5C<!&'%O*_-:A?%M>"UUGER%F)9[?
M*=U1O@H302)8HJK5G^!QP?-KFGP@69I=7"R8E"S.'@.@F,Z5 'Z_9$R^#)2!
M\K)L_A]02P,$%     @ SX.&5B0T!B\@"   7AP  !D   !X;"]W;W)K<VAE
M971S+W-H965T-# N>&ULM5E;;]LX%G[7KR \W8$#)+;D-/<+D*0=;(#M-FBQ
MTX?!/M#2D<6-)*HD9<?SZ_<<4E?'4=(@>4DLB3S\SOT[TOE*JGN= !CVD*6Y
MOA@EQA2GTZD.$\BXGL@"<GP22Y5Q@Y=J,=6% A[935DZG?G^X33C(A]=GMM[
M=^KR7)8F%3G<*:;++.-J?0VI7%V,@E%]XYM8)(9N3"_/"[Z [V#^4]PIO)HV
M4B*10:Z%S)F"^&)T%9Q>!T>TP:[X4\!*=WXS4F4NY3U=W$87(Y\000JA(1$<
M_RWA!M*4)"&.GY7047,F;>S^KJ7_895'9>9<PXU,?XC()!>CXQ&+(.9E:K[)
MU3^A4NB Y(4RU?8O6[FU^T<C%I;:R*S:C @RD;O__*$R1&?#L?_$AEFU869Q
MNX,LRD_<\,MS)5=,T6J41C^LJG8W@A,Y>>6[4?A4X#YS^8,KQ7.CV?@3&"Y2
MO7,^-2B7GD[#2L:UDS%[0D8P8U]D;A+-/N<11'T!4P34H)K5J*YG@Q(_03AA
M^\$NF_FS&?O IDPG7($>$+W?*+QO1>^_6&'VU[]P#;LUD.G_;M/>"?RX72"E
MS:DN> @7(\P+#6H)H\O??PL._;,!N!\;N!^'I-=P&3P40G$;R 94M@WFL* #
MM@:NABQXT$ Z&)1T5\Y3$;+&D']]@6P.:JOI!B6]TG2'#<[#M_;TX3O /6K@
M'KW0TZ!"H8$52H2P#:63$_A6$)7=Y6403 [.I\LMQQ\WQQ\/'G][]W70DX.[
M7VF:DP;;R5M[\N0=X 9^6U3]%_GRJ51]9GM@<W4(2:>\!X.B;E*N-;MB7U4D
M<FR[[+LMI(.N'A;Y6N/-6LBSM_9V)?&-$;<M)1AL ;^0NI6@%^9NT':)8+BZ
M?X,(LH+:@V8R9JO*A+M(4'2HA'VR%<]+Q9+4QC$_$L VE "[(SU9 8K9.',F
MO?+ZP<8^_RQYBK@4^_P0 D2:?0B.)[[OEG_-400)JT&S.80R@]J:?)["KEUP
M([."YVLOXVLDA!% 9F\CU]2&YWCDHI4Q!CRJ,,BF3(*+=8$LD!E9HUYR@_]3
M# EDF*;1;.?487)_O=]_.SD\.CD3.5LE,@6&A[!<&H8W"J[,QC)N&'>>)V-]
M\"=^8$U38=I8719H5!*6 B:H27C.]GT6\35:\7@6')V1*#392@ECP"ZM)*O6
M*6-2A];/_+-]?R^J#%,]Q<.%C.SCX&R'M <>)C4>#U6*0)V15AOZQKM659FG
M:T87= KZUZ#P0BH#$=,\A597ZYRJT,C:]XZQ,1P<4-@:F1PSBELGD9+6,6A'
MCEKO=1Y4H#UP_C2) F#S4F-@HGB[<PXH$[H1P30NU[5[MUJJ>E;ISISNNF?
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M*X0V#"V01"+E5S+;0.,L6( $,)JU_5#L RU=VT0IT2,IN_OWHQZ6+%LFK%3
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MM[W1V41ORT1OVZT/B,,SB^/V=.!)WS>?HU1/VQTOHEJFV*OJN&?-=2[9EFI
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MS-\?BJ)\WJ@*[&Y!-_L'4$L#!!0    ( ,^#AE9KL>B66 ,  -05   -
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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MP;7MD\*M+\O^J3W@!C&T)Q).V,NR Z>#/(.R4;*$NY?LE"NN"\&ZX+H ,$$
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M&^IM!'H;ZFT$>EMGLX1 ;T.]C4!O0[V-0&]#O8U ;T.]C4!O0[V-0&]#O8U
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M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
MSX.&5OKYIHON    *P(  !$              ( !KP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ SX.&5IE<G",0!@  G"<  !,
M ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #/@X96#\>;
M.%,'  "W*P  &               @($-"   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ SX.&5I@2(**[!0  T1<  !@
M ("!E@\  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( ,^#
MAE;PH7#T2P,  *,.   8              " @8<5  !X;"]W;W)K<VAE971S
M+W-H965T,RYX;6Q02P$"% ,4    " #/@X96=J(Y&-T$  !W$P  &
M        @($(&0  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%
M  @ SX.&5GHNG?]X @  3P<  !@              ("!&QX  'AL+W=O<FMS
M:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( ,^#AE9L"\XP:08  $(H   8
M              " @<D@  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"
M% ,4    " #/@X96&&@(IE\"  #Y!   &               @(%H)P  >&PO
M=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ SX.&5J!1_'+4!@
M!!\  !@              ("!_2D  'AL+W=O<FMS:&5E=',O<VAE970X+GAM
M;%!+ 0(4 Q0    ( ,^#AE:.XW4MCQ<  %Y'   8              " @0<Q
M  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #/@X96[5ZE
M_$0&  !0$@  &0              @(',2   >&PO=V]R:W-H965T<R]S:&5E
M=#$P+GAM;%!+ 0(4 Q0    ( ,^#AE9W9P!Y AH  .!,   9
M  " @4=/  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @
MSX.&5D<:/,8/!@  3P\  !D              ("!@&D  'AL+W=O<FMS:&5E
M=',O<VAE970Q,BYX;6Q02P$"% ,4    " #/@X96_?WYN.L#   !"0  &0
M            @('&;P  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4
M Q0    ( ,^#AE:QTQ7G)PT  +PC   9              " @>AS  !X;"]W
M;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ SX.&5L.&)%W%#
MGB<  !D              ("!1H$  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX
M;6Q02P$"% ,4    " #/@X96Y\ H2&4&   D$   &0              @(%"
MC@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( ,^#AE9C
MMD*I20L  &PB   9              " @=Z4  !X;"]W;W)K<VAE971S+W-H
M965T,3<N>&UL4$L! A0#%     @ SX.&5C/;BI*%"@  'B   !D
M     ("!7J   'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,^#AE:D,]B4W (  )<&   9              "
M@>C:  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ SX.&
M5JH3.@1Y!0  LA$  !D              ("!^]T  'AL+W=O<FMS:&5E=',O
M<VAE970R-"YX;6Q02P$"% ,4    " #/@X96W%/G<>4&  #0,P  &0
M        @(&KXP  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0
M   ( ,^#AE8/Z!Z66 (  !0&   9              " @<?J  !X;"]W;W)K
M<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ SX.&5LY57"%J P  ]@T
M !D              ("!5NT  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q0
M2P$"% ,4    " #/@X962YH)&)@%  #"*   &0              @('W\
M>&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( ,^#AE9E@4V<
M/00  ,4;   9              " @<;V  !X;"]W;W)K<VAE971S+W-H965T
M,CDN>&UL4$L! A0#%     @ SX.&5IJ*<P3= P  #Q(  !D
M ("!.OL  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " #/
M@X96']- G^T%   *)@  &0              @(%._P  >&PO=V]R:W-H965T
M<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( ,^#AE80>1_S-P0  "P6   9
M          " @7(% 0!X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#
M%     @ SX.&5E!TS".3 P  % X  !D              ("!X D! 'AL+W=O
M<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #/@X96EL0K_>4"  #
M"0  &0              @(&J#0$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM
M;%!+ 0(4 Q0    ( ,^#AE84XDRX80,  * *   9              " @<80
M 0!X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ SX.&5@=E
M[:?+ @  F @  !D              ("!7A0! 'AL+W=O<FMS:&5E=',O<VAE
M970S-BYX;6Q02P$"% ,4    " #/@X96 JDU!8,)   ">0  &0
M    @(%@%P$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    (
M ,^#AE:^=@PP]P0  ! ?   9              " @1HA 0!X;"]W;W)K<VAE
M971S+W-H965T,S@N>&UL4$L! A0#%     @ SX.&5AW.%5T[!0  .!L  !D
M             ("!2"8! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"
M% ,4    " #/@X96)#0&+R (  !>'   &0              @(&Z*P$ >&PO
M=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( ,^#AE:ZW\W]]@(
M &P+   9              " @1$T 0!X;"]W;W)K<VAE971S+W-H965T-#$N
M>&UL4$L! A0#%     @ SX.&5N,N9 M<!@  JRT  !D              ("!
M/C<! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " #/@X96
M:^]0NRL#  !_"0  &0              @('1/0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0S+GAM;%!+ 0(4 Q0    ( ,^#AE9 ?$MZ/00  &H4   9
M      " @3-! 0!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%
M  @ SX.&5I/5=/!<!   E1<  !D              ("!IT4! 'AL+W=O<FMS
M:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " #/@X96Y=^)=-('  ".3@
M&0              @($Z2@$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+
M 0(4 Q0    ( ,^#AE9KL>B66 ,  -05   -              "  4-2 0!X
M;"]S='EL97,N>&UL4$L! A0#%     @ SX.&5I>*NQS     $P(   L
M         ( !QE4! %]R96QS+RYR96QS4$L! A0#%     @ SX.&5FT3"RWJ
M P  )A\   \              ( !KU8! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( ,^#AE;]+-6EK@$  ,$;   :              "  <9: 0!X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,^#AE8F^H>GM0$
M -P;   3              "  :Q< 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     V #8 L0X  ))> 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>149</ContextCount>
  <ElementCount>261</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>25</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Consolidated Statements of Operations (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals</Role>
      <ShortName>Consolidated Statements of Operations (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Consolidated Statements of Changes in Shareholders??? (Deficit) Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders??? (Deficit) Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - Consolidated Statements of Changes in Shareholders??? (Deficit) Equity (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3_Parentheticals</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders??? (Deficit) Equity (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Statement - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Organization and Business Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperations</Role>
      <ShortName>Organization and Business Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Revision of Previously Issued Financial Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatements</Role>
      <ShortName>Revision of Previously Issued Financial Statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Initial Public Offering</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/InitialPublicOffering</Role>
      <ShortName>Initial Public Offering</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Private Placement Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrants</Role>
      <ShortName>Private Placement Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Commitments &amp; Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingencies</Role>
      <ShortName>Commitments &amp; Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Shareholders??? Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficit</Role>
      <ShortName>Shareholders??? Deficit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Revision of Previously Issued Financial Statements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables</Role>
      <ShortName>Revision of Previously Issued Financial Statements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatements</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Initial Public Offering (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingTables</Role>
      <ShortName>Initial Public Offering (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/InitialPublicOffering</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Organization and Business Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails</Role>
      <ShortName>Organization and Business Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperations</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Revision of Previously Issued Financial Statements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsDetails</Role>
      <ShortName>Revision of Previously Issued Financial Statements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Revision of Previously Issued Financial Statements (Details) - Schedule of restatement of financial statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable</Role>
      <ShortName>Revision of Previously Issued Financial Statements (Details) - Schedule of restatement of financial statements</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable</Role>
      <ShortName>Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of operations</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of operations (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals</Role>
      <ShortName>Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of operations (Parentheticals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of cash flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable</Role>
      <ShortName>Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of cash flows</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - Significant Accounting Policies (Details) - Schedule of unrealized holding losses and fair value of held to maturity securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable</Role>
      <ShortName>Significant Accounting Policies (Details) - Schedule of unrealized holding losses and fair value of held to maturity securities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - Significant Accounting Policies (Details) - Schedule of basic and diluted net income per share for each class of ordinary share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable</Role>
      <ShortName>Significant Accounting Policies (Details) - Schedule of basic and diluted net income per share for each class of ordinary share</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - Initial Public Offering (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails</Role>
      <ShortName>Initial Public Offering (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - Initial Public Offering (Details) - Schedule of the ordinary share reflected on the balance sheet are reconciled</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable</Role>
      <ShortName>Initial Public Offering (Details) - Schedule of the ordinary share reflected on the balance sheet are reconciled</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - Private Placement Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails</Role>
      <ShortName>Private Placement Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrants</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactions</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - Commitments &amp; Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails</Role>
      <ShortName>Commitments &amp; Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingencies</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>038 - Disclosure - Shareholders??? Deficit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails</Role>
      <ShortName>Shareholders??? Deficit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficit</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>039 - Disclosure - Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails</Role>
      <ShortName>Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/Warrants</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>040 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>041 - Disclosure - Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable</Role>
      <ShortName>Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>042 - Disclosure - Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable</Role>
      <ShortName>Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>043 - Disclosure - Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable</Role>
      <ShortName>Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>044 - Disclosure - Fair Value Measurements (Details) - Schedule of changes in the fair value of level 3 warrant liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable</Role>
      <ShortName>Fair Value Measurements (Details) - Schedule of changes in the fair value of level 3 warrant liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="f10k2022_freedomacq1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>045 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.FreedomAcquisitionICorp.com/role/SubsequentEvents</ParentRole>
      <Position>46</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 16 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:EarningsPerShareDiluted -  f10k2022_freedomacq1.htm 10772, 10773, 10774, 10775, 10827, 10828, 10831, 10832, 10835, 10836, 10839, 10840, 10843, 10844, 10847, 10848</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Not-Referenced] WARN: 6 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:EarningsPerShareDiluted -  f10k2022_freedomacq1.htm 10829, 10833, 10837, 10841, 10845, 10849</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="f10k2022_freedomacq1.htm">f10k2022_freedomacq1.htm</File>
    <File>f10k2022ex31-1_freedomacq1.htm</File>
    <File>f10k2022ex31-2_freedomacq1.htm</File>
    <File>f10k2022ex32-1_freedomacq1.htm</File>
    <File>f10k2022ex32-2_freedomacq1.htm</File>
    <File>f10k2022ex4-1_freedomacq1.htm</File>
    <File>fact-20221231.xsd</File>
    <File>fact-20221231_cal.xml</File>
    <File>fact-20221231_def.xml</File>
    <File>fact-20221231_lab.xml</File>
    <File>fact-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="445">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>65
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "f10k2022_freedomacq1.htm": {
   "axisCustom": 0,
   "axisStandard": 11,
   "baseTaxonomies": {
    "http://fasb.org/srt/2022": 4,
    "http://fasb.org/us-gaap/2022": 445,
    "http://xbrl.sec.gov/dei/2022": 39
   },
   "contextCount": 149,
   "dts": {
    "calculationLink": {
     "local": [
      "fact-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fact-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "f10k2022_freedomacq1.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fact-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fact-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "fact-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd"
     ]
    }
   },
   "elementCount": 394,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 101,
    "http://www.FreedomAcquisitionICorp.com/20221231": 37,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 142
   },
   "keyCustom": 77,
   "keyStandard": 184,
   "memberCustom": 5,
   "memberStandard": 20,
   "nsprefix": "fact",
   "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:CondensedFinancialStatementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - Revision of Previously Issued Financial Statements",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatements",
     "shortName": "Revision of Previously Issued Financial Statements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:CondensedFinancialStatementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fact:ProposedPublicOfferingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - Initial Public Offering",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOffering",
     "shortName": "Initial Public Offering",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fact:ProposedPublicOfferingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fact:PrivatePlacementWarrantsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - Private Placement Warrants",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrants",
     "shortName": "Private Placement Warrants",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fact:PrivatePlacementWarrantsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - Related Party Transactions",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - Commitments & Contingencies",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingencies",
     "shortName": "Commitments & Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - Shareholders\u2019 Deficit",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficit",
     "shortName": "Shareholders\u2019 Deficit",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c102",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fact:WarrantsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - Warrants",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.FreedomAcquisitionICorp.com/role/Warrants",
     "shortName": "Warrants",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c102",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fact:WarrantsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.FreedomAcquisitionICorp.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c4",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c4",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - Accounting Policies, by Policy (Policies)",
     "menuCat": "Policies",
     "order": "20",
     "role": "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - Revision of Previously Issued Financial Statements (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables",
     "shortName": "Revision of Previously Issued Financial Statements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - Initial Public Offering (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingTables",
     "shortName": "Initial Public Offering (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c99",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherUnderwritingExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - Organization and Business Operations (Details)",
     "menuCat": "Details",
     "order": "25",
     "role": "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
     "shortName": "Organization and Business Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": "0",
      "lang": null,
      "name": "fact:NetTangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableOtherCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - Revision of Previously Issued Financial Statements (Details)",
     "menuCat": "Details",
     "order": "26",
     "role": "http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsDetails",
     "shortName": "Revision of Previously Issued Financial Statements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c1",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableOtherCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c46",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Liabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - Revision of Previously Issued Financial Statements (Details) - Schedule of restatement of financial statements",
     "menuCat": "Details",
     "order": "27",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable",
     "shortName": "Revision of Previously Issued Financial Statements (Details) - Schedule of restatement of financial statements",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c46",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Liabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c49",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of operations",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable",
     "shortName": "Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of operations",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c49",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "028 - Disclosure - Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of operations (Parentheticals)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals",
     "shortName": "Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of operations (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c4",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c2",
      "decimals": "0",
      "lang": null,
      "name": "fact:SharesSubjectToPossibleRedemption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c49",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "029 - Disclosure - Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of cash flows",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable",
     "shortName": "Revision of Previously Issued Financial Statements (Details) - Schedule of condensed statement of cash flows",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedCashFlowStatementTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c46",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c4",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "030 - Disclosure - Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c4",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c5",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "fact:TradingSecuritiesFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "031 - Disclosure - Significant Accounting Policies (Details) - Schedule of unrealized holding losses and fair value of held to maturity securities",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable",
     "shortName": "Significant Accounting Policies (Details) - Schedule of unrealized holding losses and fair value of held to maturity securities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c5",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "fact:TradingSecuritiesFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c9",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "fact:AllocationOfNetIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "032 - Disclosure - Significant Accounting Policies (Details) - Schedule of basic and diluted net income per share for each class of ordinary share",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable",
     "shortName": "Significant Accounting Policies (Details) - Schedule of basic and diluted net income per share for each class of ordinary share",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c9",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "fact:AllocationOfNetIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c4",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "fact:SaleOfOrdinarySharesRedemption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "033 - Disclosure - Initial Public Offering (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails",
     "shortName": "Initial Public Offering (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c4",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "fact:SaleOfOrdinarySharesRedemption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "fact:ProceedsFromGrossProceedsFromIPO",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "034 - Disclosure - Initial Public Offering (Details) - Schedule of the ordinary share reflected on the balance sheet are reconciled",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable",
     "shortName": "Initial Public Offering (Details) - Schedule of the ordinary share reflected on the balance sheet are reconciled",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "fact:ProceedsFromGrossProceedsFromIPO",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c85",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "035 - Disclosure - Private Placement Warrants (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails",
     "shortName": "Private Placement Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c85",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c4",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "036 - Disclosure - Related Party Transactions (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails",
     "shortName": "Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c92",
      "decimals": "0",
      "lang": null,
      "name": "fact:SponsorShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c99",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherUnderwritingExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "037 - Disclosure - Commitments & Contingencies (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
     "shortName": "Commitments & Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c99",
      "decimals": "2",
      "lang": null,
      "name": "fact:DeferredUnderwritingDiscountPerUnit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c4",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "038 - Disclosure - Shareholders\u2019 Deficit (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails",
     "shortName": "Shareholders\u2019 Deficit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c17",
      "decimals": null,
      "lang": "en-US",
      "name": "fact:OrdinarySharesDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fact:WarrantExpirationTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "039 - Disclosure - Warrants (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails",
     "shortName": "Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fact:WarrantExpirationTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "fact:FairValueWarrantLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "040 - Disclosure - Fair Value Measurements (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "fact:FairValueWarrantLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "fact:InvestmentsHeldInTrustAccountUSTreasureSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "041 - Disclosure - Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable",
     "shortName": "Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "fact:InvestmentsHeldInTrustAccountUSTreasureSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c4",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "042 - Disclosure - Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable",
     "shortName": "Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c4",
      "decimals": "2",
      "lang": null,
      "name": "fact:FairValueMeasurementStrikePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c117",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueNetAssetLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "043 - Disclosure - Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable",
     "shortName": "Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c125",
      "decimals": "0",
      "lang": null,
      "name": "fact:FairValueInitialMeasurement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "fact:ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c128",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueNetAssetLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "044 - Disclosure - Fair Value Measurements (Details) - Schedule of changes in the fair value of level 3 warrant liabilities",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable",
     "shortName": "Fair Value Measurements (Details) - Schedule of changes in the fair value of level 3 warrant liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c140",
      "decimals": "0",
      "lang": null,
      "name": "fact:FairValueInitialMeasurement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c9",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "fact:AggregateSharesOfCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "045 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c9",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "fact:AggregateSharesOfCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - Consolidated Statements of Operations (Parentheticals)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals",
     "shortName": "Consolidated Statements of Operations (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c14",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "005 - Statement - Consolidated Statements of Changes in Shareholders\u2019 (Deficit) Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3",
     "shortName": "Consolidated Statements of Changes in Shareholders\u2019 (Deficit) Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c14",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c8",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesOther",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "006 - Statement - Consolidated Statements of Changes in Shareholders\u2019 (Deficit) Equity (Parentheticals)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3_Parentheticals",
     "shortName": "Consolidated Statements of Changes in Shareholders\u2019 (Deficit) Equity (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "007 - Statement - Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow",
     "shortName": "Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:InterestIncomeOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - Organization and Business Operations",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperations",
     "shortName": "Organization and Business Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10k2022_freedomacq1.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 25,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r296",
      "r297",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r296",
      "r297",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r296",
      "r297",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r296",
      "r297",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r296",
      "r297",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "fact_AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of accretion of Class A ordinary shares subject to possible redemption.",
        "label": "Accretion Of Class AOrdinary Shares Subject To Possible Redemptionin Shares",
        "terseLabel": "Accretion of Class A ordinary shares subject to possible redemption"
       }
      }
     },
     "localname": "AccretionOfClassAOrdinarySharesSubjectToPossibleRedemptioninShares",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_AggregateGrossProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate gross proceeds.",
        "label": "Aggregate Gross Proceeds",
        "terseLabel": "Aggregate amount"
       }
      }
     },
     "localname": "AggregateGrossProceeds",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_AggregatePurchasePrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of aggregate purchase price.",
        "label": "Aggregate Purchase Price",
        "terseLabel": "Aggregate purchase price (in Dollars)"
       }
      }
     },
     "localname": "AggregatePurchasePrice",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_AggregateSharesOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Aggregate Shares Of Common Stock",
        "terseLabel": "Aggregate ordinary shares"
       }
      }
     },
     "localname": "AggregateSharesOfCommonStock",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fact_AllocationOfNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income.",
        "label": "Allocation Of Net Income",
        "terseLabel": "Allocation of net income"
       }
      }
     },
     "localname": "AllocationOfNetIncome",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_AmortizedCostAndCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost and carrying value.",
        "label": "Amortized Cost And Carrying Value",
        "terseLabel": "Amortized Cost and Carrying Value"
       }
      }
     },
     "localname": "AmortizedCostAndCarryingValue",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_AsRestatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "As Restated Member",
        "terseLabel": "As Restated [Member]"
       }
      }
     },
     "localname": "AsRestatedMember",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "fact_BalanceSheetAsOfSeptember302022UnauditedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet As Of September302022 Unaudited Abstract",
        "terseLabel": "Balance Sheet as of September 30, 2022 (unaudited)"
       }
      }
     },
     "localname": "BalanceSheetAsOfSeptember302022UnauditedAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_BusinessCombinationFairMarketValueEqualPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination fair market value equal percentage.",
        "label": "Business Combination Fair Market Value Equal Percentage",
        "terseLabel": "Business combination fair market value equal percentage"
       }
      }
     },
     "localname": "BusinessCombinationFairMarketValueEqualPercentage",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fact_BusinessCombinationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination Member",
        "terseLabel": "Business Combination [Member]"
       }
      }
     },
     "localname": "BusinessCombinationMember",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fact_CashDepositedInTrustAccount": {
     "auth_ref": [],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash deposited in Trust Account.",
        "label": "Cash Deposited In Trust Account",
        "terseLabel": "Investment of cash into Trust Account"
       }
      }
     },
     "localname": "CashDepositedInTrustAccount",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_ChangeInDeferredUnderwritingFee": {
     "auth_ref": [],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in deferred underwriting fee.",
        "label": "Change In Deferred Underwriting Fee",
        "terseLabel": "Change in deferred underwriting fee"
       }
      }
     },
     "localname": "ChangeInDeferredUnderwritingFee",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_ChangeInFairValueOfWarrantLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value of warrant liabilities.",
        "label": "Change In Fair Value Of Warrant Liabilities",
        "terseLabel": "Change in fair value of warrant liabilities"
       }
      }
     },
     "localname": "ChangeInFairValueOfWarrantLiabilities",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_CommitmentsContingenciesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments &amp; Contingencies (Details) [Line Items]"
       }
      }
     },
     "localname": "CommitmentsContingenciesDetailsLineItems",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_CommitmentsContingenciesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments &amp; Contingencies (Details) [Table]"
       }
      }
     },
     "localname": "CommitmentsContingenciesDetailsTable",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_CommonStockValueOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value One",
        "terseLabel": "Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding at December 31, 2022 and 2021"
       }
      }
     },
     "localname": "CommonStockValueOne",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Statement Of Cash Flows For The Nine Months Ended September302022 Unaudited Abstract",
        "terseLabel": "Condensed Statement of Cash Flows for the Nine Months Ended September 30, 2022 (unaudited)"
       }
      }
     },
     "localname": "CondensedStatementOfCashFlowsForTheNineMonthsEndedSeptember302022UnauditedAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Statement Of Operations For The Nine Months Ended September302022 Unaudited Abstract",
        "terseLabel": "Condensed Statement of Operations for the Nine Months Ended September 30, 2022 (unaudited)"
       }
      }
     },
     "localname": "CondensedStatementOfOperationsForTheNineMonthsEndedSeptember302022UnauditedAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Statement Of Operations For The Six Months Ended June302022 Unaudited Abstract",
        "terseLabel": "Condensed Statement of Operations for the Six Months Ended June 30, 2022 (unaudited)"
       }
      }
     },
     "localname": "CondensedStatementOfOperationsForTheSixMonthsEndedJune302022UnauditedAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_ConvertibleNoteAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of convertible note.",
        "label": "Convertible Note Amount",
        "terseLabel": "Convertible Note \u2013 April 1, 2022"
       }
      }
     },
     "localname": "ConvertibleNoteAmount",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_ConvertibleNoteone": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of convertible note.",
        "label": "Convertible Noteone",
        "terseLabel": "Convertible Note \u2013 June 6, 2022"
       }
      }
     },
     "localname": "ConvertibleNoteone",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_ConvertibleNotesTwo": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of convertible note.",
        "label": "Convertible Notes Two",
        "terseLabel": "Convertible Note \u2013 December 14, 2022"
       }
      }
     },
     "localname": "ConvertibleNotesTwo",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy related to convertible promissory note related party.",
        "label": "Convertible Promissory Note Related Party Policy Text Block",
        "terseLabel": "Convertible Promissory Notes\u2014Related Party"
       }
      }
     },
     "localname": "ConvertiblePromissoryNoteRelatedPartyPolicyTextBlock",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "fact_DeferredOfferingCostsIncludedInAccruedExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is deferred offering costs included in accrued expenses.",
        "label": "Deferred Offering Costs Included In Accrued Expenses",
        "terseLabel": "Deferred underwriters\u2019 discount payable charged to additional paid-in capital"
       }
      }
     },
     "localname": "DeferredOfferingCostsIncludedInAccruedExpenses",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_DeferredOfferingCostsPaidUnderPromissoryNote": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of deferred offering costs paid under promissory note.",
        "label": "Deferred Offering Costs Paid Under Promissory Note",
        "terseLabel": "Deferred offering costs paid under promissory note"
       }
      }
     },
     "localname": "DeferredOfferingCostsPaidUnderPromissoryNote",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_DeferredUnderwritingDiscountPerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred underwriting discount, per unit.",
        "label": "Deferred Underwriting Discount Per Unit",
        "terseLabel": "Deferred underwriting discount, per unit (in Dollars per share)"
       }
      }
     },
     "localname": "DeferredUnderwritingDiscountPerUnit",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "fact_DeferredUnderwritingFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred underwriting fee.",
        "label": "Deferred Underwriting Fee",
        "terseLabel": "Deferred underwriting fee"
       }
      }
     },
     "localname": "DeferredUnderwritingFee",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_DenominatorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Denominator Abstract",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "DenominatorAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_DerivativeWarrantLiabilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative warrant liabilities.",
        "label": "Derivative Warrant Liabilities",
        "terseLabel": "Derivative warrant liabilities (in Shares)"
       }
      }
     },
     "localname": "DerivativeWarrantLiabilities",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fact_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "fact_DrawnDownAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in liability for separate account from withdrawal of funds.",
        "label": "Drawn Down Amount",
        "terseLabel": "Drawn down amount (in Dollars)"
       }
      }
     },
     "localname": "DrawnDownAmount",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_EmergingGrowthCompanyStatusPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire policy disclosure of Emerging Growth Company Status.",
        "label": "Emerging Growth Company Status Policy Text Block",
        "terseLabel": "Emerging Growth Company"
       }
      }
     },
     "localname": "EmergingGrowthCompanyStatusPolicyTextBlock",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "fact_ExtensionAmendmentProposalAbstain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension amendment proposal abstain.",
        "label": "Extension Amendment Proposal Abstain",
        "terseLabel": "Extension amendment proposal abstain"
       }
      }
     },
     "localname": "ExtensionAmendmentProposalAbstain",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fact_ExtensionAmendmentProposalAgainst": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension amendment proposal against.",
        "label": "Extension Amendment Proposal Against",
        "terseLabel": "Extension amendment proposal against"
       }
      }
     },
     "localname": "ExtensionAmendmentProposalAgainst",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fact_ExtensionAmendmentProposalFor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension Amendment Proposal For.",
        "label": "Extension Amendment Proposal For",
        "terseLabel": "Extension amendment proposal for"
       }
      }
     },
     "localname": "ExtensionAmendmentProposalFor",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fact_FairValueAssetsLevel1ToLevel2TransferAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.",
        "label": "Fair Value Assets Level1 To Level2 Transfer Amount",
        "terseLabel": "Transfer to Level 1"
       }
      }
     },
     "localname": "FairValueAssetsLevel1ToLevel2TransferAmount",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_FairValueInitialMeasurement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value initial measurement.",
        "label": "Fair Value Initial Measurement",
        "terseLabel": "Initial measurement on March 2, 2021"
       }
      }
     },
     "localname": "FairValueInitialMeasurement",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_FairValueMeasurementStrikePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strike price.",
        "label": "Fair Value Measurement Strike Price",
        "terseLabel": "Strike price"
       }
      }
     },
     "localname": "FairValueMeasurementStrikePrice",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "fact_FairValueMeasurementsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements (Details) [Line Items]"
       }
      }
     },
     "localname": "FairValueMeasurementsDetailsLineItems",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis [Line Items]"
       }
      }
     },
     "localname": "FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisLineItems",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis [Table]"
       }
      }
     },
     "localname": "FairValueMeasurementsDetailsScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements (Details) - Schedule of changes in the fair value of level 3 warrant liabilities [Line Items]"
       }
      }
     },
     "localname": "FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesLineItems",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements (Details) - Schedule of changes in the fair value of level 3 warrant liabilities [Table]"
       }
      }
     },
     "localname": "FairValueMeasurementsDetailsScheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]"
       }
      }
     },
     "localname": "FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesLineItems",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Table]"
       }
      }
     },
     "localname": "FairValueMeasurementsDetailsScheduleofchangesinthefairvalueofwarrantliabilitiesTable",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_FairValueMeasurementsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements (Details) [Table]"
       }
      }
     },
     "localname": "FairValueMeasurementsDetailsTable",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_FairValueWarrantLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the fair value warrant liabilities.",
        "label": "Fair Value Warrant Liabilities",
        "terseLabel": "Fair value warrant liabilities"
       }
      }
     },
     "localname": "FairValueWarrantLiabilities",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_FounderSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Founder Shares Member",
        "terseLabel": "Founder Shares [Member]"
       }
      }
     },
     "localname": "FounderSharesMember",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fact_GeneratingGrossProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Generating Gross Proceeds",
        "terseLabel": "Generating gross proceeds"
       }
      }
     },
     "localname": "GeneratingGrossProceeds",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_GrossUnrealizedGain": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Unrealized Gains",
        "label": "Gross Unrealized Gain",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "GrossUnrealizedGain",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_GrossUnrealizedGainsAndLosses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gross unrealized gains and losses.",
        "label": "Gross Unrealized Gains And Losses",
        "terseLabel": "Gross Unrealized Gains (Losses)"
       }
      }
     },
     "localname": "GrossUnrealizedGainsAndLosses",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_InitialPublicOfferingDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering (Details) [Line Items]"
       }
      }
     },
     "localname": "InitialPublicOfferingDetailsLineItems",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_InitialPublicOfferingDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering (Details) [Table]"
       }
      }
     },
     "localname": "InitialPublicOfferingDetailsTable",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in value of Class A ordinary shares subject to possible redemption.",
        "label": "Initial Value Of Class AOrdinary Share Subject To Possible Redemption",
        "terseLabel": "Initial value of Class A ordinary shares subject to possible redemption"
       }
      }
     },
     "localname": "InitialValueOfClassAOrdinaryShareSubjectToPossibleRedemption",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_InitialValueOfWarrantLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of  initial value of warrant liabilities.",
        "label": "Initial Value Of Warrant Liabilities",
        "terseLabel": "Initial value of warrant liabilities"
       }
      }
     },
     "localname": "InitialValueOfWarrantLiabilities",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_InvestmentManagementTrustAgreementAbstain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment management trust agreement against.",
        "label": "Investment Management Trust Agreement Abstain",
        "terseLabel": "Investment management trust agreement against"
       }
      }
     },
     "localname": "InvestmentManagementTrustAgreementAbstain",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fact_InvestmentManagementTrustAgreementAgainst": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment management trust agreement against.",
        "label": "Investment Management Trust Agreement Against",
        "terseLabel": "Investment management trust agreement against"
       }
      }
     },
     "localname": "InvestmentManagementTrustAgreementAgainst",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fact_InvestmentManagementTrustAgreementFor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment management trust agreement for.",
        "label": "Investment Management Trust Agreement For",
        "terseLabel": "Investment management trust agreement for"
       }
      }
     },
     "localname": "InvestmentManagementTrustAgreementFor",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fact_InvestmentsHeldInTrustAccountNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Investments held in Trust Account.",
        "label": "Investments Held In Trust Account Net",
        "terseLabel": "Total Investments held in Trust Account"
       }
      }
     },
     "localname": "InvestmentsHeldInTrustAccountNet",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_InvestmentsHeldInTrustAccountUSMoneyMarketFund": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of investments held in trust account.",
        "label": "Investments Held In Trust Account USMoney Market Fund",
        "terseLabel": "Investments held in trust account- U.S. Money Market Fund"
       }
      }
     },
     "localname": "InvestmentsHeldInTrustAccountUSMoneyMarketFund",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_InvestmentsHeldInTrustAccountUSTreasureSecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of investments held in trust account US treasure securities.",
        "label": "Investments Held In Trust Account USTreasure Securities",
        "terseLabel": "Investments held in trust account- U.S. Treasury Securities"
       }
      }
     },
     "localname": "InvestmentsHeldInTrustAccountUSTreasureSecurities",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_IssuedAndOutstandingInterestPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issued and outstanding interest percentage.",
        "label": "Issued And Outstanding Interest Percentage",
        "terseLabel": "Issued and outstanding interest percentage"
       }
      }
     },
     "localname": "IssuedAndOutstandingInterestPercentage",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fact_IssuedAndOutstandingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Issued And Outstanding Shares",
        "terseLabel": "Issued and outstanding ordinary shares"
       }
      }
     },
     "localname": "IssuedAndOutstandingShares",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fact_LessAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less Abstract",
        "terseLabel": "Less:"
       }
      }
     },
     "localname": "LessAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Redeemable Ordinary Shares And Shareholders Deficit Abstract",
        "terseLabel": "Liabilities, Redeemable Ordinary Shares and Shareholders\u2019 Deficit"
       }
      }
     },
     "localname": "LiabilitiesRedeemableOrdinarySharesAndShareholdersDeficitAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_NetProceedsOfTheSaleOfTheUnits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net proceeds of the sale of the Units.",
        "label": "Net Proceeds Of The Sale Of The Units",
        "terseLabel": "Net proceeds of the sale of the units"
       }
      }
     },
     "localname": "NetProceedsOfTheSaleOfTheUnits",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_NetTangibleAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net tangible assets.",
        "label": "Net Tangible Assets",
        "terseLabel": "Net tangible assets"
       }
      }
     },
     "localname": "NetTangibleAssets",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_NumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Numerator Abstract",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NumeratorAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_OfferingCostsAllocatedToWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offering costs allocated to warrants.",
        "label": "Offering Costs Allocated To Warrants",
        "negatedLabel": "Offering costs allocated to warrants"
       }
      }
     },
     "localname": "OfferingCostsAllocatedToWarrants",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_OfficeSpaceAndAdministrativeSupportServices": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expenses for office space and administrative support services.",
        "label": "Office Space And Administrative Support Services",
        "terseLabel": "Sponsor amount"
       }
      }
     },
     "localname": "OfficeSpaceAndAdministrativeSupportServices",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_OperationalCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The adjustment to expense previously capitalized costs of operational costs.",
        "label": "Operational Costs",
        "terseLabel": "Operational costs"
       }
      }
     },
     "localname": "OperationalCosts",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_OrdinarySharesDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary shares, description.",
        "label": "Ordinary Shares Description",
        "terseLabel": "Ordinary shares, description"
       }
      }
     },
     "localname": "OrdinarySharesDescription",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_OrdinarySharesSubjectToPossibleRedemption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary shares subject to possible redemption.",
        "label": "Ordinary Shares Subject To Possible Redemption",
        "terseLabel": "Ordinary shares subject to possible redemption (in Shares)"
       }
      }
     },
     "localname": "OrdinarySharesSubjectToPossibleRedemption",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fact_OrganizationandBusinessOperationsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization and Business Operations (Details) [Line Items]"
       }
      }
     },
     "localname": "OrganizationandBusinessOperationsDetailsLineItems",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_OrganizationandBusinessOperationsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization and Business Operations (Details) [Table]"
       }
      }
     },
     "localname": "OrganizationandBusinessOperationsDetailsTable",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_PartialReversalOfTransactionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partial reversal of transaction costs incurred in connection with IPO.",
        "label": "Partial Reversal Of Transaction Costs",
        "terseLabel": "Reduction of transaction costs incurred in connection with IPO",
        "verboseLabel": "Partial reversal of transaction costs"
       }
      }
     },
     "localname": "PartialReversalOfTransactionCosts",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_PlusAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plus Abstract",
        "terseLabel": "Plus:"
       }
      }
     },
     "localname": "PlusAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_PlusAbstract0": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plus Abstract0",
        "terseLabel": "Plus:"
       }
      }
     },
     "localname": "PlusAbstract0",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_PrivatePlacementWarrantsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Warrants (Details) [Line Items]"
       }
      }
     },
     "localname": "PrivatePlacementWarrantsDetailsLineItems",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_PrivatePlacementWarrantsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Warrants (Details) [Table]"
       }
      }
     },
     "localname": "PrivatePlacementWarrantsDetailsTable",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_PrivatePlacementWarrantsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Warrants Disclosure Abstract"
       }
      }
     },
     "localname": "PrivatePlacementWarrantsDisclosureAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "fact_PrivatePlacementWarrantsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of Private Placement.",
        "label": "Private Placement Warrants Disclosure Text Block",
        "terseLabel": "Private Placement Warrants"
       }
      }
     },
     "localname": "PrivatePlacementWarrantsDisclosureTextBlock",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "fact_ProceedsFromGrossProceedsFromIPO": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amonut is gross proceeds from IPO.",
        "label": "Proceeds From Gross Proceeds From IPO",
        "terseLabel": "Gross proceeds from IPO"
       }
      }
     },
     "localname": "ProceedsFromGrossProceedsFromIPO",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_PromissioryNoteRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is related party promissiory note.",
        "label": "Promissiory Note Related Party",
        "terseLabel": "Promissory note"
       }
      }
     },
     "localname": "PromissioryNoteRelatedParty",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_PromissoryNote": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Promissory notes may also be referred to as an IOU, a loan agreement, or just a note.",
        "label": "Promissory Note",
        "terseLabel": "Promissory note (in Dollars)"
       }
      }
     },
     "localname": "PromissoryNote",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_ProposedPublicOfferingDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering [Abstract]"
       }
      }
     },
     "localname": "ProposedPublicOfferingDisclosureAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "fact_ProposedPublicOfferingDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of initial public offering.",
        "label": "Proposed Public Offering Disclosure Text Block",
        "terseLabel": "Initial Public Offering"
       }
      }
     },
     "localname": "ProposedPublicOfferingDisclosureTextBlock",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOffering"
     ],
     "xbrltype": "textBlockItemType"
    },
    "fact_PublicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Member",
        "terseLabel": "Public [Member]"
       }
      }
     },
     "localname": "PublicMember",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "fact_PublicPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public per share.",
        "label": "Public Per Share",
        "terseLabel": "Public per share (in Dollars per share)"
       }
      }
     },
     "localname": "PublicPerShare",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "fact_PublicWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Warrants Member",
        "terseLabel": "Public Warrants [Member]"
       }
      }
     },
     "localname": "PublicWarrantsMember",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fact_RedeemPublicSharesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeem public shares, percentage.",
        "label": "Redeem Public Shares Percentage",
        "terseLabel": "Redeem public shares, percentage"
       }
      }
     },
     "localname": "RedeemPublicSharesPercentage",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fact_RedemptionsOfWarrantsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redemptions of warrants, description.",
        "label": "Redemptions Of Warrants Description",
        "terseLabel": "Redemptions of warrants, description"
       }
      }
     },
     "localname": "RedemptionsOfWarrantsDescription",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_RelatedPartyTransactionsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions (Details) [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDetailsLineItems",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_RelatedPartyTransactionsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions (Details) [Table]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDetailsTable",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_SaleOfOrdinarySharesRedemption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ordinary share sale of redemption.",
        "label": "Sale Of Ordinary Shares Redemption",
        "terseLabel": "Sale of ordinary shares (in Shares)"
       }
      }
     },
     "localname": "SaleOfOrdinarySharesRedemption",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fact_ScheduleOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Assets That Are Measured At Fair Value On ARecurring Basis Abstract"
       }
      }
     },
     "localname": "ScheduleOfAssetsThatAreMeasuredAtFairValueOnARecurringBasisAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "fact_ScheduleOfBasicAndDilutedNetIncomePerShareForEachClassOfOrdinaryShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Basic And Diluted Net Income Per Share For Each Class Of Ordinary Share Abstract"
       }
      }
     },
     "localname": "ScheduleOfBasicAndDilutedNetIncomePerShareForEachClassOfOrdinaryShareAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Changes In The Fair Value Of Level3 Warrant Liabilities Abstract"
       }
      }
     },
     "localname": "ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "fact_ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Changes In The Fair Value Of Level3 Warrant Liabilities Table Text Block",
        "terseLabel": "Schedule of changes in the fair value of level 3 warrant liabilities"
       }
      }
     },
     "localname": "ScheduleOfChangesInTheFairValueOfLevel3WarrantLiabilitiesTableTextBlock",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "fact_ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Changes In The Fair Value Of Warrant Liabilities Abstract"
       }
      }
     },
     "localname": "ScheduleOfChangesInTheFairValueOfWarrantLiabilitiesAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "fact_ScheduleOfCondensedStatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Condensed Statement Of Cash Flows Abstract"
       }
      }
     },
     "localname": "ScheduleOfCondensedStatementOfCashFlowsAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "fact_ScheduleOfCondensedStatementOfOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Condensed Statement Of Operations Abstract"
       }
      }
     },
     "localname": "ScheduleOfCondensedStatementOfOperationsAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "fact_ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfQuantitativeInformationRegardingLevel3FairValueMeasurementsAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "fact_ScheduleOfRestatementOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Restatement Of Financial Statements Abstract"
       }
      }
     },
     "localname": "ScheduleOfRestatementOfFinancialStatementsAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "fact_ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of the Ordinary Share Reflected on the Balance Sheet are Reconciled [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfTheOrdinaryShareReflectedOnTheBalanceSheetAreReconciledAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "fact_ScheduleOfUnrealizedHoldingLossesAndFairValueOfHeldToMaturitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Unrealized Holding Losses And Fair Value Of Held To Maturity Securities Abstract"
       }
      }
     },
     "localname": "ScheduleOfUnrealizedHoldingLossesAndFairValueOfHeldToMaturitySecuritiesAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "fact_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rates",
        "terseLabel": "Volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_ShareholdersDeficitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders Deficit Abstract",
        "terseLabel": "Shareholders\u2019 Deficit:"
       }
      }
     },
     "localname": "ShareholdersDeficitAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_ShareholdersDeficitDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Deficit (Details) [Line Items]"
       }
      }
     },
     "localname": "ShareholdersDeficitDetailsLineItems",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_ShareholdersDeficitDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Deficit (Details) [Table]"
       }
      }
     },
     "localname": "ShareholdersDeficitDetailsTable",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_SharesSubjectToPossibleRedemption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares subject to possible redemption.",
        "label": "Shares Subject To Possible Redemption",
        "terseLabel": "Ordinary shares subject to possible redemption"
       }
      }
     },
     "localname": "SharesSubjectToPossibleRedemption",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "fact_SignificantAccountingPoliciesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsLineItems",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of basic and diluted net income per share for each class of ordinary share [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareLineItems",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of basic and diluted net income per share for each class of ordinary share [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_SignificantAccountingPoliciesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsTable",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_SponsorShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The shares for sponsor.",
        "label": "Sponsor Share",
        "terseLabel": "Sponsor share (in Shares)"
       }
      }
     },
     "localname": "SponsorShare",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fact_StockIssuedDuringPeriodSponsorAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sponsor amount.",
        "label": "Stock Issued During Period Sponsor Amount",
        "terseLabel": "Sponsor amount"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSponsorAmount",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_SubsequentEventsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventsDetailsLineItems",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_SubsequentEventsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Table]"
       }
      }
     },
     "localname": "SubsequentEventsDetailsTable",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_TotalNumberOfOrdinarySharesOutstandingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of ordinary shares outstanding percentage.",
        "label": "Total Number Of Ordinary Shares Outstanding Percentage",
        "terseLabel": "Total number of ordinary shares outstanding percentage"
       }
      }
     },
     "localname": "TotalNumberOfOrdinarySharesOutstandingPercentage",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fact_TotalTransactionCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total transaction cost.",
        "label": "Total Transaction Cost",
        "terseLabel": "Total transaction cost"
       }
      }
     },
     "localname": "TotalTransactionCost",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_TotalWarrantLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total warrant liabilities.",
        "label": "Total Warrant Liabilities",
        "terseLabel": "Total Warrant liabilities"
       }
      }
     },
     "localname": "TotalWarrantLiabilities",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_TradingSecuritiesFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of trading securities fair value.",
        "label": "Trading Securities Fair Value",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "TradingSecuritiesFairValue",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_TrustAccountPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trust account per share.",
        "label": "Trust Account Per Share",
        "terseLabel": "Trust account per share (in Dollars per share)"
       }
      }
     },
     "localname": "TrustAccountPerShare",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "fact_VotingPowerPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Voting Power Percentage",
        "terseLabel": "Voting power percentage"
       }
      }
     },
     "localname": "VotingPowerPercentage",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fact_WarrantExpirationTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant expiration term.",
        "label": "Warrant Expiration Term",
        "terseLabel": "Warrant expiration term"
       }
      }
     },
     "localname": "WarrantExpirationTerm",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fact_WarrantLiabilitiesPrivateWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant liabilities private warrants.",
        "label": "Warrant Liabilities Private Warrants",
        "terseLabel": "Warrant liabilities \u2013 Private warrants"
       }
      }
     },
     "localname": "WarrantLiabilitiesPrivateWarrants",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_WarrantLiabilitiesPublicWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant liabilities public warrants.",
        "label": "Warrant Liabilities Public Warrants",
        "terseLabel": "Warrant liabilities \u2013 Public warrants"
       }
      }
     },
     "localname": "WarrantLiabilitiesPublicWarrants",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fact_WarrantTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant term.",
        "label": "Warrant Term",
        "terseLabel": "Warrant term"
       }
      }
     },
     "localname": "WarrantTerm",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fact_WarrantsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants (Details) [Line Items]"
       }
      }
     },
     "localname": "WarrantsDetailsLineItems",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_WarrantsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants (Details) [Table]"
       }
      }
     },
     "localname": "WarrantsDetailsTable",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fact_WarrantsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Disclosure Abstract"
       }
      }
     },
     "localname": "WarrantsDisclosureAbstract",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "fact_WarrantsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of warrants.",
        "label": "Warrants Disclosure Text Block",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantsDisclosureTextBlock",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/Warrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "fact_WarrantsPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants purchase.",
        "label": "Warrants Purchase",
        "terseLabel": "Warrants purchase (in Shares)"
       }
      }
     },
     "localname": "WarrantsPurchase",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fact_WorkingCapitalLoans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Working capital loans.",
        "label": "Working Capital Loans",
        "terseLabel": "Working capital loans"
       }
      }
     },
     "localname": "WorkingCapitalLoans",
     "nsuri": "http://www.FreedomAcquisitionICorp.com/20221231",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_CondensedCashFlowStatementTable": {
     "auth_ref": [
      "r115",
      "r273",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.",
        "label": "Condensed Cash Flow Statement [Table]"
       }
      }
     },
     "localname": "CondensedCashFlowStatementTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CondensedCashFlowStatementsCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Condensed Cash Flow Statements, Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedCashFlowStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract",
     "nsuri": "http://fasb.org/srt/2022",
     "xbrltype": "stringItemType"
    },
    "srt_CondensedFinancialStatementsCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Condensed Financial Statements, Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedFinancialStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CondensedFinancialStatementsTextBlock": {
     "auth_ref": [
      "r115",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for condensed financial statements.",
        "label": "Condensed Financial Statements [Text Block]",
        "terseLabel": "Revision of Previously Issued Financial Statements"
       }
      }
     },
     "localname": "CondensedFinancialStatementsTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_CondensedIncomeStatementTable": {
     "auth_ref": [
      "r115",
      "r273",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about condensed income statement including, but not limited to, income statements of consolidated entities and consolidation eliminations.",
        "label": "Condensed Income Statement [Table]"
       }
      }
     },
     "localname": "CondensedIncomeStatementTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CondensedIncomeStatementsCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Condensed Income Statements, Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedIncomeStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Director [Member]",
        "terseLabel": "Director [Member]"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r126",
      "r127",
      "r139",
      "r221",
      "r222",
      "r316",
      "r317",
      "r318",
      "r319",
      "r321",
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Revision of Prior Period, Adjustment [Member]",
        "terseLabel": "Adjustment [Member]",
        "verboseLabel": "Adjusted [Member]"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r90",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r139",
      "r158",
      "r159",
      "r211",
      "r220",
      "r221",
      "r222",
      "r223",
      "r240",
      "r242",
      "r243",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r196",
      "r322",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.",
        "label": "Forecast [Member]",
        "terseLabel": "Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r90",
      "r116",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r130",
      "r139",
      "r211",
      "r220",
      "r221",
      "r222",
      "r240",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r320",
      "r321",
      "r323",
      "r324",
      "r325",
      "r331",
      "r332",
      "r342",
      "r344",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Previously Reported [Member]",
        "terseLabel": "As Previously Reported [Member]",
        "verboseLabel": "Previously Reported [Member]"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r131",
      "r196",
      "r304",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfCondensedCashFlowStatementTableTextBlock": {
     "auth_ref": [
      "r312",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.",
        "label": "Condensed Cash Flow Statement [Table Text Block]",
        "terseLabel": "Schedule of condensed statement of cash flows"
       }
      }
     },
     "localname": "ScheduleOfCondensedCashFlowStatementTableTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_ScheduleOfCondensedFinancialStatementsTable": {
     "auth_ref": [
      "r115",
      "r273",
      "r274",
      "r275",
      "r276",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.",
        "label": "Condensed Financial Statements [Table]"
       }
      }
     },
     "localname": "ScheduleOfCondensedFinancialStatementsTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfCondensedFinancialStatementsTableTextBlock": {
     "auth_ref": [
      "r312",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.",
        "label": "Condensed Financial Statements [Table Text Block]",
        "terseLabel": "Schedule of restatement of financial statements"
       }
      }
     },
     "localname": "ScheduleOfCondensedFinancialStatementsTableTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": {
     "auth_ref": [
      "r312",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.",
        "label": "Condensed Income Statement [Table Text Block]",
        "terseLabel": "Schedule of condensed statement of operations"
       }
      }
     },
     "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r131",
      "r196",
      "r304",
      "r306",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r329",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableOtherCurrent": {
     "auth_ref": [
      "r10"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable, Other, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableOtherCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RevisionofPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r5",
      "r292"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r313",
      "r314",
      "r315",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Accretion portion net against additional paid-in-capital"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r43",
      "r46",
      "r47"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "terseLabel": "Excess of the fair value of private placement warrants over cash received"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r73",
      "r80",
      "r96",
      "r112",
      "r149",
      "r151",
      "r153",
      "r156",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r214",
      "r216",
      "r228",
      "r292",
      "r335",
      "r336",
      "r348"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r92",
      "r101",
      "r112",
      "r156",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r214",
      "r216",
      "r228",
      "r292",
      "r335",
      "r336",
      "r348"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldInTrust": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.",
        "label": "Assets Held-in-trust",
        "terseLabel": "Cash outside the trust account"
       }
      }
     },
     "localname": "AssetsHeldInTrust",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsHeldInTrustNoncurrent": {
     "auth_ref": [
      "r309"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.",
        "label": "Assets Held-in-trust, Noncurrent",
        "terseLabel": "Cash and marketable securities held in Trust Account"
       }
      }
     },
     "localname": "AssetsHeldInTrustNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r213",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r55",
      "r56",
      "r213",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.",
        "label": "Business Acquisition, Description of Acquired Entity",
        "terseLabel": "Business combination, description"
       }
      }
     },
     "localname": "BusinessAcquisitionDescriptionOfAcquiredEntity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of outstanding voting securities"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Trust account price per share (in Dollars per share)",
        "verboseLabel": "Class A ordinary shares equals or exceeds (in Dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r269",
      "r270",
      "r292",
      "r307"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash in trust account"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r29",
      "r94",
      "r277"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r24",
      "r29",
      "r34"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash \u2013 Ending",
        "periodStartLabel": "Cash \u2013 Beginning"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r24",
      "r71"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net Change in Cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFDICInsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash, FDIC Insured Amount",
        "terseLabel": "Federal depository insurance coverage"
       }
      }
     },
     "localname": "CashFDICInsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Cash [Member]"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r97",
      "r98",
      "r99",
      "r112",
      "r133",
      "r134",
      "r136",
      "r138",
      "r141",
      "r142",
      "r156",
      "r164",
      "r166",
      "r167",
      "r168",
      "r171",
      "r172",
      "r174",
      "r175",
      "r177",
      "r181",
      "r187",
      "r228",
      "r272",
      "r303",
      "r310",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement",
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation",
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails",
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "netLabel": "Warrant exercise price",
        "terseLabel": "Warrant price per share",
        "verboseLabel": "Price per warrant (in Dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "terseLabel": "Purchase of warrants (in Shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Ordinary shares warrants issued (in Shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r15",
      "r76",
      "r84"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies (See Note 7)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r42",
      "r162",
      "r163",
      "r271",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments &amp; Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Class A [Member]",
        "netLabel": "Class A Ordinary Shares [Member]",
        "terseLabel": "Class A Ordinary Shares",
        "verboseLabel": "Class A"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation",
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails",
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Class B [Member]",
        "netLabel": "Class B Ordinary Shares [Member]",
        "terseLabel": "Class B Ordinary Shares",
        "verboseLabel": "Class B"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation",
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3",
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockHeldInTrust": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of common stock held in trust.",
        "label": "Common Stock Held in Trust",
        "terseLabel": "Trust account (in Dollars)"
       }
      }
     },
     "localname": "CommonStockHeldInTrust",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r313",
      "r314",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary Shares",
        "verboseLabel": "Ordinary Shares [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3",
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNoParValue": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value common stock.",
        "label": "Common Stock, No Par Value",
        "terseLabel": "Ordinary share, par value"
       }
      }
     },
     "localname": "CommonStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockOtherSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.",
        "label": "Common Stock, Other Shares, Outstanding",
        "terseLabel": "Ordinary shares outstanding (in Shares)"
       }
      }
     },
     "localname": "CommonStockOtherSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary shares, par value (in Dollars per share)",
        "verboseLabel": "Common stock, par value (in Dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Ordinary shares, shares authorized",
        "verboseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Ordinary shares, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r4",
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Ordinary shares, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r4",
      "r292"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized at December 31, 2022 and 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonUnitOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common units of ownership outstanding of a limited liability company (LLC).",
        "label": "Common Unit, Outstanding",
        "terseLabel": "Outstanding shares"
       }
      }
     },
     "localname": "CommonUnitOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r79",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r57",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleNotesPayableCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.",
        "label": "Convertible Notes Payable, Current",
        "terseLabel": "Convertible promissory note \u2013 related party"
       }
      }
     },
     "localname": "ConvertibleNotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "Offering Costs"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "netLabel": "underwriting fee payableU",
        "terseLabel": "Deferred underwriters\u2019 discount payable",
        "verboseLabel": "Underwriting fee payable"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r333"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Warrant Liabilities"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "terseLabel": "Acquiror Cash"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r108",
      "r121",
      "r122",
      "r124",
      "r125",
      "r126",
      "r132",
      "r133",
      "r136",
      "r137",
      "r138",
      "r139",
      "r222",
      "r223",
      "r257",
      "r258",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "netLabel": "Basic and diluted net income per share",
        "terseLabel": "Basic net income per share (in Dollars per share)",
        "verboseLabel": "Basic and Diluted Net Income (Loss) per shares"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r108",
      "r121",
      "r122",
      "r124",
      "r125",
      "r126",
      "r133",
      "r136",
      "r137",
      "r138",
      "r139",
      "r222",
      "r223",
      "r257",
      "r258",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income per share",
        "verboseLabel": "Diluted Net Income (Loss) per shares"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r36",
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income Per Ordinary Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r113",
      "r205",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal excise tax"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r338",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "Excise tax percentage"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r46",
      "r89",
      "r105",
      "r106",
      "r107",
      "r116",
      "r117",
      "r118",
      "r120",
      "r127",
      "r130",
      "r140",
      "r157",
      "r189",
      "r200",
      "r201",
      "r202",
      "r210",
      "r211",
      "r221",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r243",
      "r259",
      "r260",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense related to distribution, servicing and underwriting fees.",
        "label": "Expense Related to Distribution or Servicing and Underwriting Fees",
        "terseLabel": "Underwriting fee"
       }
      }
     },
     "localname": "ExpenseRelatedToDistributionOrServicingAndUnderwritingFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r27",
      "r44"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Adjustment of Warrants",
        "negatedLabel": "Change in fair value of warrant liabilities"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Schedule of quantitative information regarding Level 3 fair value measurements"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r64",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of assets that are measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r173",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r224",
      "r253",
      "r254",
      "r255",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable",
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r173",
      "r190",
      "r195",
      "r224",
      "r253",
      "r286",
      "r287",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices In Active Markets (Level 1) [Member]",
        "verboseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r173",
      "r190",
      "r195",
      "r224",
      "r254",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs (Level 2) [Member]",
        "verboseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r173",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r224",
      "r255",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Other Unobservable Inputs (Level 3) [Member]",
        "verboseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable",
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)",
        "terseLabel": "Change in valuation inputs or other assumptions",
        "verboseLabel": "Change in fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r173",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r253",
      "r254",
      "r255",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofassetsthataremeasuredatfairvalueonarecurringbasisTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetAssetLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of asset after deduction of liability.",
        "label": "Fair Value, Net Asset (Liability)",
        "periodEndLabel": "Fair value as of ending",
        "periodStartLabel": "Fair value as of beginning"
       }
      }
     },
     "localname": "FairValueNetAssetLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3": {
     "auth_ref": [
      "r225",
      "r227"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset) out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers out of Level 3",
        "terseLabel": "Transferred amount"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r68",
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueOptionChangesInFairValueGainLoss1": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.",
        "label": "Fair Value, Option, Changes in Fair Value, Gain (Loss)",
        "negatedLabel": "Change in fair value of convertible note",
        "terseLabel": "Change in fair value of convertible note"
       }
      }
     },
     "localname": "FairValueOptionChangesInFairValueGainLoss1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r229",
      "r230",
      "r231",
      "r232"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign currency exchange loss"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForwardContractIndexedToEquitySettlementShareFairValuePerShare": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value per share that would be issued upon settlement of forward contract indexed to equity.",
        "label": "Forward Contract Indexed to Equity, Settlement, Share, Fair Value Per Share",
        "terseLabel": "Fair value per share (in Dollars per share)"
       }
      }
     },
     "localname": "ForwardContractIndexedToEquitySettlementShareFairValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO [Member]",
        "verboseLabel": "Initial Public Offering [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails",
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r104",
      "r203",
      "r204",
      "r206",
      "r207",
      "r208",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in current assets and current liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income earned from interest bearing assets classified as other.",
        "label": "Interest Income, Other",
        "negatedLabel": "Interest earned on marketable securities held in Trust Account"
       }
      }
     },
     "localname": "InterestIncomeOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r18",
      "r148"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income on marketable securities held in Trust Account",
        "verboseLabel": "Interest income earned"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement",
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r155",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments Held in Trust Account"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r12",
      "r112",
      "r156",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r215",
      "r216",
      "r217",
      "r228",
      "r282",
      "r335",
      "r348",
      "r349"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Total Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r9",
      "r75",
      "r83",
      "r292",
      "r311",
      "r330",
      "r343"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities, Redeemable Ordinary Shares and Shareholders\u2019 Deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r93",
      "r112",
      "r156",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r215",
      "r216",
      "r217",
      "r228",
      "r292",
      "r335",
      "r348",
      "r349"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Marketable Securities [Line Items]"
       }
      }
     },
     "localname": "MarketableSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in marketable security.",
        "label": "Marketable Securities [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of unrealized holding losses and fair value of held to maturity securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds [Member]"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows from Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows from Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r24",
      "r25",
      "r28"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash Flows from Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r17",
      "r28",
      "r77",
      "r85",
      "r91",
      "r102",
      "r103",
      "r107",
      "r112",
      "r119",
      "r121",
      "r122",
      "r124",
      "r125",
      "r129",
      "r130",
      "r135",
      "r149",
      "r150",
      "r152",
      "r154",
      "r156",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r223",
      "r228",
      "r283",
      "r335"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net Income (Loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofcashflowsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoninterestExpenseOfferingCost": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": {
       "order": 6.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Includes offering costs of open-end investment companies, and closed-end funds with a continuous offering period.",
        "label": "Noninterest Expense Offering Cost",
        "negatedLabel": "Offering expenses related to warrant issuance"
       }
      }
     },
     "localname": "NoninterestExpenseOfferingCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "terseLabel": "Operating costs"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r149",
      "r150",
      "r152",
      "r154",
      "r283"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r241",
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operational Costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in number of shares that would be issued upon settlement from change in fair value of share for option contract indexed to equity.",
        "label": "Option Contract Indexed to Equity, Settlement, Number of Shares, Effect of Change in Fair Value of Share",
        "terseLabel": "Fair value of shares (in Shares)"
       }
      }
     },
     "localname": "OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization and Business Operations"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLongTermDebt": {
     "auth_ref": [
      "r2",
      "r74",
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other.",
        "label": "Other Long-Term Debt",
        "terseLabel": "Agreed to loan"
       }
      }
     },
     "localname": "OtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOwnershipInterestsOfferingCosts": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of offering costs allocated to the other unit holders.",
        "label": "Other Ownership Interests, Offering Costs",
        "terseLabel": "Other offering costs"
       }
      }
     },
     "localname": "OtherOwnershipInterestsOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherUnderwritingExpense": {
     "auth_ref": [
      "r86",
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts.",
        "label": "Other Underwriting Expense",
        "terseLabel": "Underwriting fee",
        "verboseLabel": "Underwriting discount amount"
       }
      }
     },
     "localname": "OtherUnderwritingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Payments of offering costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r3",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preference shares, par value (in Dollars per share)",
        "verboseLabel": "Preferred stock, par value (in Dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preference shares, shares authorized",
        "verboseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r3",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preference shares, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preference shares, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r3",
      "r292"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at December 31, 2022 and 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r100",
      "r160",
      "r161",
      "r278"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses - short term"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseNoncurrent": {
     "auth_ref": [
      "r308"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.",
        "label": "Prepaid Expense, Noncurrent",
        "terseLabel": "Prepaid expenses - long term"
       }
      }
     },
     "localname": "PrepaidExpenseNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]",
        "terseLabel": "Private Placement [Member]",
        "verboseLabel": "Private Placement Warrants [Member]"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of Convertible Promissory Note"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from Initial Public Offering, net of underwriters\u2019 discount"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Ordinary share issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Proceeds from Issuance of Private Placement",
        "terseLabel": "Proceeds from issuance of Private Placement Warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfUnsecuredDebt": {
     "auth_ref": [
      "r21"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt.",
        "label": "Proceeds from Issuance of Unsecured Debt",
        "terseLabel": "Issued unsecured promissory note amount"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfUnsecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "negatedLabel": "Proceeds allocated to Public Warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r72",
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction, Amounts of Transaction",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r88",
      "r246",
      "r247",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r244",
      "r245",
      "r247",
      "r248",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.",
        "label": "Repayments of Related Party Debt",
        "negatedLabel": "Repayment of promissory note to related party"
       }
      }
     },
     "localname": "RepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfUnsecuredDebt": {
     "auth_ref": [
      "r22"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.",
        "label": "Repayments of Unsecured Debt",
        "terseLabel": "Unsecured promissory note (in Dollars)"
       }
      }
     },
     "localname": "RepaymentsOfUnsecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r6",
      "r47",
      "r82",
      "r263",
      "r268",
      "r292"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r89",
      "r116",
      "r117",
      "r118",
      "r120",
      "r127",
      "r130",
      "r157",
      "r200",
      "r201",
      "r202",
      "r210",
      "r211",
      "r221",
      "r259",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails",
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Consummated share units (in Shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Price per unit (in Dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.",
        "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]",
        "terseLabel": "Schedule of the ordinary share reflected on the balance sheet are reconciled"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.",
        "label": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of changes in the fair value of warrant liabilities"
       }
      }
     },
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of basic and diluted net income per share for each class of ordinary share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "terseLabel": "Business Combination [Member]",
        "verboseLabel": "Business Acquisition [Member]"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price",
        "verboseLabel": "Common stock, par value (in Dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofquantitativeinformationregardingLevel3fairvaluemeasurementsTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "terseLabel": "Shares issued (in Shares)",
        "verboseLabel": "Shares issued"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Price per share",
        "verboseLabel": "Price per share (in Dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails",
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance (in Shares)",
        "periodStartLabel": "Balance (in Shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.",
        "label": "Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block]",
        "terseLabel": "Ordinary Shares Subject to Possible Redemption"
       }
      }
     },
     "localname": "SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r35",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r97",
      "r98",
      "r99",
      "r112",
      "r133",
      "r134",
      "r136",
      "r138",
      "r141",
      "r142",
      "r156",
      "r164",
      "r166",
      "r167",
      "r168",
      "r171",
      "r172",
      "r174",
      "r175",
      "r177",
      "r181",
      "r187",
      "r228",
      "r272",
      "r303",
      "r310",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/DocumentAndEntityInformation",
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails",
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofcondensedstatementofoperationsTable_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficitDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r16",
      "r46",
      "r89",
      "r105",
      "r106",
      "r107",
      "r116",
      "r117",
      "r118",
      "r120",
      "r127",
      "r130",
      "r140",
      "r157",
      "r189",
      "r200",
      "r201",
      "r202",
      "r210",
      "r211",
      "r221",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r243",
      "r259",
      "r260",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r140",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement",
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement_Parentheticals",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "terseLabel": "Consideration shares (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r3",
      "r4",
      "r46",
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Sale of unit (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Shares, Other",
        "terseLabel": "Sale of 34,500,000 Units on March 2, 2021 through public offering (in Shares)",
        "verboseLabel": "Sale of Units through public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "auth_ref": [
      "r16",
      "r46",
      "r47"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Value, Conversion of Units",
        "terseLabel": "Proceeds received on convertible note less than fair value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r3",
      "r4",
      "r46",
      "r47"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Sale of 34,500,000 Units on March 2, 2021 through public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Value, Other",
        "terseLabel": "Reduction of deferred underwriting fee payable",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued": {
     "auth_ref": [
      "r3",
      "r4",
      "r46",
      "r47",
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.",
        "label": "Stock Issued During Period, Value, Treasury Stock Reissued",
        "terseLabel": "Accretion of Class A ordinary shares subject to possible redemption"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueTreasuryStockReissued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodShares": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of stock bought back by the entity at the exercise price or redemption price.",
        "label": "Stock Redeemed or Called During Period, Shares",
        "terseLabel": "Class A ordinary shares subject to possible redemption (in Shares)"
       }
      }
     },
     "localname": "StockRedeemedOrCalledDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodValue": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.",
        "label": "Stock Redeemed or Called During Period, Value",
        "terseLabel": "Remeasurement of Class A ordinary shares subject to possible redemption"
       }
      }
     },
     "localname": "StockRedeemedOrCalledDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased",
        "terseLabel": "Remaining shares outstanding"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r4",
      "r7",
      "r8",
      "r41",
      "r292",
      "r311",
      "r330",
      "r343"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "terseLabel": "Total Shareholders\u2019 Equity (Deficit)",
        "totalLabel": "Total Shareholders\u2019 Deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofrestatementoffinancialstatementsTable",
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r50",
      "r111",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r189",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders\u2019 Deficit"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "terseLabel": "Class A ordinary shares subject to possible redemption"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r239",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r239",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r239",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r250",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails",
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/PrivatePlacementWarrantsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails",
      "http://www.FreedomAcquisitionICorp.com/role/WarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of noncash financing activities:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalDeferredPurchasePrice": {
     "auth_ref": [
      "r31",
      "r32",
      "r33"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral.",
        "label": "Supplemental Deferred Purchase Price",
        "terseLabel": "Aggregate purchase price"
       }
      }
     },
     "localname": "SupplementalDeferredPurchasePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/CommitmentsContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity to its redemption value during the period.",
        "label": "Temporary Equity, Accretion to Redemption Value",
        "terseLabel": "Accretion of carrying value to redemption value"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.",
        "label": "Temporary Equity, Aggregate Amount of Redemption Requirement",
        "terseLabel": "Redemption amount (in Dollars)"
       }
      }
     },
     "localname": "TemporaryEquityAggregateAmountOfRedemptionRequirement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r164",
      "r166",
      "r167",
      "r168",
      "r171",
      "r172"
     ],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Contingently redeemable ordinary share as of December 31, 2022",
        "periodStartLabel": "Contingently redeemable ordinary share as of December 31, 2021",
        "terseLabel": "Class A Ordinary shares subject to possible redemption 34,500,000 shares subject to possible redemption at redemption value at December 31, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityOtherChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in temporary equity from changes classified as other.",
        "label": "Temporary Equity, Other Changes",
        "terseLabel": "Accretion of carrying value to redemption value"
       }
      }
     },
     "localname": "TemporaryEquityOtherChanges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleoftheordinarysharereflectedonthebalancesheetarereconciledTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityRedemptionPricePerShare": {
     "auth_ref": [
      "r1",
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Redemption Price Per Share",
        "terseLabel": "Redemption price per share (in Dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityRedemptionPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r280",
      "r286",
      "r288",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. Treasury Securities [Member]"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofunrealizedholdinglossesandfairvalueofheldtomaturitysecuritiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r38",
      "r39",
      "r40",
      "r143",
      "r144",
      "r146",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantExercisePriceDecrease": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision.",
        "label": "Warrant, Exercise Price, Decrease",
        "terseLabel": "Exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "WarrantExercisePriceDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_WarrantExercisePriceIncrease": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.",
        "label": "Warrant, Exercise Price, Increase",
        "terseLabel": "Warrant price, per share"
       }
      }
     },
     "localname": "WarrantExercisePriceIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrants [Member]",
        "netLabel": "Private Placement Warrants [Member]",
        "terseLabel": "Warrant Liabilities [Member]",
        "verboseLabel": "Total Warrant Liabilities [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/OrganizationandBusinessOperationsDetails",
      "http://www.FreedomAcquisitionICorp.com/role/Scheduleofchangesinthefairvalueoflevel3warrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofchangesinthefairvalueofwarrantliabilitiesTable",
      "http://www.FreedomAcquisitionICorp.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "calculation": {
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Warrant liabilities"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r132",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average shares outstanding (in Shares)",
        "verboseLabel": "Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.FreedomAcquisitionICorp.com/role/ConsolidatedIncomeStatement",
      "http://www.FreedomAcquisitionICorp.com/role/ScheduleofbasicanddilutednetincomepershareforeachclassofordinaryshareTable"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "04",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "5",
   "Subparagraph": "Schedule I",
   "Subsection": "04",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "7",
   "Subparagraph": "Schedule II",
   "Subsection": "05",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "9",
   "Subsection": "06",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r293": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r294": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r295": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r296": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r297": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r298": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r299": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r301": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r302": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=d3e5283-111683",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(b))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r352": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r353": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "04",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.F)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.14)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.7)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "720",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=35755714&loc=d3e28434-158551",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>66
<FILENAME>0001213900-23-027997-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-027997-xbrl.zip
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MH2=##KEZLA^D:1QR&)>OI,^8:4[<'H.B3H*(=O56ELDFXAPN1 ;]Z9A"QKR
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MSJA$B9IB941@9?WNWTP>L^Z!,\N+I:RN$DVJ/"'ZFL5\3T>PFL/<2OB/;&I
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M24#\#A\=O.X<O:''GIZ[I1 V'6SA:A2*V?->O]-]Q9*%;H<8YG42 )<U&:G
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MZC\=L>*,%]:S667&VWD=GYA8=F)]S!66OM5SWV*:BW)V/ B#RY*O%5VE@=(
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M:&X@E;XP3'BUA@FW&*[DHD[%"%_ W[2CN6%(0/[E-V4GKK,MAU;]BP?TN[4
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MT9BR+542R5J(W9QD^7B\8CR\0@&H929THL96,#*X("M8#<XBMO.BQ8 55EI
M?=A@1$30G#OGU=^Y??'W^%I=J80O *JC>6@KJI#?26O*-R]ZS7%U/61T=#VM
MDRS5>_@PX+DM"#2<8/D7GV"C@>+:^]J^4&RI7G <+,EPF5C0I5=>T-$";N"V
M/7\>7,X@Y^@80I,6!C'T.S'(44$6?$][(A?1D8Y^FI0L @MZT&ZA^5[PQVNR
M]FE#0":_(0TC-95-:1Y>$[B R-,M'=+FN,(4!]PJ15.!N?ER$%\I6KU%=QVI
M<APB!YPP1BN:4Z(YFM\Q_7DU_9E1#PCK0GL>B^1BJ\<[M[S2O&I]%ILV%0.3
MIKRS"+% 6F?%(YP:ZC#*HO!P"BQ3NC >DD\"B$[O4/R)5_,B2Q0RSGX7<X'#
M&*.-L*M_Q@DP7R"ZW:..M1<#SU#3,5(*S6N A.WT>_U=\;+W>J_WZLWK?0&]
M6SPY!:K#( W0?>'["4GEB$Y V2-RV-L'DL0?V->TOSXH3E]1G$V@A8_$0 3C
M@\5"X^D0,?PHLS:)\\LQDRS3'!NS/<RP98EH@$W;T5'(28(."3(K(-8$&=13
M6R<-S;F*!018R#H_[M.VRCW"J?VI/$G26"6W'6[,9)H1;!,Q^7U$LG)_"?0E
MJGQ7/$04$]!_79<;S#% G1 %%O;NF>\]\SWAN^@:"1WJP(Z$/!ND3LZLN\1H
ML>0O3#GZ:F23DG@@I! =D_I5G55A(C?5%#P4D;[K%_&^D7J6<:75(H.G/.FB
MKJN.9T27#,@LB4^B*8WT0LO1+\T OT(W)W&$%Y;&C:K>#@SS7,%,E+]KLNS+
M?7585S#A-_!.ORMF2B9I,3H7@,@9?H<P@.1U 9*F(I#DBB#'RJR"R93B+SS4
M%7%1F&*$,#X6<6#11Q2+A$1D D+^)<7$:3>2TKY<[=K!.'LJ>)BS]@)D3OMD
M=602KYKU71!9@P';CKWF':,MQLQ5SQ$DOIRU6_9("S_/R&@31*!.!>QUPSZ-
M0#>5,W(/8<)9''D,%6=<8EK.-\J%KP9P!O*2@A8/PN"R& \A'0"=Q1*8>HOP
M>(PU,"MIDC%5^,5_:TI+?J69#9G3,5^>[</'Z/Y@D!L!G)<%VS#:(_28IT;-
MJ)IQ2JV##@0:WI3K %N-S':5YI,4UDP?+"$].^>Z*1.PT)WDVLVEG$^ *40F
M=!D$!AS'I;A,XFLDNYI\Z@AF40Z8-J2NOR-WS2&_.1]$U.>#>*5\$(DZFA^,
M F4#9/^13Z9PE>&BH.AD+;T7^%,^M=WUN[U^J8M_?/[EPDTV(1[!; >8 G$>
M.,8!NX:]C-S1_I4$Z>N2Z(?-2#*L0E/@*PF4.:<"O*@2PZ)I>R G.A)=H]4M
M:@+AO>2LE1RNSM!AHO9M%,$JF^&5-@/>-KMA0PK8'(N?&J@:S.WATI;.P$@6
M9,;J!"% "X0;DV5$*:FRD3L11%WFC?8.NX=VGV4RD+ !>Y^_AVI6+'ZW;VV6
M\Z]@\"K("C 0#!(,XY3(B4,X"X=T(<GC@%64&@W>(S\R<45805Y\&TC\':WQ
M0.TU[AO%FU:V+1NKN?D9JBRQ_/K>(& 3BRV-1;FV<;1@3!0F[9!:G2DL0Q/[
M<XD_$XV7PS%F+&LJS/(V%E['<P1[PA\JGXP8*5+V O@,+ATK(XZ%EJQ$L&^)
M'+)COS";=70@@@Y]D/K=82F\5P=3C#2;KL1E:U?_D$TPE1=TNV1'N8I#6(A0
MM>3_D4WM#,ZNE<,,,>]U7YD[;B@GXV'J4#U#JV[B&89(H<8Z3U0Y<2#C!$&R
M-08<#\CBKNZKQ&5> 9?9Z>_N_+*(U^ YKJ@-:!&F7$82M8U]D6RS:$@%6L.A
M-.S<N@9!GJA&@ZGY*I3,GQAI@&4APS/J.A3X0PB?Q*ER?F6KN?57>5:.GE+B
MA"K(_[[X4Y'$%K&[HW9Q05A3*#OSWZ@#Z-46<ZO])._MLNB6@S:ZY1ZC6UZU
MT2VW @6[9T"E!PFI 06$]&^0Q71XZP*2:XEF.<VKQVE;(<9K^X6F/0+I$N0O
M-)<(U$W*J46C8#27$>91S#.',&@:[CKJM+P>CT8P$92W=P:[)6\PV9:R&%5P
MC>@"XT]1H+U2D?8(F<#RY[U]X+$#!IPE:7EG6+3F::6D9+T%^0V=2&3W#14;
M<4<@<B4&G7RB@*C3[.HB9$]@@8!'5@$6"ZW#)"*B^%O@)G@V9^U5MVOQU*4U
MO7$$P#_R2(F#K@:"Z=<ETID%TG[2PON&2V%6 E< ^W>!?7TUR#Q'[/3SQ.RB
M#C] $)T]VFC-S,2YL6PC+B%"*>,:KL;0Z2SR5N)*PIJ2'J#S%4!2(:$BL(YK
M(R ]20[ZF*=V;-&GPUG'W#AI3DDZ@=]5XFCVE7-2-H.<@;X)[>Z,=I$>P=TX
M5Y=YR/KJQ=Y_[(N+!>T910HE.*_6YK!<7>ZX%H Z1%<6HSE:!H7)ZUB;D)$<
MH=Y/9,2D'12:\[[WIP[M,H19+%P3AS*[9!B?N&28$ENY3C(NGPIHH(: UQ$M
M0ZRJ(*-E&@5+PP'O3*O$\_[1"J0*:2Y0*LI>8G*M"?5\>[V"]'F:_' FA(YW
M\TO3-(KSL@F)9A.:H[W>W(1:^G,/ 09U O9:TV=!F""WF8?V3)TV61O!VN[N
MXYI:'7CDM:KB1MZ GD*FVB(/\E:)<AXQ*A,@Q9X<S>,HNZ@/NMH8BVHL:7K?
M,+TS0TD;C\-S0@MT!;F.#9Y6ZALE*]%MR'FNBU,]9:0Y7#5DJS33@0)QOXVR
MVK"I_*8B4%W"K;SR6TS-M)-0^RI23HE5T26(JKX-'C*I "2XT#/]:.9Z_W4M
M%APK92,J)[R!DIL+17U>^_:,]EVQ?SJ4X\9PWCSE4.MT7#B#@*"QEKM<YS>B
MG8>P>(Y82;;9:2B'3+:O98*@?#J(U&V;<VI#*PX:0)WFF=IBQX#R80PS+"H5
MC[-U;=R248D8R.&W-(NGI0H\3'N+!-'=CHOO4P"R8O1N,I<*@%JY\R*F&A<Q
M"@CIHN,-%K= P0CNC(SA)D[496SVV.4/-KWDIL71!9N*Y(<B+)GM'=IU9?6>
M$%68E J>ZV@,-)LK2O))42%+&;_H"IC*E*,G$FT_L+7AR'9OZCQ1  8)Z5$^
M40GYB(/T6\JA)SH[W^H0.L(*87/7$B"\N81DBVGDV<B[\=*"$#25 4,\,1W2
M,?SP-]XH7;TM<T/'1SD&:"4*#8<F,FX>>0+)<YXR>I3GA/BP3=,M?7@;8D/#
MU=!46+;%>-.7VQ9M^AQ\RPXI&9K\#8TO,2XFQN%B"Z97*12IP8)P.)<L412!
MMS9KP#&-4#8!6C$R!)T>*IW@CTXP;>@M&)0AZ\LS(&X*HL*PJ9C9W !D7<KP
M@/?RA*5_:V=>(;V&RL#A*>">#8G'41.U+2B(3M.[CI-O3CI1*P1OV%0N8,>'
MBC)<O[(.\XLE^UM)&K>8ZJ-D'&4!$@ #A%=-NQIBNI9/=CV;.401^S87#..N
MHLPBNIBHLCQR*ANG?&A<N&8GP13E+Y"Q/(Z!8H'4>4P\9-^<-B=%2PM""\<S
MT,B/=4.IINAQG!DZLX=H5?9T7@)"_#'\(1!@S/W#@8P5!C[H=G 0%%X28'X@
M6KMU .M<UE3A;P/*-R,;]S<CR0Z4I;X<.2PQH+L8SD"F 6(I!DC_)R06$J5W
M!D+;\RV*KSD[+9M-6?!S!J#]!#PR$E+1<F<+NE$A"H-S0Q:):X4!T>27"Q+/
M!22WTQXD&GR[O/9+SA&,R5F&@:(08'E-(].K3OVY_"3*)!9\E7!(G$VC9!/-
MNO2_@P@CXS0_T4A^Q!FI,QPUNL=*DZ-!,^Q5(GU8T'%\39^3(R]BE+X27@V*
M!@BQPUA#.B(?@^]L)B<:F6 4&<H3OD*4(I  @%&C[R&/@LR&3++DC5)3D>D-
MX@W,&NY1R+%O5W#T3/AE7CJY)O0>(^B^X4! B"F)X@PYB#,8!U,K\M3ON .)
MI#$*"G79(1.D'1MA)E7)5:#9 0:[<XZ 1F5R@LLQ(O$J\ E+E.9-B(N(^$G5
M^NQP95'-,.5K,#.[K*^ 5?U(1^<K8#KSYCO3CLY1CI'?G>(*HK<D,XU-\3!3
MA*)*BIK:BA%A<9U)7E-.Y'@III-=W 7<F:=+?"<3VQ@HE9<4SG499QHYKI2
MR35UB]TT@ANID1J_F29LAJD=8G$1B$: 50X8@F<'I)><LBQ2G8"L6R':0S>X
M<C;II%EULWP^:\XD8T=QHRG'@6*]F!P.1I66\48:(+MI3!0#H>L<<=7@;[G8
M#LYT.$N"D- X"UO+K5QQ&-3Z??&ED'&K.^OA3F*^MRX[@-<L"YS@8AM!44J>
M=PX/8<M98&%LKDC"""B%NJS_+,3<V_?.,&: 3V-'C$W^.*-2H(U%8REK!%Q]
M?]7W@$L>%K4X$Y=RZ[=Q83,=*>U07'(56X;8P8P5&C9[/&]Y!W2,NS%:&&R%
MCA'K:;4TL>!A)&1G<?$^O,(2UK&MU<>SU%N5./HZU!AGM-K !>G?U<-%P&D/
M VB^,1+KAF)S';;1B_<8O?BZC5[<Q$#"+=<RK?\E'@>#P";)$K=>%;[1L8D;
M< Y'K[.VP-04WZAGCIX)LE>VJEYMCT85D>*O& 0,<55-'D2QE$!$T%SH:S\!
M2-FKCH1X/TEO1A2=<Q6LN"I:U[K+HC#J/P)B*L[+++!,64=('?74P4(E[<68
M:#N4IP#GHB@WJ.8%VE+H&DR[<*9P_][J_7=,TD%#<%FQ*KBL1R^PPH*BWDT;
M@C )B/*JU6%S7'DT3J3:E(X43!27BV1\<T/<3#<]+>S9<^:F2QX8(2S"Z]N:
M23=L*J?V0'FD2%1LI72J+S3NGBX=T$91;=?4SB)/Z5- J9D&_)@R&*OA/R6+
MDD:D0-3C7 &Y R&3A#1-7G7$/%E!B,10_%!-^*PIRJK#OJ,AVJ>B$F(B99@"
MNXEGBH !8GB'D96Q*[+89JBVJ6O2J5AG-J:C-,?48)70:SPW5M5&<@B#1DM"
MM72AYQK>S(1<\/!.X<["/T)0Z4(&LM&VG0)A1ONNM>H]0=M=Q2YA,3<+ /18
M3( M>2;HP)@AJFC8!7*Y#H&@FD@6*!,'9(PY:MZ"4R]1.%QP*P_\%M_EKPC)
MB $^+G].J>(P7R&^Z*H&N$Y&-6=GY6B0HM;G,$9@V2*7PV3 HUL>CR@1 2U%
MD*N6#;>I#L6G2Z%#$-$FC<$T3J1^-@/)+)IQ+\(Z>^MP]1'3(R-<>)L]KASQ
M:=0IW0XCIW:64T#72K5*) +.$HU2$P)$](I@=AWU3RX";23DV2 1#F-&#XSL
M>^2P*2QU")^)YLI4501QICZ+RDY8PY=G@\C(IDP+ZEK/4H:U13>!M<97\&L[
MCK$O6U83EC(2C$F-K6E:;DR\VY3/V,J+N\4TJ93]WJB"@EAK!07O;A44;@Z_
M;I6;#9O*1SG\AFJ-W<)?*1/5\H2MO&Y;3$D^ ,=8&M9<5$)LYI*Q0<1<]:5
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MN5:>U('FII@A'4XNR""U$7(:PKPQU X&FX[9^EI/7+J#H[U>">%A21%W@]2
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M4'1+Y^E4%AA[KY6/$K5%]"OODI_IM_:>+XP3FQIOV]!S,[X;CY/7A50I.>U
MR)G'37-@_>A'J.<>'F]SA%UO$+(SA+;X2DU):(@LN<F*:QN:^@%[ZPX,)#;3
M1.LNS\NL6,G'WH/H  4CG#I<U7#)T-4UAIV$CBE,]:40!<#9EK9V7!1R[NFX
M(;;&-L_PE CF-D9<*K1PK_;T$6FNSZ?G#E/[!]A7]QI+1#129R#)6*I=0JX+
M8[6OLZ:P'8H'B<EEMTLGC?_C8ZS6A5N<OF#9[[X;R!^:V[+D"?[G'Y[_ ?_;
M?6$N_\T#N2GR;@D/?O['XV>_#[G2-<?C9& W0")(L#+N)_[P%_/G+C_^43PW
M_P+^U.5_N9<'W>.;_/:KK[\-K_)V [S/$>5VD3F/'($TA_Y_Z!G5C04D'HLJ
M($-DVUH0!V%5^@$#HS/[T"JRIRISW$A0\50I*V"%#JJ-%.+,.JVL$*_[G[H&
M_@<<GL_,8-P"S78@2&CW_(Z"^7UYAOD]),SOF\\&YG?'L[I7H/1\WY_O^].Y
M[P&!7W(M\*BKEC,:ZCH-ERUY\2$J1?H2[DK%A"-TMJX;YZL7ZXSJ13[B=-]'
M?/Y1@[D!(7LH8M%O@!6"IERNG($"7H6M=[H#E*+7# N($I+*-WR>YZA1X"JV
M5-8",(O5E5 )M^$?%<Z(*FM9YP=Y=DK.5NULU>XX(B#3/^;D%JN5S5$#A\T/
MYKL&1LH9RV9C@[%BEJ>M[^["" /($;(M;M\C;6INW>3RLP4X6X"S!?B=+8""
MIPCK L!30ZO%#;:,ZD,.Z!?F#SL?V?.1/1_9W_O2KM2AA;##;4'H>LA;R4"^
M*3,7?%PF2*"7-<R==\[[G4_K^;3>=420JK\Z[HJ-2N**? >QHUGK;MNROI'#
M/)$>X)--\ ZF%P,*@F,&HD"GQ/G39_4YS(R TY_;>>G^[SSU\M_I44.99VO
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M15O;=?SGLB9Q55+ EF0(K !R&<?1"&T=4F]KM;=FY V.K3'ZDL"+*LRDB#.
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M,PPY448;/H8Q&ZV4E^ED!Y[:>F!K7#7U9JT5,I,25IP72%:8SYAO"^([!I<
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MY@'_Q <F>'BSTU;)[/J+*00"_,]"1X7RXQ[ALI=TKT+9Q&NHF&'C'TFI2)<
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MB,D/V@VN"--LG_/W)SPU;BMGYD5VIGE_]KM$,9VU)J+,O9MK4Y7"63G.-LJ
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M5"[#[^<6?EAQG#,/4CO/W/EJZ%[E= ? Q5J6!',&!$14:X2Q-C[7X0P3*F,
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M_T.X =SA<9<1M,4+X4]%V4S+W(1T.W 3D'NMT-A"=G_FMAYW\I"LCIC\'EG
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MY,XPN=\-)@>J[> L$:($<#<MPD_630U" SGKO=-]1H0#'G\!?4^^*^\@A0(
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M VBP8D*S)!YQ\+^0E0(9)E+J'H6:)<2>#=8$"P:X,TM&_39YGOC]59[54B5
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M!X_B-NYC[D4D*)^]F[)M]<*0F42,(65!.TD@YS(K9@TVY(W;_&DT@8'4E!Q
M,TIJXZR B!(A6@34+RR.\0UG(QE[;E4%S6ZKX%$!-%B  RMHSF3J\)"N7\\.
M>9"X[<CLEA-L*"-=F-U-V])7]A28FH)KA8L:<HD=%#-I(%BN3#VNJEQL2Q72
M2-%-B ^:91-.F!$11M #:#SAT9SDHV4C$31X/(:O)JW69P6EA=5*'(Y07<&-
M'#7^X3*_-A1:H\B0=)?'["X&G+B-?4TA,C86XA7KAM@\L=RLTA8MH?Q#SD18
M3^;W<])!4Y/'TV+2@B:!&4Q:.AR,[Y>RJ#&(>J'E8]A&%9_*.*FQP Y'V013
M:-B<F730"'EST";F+9@U.4A&()J42F!J<$[',\69P6(3+\7VQF(PWR836&)]
MG3R4J!%U[!M:N3CYN ^5C8C[FNXIHR6X)IB0'GG64+CM]]Q/*:ZQ\]4X=S<5
M$=,0^,N3J( TXT_M\J:JBW_G!";DN@ZR>#LG1HH!%UE!#$V^BXHT]>$*-V\_
M*\7C8TBR,Y(<@FK7;5%R[6!&;"44L]":/>I@I"\EJDLZ#U^??YM>?/=$2\*+
M&6P=K"&=YREUYKU5$A@9R@LX[?#\5TT)W_G\(V\[X^-'>1")"#!"(4S?U8TM
M10[T8_E23C7MGB$25Y*2&"6=K7509U,,!._1I!+QRZMUO:^W&J$R&DR$C3VT
M8,TR.;KX<Y,3MSA/)G=8^GW (C'>AH)/.*^L9ZD-M6;P-_G@6,U_)84P_,/(
M"F&ZS&//J1X[*O9$3RWHJ@]P[=C"?C;L/GJ67VJQ:'_CE?Z\DA9=^!G0\J#X
MW!TB=$JZ[\ OI"\2U"*,!15A-E8#F6Z=\#+V;J5D5[FWL!B>Z(D#FQRI0/;1
MX%?XU_!QJN5U8(*P 5!OVD@/#%%E0R_:2PG_W6"]K61Z/B_[![=QS?"0H&+?
M? K6RJXX;(,RRZ@T.$#H.ITZS36:AVGYN7V9K>[L\#3AO4YADZ9"3Q5-14SM
M"/(&[E7<>9!D!@0AL;*0$9\_"[XT8I/2Q!#[E&S1;,?I(UA6I=J&/\YPR2B,
MQ18$K6:.E"I,[3>EJUN#,5<_OR#+,2@*/N]T9Y*MJ.9.I$S6K_].NF[]=KMH
MNR74 A.B9=IURDS412BG;"9-12FJP_$_M K$PWY^%H/&W'#3S;7XB67HY8AD
M9L+#!AX$)3S;3EGTM@OC-IP#)=<B'>DU?<]O-!=(G^9(<&6=4%Q/_JDS^W:-
M"BD 4L&Y #^*RX ]EA6/YQ2."=D#PE>?U3@Y=IWJ'*Q-8B3+*,Z% 0NPB!+!
M0DB33-OIOH?>C$0UB#.QXNM.2(1=V[&&C_ER=KY/,<8M_$_D&1'2 8U1)]%5
MS_PDNYV:N Y*9UWGK)?TN!&M!1&Y+ZL%IYGW\E)X]9"C[[KB&GBU]%I9JWQV
MT>2#ULM-I8ZRZR"G!RV<R')F::=84-;<*(H 1IQ-+'3'-*FE+U2D)^ ;9&"/
MLJ9H K&C&PM=J<$L;*PC#)CK ;M,P]2TWOZ5?J(ZQA%U]:!QX1%KR\S9NBO8
M^/>=%L *HT#S$C]S=OKD^?G:@6*G5]V0(_ODR3];1J<<[^5QV T3\?R B?B(
MF(BG9U\,)N(S/"FOC-%,6LGK,70K65^%R#LH,JQ1'%2DVI+"*&W)I[$.EH9%
M<]M7[OXRFE .*7$1:_'J!28/)&7+KJH^I&CL91;<\NAFZ[HN^E3M8,(F'SV1
M&,P%YDKN3XBNN"W"  A=W??PR[W]#?GJ1+]0L]_6Y,[\A85"%)JH9!N[0$M_
M=+F7X7WPV4:B9<KF*W7W:QHJK;2DBN7"(X2_/1H='YT?JQQTK: [JBVB(BRJ
M1)6J*QR[\/K<8_VL$WAWGYVC]3^4P-IDXPQY(3J])T?9\=%W:V;WO3H HAYR
M? '5=Z7=DVZ-+7)Z*:D@SAG&(,GYZWB_L;O@HYW^U*S,X78FYCD0G3 XAS4A
MM"Q4C_OI*$-_;U;W^+O.^+N;AYU\V+ [B4RK;D"74/N+/=<GO>LI[XK;/%_R
M\0#7= E[@PI%EIET--\[9F&/3*<JNC*R 0L]LU0>V0ATQ3%ES^BKZ'3F\R93
M0C.OA31*Z0]QT:M2ZR$3/DB UD3E.F+E.F+U1>1>WL+27--%0LQT?2:XF"@_
MKNM%;=&M=%Y+E!<(,8L>\^4NT!-24HZCX4CU&MV+=,')R/%]V02NKP9#XQGK
M5OR>9<&\I_YK+]7%;Z8 *IM;FCTZ>G"HR6\2WFGD[9% DL7,;6)+[E7EK*7L
MES!J4=O0A93-YCFW )SD,]YQU@M>$W!<37O3;4Y[(!Z/8GE=;L>:9D+-32E$
M?I\XNVX$>(NA)UL,?<.Y49[&-8U/[DE0;&"N[)Y?_T;/ZSO*M4T2AVAHI1K9
M\;NJ1G?$C9E[,2DKF#P3V&XU[3C/=E_F:NTDH\=00%CB1IFV)6B,<O/9@R:/
M6MN\[09I*>7(5H/G#&8D:X+TP.2MS*/2G7![(->)Z1Y.V\!'0E1/0)+,546I
M\2?8Z%UT5$QFP9803M7X?D.:W>OC>_,(I*UQ'<L5]Q.*]#;G%'$)"TH&:QL2
M?ST;HG?R:4!!P=3\FY@4/'1"PK =+GBS%/;D%7L!LI(\L'S"Z=P5US2^(Z."
MQXE63MQ6".^PZ12#\O  -\<:0PP[%K-%]J 5%^150Z!RP@+=:>O2'L+@;A[P
M2\-<MMO?H$)]83XL9S")SV"E'!12UH:3'592C.]6U]\QCP$>T#_JXOO+Z(>_
M%/[Z*W[XRY]& W')/]8FXC%)(Q1&KZX+X!-E8]S43 ESY5C'9#"B!DP8/$#0
MN2Z:P9;V.[YOS7-?$IL0]-BVK1/:%4.^9?!W-C:3!PF/$#4!A:AG<=+]'B-[
M_>>:&_#N\KD@=Z.<P-K&:0);&-;D(:CAW^&;>J<$#-0Z71JY(<7>4FX^0UOM
MM=VBK/;W<3&W(3M,BTC1=M;/+<%"+N_RG*@NEJ Z*7EYM:S&[Y*W2E'R?[+9
MXGOX$6&&7/&P(AQ!>!@EJ:C\1J[+_GNDZEV(B-:?F36,YVI6*HW]7)LNTCV#
MICY5R8/ZOVY%\VLRD["#N:;.?>:8( ]._.#F$0^:L94JOD2IJ1[[MUSTW_$\
M&DD2*]5K=#'3)JY7$QTJO;N-FJD[0-MU409%/=-U;0>T4C']X&51\A]O-6DS
MQ]#0W'5JS+><3^2!J*@\9(@%A@>$.S=U@@9H^B,VJC%J29DB3AEA&!(HP3Y$
M:<>2Z>E<>PY2=3VZT1 "B( 54ZF?DJJR'=3(:)+EYJWWIV:W4\.??0!DUQ3G
M-X<4Y\=,<9Y_,2G.3_Q<;&,$7X9;U#L;O0M?74C7#^F%1FZF=.\>ZNJ]C+:]
MFA*/]UVNN=W0%+</1W?L^YZ4Q?Q=R+I)3$&]O),ZXQPKJ''D 1FD0=H1N,ED
M'S!-,%A>D8GI?M,[2S+*L'E??W=Z<49XF>&;Q?!X!S*?ZQHI7WQ-*S,$M=2E
M@Q/4C4'8!4*@YT1LS59DA1:KA 7T09JLDLIOPKY1=-C7Q6J> 3%[VR[#$29*
M*MND!2O&,?X8J*:Q8'J&E2881T'W!^YP:=9T?[MBW6M#*PU+JE^=P(&26QWL
MEMKV4Y2/./I(7%J+/0 #\]$]I;+Q=&DC:,#L[4G:]Q<.AM!M*"G?XVA&;BA$
M!R82\IL'*1&A6-[T+)<A>RC@-0EX!2M[)%.<YQEM,MYVQU(71. NM&3/ U54
M<@-;PJ8/_F1GX9U4*^/);SQS_=O7YV>G9V?TX]?GW^)_^EE$_(YU@;W&M(\6
MD;_N-&S\;V)NQS>=?WOVH>,/<9YRA7V BHW9EH>H9J7;[ 3O/GL3<8>6N%*X
M3;&'=LX5(),@O'0F'>]\49L<*;4ZQ-)HC1I.B@8<,?@2*(V*-P(>&DH(I85Z
M')X)I2;[>$EJN0;='(/T9<:3,SD8]OQI=7V]PLICZ0TP2YIX>:U).Z3X])0W
MR2NEKT$+G%M8:$J@\0%WCZZG$CW/FFA)\<[.T(O<Z@X@7<"H\_=\.?:T#K+R
M>;TR58<0F6A/8#<8'I\Z82IF\Z#X=R9D7G AUM?9W/ZB\QFO5<KB7<Z,<[B@
M\8W4:"U"ECPY.QFXJG+>%KVHJ-X\^EB?"<+<5XVZ_9ZNOL.E:^X('Y<X,I?5
M&P7 Q_?5J4.&_+D)SAO4'@D(BQ?)!QP[:D'*1SVXPVV?HYIP"H/T"6M "A:5
MT['H*!<F*!<L?+X'Z7)JV6CEDK A#EM:U@%F<!##414[%TE49)<.UU=*2[K5
MT*V]E+Y"1K/1"A<^]MU5</AA>27AKU)'9F)@IK,'6F,W)UJK$B5FZ$W4+8([
M8"RU&^:=85[O/!1;EI#QEHVI>Q++V@R.8NDBUA5^ 8AE:O%W&U:9#EU9RM$,
MSR)!XN10J!^6+C%"KA>,:I20Z*;OAN9/DU^K^3:9X@#JC^4:L5LEZBZM?\:!
M$V&$%M9S.T5JK;$AI[V75T^4/+V[[QYRPX+PT>ZA\[.H/,%?0RZ..N)X.VIP
M\'8Y6W^['(<:UDS8C6Q\O%M+Y<MCEG$YBI^<.5FD+$Q8<J-?E&/TEQ*\ONZ#
M ^6!OY/M52F)S8I:5(2[U>.S,5N.N0O^I.>7V%S:B<!6K?&WIU:>$JT2*5D2
M(?_P8LK2<)--_#OZM<#$M<GUF*)1A1?*7AY"?4 -L1MU%J@/TL6Q)U/WN#O:
M&S\T]8;](L6AZ,#69O/W9L\Z^Q2FAU"7Q0+OF:44VL0[X!Y0;Y,4M<E=^UP)
M@F5QB'"S]J;P1;@B43KP7A2)VP73P$P6Z^!Y_-QVFZ#"7MX2ZJ!(^M6F_WPI
M_K?I\XMG2$FX-OU-V/2FF,&B9G,TC2)$W7"TKD]Q;9/ V8 ]8*FT$73S/+UX
M_CQ]_OR;S6"P)=P/I\^B^Z8#+8JLRM!RA5HO?'.:_.([F_O^*C\5S;AMT$NA
M_NF78'*M$&P/HWKI"UU?:&- DL$WA%F@C[Q>"()'NSG\C5B$\%+&3TK37_P&
M+-C8\'D;FX:CA*AAE5V]<4A[M 8ZL]0.OW$,4^@+B=$E?<*[K&3C'0PAHPV_
M_?9)^N3)DXV-HSN7_<#B3Z.9X.EL. <>8LB#TTC5& \)1N2+YBG2^)A#,YN;
M1[FGSYA0\QXI$2-T[:C?1FA\'_?N8:@BI9(%^@%#2,TF2&BMK'>8+>;/K&%M
M+BRS1NN.X]"UWYA,+.=]22FV"*>AVS];+HE3@7B@0!P;%MW;_ 89ZK@BM1LE
M2ZXL2%':='E;0*IQH\QQF >?=<>$2\'VW*3&A=>]=]MO E=RF8!'8>/'O7(W
M.T)=QK6M;-6]C;:Z/[+!!TME>U@!Q6TR>XK&RO<M_KAKBOK;0XKZ8Z:H+PXI
MZD_C7&QC#/\HC@IR^C$KDO!D8(.)_&1:(4$@F5-SYG:6F(C/8RN1:X:EAN8/
MXNP9!<V.6!&P:Q2.-^X@_Q'?17XYNBYLO%&&UMX4;JR$PGMI*/^\Q6:8 )7S
M9L-OG;8\ Q09\RJ9UGQ=9&4_[&5+%9I\D6E]\31L7QHV/=KRQM%#,&B-'?.F
MZ>:00!K@<SZ\-] !' DKPG@-2;EV8?.UE)WWI:[&.I5D4MWY"+@F$WG<8A]L
M!_?BS&.XY?L!]8#>QUL[I[@K)NHES*3.1X/.2U%FM92%48UNHT=#V,5HA^,A
MR*KGG7-FG:?P5_I&8)Q&1F#P@)J;G*N^\/A4<\+@V9UEF[U Q.HJ:I9BC*%)
M@63PM\%+[G(7<9%+U&Q]T,5U\"MY9D\*;;2OYT=02Y_H.,0[*!M&*D(J-WEV
ME#LD12?'2I666[>8/O?>-II1E S'*"^+_!;3WFRH&8MVN&%65B\1/4K6=VQ_
M83SM5^0L@VD0=;>C/:#SWRSK=DP5>N2)9%HN+!.JAM0H<]QZFKIL*U'YW&W
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M/.8OCG8>9#902?OPO'R*RWET]6>^KHC^/JHPJ%]-0^_ISSX:M O:62+/41?
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M&9%",%8=7$N9*1;J6D-?R5<Y4<->&D=$]O*>?$5%*YV=72L5+NX!O),$@ ;
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ML^NVS!1!G^&KD,F<ADTA0X]'[N"+?%O%:=DB]MFWTM4A>F1AO;>=71]PQS!
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M9E_T9#0M*@T^>?:5$OK+0<;IR)PFOU9SW]=+/I722#PB(O5 B33T?J=@%\F
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M&7!'L2K;TX5>B;/S]"@[/KHXUG<:4H7+\18.RJ>8V8A3-WNI,S'D#*HRN>#
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M%*1NM?_1,'5 FRAUZLGTW:7!:@Q:!T4=W12<W8[6!]]G'@\L'/;QW._*U@S
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M:I6"9CN.,@:SU69]7: !A_TOUQ;I5L(0^0A7P5E73M^""SK+KV&T@^"M5EX
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M(_"AA;&RNFT'D='1.14/%\IW,:R19/D<)"&-J@H3NU!1*>D,GIX[90N8WC$
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M*1>6P%3*@2,OJF_E#! DO!%L9D1^C"@;W?>E+UE#M<4:!LTUC,;C&FM0>;T
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M=W&7"2+)W@9Z5Q_8%:W'9QZZE\A'7LDN9!2"".N:<[]QR"&!DC&Q+&*/KX=
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MU>:U)-, H:M65W;HHJ0;X!!A'K-_<^'IA9:,P&"+/$WI)]'YW'&.R5JI,#0
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M<D[EX;M>L^%$$$5^J>76=1X@L ].0Z1PV;0N&T/TCPZ'/A9H>!@70A\;BM=
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M'=IK7VKNL+).R (BE )3Z"%SGV$:J)S%0D">'7"YB5U?U;^^H?, 7*=9GN5
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MXZ^TEULI;H1J40YV+)._*-B4IF^M=*MD ;Z'<T60?QKK@0$R"=R%TT+KPD%
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MC*&H12EG-/;."]:V"Q9BZ))=,7@[^]?&Q6@X_WK:N".KWQ]X[W?AW[FXGM!
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ML19Q0T=*=?D%-9+0"5GD^G^QT0BFRAU+-.;&>%5T&4%[)"K5:9U":W"D[0"
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M[N^DCMDN(WG\F)&\RXSDT\>,Y*V<E$9P\^C!!#>' R#TA5;.I</UK+70R[C
MNZ7%!4T(;%:;PX^_ V*^5JH7E7;Q&1/\+6+.[F3]V >/A(T!5>,*K5=D_X+H
M%^GS(KZ,,*^)^2A+!.VT&O30/D=749)*?K-&?MES[<.GP3'R(!^'+2B KJ=P
M1=C# D=Z;,&"%BS,?C*S!7F/)IPY(C^P*4[HJAIJ\=._& .J+&O.%D' 4;JR
M&[+RXTZU M[+_Q[[$V_U<*QTZ[#^\5&DN_][%,3;$L2(&[/Z:F:AS K )A??
M0)/HOS+ F'&J7* M?@R6(::BO!"!7C<EC.19-+>4-"2#5+.5ZW]=Y09LV"EX
M00Z_-LJ/$^MI&$+VKH2._>LL-HT@ ]5ESYF&@"*>0@P$XY<%5K?W67%K 'F(
M?D2OBOT-QQ48*@'>JQ@RY(PA#P#CV+7Z=C(D\"X+?H['!.I\?(@3/?1RY11H
M_FYX"F4 H>+NSOQS AD(O9_?'0X.#X\M_$M(>2[@EQ^S'X,9"]A>JGM*,HMU
M,\7.1*]U",-P**=>E0**S;/PC :BFFA&15P5.68ML00+X6>D=0!#S "0P=1@
M1^')\=/P]/"P^6JJR<2O4<<I@=0 :LT$0K*Q5'9)GP>E,""W_CH>%37(O!X?
M+.+1/N739?P"K0$Y5YI"\^5XK>JU<T&6PZ"-44P]0I$>4O >HNC_H4(+Z VY
M!)>GPCF>=$X0MH8WA4)=<>QE1QF3+6/!?X93&8;^ZP@30%K0NT/TG+RMZ@(^
M")0]W9/V$ZWXZK?14LNVO+D!I8T( UH H?_79KS:[S?@FFKS#8 $/=3#OI=L
M+:4F* #JZ#]6EI*_TJ_ETR%B8:I,G(^I601H7=!"$T,B6R_U)0;,,50J/^VD
MBGG3#7KW"A*AV$%U#JDI6%J]Z<?A\/1,B^Z)ZH.ZP1(3 .>+Y^Q8'1V%PY/C
M\.3Y62\^#@>]71>, M^7"9(A<;6J4#]9[#^@#P,*.*P(#28&#4X_#,+XP\,?
M(9@3/!TX<1D3W_\Y*<<UD;_!.,^S*%U"W8P6F=>FE_VE <.@< Z!AT%3H$&[
MQ0<.?_P]AOBF^EE?Y&F^P/@W_\6L(,S@W.GJ^EVZNM[Z75WGW-4UP$D<?2U1
MN!56F%YZ%TOCL16T\TU98=""O8ZANI@BBUVQZ"<-3V;%EWGJ-DKK%W6ZN.QZ
MQF *_^W)V9.M1K-)#+[G"#4GT#E:CHV[PWBH"_"BN0![P_U[N@;#[=:@;S0W
MF\UZX/_[?'ZV7+I-Q.>WFAE2_CHJOM>OO*#C0S^\<%PA_A6$]B>[(5F;+,^Y
M]1YX =YK#TQ_75^>-!9]]=%?\"!^.ROS*#B/@G/7*_..[S1?Q+[J1; ="4PC
ME'@"AEV;;,]OAWD^.,8!RSPH04N_??+3:VCLU(ZK2\3S)OCUUY=[QZT+WJ&%
M6T6/(Y]J#ZU/F/@KSQM?P0Y3^ Y:];VCV?H]CQ/8<@+/M LZA C*PYW"\V>#
MLZU&_Y=[,O"3X>#930:^N0+:B!_L2_7,*R9T;>$)_I)&_T&Z:(2U#E'UG+15
MSY=S=&VQ(>N^S%L#@9:3\%G'L;CEM]^#J1X-CFXXR_9!NH\3[-/1.[>3W\Q$
MSP;'7R:Q=VO"W9$Z?9\#HO$YQ-7=VKCW45%AS=R;;#S8.S7Z==4N;;HAG9KQ
M^=E1>#1LZ8QUS[RK\3P=G*P?RE_N>!0]1^]/6I/[-9KG@^<;;]"7F#9?=NS:
M[-'?ROX\CF:G1W.?[[HFX_4]6[K'T3R.YFZ/W&T?J"Y"]GNV.-_(:*A2YIX,
MYO][F..XSU>76[WV30GV_1K-XS'[FL?LM@]1N^CSFQ+>^S6:QZ.TVS?6JPG
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M%]Y+V-*>'\"UHA_#7<]%G3*,LOYZR%W$0/SD8(9,DI* 4:]B@P-:6E@V& ;
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M:7BH//3&$T6L??=(6WG7^ C]#%9[$OLR"*_FP@(! *Y=S-PR^ZE6,GO)E1T
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MGFTG]VLC:)502I>D *E9N@20_$4\AZL.[]/:Z$),M]I"C-#]JFGMANH,)_6
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MX<XRMW%@"<7XR;\[3TY,V8K1O1 -)7G'-U"E:TRBX'4< BD97)PL[_)[E=N
M PL"""*S%.9%)X,<$MZAKW7Z%PFI(3^LG%'FU+ ][3_RRB&+2!,YC,Q&91$R
M?,<@:7D*A/N%0&+:1JC!4!$ +M-)@8]"NY$_#M:G-C=1^IN[9N#'X-2ZL3B\
MR4X.3T@#7];4,AY<'/RS@^@&0FW:Y6V$\FA[J!BIJ=),%!]MJCT^A7I8\95^
M@IIJZ>2&W*08UW.HJQO'EGVY5ZVX)<])6]H3K(&EX@ \@85$=HEK$*,T8PX
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MQK#17%V)WJSK64E0MSE'W>C22>(V<#K7BL"MW7!U@GRM7/*=D1%-Z<SWL:Q
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MI;*BL[_!S=,-K=%M:XVJ3(*]\\5QY??["DKO2D4'A=EI#:UM[9=O3Y_.2Z<
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M# PGV?&W+@2O:25H)5>\W)<SW)93N2L/CKCG"^E%W;9F=,M4NN](3GHH*,&
M<[%1F.EY#!G2'H4?Q13>@[E>*_&2#?C)$!--93]GS/8JMU.J,[^'")/ SAG_
M[Y4M%G;!UU7@,';UCM;JE#')M\)B%=KEQ4DWEVC9[&IZ,RVW:@=&>@X*$_J5
M/ GC0/+*' [=@"UR?6Y,I]9%-%L[5Y*>MYR<V=QAX-6FM;O+.XJ]NXJGK9WD
M%3:KW>UKG59I0/-]N.M^'5!(;VFD@>?Y;3(F79A;:@^]OEZ<$ /5MZ[S;(W8
MZ-OKG[ '5W88K(YBU85@HEH&,&RGV@XG!P3^2F*;FV,#0VNT=*W1V$HCAC+J
M2GWMCUI-IMH+HM FSR?17-G/S%LIB>:PCQM.'^!;(+N2T[UMV;ZSU8AQ8=]7
M37&[*HIOP5Z<LYGC63X*;]H0L1\%I':S1?67A6HP:Q+76D6GM$+)D:Y3[II3
M:PH2MFV-(Q3P*VD<6^;=@R:Q_YK$):]9.F@2N],DPKY60K6#/3"GZFTPF%I#
M549R-$I$!$TCC  SUR-)V?VBCBRO3NI&9Q][(:TAP^4&7L+^(5HC LN(;>2[
M*#<QV\?5;&(I<#'DAUW*F&7<:XGE(Z?>NM:SZ3/U%LQ\*H94_U&OD'!G'YLV
M;9A/;\9BF\)=RF;2OM8JK5QL2WS&&? LEKX%3SW!=X[[JE[O;R97? =CJSMG
M@YQMTS6C(*9,S7.V.NLU?]JV9+QC,_-5.@AF$?]1FTJJ.)A2K@S6D[_6A<1[
MV1%J#9D8;I)W,[[C&W*+^Y%_I/H-K=_O[":XG"(!Q0J0SYQ$1M;^AR.+\FUK
M152TMQ['K>S W(;')40GQ_N6,LURJL%Z;:UEE Z(U<K15LC.#AUO,^'940>O
M$B!DSOFVYYRVY9!LZ+!(]XR557W>FWS8LC]SI5UKMKI:4P>#N%=1?L[!Q5D#
MUUAE+DX4O5'I!'+C3I73-40@SAW_'P'"GN&LP+5[QSS?M8:@IN(7I_8H^4'L
M2=XK9#[OZN+G<!K@B8%_$(WN0.6] *5Q6"0XAKM3)*\E)UMESWPFN]N"^8H7
M;#Q7IE]:=9X7BB5( .UO[-&R;5C5V[X:VSMBI?4YX]UI.$5-QV65@#7,*LW"
MV9&'\8*0IN<7\O8Q/RL"ZZSHY'8-K6\<\*"WRP9O1X"7XX.#[?.6;9_[8#:;
M4AC/G%):P-3Q I>B8<!:Y)!*<T(=,CZVG#O*<SQ"H(FSJ>EYZJD*\@]VQWU5
M>3\(U0L&_P:S *-%,\?S*)+ILA%[(B"' @)B/2F^"9&]CF:VK$8^52*656AK
M2ZTJ<F0%!PKX%V*_TQO!?-2QY)YSWH-S*_CN+F2[/,==\?S#$GM7C7Q=/(TY
M$$E[QSQ%C]HR=(3#4=O,4<M'6EIH$='KUN T%;G2SA<0:E+R$\,ZYR&(F$<.
M$X(3QR41L+XU.D80!W-F@?ZRMUQ4],PMJ\HXG+FR9TYR8P('Y<I&ORM&HTYY
MB;T $<@[@8;6Z*[1CZM>"4FX;$9$?G\J9Q4X5B$]4S4H+T>%LFS^2!X,9]_
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M'MG6L(A' N(DM -^"PA+IJ(DJ&OF/XA!3VG,G PH$0/7,R23N"JMIR<V0H2
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MB$[G@CG4OUC-7,;# L\=(>_RBMA-7K@V"J):]@76""]EB\Z8+>K>B0_I;GQ
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MCCP+Q[QS7-@[ >%[<!Z$'@/W!WHKT$E#]E&J0OVV86.:)7%GFYFXLX6DP$Z
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M."8Z:<@Y$P,.'XD61=0QR.J9*]I-YDBH:)X:3\E-2J>0%1]&#&&XP<49[!@
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M\RM/$8H$.74[8:NX]7!F_4<FV+'%5OS29[_UC0Q1<\,X5TQ)"V:74AN-C3*
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M9N\4W8?#+3"G=9/#S=[CWUPH]FM%ZP+M?8.^!1>F0<DM;9GT8YT!2TY26*P
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M9AH9,J]Q?=@QGU'C^K(C<6I<GU;';-..QT0,\^6;!MM![)<@B)],V\'>(+(
MQZ+\!N#Y6KAM2$]M&TI'LFUOZNSF&6Z27+R"VX,-"S\P?6]K!P6$YP2(X1IK
M,6CUG.30LY!#RT6.HE,5"Y$CV7K;(3DT;F+M*R1P)]^4&J/B,36);8JF[B]G
M,TBH,)#RM=Q.\:&[A]2[V,DW^:73SM>[2-%=XB4-A&A250.%^([?^GP-C10
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M,@#Q:*V@E2]>BI5VQ$71>S,?<2++1XY8"XX8"HDAQ>"?.83_P9,'T"Y>. V
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M(&PF,)9NV,RMC( Y&<H$#4HY^32/.%4;+,J:L&0B&&%Y3;6RRL?P-!(DB:*
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MB*,@[B1()&T5G!:>\&D=%0=YYT7"D%0:Y3R4"5.9;;U7):V?1ZM#F!ACA"[
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MJY"7#,\\[:B>5^ %K9<S^M= ^J[,U,#>U*I__1;G!$P6>AF)EF_WKIOMYUI
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MI7KH4%/_VY;__:;_I?L;4$L#!!0    ( ,^#AE9@PX*+KW$  ,X7 P =
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M:7 *,V-GL:"%YIOH*KTQ>53#SJ*>T)[YGMSW[_LE'=UL=CMFYBH!05X9N#1
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M3Y^>\-O;,=^>N P9)=\=.N1E6S^]5XDF%#>:=NDZ]80A6,5LABA-TMHD=BC
M2U^DD1SEA*-*HZE=!:,EHAG82[;H+WLQ^BY0C?;%P95L9\6E@NK-G@BY7>)4
M3\8XE<2IGNQ%G.KQ%?[7+G1XUG\DA.Z>!+3^M[\8BF&L^P=CUI1DR10@=6O%
M)' P:-^%25&0F@WLKS_9_/G_'L.D6RLYZB'8^\OO?G@=O7S]PP]O+U^]>O/3
M__SW9R>?T;_?O;U\J?]^X*3N:'%XFR[JZZ_):0]GZ/TO^AG2O.=)INP%HX3\
MEIEEC:TEOWG_2M^1L9R\?/_JV[Z?NP;[XK^>7WSU_$7[O>T'R<^0K!3,LUC
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MTXV"FR/$;0O.5\7I^J#::,*]J7)OK^B(N0UH^W/BD]_^ZCVDO@L*EV+$;?R
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MMP/;1 ;%M.NNC)EKY\+859/5JJBW*<.R&C^T-+>F_Z8FE0T&V/CR103] K3
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MY"@X\$.7SU9OV,2'>9"<=?AC\GT5Y>H.% 4)XV:..13.U* ;&H;+4HMFL8F
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M17;'<&U3BF]7E10@")Q-S R,>O #\,1Z"-"TCBV$^OGIT>PN]\;5PE2])IH
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M=<4Q=]E>.NVL5&Z> :<^XR[9'F=-)^B9FEO0(9=-\I_X=TLI&!GD4S)(NI4
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MWT6JMI<Q>(; JA(\I^L&$R@IO&@S-'O+%G?G!'I."K8CAC;/HL&5-#:WA7,
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M+[_[^=7?R;'QU_<__O#M_P=02P,$%     @ SX.&5K37]VTC%0  %/(  !$
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MWM4JTKQ!4X.E4>U!%],_;9>8\S8A+M);!A689D!S.6$BDBW6,WN>'L<E'7R
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MQLVLP9#W! [(R/0"1@)<^&*38'G%5AV&@, [Z/Q;-W=N#"?>>3BD[YU'LA"
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MF(+I (7+"7%\D0#[B90V,, &!MC  !L88 ,#;&" #0P@2<,&!MC @..7@?;
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MT6\1MOZN0<E.?!+KN!3>'C2J+]8M)A>9>E<K@8*FMMM'"?Q+KS'X'?X=ZXN
M<3E]7A- /YC_?*T-:.U0@[F3!DE_K#$&'*9+\:,#A [THUTLQ"U81S !WL?&
MS:77><%@8<CYWKF;=P<""QO-2F;D?4[SM!EEPJ!1/U8Y4!%1[<;.NYW$!4_B
M+NCJ"]/^TN%?%DPX.V;'\QJ4,0)T-K'J_;)O=;8Z"E\^YUV3" [/,E94SDRU
MC66?@1FCK1*AD.!B[PYA!5-WJXQPKV*P3K(IO7V- ;X/G=3ST085\L\)$QV@
MG"31&XK1PRUQJ=D^HJJ;46GRD+A5=$6%Z35YL)F)[AX:>54&#CI]3:<-W9[!
M+;6]#B)DC!28+^0.HV(860^YHD4[KRE#Z$SJXJ/OS<=EX>!:NLWSJ!,Q;>5U
M:ISXS1PB&=?[#'2>1%2S!_?*;"1;$Q ZG#3XK"']Y6' ,*)(&GRV$FM]E=1-
M-'NKN@>,-;A:@ZLUN%J#JS6X6H.K-;CRWA:CU2H*\P[=_$M8J%K2'@.S(9K=
MKY5VTXXV+OK*DU:\SG3+X&R8,CC3I4Q*7D4'\'!Q#9P8X [GBF5 8' $UE0A
M,Q$-*UURN0%)/L;K*%9M]&G2'JHT6@CI.BB(25.*!4+F8=A;)R64#K387@69
MRI7Y.*L13N:3R@%P%<'9$MSY3Q^C,%G&E]CM\&L:@CY>([4<C6=6"\E7!^3,
M:K-2%V2>0=Z@*=9&J<2GJ(/OT%2S/@$PB]\.Q"?Y9UZY8 D2WW4"B11]ZZ*T
M+DKKHK0N2NNBM"Y*ZZ*T+DKKHK0N2NNBM"[*H_+E6!?E\<C!NBBMB]*Z**V+
M<K@NRK9/H2A7I]D'4W(9F@V6B=IQE_6C6U-=)U[.@^BQEN A;7#<J_ZJUWS*
MPTZPYBF=OG(+:@<'C1N$;D<5$.">);4+K?ZV5&N)X!67JO(4UA!A#1'6$&$-
M$=80<=1RL(:(H1HBOJE81,%;)3T:L7L]R\BAJ/L>3YTMOCJ-0@_]!M&K5SL]
M3R',[Z<JI23">;@R%,*7IS=(_\BU<B8'#ESKR=9X;*/@ M &/U?<JW%+2QI"
MX 2XC#VNY^*'"S3(&,1.Z,T='VYPU=1HO@1H_ C^!'<(V<:[3B&[4AM22HW4
M?43( ".@QNB\9 LX$_NG\!I?>H[^X,5#A<3&[#*CKD2HE'$?[6ZDY/'_< 4C
MM-"QIM 0PD9AI.EVR33-<"_>AM6? IAR&T+)%-]RH>\FN5;?9T_^K19G3:^A
M',1.08F*8Z_VNJC[H:[6:*=B3,H#[?JN!8,1>8=;"9SF+GGUK<<GNR-LM,^7
M"LW75M\"-B^INU 4@FU^IEREH:='#7<P,?'JT"6J+ARU;:;[NQG,&J5L=_<
M+<*C,#+78$*U^&AHJK;298_7&73PPVW'K>IWP64#H'S=G%"XGQA,!)3OFMP
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MPSU^'L4)9Q=8)I6!B8L7&YX&PBI32/.(=7QP*K?9L/@-3(("0&I*KRI/5/Q
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M$N6-?L!F%S;/U#8<.589:&\XHK'@\'Z582.E5 4"6LB@:(EP^SW"C1.GT2.
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M_+O\90___%D6[O81!HC\;IO"#1N0*$U?X_FO8YCC#=[B#4Z^P1O\ ?WJG?<
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M&YM/:QT0;&1;1>>#(K$31/5$I\8".=.:5Z $77,EO5 (LI7W@D46"2GZ37J
M07_'L?4NC9UM1I08P,<S4Q8K@#U=@IR('EVDTOI=/Q$-!*"EFVE223NDJ3)O
M)/$33'/< _(VR6&YX32R*=G,XDVN!A&_W6XY">P1U\,L2]#]'*,% +F-3[X'
M*8P\W)-Z[Z6YJY!(/1ZWC%YRLI@VA_[)2W$]77QOWX6/VUPQ@LY$W(1;N3C[
M1 !Q9*V8TKQ?G1HQ5-C7E"0IRL8G%]+T(!+' ,?QHB.?!(!4S;Y(K]QP$\)@
M,@.'_O[6+6?:(/+B!HIUP"%&.O9S&N:-=T<09N2N*J]CQX>=L5@TI=:,<!,<
M*>@4?D@F8#*K_=^'DKDX+VP#88^A_ZNX.5ZC\+>4E3$4]LXT I+5)OS 8>,'
MMRTUW7%2NS,WVYAV;&;*[+:<=&'-/%8P9[JW9QXW.2Y"Q%3UQ-'[84Y[_<9(
MAF+\B<#81SK5Z \=_DX._/9\:+@OG&H&>5VWYH#/[]&I@M\%X,T7SI\V4I:V
MWS5B2I@<%-0,>7]X^ 7Z^3I9)>@00L<MME?N]OU@<5X_=.DJUH\1*4@<X:D,
MUADU6&=T!9 G8%^L@9['Y2(NM L]OM5=QI4(HGLZL4^Z$[/;YF0&MPVON<*\
M;IL3^6US8L[/H6XQJ</+\C&@Y<D2>*>^<V*\4&5)^TL7>Y1,/0.KM-!A21;A
M%.&#K!U<!.UT@>#'ZZ"1Z!*&Q85Q!/Z_XR^/CX]/L/&4]J/_'IP<H=_@_\I;
MQ3ODVR0-?X?!]R#&]9-#7)(PP%7SD]K$!+P<B9X/<;EB<'9R!#"UB$J#?CAQ
M'0[$$X1.)!"3D*.)X,I+ERGIZ1"0U5<P)>(_J51R-W5AEE4#35U\*[$%GX<Q
MN$RBR$LSL$<22$:XUIGUV,^712&A1K^D%"QAZN"QS%_5;)#1C'4=-OZG\O%X
M@ ^\O4L1K5&=VI,>+[W-'+@6Q1"IGR:]^\ZE/5:-IWQ98Y)A;.5$^ZA@0:5T
M1/!Y\Y_"G&-S!QUK<5(WVL:W7VSD(,6! XKV!T_U6;=&>SD+9=+40'[<FV2Z
ML '9;G.0*7G@ %^P$F8)GIE(ER2<0(46 Y+]ZO(^D^3U=9>W+4E= 'C6?^Q(
M POTE&X9<IGO\E/Z*F>_S%5?W\Y<!RQF=_T%/8*-(E^67MTJ.SH)NY."I>9<
MF/UC6X/E',&3/K,MJ\Z*H+'TYZ(BG,'[^C^.<P/TZEX1NLD>U:*=W+BQ.="H
M'A:S>DLK\)$C6+Q7M+N30/4%W3X!_H/9<6SF-^PJ',NXHQ%P_(6L>=9\/CP(
MA.KEN:)Z*?+[?'OTS>G7S3\6/B"L81HX@>S[) 7LKGR1/,*.HH9.:)7A[>+"
MP\.!1?/:F(-%1L([X0G5M<6,(CO3V6%F4PQ9!2!-49J-#4:U!K(R#8PE:Q$$
MI%V#%ZV\,+B)+[Q]F'O1R$+%V\5)*B0;%E[:8S4:X-(@K]";R:<37)>=$#.N
ME=8HP-A8<.Y@[H4Q#*Z\-$92F"U\_[ [D/2[(G9G9!E2V-!ZO(T<)GXV;3D0
M!"Y+".BSLRE9BO@/B)I9[F'JX7CABR0CX<-%<9ZQ8\?Y^S@PU'&!X=UWY7C@
MXPFN0R2D/&N*D!A7TZ2#VR1.RH5O8C_9P6+9B8I)R/=S<=5)H>+)4[Y%;[:0
MS "?%\G]7SBM,*',T*9LJ>%O? 5>)RD,'V.:G^V_D-Y7N'EF$O^ 3L5W29:=
MPPT:L_8^CBQN.CN[$#P-^#@B6*P _&() ,N&[U&296[O2@.^-Z52ESC&\GD3
M/\&,Y-U0X2?=7=%O1A9&[C;6U3$>)+R.:L6?RY,NB8W*SCF00!EGF^(F)(J;
MY&D12"S[=9=1$*F;+9/0I\R#9LJSNLEZY:5YZ$5W$)$[\Z+EIG&,$$U*R8 M
M7\5Z8I,4),['? ># QD$D@W(ZSE4)<:2<R QA/@!G\0QI']\#O,MN%DMW27(
M*#.R,DVK4<BBCUH=*F9X)YT(TF(FDW].L]@F8M$ 9_2U%Z;4+4$R("^(9I3=
MQ-7O2TWB9.2[7F-C^ZYJ=>!X/C*J8:(C8H.F%&$22!S]1NDI7&_*:;RQ/N];
MRJ<>C4:OQO&(;4/C,9'I[=;FHJ-GA$5&ZCO&RWU^@KB % P6B';>([P]8'_N
M<M-S0YQ[6>B/?-KH[>W 4*<%(*_66+$&\.@B#&<5"=6BBW[A].PQ$H9683)M
M@CF(M=,&DG4**;#5K17#/B\'*#RE@Z$,YIOBM&'O83M:G D%Y^@@?P,QK![&
M51CG3),GA6QLRA:?"N.?\@HG A<<UI=/N8(#G2[#Z("/@%O$H9O"FHZOY"]J
MECAWU@QGR;BUMM3JMG&!8=5FJQD2% QA?3)N3^/A;.@6H1ETOA:2._$)6^[B
MPD7!@857BU-%<&8@-AV^B02GB;"+N@$">%BGJMY9^LFR8DCJ/XD/H^&&EX<4
M;4![M9+7X"U\)G\9.VY";4_[MB EN'B5E+R(& S.OCKZN@B#_A"'>88=1.^1
M1&S!*8EF/@'Y-DT.CUNP/SQ$Z(I)-AN8MA1[!W*H)05-J50GF6%K#\X&Q8,!
MQQS8$<[FAM9]E'*8II)*IA5A/@+*$ ,%Z>S2S8U#4PTXUK56<I6R4GJ>S.E$
M&85AVM[/.JCUEP-UJ6;KA!/A6I3!GR310G]_^^VG=4'D=2K_Z,,L(WZY+>P8
MU?=I^.3E2!N./!^2+O?/1>\!D* /!_BXH5\*?1@^.:[38BPP[5!J$Y(.>)B1
MKZBHB8@[X>8ODUV4C%U</,PXL.A535 M?^OL..6SM'>&<FAA;$LEB]+&;C!8
MIA=>%+&.Z"E$3&%7-PJ9'+!1Y8_MT'%XNZN+0T\\%4DW] P4;3-%V1C%39V=
MD%+0N'%2.^AEAY1>UN@&'WJ"SE-HN<5E-(@W[(3EO*1IDZ\,D7"Y(4J_18-,
M?V\'/G,M +EEMA(?PB"K-$M  L7:\1T@PEIKOO6:@2!NK?Q&@J%JHV$3SS3N
M0T73G4(55=_7MF=6&3)^SE\*R>V_3U+R?^Q-\!Z],,[0_WN)IJ]ZB:8S?35Q
MU5<]BDUC^%ZGY+I[*<[]< I;@/[^<S$[\D&4"O%PU6%F![!04E0/83XMARK
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M#YT40E'C5-L$SL72T,6R3!^]./R=9*Q<)'&61&% TU?B8(4XA;-;:-!@4>O
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MG0X"3EH(J/*UU4= B0QFC[!5=- [(EH3;-\2C;UYG2/0$*='!(N@]6G?16#
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M2D<C[70>'Z4*(QI-3OFX#CJ]E\](Q<FVX;XL?9XM-V@KM/P4:H?2EK;SS52
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M3)YCC2XPW3G6*VFT]^=5S<"C0("&B2U:UBMBL"E>5[]@8&=H32 1N\O-"K$
M&V=)*: XN \?XW 3^AZZ8:CQA83J1:$?PFP-/^;G4<\!.3Q!: @H#FZ0(?#R
M\H?PDCC#H[FHRY*L8XA'*WUH*,W,NU7$&5HP(%N2I5^FDF/A5FYZ5/ !XEYZ
M8>R'^P@2:6PMX#H]0H63;0NL!'NS)]K5#J:/2$Q_2)/G?'N1[/9>_'*/1/J0
M"<6+%]VCOIQE@Y,Z9+QHGV(!0%< Q1*-Z_5/__?5*_#S3^]__/I?/_^/OS]\
M_$?\]=O@]S=/C_]XB3]<'IY_>).^??/WTU\^K%^RZ,V3__MQ]+?\=7X/__;[
MF[-?/Y[X[_+C?UY?G][__?73Q_.+?QP_!??I/]=7E[]NO_&>?WE]?G-S!__^
M^\-7V0_KWT_BK_X[__V;('GWTYNOWWU(EU^?__/V[=?GMQ^^?GQY^?K;E\7J
MIRSXV\U?_=4_/YXDW]R^/[WX9?OC[U?7SV]^7?Z>_OCMWW[Y[1\W=W_[[Z\>
MKYX.IX>OL^U__7*(GJ)?\K_G/T:_7?]CM[S8OOVOQ]?^YO<W[][],W_\_?3Z
MW>KZ<+%ZO7D.+M[]=/G+V=/EW[;WOZ3I>_A?V]O-XNZ;1R\(WGY]^?;M_?7N
MVZ_6__/\U47R/X_OLK\??[58_WC[YNN_[W^_^W$7G?\S./OE</7#WU<_W"'A
MO+CZZX___><__PM<W-^]>N4D0E/[4ZA#I_2$:T!"X(<,+C=761[NO'ST7G2=
MQ:U7<FKOSWO!TM;>U3#7!SF;(\VCFX'6  G 59^0LH'_AYV[3UZ$'[\3ZP)*
M>SKPPJK Q6M*B":1Z!7R0V.ZVV95.MQMZ0?*I#!\8M56O&EEC;^/@\<1%QBI
M,3<#V%$.T$.<>O^+%X%;RYJ4ATV)$N-N9%E#2NP33//P(8)MPTZSG*^)WFFT
ML&4-U 1&?D/5<BG0,.SAQ;(__N%;1)SOBT4!6=6=#6@(QROURIAR0ZY9C%B<
MTYHU=V'VZT4*@S#'/XW_T.;NY"*PB0L-7QCK&>2=368 /,6U<J; Q<XC6XB\
M::P3"1*Y/SS\ OU\G;Q'6@<>W0A:IHW2LINX_A7M$C7I53L>7$Z*=HX%O:Q\
M8]$7M]@)MYA:)5E&#M]Z8<=9IZ.+6+_;[EB4-G;P7GDI#KW*RN#^:3\.V6ZV
MDZ(E\'"$^!;FX";VDQU2%& *VC+M^G169&A3%%6H8-Y;O:Q\B\0Y1>(\K8!)
M-G/PVA%#Q#LF-V@2MHM>)%GN.OE>C8&MPMIRG(T;E=9=3Z_15Q?[H1?=Q%F>
M'G;UVWQDH5+;TV&9+!%<HOI /Y:->*OIH#'?J<U&B\_,\E12HA@JGG7-J\G/
M,NY&MN])/BC<IB/E!%"66'W'*#_EY#23L:]]D@D1-[\5J?ZP]CY.;?CC;&/=
M#\&#A&OT(_H5&N]67&1\:AOW!"@.,)O<PN=&[$.:Q.A''S:.LVEE2'M[%P]7
M72"Y63G85@'JI< ]SLGQTL"Y3\Q4"IH2:D0EX[?ES6KY'N*4GK$/M6I=^Z=8
MN37OV%HMP<]TQ+^<'EM=TK?.J182$WRM3S!]2#0(><R\ )"J@!32U>$!B22H
M7D0]ZCKR^B@3^-C8PHD0QB5!;N( -RHZ>%'T<K/#_NX4$891;3N;Y&LS!L.V
MDFH*J*Q@^T5=L)TI?4Y,DP-EHV6)'$*W\2TJ"H?'$(A99TW%ZL84%JO_%S/Z
MV#@W\CHAC2>IO9MU0O'*+S/FV<T!84# LZ;0D:57P_$=)2-[75Z9@Z!A-D@I
M08T#4X/?_-FV,T2XD RZ*6P+@)0;E1B(\=747K(T__=EF$(?_4E='T&S&KH(
M^E>MAS 6M*59]+?FF;N*08POWR+;^:3'K.8@8Y;-1Y3RLC>'QD?.G&C[^V8!
MP4MVH*^/<JS[KUI$^3K!CX>@Z4OD\)#!WPXPSJ^><,;Q),\,YA[6WQ L*'B=
MV:NQ@ R>Q<-?R*IV<U(>IOJW/SY:[GT8>VF87"?HB/$R#2&1G/V<A:VI@GP8
MN,H@'>3\L2AG2WDO"/ SKUT6>1EZ;)":/Y?)KE>18GB,7W^#"6Q9D>"TZ$/
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M4H5ID&3-09G2Y:2JA U2H>HL\ AM$:R\-'^9.A!-O)?-&#0A)-SBBV0.()-
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MK2CX7V3E](LOP7H;9@"=1KOBQ8!?"H5:7ZU8/OW0V^&%S(8D.>-+<)OD\#L
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MZ"-0C'?)&R8"+#X(,+5,\S*\:5'7XL'QMLO-HBC60T-'6!U\6%PIEP.-]8Y
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M\7NWWZ@&QFSSOB;!;->ZQ 4^4EPN (- ["87&+3TY2()N+%IA2^Y-?>(6ID
M>C05*P"\A'M_LA!#MD-9@2B6/CP,4Z'UOY1WLZ@@7CFV5IRZI?$L\X %?)?H
M? 0M'V^-0 +TQ2Y3POJ F*QDV97MN HT&W\(='YAQF,E7CI18.5(,K5.5=K8
ML^G@(!RXHUEVU)\CCQBD<T"14ECXLN80&2A"IF<OD&-NN:CO(@A2K+K0_[U#
M>LRIY/(HAAZ5/P \":R?$^?U9QFXL*\)+M(6+P<>)"=&Y%_&+N\*+BZJY#]Q
M?6LH1^.QPO".V'%X;J\(80B>.@4F\0.7'<O&= /WU[1WGVE"9NX"KCK:,5W
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M$?+DZ'Y6PDGX,?*)8"'I 9<C+HI37*-#P8O^ ;WT*@XND=QPKV(Z'M ) ,_
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M8:_ITW3Z(%[&.%U8$N]KF1*:UN[_UD*)H[8K#^)6%+Q+BE:R+)1I=\8NGJ%
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M]#)(IYHFW6B2:P,\<-*&KW=R%F"E0@,/D++/W-2C_FVB9[)*@FQ<:9*00CB
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M;6%C<3$N:'1M4$L! A0#%     @ SX.&5I/&HP5S!P  K"8  !X
M     ( !BK " &8Q,&LR,#(R97@S,2TQ7V9R965D;VUA8W$Q+FAT;5!+ 0(4
M Q0    ( ,^#AE9@CM54?P<  !<G   >              "  3FX @!F,3!K
M,C R,F5X,S$M,E]F<F5E9&]M86-Q,2YH=&U02P$"% ,4    " #/@X96J>Z[
MR^$$   T$P  '@              @ 'TOP( 9C$P:S(P,C)E>#,R+3%?9G)E
M961O;6%C<3$N:'1M4$L! A0#%     @ SX.&5H/2[,S(!   K!,  !X
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M &9A8W0M,C R,C$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( ,^#AE:<J3B)13X
M +%,!  5              "  7@F! !F86-T+3(P,C(Q,C,Q7W!R92YX;6Q0
52P4&      L "P , P  \&0$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
